,Term,Adjusted P-value,Genes,drug
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,ITGB5;BASP1;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,Thioguanine
1,Hypoxia,0.0011498441099464,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,Thioguanine
2,IL-2/STAT5 Signaling,0.0193889584509725,PRNP;SPP1;LIF;CKAP4;IGF1R,Thioguanine
3,Estrogen Response Early,0.0193889584509725,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,Thioguanine
4,mTORC1 Signaling,0.0193889584509725,TES;PRDX1;DHCR24;BCAT1;HSP90B1,Thioguanine
5,Allograft Rejection,0.0193889584509725,TGFB2;LIF;HLA-A;TLR6;BCAT1,Thioguanine
6,UV Response Dn,0.0296273639464698,PMP22;NR3C1;MT1E;IGF1R,Thioguanine
0,Epithelial Mesenchymal Transition,1.2580631333143412e-08,GJA1;LGALS1;TNFRSF12A;DST;COL4A2;ITGB5;SERPINE1;FN1;LAMC1;EDIL3;THBS1;LOXL2,Mercaptopurine
1,UV Response Dn,1.138414853582078e-05,TJP1;GJA1;ANXA2;CAV1;MAP1B;SERPINE1;LAMC1;RND3,Mercaptopurine
2,TNF-alpha Signaling via NF-kB,0.00034853163267641214,MARCKS;TUBB2A;CCND1;PLK2;SERPINE1;LIF;IL6ST,Mercaptopurine
3,Estrogen Response Early,0.00034853163267641214,ABLIM1;GJA1;CCND1;MYOF;FLNB;SFN;IL6ST,Mercaptopurine
4,Estrogen Response Late,0.00034853163267641214,CCND1;CAV1;MYOF;CD9;FLNB;SFN;IL6ST,Mercaptopurine
5,p53 Pathway,0.00034853163267641214,APP;PLK2;LIF;SFN;PTPN14;TM4SF1;EPHA2,Mercaptopurine
6,Coagulation,0.00034853163267641214,SERPINE1;CAPN2;FN1;CD9;GNG12;THBS1,Mercaptopurine
7,Apoptosis,0.0058172295253011,APP;CCND1;TNFRSF12A;CAV1;TIMP2,Mercaptopurine
8,TGF-beta Signaling,0.010002379274016,TJP1;SERPINE1;THBS1,Mercaptopurine
10,Apical Junction,0.0108779611049612,TJP1;SGCE;RRAS;ITGA3;EGFR,Mercaptopurine
9,Myogenesis,0.0108779611049612,APP;ABLIM1;COL4A2;ITGB5;CNN3,Mercaptopurine
11,Cholesterol Homeostasis,0.018244325641248,TNFRSF12A;GPX8;CD9,Mercaptopurine
12,IL-6/JAK/STAT3 Signaling,0.0262831025680107,TNFRSF12A;CD9;IL6ST,Mercaptopurine
13,Protein Secretion,0.0318567609591555,DST;CAV2;EGFR,Mercaptopurine
14,Mitotic Spindle,0.0342441892998248,MYO1E;MARCKS;DST;FLNB,Mercaptopurine
15,IL-2/STAT5 Signaling,0.0342441892998248,MYO1E;AHNAK;LIF;CKAP4,Mercaptopurine
16,Hypoxia,0.0342441892998248,ANXA2;CAV1;SERPINE1;EGFR,Mercaptopurine
17,Complement,0.0342441892998248,COL4A2;SERPINE1;FN1;TIMP2,Mercaptopurine
18,Inflammatory Response,0.0342441892998248,AXL;SERPINE1;LIF;SGMS2,Mercaptopurine
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FN1;FAS;VEGFC;TGFBI;EDIL3,Colchicine
1,UV Response Dn,0.0001626453972816861,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Colchicine
2,IL-2/STAT5 Signaling,0.0006734801215400478,PRNP;CSF1;BHLHE40;ITGA6;AHR;WLS;IGF1R,Colchicine
3,Hypoxia,0.0006734801215400478,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Colchicine
4,TNF-alpha Signaling via NF-kB,0.0041576445857644,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Colchicine
5,Myogenesis,0.0123887890362058,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,Colchicine
6,Complement,0.0123887890362058,DOCK10;LYN;CEBPB;FN1;PSMB9,Colchicine
7,mTORC1 Signaling,0.0123887890362058,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Colchicine
8,Inflammatory Response,0.0123887890362058,LYN;CSF1;ITGB3;LPAR1;AHR,Colchicine
9,Xenobiotic Metabolism,0.0123887890362058,TGFB2;PROS1;GCNT2;FAS;BCAT1,Colchicine
10,Allograft Rejection,0.0123887890362058,LYN;TGFB2;CSF1;FAS;BCAT1,Colchicine
11,Apoptosis,0.0298032274050906,TGFB2;FAS;BAX;BCL2L2,Colchicine
12,IL-6/JAK/STAT3 Signaling,0.0299335334802344,CSF1;ITGB3;FAS,Colchicine
13,Interferon Alpha Response,0.0373057438009113,CSF1;PSMB8;PSMB9,Colchicine
14,Estrogen Response Early,0.0494004138232658,DYNLT3;BHLHE40;RHOBTB3;IGF1R,Colchicine
0,Epithelial Mesenchymal Transition,2.407824206812236e-12,SPARC;TNFRSF12A;SDC4;DST;COL12A1;SERPINE1;FN1;THBS1;LOXL2;NT5E;LGALS1;COL4A2;SNAI2;SDC1;CD44,Mechlorethamine hydrochloride
1,Coagulation,4.998378071404898e-07,SPARC;PLAU;SERPINE1;CAPN2;FN1;CD9;PLAT;GNG12;THBS1,Mechlorethamine hydrochloride
2,UV Response Dn,4.998378071404898e-07,TJP1;NRP1;ANXA2;CAV1;MAP1B;SERPINE1;SNAI2;MET;RND3,Mechlorethamine hydrochloride
3,TNF-alpha Signaling via NF-kB,5.377651841632184e-07,FOSL1;MARCKS;TUBB2A;CCND1;SDC4;PLAU;PLK2;SERPINE1;IL6ST;CD44,Mechlorethamine hydrochloride
4,Hypoxia,4.174074255246993e-05,EXT1;ANXA2;SDC4;CAV1;SERPINE1;KDELR3;EGFR;TMEM45A,Mechlorethamine hydrochloride
5,Glycolysis,4.174074255246993e-05,EXT1;TPST1;NT5E;SDC1;KDELR3;MET;EGFR;CD44,Mechlorethamine hydrochloride
6,Apoptosis,7.979893638553336e-05,APP;CCND1;TNFRSF12A;CAV1;TIMP2;PLAT;CD44,Mechlorethamine hydrochloride
7,Estrogen Response Late,0.00027924785527270275,ST14;CCND1;CAV1;CD9;IL6ST;CD44;MAPK13,Mechlorethamine hydrochloride
8,IL-2/STAT5 Signaling,0.0017239014136096,MYO1E;NRP1;NT5E;AHNAK;CKAP4;CD44,Mechlorethamine hydrochloride
9,p53 Pathway,0.0017239014136096,APP;ST14;PLK2;SDC1;PTPN14;EPHA2,Mechlorethamine hydrochloride
10,IL-6/JAK/STAT3 Signaling,0.0029458748773576,TNFRSF12A;CD9;IL6ST;CD44,Mechlorethamine hydrochloride
11,TGF-beta Signaling,0.007085018652428,TJP1;SERPINE1;THBS1,Mechlorethamine hydrochloride
12,Apical Junction,0.0075339952838064,TJP1;SGCE;ITGA3;EGFR;MAPK13,Mechlorethamine hydrochloride
13,Complement,0.0075339952838064,COL4A2;SERPINE1;FN1;TIMP2;PLAT,Mechlorethamine hydrochloride
14,KRAS Signaling Up,0.0075339952838064,NRP1;PLAU;LY96;PLAT;DCBLD2,Mechlorethamine hydrochloride
15,Cholesterol Homeostasis,0.012923063995884,TNFRSF12A;GPX8;CD9,Mechlorethamine hydrochloride
16,Protein Secretion,0.0247774807460098,DST;CAV2;EGFR,Mechlorethamine hydrochloride
17,Hedgehog Signaling,0.0249826904231739,NRP1;NRP2,Mechlorethamine hydrochloride
18,Angiogenesis,0.0249826904231739,APP;NRP1,Mechlorethamine hydrochloride
19,Mitotic Spindle,0.0292615691636069,MYO1E;MARCKS;DST;ARHGAP29,Mechlorethamine hydrochloride
20,Inflammatory Response,0.0292615691636069,AXL;SERPINE1;MET;DCBLD2,Mechlorethamine hydrochloride
21,Apical Surface,0.0315728386950691,APP;DCBLD2,Mechlorethamine hydrochloride
0,Epithelial Mesenchymal Transition,1.2231169351667208e-08,LGALS1;TNFRSF12A;SDC4;DST;COL4A2;ITGB5;SERPINE1;FN1;VIM;LAMC1;FSTL1;LOXL2,Allopurinol
1,TNF-alpha Signaling via NF-kB,1.2680729035681635e-05,FOSL1;MARCKS;TUBB2A;CCND1;SDC4;PLK2;SERPINE1;LIF;IL6ST,Allopurinol
2,UV Response Dn,9.256242121721973e-05,TJP1;ANXA2;CAV1;MAP1B;SERPINE1;LAMC1;RND3,Allopurinol
3,p53 Pathway,0.0005749220549732116,APP;PLK2;LIF;SFN;PTPN14;EPHA2;S100A10,Allopurinol
4,Hypoxia,0.0029576739939381,EXT1;ANXA2;SDC4;CAV1;SERPINE1;EGFR,Allopurinol
5,Estrogen Response Late,0.0029576739939381,CCND1;CAV1;MYOF;CD9;SFN;IL6ST,Allopurinol
6,Coagulation,0.0032383521776355,SERPINE1;CAPN2;FN1;CD9;GNG12,Allopurinol
7,Apoptosis,0.0056556398162649,APP;CCND1;TNFRSF12A;CAV1;TIMP2,Allopurinol
10,Apical Junction,0.0105757955187123,TJP1;SGCE;RRAS;ITGA3;EGFR,Allopurinol
8,Estrogen Response Early,0.0105757955187123,ABLIM1;CCND1;MYOF;SFN;IL6ST,Allopurinol
9,Myogenesis,0.0105757955187123,APP;ABLIM1;COL4A2;ITGB5;CNN3,Allopurinol
11,Cholesterol Homeostasis,0.01773753881788,TNFRSF12A;GPX8;CD9,Allopurinol
12,IL-6/JAK/STAT3 Signaling,0.0255530163855659,TNFRSF12A;CD9;IL6ST,Allopurinol
13,Protein Secretion,0.0309718509325123,DST;CAV2;EGFR,Allopurinol
14,Angiogenesis,0.032575468885119,APP;FSTL1,Allopurinol
16,Complement,0.0351425708092338,COL4A2;SERPINE1;FN1;TIMP2,Allopurinol
15,IL-2/STAT5 Signaling,0.0351425708092338,MYO1E;AHNAK;LIF;CKAP4,Allopurinol
17,Inflammatory Response,0.0351425708092338,AXL;SERPINE1;LIF;SGMS2,Allopurinol
0,Epithelial Mesenchymal Transition,7.400703444767422e-10,SERPINE2;DST;ITGB5;IGFBP3;FN1;VEGFC;GJA1;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Guanazole
1,KRAS Signaling Up,1.1956115947928398e-05,TMEM158;IGFBP3;GFPT2;SPP1;LIF;LY96;PLAT;SOX9;LCP1,Guanazole
2,UV Response Dn,0.0009438322597205188,GJA1;ANXA2;CAV1;MAP1B;PMP22;RND3,Guanazole
3,Hypoxia,0.004182996077141,CDKN1C;SRPX;ANXA2;IGFBP3;CAV1;TGFBI,Guanazole
4,IL-2/STAT5 Signaling,0.0109686107808359,CDKN1C;PRNP;SPP1;LIF;CKAP4,Guanazole
5,TNF-alpha Signaling via NF-kB,0.0109686107808359,MARCKS;GFPT2;LIF;IL6ST;FJX1,Guanazole
6,Estrogen Response Early,0.0109686107808359,GJA1;DYNLT3;TBC1D30;FLNB;IL6ST,Guanazole
7,Estrogen Response Late,0.0109686107808359,CAV1;DYNLT3;FLNB;IL6ST;MAPK13,Guanazole
8,Myogenesis,0.0109686107808359,PRNP;MEF2C;ITGB5;IGFBP3;ADAM12,Guanazole
9,Glycolysis,0.0109686107808359,TPST1;IGFBP3;PKP2;TGFBI;SOX9,Guanazole
10,Mitotic Spindle,0.0497016358587735,MARCKS;DST;FLNB;EZR,Guanazole
11,Allograft Rejection,0.0497016358587735,TGFB2;LIF;HLA-A;TLR6,Guanazole
0,Epithelial Mesenchymal Transition,1.1532245388714796e-08,GLIPR1;CALD1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;PLOD3;SPOCK1;VEGFC;EDIL3,Dactinomycin D
1,UV Response Dn,0.0014157483895807,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3,Dactinomycin D
2,Androgen Response,0.0175775356192238,CDK6;ADAMTS1;SGK1;ELL2,Dactinomycin D
3,Estrogen Response Late,0.0274215269520897,TFAP2C;TFPI2;SGK1;JAK2;PRSS23,Dactinomycin D
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,GLIPR1;ITGB5;ITGB3;DPYSL3;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,Pyrimethamine
1,Hypoxia,0.00013995425444063446,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,Pyrimethamine
2,KRAS Signaling Up,0.0064223778154084,TMEM158;SPP1;LIF;SOX9;GNG11;PSMB8,Pyrimethamine
3,mTORC1 Signaling,0.0252610430104099,DHFR;TES;DHCR24;BCAT1;HSP90B1,Pyrimethamine
4,Allograft Rejection,0.0252610430104099,TGFB2;LIF;HLA-A;TLR6;BCAT1,Pyrimethamine
5,UV Response Dn,0.0375279943321951,ITGB3;PMP22;NR3C1;MT1E,Pyrimethamine
0,Epithelial Mesenchymal Transition,0.00027990850888126893,VCAN;SPARC;LGALS1;SPP1;FN1;TGFBI;EMP3;THBS1,Chlorambucil
1,Interferon Alpha Response,0.0271352527868614,BST2;IFITM1;HLA-C;TXNIP,Chlorambucil
2,Hypoxia,0.0421017383506832,CDKN1C;SRPX;CAV1;GLRX;TGFBI,Chlorambucil
3,Coagulation,0.0484798389604245,SPARC;CAPN2;FN1;THBS1,Chlorambucil
0,Epithelial Mesenchymal Transition,4.208522064644625e-11,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;GJA1;LGALS1;DPYSL3;ADAM12;SPP1;SDC1;TGFBI;EDIL3,Thiotepa
1,Estrogen Response Early,0.0007008573622530579,GJA1;DYNLT3;CLDN7;TBC1D30;FLNB;SFN;IL6ST,Thiotepa
2,Estrogen Response Late,0.0007008573622530579,ST14;CAV1;DYNLT3;FLNB;SFN;IL6ST;MAPK13,Thiotepa
3,IL-2/STAT5 Signaling,0.0027041590801719,CDKN1C;PRNP;AHNAK;SPP1;LIF;CKAP4,Thiotepa
4,Myogenesis,0.0027041590801719,APP;PRNP;MEF2C;SPARC;ITGB5;ADAM12,Thiotepa
5,p53 Pathway,0.0027041590801719,APP;ST14;LIF;SDC1;SFN;TM4SF1,Thiotepa
6,UV Response Dn,0.0035886921515687,GJA1;ANXA2;CAV1;MAP1B;RND3,Thiotepa
7,Hypoxia,0.0118180318177356,CDKN1C;SRPX;ANXA2;CAV1;TGFBI,Thiotepa
8,Apical Junction,0.0118180318177356,SGCE;CLDN4;CLDN7;TGFBI;MAPK13,Thiotepa
9,Coagulation,0.0163300510182482,SPARC;CAPN2;FN1;PLAT,Thiotepa
10,Angiogenesis,0.0406135715970314,APP;SPP1,Thiotepa
11,Mitotic Spindle,0.0413104505839156,MARCKS;DST;FLNB;EZR,Thiotepa
12,Glycolysis,0.0413104505839156,TPST1;PKP2;SDC1;TGFBI,Thiotepa
13,KRAS Signaling Up,0.0413104505839156,SPP1;LIF;LY96;PLAT,Thiotepa
14,Apical Surface,0.043582898904566,SRPX;APP,Thiotepa
0,Epithelial Mesenchymal Transition,0.0202811931012899,SPARC;ITGB3;ADAM12;SPP1;TGFBI;EMP3,Melphalan hydrochloride
0,Epithelial Mesenchymal Transition,2.39122318958568e-05,GJA1;LGALS1;TNFRSF12A;DST;ITGB5;DPYSL3;FN1;SDC1;EDIL3,Triethylenemelamine
1,Estrogen Response Early,0.0005420693661175995,GJA1;DYNLT3;CLDN7;TBC1D30;FLNB;SFN;IL6ST,Triethylenemelamine
2,Estrogen Response Late,0.0005420693661175995,ST14;CAV1;DYNLT3;FLNB;SFN;IL6ST;MAPK13,Triethylenemelamine
3,p53 Pathway,0.0005420693661175995,APP;ST14;LIF;SDC1;SFN;PTPN14;EPHA2,Triethylenemelamine
4,Apical Junction,0.0033463968617128,SGCE;CLDN4;ITGA3;CLDN7;GNAI1;MAPK13,Triethylenemelamine
5,UV Response Dn,0.0043176452448561,GJA1;ANXA2;CAV1;MAP1B;RND3,Triethylenemelamine
6,IL-2/STAT5 Signaling,0.0109686107808359,CDKN1C;PRNP;AHNAK;LIF;CKAP4,Triethylenemelamine
7,TNF-alpha Signaling via NF-kB,0.0109686107808359,MARCKS;TUBB2A;GFPT2;LIF;IL6ST,Triethylenemelamine
8,Hypoxia,0.0109686107808359,CDKN1C;SRPX;ANXA2;CAV1;TMEM45A,Triethylenemelamine
9,Myogenesis,0.0109686107808359,APP;PRNP;MEF2C;KLF5;ITGB5,Triethylenemelamine
10,Coagulation,0.0153094228296077,CAPN2;FN1;PLAT;GNG12,Triethylenemelamine
11,Cholesterol Homeostasis,0.016723965171144,TNFRSF12A;GPX8;GNAI1,Triethylenemelamine
12,Apoptosis,0.0221427355580035,APP;TNFRSF12A;CAV1;PLAT,Triethylenemelamine
13,KRAS Signaling Up,0.042601402164663,GFPT2;LIF;LY96;PLAT,Triethylenemelamine
14,Apical Surface,0.0449448644953337,SRPX;APP,Triethylenemelamine
0,IL-2/STAT5 Signaling,0.0465335002823341,PLAGL1;SPP1;PLIN2;AHR;IGF1R,Drostanolone propionate
1,Complement,0.0465335002823341,DOCK10;CEBPB;ERAP2;FDX1;PSMB9,Drostanolone propionate
2,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Drostanolone propionate
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,GLIPR1;DST;ITGB5;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EMP3;EDIL3,Fluorouracil
1,Estrogen Response Late,0.0012155494876576,CAV1;DYNLT3;MYOF;FLNB;SFN;IL6ST;PRSS23,Fluorouracil
2,Estrogen Response Early,0.0062533678728977,DYNLT3;MYOF;FLNB;SFN;IL6ST;PRSS23,Fluorouracil
3,UV Response Dn,0.0072614942754399,ANXA2;CAV1;MAP1B;PMP22;RND3,Fluorouracil
4,Coagulation,0.0377632429796991,CAPN2;FN1;GNG12;PRSS23,Fluorouracil
0,Apical Junction,0.0010841387322351,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Nandrolone phenpropionate
1,p53 Pathway,0.0010841387322351,VAMP8;APP;PLK2;SFN;PTPN14;S100A10;IER3,Nandrolone phenpropionate
2,Epithelial Mesenchymal Transition,0.0042709901190239,TNFRSF12A;SDC4;DST;COL12A1;PFN2;CAP2,Nandrolone phenpropionate
3,Cholesterol Homeostasis,0.0042709901190239,ALCAM;TNFRSF12A;MAL2;CD9,Nandrolone phenpropionate
4,Angiogenesis,0.0043176452448561,APP;NRP1;PTK2,Nandrolone phenpropionate
5,UV Response Dn,0.0043176452448561,TJP1;NRP1;ID1;MET;CAP2,Nandrolone phenpropionate
6,Apoptosis,0.0056697912331883,APP;GPX1;TNFRSF12A;PTK2;IER3,Nandrolone phenpropionate
7,Protein Secretion,0.0056697912331883,SCRN1;DST;CAV2;EGFR,Nandrolone phenpropionate
8,Glycolysis,0.0121873453120398,MIF;MET;EGFR;IER3;IL13RA1,Nandrolone phenpropionate
9,IL-6/JAK/STAT3 Signaling,0.0313206972268794,TNFRSF12A;CD9;IL13RA1,Nandrolone phenpropionate
10,TNF-alpha Signaling via NF-kB,0.0497016358587735,TUBB2A;SDC4;PLK2;IER3,Nandrolone phenpropionate
11,Hypoxia,0.0497016358587735,SDC4;MIF;EGFR;IER3,Nandrolone phenpropionate
0,Hypoxia,0.0003167385758393306,SRPX;TES;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Testolactone
1,Epithelial Mesenchymal Transition,0.0014126656207913,ITGB5;ITGB3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Testolactone
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Testolactone
3,Interferon Alpha Response,0.0153528403925663,LGALS3BP;TXNIP;PSMB8;PSMB9,Testolactone
4,TNF-alpha Signaling via NF-kB,0.0285848644591481,CEBPB;IRS2;SGK1;FJX1;LITAF,Testolactone
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,TNFRSF12A;SDC4;CALD1;COL4A1;COL12A1;SERPINE1;SNAI2;LAMC1;FSTL1;LOXL2;CAP2,Mitramycin
1,UV Response Dn,8.93689474895658e-06,TJP1;NRP1;ANXA2;SERPINE1;SNAI2;PRKCA;LAMC1;CAP2,Mitramycin
2,Hypoxia,8.93689474895658e-06,EXT1;ANXA2;SDC4;SERPINE1;PRKCA;MIF;KDELR3;ETS1;EGFR,Mitramycin
3,Angiogenesis,0.0002834880851943317,APP;NRP1;FSTL1;PTK2,Mitramycin
4,Apical Junction,0.0004862197950630589,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,Mitramycin
5,Cholesterol Homeostasis,0.0031924572606845,TNFRSF12A;MAL2;CD9;CLU,Mitramycin
6,IL-6/JAK/STAT3 Signaling,0.0050376935927922,TNFRSF12A;PDGFC;CD9;IL6ST,Mitramycin
7,Apoptosis,0.0059788192343372,APP;TNFRSF12A;TIMP2;CLU;PTK2,Mitramycin
11,p53 Pathway,0.0102484494669426,VAMP8;APP;PLK2;PTPN14;EPHA2,Mitramycin
10,Glycolysis,0.0102484494669426,EXT1;TPST1;MIF;KDELR3;EGFR,Mitramycin
8,TNF-alpha Signaling via NF-kB,0.0102484494669426,SDC4;PLAU;PLK2;SERPINE1;IL6ST,Mitramycin
9,Xenobiotic Metabolism,0.0102484494669426,TPST1;ELOVL5;SERPINE1;MAN1A1;EPHA2,Mitramycin
12,Coagulation,0.0145243242229611,PLAU;SERPINE1;CD9;CLU,Mitramycin
16,KRAS Signaling Up,0.0393360540486549,NRP1;PLAU;PLEK2;ETS1,Mitramycin
13,Estrogen Response Early,0.0393360540486549,ABLIM1;ELOVL5;ENDOD1;IL6ST,Mitramycin
14,Estrogen Response Late,0.0393360540486549,ELOVL5;CD9;LSR;IL6ST,Mitramycin
15,Complement,0.0393360540486549,GCA;SERPINE1;TIMP2;CLU,Mitramycin
17,Apical Surface,0.0419939390486703,APP;ATP8B1,Mitramycin
0,Epithelial Mesenchymal Transition,7.176439704016895e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;GJA1;LGALS1;SPP1;SDC1;TGFBI;EDIL3,Pipobroman
1,Estrogen Response Late,0.0010512860433795,ST14;CAV1;MYOF;FLNB;SFN;IL6ST;MAPK13,Pipobroman
2,Estrogen Response Early,0.0032449908962063,GJA1;MYOF;TBC1D30;FLNB;SFN;IL6ST,Pipobroman
3,Apical Junction,0.0032449908962063,SGCE;CLDN4;ITGA3;MSN;TGFBI;MAPK13,Pipobroman
4,p53 Pathway,0.0032449908962063,APP;ST14;LIF;SDC1;SFN;TM4SF1,Pipobroman
5,Coagulation,0.0034542423228112,SPARC;CAPN2;FN1;PLAT;THBS1,Pipobroman
6,UV Response Dn,0.0035886921515687,GJA1;ANXA2;CAV1;MAP1B;RND3,Pipobroman
7,IL-2/STAT5 Signaling,0.010636228635962,CDKN1C;AHNAK;SPP1;LIF;CKAP4,Pipobroman
8,Hypoxia,0.010636228635962,CDKN1C;SRPX;ANXA2;CAV1;TGFBI,Pipobroman
9,KRAS Signaling Up,0.010636228635962,SPP1;LIF;LY96;PLAT;LCP1,Pipobroman
10,Angiogenesis,0.0406135715970314,APP;SPP1,Pipobroman
11,TNF-alpha Signaling via NF-kB,0.0413104505839156,MARCKS;TUBB2A;LIF;IL6ST,Pipobroman
12,Myogenesis,0.0413104505839156,APP;MEF2C;SPARC;ITGB5,Pipobroman
13,Allograft Rejection,0.0413104505839156,LIF;CSK;HLA-A;TLR6,Pipobroman
14,Apical Surface,0.043582898904566,SRPX;APP,Pipobroman
0,Hypoxia,0.0197741632737576,CDKN1C;SRPX;DTNA;IRS2;AMPD3;MT1E,Cyclophosphamide
1,Interferon Alpha Response,0.0278493383865157,BST2;TXNIP;PSMB8;PSMB9,Cyclophosphamide
0,Apical Junction,1.159380940405178e-05,TJP1;SGCE;CLDN4;JUP;ITGA3;CLDN7;EGFR;GNAI1;MAPK13,Hydroxyurea
1,Epithelial Mesenchymal Transition,1.159380940405178e-05,GJA1;LGALS1;TNFRSF12A;DST;ITGB5;DPYSL3;FN1;SDC1;EDIL3,Hydroxyurea
2,Estrogen Response Early,0.0004205144173518348,GJA1;DYNLT3;CLDN7;TBC1D30;FLNB;SFN;IL6ST,Hydroxyurea
3,Estrogen Response Late,0.0004205144173518348,ST14;CAV1;DYNLT3;FLNB;SFN;IL6ST;MAPK13,Hydroxyurea
4,p53 Pathway,0.0004205144173518348,APP;ST14;LIF;SDC1;SFN;PTPN14;EPHA2,Hydroxyurea
5,UV Response Dn,0.0004576156410766151,TJP1;GJA1;ANXA2;CAV1;MAP1B;RND3,Hydroxyurea
6,KRAS Signaling Up,0.0151946123370886,JUP;GFPT2;LIF;LY96;PLAT,Hydroxyurea
7,Coagulation,0.0204125637728103,CAPN2;FN1;PLAT;GNG12,Hydroxyurea
8,Cholesterol Homeostasis,0.0216229044637013,TNFRSF12A;GPX8;GNAI1,Hydroxyurea
9,Apoptosis,0.0279132666428166,APP;TNFRSF12A;CAV1;PLAT,Hydroxyurea
10,Protein Secretion,0.0360399719941961,DST;CAV2;EGFR,Hydroxyurea
11,IL-2/STAT5 Signaling,0.0361466442609262,PRNP;AHNAK;LIF;CKAP4,Hydroxyurea
12,TNF-alpha Signaling via NF-kB,0.0361466442609262,MARCKS;GFPT2;LIF;IL6ST,Hydroxyurea
13,Hypoxia,0.0361466442609262,SRPX;ANXA2;CAV1;EGFR,Hydroxyurea
14,Myogenesis,0.0361466442609262,APP;PRNP;KLF5;ITGB5,Hydroxyurea
15,Glycolysis,0.0361466442609262,TPST1;PKP2;SDC1;EGFR,Hydroxyurea
16,Apical Surface,0.0384554990334406,SRPX;APP,Hydroxyurea
0,Epithelial Mesenchymal Transition,1.5835560326732093e-07,ITGB5;IGFBP3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,Curcumin
1,KRAS Signaling Up,0.00011785621426579744,TMEM158;IGFBP3;HKDC1;SPP1;LIF;SOX9;GNG11;PSMB8,Curcumin
2,Hypoxia,0.0007008573622530579,SRPX;TES;DTNA;IGFBP3;TGFBI;AMPD3;MT1E,Curcumin
3,Myogenesis,0.0265905715899052,PRNP;DTNA;ITGB5;IGFBP3;ADAM12,Curcumin
0,Estrogen Response Early,0.0141968351709029,ABLIM1;KRT18;MYOF;KRT8;FLNB;SFN,"Benzamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-"
1,Protein Secretion,0.01924292782173,TPD52;KRT18;SCRN1;DST,"Benzamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-"
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"Benzamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-"
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,"Benzamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-"
0,Epithelial Mesenchymal Transition,1.9794450408415118e-07,ITGB5;IGFBP3;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,Uracil mustard
1,Hypoxia,0.0001473202678322468,SRPX;TES;DTNA;IGFBP3;GCNT2;TGFBI;AMPD3;MT1E,Uracil mustard
2,Myogenesis,0.0008760717028163224,FDPS;WWTR1;PRNP;DTNA;ITGB5;IGFBP3;ADAM12,Uracil mustard
3,KRAS Signaling Up,0.0050702982753224,TMEM158;IGFBP3;SPP1;SOX9;GNG11;PSMB8,Uracil mustard
4,UV Response Dn,0.0474037823143518,ITGB3;PMP22;LPAR1;MT1E,Uracil mustard
0,Apical Junction,0.0147038649984352,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,Dexamethasone
1,Estrogen Response Early,0.0481954110067032,ABLIM1;KRT18;MYOF;KRT8;SFN,Dexamethasone
0,Hypoxia,0.0013798129319357,SRPX;TES;PLIN2;TGFBI;AMPD3;NR3C1;MT1E,Chelerythrine chloride
1,Epithelial Mesenchymal Transition,0.0013798129319357,ITGB5;ITGB3;ADAM12;SPP1;TGFBI;EMP3;EDIL3,Chelerythrine chloride
2,Interferon Alpha Response,0.0017713508023572,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Chelerythrine chloride
3,mTORC1 Signaling,0.0053238131890886,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Chelerythrine chloride
4,IL-2/STAT5 Signaling,0.023266750141167,IFITM3;SPP1;PLIN2;AHR;IGF1R,Chelerythrine chloride
5,Interferon Gamma Response,0.023266750141167,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Chelerythrine chloride
6,UV Response Dn,0.0355528367357638,ITGB3;NR3C1;MT1E;IGF1R,Chelerythrine chloride
7,Apoptosis,0.0457952030858709,IFITM3;TGFB2;BAX;TXNIP,Chelerythrine chloride
0,UV Response Dn,1.340534212343487e-05,TJP1;NRP1;GJA1;ANXA2;CAV1;MAP1B;ID1;MET,Mitotane
1,Epithelial Mesenchymal Transition,1.340534212343487e-05,GJA1;VCAN;SDC4;DST;COL4A1;COL12A1;ITGAV;THBS1;PFN2,Mitotane
2,Angiogenesis,0.0003779841135924423,APP;NRP1;VCAN;ITGAV,Mitotane
3,Estrogen Response Early,0.0006077747438288237,AR;ABLIM1;GJA1;MYOF;KRT8;FLNB;SFN,Mitotane
4,IL-2/STAT5 Signaling,0.0027363919377296,NRP1;ALCAM;AHNAK;LIF;ITGAV;CKAP4,Mitotane
5,Estrogen Response Late,0.0027363919377296,CAV1;MYOF;CD9;FLNB;SFN;LSR,Mitotane
6,Cholesterol Homeostasis,0.0027363919377296,ALCAM;GPX8;MAL2;CD9,Mitotane
7,TGF-beta Signaling,0.011565251035581,TJP1;ID1;THBS1,Mitotane
8,Mitotic Spindle,0.0122981393603311,MARCKS;DST;ARHGAP29;FLNB;EZR,Mitotane
9,TNF-alpha Signaling via NF-kB,0.0122981393603311,MARCKS;TUBB2A;SDC4;PLK2;LIF,Mitotane
0,Apical Junction,0.0009438322597205188,TJP1;SGCE;RRAS;ITGA3;CTNNA1;EGFR;PTK2,DTIC-Dome
1,p53 Pathway,0.0009438322597205188,APP;PLK2;LIF;SFN;PTPN14;EPHA2;S100A10,DTIC-Dome
2,UV Response Dn,0.0009438322597205188,TJP1;ANXA2;CAV1;MAP1B;ID1;MET,DTIC-Dome
3,Apoptosis,0.0013062457739896,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2,DTIC-Dome
4,Epithelial Mesenchymal Transition,0.0028473267460159,TNFRSF12A;SDC4;DST;VIM;FSTL1;PFN2,DTIC-Dome
5,Cholesterol Homeostasis,0.0028473267460159,TNFRSF12A;GPX8;CD9;S100A11,DTIC-Dome
6,Angiogenesis,0.0036214060155425,APP;FSTL1;PTK2,DTIC-Dome
7,Protein Secretion,0.0056697912331883,SCRN1;DST;CAV2;EGFR,DTIC-Dome
8,Estrogen Response Late,0.0109686107808359,CAV1;MYOF;CD9;SFN;LSR,DTIC-Dome
9,Inflammatory Response,0.0109686107808359,AXL;LIF;SGMS2;OSMR;MET,DTIC-Dome
10,IL-6/JAK/STAT3 Signaling,0.0284733611153449,TNFRSF12A;CD9;OSMR,DTIC-Dome
11,TNF-alpha Signaling via NF-kB,0.0458784331004063,MARCKS;SDC4;PLK2;LIF,DTIC-Dome
12,Hypoxia,0.0458784331004063,ANXA2;SDC4;CAV1;EGFR,DTIC-Dome
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,GJA1;TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;PLOD2;ITGAV;LOXL2;CAP2,Vinblastine sulfate
1,UV Response Dn,8.15911714596976e-07,TJP1;NRP1;GJA1;DDAH1;ANXA2;SERPINE1;SNAI2;PRKCA;CAP2,Vinblastine sulfate
2,Hypoxia,9.08474984965522e-05,ANXA2;SDC4;SERPINE1;PRKCA;MIF;KDELR3;ETS1;EGFR,Vinblastine sulfate
3,Angiogenesis,0.0002834880851943317,APP;NRP1;ITGAV;PTK2,Vinblastine sulfate
4,Apical Junction,0.0031924572606845,TJP1;RRAS;ITGA3;EGFR;ACTB;PTK2,Vinblastine sulfate
5,Cholesterol Homeostasis,0.0031924572606845,ALCAM;TNFRSF12A;MAL2;CD9,Vinblastine sulfate
6,TGF-beta Signaling,0.0111801266912101,TJP1;SERPINE1;ID3,Vinblastine sulfate
7,TNF-alpha Signaling via NF-kB,0.0111801266912101,TUBB2A;SDC4;PLAU;PLK2;SERPINE1,Vinblastine sulfate
8,Xenobiotic Metabolism,0.0111801266912101,TPST1;ELOVL5;SERPINE1;MAN1A1;EPHA2,Vinblastine sulfate
9,Glycolysis,0.0111801266912101,TPST1;PLOD2;MIF;KDELR3;EGFR,Vinblastine sulfate
10,p53 Pathway,0.0111801266912101,VAMP8;APP;PLK2;PTPN14;EPHA2,Vinblastine sulfate
11,IL-6/JAK/STAT3 Signaling,0.0292642878129934,TNFRSF12A;PDGFC;CD9,Vinblastine sulfate
12,Hedgehog Signaling,0.0397349125961341,NRP1;NRP2,Vinblastine sulfate
13,Estrogen Response Early,0.0445808612551423,ABLIM1;GJA1;ELOVL5;ENDOD1,Vinblastine sulfate
14,KRAS Signaling Up,0.0445808612551423,NRP1;PLAU;PLEK2;ETS1,Vinblastine sulfate
15,Apical Surface,0.0472431814297541,APP;ATP8B1,Vinblastine sulfate
0,Epithelial Mesenchymal Transition,4.471554693684914e-11,TNFRSF12A;SDC4;DST;SERPINE1;COL12A1;FN1;LAMC1;FSTL1;LOXL2;NT5E;LGALS1;COL4A2;VIM;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
1,TNF-alpha Signaling via NF-kB,1.0755303683264367e-06,FOSL1;MARCKS;TUBB2A;CCND1;SDC4;PLAU;PLK2;SERPINE1;IL6ST;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
2,UV Response Dn,6.159211245902508e-06,TJP1;ANXA2;CAV1;MAP1B;SERPINE1;LAMC1;MET;RND3,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
3,Hypoxia,6.159211245902508e-06,EXT1;ERRFI1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;EGFR;TMEM45A,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
4,Coagulation,0.00046083626987214487,PLAU;SERPINE1;CAPN2;FN1;CD9;GNG12,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
5,Apoptosis,0.0008972193195080209,APP;CCND1;TNFRSF12A;CAV1;TIMP2;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
6,Glycolysis,0.0022002070310123,EXT1;TPST1;NT5E;MET;EGFR;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
7,Cholesterol Homeostasis,0.0022002070310123,ERRFI1;TNFRSF12A;GPX8;CD9,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
8,IL-6/JAK/STAT3 Signaling,0.0036005137389926,TNFRSF12A;CD9;IL6ST;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
12,Inflammatory Response,0.0086930714813151,AXL;SERPINE1;SGMS2;MET;DCBLD2,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
11,Apical Junction,0.0086930714813151,TJP1;SGCE;RRAS;ITGA3;EGFR,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
9,IL-2/STAT5 Signaling,0.0086930714813151,MYO1E;NT5E;AHNAK;CKAP4;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
10,Estrogen Response Late,0.0086930714813151,CCND1;CAV1;CD9;IL6ST;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
13,Protein Secretion,0.0292615691636069,DST;CAV2;EGFR,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
14,Angiogenesis,0.0292615691636069,APP;FSTL1,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
15,Mitotic Spindle,0.0292615691636069,MYO1E;MARCKS;DST;ARHGAP29,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
16,Estrogen Response Early,0.0292615691636069,ABLIM1;CCND1;IL6ST;CD44,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
17,Myogenesis,0.0292615691636069,APP;ABLIM1;COL4A2;CNN3,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
18,Complement,0.0292615691636069,COL4A2;SERPINE1;FN1;TIMP2,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
19,Xenobiotic Metabolism,0.0292615691636069,TPST1;MT2A;SERPINE1;EPHA2,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
20,p53 Pathway,0.0292615691636069,APP;PLK2;PTPN14;EPHA2,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
21,Apical Surface,0.0315728386950691,APP;DCBLD2,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
22,TGF-beta Signaling,0.0442381927647518,TJP1;SERPINE1,"2,3-Dihydro-1H-imidazo[1,2-b]pyrazole"
0,Apical Junction,8.462849939860089e-05,TJP1;SGCE;RRAS;ITGA3;CTNNA1;FLNC;EGFR;PTK2,Oxyphenisatin acetate
1,Epithelial Mesenchymal Transition,8.462849939860089e-05,TNFRSF12A;SDC4;DST;VIM;LAMC1;FSTL1;FERMT2;PFN2,Oxyphenisatin acetate
2,UV Response Dn,8.462849939860089e-05,TJP1;ANXA2;CAV1;MAP1B;ID1;LAMC1;RND3,Oxyphenisatin acetate
3,p53 Pathway,0.0033132529408185,APP;PLK2;SFN;PTPN14;EPHA2;S100A10,Oxyphenisatin acetate
4,Cholesterol Homeostasis,0.0033132529408185,TNFRSF12A;GPX8;CD9;S100A11,Oxyphenisatin acetate
5,Angiogenesis,0.0040969441791996,APP;FSTL1;PTK2,Oxyphenisatin acetate
6,IL-6/JAK/STAT3 Signaling,0.0043569241883608,TNFRSF12A;CD9;OSMR;IL6ST,Oxyphenisatin acetate
7,Apoptosis,0.0048870927801219,APP;TNFRSF12A;CAV1;TIMP2;PTK2,Oxyphenisatin acetate
8,Protein Secretion,0.0048870927801219,SCRN1;DST;CAV2;EGFR,Oxyphenisatin acetate
9,Hypoxia,0.0088635238633017,EXT1;ANXA2;SDC4;CAV1;EGFR,Oxyphenisatin acetate
10,Estrogen Response Early,0.0088635238633017,ABLIM1;MYOF;KRT8;SFN;IL6ST,Oxyphenisatin acetate
11,Estrogen Response Late,0.0088635238633017,CAV1;MYOF;CD9;SFN;IL6ST,Oxyphenisatin acetate
12,TNF-alpha Signaling via NF-kB,0.0444881775519091,MARCKS;SDC4;PLK2;IL6ST,Oxyphenisatin acetate
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;CD44,Cylocide
1,Glycolysis,0.00013995425444063446,EXT1;NT5E;VCAN;CDK1;MIF;MET;EGFR;CD44,Cylocide
2,Cholesterol Homeostasis,0.0004386195720962052,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Cylocide
3,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;TNC;CD44,Cylocide
4,Hypoxia,0.003853426689245,EXT1;SDC4;CAV1;MIF;ETS1;EGFR,Cylocide
5,Angiogenesis,0.0042615719299879,APP;NRP1;VCAN,Cylocide
6,UV Response Dn,0.0042615719299879,NRP1;CAV1;ATP2B4;SNAI2;MET,Cylocide
7,Estrogen Response Late,0.0126305215052049,ELOVL5;CAV1;ATP2B4;CD9;CD44,Cylocide
8,Apical Junction,0.0126305215052049,VCAN;CDH3;ITGA3;EGFR;ACTB,Cylocide
9,KRAS Signaling Up,0.0126305215052049,NRP1;PLAU;GABRA3;ETS1;TRIB2,Cylocide
10,Apoptosis,0.0300552145106419,APP;TNFRSF12A;CAV1;CD44,Cylocide
11,IL-6/JAK/STAT3 Signaling,0.0300552145106419,TNFRSF12A;CD9;CD44,Cylocide
12,Hedgehog Signaling,0.0408088291527864,NRP1;NRP2,Cylocide
13,IL-2/STAT5 Signaling,0.0457857493971732,NRP1;NT5E;ALCAM;CD44,Cylocide
14,mTORC1 Signaling,0.0457857493971732,ELOVL5;PLK1;CD9;HMGCR,Cylocide
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44;LOXL2,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
1,Hypoxia,1.3043035579558251e-05,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
2,Glycolysis,8.839216069934808e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
3,Cholesterol Homeostasis,0.00031165074859467216,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
4,UV Response Dn,0.0006177811154534304,NRP1;CAV1;ATP2B4;SNAI2;PRKCA;MET,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
5,Estrogen Response Late,0.0030421789651934,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
6,Angiogenesis,0.0039506247442282,APP;NRP1;VCAN,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
10,KRAS Signaling Up,0.0108779611049612,NRP1;GALNT3;PLAU;SPRY2;ETS1,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
9,TNF-alpha Signaling via NF-kB,0.0108779611049612,FOSL1;SDC4;PLAU;PLK2;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
8,IL-2/STAT5 Signaling,0.0108779611049612,MYO1E;NRP1;NT5E;ALCAM;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
7,Mitotic Spindle,0.0108779611049612,FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
11,Apoptosis,0.0261686874776405,APP;TNFRSF12A;CAV1;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
12,IL-6/JAK/STAT3 Signaling,0.0262831025680107,TNFRSF12A;CD9;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
13,Protein Secretion,0.0318567609591555,CAV2;PAM;EGFR,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
14,Hedgehog Signaling,0.0335061965675509,NRP1;NRP2,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
15,Estrogen Response Early,0.0361466442609262,FARP1;ELOVL5;ENDOD1;CD44,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
16,Apical Junction,0.0361466442609262,VCAN;ITGA3;EGFR;ACTB,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
17,mTORC1 Signaling,0.0361466442609262,ELOVL5;PLK1;CD9;HMGCR,"9H-Purine, 6-amino-9-(3-deoxy-beta-D-ribofuranosyl)-"
0,Estrogen Response Early,0.00017678432139869616,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,Vincristine sulfate
1,Estrogen Response Late,0.0060843579303869,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,Vincristine sulfate
2,UV Response Dn,0.0062802112652453,TJP1;ANXA2;NFIB;MAP1B;ID1,Vincristine sulfate
0,Cholesterol Homeostasis,0.0009855806656683629,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,alpha-Thiodeoxyguanosine
1,Apical Junction,0.0009855806656683629,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,alpha-Thiodeoxyguanosine
2,Epithelial Mesenchymal Transition,0.0038027237064918,TNFRSF12A;SDC4;DST;FSTL1;PFN2;CAP2,alpha-Thiodeoxyguanosine
3,p53 Pathway,0.0038027237064918,VAMP8;APP;PLK2;SFN;PTPN14;S100A10,alpha-Thiodeoxyguanosine
4,Angiogenesis,0.0039251320407783,APP;FSTL1;PTK2,alpha-Thiodeoxyguanosine
5,UV Response Dn,0.0039251320407783,TJP1;ANXA2;ID1;MET;CAP2,alpha-Thiodeoxyguanosine
6,Protein Secretion,0.0058906921903255,SCRN1;DST;CAV2;EGFR,alpha-Thiodeoxyguanosine
7,Apoptosis,0.0316370679059388,APP;GPX1;TNFRSF12A;PTK2,alpha-Thiodeoxyguanosine
8,IL-6/JAK/STAT3 Signaling,0.0316370679059388,TNFRSF12A;CD9;OSMR,alpha-Thiodeoxyguanosine
0,Cholesterol Homeostasis,0.0010184333545239,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Megestrol acetate
1,Apical Junction,0.0010184333545239,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Megestrol acetate
2,Protein Secretion,0.0012449270265448,KRT18;SCRN1;DST;CAV2;EGFR,Megestrol acetate
3,Apoptosis,0.0100185619602408,APP;GPX1;KRT18;TNFRSF12A;PTK2,Megestrol acetate
4,p53 Pathway,0.0206076929821765,VAMP8;APP;SFN;PTPN14;S100A10,Megestrol acetate
5,UV Response Dn,0.0306149427446855,TJP1;ANXA2;ID1;MET,Megestrol acetate
0,Epithelial Mesenchymal Transition,0.0025625097307377,SPARC;ITGB5;ITGB3;SPP1;FN1;TGFBI;EMP3,Ellipticine
1,Interferon Alpha Response,0.0278493383865157,BST2;HLA-C;TXNIP;PSMB8,Ellipticine
2,Hypoxia,0.0324072591251969,SRPX;DTNA;TGFBI;NR3C1;MT1E,Ellipticine
3,mTORC1 Signaling,0.0324072591251969,PLK1;DHCR24;HMGCR;BCAT1;HSP90B1,Ellipticine
4,Coagulation,0.0385155731304108,SPARC;ITGB3;CAPN2;FN1,Ellipticine
5,UV Response Dn,0.0385155731304108,ITGB3;NR3C1;MT1E;IGF1R,Ellipticine
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,ITGB5;BASP1;ITGB3;ADAM12;SPP1;FN1;TGFBI;EMP3;EDIL3,Fluorodopan
1,Hypoxia,0.0008979734953867304,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,Fluorodopan
2,mTORC1 Signaling,0.0008979734953867304,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Fluorodopan
3,Interferon Alpha Response,0.0146387547929121,IFITM3;LGALS3BP;TXNIP;PSMB8,Fluorodopan
4,Mitotic Spindle,0.0266778918075583,PLK1;CDK1;FLNB;EZR;AURKA,Fluorodopan
5,UV Response Dn,0.0404907307268421,ITGB3;NR3C1;MT1E;IGF1R,Fluorodopan
0,Epithelial Mesenchymal Transition,2.620279283883904e-12,TNFRSF12A;SDC4;DST;SERPINE1;FN1;LAMC1;THBS1;FSTL1;LOXL2;NT5E;LGALS1;COL4A2;VIM;CD44;PFN2,Procarbazine hydrochloride
1,TNF-alpha Signaling via NF-kB,9.154933313891993e-08,FOSL1;MARCKS;TUBB2A;CCND1;SDC4;PLK2;SERPINE1;LIF;IL6ST;PHLDA1;CD44,Procarbazine hydrochloride
2,UV Response Dn,5.439411430646507e-07,TJP1;ANXA2;CAV1;MAP1B;SERPINE1;AKT3;LAMC1;MET;RND3,Procarbazine hydrochloride
3,IL-2/STAT5 Signaling,0.00027861016315799606,MYO1E;NT5E;AHNAK;LIF;PHLDA1;CKAP4;CD44,Procarbazine hydrochloride
4,Hypoxia,0.00027861016315799606,EXT1;ANXA2;SDC4;CAV1;SERPINE1;PAM;EGFR,Procarbazine hydrochloride
5,Estrogen Response Late,0.00027861016315799606,CCND1;CAV1;MYOF;CD9;SFN;IL6ST;CD44,Procarbazine hydrochloride
6,Glycolysis,0.00027861016315799606,EXT1;NT5E;PAM;MET;EGFR;CD44;IL13RA1,Procarbazine hydrochloride
7,p53 Pathway,0.00027861016315799606,APP;PLK2;LIF;SFN;PTPN14;EPHA2;S100A10,Procarbazine hydrochloride
8,Coagulation,0.00027861016315799606,SERPINE1;CAPN2;FN1;CD9;GNG12;THBS1,Procarbazine hydrochloride
9,IL-6/JAK/STAT3 Signaling,0.0002791960320700874,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,Procarbazine hydrochloride
10,Protein Secretion,0.0004052401757961237,SCRN1;DST;CAV2;PAM;EGFR,Procarbazine hydrochloride
11,Apoptosis,0.0004881928650264232,APP;CCND1;TNFRSF12A;CAV1;TIMP2;CD44,Procarbazine hydrochloride
12,Estrogen Response Early,0.0012769829042738,ABLIM1;CCND1;MYOF;SFN;IL6ST;CD44,Procarbazine hydrochloride
13,Apical Junction,0.0012769829042738,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR,Procarbazine hydrochloride
14,Cholesterol Homeostasis,0.0012769829042738,TNFRSF12A;GPX8;CD9;S100A11,Procarbazine hydrochloride
15,TGF-beta Signaling,0.0057826255177905,TJP1;SERPINE1;THBS1,Procarbazine hydrochloride
16,Inflammatory Response,0.0072341996237242,AXL;SERPINE1;LIF;SGMS2;MET,Procarbazine hydrochloride
17,Angiogenesis,0.0286974368749857,APP;FSTL1,Procarbazine hydrochloride
18,Mitotic Spindle,0.0318434723251016,MYO1E;MARCKS;DST;ARHGAP29,Procarbazine hydrochloride
19,Myogenesis,0.0318434723251016,APP;ABLIM1;COL4A2;CNN3,Procarbazine hydrochloride
20,Complement,0.0318434723251016,COL4A2;SERPINE1;FN1;TIMP2,Procarbazine hydrochloride
0,Epithelial Mesenchymal Transition,1.2231169351667208e-08,VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;VIM;THBS1;CD44,Lomustine
1,Glycolysis,0.00012890523435321594,VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1;IER3,Lomustine
2,Angiogenesis,0.0003575525398847427,APP;NRP1;VCAN;ITGAV,Lomustine
3,Protein Secretion,0.0010541720789291,SCRN1;DST;CAV2;PAM;EGFR,Lomustine
4,Apoptosis,0.0011083297476275,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,Lomustine
5,TNF-alpha Signaling via NF-kB,0.0022649190025126,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Lomustine
6,Hypoxia,0.0022649190025126,SDC4;CAV1;MIF;PAM;EGFR;IER3,Lomustine
7,Cholesterol Homeostasis,0.0022649190025126,ALCAM;TNFRSF12A;MAL2;CD9,Lomustine
8,IL-6/JAK/STAT3 Signaling,0.0037064112019041,TNFRSF12A;CD9;CD44;IL13RA1,Lomustine
9,IL-2/STAT5 Signaling,0.0105757955187123,NRP1;ALCAM;AHNAK;ITGAV;CD44,Lomustine
10,Apical Junction,0.0105757955187123,TJP1;VCAN;ITGA3;CTNNA1;EGFR,Lomustine
11,Coagulation,0.0148841610843408,SPARC;PLAU;CD9;THBS1,Lomustine
12,UV Response Dn,0.015953195971176,TJP1;NRP1;CAV1;MET,Lomustine
13,Pperoxisome,0.0383633082350816,SEMA3C;ELOVL5;PRDX1,Lomustine
14,Estrogen Response Late,0.0421710849710805,ELOVL5;CAV1;CD9;CD44,Lomustine
0,UV Response Dn,0.0321860827343824,SDC2;DLC1;ITGB3;PMP22;VLDLR,Daunoblastin
0,Epithelial Mesenchymal Transition,1.2580631333143412e-08,GJA1;SPARC;LGALS1;DST;COL4A2;ITGB5;SPP1;FN1;TGFBI;EMP3;EDIL3;THBS1,Tritylcysteine
1,Coagulation,0.0012198607143674,SPARC;CAPN2;FN1;PLAT;GNG12;THBS1,Tritylcysteine
2,Estrogen Response Late,0.0060843579303869,CAV1;DYNLT3;MYOF;FLNB;IL6ST;MAPK13,Tritylcysteine
3,IL-2/STAT5 Signaling,0.0170939388792247,CDKN1C;AHNAK;SPP1;LIF;CKAP4,Tritylcysteine
4,Estrogen Response Early,0.0170939388792247,GJA1;DYNLT3;MYOF;FLNB;IL6ST,Tritylcysteine
5,Myogenesis,0.0170939388792247,APP;MEF2C;SPARC;COL4A2;ITGB5,Tritylcysteine
6,KRAS Signaling Up,0.0170939388792247,SPP1;LIF;PLAT;ETV1;LCP1,Tritylcysteine
7,UV Response Dn,0.0266646275518229,GJA1;CAV1;MAP1B;RND3,Tritylcysteine
0,Apical Junction,0.0002430784419232072,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,Zanosar
1,Apoptosis,0.0002710816809567383,APP;GPX1;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,Zanosar
2,Angiogenesis,0.0003371209661770431,APP;FSTL1;PTK2;FGFR1,Zanosar
3,UV Response Dn,0.0064764678672842,TJP1;ANXA2;CAV1;ID1;LAMC1,Zanosar
4,Protein Secretion,0.0090716659731012,KRT18;SCRN1;CAV2;EGFR,Zanosar
5,Hypoxia,0.0137107634760448,EXT1;ANXA2;SDC4;CAV1;EGFR,Zanosar
6,Epithelial Mesenchymal Transition,0.0137107634760448,TNFRSF12A;SDC4;VIM;LAMC1;FSTL1,Zanosar
7,p53 Pathway,0.0137107634760448,VAMP8;APP;PTPN14;EPHA2;S100A10,Zanosar
8,Cholesterol Homeostasis,0.022298620228192,TNFRSF12A;GPX8;CD9,Zanosar
9,IL-6/JAK/STAT3 Signaling,0.0313206972268794,TNFRSF12A;CD9;OSMR,Zanosar
0,Angiogenesis,0.0009500681774080306,APP;FSTL1;PTK2;FGFR1,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
1,Apical Junction,0.0078589623267498,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
2,TGF-beta Signaling,0.0257596162277206,TJP1;SMURF2;ID1,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
3,p53 Pathway,0.0257596162277206,VAMP8;APP;SFN;EPHA2;S100A10,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
4,UV Response Dn,0.0367379312936226,TJP1;ANXA2;MAP1B;ID1,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
5,Apoptosis,0.0450682951003809,APP;GPX1;KRT18;PTK2,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid
0,Hypoxia,1.1704301067081812e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Calusterone
1,Glycolysis,1.1704301067081812e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Calusterone
2,Epithelial Mesenchymal Transition,8.93689474895658e-06,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,Calusterone
3,UV Response Dn,7.33887768222242e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;PRKCA;MET,Calusterone
4,Apoptosis,0.0011716628760634,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,Calusterone
5,TNF-alpha Signaling via NF-kB,0.0027363919377296,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Calusterone
6,Cholesterol Homeostasis,0.0027363919377296,ALCAM;TNFRSF12A;MAL2;CD9,Calusterone
7,Angiogenesis,0.0035528187803997,APP;NRP1;VCAN,Calusterone
8,IL-6/JAK/STAT3 Signaling,0.0039182061277272,TNFRSF12A;CD9;CD44;IL13RA1,Calusterone
9,IL-2/STAT5 Signaling,0.0094601072002547,MYO1E;NRP1;NT5E;ALCAM;CD44,Calusterone
10,Estrogen Response Late,0.0094601072002547,ELOVL5;CAV1;ATP2B4;CD9;CD44,Calusterone
11,Apical Junction,0.0094601072002547,VCAN;ITGA3;AKT3;EGFR;ACTB,Calusterone
12,KRAS Signaling Up,0.0094601072002547,NRP1;GALNT3;PLAU;SPRY2;ETS1,Calusterone
13,Protein Secretion,0.0327416709857987,CAV2;PAM;EGFR,Calusterone
14,Hedgehog Signaling,0.0344369242499829,NRP1;NRP2,Calusterone
15,Estrogen Response Early,0.0417945574266959,AR;ELOVL5;ENDOD1;CD44,Calusterone
0,UV Response Dn,0.0038611319715839,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Estramustine
1,Hypoxia,0.0076054474129837,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Estramustine
2,Epithelial Mesenchymal Transition,0.0076054474129837,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,Estramustine
3,IL-2/STAT5 Signaling,0.0213674235990309,PRNP;SPP1;PLIN2;AHR;IGF1R,Estramustine
4,TNF-alpha Signaling via NF-kB,0.0213674235990309,CEBPB;IRS2;SGK1;FJX1;LITAF,Estramustine
5,Complement,0.0213674235990309,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Estramustine
6,mTORC1 Signaling,0.0213674235990309,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Estramustine
7,Cholesterol Homeostasis,0.03420811057734,FDPS;FABP5;HMGCR,Estramustine
0,Epithelial Mesenchymal Transition,1.5835560326732093e-07,MMP14;LOX;CALD1;COL4A1;COL12A1;SERPINE1;TNC;SNAI2;ENO2;PDLIM4;LOXL2,Vinleurosine sulfate
1,Hypoxia,8.462849939860089e-05,LOX;SDC2;SERPINE1;VLDLR;KDELR3;ENO2;ETS1;TMEM45A,Vinleurosine sulfate
2,UV Response Dn,8.462849939860089e-05,SDC2;SERPINE1;ATP2B4;FHL2;SNAI2;VLDLR;PLPP3,Vinleurosine sulfate
3,TNF-alpha Signaling via NF-kB,0.0032449908962063,NFKBIA;PLAU;SERPINE1;TNC;IL6ST;PLPP3,Vinleurosine sulfate
4,Estrogen Response Early,0.0032449908962063,ELOVL5;ENDOD1;FHL2;IL6ST;JAK2;MYBL1,Vinleurosine sulfate
5,Hedgehog Signaling,0.0040969441791996,NRP2;CDK6;VLDLR,Vinleurosine sulfate
6,Androgen Response,0.0073049498677293,CDK6;ELOVL5;HMGCR;ELL2,Vinleurosine sulfate
7,Glycolysis,0.0118180318177356,TPST1;SDC2;VLDLR;KDELR3;ENO2,Vinleurosine sulfate
8,KRAS Signaling Up,0.0118180318177356,PLAU;GABRA3;SPRY2;ETS1;TRIB2,Vinleurosine sulfate
9,UV Response Up,0.0261658224041843,NFKBIA;MMP14;IL6ST;ENO2,Vinleurosine sulfate
10,Estrogen Response Late,0.0481955256812349,ELOVL5;ATP2B4;IL6ST;JAK2,Vinleurosine sulfate
11,Xenobiotic Metabolism,0.0481955256812349,TPST1;ELOVL5;SERPINE1;MAN1A1,Vinleurosine sulfate
0,UV Response Dn,0.00025388549819580267,TJP1;ANXA2;CAV1;MAP1B;ID1;MET;CAP2,Camptothecin
1,p53 Pathway,0.0010512860433795,APP;PLK2;LIF;SFN;PTPN14;TM4SF1;S100A10,Camptothecin
2,Protein Secretion,0.001285085962885,TPD52;SCRN1;DST;CAV2;EGFR,Camptothecin
3,Apical Junction,0.0033132529408185,TJP1;RRAS;ITGA3;FSCN1;CTNNA1;EGFR,Camptothecin
4,Cholesterol Homeostasis,0.0033132529408185,ALCAM;TNFRSF12A;GPX8;CD9,Camptothecin
5,TNF-alpha Signaling via NF-kB,0.0118180318177356,MARCKS;TUBB2A;SDC4;PLK2;LIF,Camptothecin
6,Hypoxia,0.0118180318177356,TPD52;ANXA2;SDC4;CAV1;EGFR,Camptothecin
7,Estrogen Response Late,0.0118180318177356,CAV1;MYOF;CD9;SFN;LSR,Camptothecin
8,Epithelial Mesenchymal Transition,0.0118180318177356,TNFRSF12A;SDC4;DST;PFN2;CAP2,Camptothecin
9,Apoptosis,0.0279132666428166,APP;GPX1;TNFRSF12A;CAV1,Camptothecin
10,Mitotic Spindle,0.0474088841674565,MARCKS;DST;FSCN1;ARHGAP29,Camptothecin
11,IL-2/STAT5 Signaling,0.0474088841674565,ALCAM;AHNAK;LIF;CKAP4,Camptothecin
0,Epithelial Mesenchymal Transition,8.522022148520062e-10,SPARC;DST;FN1;EMP3;THBS1;LGALS1;CDH2;COL4A2;BASP1;SPP1;TGFBI;VIM;PFN2,"Camptothecin, acetate"
1,IL-2/STAT5 Signaling,0.001209606263859,IFITM3;ALCAM;AHNAK;CTSZ;SPP1;LIF;CKAP4,"Camptothecin, acetate"
2,Apoptosis,0.0020055490671355,IFITM3;APP;BTG3;GPX1;CAV1;TXNIP,"Camptothecin, acetate"
3,p53 Pathway,0.0048167833615563,APP;LDHB;LIF;TXNIP;TM4SF1;S100A10,"Camptothecin, acetate"
4,Glycolysis,0.0210508691753416,TGFBI;PYGL;PAM;MET;IL13RA1,"Camptothecin, acetate"
5,KRAS Signaling Up,0.0210508691753416,SPP1;LIF;ETV1;LCP1;TFPI,"Camptothecin, acetate"
6,UV Response Dn,0.0321668522847387,CAV1;MAP1B;TFPI;MET,"Camptothecin, acetate"
0,mTORC1 Signaling,0.0013798129319357,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Semustine
1,Epithelial Mesenchymal Transition,0.0013798129319357,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,Semustine
2,Interferon Alpha Response,0.0017713508023572,LGALS3BP;HLA-C;TXNIP;PSMB8;PSMB9,Semustine
3,Hypoxia,0.0053238131890886,SRPX;TES;DTNA;TGFBI;AMPD3;MT1E,Semustine
4,UV Response Dn,0.0497739714300694,ITGB3;PMP22;MT1E;IGF1R,Semustine
0,Cholesterol Homeostasis,0.0008580293270186533,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
1,Apical Junction,0.0008580293270186533,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
2,UV Response Dn,0.0008580293270186533,TJP1;ANXA2;CAV1;ID1;MET;CAP2,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
3,Epithelial Mesenchymal Transition,0.0038027237064918,TNFRSF12A;SDC4;DST;VIM;PFN2;CAP2,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
4,Apoptosis,0.0068724742220464,APP;GPX1;TNFRSF12A;CAV1;PTK2,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
5,Protein Secretion,0.0068724742220464,SCRN1;DST;CAV2;EGFR,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
6,Hypoxia,0.012464330432768,ANXA2;SDC4;CAV1;MIF;EGFR,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
7,p53 Pathway,0.012464330432768,VAMP8;APP;PLK2;PTPN14;S100A10,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
8,Angiogenesis,0.0465363841215985,APP;PTK2,"1-(2-Chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea"
0,Epithelial Mesenchymal Transition,2.536145807136327e-05,GLIPR1;ITGB5;BDNF;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
1,IL-2/STAT5 Signaling,0.000766562739964282,PRNP;CSF1;BHLHE40;LIF;AHR;CKAP4;WLS,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
2,Hypoxia,0.000766562739964282,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
3,Estrogen Response Early,0.0044365109909071,RAB31;DYNLT3;BHLHE40;RHOBTB3;FLNB;PRSS23,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
4,UV Response Dn,0.0054951848570896,EFEMP1;BDNF;BHLHE40;PMP22;MT1E,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
5,TNF-alpha Signaling via NF-kB,0.0129259723006483,CSF1;BHLHE40;LIF;FJX1;LITAF,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
6,mTORC1 Signaling,0.0129259723006483,TES;BHLHE40;BCAT1;TUBA4A;HSP90B1,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
7,Allograft Rejection,0.0129259723006483,TGFB2;CSF1;LIF;HLA-A;BCAT1,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
8,KRAS Signaling Up,0.0129259723006483,TMEM158;LIF;SOX9;GNG11;PSMB8,"Hydrazinecarbothioamide, 2-[(3-hydroxy-2-pyridinyl)methylene]-"
0,Epithelial Mesenchymal Transition,0.0025625097307377,VCAN;SPARC;LGALS1;SPP1;TGFBI;EMP3;THBS1,Camptothecine sodium
0,Epithelial Mesenchymal Transition,8.297758407769535e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;GJA1;LGALS1;ADAM12;SPP1;TGFBI;EDIL3,Improsulfan hydrochloride
1,KRAS Signaling Up,0.007987935371501,SPP1;LIF;LY96;PLAT;ETV1;LCP1,Improsulfan hydrochloride
2,Coagulation,0.007987935371501,SPARC;CAPN2;FN1;PLAT;THBS1,Improsulfan hydrochloride
3,Estrogen Response Late,0.0204968989338852,ST14;CAV1;FLNB;IL6ST;MAPK13,Improsulfan hydrochloride
4,Myogenesis,0.0204968989338852,APP;MEF2C;SPARC;ITGB5;ADAM12,Improsulfan hydrochloride
5,p53 Pathway,0.0204968989338852,APP;ST14;LIF;BAX;TM4SF1,Improsulfan hydrochloride
6,Apoptosis,0.0461067350796524,APP;CAV1;BAX;PLAT,Improsulfan hydrochloride
0,Hypoxia,0.0202811931012899,CDKN1C;SRPX;DTNA;IRS2;AMPD3;MT1E,"1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-"
0,Epithelial Mesenchymal Transition,4.471554693684914e-11,SERPINE2;DST;ITGB5;IGFBP3;FN1;VEGFC;EMP3;GJA1;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Dibromdulcitol
1,Estrogen Response Late,0.0009724332372878072,ST14;CAV1;DYNLT3;FLNB;SFN;IL6ST;MAPK13,Dibromdulcitol
2,UV Response Dn,0.0009724332372878072,GJA1;ANXA2;CAV1;MAP1B;PMP22;RND3,Dibromdulcitol
3,IL-2/STAT5 Signaling,0.002154876767012,CDKN1C;PRNP;AHNAK;SPP1;LIF;CKAP4,Dibromdulcitol
4,Hypoxia,0.002154876767012,CDKN1C;SRPX;ANXA2;IGFBP3;CAV1;TGFBI,Dibromdulcitol
5,Estrogen Response Early,0.002154876767012,GJA1;DYNLT3;TBC1D30;FLNB;SFN;IL6ST,Dibromdulcitol
6,Myogenesis,0.002154876767012,APP;PRNP;MEF2C;ITGB5;IGFBP3;ADAM12,Dibromdulcitol
7,KRAS Signaling Up,0.002154876767012,IGFBP3;GFPT2;SPP1;LIF;LY96;PLAT,Dibromdulcitol
9,p53 Pathway,0.0113009929257097,APP;ST14;LIF;SFN;TM4SF1,Dibromdulcitol
8,Apical Junction,0.0113009929257097,SGCE;CLDN4;TGFBI;GNAI1;MAPK13,Dibromdulcitol
10,Coagulation,0.0157733447335352,CAPN2;FN1;PLAT;GNG12,Dibromdulcitol
11,Apoptosis,0.0247148715066605,APP;TGFB2;CAV1;PLAT,Dibromdulcitol
12,Angiogenesis,0.0365131629261773,APP;SPP1,Dibromdulcitol
13,Mitotic Spindle,0.038405809527234,MARCKS;DST;FLNB;EZR,Dibromdulcitol
14,TNF-alpha Signaling via NF-kB,0.038405809527234,MARCKS;GFPT2;LIF;IL6ST,Dibromdulcitol
15,Allograft Rejection,0.038405809527234,TGFB2;LIF;HLA-A;TLR6,Dibromdulcitol
16,Apical Surface,0.0408589677230306,SRPX;APP,Dibromdulcitol
0,Apical Junction,0.0077654365800435,TJP1;RRAS;ITGA3;FSCN1;CTNNA1;RHOF,5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
1,Cholesterol Homeostasis,0.0077654365800435,ALCAM;GPX8;MAL2;CD9,5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2,Protein Secretion,0.0137449484440928,TPD52;KRT18;SCRN1;DST,5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
3,UV Response Dn,0.0444410459197048,TJP1;ANXA2;ID1;MET,5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
0,Epithelial Mesenchymal Transition,1.5026865203476855e-08,SPARC;LGALS1;CDH2;DST;COL4A2;BASP1;SPP1;FN1;TGFBI;VIM;EMP3;THBS1,Deoxycamptothecin
1,p53 Pathway,0.0014126656207913,APP;LDHB;LIF;BAX;TXNIP;TM4SF1;S100A10,Deoxycamptothecin
2,Apoptosis,0.0022694371022849,APP;BTG3;GPX1;CAV1;BAX;TXNIP,Deoxycamptothecin
3,Interferon Alpha Response,0.0153528403925663,BST2;HLA-C;TXNIP;B2M,Deoxycamptothecin
4,Glycolysis,0.0285848644591481,CDK1;TGFBI;PYGL;MET;IL13RA1,Deoxycamptothecin
5,Coagulation,0.0363993328485201,SPARC;CAPN2;FN1;THBS1,Deoxycamptothecin
6,UV Response Dn,0.0363993328485201,CAV1;MET;RND3;MGLL,Deoxycamptothecin
16,Allograft Rejection,0.0431751584227729,LIF;HLA-A;TLR6;B2M,Deoxycamptothecin
15,Inflammatory Response,0.0431751584227729,BST2;LIF;EMP3;MET,Deoxycamptothecin
14,mTORC1 Signaling,0.0431751584227729,PRDX1;PLK1;DHCR24;HMGCR,Deoxycamptothecin
13,Interferon Gamma Response,0.0431751584227729,BST2;TXNIP;HLA-A;B2M,Deoxycamptothecin
12,Myogenesis,0.0431751584227729,APP;MEF2C;SPARC;COL4A2,Deoxycamptothecin
9,Angiogenesis,0.0431751584227729,APP;SPP1,Deoxycamptothecin
10,Mitotic Spindle,0.0431751584227729,CCDC88A;DST;PLK1;CDK1,Deoxycamptothecin
17,KRAS Signaling Up,0.0431751584227729,SPP1;LIF;ETV1;LCP1,Deoxycamptothecin
8,Androgen Response,0.0431751584227729,DHCR24;HMGCR;B2M,Deoxycamptothecin
7,Fatty Acid Metabolism,0.0431751584227729,LGALS1;DHCR24;MGLL;S100A10,Deoxycamptothecin
11,IL-2/STAT5 Signaling,0.0431751584227729,CTSZ;SPP1;LIF;CKAP4,Deoxycamptothecin
18,Apical Surface,0.0462351476865873,SRPX;APP,Deoxycamptothecin
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,VCAN;SPARC;LGALS1;CDH2;DST;SPP1;FN1;TGFBI;EMP3;THBS1,10-Hydroxycamptothecin
1,Glycolysis,0.010394111464411,VCAN;CITED2;CDK1;GLRX;TGFBI;IL13RA1,10-Hydroxycamptothecin
2,Angiogenesis,0.0104984194591991,APP;VCAN;SPP1,10-Hydroxycamptothecin
3,Apoptosis,0.0132503561409636,APP;BTG3;CAV1;BAX;TXNIP,10-Hydroxycamptothecin
4,Hypoxia,0.017034584924783,SRPX;CITED2;CAV1;GLRX;TGFBI,10-Hydroxycamptothecin
5,mTORC1 Signaling,0.017034584924783,PRDX1;PLK1;GLRX;DHCR24;HMGCR,10-Hydroxycamptothecin
6,p53 Pathway,0.017034584924783,APP;LDHB;BAX;TXNIP;TM4SF1,10-Hydroxycamptothecin
7,KRAS Signaling Up,0.017034584924783,SPP1;GLRX;ETV1;LCP1;TFPI,10-Hydroxycamptothecin
8,UV Response Dn,0.0269938204845614,CITED2;CAV1;TFPI;MGLL,10-Hydroxycamptothecin
0,Epithelial Mesenchymal Transition,1.2580631333143412e-08,GJA1;VCAN;LGALS1;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;VIM;THBS1;CD44,5-Hydroxypicolinaldehyde thiosemicarbazone
1,UV Response Dn,0.00014281059273513902,TJP1;NRP1;GJA1;ANXA2;CAV1;ID1;MET,5-Hydroxypicolinaldehyde thiosemicarbazone
2,Angiogenesis,0.0003677683267385925,APP;NRP1;VCAN;ITGAV,5-Hydroxypicolinaldehyde thiosemicarbazone
3,Glycolysis,0.0005913483994010176,VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1,5-Hydroxypicolinaldehyde thiosemicarbazone
4,Protein Secretion,0.0008674330249473783,SCRN1;DST;CAV2;PAM;EGFR,5-Hydroxypicolinaldehyde thiosemicarbazone
5,Hypoxia,0.002329630974013,ANXA2;SDC4;CAV1;MIF;PAM;EGFR,5-Hydroxypicolinaldehyde thiosemicarbazone
6,Apical Junction,0.002329630974013,TJP1;VCAN;RRAS;ITGA3;CTNNA1;EGFR,5-Hydroxypicolinaldehyde thiosemicarbazone
7,Cholesterol Homeostasis,0.002329630974013,ALCAM;TNFRSF12A;MAL2;CD9,5-Hydroxypicolinaldehyde thiosemicarbazone
8,IL-6/JAK/STAT3 Signaling,0.0038123086648157,TNFRSF12A;CD9;CD44;IL13RA1,5-Hydroxypicolinaldehyde thiosemicarbazone
9,Fatty Acid Metabolism,0.0042307123820371,LGALS1;ELOVL5;PCBD1;MIF;S100A10,5-Hydroxypicolinaldehyde thiosemicarbazone
10,Apoptosis,0.0042307123820371,APP;GPX1;TNFRSF12A;CAV1;CD44,5-Hydroxypicolinaldehyde thiosemicarbazone
11,TGF-beta Signaling,0.007501784455512,TJP1;ID1;THBS1,5-Hydroxypicolinaldehyde thiosemicarbazone
12,IL-2/STAT5 Signaling,0.0079771714769715,NRP1;ALCAM;AHNAK;ITGAV;CD44,5-Hydroxypicolinaldehyde thiosemicarbazone
13,TNF-alpha Signaling via NF-kB,0.0079771714769715,TUBB2A;SDC4;PLAU;PLK2;CD44,5-Hydroxypicolinaldehyde thiosemicarbazone
14,Estrogen Response Late,0.0079771714769715,ELOVL5;CAV1;CD9;LSR;CD44,5-Hydroxypicolinaldehyde thiosemicarbazone
15,Pperoxisome,0.0345269774115735,SEMA3C;ELOVL5;PRDX1,5-Hydroxypicolinaldehyde thiosemicarbazone
16,p53 Pathway,0.0382729174527454,APP;PLK2;PTPN14;S100A10,5-Hydroxypicolinaldehyde thiosemicarbazone
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,NOTCH2;NT5E;LGALS1;TNFRSF12A;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,Ifosfamide
1,Apoptosis,0.0003285838557051374,CCND1;TNFRSF12A;CAV1;TIMP2;BAX;PTK2;CD44,Ifosfamide
2,TNF-alpha Signaling via NF-kB,0.0005256430216897934,FOSL1;MARCKS;CCND1;PLK2;SERPINE1;IL6ST;CD44,Ifosfamide
3,Hypoxia,0.0005256430216897934,EXT1;MT2A;CAV1;SERPINE1;NEDD4L;ETS1;EGFR,Ifosfamide
4,Apical Junction,0.0005256430216897934,SGCE;ITGA3;AKT3;RAC2;EGFR;ACTB;PTK2,Ifosfamide
5,UV Response Dn,0.0005720195513457688,NOTCH2;CAV1;SERPINE1;AKT3;LAMC1;RND3,Ifosfamide
6,Androgen Response,0.0008347063576474292,CDK6;CCND1;ELOVL5;HMGCR;B2M,Ifosfamide
7,Estrogen Response Late,0.0025351491376612,FARP1;CCND1;ELOVL5;CAV1;IL6ST;CD44,Ifosfamide
8,IL-6/JAK/STAT3 Signaling,0.0042358985164619,TNFRSF12A;OSMR;IL6ST;CD44,Ifosfamide
13,p53 Pathway,0.0094966327106804,VAMP8;PLK2;BAX;STOM;PTPN14,Ifosfamide
12,Complement,0.0094966327106804,GCA;ERAP2;SERPINE1;GNB4;TIMP2,Ifosfamide
9,Mitotic Spindle,0.0094966327106804,NOTCH2;FARP1;MYO1E;MARCKS;PLK1,Ifosfamide
10,G2-M Checkpoint,0.0094966327106804,NOTCH2;MARCKS;MT2A;CCND1;PLK1,Ifosfamide
11,Estrogen Response Early,0.0094966327106804,FARP1;CCND1;ELOVL5;IL6ST;CD44,Ifosfamide
14,Notch Signaling,0.0296920589925996,NOTCH2;CCND1,Ifosfamide
15,Hedgehog Signaling,0.0328492123211284,NRP2;CDK6,Ifosfamide
16,Angiogenesis,0.0328492123211284,FSTL1;PTK2,Ifosfamide
17,Xenobiotic Metabolism,0.0380490992220275,CBR1;MT2A;ELOVL5;SERPINE1,Ifosfamide
18,Glycolysis,0.0380490992220275,EXT1;NT5E;EGFR;CD44,Ifosfamide
0,Epithelial Mesenchymal Transition,8.073494667019005e-10,DST;ITGB5;FN1;VEGFC;EMP3;GJA1;GLIPR1;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Carbendazim
1,UV Response Dn,0.0015444527886335,GJA1;ANXA2;CAV1;MAP1B;PMP22;RND3,Carbendazim
2,Estrogen Response Early,0.0045632684477902,GJA1;DYNLT3;MYOF;FLNB;SFN;IL6ST,Carbendazim
3,Estrogen Response Late,0.0045632684477902,CAV1;DYNLT3;MYOF;FLNB;SFN;IL6ST,Carbendazim
4,IL-2/STAT5 Signaling,0.0234244903676122,PRNP;AHNAK;SPP1;LIF;CKAP4,Carbendazim
0,Epithelial Mesenchymal Transition,2.657192674688844e-06,NT5E;VCAN;SPARC;LGALS1;COL4A1;COL12A1;SPP1;SNAI2;THBS1;CD44,10-Methoxycamptothecin
1,Glycolysis,1.521687484281796e-05,NT5E;VCAN;CITED2;CDK1;MIF;PAM;MET;CD44;IL13RA1,10-Methoxycamptothecin
2,Angiogenesis,0.0082427772856345,NRP1;VCAN;SPP1,10-Methoxycamptothecin
3,UV Response Dn,0.0082427772856345,NRP1;CITED2;ATP2B4;SNAI2;MET,10-Methoxycamptothecin
4,IL-2/STAT5 Signaling,0.023266750141167,NRP1;NT5E;ALCAM;SPP1;CD44,10-Methoxycamptothecin
5,KRAS Signaling Up,0.023266750141167,NRP1;GABRA3;SPP1;ETV1;LCP1,10-Methoxycamptothecin
0,Apoptosis,0.0005750217474839904,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44;IER3,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
1,Glycolysis,0.0011498441099464,MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
2,Protein Secretion,0.0014055627719054,SCRN1;DST;CAV2;PAM;EGFR,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
7,p53 Pathway,0.0020132613355668,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
6,Epithelial Mesenchymal Transition,0.0020132613355668,TNFRSF12A;SDC4;DST;COL12A1;VIM;CD44,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
8,Cholesterol Homeostasis,0.0020132613355668,ALCAM;TNFRSF12A;MAL2;CD9,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
4,Hypoxia,0.0020132613355668,SDC4;CAV1;MIF;PAM;EGFR;IER3,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
3,TNF-alpha Signaling via NF-kB,0.0020132613355668,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
5,Apical Junction,0.0020132613355668,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
9,Angiogenesis,0.0024978112986771,APP;NRP1;PTK2,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
10,UV Response Dn,0.0024978112986771,TJP1;NRP1;CAV1;ID1;MET,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
11,IL-6/JAK/STAT3 Signaling,0.0027798084014281,TNFRSF12A;CD9;CD44;IL13RA1,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
12,Estrogen Response Late,0.008948750054295,ELOVL5;CAV1;CD9;LSR;CD44,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
13,Fatty Acid Metabolism,0.0204420487532689,ELOVL5;PCBD1;MIF;S100A10,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
14,Pperoxisome,0.0358057543527429,SEMA3C;ELOVL5;PRDX1,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
15,IL-2/STAT5 Signaling,0.0388901002936167,NRP1;ALCAM;AHNAK;CD44,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
16,Apical Surface,0.0420607020678256,APP;ATP8B1,"2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol"
0,Epithelial Mesenchymal Transition,2.657192674688844e-06,ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;TGFBI;EDIL3,Inosine dialdehyde
1,Hypoxia,0.00015468628122385913,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,Inosine dialdehyde
2,UV Response Dn,0.0012012410578261,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Inosine dialdehyde
3,TNF-alpha Signaling via NF-kB,0.0199429286924289,CEBPB;IRS2;SGK1;FJX1;LITAF,Inosine dialdehyde
4,Myogenesis,0.0199429286924289,FDPS;PRNP;DTNA;ITGB5;ADAM12,Inosine dialdehyde
5,Complement,0.0199429286924289,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Inosine dialdehyde
6,mTORC1 Signaling,0.0199429286924289,TES;HMGCR;BCAT1;AURKA;HSP90B1,Inosine dialdehyde
0,Apoptosis,0.0006078801330545041,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Tretinoin
1,Hypoxia,0.0008103663251050982,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;EGFR,Tretinoin
2,Epithelial Mesenchymal Transition,0.0008103663251050982,NT5E;TNFRSF12A;SDC4;COL12A1;VIM;CD44;LOXL2,Tretinoin
3,Apical Junction,0.0245962787206623,TJP1;ITGA3;EGFR;ACTB;PTK2,Tretinoin
4,Glycolysis,0.0245962787206623,EXT1;NT5E;MIF;EGFR;CD44,Tretinoin
5,Cholesterol Homeostasis,0.037502224929232,TNFRSF12A;CD9;HMGCR,Tretinoin
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,NT5E;VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,Veham-Sandoz
1,KRAS Signaling Up,0.00012890523435321594,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,Veham-Sandoz
2,Hedgehog Signaling,0.0003575525398847427,NRP1;NRP2;CDK6;VLDLR,Veham-Sandoz
3,Glycolysis,0.0044365109909071,NT5E;VCAN;CDK1;MIF;VLDLR;CD44,Veham-Sandoz
4,Angiogenesis,0.0053772392351995,NRP1;VCAN;ITGAV,Veham-Sandoz
5,Androgen Response,0.0093214204041338,CDK6;ELOVL5;ITGAV;HMGCR,Veham-Sandoz
6,UV Response Dn,0.02660630822682,NRP1;ATP2B4;SNAI2;VLDLR,Veham-Sandoz
7,Cholesterol Homeostasis,0.02660630822682,TNFRSF12A;MAL2;HMGCR,Veham-Sandoz
0,UV Response Dn,0.0314010563262267,SDC2;DLC1;ITGB3;PMP22;LPAR1,Adriblastin
0,Epithelial Mesenchymal Transition,4.208522064644625e-11,BDNF;SERPINE1;TNC;VEGFC;DKK1;LOXL2;GLIPR1;MMP14;LOX;CALD1;COL4A1;SPOCK1;SNAI2;MYL9,Blenoxane (TN) (Bristol Meyers)
1,UV Response Dn,0.0013728469232298,DDAH1;BDNF;SERPINE1;LPAR1;SNAI2;PLPP3,Blenoxane (TN) (Bristol Meyers)
2,TNF-alpha Signaling via NF-kB,0.0023178506401474,NFKBIA;GCH1;SERPINE1;TNC;IL6ST;PLPP3,Blenoxane (TN) (Bristol Meyers)
3,Hypoxia,0.0023178506401474,LOX;SERPINE1;ADM;KDELR3;ETS1;TMEM45A,Blenoxane (TN) (Bristol Meyers)
4,Estrogen Response Early,0.0023178506401474,ABLIM1;ENDOD1;NAV2;IL6ST;MYBL1;PRSS23,Blenoxane (TN) (Bristol Meyers)
5,Inflammatory Response,0.0023178506401474,NFKBIA;MMP14;GCH1;SERPINE1;LPAR1;ADM,Blenoxane (TN) (Bristol Meyers)
6,Xenobiotic Metabolism,0.0023178506401474,TPST1;GCH1;SERPINE1;MAN1A1;PTGR1;EPHA2,Blenoxane (TN) (Bristol Meyers)
7,Coagulation,0.0204125637728103,MMP14;SERPINE1;CLU;PRSS23,Blenoxane (TN) (Bristol Meyers)
8,UV Response Up,0.0290731360046492,NFKBIA;MMP14;GCH1;IL6ST,Blenoxane (TN) (Bristol Meyers)
9,Hedgehog Signaling,0.0446749287567346,NRP2;CDK6,Blenoxane (TN) (Bristol Meyers)
10,Myogenesis,0.0481955256812349,PRNP;ABLIM1;NAV2;CLU,Blenoxane (TN) (Bristol Meyers)
11,Apical Junction,0.0481955256812349,RRAS;LAYN;PARVA;MYL9,Blenoxane (TN) (Bristol Meyers)
0,Epithelial Mesenchymal Transition,0.00015074451455375783,VCAN;COL4A1;ITGB3;COL12A1;TNC;SNAI2;ITGAV;PDLIM4,Paclitaxel
1,UV Response Dn,0.00015074451455375783,SDC2;DLC1;ITGB3;ATP2B4;SNAI2;VLDLR;PLPP3,Paclitaxel
2,Hedgehog Signaling,0.0097302424255992,NRP2;CDK6;VLDLR,Paclitaxel
3,Glycolysis,0.0315763037630124,TPST1;VCAN;SDC2;CDK1;VLDLR,Paclitaxel
0,Epithelial Mesenchymal Transition,0.0088730219818143,VCAN;SPARC;COL4A1;WIPF1;SPP1;FBLN1,Dichloroallyl lawsone
1,KRAS Signaling Up,0.0088730219818143,ALDH1A3;CFH;GABRA3;SPP1;LY96;LCP1,Dichloroallyl lawsone
2,Hypoxia,0.0290834376764588,ISG20;CDKN1C;SRPX;HOXB9;RRAGD,Dichloroallyl lawsone
3,Interferon Gamma Response,0.0290834376764588,ISG20;BST2;APOL6;CFH;SAMHD1,Dichloroallyl lawsone
0,Epithelial Mesenchymal Transition,4.471554693684914e-11,SERPINE2;DST;ITGB5;IGFBP3;FN1;VEGFC;EMP3;GJA1;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Dianhydrodulcitol
1,KRAS Signaling Up,0.0009724332372878072,IGFBP3;GFPT2;SPP1;LIF;LY96;PLAT;LCP1,Dianhydrodulcitol
2,UV Response Dn,0.0009724332372878072,GJA1;ANXA2;CAV1;MAP1B;PMP22;RND3,Dianhydrodulcitol
3,Hypoxia,0.0034478028272192,CDKN1C;SRPX;ANXA2;IGFBP3;CAV1;TGFBI,Dianhydrodulcitol
4,Estrogen Response Late,0.0034478028272192,ST14;CAV1;DYNLT3;FLNB;IL6ST;MAPK13,Dianhydrodulcitol
5,IL-2/STAT5 Signaling,0.0113009929257097,CDKN1C;PRNP;SPP1;LIF;CKAP4,Dianhydrodulcitol
6,Estrogen Response Early,0.0113009929257097,GJA1;DYNLT3;TBC1D30;FLNB;IL6ST,Dianhydrodulcitol
7,Myogenesis,0.0113009929257097,PRNP;MEF2C;ITGB5;IGFBP3;ADAM12,Dianhydrodulcitol
8,Apical Junction,0.0113009929257097,SGCE;CLDN4;TGFBI;GNAI1;MAPK13,Dianhydrodulcitol
9,Allograft Rejection,0.0113009929257097,TGFB2;LIF;CSK;HLA-A;TLR6,Dianhydrodulcitol
0,Glycolysis,2.151060736652873e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
1,Epithelial Mesenchymal Transition,1.2318422491805016e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
2,Hypoxia,8.348148510493986e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
3,TNF-alpha Signaling via NF-kB,0.0043097535340241,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
4,Angiogenesis,0.0044484829795487,APP;NRP1;VCAN,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
5,UV Response Dn,0.0044484829795487,NRP1;ATP2B4;SNAI2;PRKCA;MET,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
6,IL-6/JAK/STAT3 Signaling,0.0046292319501333,TNFRSF12A;CD9;CD44;IL13RA1,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
7,Apoptosis,0.0054940501072288,APP;GPX1;TNFRSF12A;CD44;IER3,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
8,p53 Pathway,0.0113009929257097,VAMP8;APP;HDAC3;PLK2;IER3,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
9,KRAS Signaling Up,0.0113009929257097,NRP1;GALNT3;PLAU;SPRY2;ETS1,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
10,Cholesterol Homeostasis,0.0187971839940131,ALCAM;TNFRSF12A;CD9,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
11,Protein Secretion,0.0351014310568473,CAV2;PAM;EGFR,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
12,IL-2/STAT5 Signaling,0.0409661968290497,NRP1;NT5E;ALCAM;CD44,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
13,Estrogen Response Late,0.0409661968290497,ELOVL5;ATP2B4;CD9;CD44,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
14,Apical Junction,0.0409661968290497,VCAN;ITGA3;EGFR;ACTB,"L-Aspartic acid, N-(2-chloro-5-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-"
0,Epithelial Mesenchymal Transition,2.226875670946701e-07,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC;EDIL3,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
1,UV Response Dn,0.00017851324091892374,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
2,IL-2/STAT5 Signaling,0.0005913483994010176,PRNP;CSF1;BHLHE40;SPP1;PLIN2;AHR;IGF1R,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
3,TNF-alpha Signaling via NF-kB,0.0005913483994010176,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
4,Hypoxia,0.0005913483994010176,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
5,Myogenesis,0.0038027237064918,FDPS;WWTR1;PRNP;ITGB5;BHLHE40;ADAM12,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
6,Inflammatory Response,0.0166191072436907,LYN;CSF1;ITGB3;LPAR1;AHR,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
7,Xenobiotic Metabolism,0.0166191072436907,TGFB2;PROS1;GCNT2;FAS;BCAT1,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
8,Allograft Rejection,0.0166191072436907,LYN;TGFB2;CSF1;FAS;BCAT1,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
9,IL-6/JAK/STAT3 Signaling,0.0427100416730174,CSF1;ITGB3;FAS,"Aspartic acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, monohydrate, L-"
0,Epithelial Mesenchymal Transition,0.0003167385758393306,ITGB5;BDNF;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,Carboquone
1,Hypoxia,0.0014126656207913,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,Carboquone
2,mTORC1 Signaling,0.0072674275279622,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Carboquone
3,UV Response Dn,0.0084390338876734,BDNF;ITGB3;PMP22;MT1E;IGF1R,Carboquone
4,Interferon Alpha Response,0.012282272314053,CSF1;TXNIP;PSMB8;PSMB9,Carboquone
5,IL-2/STAT5 Signaling,0.0204177603279629,PRNP;CSF1;SPP1;AHR;IGF1R,Carboquone
6,Complement,0.0204177603279629,DOCK10;LYN;ERAP2;FN1;PSMB9,Carboquone
7,Cholesterol Homeostasis,0.032687750107236,FDPS;FABP5;HMGCR,Carboquone
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;SNAI2;VIM;CD44;LOXL2,"Mitomycin C, K-35 deriv."
1,Hypoxia,0.00013995425444063446,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,"Mitomycin C, K-35 deriv."
2,UV Response Dn,0.0010868371475569,TJP1;RBPMS;CAV1;SERPINE1;SNAI2;PRKCA,"Mitomycin C, K-35 deriv."
3,Apoptosis,0.0015041618003516,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"Mitomycin C, K-35 deriv."
4,TNF-alpha Signaling via NF-kB,0.002752447635175,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,"Mitomycin C, K-35 deriv."
5,Apical Junction,0.002752447635175,TJP1;ITGA3;FLNC;EGFR;ACTB;PTK2,"Mitomycin C, K-35 deriv."
6,Glycolysis,0.002752447635175,EXT1;TPST1;NT5E;MIF;EGFR;CD44,"Mitomycin C, K-35 deriv."
7,Estrogen Response Late,0.014033912783561,FARP1;ELOVL5;CAV1;CD9;CD44,"Mitomycin C, K-35 deriv."
8,p53 Pathway,0.014033912783561,VAMP8;APP;PLK2;STOM;PTPN14,"Mitomycin C, K-35 deriv."
9,Cholesterol Homeostasis,0.0231094791455808,TNFRSF12A;CD9;HMGCR,"Mitomycin C, K-35 deriv."
10,IL-6/JAK/STAT3 Signaling,0.032787506738882,TNFRSF12A;CD9;CD44,"Mitomycin C, K-35 deriv."
11,Androgen Response,0.0361466442609262,CDK6;ELOVL5;HMGCR,"Mitomycin C, K-35 deriv."
12,Hedgehog Signaling,0.0361466442609262,NRP2;CDK6,"Mitomycin C, K-35 deriv."
13,Angiogenesis,0.0361466442609262,APP;PTK2,"Mitomycin C, K-35 deriv."
14,Mitotic Spindle,0.0361466442609262,FARP1;PLK1;ARHGAP29;CDC42EP1,"Mitomycin C, K-35 deriv."
15,Estrogen Response Early,0.0361466442609262,FARP1;ELOVL5;ENDOD1;CD44,"Mitomycin C, K-35 deriv."
16,mTORC1 Signaling,0.0361466442609262,ELOVL5;PLK1;CD9;HMGCR,"Mitomycin C, K-35 deriv."
17,Xenobiotic Metabolism,0.0361466442609262,TPST1;ELOVL5;SERPINE1;MAN1A1,"Mitomycin C, K-35 deriv."
18,KRAS Signaling Up,0.0361466442609262,PLAU;SPRY2;PLEK2;ETS1,"Mitomycin C, K-35 deriv."
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;SPARC;LGALS1;ITGB3;SPP1;FN1;TGFBI;EMP3,Piperazinedione 593A
1,Interferon Alpha Response,0.0278493383865157,BST2;IFITM1;HLA-C;TXNIP,Piperazinedione 593A
0,PI3K/AKT/mTOR  Signaling,0.0465335002823341,CDK1;PTEN;PLCB1;HSP90B1,Triazinate
1,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Triazinate
2,E2F Targets,0.0465335002823341,DNMT1;PLK1;CDK1;TP53;AURKA,Triazinate
0,Epithelial Mesenchymal Transition,0.016485554571269,ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,Vepesid J
1,UV Response Dn,0.016485554571269,DLC1;ITGB3;PMP22;LPAR1;MT1E,Vepesid J
0,UV Response Dn,0.000238017654558565,TJP1;ANXA2;CAV1;MAP1B;ID1;MET;CAP2,Amsacrine hydrochloride
1,Cholesterol Homeostasis,0.0005194179143244536,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Amsacrine hydrochloride
2,Epithelial Mesenchymal Transition,0.0006570537771122417,TNFRSF12A;SDC4;DST;VIM;FSTL1;PFN2;CAP2,Amsacrine hydrochloride
3,Apical Junction,0.0030421789651934,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Amsacrine hydrochloride
4,p53 Pathway,0.0030421789651934,APP;PLK2;SFN;PTPN14;EPHA2;S100A10,Amsacrine hydrochloride
5,Angiogenesis,0.0038408851679996,APP;FSTL1;PTK2,Amsacrine hydrochloride
6,Apoptosis,0.0051543556665348,APP;GPX1;TNFRSF12A;CAV1;PTK2,Amsacrine hydrochloride
7,Protein Secretion,0.0051543556665348,SCRN1;DST;CAV2;EGFR,Amsacrine hydrochloride
8,Hypoxia,0.0099714643462144,EXT1;ANXA2;SDC4;CAV1;EGFR,Amsacrine hydrochloride
9,Estrogen Response Late,0.0099714643462144,CAV1;MYOF;CD9;SFN;LSR,Amsacrine hydrochloride
10,IL-6/JAK/STAT3 Signaling,0.0258848737412226,TNFRSF12A;CD9;OSMR,Amsacrine hydrochloride
11,TNF-alpha Signaling via NF-kB,0.0417076664549148,MARCKS;TUBB2A;SDC4;PLK2,Amsacrine hydrochloride
12,Inflammatory Response,0.0417076664549148,AXL;SGMS2;OSMR;MET,Amsacrine hydrochloride
0,UV Response Dn,0.0036895261061802,INPP4B;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Omacetaxine mepesuccinate
1,Androgen Response,0.0343560923466647,INPP4B;CDK6;ADAMTS1;HMGCR,Omacetaxine mepesuccinate
2,IL-2/STAT5 Signaling,0.0357310805739351,PRNP;PLAGL1;SPP1;PLIN2;IGF1R,Omacetaxine mepesuccinate
3,Epithelial Mesenchymal Transition,0.0357310805739351,ITGB3;ADAM12;PMP22;SPP1;VEGFC,Omacetaxine mepesuccinate
0,Hypoxia,0.00030937256244771826,SRPX;TES;DTNA;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,4-Hydroxy-3-beta-D-ribofuranosylpyrazole-5-carboxamide
1,mTORC1 Signaling,0.0106476263781772,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,4-Hydroxy-3-beta-D-ribofuranosylpyrazole-5-carboxamide
2,Epithelial Mesenchymal Transition,0.0465335002823341,ITGB3;ADAM12;PMP22;SPP1;TGFBI,4-Hydroxy-3-beta-D-ribofuranosylpyrazole-5-carboxamide
0,Hypoxia,0.0026282151084489,SRPX;TES;DTNA;PLIN2;TGFBI;AMPD3;MT1E,"2,2'-Cyclocytidine hydrochloride"
1,mTORC1 Signaling,0.0101405965506449,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"2,2'-Cyclocytidine hydrochloride"
2,Interferon Alpha Response,0.0190422826574466,LGALS3BP;TXNIP;PSMB8;PSMB9,"2,2'-Cyclocytidine hydrochloride"
0,Hypoxia,0.0013798129319357,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
1,Epithelial Mesenchymal Transition,0.0013798129319357,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
2,mTORC1 Signaling,0.0070984175854514,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
3,Interferon Alpha Response,0.0149957975927392,LGALS3BP;TXNIP;PSMB8;PSMB9,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
4,KRAS Signaling Up,0.0279201001694004,TMEM158;SPP1;LCP1;GNG11;PSMB8,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
5,UV Response Dn,0.036488651282496,ITGB3;PMP22;MT1E;IGF1R,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
6,Cholesterol Homeostasis,0.036488651282496,FDPS;FABP5;HMGCR,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-"
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,Alanosine monosodium salt
1,Hypoxia,0.0101405965506449,CDKN1C;SRPX;DTNA;TGFBI;AMPD3;MT1E,Alanosine monosodium salt
0,p53 Pathway,0.0060843579303869,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Maytansin
1,Estrogen Response Early,0.0060843579303869,ABLIM1;KRT19;KRT18;KRT8;FLNB;SFN,Maytansin
2,UV Response Dn,0.0474037823143518,TJP1;ANXA2;MAP1B;ID1,Maytansin
0,Epithelial Mesenchymal Transition,0.0002946405356644936,SPARC;LGALS1;BASP1;SPP1;FN1;TGFBI;EMP3;THBS1,Amsacrine mesylate
1,Interferon Alpha Response,0.0025305011462247,BST2;HLA-C;TXNIP;B2M;PSMB8,Amsacrine mesylate
2,Interferon Gamma Response,0.0443176193165087,BST2;TXNIP;HLA-A;B2M;PSMB8,Amsacrine mesylate
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;ECM1;SPARC;LGALS1;COL4A1;COL12A1;TNC;SNAI2;CD44,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
1,KRAS Signaling Up,0.0012155494876576,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
2,Estrogen Response Early,0.0062533678728977,ELOVL5;ELOVL2;ENDOD1;PMAIP1;JAK2;CD44,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
3,Hedgehog Signaling,0.0071056375607994,NRP1;NRP2;CDK6,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
4,IL-2/STAT5 Signaling,0.0175687705147588,NRP1;NT5E;ECM1;ALCAM;CD44,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
5,TNF-alpha Signaling via NF-kB,0.0175687705147588,FOSL1;PLAU;PLK2;TNC;CD44,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
6,Glycolysis,0.0175687705147588,NT5E;VCAN;CDK1;MIF;CD44,"Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-"
0,UV Response Dn,0.00034909256001922865,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Triptolide
1,IL-2/STAT5 Signaling,0.0074364374704729,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;IGF1R,Triptolide
2,mTORC1 Signaling,0.0074364374704729,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,Triptolide
3,TNF-alpha Signaling via NF-kB,0.0208925919634969,CEBPB;BHLHE40;SGK1;FJX1;LITAF,Triptolide
4,Hypoxia,0.0208925919634969,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,Triptolide
5,Complement,0.0208925919634969,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Triptolide
6,Epithelial Mesenchymal Transition,0.0208925919634969,BDNF;ITGB3;PMP22;SPP1;VEGFC,Triptolide
0,Hypoxia,0.0182530737911609,CDKN1C;SRPX;HOXB9;COL5A1;RRAGD;TNFAIP3,Acivicin
0,Epithelial Mesenchymal Transition,8.297758407769535e-10,BDNF;ITGB3;TFPI2;PLOD3;VEGFC;GLIPR1;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;EDIL3;FBN1,Zorubicin hydrochloride
1,UV Response Dn,0.0001467775536444484,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3;MT1E,Zorubicin hydrochloride
2,TNF-alpha Signaling via NF-kB,0.0059909515286257,CSF1;BHLHE40;PLPP3;SGK1;FJX1;LITAF,Zorubicin hydrochloride
3,Coagulation,0.0059909515286257,PROS1;ITGB3;TFPI2;PRSS23;FBN1,Zorubicin hydrochloride
4,Hypoxia,0.0204968989338852,SRPX;BHLHE40;GCNT2;MT1E;TMEM45A,Zorubicin hydrochloride
5,Myogenesis,0.0204968989338852,WWTR1;FDPS;PRNP;BHLHE40;ADAM12,Zorubicin hydrochloride
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,NT5E;VCAN;ECM1;SPARC;LGALS1;COL12A1;TNC;SNAI2;CD44,Asaley
1,Estrogen Response Early,0.0060843579303869,ELOVL5;ELOVL2;DLC1;ENDOD1;JAK2;CD44,Asaley
2,Glycolysis,0.0060843579303869,NT5E;VCAN;CDK1;MIF;CD44;IER3,Asaley
3,KRAS Signaling Up,0.0299143930386433,GALNT3;GABRA3;SPRY2;ETS1;TRIB2,Asaley
0,Epithelial Mesenchymal Transition,1.2580631333143412e-08,GJA1;SPARC;LGALS1;SERPINE2;DST;ITGB5;SPP1;FN1;TGFBI;EMP3;EDIL3;THBS1,Dexrazoxane
1,Estrogen Response Late,0.0058290339197439,TOP2A;ST14;CAV1;FLNB;IL6ST;MAPK13,Dexrazoxane
2,KRAS Signaling Up,0.0058290339197439,SPP1;LIF;LY96;PLAT;ETV1;LCP1,Dexrazoxane
3,Coagulation,0.0058290339197439,SPARC;CAPN2;FN1;PLAT;THBS1,Dexrazoxane
4,Apoptosis,0.0093075672404817,TOP2A;APP;CAV1;BAX;PLAT,Dexrazoxane
5,Mitotic Spindle,0.0149571965193216,TOP2A;MARCKS;DST;CDK1;FLNB,Dexrazoxane
6,IL-2/STAT5 Signaling,0.0149571965193216,CDKN1C;AHNAK;SPP1;LIF;CKAP4,Dexrazoxane
7,p53 Pathway,0.0149571965193216,APP;ST14;LIF;BAX;TM4SF1,Dexrazoxane
8,UV Response Dn,0.0237018911571759,GJA1;CAV1;MAP1B;RND3,Dexrazoxane
9,Angiogenesis,0.0433759731131114,APP;SPP1,Dexrazoxane
10,Hypoxia,0.0433759731131114,CDKN1C;SRPX;CAV1;TGFBI,Dexrazoxane
11,G2-M Checkpoint,0.0433759731131114,TOP2A;MARCKS;CDK1;AURKB,Dexrazoxane
12,Myogenesis,0.0433759731131114,APP;MEF2C;SPARC;ITGB5,Dexrazoxane
13,Apical Junction,0.0433759731131114,SGCE;MSN;TGFBI;MAPK13,Dexrazoxane
14,Allograft Rejection,0.0433759731131114,LIF;CSK;HLA-A;TLR6,Dexrazoxane
15,Apical Surface,0.0459663386884094,SRPX;APP,Dexrazoxane
0,Epithelial Mesenchymal Transition,3.18829758611424e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
2,TNF-alpha Signaling via NF-kB,0.0007227591548234659,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
3,Hypoxia,0.0007227591548234659,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
4,IL-2/STAT5 Signaling,0.0043453523034906,PRNP;CSF1;BHLHE40;PLIN2;AHR;IGF1R,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
5,Myogenesis,0.0162497937493865,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
6,Inflammatory Response,0.0162497937493865,LYN;CSF1;ITGB3;LPAR1;AHR,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
7,Xenobiotic Metabolism,0.0162497937493865,TGFB2;PROS1;GCNT2;FAS;BCAT1,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
8,Allograft Rejection,0.0162497937493865,LYN;TGFB2;CSF1;FAS;BCAT1,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
9,IL-6/JAK/STAT3 Signaling,0.0417609296358392,CSF1;ITGB3;FAS,"2-({4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-naphthalene-1-carbonyl}-amino)-pentanedioic acid"
0,Hypoxia,0.0060843579303869,CDKN1C;SRPX;HOXB9;COL5A1;CAV1;RRAGD,Elesclomol
1,Myogenesis,0.0060843579303869,MEF2C;ITGB5;ADAM12;FHL1;NCAM1;MYLK,Elesclomol
2,Epithelial Mesenchymal Transition,0.0060843579303869,COL5A1;ITGB5;ADAM12;SPP1;FBLN1;MYLK,Elesclomol
3,Estrogen Response Late,0.0239315144309146,ST14;OPN3;CAV1;SCNN1A;MAPK13,Elesclomol
4,KRAS Signaling Up,0.0239315144309146,ALDH1A3;SPP1;LY96;LCP1;MPZL2,Elesclomol
0,Estrogen Response Early,0.0021682774644703,ABLIM1;RAB31;KRT18;MYOF;NRIP1;SFN;PAPSS2,9-Methoxycamptothecin
1,Epithelial Mesenchymal Transition,0.008365992154282,SDC4;DST;BASP1;TGFBI;FERMT2;PFN2,9-Methoxycamptothecin
2,UV Response Dn,0.0086352904897123,TJP1;ANXA2;NFIB;MAP1B;ID1,9-Methoxycamptothecin
3,Protein Secretion,0.0113395824663766,TPD52;KRT18;SCRN1;DST,9-Methoxycamptothecin
4,TGF-beta Signaling,0.0137107634760448,TJP1;RAB31;ID1,9-Methoxycamptothecin
5,Estrogen Response Late,0.0137107634760448,RAB31;MYOF;NRIP1;SFN;PAPSS2,9-Methoxycamptothecin
6,Apical Junction,0.0137107634760448,TJP1;RRAS;FSCN1;CTNNA1;TGFBI,9-Methoxycamptothecin
7,p53 Pathway,0.0137107634760448,APP;LIF;SFN;TM4SF1;S100A10,9-Methoxycamptothecin
8,Angiogenesis,0.0497016358587735,APP;FGFR1,9-Methoxycamptothecin
9,Mitotic Spindle,0.0497016358587735,MARCKS;DST;FSCN1;MID1,9-Methoxycamptothecin
10,IL-2/STAT5 Signaling,0.0497016358587735,AHNAK;LIF;AHR;CKAP4,9-Methoxycamptothecin
11,Hypoxia,0.0497016358587735,TPD52;ANXA2;SDC4;TGFBI,9-Methoxycamptothecin
0,Cholesterol Homeostasis,0.0008294283494513648,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Chlorozotocin
1,Apical Junction,0.0008294283494513648,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Chlorozotocin
2,UV Response Dn,0.0008294283494513648,TJP1;ANXA2;CAV1;ID1;MET;CAP2,Chlorozotocin
3,Epithelial Mesenchymal Transition,0.0036759662496088,TNFRSF12A;SDC4;DST;VIM;PFN2;CAP2,Chlorozotocin
4,Apoptosis,0.0066433917479782,APP;GPX1;TNFRSF12A;CAV1;PTK2,Chlorozotocin
5,Protein Secretion,0.0066433917479782,SCRN1;DST;CAV2;EGFR,Chlorozotocin
6,Hypoxia,0.0120488527516758,ANXA2;SDC4;CAV1;MIF;EGFR,Chlorozotocin
7,p53 Pathway,0.0120488527516758,VAMP8;APP;PLK2;PTPN14;S100A10,Chlorozotocin
8,Angiogenesis,0.0449851713175453,APP;PTK2,Chlorozotocin
0,Hypoxia,0.0009198752879571384,SRPX;TES;DTNA;PLIN2;TGFBI;NR3C1;MT1E,Niclosamide
1,mTORC1 Signaling,0.0009198752879571384,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Niclosamide
2,Epithelial Mesenchymal Transition,0.0009198752879571384,ITGB5;BASP1;ITGB3;SPP1;FN1;TGFBI;EMP3,Niclosamide
3,Interferon Alpha Response,0.0013285131017679,IFITM3;LGALS3BP;HLA-C;TXNIP;PSMB8,Niclosamide
4,IL-2/STAT5 Signaling,0.023266750141167,IFITM3;SPP1;PLIN2;AHR;IGF1R,Niclosamide
5,Complement,0.023266750141167,DOCK10;ERAP2;CTSL;FDX1;FN1,Niclosamide
6,UV Response Dn,0.0355528367357638,ITGB3;NR3C1;MT1E;IGF1R,Niclosamide
7,Apoptosis,0.0457952030858709,IFITM3;BAX;TXNIP;BIRC3,Niclosamide
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
1,Glycolysis,1.340534212343487e-05,EXT1;NT5E;VCAN;CDK1;MIF;PAM;MET;CD44;IER3,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
2,TNF-alpha Signaling via NF-kB,0.0031924572606845,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
3,Hypoxia,0.0031924572606845,EXT1;SDC4;MIF;ETS1;PAM;IER3,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
4,KRAS Signaling Up,0.0031924572606845,NRP1;GALNT3;PLAU;SPRY2;ETS1;TRIB2,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
5,Cholesterol Homeostasis,0.0031924572606845,ALCAM;TNFRSF12A;CD9;HMGCR,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
6,Angiogenesis,0.0040603643204568,APP;NRP1;VCAN,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
7,Estrogen Response Late,0.0153726742004139,ELOVL5;ATP2B4;CD9;JAK2;CD44,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
8,UV Response Dn,0.024360277022653,NRP1;ATP2B4;SNAI2;MET,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
9,Apoptosis,0.0319246776141746,APP;TNFRSF12A;CD44;IER3,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
10,IL-6/JAK/STAT3 Signaling,0.0319246776141746,TNFRSF12A;CD9;CD44,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
11,Hedgehog Signaling,0.0430461553124786,NRP1;NRP2,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
12,IL-2/STAT5 Signaling,0.0445808612551423,NRP1;NT5E;ALCAM;CD44,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
13,Estrogen Response Early,0.0445808612551423,ELOVL5;ENDOD1;JAK2;CD44,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
14,mTORC1 Signaling,0.0445808612551423,ELOVL5;PLK1;CD9;HMGCR,"Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide"
0,Epithelial Mesenchymal Transition,2.8259910422376216e-05,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;FN1;FAS;TGFBI;EDIL3,Tamoxifen citrate
1,UV Response Dn,0.00015471147546306725,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Tamoxifen citrate
2,IL-2/STAT5 Signaling,0.0006406274326844358,PRNP;CSF1;BHLHE40;ITGA6;AHR;WLS;IGF1R,Tamoxifen citrate
3,Hypoxia,0.0006406274326844358,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Tamoxifen citrate
4,TNF-alpha Signaling via NF-kB,0.0039548326547515,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Tamoxifen citrate
5,Interferon Alpha Response,0.0092831127955052,LGALS3BP;CSF1;PSMB8;PSMB9,Tamoxifen citrate
10,Allograft Rejection,0.0117844578637079,LYN;TGFB2;CSF1;FAS;BCAT1,Tamoxifen citrate
9,Xenobiotic Metabolism,0.0117844578637079,TGFB2;PROS1;GCNT2;FAS;BCAT1,Tamoxifen citrate
8,Inflammatory Response,0.0117844578637079,LYN;CSF1;ITGB3;LPAR1;AHR,Tamoxifen citrate
7,mTORC1 Signaling,0.0117844578637079,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Tamoxifen citrate
6,Complement,0.0117844578637079,DOCK10;LYN;CEBPB;FN1;PSMB9,Tamoxifen citrate
11,Apoptosis,0.0283494114341106,TGFB2;FAS;BAX;BCL2L2,Tamoxifen citrate
12,IL-6/JAK/STAT3 Signaling,0.0284733611153449,CSF1;ITGB3;FAS,Tamoxifen citrate
13,Estrogen Response Early,0.0440537226930038,DYNLT3;BHLHE40;RHOBTB3;IGF1R,Tamoxifen citrate
14,Myogenesis,0.0440537226930038,FDPS;PRNP;ITGB5;BHLHE40,Tamoxifen citrate
15,Interferon Gamma Response,0.0440537226930038,LGALS3BP;FAS;PSMB8;PSMB9,Tamoxifen citrate
16,Apical Surface,0.0468676394470057,LYN;SRPX,Tamoxifen citrate
0,Epithelial Mesenchymal Transition,8.970549630021117e-10,SERPINE2;ITGB5;IGFBP3;ITGB3;FN1;VEGFC;EMP3;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Diaziquone
1,Hypoxia,0.0013141075542244,CDKN1C;SRPX;DTNA;IGFBP3;TGFBI;AMPD3;MT1E,Diaziquone
2,Myogenesis,0.0443176193165087,MEF2C;DTNA;ITGB5;IGFBP3;ADAM12,Diaziquone
0,Glycolysis,2.151060736652873e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
1,Hypoxia,8.348148510493986e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
2,Epithelial Mesenchymal Transition,8.348148510493986e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;CD44,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
3,TNF-alpha Signaling via NF-kB,0.0035203312496197,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
4,Cholesterol Homeostasis,0.0035203312496197,ALCAM;TNFRSF12A;MAL2;CD9,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
5,Angiogenesis,0.0038129854110418,APP;NRP1;VCAN,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
6,UV Response Dn,0.0038129854110418,NRP1;ATP2B4;SNAI2;PRKCA;MET,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
7,IL-6/JAK/STAT3 Signaling,0.0040505779563667,TNFRSF12A;CD9;CD44;IL13RA1,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
8,Apoptosis,0.0048836000953145,APP;GPX1;TNFRSF12A;CD44;IER3,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
9,Estrogen Response Late,0.0102736299324633,ELOVL5;ATP2B4;CD9;JAK2;CD44,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
10,KRAS Signaling Up,0.0102736299324633,NRP1;GALNT3;PLAU;SPRY2;ETS1,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
11,Protein Secretion,0.0351014310568473,CAV2;PAM;EGFR,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
12,Hedgehog Signaling,0.0361466442609262,NRP1;NRP2,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
13,IL-2/STAT5 Signaling,0.0361466442609262,NRP1;NT5E;ALCAM;CD44,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
14,Estrogen Response Early,0.0361466442609262,ELOVL5;ENDOD1;JAK2;CD44,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
15,Apical Junction,0.0361466442609262,VCAN;ITGA3;EGFR;ACTB,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
16,p53 Pathway,0.0361466442609262,APP;HDAC3;PLK2;IER3,"2-[[4-[(2,4-Diamino-5-ethylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid"
0,UV Response Dn,0.0023805529897698,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,Thiocolchicine
1,TGF-beta Signaling,0.0023805529897698,TJP1;RAB31;SMURF2;ID1,Thiocolchicine
2,Apical Junction,0.0052393082178332,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,Thiocolchicine
3,Angiogenesis,0.0059533720103995,FSTL1;PTK2;FGFR1,Thiocolchicine
0,Angiogenesis,0.0009438322597205188,APP;NRP1;FSTL1;PTK2,CO-Vidarabine
1,Apical Junction,0.0009438322597205188,TJP1;RRAS;ITGA3;CTNNA1;EGFR;ACTB;PTK2,CO-Vidarabine
2,UV Response Dn,0.0009438322597205188,TJP1;NRP1;ANXA2;CAV1;ID1;MET,CO-Vidarabine
3,Apoptosis,0.0013062457739896,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,CO-Vidarabine
4,Hypoxia,0.0021354950595119,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,CO-Vidarabine
5,Epithelial Mesenchymal Transition,0.0021354950595119,TNFRSF12A;SDC4;COL12A1;VIM;FSTL1;CD44,CO-Vidarabine
6,p53 Pathway,0.0021354950595119,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,CO-Vidarabine
7,Cholesterol Homeostasis,0.0021354950595119,ALCAM;TNFRSF12A;MAL2;CD9,CO-Vidarabine
8,IL-6/JAK/STAT3 Signaling,0.003494616276081,TNFRSF12A;CD9;OSMR;CD44,CO-Vidarabine
9,Estrogen Response Late,0.0099714643462144,ELOVL5;CAV1;CD9;LSR;CD44,CO-Vidarabine
10,Glycolysis,0.0099714643462144,EXT1;MIF;MET;EGFR;CD44,CO-Vidarabine
11,Fatty Acid Metabolism,0.0224862536285958,ELOVL5;PCBD1;MIF;S100A10,CO-Vidarabine
12,Protein Secretion,0.0314483409468586,SCRN1;CAV2;EGFR,CO-Vidarabine
13,IL-2/STAT5 Signaling,0.0372762268940801,NRP1;ALCAM;AHNAK;CD44,CO-Vidarabine
14,TNF-alpha Signaling via NF-kB,0.0372762268940801,SDC4;PLAU;PLK2;CD44,CO-Vidarabine
15,Inflammatory Response,0.0372762268940801,AXL;SGMS2;OSMR;MET,CO-Vidarabine
16,Apical Surface,0.0396572333782356,APP;ATP8B1,CO-Vidarabine
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,ITGB5;BASP1;ITGB3;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
1,UV Response Dn,0.0017589601203882,ITGB3;PMP22;PTPRM;NR3C1;MT1E;IGF1R,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
2,Hypoxia,0.0069294076429407,SRPX;TES;DTNA;TGFBI;NR3C1;MT1E,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
3,Interferon Alpha Response,0.0131032538252395,LGALS3BP;HLA-C;TXNIP;PSMB8,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
4,Androgen Response,0.0131032538252395,ADAMTS1;LIFR;DHCR24;HMGCR,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
5,IL-2/STAT5 Signaling,0.0151418532664738,PRNP;SPP1;LIF;CKAP4;IGF1R,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
6,Estrogen Response Early,0.0151418532664738,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
7,Interferon Gamma Response,0.0151418532664738,LGALS3BP;TNFAIP2;TXNIP;HLA-A;PSMB8,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
8,mTORC1 Signaling,0.0151418532664738,TES;DHCR24;HMGCR;BCAT1;HSP90B1,Sodium;2-[(2-phosphonoacetyl)amino]butanedioic acid
0,Estrogen Response Early,0.0432096788335959,ABLIM1;KRT19;KRT18;KRT8;FLNB,"23,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24, 25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-, [3S-[3R*[S* (1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*, 23R*,26S*,27S*,34aR*]]-"
1,Epithelial Mesenchymal Transition,0.0432096788335959,GLIPR1;CALD1;VEGFC;FGF2;EDIL3,"23,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24, 25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-, [3S-[3R*[S* (1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*, 23R*,26S*,27S*,34aR*]]-"
0,Epithelial Mesenchymal Transition,2.274386600265245e-16,SPARC;TNFRSF12A;SDC4;DST;COL12A1;SERPINE1;TNC;FN1;THBS1;LOXL2;NT5E;LGALS1;LOX;COL4A2;COL4A1;SNAI2;SDC1;CD44,Carboplatin
1,UV Response Dn,5.219485610995944e-07,TJP1;NRP1;ANXA2;CAV1;MAP1B;SERPINE1;SNAI2;MET;RND3,Carboplatin
2,TNF-alpha Signaling via NF-kB,5.219485610995944e-07,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;SERPINE1;TNC;IL6ST;CD44,Carboplatin
3,Hypoxia,5.219485610995944e-07,EXT1;CDKN1C;LOX;ANXA2;SDC4;CAV1;SERPINE1;KDELR3;EGFR;TMEM45A,Carboplatin
4,Coagulation,3.016916597895156e-06,SPARC;PLAU;SERPINE1;FN1;CD9;PLAT;GNG12;THBS1,Carboplatin
5,Glycolysis,4.051307365386787e-05,EXT1;TPST1;NT5E;SDC1;KDELR3;MET;EGFR;CD44,Carboplatin
6,IL-2/STAT5 Signaling,0.0003001278699800597,CDKN1C;MYO1E;NRP1;NT5E;AHNAK;CKAP4;CD44,Carboplatin
7,TGF-beta Signaling,0.0005805536773287194,CDKN1C;TJP1;SERPINE1;THBS1,Carboplatin
8,Apoptosis,0.0005805536773287194,APP;TNFRSF12A;CAV1;TIMP2;PLAT;CD44,Carboplatin
10,p53 Pathway,0.0015210894825967,APP;ST14;PLK2;SDC1;PTPN14;EPHA2,Carboplatin
9,Estrogen Response Late,0.0015210894825967,ST14;CAV1;CD9;IL6ST;CD44;MAPK13,Carboplatin
11,IL-6/JAK/STAT3 Signaling,0.0026209622070608,TNFRSF12A;CD9;IL6ST;CD44,Carboplatin
12,Apical Junction,0.0073124071872239,TJP1;SGCE;ITGA3;EGFR;MAPK13,Carboplatin
13,Complement,0.0073124071872239,COL4A2;SERPINE1;FN1;TIMP2;PLAT,Carboplatin
14,KRAS Signaling Up,0.0073124071872239,NRP1;PLAU;LY96;PLAT;DCBLD2,Carboplatin
15,Cholesterol Homeostasis,0.012542973878358,TNFRSF12A;GPX8;CD9,Carboplatin
16,Protein Secretion,0.0240487313123037,DST;CAV2;EGFR,Carboplatin
17,Hedgehog Signaling,0.0242479054107276,NRP1;NRP2,Carboplatin
18,Angiogenesis,0.0242479054107276,APP;NRP1,Carboplatin
20,Inflammatory Response,0.028400934776442,AXL;SERPINE1;MET;DCBLD2,Carboplatin
19,Mitotic Spindle,0.028400934776442,MYO1E;MARCKS;DST;ARHGAP29,Carboplatin
21,Apical Surface,0.0306442257922729,APP;DCBLD2,Carboplatin
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,GLIPR1;CALD1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;PLOD3;SPOCK1;VEGFC,N-Trifluoroacetyladriamycin-14-valerate
1,UV Response Dn,1.2016601232255267e-05,BDNF;SDC2;ITGB3;BHLHE40;PMP22;LPAR1;VLDLR;PLPP3,N-Trifluoroacetyladriamycin-14-valerate
2,Androgen Response,0.0018502657594518,CDK6;ADAMTS1;HMGCR;SGK1;ELL2,N-Trifluoroacetyladriamycin-14-valerate
3,Hypoxia,0.0048167833615563,SRPX;SDC2;BHLHE40;GCNT2;VLDLR;TMEM45A,N-Trifluoroacetyladriamycin-14-valerate
4,Hedgehog Signaling,0.0058381454553595,ADGRG1;CDK6;VLDLR,N-Trifluoroacetyladriamycin-14-valerate
5,Estrogen Response Late,0.0180436021502928,TFAP2C;TFPI2;SGK1;JAK2;PRSS23,N-Trifluoroacetyladriamycin-14-valerate
6,Myogenesis,0.0180436021502928,WWTR1;PRNP;MEF2C;BHLHE40;ADAM12,N-Trifluoroacetyladriamycin-14-valerate
0,Epithelial Mesenchymal Transition,3.0451894380272395e-12,SPARC;DST;ITGB5;FN1;EMP3;THBS1;GJA1;VCAN;LGALS1;CDH2;COL4A2;BASP1;SPP1;TGFBI;VIM,7-Chlorocamptothecin
1,UV Response Dn,0.0018447630530901,GJA1;CAV1;MAP1B;MET;RND3;MGLL,7-Chlorocamptothecin
2,Angiogenesis,0.0110105374815991,APP;VCAN;SPP1,7-Chlorocamptothecin
9,p53 Pathway,0.0129931202087036,APP;LIF;BAX;TXNIP;TM4SF1,7-Chlorocamptothecin
8,Glycolysis,0.0129931202087036,VCAN;CDK1;GLRX;TGFBI;MET,7-Chlorocamptothecin
7,mTORC1 Signaling,0.0129931202087036,PRDX1;PLK1;GLRX;DHCR24;HMGCR,7-Chlorocamptothecin
10,KRAS Signaling Up,0.0129931202087036,SPP1;LIF;GLRX;ETV1;LCP1,7-Chlorocamptothecin
5,Myogenesis,0.0129931202087036,APP;MEF2C;SPARC;COL4A2;ITGB5,7-Chlorocamptothecin
4,Hypoxia,0.0129931202087036,CDKN1C;SRPX;CAV1;GLRX;TGFBI,7-Chlorocamptothecin
3,IL-2/STAT5 Signaling,0.0129931202087036,CDKN1C;AHNAK;SPP1;LIF;CKAP4,7-Chlorocamptothecin
6,Apical Junction,0.0129931202087036,SGCE;VCAN;ITGA3;MSN;TGFBI,7-Chlorocamptothecin
11,Coagulation,0.0182862550464759,SPARC;CAPN2;FN1;THBS1,7-Chlorocamptothecin
12,Fatty Acid Metabolism,0.0267917514652034,LGALS1;DHCR24;MGLL;CBR3,7-Chlorocamptothecin
13,Apoptosis,0.0267917514652034,APP;CAV1;BAX;TXNIP,7-Chlorocamptothecin
14,Interferon Alpha Response,0.0365171671026806,BST2;HLA-C;TXNIP,7-Chlorocamptothecin
15,Androgen Response,0.0371459741747464,LIFR;DHCR24;HMGCR,7-Chlorocamptothecin
16,Mitotic Spindle,0.0388576425804956,DST;PLK1;CDK1;FLNB,7-Chlorocamptothecin
17,Estrogen Response Early,0.0388576425804956,GJA1;MYOF;FLNB;IL6ST,7-Chlorocamptothecin
18,Estrogen Response Late,0.0388576425804956,CAV1;MYOF;FLNB;IL6ST,7-Chlorocamptothecin
19,Inflammatory Response,0.0388576425804956,BST2;LIF;EMP3;MET,7-Chlorocamptothecin
20,Apical Surface,0.0418318002878647,SRPX;APP,7-Chlorocamptothecin
21,Reactive Oxygen Species Pathway,0.0488464137558451,PRDX1;GLRX,7-Chlorocamptothecin
0,Apoptosis,0.0005749220549732116,TOP2A;APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,Amsacrine
1,Cholesterol Homeostasis,0.0005749220549732116,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Amsacrine
2,TNF-alpha Signaling via NF-kB,0.0005749220549732116,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;CD44,Amsacrine
3,Epithelial Mesenchymal Transition,0.0005749220549732116,LGALS1;TNFRSF12A;SDC4;DST;COL12A1;VIM;CD44,Amsacrine
4,UV Response Dn,0.0006006205289130573,TJP1;NRP1;ANXA2;CAV1;ID1;MET,Amsacrine
5,Protein Secretion,0.000702781385952737,SCRN1;DST;CAV2;PAM;EGFR,Amsacrine
10,p53 Pathway,0.0016132767239662,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Amsacrine
9,Glycolysis,0.0016132767239662,EXT1;PAM;MET;EGFR;CD44;IL13RA1,Amsacrine
8,Apical Junction,0.0016132767239662,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Amsacrine
7,Estrogen Response Late,0.0016132767239662,TOP2A;ELOVL5;CAV1;CD9;LSR;CD44,Amsacrine
6,Hypoxia,0.0016132767239662,EXT1;ANXA2;SDC4;CAV1;PAM;EGFR,Amsacrine
11,Angiogenesis,0.0022405163479998,APP;NRP1;PTK2,Amsacrine
12,IL-6/JAK/STAT3 Signaling,0.0025659769859336,TNFRSF12A;CD9;CD44;IL13RA1,Amsacrine
13,IL-2/STAT5 Signaling,0.0081335035998653,NRP1;ALCAM;AHNAK;CKAP4;CD44,Amsacrine
14,Fatty Acid Metabolism,0.019079245503051,LGALS1;ELOVL5;PCBD1;S100A10,Amsacrine
15,Pperoxisome,0.0335678947056964,TOP2A;ELOVL5;PRDX1,Amsacrine
16,Mitotic Spindle,0.0366024473351686,TOP2A;MARCKS;DST;ARHGAP29,Amsacrine
17,Apical Surface,0.0397239963973909,APP;ATP8B1,Amsacrine
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,ITGB5;BASP1;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,C.I. Natural Red 20
1,Hypoxia,0.0001362712477448283,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,C.I. Natural Red 20
2,Interferon Alpha Response,0.0176141114581381,LGALS3BP;TXNIP;PSMB8;PSMB9,C.I. Natural Red 20
3,TNF-alpha Signaling via NF-kB,0.0245962787206623,CEBPB;IRS2;SGK1;FJX1;LITAF,C.I. Natural Red 20
4,Complement,0.0245962787206623,DOCK10;LYN;CEBPB;FN1;PSMB9,C.I. Natural Red 20
5,UV Response Dn,0.0365404155339795,ITGB3;PMP22;MT1E;IGF1R,C.I. Natural Red 20
0,UV Response Dn,0.0032605114426708,SDC2;DLC1;ITGB3;PMP22;LPAR1;VLDLR,"[(4E,6Z)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate"
1,Epithelial Mesenchymal Transition,0.0096335667231127,ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,"[(4E,6Z)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate"
0,Epithelial Mesenchymal Transition,1.8979947676348883e-06,GJA1;SPARC;SERPINE2;DST;ITGB5;SPP1;FN1;TGFBI;EDIL3;MYLK,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
1,Estrogen Response Late,0.0009855806656683629,ISG20;ST14;CAV1;SCNN1A;FLNB;IL6ST;MAPK13,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
2,Estrogen Response Early,0.0038027237064918,GJA1;SCNN1A;CLDN7;TBC1D30;FLNB;IL6ST,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
3,KRAS Signaling Up,0.0038027237064918,SPP1;LIF;LY96;PLAT;LCP1;MPZL2,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
4,Hypoxia,0.0142449490660206,ISG20;CDKN1C;SRPX;CAV1;TGFBI,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
5,Myogenesis,0.0142449490660206,MEF2C;SPARC;ITGB5;NCAM1;MYLK,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
6,Apical Junction,0.0142449490660206,CLDN4;CLDN7;TGFBI;MAPK13;MPZL2,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
7,Coagulation,0.0191367785370096,SPARC;CAPN2;FN1;PLAT,ab-Dichloro-ce-dihydroxy-df-bis(isopropylamine)platinum
0,Interferon Alpha Response,0.0443176193165087,BST2;TXNIP;B2M;PSMB8,Elliptinium acetate
1,Interferon Gamma Response,0.0443176193165087,BST2;TXNIP;JAK2;B2M;PSMB8,Elliptinium acetate
2,E2F Targets,0.0443176193165087,DNMT1;PLK1;CDK1;TP53;AURKA,Elliptinium acetate
0,Epithelial Mesenchymal Transition,9.435473499857561e-09,SERPINE2;ITGB5;IGFBP3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,Eloxatin (TN) (Sanofi Synthelab)
1,KRAS Signaling Up,0.0008870225991015264,TMEM158;IGFBP3;HKDC1;SPP1;LIF;SOX9;LCP1,Eloxatin (TN) (Sanofi Synthelab)
2,Hypoxia,0.0034224513358426,SRPX;DTNA;IGFBP3;CAV1;TGFBI;AMPD3,Eloxatin (TN) (Sanofi Synthelab)
3,Myogenesis,0.0034224513358426,PRNP;MEF2C;DTNA;ITGB5;IGFBP3;ADAM12,Eloxatin (TN) (Sanofi Synthelab)
4,Allograft Rejection,0.017948635823186,TGFB2;PRF1;LIF;HLA-A;TLR6,Eloxatin (TN) (Sanofi Synthelab)
0,Epithelial Mesenchymal Transition,2.7837256591978365e-06,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;SPOCK1;VEGFC,4'-Deoxydoxorubicin hydrochloride
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3;MT1E,4'-Deoxydoxorubicin hydrochloride
2,TNF-alpha Signaling via NF-kB,0.0074364374704729,CSF1;BHLHE40;PLPP3;SGK1;FJX1;LITAF,4'-Deoxydoxorubicin hydrochloride
3,Androgen Response,0.0175775356192238,ADAMTS1;HMGCR;SGK1;ELL2,4'-Deoxydoxorubicin hydrochloride
4,Myogenesis,0.0243746906240797,FDPS;WWTR1;PRNP;BHLHE40;ADAM12,4'-Deoxydoxorubicin hydrochloride
5,Complement,0.0243746906240797,DOCK10;LYN;ERAP2;TFPI2;JAK2,4'-Deoxydoxorubicin hydrochloride
6,Coagulation,0.0320768859287019,PROS1;ITGB3;TFPI2;PRSS23,4'-Deoxydoxorubicin hydrochloride
0,UV Response Dn,0.0033463143753727,SDC2;DLC1;ITGB3;PMP22;LPAR1;VLDLR,"N,N-Dibenzyldaunorubicin hydrochloride"
0,Epithelial Mesenchymal Transition,2.4673931979253548e-06,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;AREG;CD44,Menogaril
1,Angiogenesis,0.0005976235309502128,APP;NRP1;VCAN;ITGAV,Menogaril
2,TNF-alpha Signaling via NF-kB,0.0006406274326844358,FOSL1;TUBB2A;SDC4;PLAU;PLK2;AREG;CD44,Menogaril
3,Glycolysis,0.0006406274326844358,EXT1;NT5E;VCAN;MIF;MET;EGFR;CD44,Menogaril
4,UV Response Dn,0.0006692628750745495,TJP1;NRP1;ATP2B4;SNAI2;PRKCA;MET,Menogaril
5,Hypoxia,0.0025237668885141,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR,Menogaril
6,Apical Junction,0.0025237668885141,TJP1;VCAN;CDH3;ITGA3;EGFR;ACTB,Menogaril
7,Cholesterol Homeostasis,0.0025237668885141,ALCAM;TNFRSF12A;MAL2;CD9,Menogaril
8,IL-2/STAT5 Signaling,0.0129629036500787,NRP1;NT5E;ALCAM;ITGAV;CD44,Menogaril
9,Estrogen Response Late,0.0129629036500787,ELOVL5;ATP2B4;CD9;AREG;CD44,Menogaril
10,IL-6/JAK/STAT3 Signaling,0.0336503358635895,TNFRSF12A;CD9;CD44,Menogaril
11,Notch Signaling,0.0361871968972308,MAML2;PRKCA,Menogaril
12,Pperoxisome,0.046035969882098,SEMA3C;ELOVL5;PRDX1,Menogaril
13,Estrogen Response Early,0.046990637539204,ELOVL5;ENDOD1;AREG;CD44,Menogaril
14,KRAS Signaling Up,0.046990637539204,NRP1;PLAU;ETS1;DUSP6,Menogaril
15,Apical Surface,0.0497968669124436,APP;ATP8B1,Menogaril
0,Epithelial Mesenchymal Transition,8.74628588927059e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;LGALS1;COL4A2;ADAM12;SPP1;TGFBI;EDIL3,Carboxyphthalato platinum
1,Myogenesis,0.0063147867463893,APP;MEF2C;SPARC;COL4A2;ITGB5;ADAM12,Carboxyphthalato platinum
2,KRAS Signaling Up,0.0063147867463893,SPP1;LIF;LY96;PLAT;ETV1;LCP1,Carboxyphthalato platinum
3,Coagulation,0.0063147867463893,SPARC;CAPN2;FN1;PLAT;THBS1,Carboxyphthalato platinum
0,Epithelial Mesenchymal Transition,0.0020368667090479,GLIPR1;LOX;CALD1;BDNF;VEGFC;DKK1;LOXL2,Bleomycin pep-CU (formerly)
0,Epithelial Mesenchymal Transition,8.297758407769535e-10,TNFRSF12A;SDC4;DST;COL12A1;THBS1;NT5E;VCAN;LGALS1;COL4A1;ITGAV;VIM;CD44;CAP2,Mitoxantrone
1,Glycolysis,1.340534212343487e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1,Mitoxantrone
2,UV Response Dn,9.785170242963228e-05,TJP1;NRP1;ANXA2;CAV1;ID1;MET;CAP2,Mitoxantrone
3,Angiogenesis,0.0002834880851943317,APP;NRP1;VCAN;ITGAV,Mitoxantrone
4,TNF-alpha Signaling via NF-kB,0.0004051831625525491,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;CD44,Mitoxantrone
5,Hypoxia,0.0004051831625525491,EXT1;ANXA2;SDC4;CAV1;MIF;PAM;EGFR,Mitoxantrone
6,Protein Secretion,0.0006368059905367657,SCRN1;DST;CAV2;PAM;EGFR,Mitoxantrone
7,Apoptosis,0.0007322892975396346,TOP2A;APP;GPX1;TNFRSF12A;CAV1;CD44,Mitoxantrone
10,Cholesterol Homeostasis,0.0017413403240097,ALCAM;TNFRSF12A;MAL2;CD9,Mitoxantrone
9,Apical Junction,0.0017413403240097,TJP1;VCAN;RRAS;ITGA3;CTNNA1;EGFR,Mitoxantrone
8,IL-2/STAT5 Signaling,0.0017413403240097,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,Mitoxantrone
11,IL-6/JAK/STAT3 Signaling,0.0029386545957954,TNFRSF12A;CD9;CD44;IL13RA1,Mitoxantrone
12,Fatty Acid Metabolism,0.0033845510688347,LGALS1;ELOVL5;PCBD1;MIF;S100A10,Mitoxantrone
13,Pperoxisome,0.0048774913728193,TOP2A;SEMA3C;ELOVL5;PRDX1,Mitoxantrone
14,TGF-beta Signaling,0.0061681338856432,TJP1;ID1;THBS1,Mitoxantrone
15,Estrogen Response Late,0.0076863371002069,TOP2A;ELOVL5;CAV1;CD9;CD44,Mitoxantrone
16,Mitotic Spindle,0.0371507177126186,TOP2A;MARCKS;DST;ARHGAP29,Mitoxantrone
17,p53 Pathway,0.0371507177126186,APP;PLK2;PTPN14;S100A10,Mitoxantrone
18,Apical Surface,0.0397837317303193,APP;ATP8B1,Mitoxantrone
0,Hypoxia,0.0011498441099464,EXT1;SDC4;MIF;ETS1;PAM;EGFR;IER3,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
1,Glycolysis,0.0011498441099464,EXT1;MIF;PAM;MET;EGFR;CD44;IER3,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
2,Apoptosis,0.0018472162460459,APP;GPX1;TNFRSF12A;PTK2;CD44;IER3,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
3,TNF-alpha Signaling via NF-kB,0.0025884788600145,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
4,Apical Junction,0.0025884788600145,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
5,p53 Pathway,0.0025884788600145,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
6,Cholesterol Homeostasis,0.0025884788600145,ALCAM;TNFRSF12A;MAL2;CD9,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
7,Angiogenesis,0.0033607745219997,APP;NRP1;PTK2,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
8,Protein Secretion,0.0053452577282583,SCRN1;CAV2;PAM;EGFR,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
9,Epithelial Mesenchymal Transition,0.0116333750705835,TNFRSF12A;SDC4;COL12A1;VIM;CD44,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
10,UV Response Dn,0.0188537770568444,TJP1;NRP1;ID1;MET,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
11,Fatty Acid Metabolism,0.0238490568788138,ELOVL5;PCBD1;MIF;S100A10,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
12,IL-6/JAK/STAT3 Signaling,0.0255530163855659,TNFRSF12A;CD9;CD44,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
13,Pperoxisome,0.0383633082350816,SEMA3C;ELOVL5;PRDX1,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
14,IL-2/STAT5 Signaling,0.039535392160388,NRP1;ALCAM;AHNAK;CD44,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
15,Estrogen Response Late,0.039535392160388,ELOVL5;CD9;LSR;CD44,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
16,Apical Surface,0.0420607020678256,APP;ATP8B1,"1,4,5,6,8-Pentaazaacenaphthylen-3-amine"
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;SNAI2;VIM;CD44;LOXL2,Dimethane sulfonate
1,Hypoxia,0.00015468628122385913,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,Dimethane sulfonate
2,TNF-alpha Signaling via NF-kB,0.0006899064659678538,FOSL1;SDC4;PLAU;PLK2;SERPINE1;IL6ST;CD44,Dimethane sulfonate
3,Estrogen Response Late,0.0006899064659678538,FARP1;ELOVL5;CAV1;ATP2B4;CD9;IL6ST;CD44,Dimethane sulfonate
4,UV Response Dn,0.0007207446346956688,CAV1;SERPINE1;AKT3;ATP2B4;SNAI2;RND3,Dimethane sulfonate
5,Apoptosis,0.0011083297476275,APP;TNFRSF12A;CAV1;TIMP2;BAX;CD44,Dimethane sulfonate
6,Apical Junction,0.0026619065945443,SGCE;ITGA3;AKT3;RAC2;EGFR;ACTB,Dimethane sulfonate
7,Glycolysis,0.0026619065945443,EXT1;NT5E;CDK1;MIF;EGFR;CD44,Dimethane sulfonate
8,IL-6/JAK/STAT3 Signaling,0.004447693442285,TNFRSF12A;CD9;IL6ST;CD44,Dimethane sulfonate
9,Androgen Response,0.0067114226909763,CDK6;ELOVL5;HMGCR;B2M,Dimethane sulfonate
10,Mitotic Spindle,0.0124220782252489,FARP1;MYO1E;PLK1;CDK1;ARHGAP29,Dimethane sulfonate
11,Cholesterol Homeostasis,0.021285046581456,TNFRSF12A;CD9;HMGCR,Dimethane sulfonate
12,Hedgehog Signaling,0.0451044953793955,NRP2;CDK6,Dimethane sulfonate
13,Estrogen Response Early,0.0474424705924656,FARP1;ELOVL5;IL6ST;CD44,Dimethane sulfonate
14,mTORC1 Signaling,0.0474424705924656,ELOVL5;PLK1;CD9;HMGCR,Dimethane sulfonate
15,Xenobiotic Metabolism,0.0474424705924656,GSTM4;MT2A;ELOVL5;SERPINE1,Dimethane sulfonate
0,Estrogen Response Early,1.9612612598893845e-06,KRT19;RAB31;KRT18;DYNLT3;MYOF;NRIP1;KRT8;RHOBTB3;FLNB;SFN,1-beta-D-Arabinofuranosylcytosine
1,Epithelial Mesenchymal Transition,0.00011417320756999128,DST;ITGB5;BASP1;FN1;TGFBI;EMP3;EDIL3;PFN2,1-beta-D-Arabinofuranosylcytosine
2,Estrogen Response Late,0.0006789555696826499,KRT19;RAB31;DYNLT3;MYOF;NRIP1;FLNB;SFN,1-beta-D-Arabinofuranosylcytosine
3,Androgen Response,0.0123841728226349,TPD52;KRT19;ADAMTS1;KRT8,1-beta-D-Arabinofuranosylcytosine
0,UV Response Dn,0.000238017654558565,TJP1;ANXA2;CAV1;MAP1B;ID1;MET;CAP2,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
1,Apical Junction,0.0006570537771122417,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
2,Epithelial Mesenchymal Transition,0.0006570537771122417,TNFRSF12A;SDC4;DST;VIM;FSTL1;PFN2;CAP2,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
3,p53 Pathway,0.0031061746320174,VAMP8;APP;PLK2;SFN;PTPN14;S100A10,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
4,Cholesterol Homeostasis,0.0031061746320174,ALCAM;TNFRSF12A;GPX8;CD9,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
5,Angiogenesis,0.0038408851679996,APP;FSTL1;PTK2,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
6,Apoptosis,0.0051543556665348,APP;GPX1;TNFRSF12A;CAV1;PTK2,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
7,Protein Secretion,0.0051543556665348,SCRN1;DST;CAV2;EGFR,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
8,IL-6/JAK/STAT3 Signaling,0.0316370679059388,TNFRSF12A;CD9;OSMR,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
9,Mitotic Spindle,0.0451833053261577,MARCKS;DST;ARHGAP29;RHOF,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
10,Hypoxia,0.0451833053261577,ANXA2;SDC4;CAV1;EGFR,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
11,Estrogen Response Late,0.0451833053261577,CAV1;CD9;SFN;LSR,"Morpholine, 4-[(3,4,12,14-tetrahydro-4-hydroxy-11-methoxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl)acetyl]-"
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,NT5E;VCAN;SPARC;LGALS1;SDC4;COL4A1;COL12A1;SNAI2;THBS1;CD44,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
1,Glycolysis,1.4492261755064726e-05,NT5E;VCAN;CITED2;CDK1;MIF;PAM;MET;CD44;IL13RA1,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
2,TNF-alpha Signaling via NF-kB,0.0062802112652453,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
3,Angiogenesis,0.0062802112652453,APP;NRP1;VCAN,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
4,UV Response Dn,0.0062802112652453,NRP1;CITED2;ATP2B4;SNAI2;MET,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
5,Hypoxia,0.0189932654213608,SDC4;CITED2;MIF;ETS1;PAM,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
6,Estrogen Response Late,0.0189932654213608,ELOVL5;ATP2B4;CD9;JAK2;CD44,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
7,Coagulation,0.0255157047160129,SPARC;PLAU;CD9;THBS1,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
8,Cholesterol Homeostasis,0.0270286305796267,ALCAM;CD9;HMGCR,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
9,IL-6/JAK/STAT3 Signaling,0.0379644814871266,CD9;CD44;IL13RA1,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
10,Hedgehog Signaling,0.0451833053261577,NRP1;NRP2,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
11,IL-2/STAT5 Signaling,0.0451833053261577,NRP1;NT5E;ALCAM;CD44,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
12,Estrogen Response Early,0.0451833053261577,ELOVL5;ENDOD1;JAK2;CD44,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
13,Apical Junction,0.0451833053261577,VCAN;ITGA3;MSN;ACTB,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
14,mTORC1 Signaling,0.0451833053261577,ELOVL5;PLK1;CD9;HMGCR,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
15,KRAS Signaling Up,0.0451833053261577,NRP1;PLAU;SPRY2;ETS1,"Methyl 2-(19-hydroxy-10-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl)acetate"
0,Epithelial Mesenchymal Transition,9.419077111522171e-10,SPARC;DST;COL12A1;EMP3;THBS1;NT5E;VCAN;LGALS1;CDH2;COL4A1;SPP1;SNAI2;CD44,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
1,Glycolysis,1.3285963373444218e-06,NT5E;VCAN;CITED2;CDK1;GLRX;MIF;PAM;MET;CD44;IL13RA1,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
2,Angiogenesis,0.0004290630478616912,APP;NRP1;VCAN;SPP1,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
3,UV Response Dn,0.000900930793369586,NRP1;CITED2;CAV1;ATP2B4;SNAI2;MET,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
4,Estrogen Response Late,0.0035492087927257,BTG3;ELOVL5;CAV1;ATP2B4;JAK2;CD44,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
5,KRAS Signaling Up,0.0035492087927257,NRP1;GABRA3;SPP1;GLRX;ETV1;LCP1,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
6,Apoptosis,0.0077563060337348,APP;BTG3;CAV1;BAX;CD44,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
7,IL-2/STAT5 Signaling,0.0126909546224547,NRP1;NT5E;ALCAM;SPP1;CD44,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
8,TNF-alpha Signaling via NF-kB,0.0126909546224547,FOSL1;BTG3;TUBB2A;PLK2;CD44,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
9,Hypoxia,0.0126909546224547,CITED2;CAV1;GLRX;MIF;PAM,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
10,mTORC1 Signaling,0.0126909546224547,ELOVL5;PRDX1;PLK1;GLRX;HMGCR,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
11,Hedgehog Signaling,0.0488632033276785,NRP1;NRP2,"4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-, (S)-"
0,Epithelial Mesenchymal Transition,7.400703444767422e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;GJA1;LGALS1;SPP1;SDC1;TGFBI;EDIL3,Triglycidyl isocyanurate
1,Estrogen Response Late,0.0001215392209616036,ST14;CAV1;DYNLT3;MYOF;FLNB;SFN;IL6ST;MAPK13,Triglycidyl isocyanurate
2,Estrogen Response Early,0.000559102827418411,GJA1;DYNLT3;MYOF;TBC1D30;FLNB;SFN;IL6ST,Triglycidyl isocyanurate
3,Coagulation,0.000559102827418411,SPARC;CAPN2;FN1;PLAT;GNG12;THBS1,Triglycidyl isocyanurate
4,IL-2/STAT5 Signaling,0.002390283472652,CDKN1C;PRNP;AHNAK;SPP1;LIF;CKAP4,Triglycidyl isocyanurate
5,Apical Junction,0.002390283472652,SGCE;CLDN4;ITGA3;MSN;TGFBI;MAPK13,Triglycidyl isocyanurate
6,p53 Pathway,0.002390283472652,APP;ST14;LIF;SDC1;SFN;TM4SF1,Triglycidyl isocyanurate
7,UV Response Dn,0.0032382339336421,GJA1;ANXA2;CAV1;MAP1B;RND3,Triglycidyl isocyanurate
8,Hypoxia,0.0109686107808359,CDKN1C;SRPX;ANXA2;CAV1;TGFBI,Triglycidyl isocyanurate
9,Myogenesis,0.0109686107808359,APP;PRNP;MEF2C;SPARC;ITGB5,Triglycidyl isocyanurate
10,Angiogenesis,0.0418827457094387,APP;SPP1,Triglycidyl isocyanurate
11,TNF-alpha Signaling via NF-kB,0.0458784331004063,MARCKS;TUBB2A;LIF;IL6ST,Triglycidyl isocyanurate
12,KRAS Signaling Up,0.0458784331004063,SPP1;LIF;LY96;PLAT,Triglycidyl isocyanurate
13,Apical Surface,0.0481552119592861,SRPX;APP,Triglycidyl isocyanurate
0,Epithelial Mesenchymal Transition,1.929958914820474e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;ITGAV;AREG,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
1,Angiogenesis,0.0005976235309502128,APP;NRP1;VCAN;ITGAV,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
2,TNF-alpha Signaling via NF-kB,0.0050475337770282,TUBB2A;SDC4;PLAU;PLK2;TNC;AREG,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
3,Cholesterol Homeostasis,0.0050475337770282,ALCAM;TNFRSF12A;MAL2;CD9,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
4,UV Response Dn,0.0061232059836142,NRP1;GJA1;ATP2B4;SNAI2;PRKCA,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
5,Hypoxia,0.0162036295625984,SDC4;PRKCA;MIF;ETS1;EGFR,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
6,Estrogen Response Early,0.0162036295625984,GJA1;ELOVL5;ENDOD1;JAK2;AREG,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
7,Estrogen Response Late,0.0162036295625984,ELOVL5;ATP2B4;CD9;JAK2;AREG,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
8,Coagulation,0.0221136107538778,SPARC;PLAU;CD9;DUSP6,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
9,Notch Signaling,0.043424636276677,MAML2;PRKCA,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
10,Hedgehog Signaling,0.0494977903838821,NRP1;NRP2,"Octanoic acid,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl ester"
0,Epithelial Mesenchymal Transition,0.0202811931012899,SPARC;ITGB3;ADAM12;SPP1;TGFBI;EMP3,"1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride"
1,Interferon Alpha Response,0.0285634239861699,BST2;IFITM1;HLA-C;TXNIP,"1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride"
2,Hypoxia,0.0332382144873815,CDKN1C;SRPX;DTNA;TGFBI;MT1E,"1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride"
3,Myogenesis,0.0332382144873815,MEF2C;DTNA;SPARC;ADAM12;IGFBP7,"1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride"
0,Epithelial Mesenchymal Transition,4.603071008205059e-11,SPARC;DST;FN1;EMP3;THBS1;GJA1;LGALS1;CDH2;COL4A2;BASP1;TGFBI;VIM;CD44;PFN2,(+)-Camptothecin
1,TNF-alpha Signaling via NF-kB,1.2680729035681635e-05,FOSL1;BTG3;MARCKS;TUBB2A;PLK2;LIF;IL6ST;PHLDA1;CD44,(+)-Camptothecin
2,UV Response Dn,9.256242121721973e-05,TJP1;GJA1;CAV1;MAP1B;AKT3;MET;RND3,(+)-Camptothecin
3,Apical Junction,0.0005749220549732116,TJP1;SGCE;ITGA3;AKT3;CTNNA1;MSN;TGFBI,(+)-Camptothecin
4,IL-2/STAT5 Signaling,0.0029576739939381,ALCAM;AHNAK;LIF;PHLDA1;CKAP4;CD44,(+)-Camptothecin
5,Glycolysis,0.0029576739939381,TGFBI;PYGL;PAM;MET;CD44;IL13RA1,(+)-Camptothecin
6,Apoptosis,0.0060134149442906,APP;BTG3;GPX1;CAV1;CD44,(+)-Camptothecin
7,Protein Secretion,0.0060134149442906,SCRN1;DST;CAV2;PAM,(+)-Camptothecin
8,Estrogen Response Late,0.0105757955187123,BTG3;CAV1;MYOF;IL6ST;CD44,(+)-Camptothecin
9,Myogenesis,0.0105757955187123,APP;MEF2C;SPARC;COL4A2;CNN3,(+)-Camptothecin
10,p53 Pathway,0.0105757955187123,APP;PLK2;LIF;TM4SF1;S100A10,(+)-Camptothecin
11,Coagulation,0.0148841610843408,SPARC;CAPN2;FN1;THBS1,(+)-Camptothecin
12,Cholesterol Homeostasis,0.0163731127549661,ALCAM;GPX8;S100A11,(+)-Camptothecin
13,IL-6/JAK/STAT3 Signaling,0.0237278009294541,IL6ST;CD44;IL13RA1,(+)-Camptothecin
14,Estrogen Response Early,0.039535392160388,GJA1;MYOF;IL6ST;CD44,(+)-Camptothecin
15,Inflammatory Response,0.039535392160388,LIF;SGMS2;EMP3;MET,(+)-Camptothecin
0,Epithelial Mesenchymal Transition,0.0102053433060237,VCAN;SPARC;COL4A1;TNC;SPP1;SNAI2,"Aphidicolin glycinate, hydrochloride"
1,Hedgehog Signaling,0.0102053433060237,NRP2;CDK6;VLDLR,"Aphidicolin glycinate, hydrochloride"
2,UV Response Dn,0.0102053433060237,SDC2;DLC1;ATP2B4;SNAI2;VLDLR,"Aphidicolin glycinate, hydrochloride"
3,KRAS Signaling Up,0.0324072591251969,GABRA3;SPP1;LCP1;TRIB2;DUSP6,"Aphidicolin glycinate, hydrochloride"
0,Epithelial Mesenchymal Transition,0.00030937256244771826,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,Amonafide
1,UV Response Dn,0.0018018615867391,ITGB3;PMP22;PTPRM;NR3C1;MT1E;IGF1R,Amonafide
2,Hypoxia,0.023266750141167,SRPX;DTNA;TGFBI;NR3C1;MT1E,Amonafide
3,mTORC1 Signaling,0.023266750141167,PLK1;DHCR24;HMGCR;BCAT1;HSP90B1,Amonafide
4,p53 Pathway,0.023266750141167,LIF;BAX;TXNIP;TP53;TM4SF1,Amonafide
5,KRAS Signaling Up,0.023266750141167,TMEM158;SPP1;LIF;LCP1;PSMB8,Amonafide
0,Epithelial Mesenchymal Transition,0.0001325882410490221,VCAN;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;CD44,Fludara
1,Glycolysis,0.0001325882410490221,VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Fludara
2,Angiogenesis,0.0003677683267385925,APP;NRP1;VCAN;ITGAV,Fludara
3,Protein Secretion,0.0010842912811842,SCRN1;DST;CAV2;PAM;EGFR,Fludara
4,TNF-alpha Signaling via NF-kB,0.002662435398872,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Fludara
5,Hypoxia,0.002662435398872,SDC4;MIF;ETS1;PAM;EGFR;IER3,Fludara
6,Cholesterol Homeostasis,0.002662435398872,ALCAM;TNFRSF12A;MAL2;CD9,Fludara
7,IL-6/JAK/STAT3 Signaling,0.0042888472479176,TNFRSF12A;CD9;CD44;IL13RA1,Fludara
8,Apoptosis,0.0051708706891565,APP;GPX1;TNFRSF12A;CD44;IER3,Fludara
9,IL-2/STAT5 Signaling,0.0099714643462144,NRP1;ALCAM;AHNAK;ITGAV;CD44,Fludara
10,Apical Junction,0.0099714643462144,TJP1;VCAN;ITGA3;CTNNA1;EGFR,Fludara
11,p53 Pathway,0.0099714643462144,VAMP8;APP;PLK2;PTPN14;IER3,Fludara
12,UV Response Dn,0.0164090015703525,TJP1;NRP1;ID1;MET,Fludara
13,Pperoxisome,0.039459402756084,SEMA3C;ELOVL5;PRDX1,Fludara
14,Apical Surface,0.0490307612676367,APP;ATP8B1,Fludara
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;THBS1;CD44,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
1,Glycolysis,1.138796860580933e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
2,Hypoxia,8.695357053038835e-06,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
3,UV Response Dn,0.000772226394316788,NRP1;CAV1;AKT3;ATP2B4;SNAI2;MET,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
4,Apoptosis,0.0011399963118454,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
5,TNF-alpha Signaling via NF-kB,0.0026075819701658,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
6,Apical Junction,0.0026075819701658,VCAN;ITGA3;AKT3;MSN;EGFR;ACTB,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
7,Angiogenesis,0.0034567966511997,APP;NRP1;VCAN,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
8,IL-6/JAK/STAT3 Signaling,0.0038123086648157,TNFRSF12A;CD9;CD44;IL13RA1,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
9,IL-2/STAT5 Signaling,0.0099714643462144,MYO1E;NRP1;NT5E;ALCAM;CD44,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
10,Estrogen Response Late,0.0099714643462144,ELOVL5;CAV1;ATP2B4;CD9;CD44,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
11,KRAS Signaling Up,0.0099714643462144,NRP1;GALNT3;PLAU;SPRY2;ETS1,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
12,Coagulation,0.0141317749196379,SPARC;PLAU;CD9;THBS1,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
13,Cholesterol Homeostasis,0.015637993406784,ALCAM;TNFRSF12A;CD9,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
14,Protein Secretion,0.0297329768952118,CAV2;PAM;EGFR,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
15,Hedgehog Signaling,0.031412059282079,NRP1;NRP2,"2,3-Dimethoxy-6-methyl-5H-(1,3)dioxolo(4',5':5,6)indeno(1,2-c)isoquinoline-5,12(6H)-dione"
0,Epithelial Mesenchymal Transition,1.1881707370191004e-08,ITGB5;BASP1;IGFBP3;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
1,Hypoxia,1.0755303683264367e-06,SRPX;TES;DTNA;IGFBP3;GCNT2;IRS2;TGFBI;AMPD3;NR3C1;MT1E,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
2,TNF-alpha Signaling via NF-kB,0.0034478028272192,CEBPB;LIF;IRS2;SGK1;FJX1;LITAF,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
3,Myogenesis,0.0034478028272192,FDPS;PRNP;DTNA;ITGB5;IGFBP3;ADAM12,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
4,KRAS Signaling Up,0.0034478028272192,IGFBP3;SPP1;LIF;SOX9;GNG11;PSMB8,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
5,UV Response Dn,0.0044484829795487,ITGB3;PMP22;NR3C1;MT1E;IGF1R,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
6,Interferon Alpha Response,0.0472686886489035,LGALS3BP;PSMB8;PSMB9,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
7,IL-2/STAT5 Signaling,0.0472686886489035,PRNP;SPP1;LIF;IGF1R,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
8,Estrogen Response Early,0.0472686886489035,DYNLT3;RHOBTB3;FLNB;IGF1R,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
9,Interferon Gamma Response,0.0472686886489035,LGALS3BP;HLA-A;PSMB8;PSMB9,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
10,Complement,0.0472686886489035,DOCK10;CEBPB;FN1;PSMB9,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
11,Glycolysis,0.0472686886489035,IGFBP3;IRS2;TGFBI;SOX9,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
12,Allograft Rejection,0.0472686886489035,TGFB2;LIF;HLA-A;BCAT1,N'-(1-(Pyridin-2-yl)ethylidene)azetidine-1-carbothiohydrazide
0,Epithelial Mesenchymal Transition,1.7320144107363228e-07,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44;LOXL2,Colchicine deriv
1,Hypoxia,8.45381935712109e-06,EXT1;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Colchicine deriv
2,Glycolysis,8.45381935712109e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,Colchicine deriv
3,Angiogenesis,0.00026816440491355705,APP;NRP1;VCAN;PTK2,Colchicine deriv
4,UV Response Dn,0.0006006205289130573,NRP1;CAV1;ATP2B4;SNAI2;PRKCA;MET,Colchicine deriv
5,Apoptosis,0.0009236081230229626,APP;TNFRSF12A;CAV1;PTK2;CD44;IER3,Colchicine deriv
7,Estrogen Response Late,0.0020132613355668,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,Colchicine deriv
8,Cholesterol Homeostasis,0.0020132613355668,ALCAM;TNFRSF12A;MAL2;CD9,Colchicine deriv
6,TNF-alpha Signaling via NF-kB,0.0020132613355668,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Colchicine deriv
9,Apical Junction,0.0105757955187123,VCAN;ITGA3;EGFR;ACTB;PTK2,Colchicine deriv
10,KRAS Signaling Up,0.0105757955187123,NRP1;GALNT3;PLAU;SPRY2;ETS1,Colchicine deriv
11,IL-6/JAK/STAT3 Signaling,0.0276824344176964,TNFRSF12A;CD9;CD44,Colchicine deriv
12,Protein Secretion,0.033354301004244,CAV2;PAM;EGFR,Colchicine deriv
13,Hedgehog Signaling,0.0349022880911989,NRP1;NRP2,Colchicine deriv
15,Estrogen Response Early,0.0372097808568358,FARP1;ELOVL5;ENDOD1;CD44,Colchicine deriv
14,IL-2/STAT5 Signaling,0.0372097808568358,NRP1;NT5E;ALCAM;CD44,Colchicine deriv
16,p53 Pathway,0.0372097808568358,VAMP8;APP;PLK2;IER3,Colchicine deriv
0,Hypoxia,0.000324104589230943,SRPX;TES;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Malformin A
1,mTORC1 Signaling,0.0074364374704729,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Malformin A
2,Epithelial Mesenchymal Transition,0.0074364374704729,ITGB5;ITGB3;ADAM12;PMP22;SPP1;TGFBI,Malformin A
3,Interferon Alpha Response,0.0157098831923934,LGALS3BP;TXNIP;PSMB8;PSMB9,Malformin A
4,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,Malformin A
5,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Malformin A
6,UV Response Dn,0.033447930342288,ITGB3;PMP22;MT1E;IGF1R,Malformin A
7,Cholesterol Homeostasis,0.033447930342288,FDPS;FABP5;HMGCR,Malformin A
0,Epithelial Mesenchymal Transition,0.0197741632737576,SPARC;LGALS1;BASP1;SPP1;EMP3;THBS1,"8,9-Dimethoxycamptothecin"
1,Apoptosis,0.0207734511863554,IFITM3;BTG3;GPX1;BAX;TXNIP,"8,9-Dimethoxycamptothecin"
2,Androgen Response,0.0207734511863554,ELOVL5;DHCR24;HMGCR;B2M,"8,9-Dimethoxycamptothecin"
3,mTORC1 Signaling,0.0324072591251969,ELOVL5;PRDX1;PLK1;DHCR24;HMGCR,"8,9-Dimethoxycamptothecin"
0,Epithelial Mesenchymal Transition,4.7345873227252027e-11,SPARC;SERPINE2;DST;ITGB5;IGFBP3;FN1;EMP3;GJA1;DPYSL3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,Hepsulfam
1,Estrogen Response Late,0.0045632684477902,ST14;CAV1;DYNLT3;FLNB;IL6ST;MAPK13,Hepsulfam
2,Myogenesis,0.0045632684477902,PRNP;MEF2C;SPARC;ITGB5;IGFBP3;ADAM12,Hepsulfam
3,KRAS Signaling Up,0.0045632684477902,IGFBP3;SPP1;LIF;LY96;PLAT;LCP1,Hepsulfam
4,IL-2/STAT5 Signaling,0.0170939388792247,CDKN1C;PRNP;SPP1;LIF;CKAP4,Hepsulfam
5,Hypoxia,0.0170939388792247,CDKN1C;SRPX;IGFBP3;CAV1;TGFBI,Hepsulfam
6,Estrogen Response Early,0.0170939388792247,GJA1;DYNLT3;TBC1D30;FLNB;IL6ST,Hepsulfam
7,Coagulation,0.0229641342444116,SPARC;CAPN2;FN1;PLAT,Hepsulfam
8,UV Response Dn,0.0237018911571759,GJA1;CAV1;PMP22;RND3,Hepsulfam
0,Epithelial Mesenchymal Transition,2.72045916694334e-06,BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;SPOCK1;VEGFC;EDIL3,"[(4E,6Z,10Z)-20,22-dihydroxy-13,14,17-trimethoxy-4,8,10,12,16-pentamethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate"
1,UV Response Dn,0.00017057931910030493,BDNF;DLC1;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"[(4E,6Z,10Z)-20,22-dihydroxy-13,14,17-trimethoxy-4,8,10,12,16-pentamethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate"
2,Complement,0.0476414407652468,DOCK10;ERAP2;TFPI2;FDX1;JAK2,"[(4E,6Z,10Z)-20,22-dihydroxy-13,14,17-trimethoxy-4,8,10,12,16-pentamethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate"
0,Epithelial Mesenchymal Transition,0.00015867843637237667,GLIPR1;BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,Tanespimycin
1,UV Response Dn,0.00015867843637237667,BDNF;SDC2;ITGB3;PMP22;LPAR1;VLDLR;PLPP3,Tanespimycin
2,Hedgehog Signaling,0.0102423604479991,NRP2;CDK6;VLDLR,Tanespimycin
3,Androgen Response,0.015979577835658,CDK6;HMGCR;SGK1;ELL2,Tanespimycin
0,Epithelial Mesenchymal Transition,0.0002651764820980442,TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;ITGAV;LOXL2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
1,Angiogenesis,0.0005516524901078888,APP;NRP1;ITGAV;PTK2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
2,Hypoxia,0.0007884645325346902,EXT1;ANXA2;SDC4;SERPINE1;MIF;ETS1;EGFR,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
3,Apical Junction,0.0037274095584208,TJP1;RRAS;ITGA3;EGFR;ACTB;PTK2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
4,Cholesterol Homeostasis,0.0037274095584208,TNFRSF12A;MAL2;CD9;CLU,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
5,UV Response Dn,0.004710158448934,TJP1;NRP1;ANXA2;SERPINE1;SNAI2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
6,TNF-alpha Signaling via NF-kB,0.0132952857949526,TUBB2A;SDC4;PLAU;PLK2;SERPINE1,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
7,Xenobiotic Metabolism,0.0132952857949526,TPST1;ELOVL5;SERPINE1;MAN1A1;EPHA2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
8,p53 Pathway,0.0132952857949526,VAMP8;APP;PLK2;PTPN14;EPHA2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
9,Coagulation,0.0183713073955292,PLAU;SERPINE1;CD9;CLU,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
10,Apoptosis,0.0284733611153449,APP;TNFRSF12A;CLU;PTK2,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
11,IL-6/JAK/STAT3 Signaling,0.0284733611153449,TNFRSF12A;PDGFC;CD9,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
12,Pperoxisome,0.0424947414296289,SEMA3C;ELOVL5;PRDX1,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
13,Glycolysis,0.0433759731131114,EXT1;TPST1;MIF;EGFR,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
14,KRAS Signaling Up,0.0433759731131114,NRP1;PLAU;PLEK2;ETS1,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
15,Apical Surface,0.0459663386884094,APP;ATP8B1,"4,12,18-Tetraoxatetracyclo[15.3.1.03,5.011,13] heneicos-14-ene-6,19-dione, 10-hydroxy-8-[2-methoxy-1,3,7-trimethyl-8-(2-methyl-4-oxazolyl)-3,5,7-octatrienyl]-11,16-dimethyl-, [1S-[1R*,3R*,5S*, 8R*(1R*,2S*,3E,5E,7E),10R*,11S*,13S*,14E,16S*,17S*]]-"
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,ITGB5;ITGB3;DPYSL3;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
2,KRAS Signaling Up,0.0069294076429407,TMEM158;SPP1;LIF;SOX9;GNG11;PSMB8,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
3,UV Response Dn,0.0080465206835956,ITGB3;PMP22;NR3C1;MT1E;IGF1R,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
4,IL-2/STAT5 Signaling,0.0194680970568948,PRNP;SPP1;LIF;CKAP4;IGF1R,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
5,mTORC1 Signaling,0.0194680970568948,TES;DHCR24;HMGCR;BCAT1;HSP90B1,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
6,Allograft Rejection,0.0194680970568948,TGFB2;LIF;HLA-A;TLR6;BCAT1,"9, bis(4,5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride"
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,VCAN;SPARC;LGALS1;DST;COL4A2;SPP1;FN1;SNAI2;TGFBI;EMP3;THBS1,Clomesone
1,KRAS Signaling Up,0.0078738145943993,GABRA3;SPP1;LY96;PLAT;ETV1;LCP1,Clomesone
2,Coagulation,0.0078738145943993,SPARC;CAPN2;FN1;PLAT;THBS1,Clomesone
3,Angiogenesis,0.0078738145943993,APP;VCAN;SPP1,Clomesone
4,Apoptosis,0.0106002849127709,APP;CAV1;BAX;PMAIP1;PLAT,Clomesone
5,Apical Junction,0.0227127798997107,VCAN;RAC2;MSN;TGFBI;MAPK13,Clomesone
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,LOX;TNFRSF12A;CALD1;COL4A1;COL12A1;SERPINE1;SNAI2;PLOD2;LAMC1;DKK1;LOXL2,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
1,Hypoxia,1.340534212343487e-05,EXT1;LOX;ANXA2;SERPINE1;PRKCA;KDELR3;ETS1;EGFR;TMEM45A,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
2,UV Response Dn,9.785170242963228e-05,TJP1;DDAH1;ANXA2;SERPINE1;SNAI2;PRKCA;LAMC1,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
3,TNF-alpha Signaling via NF-kB,0.0175687705147588,NFKBIA;CCND1;PLAU;SERPINE1;IL6ST,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
4,Apical Junction,0.0175687705147588,TJP1;RRAS;EGFR;ACTB;PTK2,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
5,Xenobiotic Metabolism,0.0175687705147588,TPST1;SERPINE1;MAN1A1;PTGR1;EPHA2,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
6,Glycolysis,0.0175687705147588,EXT1;TPST1;PLOD2;KDELR3;EGFR,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
7,Apoptosis,0.0390190504173245,CCND1;TNFRSF12A;CLU;PTK2,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
8,IL-6/JAK/STAT3 Signaling,0.0390190504173245,TNFRSF12A;PDGFC;IL6ST,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
9,Notch Signaling,0.041197731852232,CCND1;PRKCA,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
10,Androgen Response,0.0430461553124786,CDK6;CCND1;ELL2,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
11,Hedgehog Signaling,0.0430461553124786,NRP2;CDK6,"[(5Z,8E,13E)-25-acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
0,Hedgehog Signaling,0.0157005281631133,NRP2;CDK6;VLDLR,Amsalog
1,UV Response Dn,0.0157005281631133,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,Amsalog
2,E2F Targets,0.0443176193165087,DNMT1;PLK1;CDK1;TP53;AURKB,Amsalog
0,Epithelial Mesenchymal Transition,7.849230926268477e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;GJA1;LGALS1;COL4A2;SPP1;TGFBI;EDIL3,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
1,Estrogen Response Late,0.0056671163108622,ST14;CAV1;MYOF;FLNB;IL6ST;MAPK13,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
2,KRAS Signaling Up,0.0056671163108622,SPP1;LIF;LY96;PLAT;ETV1;LCP1,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
3,Coagulation,0.0056671163108622,SPARC;CAPN2;FN1;PLAT;THBS1,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
4,IL-2/STAT5 Signaling,0.0145417188382294,CDKN1C;AHNAK;SPP1;LIF;CKAP4,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
5,Estrogen Response Early,0.0145417188382294,GJA1;MYOF;TBC1D30;FLNB;IL6ST,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
6,Myogenesis,0.0145417188382294,APP;MEF2C;SPARC;COL4A2;ITGB5,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
7,Apical Junction,0.0145417188382294,SGCE;CLDN4;MSN;TGFBI;MAPK13,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
8,UV Response Dn,0.0230435052916988,GJA1;CAV1;MAP1B;RND3,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
9,Angiogenesis,0.0421710849710805,APP;SPP1,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
10,Mitotic Spindle,0.0421710849710805,MARCKS;DST;CDK1;FLNB,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
11,TNF-alpha Signaling via NF-kB,0.0421710849710805,MARCKS;TUBB2A;LIF;IL6ST,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
12,Hypoxia,0.0421710849710805,CDKN1C;SRPX;CAV1;TGFBI,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
13,p53 Pathway,0.0421710849710805,APP;ST14;LIF;TM4SF1,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
14,Allograft Rejection,0.0421710849710805,LIF;CSK;HLA-A;TLR6,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
15,Apical Surface,0.0446894959470647,SRPX;APP,1-(2-Chloroethyl)-4-(3-chloropropyl)piperazine dihydrochloride
0,Epithelial Mesenchymal Transition,6.952175963266367e-10,SPARC;SERPINE2;DST;ITGB5;FN1;EMP3;THBS1;GJA1;LGALS1;SPP1;SDC1;TGFBI;EDIL3,Cyclodisone
1,Estrogen Response Late,0.0048671637305651,ST14;CAV1;MYOF;FLNB;IL6ST;MAPK13,Cyclodisone
2,Apical Junction,0.0048671637305651,SGCE;CLDN4;ITGA3;MSN;TGFBI;MAPK13,Cyclodisone
3,Coagulation,0.0048671637305651,SPARC;CAPN2;FN1;PLAT;THBS1,Cyclodisone
4,UV Response Dn,0.0048671637305651,GJA1;ANXA2;CAV1;MAP1B;RND3,Cyclodisone
5,IL-2/STAT5 Signaling,0.0103038464910882,CDKN1C;AHNAK;SPP1;LIF;CKAP4,Cyclodisone
6,Hypoxia,0.0103038464910882,CDKN1C;SRPX;ANXA2;CAV1;TGFBI,Cyclodisone
7,Estrogen Response Early,0.0103038464910882,GJA1;MYOF;TBC1D30;FLNB;IL6ST,Cyclodisone
8,p53 Pathway,0.0103038464910882,APP;ST14;LIF;SDC1;TM4SF1,Cyclodisone
9,KRAS Signaling Up,0.0103038464910882,SPP1;LIF;LY96;PLAT;LCP1,Cyclodisone
10,Angiogenesis,0.0393443974846242,APP;SPP1,Cyclodisone
11,TNF-alpha Signaling via NF-kB,0.0400194990031683,MARCKS;TUBB2A;LIF;IL6ST,Cyclodisone
12,Myogenesis,0.0400194990031683,APP;MEF2C;SPARC;ITGB5,Cyclodisone
13,Allograft Rejection,0.0400194990031683,LIF;CSK;HLA-A;TLR6,Cyclodisone
14,Apical Surface,0.0422209333137983,SRPX;APP,Cyclodisone
0,Hypoxia,1.138796860580933e-06,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR,2-Methylellipticinium iodide
1,Epithelial Mesenchymal Transition,1.138796860580933e-06,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;FSTL1;CD44;LOXL2,2-Methylellipticinium iodide
2,UV Response Dn,7.589432357213853e-06,TJP1;NRP1;CAV1;SERPINE1;AKT3;PRKCA;MET;RND3,2-Methylellipticinium iodide
3,Apoptosis,0.00014786273506731183,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,2-Methylellipticinium iodide
4,Angiogenesis,0.0002206609960431555,APP;NRP1;FSTL1;PTK2,2-Methylellipticinium iodide
5,Apical Junction,0.00033791337108629577,TJP1;SGCE;ITGA3;AKT3;EGFR;ACTB;PTK2,2-Methylellipticinium iodide
6,Glycolysis,0.00033791337108629577,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44,2-Methylellipticinium iodide
7,IL-2/STAT5 Signaling,0.0018637047792104,MYO1E;NRP1;NT5E;ALCAM;AHNAK;CD44,2-Methylellipticinium iodide
8,TNF-alpha Signaling via NF-kB,0.0018637047792104,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,2-Methylellipticinium iodide
9,Cholesterol Homeostasis,0.0018637047792104,ALCAM;TNFRSF12A;MAL2;CD9,2-Methylellipticinium iodide
10,IL-6/JAK/STAT3 Signaling,0.0031191616348492,TNFRSF12A;CD9;OSMR;CD44,2-Methylellipticinium iodide
11,Protein Secretion,0.0041234845332278,SCRN1;CAV2;PAM;EGFR,2-Methylellipticinium iodide
12,Inflammatory Response,0.0092044286272748,AXL;SERPINE1;SGMS2;OSMR;MET,2-Methylellipticinium iodide
13,Estrogen Response Late,0.0433759731131114,ELOVL5;CAV1;CD9;CD44,2-Methylellipticinium iodide
14,p53 Pathway,0.0433759731131114,VAMP8;APP;PLK2;PTPN14,2-Methylellipticinium iodide
15,Apical Surface,0.0459663386884094,APP;ATP8B1,2-Methylellipticinium iodide
0,Epithelial Mesenchymal Transition,1.9612612598893845e-06,NOTCH2;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;CD44;LOXL2,2-Methylellipticinium methanesulfonate
1,Apical Junction,1.1231502860175164e-05,TJP1;SGCE;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,2-Methylellipticinium methanesulfonate
2,Hypoxia,6.148789409429596e-05,EXT1;MT2A;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;EGFR,2-Methylellipticinium methanesulfonate
3,UV Response Dn,6.148789409429596e-05,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1,2-Methylellipticinium methanesulfonate
4,Apoptosis,0.0001018609952685926,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,2-Methylellipticinium methanesulfonate
5,Angiogenesis,0.00015834469623467176,APP;FSTL1;PTK2;FGFR1,2-Methylellipticinium methanesulfonate
6,TNF-alpha Signaling via NF-kB,0.0020060711165112,MARCKS;SDC4;DUSP1;PLK2;SERPINE1;CD44,2-Methylellipticinium methanesulfonate
7,Cholesterol Homeostasis,0.0020060711165112,TNFRSF12A;GPX8;CD9;S100A11,2-Methylellipticinium methanesulfonate
8,IL-6/JAK/STAT3 Signaling,0.0032828213502579,TNFRSF12A;CD9;OSMR;CD44,2-Methylellipticinium methanesulfonate
9,Mitotic Spindle,0.0085865387425735,NOTCH2;MARCKS;ARHGAP29;CDC42EP1;RHOF,2-Methylellipticinium methanesulfonate
10,Xenobiotic Metabolism,0.0085865387425735,CYB5A;CBR1;MT2A;SERPINE1;PAPSS2,2-Methylellipticinium methanesulfonate
11,p53 Pathway,0.0085865387425735,VAMP8;APP;PLK2;PTPN14;S100A10,2-Methylellipticinium methanesulfonate
12,Protein Secretion,0.0295423808894733,SCRN1;CAV2;EGFR,2-Methylellipticinium methanesulfonate
13,Estrogen Response Late,0.0350170616277722,CAV1;CD9;PAPSS2;CD44,2-Methylellipticinium methanesulfonate
14,Inflammatory Response,0.0350170616277722,AXL;SERPINE1;SGMS2;OSMR,2-Methylellipticinium methanesulfonate
15,Glycolysis,0.0350170616277722,EXT1;CYB5A;EGFR;CD44,2-Methylellipticinium methanesulfonate
0,Epithelial Mesenchymal Transition,4.9976199517654915e-11,SPARC;TNFRSF12A;SDC4;DST;COL12A1;THBS1;GJA1;VCAN;LGALS1;COL4A1;SPP1;ITGAV;VIM;CD44,Mitozolomide
1,Angiogenesis,1.789219037437674e-05,APP;NRP1;VCAN;SPP1;ITGAV,Mitozolomide
2,Cholesterol Homeostasis,0.0004386195720962052,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Mitozolomide
3,Glycolysis,0.0006242010882566297,VCAN;CDK1;MIF;PAM;MET;CD44;IL13RA1,Mitozolomide
4,IL-2/STAT5 Signaling,0.0037528042621055,NRP1;ALCAM;AHNAK;SPP1;ITGAV;CD44,Mitozolomide
5,UV Response Dn,0.0049718339183192,TJP1;NRP1;GJA1;CAV1;MET,Mitozolomide
6,IL-6/JAK/STAT3 Signaling,0.0051738474736784,TNFRSF12A;CD9;CD44;IL13RA1,Mitozolomide
7,Apoptosis,0.0058034226763947,APP;GPX1;TNFRSF12A;CAV1;CD44,Mitozolomide
8,Protein Secretion,0.0058034226763947,SCRN1;DST;CAV2;PAM,Mitozolomide
9,Apical Junction,0.011482292277459,TJP1;VCAN;ITGA3;CTNNA1;MSN,Mitozolomide
10,mTORC1 Signaling,0.011482292277459,ELOVL5;PRDX1;PLK1;CD9;HMGCR,Mitozolomide
11,Androgen Response,0.0429241400598498,ELOVL5;ITGAV;HMGCR,Mitozolomide
12,Mitotic Spindle,0.0429241400598498,DST;PLK1;CDK1;ARHGAP29,Mitozolomide
13,TNF-alpha Signaling via NF-kB,0.0429241400598498,TUBB2A;SDC4;PLK2;CD44,Mitozolomide
14,Hypoxia,0.0429241400598498,SDC4;CAV1;MIF;PAM,Mitozolomide
15,Estrogen Response Late,0.0429241400598498,ELOVL5;CAV1;CD9;CD44,Mitozolomide
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG;CD44,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
1,Estrogen Response Early,0.0008103663251050982,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG;CD44,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
2,KRAS Signaling Up,0.0008103663251050982,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
3,IL-2/STAT5 Signaling,0.00456755781901,NRP1;NT5E;ALCAM;LRIG1;ITGAV;CD44,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
4,Angiogenesis,0.0056845100486395,NRP1;VCAN;ITGAV,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
5,Estrogen Response Late,0.0175687705147588,ELOVL5;ATP2B4;JAK2;AREG;CD44,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
6,Glycolysis,0.0175687705147588,NT5E;VCAN;CDK1;MIF;CD44,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
7,Cholesterol Homeostasis,0.028126668696924,ALCAM;MAL2;HMGCR,"(9E)-2,3,16-Trihydroxy-18-methoxy-12-methyl-6,13-dioxatricyclo[13.4.0.05,7]nonadeca-1(15),9,16,18-tetraene-8,14-dione"
0,Epithelial Mesenchymal Transition,2.39122318958568e-05,TNFRSF12A;SDC4;CALD1;COL12A1;SERPINE1;LAMC1;DKK1;FSTL1;LOXL2,Morpholinoadriamycin
1,Hypoxia,8.102614730773575e-05,EXT1;ANXA2;SDC4;DUSP1;SERPINE1;MIF;ETS1;EGFR,Morpholinoadriamycin
2,Apical Junction,8.102614730773575e-05,TJP1;RRAS;ITGA3;FLNC;RHOF;EGFR;ACTB;PTK2,Morpholinoadriamycin
3,Xenobiotic Metabolism,0.0034167920952191,CYB5A;TPST1;ELOVL5;SERPINE1;MAN1A1;EPHA2,Morpholinoadriamycin
4,Cholesterol Homeostasis,0.0034167920952191,TNFRSF12A;MAL2;CD9;CLU,Morpholinoadriamycin
5,Angiogenesis,0.0037008387813052,APP;FSTL1;PTK2,Morpholinoadriamycin
6,UV Response Dn,0.0037008387813052,TJP1;ANXA2;DUSP1;SERPINE1;LAMC1,Morpholinoadriamycin
7,Apoptosis,0.0053324603981926,APP;TNFRSF12A;TIMP2;CLU;PTK2,Morpholinoadriamycin
8,TNF-alpha Signaling via NF-kB,0.0099714643462144,SDC4;PLAU;DUSP1;PLK2;SERPINE1,Morpholinoadriamycin
9,Glycolysis,0.0099714643462144,EXT1;CYB5A;TPST1;MIF;EGFR,Morpholinoadriamycin
10,p53 Pathway,0.0099714643462144,VAMP8;APP;PLK2;PTPN14;EPHA2,Morpholinoadriamycin
11,Coagulation,0.0140336375938071,PLAU;SERPINE1;CD9;CLU,Morpholinoadriamycin
12,IL-6/JAK/STAT3 Signaling,0.0240928440206765,TNFRSF12A;PDGFC;CD9,Morpholinoadriamycin
13,Complement,0.042601402164663,GCA;SERPINE1;TIMP2;CLU,Morpholinoadriamycin
14,Apical Surface,0.0449448644953337,APP;ATP8B1,Morpholinoadriamycin
0,Hedgehog Signaling,0.0149155017549577,NRP2;CDK6;VLDLR,"Anthra[1,9-cd]pyrazol-6(2H)-one der."
1,UV Response Dn,0.0149155017549577,SDC2;DLC1;ATP2B4;SNAI2;VLDLR,"Anthra[1,9-cd]pyrazol-6(2H)-one der."
2,Epithelial Mesenchymal Transition,0.0421017383506832,VCAN;SPARC;COL4A1;SPP1;SNAI2,"Anthra[1,9-cd]pyrazol-6(2H)-one der."
0,UV Response Dn,0.018840633795736,TJP1;ANXA2;NFIB;MAP1B;ID1,"4-[3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile"
1,TGF-beta Signaling,0.0199429286924289,TJP1;SMURF2;ID1,"4-[3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile"
2,Estrogen Response Early,0.0199429286924289,ABLIM1;KRT18;KRT8;FLNB;SFN,"4-[3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile"
3,Apical Junction,0.0199429286924289,TJP1;RRAS;CTNNA1;RHOF;PTK2,"4-[3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile"
0,Epithelial Mesenchymal Transition,0.001887664519441,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
1,UV Response Dn,0.001887664519441,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
2,Hypoxia,0.0074364374704729,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
3,TNF-alpha Signaling via NF-kB,0.0292496287488957,CEBPB;IRS2;SGK1;FJX1;LITAF,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
4,Complement,0.0292496287488957,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
5,Cholesterol Homeostasis,0.0445972404563841,FDPS;FABP5;HMGCR,"N-(3-hydroxy-1,2-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,SPARC;LGALS1;SERPINE2;DST;ITGB5;SPP1;FN1;EMP3;THBS1;MYLK,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
1,Estrogen Response Late,0.007987935371501,ISG20;ST14;CAV1;RPS6KA2;IL6ST;MAPK13,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
2,Coagulation,0.007987935371501,SPARC;CAPN2;FN1;PLAT;THBS1,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
3,Hypoxia,0.0204968989338852,ISG20;CDKN1C;SRPX;HOXB9;CAV1,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
4,Myogenesis,0.0204968989338852,MEF2C;SPARC;ITGB5;NCAM1;MYLK,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
5,KRAS Signaling Up,0.0204968989338852,SPP1;LY96;PLAT;LCP1;MPZL2,(2-Azanidylcyclohexyl)azanide;tetrachloroplatinum(2+)
0,Glycolysis,2.753529733462298e-05,NT5E;VCAN;CITED2;MIF;PAM;MET;CD44;IER3;IL13RA1,"Camptothecin,N-diethyl) glycinate"
1,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;VCAN;SPARC;LGALS1;COL12A1;SNAI2;THBS1;CD44,"Camptothecin,N-diethyl) glycinate"
2,UV Response Dn,0.0099436678366384,NRP1;CITED2;ATP2B4;SNAI2;MET,"Camptothecin,N-diethyl) glycinate"
3,TNF-alpha Signaling via NF-kB,0.0210508691753416,FOSL1;BTG3;TUBB2A;CD44;IER3,"Camptothecin,N-diethyl) glycinate"
4,Hypoxia,0.0210508691753416,CITED2;MIF;ETS1;PAM;IER3,"Camptothecin,N-diethyl) glycinate"
5,Estrogen Response Late,0.0210508691753416,BTG3;ELOVL5;ATP2B4;JAK2;CD44,"Camptothecin,N-diethyl) glycinate"
6,Apoptosis,0.0473528630547781,BTG3;GPX1;CD44;IER3,"Camptothecin,N-diethyl) glycinate"
0,Epithelial Mesenchymal Transition,5.816213991481708e-15,SPARC;TNFRSF12A;SDC4;DST;COL12A1;SERPINE1;FN1;EMP3;THBS1;LOXL2;NT5E;LGALS1;CDH2;COL4A2;SNAI2;VIM;CD44,Piceatannol
1,TNF-alpha Signaling via NF-kB,8.907502683786802e-08,FOSL1;MARCKS;TUBB2A;CCND1;SDC4;PLAU;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,Piceatannol
2,UV Response Dn,5.292400310899304e-07,TJP1;ANXA2;CAV1;MAP1B;SERPINE1;AKT3;SNAI2;MET;RND3,Piceatannol
3,Coagulation,4.113977178947941e-06,SPARC;PLAU;SERPINE1;FN1;CD9;PLAT;GNG12;THBS1,Piceatannol
4,Hypoxia,5.217214231823301e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;PAM;EGFR;TMEM45A,Piceatannol
5,Glycolysis,4.419608034967404e-05,EXT1;TPST1;NT5E;PAM;MET;EGFR;CD44;IL13RA1,Piceatannol
6,Apoptosis,8.449299146703533e-05,APP;CCND1;TNFRSF12A;CAV1;TIMP2;PLAT;CD44,Piceatannol
7,IL-2/STAT5 Signaling,0.0002864856940718752,MYO1E;NT5E;ALCAM;AHNAK;PHLDA1;CKAP4;CD44,Piceatannol
8,IL-6/JAK/STAT3 Signaling,0.0003018335481838783,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,Piceatannol
10,Cholesterol Homeostasis,0.0016942770720094,ALCAM;TNFRSF12A;GPX8;CD9,Piceatannol
9,Apical Junction,0.0016942770720094,TJP1;SGCE;ITGA3;AKT3;MSN;EGFR,Piceatannol
11,Protein Secretion,0.0041234845332278,DST;CAV2;PAM;EGFR,Piceatannol
12,TGF-beta Signaling,0.0069247241127803,TJP1;SERPINE1;THBS1,Piceatannol
13,Estrogen Response Late,0.0070386807149749,CCND1;CAV1;CD9;IL6ST;CD44,Piceatannol
14,Complement,0.0070386807149749,COL4A2;SERPINE1;FN1;TIMP2;PLAT,Piceatannol
15,Inflammatory Response,0.0070386807149749,AXL;SERPINE1;EMP3;MET;DCBLD2,Piceatannol
16,KRAS Signaling Up,0.0070386807149749,PLAU;LY96;PLAT;ETV1;DCBLD2,Piceatannol
19,p53 Pathway,0.0325319798348335,APP;PLK2;PTPN14;S100A10,Piceatannol
17,Mitotic Spindle,0.0325319798348335,MYO1E;MARCKS;DST;ARHGAP29,Piceatannol
18,Myogenesis,0.0325319798348335,APP;SPARC;COL4A2;CNN3,Piceatannol
20,Apical Surface,0.0350219723340262,APP;DCBLD2,Piceatannol
0,Hypoxia,0.0315763037630124,CDKN1C;HOXB9;COL5A1;RRAGD;TNFAIP3,Sodium;6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid
1,Complement,0.0315763037630124,CFH;ERAP2;KYNU;TNFAIP3;FYN,Sodium;6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid
2,Epithelial Mesenchymal Transition,0.0315763037630124,COL5A1;WIPF1;SPP1;TNFAIP3;FBLN1,Sodium;6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid
3,KRAS Signaling Up,0.0315763037630124,CFH;GYPC;SPP1;TNFAIP3;LCP1,Sodium;6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,ITGB5;ITGB3;DPYSL3;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,Imiquimod
1,Hypoxia,0.00134696024308,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,Imiquimod
2,KRAS Signaling Up,0.0069294076429407,TMEM158;SPP1;LIF;SOX9;LCP1;PSMB8,Imiquimod
3,UV Response Dn,0.0080465206835956,ITGB3;PMP22;NR3C1;MT1E;IGF1R,Imiquimod
4,IL-2/STAT5 Signaling,0.0194680970568948,PRNP;SPP1;LIF;CKAP4;IGF1R,Imiquimod
5,mTORC1 Signaling,0.0194680970568948,TES;DHCR24;HMGCR;BCAT1;HSP90B1,Imiquimod
6,Allograft Rejection,0.0194680970568948,TGFB2;LIF;HLA-A;TLR6;BCAT1,Imiquimod
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,VCAN;SPARC;LGALS1;CDH2;DST;BASP1;SPP1;EMP3;THBS1,"Camptothecin, 10-amino-"
1,Glycolysis,0.00015468628122385913,VCAN;CITED2;CDK1;MIF;PYGL;PAM;MET;IL13RA1,"Camptothecin, 10-amino-"
2,p53 Pathway,0.0070984175854514,APP;LDHB;BAX;TXNIP;TM4SF1;S100A10,"Camptothecin, 10-amino-"
3,Angiogenesis,0.0080658588527993,APP;VCAN;SPP1,"Camptothecin, 10-amino-"
4,Fatty Acid Metabolism,0.0090490237060239,LGALS1;ELOVL5;DHCR24;MIF;S100A10,"Camptothecin, 10-amino-"
5,Apoptosis,0.0090490237060239,APP;BTG3;GPX1;BAX;TXNIP,"Camptothecin, 10-amino-"
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,NT5E;VCAN;ECM1;SPARC;LGALS1;COL12A1;TNC;SNAI2;CD44,Fenretinide
1,KRAS Signaling Up,0.001182696798802,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,Fenretinide
2,Estrogen Response Early,0.0045632684477902,ELOVL5;ELOVL2;DLC1;ENDOD1;JAK2;CD44,Fenretinide
3,Glycolysis,0.0045632684477902,NT5E;VCAN;CDK1;MIF;CD44;IER3,Fenretinide
4,Hedgehog Signaling,0.0055308746419195,NRP1;NRP2;CDK6,Fenretinide
5,TNF-alpha Signaling via NF-kB,0.0199429286924289,FOSL1;PLAU;TNC;CD44;IER3,Fenretinide
6,UV Response Dn,0.0304738600592261,NRP1;DLC1;ATP2B4;SNAI2,Fenretinide
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;SPARC;LGALS1;SPP1;FN1;TGFBI;EMP3;THBS1,Carmustine
0,Epithelial Mesenchymal Transition,7.849230926268477e-10,BDNF;ITGB3;TFPI2;PLOD3;VEGFC;GLIPR1;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;EDIL3;FBN1,"Aureolic acid, magnesium deriv"
1,UV Response Dn,0.0001388436318258296,EFEMP1;BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3,"Aureolic acid, magnesium deriv"
2,Coagulation,0.0075561550811496,PROS1;ITGB3;TFPI2;PRSS23;FBN1,"Aureolic acid, magnesium deriv"
3,Androgen Response,0.0139821306062007,CDK6;ADAMTS1;SGK1;ELL2,"Aureolic acid, magnesium deriv"
0,Epithelial Mesenchymal Transition,8.522022148520062e-10,BDNF;ITGB3;TFPI2;PLOD3;VEGFC;GLIPR1;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;SNAI2;MYL9,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
1,UV Response Dn,8.379633825590565e-07,BDNF;SDC2;ITGB3;BHLHE40;PMP22;LPAR1;SNAI2;VLDLR;PLPP3,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
2,Hypoxia,0.0048167833615563,SRPX;SDC2;BHLHE40;GCNT2;VLDLR;TMEM45A,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
3,Myogenesis,0.0048167833615563,WWTR1;PRNP;MEF2C;BHLHE40;ADAM12;IGFBP7,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
4,Hedgehog Signaling,0.0058381454553595,NRP2;CDK6;VLDLR,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
5,Androgen Response,0.0101203992959167,CDK6;HMGCR;SGK1;ELL2,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
6,Estrogen Response Early,0.0157881518815062,TFAP2C;BHLHE40;JAK2;MYBL1;PRSS23,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
7,Estrogen Response Late,0.0157881518815062,TFAP2C;TFPI2;SGK1;JAK2;PRSS23,"4-[[(1S,9S,10S,12R)-4,12-diacetyloxy-15-[(2R)-3-benzamido-2-(3-carboxypropanoyloxy)-3-phenylpropanoyl]oxy-2-benzoyloxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-9-yl]oxy]-4-oxobutanoic acid"
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;SPARC;LGALS1;SPP1;FN1;TGFBI;EMP3;THBS1,9-Aminocamptothecin
1,Interferon Alpha Response,0.0278493383865157,BST2;HLA-C;TXNIP;B2M,9-Aminocamptothecin
2,Hypoxia,0.0324072591251969,CDKN1C;SRPX;CAV1;GLRX;TGFBI,9-Aminocamptothecin
3,KRAS Signaling Up,0.0324072591251969,SPP1;GLRX;ETV1;LCP1;TFPI,9-Aminocamptothecin
4,Coagulation,0.0398044993569801,SPARC;CAPN2;FN1;THBS1,9-Aminocamptothecin
0,Apoptosis,0.0357310805739351,IFITM3;BTG3;BAX;TXNIP;BIRC3,10-Hydroxy-9-nitrocamptothecin
1,mTORC1 Signaling,0.0357310805739351,PLK1;DHCR24;HMGCR;AURKA;HSP90B1,10-Hydroxy-9-nitrocamptothecin
2,E2F Targets,0.0357310805739351,DNMT1;PLK1;CDK1;TP53;AURKA,10-Hydroxy-9-nitrocamptothecin
3,KRAS Signaling Up,0.0357310805739351,SPP1;LCP1;TFPI;PSMB8;BIRC3,10-Hydroxy-9-nitrocamptothecin
0,Estrogen Response Early,1.6666101018324435e-05,ABLIM1;KRT19;RAB31;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
1,Estrogen Response Late,0.000755611843679078,KRT19;RAB31;MYOF;NRIP1;FLNB;SFN;LSR,4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
2,TGF-beta Signaling,0.0011774778228969,TJP1;RAB31;SMURF2;ID1,4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
3,UV Response Dn,0.0045139018468951,TJP1;ANXA2;NFIB;MAP1B;ID1,4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
0,Epithelial Mesenchymal Transition,0.0025625097307377,VCAN;SPARC;LGALS1;BASP1;SPP1;EMP3;THBS1,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-"
1,Apoptosis,0.0207734511863554,IFITM3;BTG3;GPX1;BAX;TXNIP,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-"
2,Androgen Response,0.0207734511863554,ELOVL5;DHCR24;HMGCR;B2M,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-"
3,IL-2/STAT5 Signaling,0.0259258073001575,IFITM3;ALCAM;CTSZ;SPP1;IGF1R,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-"
4,mTORC1 Signaling,0.0259258073001575,ELOVL5;PRDX1;PLK1;DHCR24;HMGCR,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-8-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-"
0,Estrogen Response Early,1.956455336933738e-05,ABLIM1;KRT19;RAB31;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,11-Hydroxymethyl-20(RS)-camptothecin
1,Estrogen Response Late,0.0068449026716853,KRT19;RAB31;MYOF;NRIP1;FLNB;SFN,11-Hydroxymethyl-20(RS)-camptothecin
0,Epithelial Mesenchymal Transition,0.0192671334462254,VCAN;SPARC;LGALS1;BASP1;SPP1;EMP3,Camptothecin propylglycinate ester hydrochloride
1,Apoptosis,0.0245616357734936,IFITM3;BTG3;BAX;TXNIP;IER3,Camptothecin propylglycinate ester hydrochloride
2,IL-2/STAT5 Signaling,0.0315763037630124,IFITM3;CTSZ;SPP1;PLIN2;IGF1R,Camptothecin propylglycinate ester hydrochloride
3,p53 Pathway,0.0315763037630124,LDHB;HDAC3;BAX;TXNIP;IER3,Camptothecin propylglycinate ester hydrochloride
0,Protein Secretion,0.003855257888655,TPD52;SCRN1;DST;CAV2;PAM,Camptothecin butylglycinate ester hydrochloride
1,Glycolysis,0.0081124772405159,MIF;PYGL;PAM;MET;IER3;IL13RA1,Camptothecin butylglycinate ester hydrochloride
2,UV Response Dn,0.0083736150203271,TJP1;NRP1;ID1;MET;CAP2,Camptothecin butylglycinate ester hydrochloride
3,Hypoxia,0.0212724572719241,TPD52;SDC4;MIF;PAM;IER3,Camptothecin butylglycinate ester hydrochloride
4,p53 Pathway,0.0212724572719241,APP;HDAC3;PLK2;S100A10;IER3,Camptothecin butylglycinate ester hydrochloride
5,Cholesterol Homeostasis,0.032434356695552,ALCAM;MAL2;CD9,Camptothecin butylglycinate ester hydrochloride
6,Fatty Acid Metabolism,0.0373797462916918,ELOVL5;PCBD1;MIF;S100A10,Camptothecin butylglycinate ester hydrochloride
7,Angiogenesis,0.0481955256812349,APP;NRP1,Camptothecin butylglycinate ester hydrochloride
8,Pperoxisome,0.0481955256812349,SEMA3C;ELOVL5;PRDX1,Camptothecin butylglycinate ester hydrochloride
9,TNF-alpha Signaling via NF-kB,0.0481955256812349,TUBB2A;SDC4;PLK2;IER3,Camptothecin butylglycinate ester hydrochloride
10,Apical Junction,0.0481955256812349,TJP1;ITGA3;FSCN1;CTNNA1,Camptothecin butylglycinate ester hydrochloride
11,Epithelial Mesenchymal Transition,0.0481955256812349,SDC4;DST;PFN2;CAP2,Camptothecin butylglycinate ester hydrochloride
0,UV Response Dn,0.002488285048354,EFEMP1;ANXA2;DUSP1;BDNF;NFIB;LPAR1,Rapamycin prodrug
1,Estrogen Response Early,0.0240977055033516,ABLIM1;KRT19;KRT18;KRT8;FLNB,Rapamycin prodrug
2,Epithelial Mesenchymal Transition,0.0240977055033516,GLIPR1;CALD1;BDNF;VEGFC;EDIL3,Rapamycin prodrug
3,Xenobiotic Metabolism,0.0240977055033516,TPST1;TGFB2;GCH1;PTGR1;EPHA2,Rapamycin prodrug
0,Epithelial Mesenchymal Transition,0.0050241690121962,GJA1;TNFRSF12A;SDC4;DST;ITGAV;PFN2,5-(6-Amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol
1,p53 Pathway,0.0050241690121962,APP;LDHB;HDAC3;PLK2;PTPN14;S100A10,5-(6-Amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol
2,Cholesterol Homeostasis,0.0050241690121962,ALCAM;TNFRSF12A;MAL2;CD9,5-(6-Amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol
3,Angiogenesis,0.0050241690121962,APP;NRP1;ITGAV,5-(6-Amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol
4,UV Response Dn,0.0050241690121962,TJP1;NRP1;GJA1;ID1;MET,5-(6-Amino-2-chloro-9-purinyl)-4-fluoro-2-(hydroxymethyl)-3-oxolanol
0,Epithelial Mesenchymal Transition,0.00015468628122385913,VCAN;SPARC;LGALS1;COL12A1;SPP1;SNAI2;THBS1;CD44,"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride"
1,Glycolysis,0.00015468628122385913,VCAN;CITED2;CDK1;MIF;PAM;MET;CD44;IL13RA1,"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride"
2,Angiogenesis,0.0082427772856345,NRP1;VCAN;SPP1,"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride"
3,UV Response Dn,0.0082427772856345,NRP1;CITED2;ATP2B4;SNAI2;MET,"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride"
4,Estrogen Response Late,0.0279201001694004,BTG3;ELOVL5;ATP2B4;JAK2;CD44,"4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride"
0,mTORC1 Signaling,0.0026282151084489,TES;PRDX1;PLK1;DHCR24;BCAT1;AURKA;HSP90B1,"Camptothecin, N-methylglycinate ester"
1,Epithelial Mesenchymal Transition,0.0101405965506449,LGALS1;BASP1;SPP1;FN1;TGFBI;EMP3,"Camptothecin, N-methylglycinate ester"
2,Interferon Alpha Response,0.0190422826574466,IFITM3;LGALS3BP;TXNIP;PSMB8,"Camptothecin, N-methylglycinate ester"
3,IL-2/STAT5 Signaling,0.0265905715899052,IFITM3;CTSZ;SPP1;LIF;IGF1R,"Camptothecin, N-methylglycinate ester"
4,p53 Pathway,0.0265905715899052,LDHB;LIF;BAX;TXNIP;TM4SF1,"Camptothecin, N-methylglycinate ester"
5,UV Response Dn,0.0395031519286265,TFPI;NR3C1;MGLL;IGF1R,"Camptothecin, N-methylglycinate ester"
6,Apoptosis,0.0498451190050296,IFITM3;BTG3;BAX;TXNIP,"Camptothecin, N-methylglycinate ester"
0,p53 Pathway,0.0122908325375989,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Navelbine ditartrate (TN)
1,Angiogenesis,0.0122908325375989,APP;FSTL1;PTK2,Navelbine ditartrate (TN)
2,Apoptosis,0.0137889885044174,APP;KRT18;TNFRSF12A;CLU;PTK2,Navelbine ditartrate (TN)
3,TGF-beta Signaling,0.020004758548032,TJP1;SMURF2;ID1,Navelbine ditartrate (TN)
4,Apical Junction,0.0212724572719241,TJP1;RRAS;RHOF;EGFR;PTK2,Navelbine ditartrate (TN)
5,Cholesterol Homeostasis,0.032434356695552,TNFRSF12A;MAL2;CLU,Navelbine ditartrate (TN)
0,Epithelial Mesenchymal Transition,8.74628588927059e-10,TNFRSF12A;COL12A1;SERPINE1;TNC;PLOD2;LOXL2;NT5E;MMP14;LOX;CALD1;COL4A1;SNAI2;ITGAV,2'-Glutaryltaxol-3-(dimethylamino)propylamide
1,Angiogenesis,0.0004270849551229572,NRP1;JAG1;ITGAV;PTK2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
2,TNF-alpha Signaling via NF-kB,0.0004270849551229572,NFKBIA;JAG1;CCND1;PLAU;SERPINE1;TNC;IL6ST,2'-Glutaryltaxol-3-(dimethylamino)propylamide
3,Hypoxia,0.0004270849551229572,LOX;SERPINE1;PRKCA;KDELR3;ETS1;EGFR;TMEM45A,2'-Glutaryltaxol-3-(dimethylamino)propylamide
4,Estrogen Response Early,0.0004270849551229572,FARP1;CCND1;ELOVL5;ENDOD1;IL6ST;JAK2;MYBL1,2'-Glutaryltaxol-3-(dimethylamino)propylamide
5,Estrogen Response Late,0.0004270849551229572,FARP1;CCND1;ELOVL5;ATP2B4;IL6ST;JAK2;ASS1,2'-Glutaryltaxol-3-(dimethylamino)propylamide
6,UV Response Dn,0.0004780449107675354,NRP1;DDAH1;SERPINE1;ATP2B4;SNAI2;PRKCA,2'-Glutaryltaxol-3-(dimethylamino)propylamide
7,Androgen Response,0.000712108861367963,CDK6;CCND1;ELOVL5;ITGAV;ELL2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
11,Notch Signaling,0.0017596184746004,JAG1;CCND1;PRKCA,2'-Glutaryltaxol-3-(dimethylamino)propylamide
10,Cholesterol Homeostasis,0.0017596184746004,JAG1;TNFRSF12A;MAL2;CLU,2'-Glutaryltaxol-3-(dimethylamino)propylamide
9,KRAS Signaling Up,0.0017596184746004,NRP1;PLAU;SPRY2;PLEK2;ETS1;TRIB2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
8,Xenobiotic Metabolism,0.0017596184746004,TPST1;ELOVL5;SERPINE1;MAN1A1;PTGR1;EPHA2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
12,Hedgehog Signaling,0.0023045311007998,NRP1;NRP2;CDK6,2'-Glutaryltaxol-3-(dimethylamino)propylamide
13,Complement,0.0086419357667191,MMP14;GCA;SERPINE1;JAK2;CLU,2'-Glutaryltaxol-3-(dimethylamino)propylamide
14,Glycolysis,0.0086419357667191,TPST1;NT5E;PLOD2;KDELR3;EGFR,2'-Glutaryltaxol-3-(dimethylamino)propylamide
15,Coagulation,0.0124389060490562,MMP14;PLAU;SERPINE1;CLU,2'-Glutaryltaxol-3-(dimethylamino)propylamide
16,Apoptosis,0.0200113492476074,CCND1;TNFRSF12A;CLU;PTK2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
17,IL-6/JAK/STAT3 Signaling,0.0205640941388602,TNFRSF12A;PDGFC;IL6ST,2'-Glutaryltaxol-3-(dimethylamino)propylamide
18,Apical Junction,0.035242978154403,RRAS;EGFR;ACTB;PTK2,2'-Glutaryltaxol-3-(dimethylamino)propylamide
19,Inflammatory Response,0.035242978154403,NFKBIA;MMP14;AXL;SERPINE1,2'-Glutaryltaxol-3-(dimethylamino)propylamide
0,Epithelial Mesenchymal Transition,1.0134397462809972e-08,GLIPR1;MMP14;LOX;CALD1;COL4A1;COL12A1;SERPINE1;TNC;SNAI2;PLOD2;PDLIM4;LOXL2,"From marine animal, Axinella sp."
1,UV Response Dn,0.00011504186636997308,RBPMS;SERPINE1;FHL2;SNAI2;VLDLR;PLPP3;TGFBR2,"From marine animal, Axinella sp."
2,TNF-alpha Signaling via NF-kB,0.002940772999687,NFKBIA;PLAU;SERPINE1;TNC;IL6ST;PLPP3,"From marine animal, Axinella sp."
3,Hypoxia,0.002940772999687,LOX;SERPINE1;VLDLR;KDELR3;ETS1;TMEM45A,"From marine animal, Axinella sp."
4,Estrogen Response Early,0.002940772999687,ENDOD1;FHL2;IL6ST;JAK2;NBL1;MYBL1,"From marine animal, Axinella sp."
5,Hedgehog Signaling,0.0037128556623996,NRP2;CDK6;VLDLR,"From marine animal, Axinella sp."
0,mTORC1 Signaling,0.0212952527563544,PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Topotecan
1,Interferon Alpha Response,0.0299915951854784,IFITM3;HLA-C;TXNIP;PSMB8,Topotecan
2,E2F Targets,0.0465335002823341,DNMT1;PLK1;CDK1;TP53;AURKA,Topotecan
0,IL-2/STAT5 Signaling,0.0065913877579192,IFITM3;CTSZ;SPP1;LIF;AHR;IGF1R,Camptothecin hemisuccinate sodium salt
1,mTORC1 Signaling,0.0065913877579192,TES;PRDX1;DHCR24;BCAT1;AURKA;HSP90B1,Camptothecin hemisuccinate sodium salt
2,Epithelial Mesenchymal Transition,0.0065913877579192,ITGB5;BASP1;SPP1;FN1;TGFBI;EMP3,Camptothecin hemisuccinate sodium salt
3,Interferon Alpha Response,0.0139246691932578,IFITM3;LGALS3BP;TXNIP;PSMB8,Camptothecin hemisuccinate sodium salt
4,p53 Pathway,0.0259258073001575,LDHB;LIF;BAX;TXNIP;TM4SF1,Camptothecin hemisuccinate sodium salt
0,Epithelial Mesenchymal Transition,0.0025625097307377,VCAN;SPARC;LGALS1;SPP1;TGFBI;EMP3;THBS1,Camptothecin phosphate
1,Androgen Response,0.0311601767795331,ELOVL5;DHCR24;HMGCR;B2M,Camptothecin phosphate
2,Glycolysis,0.0432096788335959,VCAN;CITED2;CDK1;TGFBI;MIF,Camptothecin phosphate
0,Hypoxia,0.0202811931012899,CDKN1C;SRPX;DTNA;IRS2;AMPD3;MT1E,"4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone hydrochloride"
0,Epithelial Mesenchymal Transition,0.0133454489386463,GLIPR1;BDNF;LAMC1;FGF2;EDIL3;FERMT2,CID 6711321
1,UV Response Dn,0.0133454489386463,EFEMP1;DUSP1;BDNF;BHLHE40;LAMC1,CID 6711321
2,IL-2/STAT5 Signaling,0.0282524823142742,PRNP;PLAGL1;BHLHE40;PLIN2;AHR,CID 6711321
3,Estrogen Response Early,0.0282524823142742,KRT18;BHLHE40;RHOBTB3;FLNB;PRSS23,CID 6711321
0,Epithelial Mesenchymal Transition,0.0187601036186931,VCAN;SPARC;LGALS1;BASP1;SPP1;EMP3,"Camptothecin-20-O-(N,N-dimethyl)glycinate HCl"
1,Apoptosis,0.023915276937349,IFITM3;BTG3;GPX1;BAX;TXNIP,"Camptothecin-20-O-(N,N-dimethyl)glycinate HCl"
0,Apical Junction,0.0022339828421816,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
1,p53 Pathway,0.0053381795754585,VAMP8;APP;PLK2;SFN;PTPN14;S100A10,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
2,Cholesterol Homeostasis,0.0053381795754585,ALCAM;TNFRSF12A;MAL2;CD9,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
3,Angiogenesis,0.0053381795754585,APP;NRP1;PTK2,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
4,UV Response Dn,0.0053381795754585,TJP1;NRP1;ANXA2;ID1;MET,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
5,Protein Secretion,0.0077888041183192,SCRN1;DST;CAV2;EGFR,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
6,Fatty Acid Metabolism,0.0370723072599908,ELOVL5;PCBD1;MIF;S100A10,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
7,Apoptosis,0.0370723072599908,APP;GPX1;TNFRSF12A;PTK2,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
8,Pperoxisome,0.0472686886489035,SEMA3C;ELOVL5;PRDX1,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
9,Hypoxia,0.0472686886489035,ANXA2;SDC4;MIF;EGFR,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
10,Estrogen Response Early,0.0472686886489035,ABLIM1;ELOVL5;KRT8;SFN,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
11,Estrogen Response Late,0.0472686886489035,ELOVL5;CD9;SFN;LSR,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
12,Epithelial Mesenchymal Transition,0.0472686886489035,TNFRSF12A;SDC4;DST;COL12A1,"Benzoic acid,2-[[[(4S)-4-carboxy-4-[[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]amino]butyl]amino]carbonyl]-"
0,Epithelial Mesenchymal Transition,2.318761880810356e-05,NOTCH2;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;LOXL2,"9-Methoxy-2-methylellipticinium acetate, hydrate"
1,Apical Junction,8.462849939860089e-05,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,"9-Methoxy-2-methylellipticinium acetate, hydrate"
2,UV Response Dn,8.462849939860089e-05,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1,"9-Methoxy-2-methylellipticinium acetate, hydrate"
3,Angiogenesis,0.000245178884492395,APP;FSTL1;PTK2;FGFR1,"9-Methoxy-2-methylellipticinium acetate, hydrate"
4,Hypoxia,0.0004205144173518348,EXT1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;EGFR,"9-Methoxy-2-methylellipticinium acetate, hydrate"
5,Apoptosis,0.0008444417124781373,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2,"9-Methoxy-2-methylellipticinium acetate, hydrate"
6,p53 Pathway,0.0023178506401474,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,"9-Methoxy-2-methylellipticinium acetate, hydrate"
7,TGF-beta Signaling,0.010002379274016,TJP1;SMURF2;SERPINE1,"9-Methoxy-2-methylellipticinium acetate, hydrate"
8,Mitotic Spindle,0.010636228635962,NOTCH2;MARCKS;ARHGAP29;CDC42EP1;RHOF,"9-Methoxy-2-methylellipticinium acetate, hydrate"
9,TNF-alpha Signaling via NF-kB,0.010636228635962,MARCKS;SDC4;DUSP1;PLK2;SERPINE1,"9-Methoxy-2-methylellipticinium acetate, hydrate"
10,Cholesterol Homeostasis,0.0176914672884829,TNFRSF12A;GPX8;CD9,"9-Methoxy-2-methylellipticinium acetate, hydrate"
11,IL-6/JAK/STAT3 Signaling,0.025309654324751,TNFRSF12A;CD9;OSMR,"9-Methoxy-2-methylellipticinium acetate, hydrate"
12,Protein Secretion,0.030495360918166,SCRN1;CAV2;EGFR,"9-Methoxy-2-methylellipticinium acetate, hydrate"
13,Xenobiotic Metabolism,0.0413104505839156,CYB5A;CBR1;SERPINE1;EPHA2,"9-Methoxy-2-methylellipticinium acetate, hydrate"
0,Epithelial Mesenchymal Transition,1.293009331461962e-08,NT5E;VCAN;MMP14;ECM1;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;ITGAV;PDLIM4;LOXL2,Docetaxel
1,KRAS Signaling Up,0.0001362712477448283,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,Docetaxel
2,Hedgehog Signaling,0.0003779841135924423,NRP1;NRP2;CDK6;VLDLR,Docetaxel
3,Glycolysis,0.0046900259046732,TPST1;NT5E;VCAN;CDK1;MIF;VLDLR,Docetaxel
4,Angiogenesis,0.0048409961836266,NRP1;VCAN;ITGAV,Docetaxel
5,UV Response Dn,0.0048409961836266,NRP1;ATP2B4;SNAI2;PRKCA;VLDLR,Docetaxel
6,Androgen Response,0.0084463482845621,CDK6;ELOVL5;ITGAV;HMGCR,Docetaxel
7,Hypoxia,0.0153726742004139,PRKCA;MIF;VLDLR;ETS1;TMEM45A,Docetaxel
0,Epithelial Mesenchymal Transition,3.115836277338916e-05,VCAN;SPARC;LGALS1;DST;SPP1;TGFBI;EMP3;THBS1;CD44,9-Amino-20-camptothecin
1,Glycolysis,0.0001583692879196653,VCAN;CITED2;CDK1;GLRX;TGFBI;MET;CD44;IL13RA1,9-Amino-20-camptothecin
2,Apoptosis,0.0022694371022849,APP;BTG3;CAV1;BAX;TXNIP;CD44,9-Amino-20-camptothecin
3,Hypoxia,0.0043604565167773,CDKN1C;SRPX;CITED2;CAV1;GLRX;TGFBI,9-Amino-20-camptothecin
4,mTORC1 Signaling,0.0043604565167773,ELOVL5;PRDX1;PLK1;GLRX;DHCR24;HMGCR,9-Amino-20-camptothecin
5,Angiogenesis,0.0055052687407995,APP;VCAN;SPP1,9-Amino-20-camptothecin
6,Androgen Response,0.0098160263847613,ELOVL5;DHCR24;HMGCR;B2M,9-Amino-20-camptothecin
7,KRAS Signaling Up,0.0178655402869675,SPP1;GLRX;ETV1;LCP1;TFPI,9-Amino-20-camptothecin
8,UV Response Dn,0.0283105922155156,CITED2;CAV1;TFPI;MET,9-Amino-20-camptothecin
9,Interferon Alpha Response,0.0485720532256195,BST2;TXNIP;B2M,9-Amino-20-camptothecin
10,Pperoxisome,0.0485720532256195,ELOVL5;PRDX1;DHCR24,9-Amino-20-camptothecin
11,IL-2/STAT5 Signaling,0.0485720532256195,CDKN1C;ALCAM;SPP1;CD44,9-Amino-20-camptothecin
12,Estrogen Response Late,0.0485720532256195,BTG3;ELOVL5;CAV1;CD44,9-Amino-20-camptothecin
13,Apical Junction,0.0485720532256195,VCAN;RAC2;MSN;TGFBI,9-Amino-20-camptothecin
14,E2F Targets,0.0485720532256195,DNMT1;PLK1;CDK1;AURKB,9-Amino-20-camptothecin
15,p53 Pathway,0.0485720532256195,APP;LDHB;BAX;TXNIP,9-Amino-20-camptothecin
0,Apical Junction,0.0021682774644703,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Istodax
1,p53 Pathway,0.0056946534920319,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Istodax
2,Cholesterol Homeostasis,0.0056946534920319,TNFRSF12A;GPX8;MAL2;CD9,Istodax
3,UV Response Dn,0.0488851505116753,TJP1;ABCC1;ANXA2;ID1,Istodax
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;LAMC1;FSTL1;CD44;LOXL2,Lovastatin
1,Hypoxia,1.3043035579558251e-05,EXT1;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,Lovastatin
2,Apical Junction,0.000772226394316788,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,Lovastatin
3,UV Response Dn,0.000772226394316788,TJP1;ANXA2;CAV1;SERPINE1;PRKCA;LAMC1,Lovastatin
4,Apoptosis,0.0011399963118454,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Lovastatin
5,TNF-alpha Signaling via NF-kB,0.0030421789651934,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Lovastatin
6,Angiogenesis,0.0039506247442282,APP;FSTL1;PTK2,Lovastatin
7,IL-6/JAK/STAT3 Signaling,0.0042888472479176,TNFRSF12A;CD9;OSMR;CD44,Lovastatin
10,p53 Pathway,0.0108779611049612,VAMP8;APP;PLK2;PTPN14;EPHA2,Lovastatin
8,Estrogen Response Late,0.0108779611049612,FARP1;ELOVL5;CAV1;CD9;CD44,Lovastatin
9,Glycolysis,0.0108779611049612,EXT1;NT5E;MIF;EGFR;CD44,Lovastatin
11,Cholesterol Homeostasis,0.018244325641248,TNFRSF12A;CD9;HMGCR,Lovastatin
12,Androgen Response,0.035899496322376,CDK6;ELOVL5;HMGCR,Lovastatin
13,Hedgehog Signaling,0.035899496322376,NRP2;CDK6,Lovastatin
16,Xenobiotic Metabolism,0.0361466442609262,ELOVL5;SERPINE1;MAN1A1;EPHA2,Lovastatin
14,Mitotic Spindle,0.0361466442609262,FARP1;MYO1E;ARHGAP29;CDC42EP1,Lovastatin
15,Estrogen Response Early,0.0361466442609262,FARP1;ELOVL5;ENDOD1;CD44,Lovastatin
17,KRAS Signaling Up,0.0361466442609262,PLAU;SPRY2;PLEK2;ETS1,Lovastatin
0,Hypoxia,1.1704301067081812e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,Simvastatin
1,Epithelial Mesenchymal Transition,1.1704301067081812e-06,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;LAMC1;FSTL1;CD44;LOXL2,Simvastatin
2,Apical Junction,0.0007936771274922543,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,Simvastatin
3,UV Response Dn,0.0007936771274922543,TJP1;ANXA2;CAV1;SERPINE1;PRKCA;LAMC1,Simvastatin
4,Apoptosis,0.0011716628760634,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Simvastatin
5,TNF-alpha Signaling via NF-kB,0.0031266839364488,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Simvastatin
6,Angiogenesis,0.0040603643204568,APP;FSTL1;PTK2,Simvastatin
7,IL-6/JAK/STAT3 Signaling,0.0044079818936931,TNFRSF12A;CD9;OSMR;CD44,Simvastatin
11,p53 Pathway,0.0102484494669426,VAMP8;APP;PLK2;PTPN14;EPHA2,Simvastatin
10,Glycolysis,0.0102484494669426,EXT1;NT5E;MIF;EGFR;CD44,Simvastatin
8,Estrogen Response Late,0.0102484494669426,FARP1;ELOVL5;CAV1;CD9;CD44,Simvastatin
9,Xenobiotic Metabolism,0.0102484494669426,MT2A;ELOVL5;SERPINE1;MAN1A1;EPHA2,Simvastatin
12,Cholesterol Homeostasis,0.0173087191981071,TNFRSF12A;CD9;HMGCR,Simvastatin
13,Androgen Response,0.0365289314143685,CDK6;ELOVL5;HMGCR,Simvastatin
16,Inflammatory Response,0.0371507177126186,AXL;SERPINE1;SGMS2;OSMR,Simvastatin
14,Mitotic Spindle,0.0371507177126186,FARP1;MYO1E;ARHGAP29;CDC42EP1,Simvastatin
15,Estrogen Response Early,0.0371507177126186,FARP1;ELOVL5;ENDOD1;CD44,Simvastatin
17,KRAS Signaling Up,0.0371507177126186,PLAU;SPRY2;PLEK2;ETS1,Simvastatin
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;DST;COL12A1;SNAI2;VIM;THBS1;CD44,"10,11-Methylenedioxy-20S-camptothecin"
1,Glycolysis,1.138796860580933e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1;IER3,"10,11-Methylenedioxy-20S-camptothecin"
2,Hypoxia,8.695357053038835e-06,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,"10,11-Methylenedioxy-20S-camptothecin"
3,TNF-alpha Signaling via NF-kB,4.7603530911713e-05,FOSL1;TUBB2A;SDC4;PLAU;PLK2;PHLDA1;CD44;IER3,"10,11-Methylenedioxy-20S-camptothecin"
4,Apical Junction,4.7603530911713e-05,SGCE;VCAN;ITGA3;AKT3;CTNNA1;MSN;EGFR;ACTB,"10,11-Methylenedioxy-20S-camptothecin"
5,UV Response Dn,4.7603530911713e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;MET;RND3,"10,11-Methylenedioxy-20S-camptothecin"
6,Apoptosis,8.449299146703533e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;CD44;IER3,"10,11-Methylenedioxy-20S-camptothecin"
7,IL-2/STAT5 Signaling,0.0002864856940718752,MYO1E;NRP1;NT5E;ALCAM;AHNAK;PHLDA1;CD44,"10,11-Methylenedioxy-20S-camptothecin"
8,Protein Secretion,0.0004819072360818768,SCRN1;DST;CAV2;PAM;EGFR,"10,11-Methylenedioxy-20S-camptothecin"
9,Angiogenesis,0.0027654373209597,APP;NRP1;VCAN,"10,11-Methylenedioxy-20S-camptothecin"
10,IL-6/JAK/STAT3 Signaling,0.0031191616348492,TNFRSF12A;CD9;CD44;IL13RA1,"10,11-Methylenedioxy-20S-camptothecin"
11,Estrogen Response Late,0.0099714643462144,ELOVL5;CAV1;ATP2B4;CD9;CD44,"10,11-Methylenedioxy-20S-camptothecin"
12,Cholesterol Homeostasis,0.0168409159765366,ALCAM;TNFRSF12A;CD9,"10,11-Methylenedioxy-20S-camptothecin"
13,Mitotic Spindle,0.0433759731131114,MYO1E;DST;ARHGAP29;CDC42EP1,"10,11-Methylenedioxy-20S-camptothecin"
14,KRAS Signaling Up,0.0433759731131114,NRP1;PLAU;SPRY2;ETS1,"10,11-Methylenedioxy-20S-camptothecin"
0,Epithelial Mesenchymal Transition,2.0784172928835875e-07,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SPP1;SNAI2;FBLN1;ITGAV;CD44,o6-Benzylguanine
1,Angiogenesis,0.0006435945717925369,NRP1;VCAN;SPP1;ITGAV,o6-Benzylguanine
2,IL-2/STAT5 Signaling,0.006913060482826,CDKN1C;NRP1;NT5E;SPP1;ITGAV;CD44,o6-Benzylguanine
3,Glycolysis,0.0349001252117506,NT5E;VCAN;CDK1;MIF;CD44,o6-Benzylguanine
0,Apical Junction,2.39122318958568e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;FLNC;EGFR;PTK2,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
1,Apoptosis,2.4278633275757453e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
2,Hypoxia,4.861568838464144e-05,EXT1;SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
3,Epithelial Mesenchymal Transition,4.861568838464144e-05,NT5E;LGALS1;TNFRSF12A;SDC4;VIM;FSTL1;CD44;PFN2,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
4,Glycolysis,4.861568838464144e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
5,Angiogenesis,0.00016856048308852155,APP;FSTL1;PTK2;FGFR1,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
6,TNF-alpha Signaling via NF-kB,0.00030975392349577113,FOSL1;MARCKS;SDC4;PLK2;PHLDA1;CD44;IER3,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
7,IL-6/JAK/STAT3 Signaling,0.0039314433105912,TNFRSF12A;CD9;OSMR;CD44,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
8,Fatty Acid Metabolism,0.0043602775030934,LGALS1;ELOVL5;PCBD1;MIF;S100A10,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
9,Protein Secretion,0.0045358329865506,SCRN1;CAV2;PAM;EGFR,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
10,Estrogen Response Late,0.0091405089840299,ELOVL5;CAV1;CD9;PAPSS2;CD44,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
11,p53 Pathway,0.0091405089840299,APP;PLK2;PTPN14;S100A10;IER3,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
12,UV Response Dn,0.014334827289552,TJP1;CAV1;AKT3;MET,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
13,Cholesterol Homeostasis,0.014334827289552,TNFRSF12A;GPX8;CD9,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
14,IL-2/STAT5 Signaling,0.0372762268940801,NT5E;AHNAK;PHLDA1;CD44,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
15,Inflammatory Response,0.0372762268940801,AXL;SGMS2;OSMR;MET,"9-Methoxy-2-methyl-1,2-dihydroellipticine"
0,Glycolysis,2.753529733462298e-05,NT5E;VCAN;CITED2;CDK1;MIF;PAM;MET;CD44;IER3,2-N-Methyl-6-thiaellipticinum iodide
1,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;VCAN;SPARC;LGALS1;COL12A1;SNAI2;THBS1;CD44,2-N-Methyl-6-thiaellipticinum iodide
2,UV Response Dn,0.0099436678366384,NRP1;CITED2;ATP2B4;SNAI2;MET,2-N-Methyl-6-thiaellipticinum iodide
3,Hypoxia,0.0315763037630124,CITED2;MIF;ETS1;PAM;IER3,2-N-Methyl-6-thiaellipticinum iodide
0,Epithelial Mesenchymal Transition,1.5835560326732093e-07,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;CD44;LOXL2,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
1,UV Response Dn,7.056533747865739e-07,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;AKT3;LAMC1;RND3,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
2,Hypoxia,5.79690470202589e-06,EXT1;MT2A;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;ETS1;EGFR,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
3,Apical Junction,5.79690470202589e-06,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;FLNC;EGFR;PTK2,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
4,Apoptosis,0.00010514683382564396,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
5,Angiogenesis,0.00016345258966159664,APP;FSTL1;PTK2;FGFR1,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
6,TNF-alpha Signaling via NF-kB,0.0023178506401474,MARCKS;SDC4;DUSP1;PLK2;SERPINE1;CD44,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
7,IL-6/JAK/STAT3 Signaling,0.0038123086648157,TNFRSF12A;CD9;OSMR;CD44,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
8,Mitotic Spindle,0.010636228635962,NOTCH2;MYO1E;MARCKS;ARHGAP29;CDC42EP1,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
9,p53 Pathway,0.010636228635962,VAMP8;APP;PLK2;PTPN14;S100A10,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
10,Cholesterol Homeostasis,0.0176914672884829,TNFRSF12A;GPX8;CD9,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
11,IL-2/STAT5 Signaling,0.0413104505839156,MYO1E;NT5E;AHNAK;CD44,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
12,Inflammatory Response,0.0413104505839156,AXL;SERPINE1;SGMS2;OSMR,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
13,Glycolysis,0.0413104505839156,EXT1;NT5E;EGFR;CD44,"4-Piperidinone,5-bis[(3,4-dichlorophenyl)methylene]-1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride"
0,Hypoxia,1.107163614453685e-06,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,7-Hydroxystaurosporine
1,Epithelial Mesenchymal Transition,1.107163614453685e-06,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,7-Hydroxystaurosporine
2,Glycolysis,8.45381935712109e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,7-Hydroxystaurosporine
3,UV Response Dn,6.94218159129148e-05,NRP1;CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA;MET,7-Hydroxystaurosporine
4,Angiogenesis,0.0002145315239308456,APP;NRP1;VCAN;PTK2,7-Hydroxystaurosporine
5,TNF-alpha Signaling via NF-kB,0.000383281369982141,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44;IER3,7-Hydroxystaurosporine
6,Apoptosis,0.0007916641054482537,APP;TNFRSF12A;CAV1;PTK2;CD44;IER3,7-Hydroxystaurosporine
8,Cholesterol Homeostasis,0.0020132613355668,ALCAM;TNFRSF12A;MAL2;CD9,7-Hydroxystaurosporine
7,Estrogen Response Late,0.0020132613355668,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,7-Hydroxystaurosporine
9,Apical Junction,0.0105757955187123,VCAN;ITGA3;EGFR;ACTB;PTK2,7-Hydroxystaurosporine
10,KRAS Signaling Up,0.0105757955187123,NRP1;GALNT3;PLAU;SPRY2;ETS1,7-Hydroxystaurosporine
11,IL-6/JAK/STAT3 Signaling,0.0276824344176964,TNFRSF12A;CD9;CD44,7-Hydroxystaurosporine
12,Protein Secretion,0.033354301004244,CAV2;PAM;EGFR,7-Hydroxystaurosporine
13,Hedgehog Signaling,0.0349022880911989,NRP1;NRP2,7-Hydroxystaurosporine
15,Estrogen Response Early,0.0372097808568358,FARP1;ELOVL5;ENDOD1;CD44,7-Hydroxystaurosporine
14,IL-2/STAT5 Signaling,0.0372097808568358,NRP1;NT5E;ALCAM;CD44,7-Hydroxystaurosporine
16,p53 Pathway,0.0372097808568358,VAMP8;APP;PLK2;IER3,7-Hydroxystaurosporine
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,Perifosine
1,Glycolysis,1.340534212343487e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,Perifosine
2,Hypoxia,9.08474984965522e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Perifosine
3,Cholesterol Homeostasis,0.00032030771383341304,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Perifosine
4,TNF-alpha Signaling via NF-kB,0.0031266839364488,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Perifosine
5,KRAS Signaling Up,0.0031266839364488,NRP1;GALNT3;PLAU;SPRY2;ETS1;TRIB2,Perifosine
6,Angiogenesis,0.0036307471377199,APP;NRP1;VCAN,Perifosine
7,UV Response Dn,0.0036307471377199,NRP1;ATP2B4;SNAI2;PRKCA;MET,Perifosine
8,Estrogen Response Late,0.0136645992892568,ELOVL5;ATP2B4;CD9;JAK2;CD44,Perifosine
9,Apoptosis,0.0319246776141746,APP;TNFRSF12A;CD44;IER3,Perifosine
10,IL-6/JAK/STAT3 Signaling,0.0319246776141746,TNFRSF12A;CD9;CD44,Perifosine
11,Androgen Response,0.0371507177126186,ELOVL5;AKT1;HMGCR,Perifosine
12,Hedgehog Signaling,0.0371507177126186,NRP1;NRP2,Perifosine
13,IL-2/STAT5 Signaling,0.0371507177126186,NRP1;NT5E;ALCAM;CD44,Perifosine
14,Estrogen Response Early,0.0371507177126186,ELOVL5;ENDOD1;JAK2;CD44,Perifosine
15,Apical Junction,0.0371507177126186,VCAN;ITGA3;EGFR;ACTB,Perifosine
16,mTORC1 Signaling,0.0371507177126186,ELOVL5;PLK1;CD9;HMGCR,Perifosine
17,Allograft Rejection,0.0371507177126186,AKT1;JAK2;ETS1;EGFR,Perifosine
0,Epithelial Mesenchymal Transition,1.6330421586942474e-07,GJA1;LGALS1;TNFRSF12A;SDC4;DST;COL12A1;VIM;THBS1;CD44;PFN2;CAP2,14-Chloro-20(S)-camptothecin hydrate
1,UV Response Dn,7.277050427486543e-07,TJP1;NRP1;GJA1;ANXA2;CAV1;MAP1B;ID1;MET;CAP2,14-Chloro-20(S)-camptothecin hydrate
2,Cholesterol Homeostasis,0.0003809064705045993,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,14-Chloro-20(S)-camptothecin hydrate
3,Protein Secretion,0.000993933674418871,SCRN1;DST;CAV2;PAM;EGFR,14-Chloro-20(S)-camptothecin hydrate
4,Hypoxia,0.0027886640514273,ANXA2;SDC4;CAV1;MIF;PAM;EGFR,14-Chloro-20(S)-camptothecin hydrate
5,Glycolysis,0.0027886640514273,MIF;PAM;MET;EGFR;CD44;IL13RA1,14-Chloro-20(S)-camptothecin hydrate
6,IL-6/JAK/STAT3 Signaling,0.0044930780692471,TNFRSF12A;CD9;CD44;IL13RA1,14-Chloro-20(S)-camptothecin hydrate
8,Apoptosis,0.0047399647983935,APP;GPX1;TNFRSF12A;CAV1;CD44,14-Chloro-20(S)-camptothecin hydrate
7,Fatty Acid Metabolism,0.0047399647983935,LGALS1;ELOVL5;PCBD1;MIF;S100A10,14-Chloro-20(S)-camptothecin hydrate
9,TGF-beta Signaling,0.0082519629010632,TJP1;ID1;THBS1,14-Chloro-20(S)-camptothecin hydrate
10,IL-2/STAT5 Signaling,0.0084373929083353,NRP1;ALCAM;AHNAK;CKAP4;CD44,14-Chloro-20(S)-camptothecin hydrate
11,TNF-alpha Signaling via NF-kB,0.0084373929083353,MARCKS;TUBB2A;SDC4;PLK2;CD44,14-Chloro-20(S)-camptothecin hydrate
12,Apical Junction,0.0084373929083353,TJP1;RRAS;ITGA3;CTNNA1;EGFR,14-Chloro-20(S)-camptothecin hydrate
13,Angiogenesis,0.0329078716288447,APP;NRP1,14-Chloro-20(S)-camptothecin hydrate
14,Pperoxisome,0.0337597112468718,SEMA3C;ELOVL5;PRDX1,14-Chloro-20(S)-camptothecin hydrate
15,Estrogen Response Late,0.0350835076650166,ELOVL5;CAV1;CD9;CD44,14-Chloro-20(S)-camptothecin hydrate
16,p53 Pathway,0.0350835076650166,APP;PLK2;PTPN14;S100A10,14-Chloro-20(S)-camptothecin hydrate
0,UV Response Dn,0.00034909256001922865,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"[(1S,4S,7R,10S,12R)-4-acetyloxy-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,Hypoxia,0.0009636788730979544,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"[(1S,4S,7R,10S,12R)-4-acetyloxy-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,Epithelial Mesenchymal Transition,0.0009636788730979544,ITGB5;BDNF;ITGB3;PMP22;SPP1;VEGFC;EDIL3,"[(1S,4S,7R,10S,12R)-4-acetyloxy-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
3,IL-2/STAT5 Signaling,0.0044618624822837,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,"[(1S,4S,7R,10S,12R)-4-acetyloxy-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
4,TNF-alpha Signaling via NF-kB,0.0044618624822837,CEBPB;BHLHE40;IRS2;SGK1;FJX1;LITAF,"[(1S,4S,7R,10S,12R)-4-acetyloxy-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,Epithelial Mesenchymal Transition,2.0877942443983774e-06,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,Benzoylstaurosporine
1,Hypoxia,1.1956115947928398e-05,EXT1;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,Benzoylstaurosporine
2,Apical Junction,0.0007078741947903889,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,Benzoylstaurosporine
3,UV Response Dn,0.0007078741947903889,TJP1;ANXA2;CAV1;SERPINE1;PRKCA;LAMC1,Benzoylstaurosporine
4,Apoptosis,0.0010449966191916,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Benzoylstaurosporine
5,TNF-alpha Signaling via NF-kB,0.0027886640514273,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Benzoylstaurosporine
6,Angiogenesis,0.0036214060155425,APP;FSTL1;PTK2,Benzoylstaurosporine
7,IL-6/JAK/STAT3 Signaling,0.0039314433105912,TNFRSF12A;CD9;OSMR;CD44,Benzoylstaurosporine
10,p53 Pathway,0.0099714643462144,VAMP8;APP;PLK2;PTPN14;EPHA2,Benzoylstaurosporine
8,Estrogen Response Late,0.0099714643462144,FARP1;ELOVL5;CAV1;CD9;CD44,Benzoylstaurosporine
9,Glycolysis,0.0099714643462144,EXT1;NT5E;MIF;EGFR;CD44,Benzoylstaurosporine
16,KRAS Signaling Up,0.0350835076650166,PLAU;SPRY2;PLEK2;ETS1,Benzoylstaurosporine
11,Mitotic Spindle,0.0350835076650166,FARP1;MYO1E;ARHGAP29;CDC42EP1,Benzoylstaurosporine
12,IL-2/STAT5 Signaling,0.0350835076650166,MYO1E;NT5E;AHNAK;CD44,Benzoylstaurosporine
13,Estrogen Response Early,0.0350835076650166,FARP1;ELOVL5;ENDOD1;CD44,Benzoylstaurosporine
14,Inflammatory Response,0.0350835076650166,AXL;SERPINE1;SGMS2;OSMR,Benzoylstaurosporine
15,Xenobiotic Metabolism,0.0350835076650166,ELOVL5;SERPINE1;MAN1A1;EPHA2,Benzoylstaurosporine
17,Apical Surface,0.0374540537461114,APP;ATP8B1,Benzoylstaurosporine
0,Epithelial Mesenchymal Transition,0.0202811931012899,VCAN;SPARC;LGALS1;SPP1;EMP3;CD44,"Propanoic acid,sodium salt"
1,Estrogen Response Late,0.0443176193165087,BTG3;ELOVL5;ATP2B4;JAK2;CD44,"Propanoic acid,sodium salt"
2,Glycolysis,0.0443176193165087,VCAN;CITED2;CDK1;MIF;CD44,"Propanoic acid,sodium salt"
0,Epithelial Mesenchymal Transition,4.3400383791647694e-11,BDNF;ITGB3;TFPI2;PLOD3;VEGFC;GLIPR1;LOX;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;SNAI2;MYL9,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,UV Response Dn,7.277050427486543e-07,BDNF;SDC2;ITGB3;BHLHE40;PMP22;LPAR1;SNAI2;VLDLR;PLPP3,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,Hypoxia,8.102614730773575e-05,SRPX;LOX;SDC2;BHLHE40;GCNT2;VLDLR;KDELR3;TMEM45A,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
3,Hedgehog Signaling,0.0063374605271994,NRP2;CDK6;VLDLR,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
4,Myogenesis,0.0219372215616718,WWTR1;PRNP;BHLHE40;ADAM12;IGFBP7,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
5,Coagulation,0.0280672751876142,ITGB3;TFPI2;PLAT;PRSS23,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
6,Androgen Response,0.042601402164663,CDK6;SGK1;ELL2,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
7,TNF-alpha Signaling via NF-kB,0.042601402164663,BHLHE40;PLPP3;SGK1;ICAM1,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
8,Estrogen Response Early,0.042601402164663,BHLHE40;JAK2;MYBL1;PRSS23,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
9,Estrogen Response Late,0.042601402164663,TFPI2;SGK1;JAK2;PRSS23,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
10,Apical Junction,0.042601402164663,RAC2;MYL9;MYH10;ICAM1,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
11,Complement,0.042601402164663,DOCK10;TFPI2;PLAT;JAK2,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
12,Glycolysis,0.042601402164663,TPST1;SDC2;VLDLR;KDELR3,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
13,KRAS Signaling Dn,0.042601402164663,TGFB2;SLC16A7;COPZ2;SGK1,"[(1S,4S,7R,10S,12R)-4-acetyloxy-15-[(3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(3,4,5-trihydroxyoxan-2-yl)oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,UV Response Dn,1.2653298450899256e-06,BDNF;SDC2;DLC1;ITGB3;PMP22;LPAR1;SNAI2;VLDLR;PLPP3,"2-Debenzoyl-2-(3',5'-difluorobenzoyl)-A-nortaxol"
1,Epithelial Mesenchymal Transition,1.2653298450899256e-06,GLIPR1;CALD1;BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPOCK1;SNAI2;VEGFC,"2-Debenzoyl-2-(3',5'-difluorobenzoyl)-A-nortaxol"
2,Hedgehog Signaling,0.0102423604479991,NRP2;CDK6;VLDLR,"2-Debenzoyl-2-(3',5'-difluorobenzoyl)-A-nortaxol"
0,Apical Junction,0.0022339828421816,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"[(1S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(3S)-3-(2,2-dimethylpropanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,Angiogenesis,0.0130590095711989,APP;NRP1;PTK2,"[(1S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(3S)-3-(2,2-dimethylpropanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,p53 Pathway,0.0376699764190323,VAMP8;APP;PLK2;PTPN14;EPHA2,"[(1S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(3S)-3-(2,2-dimethylpropanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
3,UV Response Dn,0.0413538047868288,TJP1;NRP1;ANXA2;ID1,"[(1S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(3S)-3-(2,2-dimethylpropanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
4,Cholesterol Homeostasis,0.0413538047868288,TNFRSF12A;MAL2;CD9,"[(1S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(3S)-3-(2,2-dimethylpropanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,Epithelial Mesenchymal Transition,8.297758407769535e-10,BDNF;ITGB3;TFPI2;VEGFC;GLIPR1;CALD1;COL4A1;DPYSL3;ADAM12;PMP22;SPOCK1;SNAI2;MYL9,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,UV Response Dn,8.15911714596976e-07,BDNF;SDC2;ITGB3;BHLHE40;PMP22;LPAR1;SNAI2;VLDLR;PLPP3,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,Androgen Response,0.0018015745552557,CDK6;ADAMTS1;HMGCR;SGK1;ELL2,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
3,Hypoxia,0.0046900259046732,SRPX;SDC2;BHLHE40;GCNT2;VLDLR;TMEM45A,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
4,Hedgehog Signaling,0.0056845100486395,NRP2;CDK6;VLDLR,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
5,Estrogen Response Early,0.0153726742004139,TFAP2C;BHLHE40;JAK2;MYBL1;PRSS23,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
6,Estrogen Response Late,0.0153726742004139,TFAP2C;TFPI2;SGK1;JAK2;PRSS23,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
7,Myogenesis,0.0153726742004139,WWTR1;PRNP;BHLHE40;ADAM12;IGFBP7,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-(3-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,Epithelial Mesenchymal Transition,7.176439704016895e-10,BDNF;VEGFC;PLOD2;FGF2;LOXL2;GJA1;GLIPR1;CALD1;PMP22;SPOCK1;SNAI2;ITGAV;EDIL3,"[(1S,2S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-naphthalen-2-ylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,UV Response Dn,1.0119243142951805e-05,GJA1;EFEMP1;BDNF;BHLHE40;PMP22;LPAR1;SNAI2;PLPP3,"[(1S,2S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-naphthalen-2-ylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,TNF-alpha Signaling via NF-kB,0.0354540954532069,TUBB2A;BHLHE40;IL6ST;PLPP3;FJX1,"[(1S,2S,3R,4S,7R,9S,10S,12R)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-naphthalen-2-ylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,Apical Junction,0.0014157483895807,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
1,UV Response Dn,0.0014157483895807,TJP1;NRP1;ANXA2;CAV1;ID1;MET,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
2,Apoptosis,0.0017416610319861,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
3,Hypoxia,0.0034167920952191,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
4,Cholesterol Homeostasis,0.0034167920952191,ALCAM;TNFRSF12A;MAL2;CD9,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
5,Angiogenesis,0.0042249736847996,APP;NRP1;PTK2,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
6,Estrogen Response Late,0.0109686107808359,ELOVL5;CAV1;CD9;LSR;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
7,Epithelial Mesenchymal Transition,0.0109686107808359,TNFRSF12A;SDC4;COL12A1;VIM;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
8,Glycolysis,0.0109686107808359,EXT1;MIF;MET;EGFR;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
9,p53 Pathway,0.0109686107808359,VAMP8;APP;PLK2;PTPN14;S100A10,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
10,Fatty Acid Metabolism,0.0245304585039227,ELOVL5;PCBD1;MIF;S100A10,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
11,IL-6/JAK/STAT3 Signaling,0.0261005810223995,TNFRSF12A;CD9;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
12,Protein Secretion,0.0314483409468586,SCRN1;CAV2;EGFR,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
13,IL-2/STAT5 Signaling,0.0397613086870188,NRP1;ALCAM;AHNAK;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
14,TNF-alpha Signaling via NF-kB,0.0397613086870188,SDC4;PLAU;PLK2;CD44,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
15,Apical Surface,0.0421358104643753,APP;ATP8B1,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine;2-hydroxyethanesulfonic acid"
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,"4-N-(3-bromophenyl)pyrido[4,3-d]pyrimidine-4,7-diamine;methanesulfonic acid"
1,Estrogen Response Late,0.0465335002823341,KRT19;MYOF;FLNB;SFN;LSR,"4-N-(3-bromophenyl)pyrido[4,3-d]pyrimidine-4,7-diamine;methanesulfonic acid"
0,Estrogen Response Early,0.0001915163481819208,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] cyclohexanecarboxylate"
1,Estrogen Response Late,0.0065913877579192,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] cyclohexanecarboxylate"
2,UV Response Dn,0.0068035622040158,TJP1;ANXA2;NFIB;MAP1B;ID1,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] cyclohexanecarboxylate"
0,Estrogen Response Early,0.0126757456883062,ABLIM1;KRT19;KRT18;KRT8;FLNB;SFN,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-(2-methylphenyl)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
1,Apical Junction,0.0276985120728179,TJP1;RRAS;CTNNA1;RHOF;PTK2,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-(2-methylphenyl)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
2,p53 Pathway,0.0276985120728179,VAMP8;APP;SFN;EPHA2;S100A10,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-(2-methylphenyl)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
3,UV Response Dn,0.0370342049330873,TJP1;ANXA2;MAP1B;ID1,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-(2-methylphenyl)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
0,Estrogen Response Early,0.0086352904897123,ABLIM1;KRT19;KRT18;KRT8;FLNB;SFN,"4,10beta-Diacetoxy-2alpha-(2-furanylcarbonyloxy)-5beta,20-epoxy-1alpha,7beta-dihydroxy-13alpha-[[(2R,3S)-2-hydroxy-3-(benzoylamino)-3-phenylpropionyl]oxy]taxa-11-ene-9-one"
1,UV Response Dn,0.0086352904897123,TJP1;ANXA2;NFIB;MAP1B;ID1,"4,10beta-Diacetoxy-2alpha-(2-furanylcarbonyloxy)-5beta,20-epoxy-1alpha,7beta-dihydroxy-13alpha-[[(2R,3S)-2-hydroxy-3-(benzoylamino)-3-phenylpropionyl]oxy]taxa-11-ene-9-one"
2,TGF-beta Signaling,0.018337695335696,TJP1;SMURF2;ID1,"4,10beta-Diacetoxy-2alpha-(2-furanylcarbonyloxy)-5beta,20-epoxy-1alpha,7beta-dihydroxy-13alpha-[[(2R,3S)-2-hydroxy-3-(benzoylamino)-3-phenylpropionyl]oxy]taxa-11-ene-9-one"
0,Estrogen Response Early,0.0017083398204918,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,2-Debenzoyl-2-(p-fluorobenzoyl)paclitaxel
1,Estrogen Response Late,0.0432096788335959,KRT19;MYOF;FLNB;SFN;LSR,2-Debenzoyl-2-(p-fluorobenzoyl)paclitaxel
0,Epithelial Mesenchymal Transition,0.0202811931012899,VCAN;SPARC;LGALS1;SPP1;EMP3;THBS1,7-Ethyl-10-hydroxycamptothecin
0,Epithelial Mesenchymal Transition,2.761916001931682e-12,NOTCH2;SPARC;TNFRSF12A;SDC4;DST;SERPINE1;COL12A1;THBS1;LOXL2;NT5E;LGALS1;COL4A2;SNAI2;VIM;CD44,Leflunomide
1,UV Response Dn,8.224643993084516e-07,NOTCH2;TJP1;ANXA2;CAV1;SERPINE1;AKT3;SNAI2;MET;RND3,Leflunomide
2,Hypoxia,8.224643993084516e-07,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;MIF;ETS1;PAM;EGFR,Leflunomide
3,TNF-alpha Signaling via NF-kB,5.745490445457625e-05,FOSL1;MARCKS;SDC4;PLAU;PLK2;SERPINE1;IL6ST;CD44,Leflunomide
4,Glycolysis,5.745490445457625e-05,EXT1;NT5E;CDK1;MIF;PAM;MET;EGFR;CD44,Leflunomide
5,Mitotic Spindle,0.0003775759353994464,NOTCH2;MYO1E;MARCKS;DST;PLK1;CDK1;ARHGAP29,Leflunomide
6,Coagulation,0.0003775759353994464,SPARC;PLAU;SERPINE1;CD9;GNG12;THBS1,Leflunomide
7,Apical Junction,0.0024717704092197,TJP1;SGCE;ITGA3;AKT3;EGFR;ACTB,Leflunomide
8,IL-6/JAK/STAT3 Signaling,0.0041300010535503,TNFRSF12A;CD9;IL6ST;CD44,Leflunomide
10,Protein Secretion,0.0048732089938147,DST;CAV2;PAM;EGFR,Leflunomide
9,Apoptosis,0.0048732089938147,APP;TNFRSF12A;CAV1;TIMP2;CD44,Leflunomide
11,TGF-beta Signaling,0.008126933160138,TJP1;SERPINE1;THBS1,Leflunomide
12,IL-2/STAT5 Signaling,0.0086419357667191,MYO1E;NT5E;AHNAK;CKAP4;CD44,Leflunomide
13,G2-M Checkpoint,0.0086419357667191,NOTCH2;MARCKS;MT2A;PLK1;CDK1,Leflunomide
14,Estrogen Response Late,0.0086419357667191,ELOVL5;CAV1;CD9;IL6ST;CD44,Leflunomide
15,Cholesterol Homeostasis,0.014823514583514,TNFRSF12A;CD9;HMGCR,Leflunomide
16,Myogenesis,0.0370978717414769,APP;SPARC;COL4A2;CNN3,Leflunomide
17,Complement,0.0370978717414769,ERAP2;COL4A2;SERPINE1;TIMP2,Leflunomide
18,mTORC1 Signaling,0.0370978717414769,ELOVL5;PLK1;CD9;HMGCR,Leflunomide
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
1,Estrogen Response Early,0.0093800518093465,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
2,Angiogenesis,0.0094741834143992,NRP1;VCAN;ITGAV,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
3,Androgen Response,0.0147811094979836,ELOVL5;STK39;ITGAV;HMGCR,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
4,IL-2/STAT5 Signaling,0.0204968989338852,CDKN1C;NRP1;ALCAM;LRIG1;ITGAV,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
5,KRAS Signaling Up,0.0204968989338852,NRP1;PLAU;GABRA3;TRIB2;DUSP6,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
0,Estrogen Response Early,0.0001988823615735332,ABLIM1;RAB31;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,serine deriv."
1,Estrogen Response Late,0.0068449026716853,RAB31;MYOF;NRIP1;FLNB;SFN;LSR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,serine deriv."
2,UV Response Dn,0.007065237673401,TJP1;ANXA2;NFIB;MAP1B;ID1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,serine deriv."
3,TGF-beta Signaling,0.016879015024902,TJP1;RAB31;ID1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,serine deriv."
4,Apical Junction,0.017948635823186,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,serine deriv."
0,Glycolysis,2.246300572035033e-05,NT5E;VCAN;CITED2;MIF;PAM;MET;CD44;IER3;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
1,Epithelial Mesenchymal Transition,0.00011417320756999128,NT5E;VCAN;SPARC;LGALS1;SDC4;COL12A1;SNAI2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
2,TNF-alpha Signaling via NF-kB,0.0039294811633749,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
3,Hypoxia,0.0039294811633749,SDC4;CITED2;MIF;ETS1;PAM;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
4,UV Response Dn,0.0048671637305651,NRP1;CITED2;ATP2B4;SNAI2;MET,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
5,Estrogen Response Late,0.0147197807015546,ELOVL5;ATP2B4;CD9;JAK2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
6,KRAS Signaling Up,0.0147197807015546,NRP1;GALNT3;PLAU;SPRY2;ETS1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
7,IL-6/JAK/STAT3 Signaling,0.0367780914406539,CD9;CD44;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
8,Hedgehog Signaling,0.0432788372330866,NRP1;NRP2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
9,Angiogenesis,0.0432788372330866,NRP1;VCAN,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
10,IL-2/STAT5 Signaling,0.0466894155036963,NRP1;NT5E;ALCAM;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
11,Estrogen Response Early,0.0466894155036963,ELOVL5;ENDOD1;JAK2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,leucine deriv."
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
1,Glycolysis,1.376764866731149e-05,EXT1;NT5E;VCAN;CDK1;MIF;PAM;EGFR;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
2,Hypoxia,9.33028362937563e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
3,Cholesterol Homeostasis,0.0003289646790721539,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
4,TNF-alpha Signaling via NF-kB,0.0004993608706053037,FOSL1;SDC4;PLAU;PLK2;TNC;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
5,KRAS Signaling Up,0.0032111889077042,NRP1;GALNT3;PLAU;SPRY2;ETS1;TRIB2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
6,Angiogenesis,0.0041701038966853,APP;NRP1;VCAN,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
7,Estrogen Response Late,0.0157881518815062,ELOVL5;ATP2B4;CD9;JAK2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
8,UV Response Dn,0.0250186628881301,NRP1;ATP2B4;SNAI2;PRKCA,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
9,Apoptosis,0.032787506738882,APP;TNFRSF12A;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
10,IL-6/JAK/STAT3 Signaling,0.032787506738882,TNFRSF12A;CD9;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
11,Hedgehog Signaling,0.0429241400598498,NRP1;NRP2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
12,IL-2/STAT5 Signaling,0.0429241400598498,NRP1;NT5E;ALCAM;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
13,Estrogen Response Early,0.0429241400598498,ELOVL5;ENDOD1;JAK2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
14,Apical Junction,0.0429241400598498,VCAN;ITGA3;EGFR;ACTB,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
15,mTORC1 Signaling,0.0429241400598498,ELOVL5;PLK1;CD9;HMGCR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,methionine deriv."
0,Glycolysis,0.0002578104687064319,NT5E;MIF;PYGL;PAM;MET;CD44;IER3;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
1,Apoptosis,0.0027708243690688,IFITM3;BTG3;GPX1;ANXA1;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
2,IL-2/STAT5 Signaling,0.0044365109909071,IFITM3;NT5E;ALCAM;CTSZ;PLIN2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
3,Hypoxia,0.0044365109909071,SDC4;PLIN2;MIF;ETS1;PAM;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
4,TNF-alpha Signaling via NF-kB,0.0193889584509725,FOSL1;BTG3;SDC4;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
5,Epithelial Mesenchymal Transition,0.0193889584509725,NT5E;LGALS1;SDC4;CD44;PFN2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
6,Fatty Acid Metabolism,0.0408840975065379,LGALS1;ELOVL5;MIF;S100A10,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,alanine deriv."
0,Glycolysis,2.21432722890737e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
1,Hypoxia,8.593682290214397e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
2,Epithelial Mesenchymal Transition,8.593682290214397e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
3,TNF-alpha Signaling via NF-kB,0.0044365109909071,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
4,Angiogenesis,0.0045793207142414,APP;NRP1;VCAN,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
5,UV Response Dn,0.0045793207142414,NRP1;ATP2B4;SNAI2;PRKCA;MET,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
6,IL-6/JAK/STAT3 Signaling,0.0047653858310196,TNFRSF12A;CD9;CD44;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
7,Apoptosis,0.0056556398162649,APP;GPX1;TNFRSF12A;CD44;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
8,KRAS Signaling Up,0.0129259723006483,NRP1;GALNT3;PLAU;SPRY2;ETS1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
9,Cholesterol Homeostasis,0.021285046581456,ALCAM;TNFRSF12A;CD9,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
10,Protein Secretion,0.039418719368652,CAV2;PAM;EGFR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
11,Hedgehog Signaling,0.039535392160388,NRP1;NRP2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
12,IL-2/STAT5 Signaling,0.039535392160388,NRP1;NT5E;ALCAM;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
13,Estrogen Response Late,0.039535392160388,ELOVL5;ATP2B4;CD9;CD44,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
14,Apical Junction,0.039535392160388,VCAN;ITGA3;EGFR;ACTB,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
15,p53 Pathway,0.039535392160388,APP;HDAC3;PLK2;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,proline deriv"
0,IL-2/STAT5 Signaling,0.0176141114581381,IFITM3;CTSZ;SPP1;PLIN2;AHR;IGF1R,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,tryptophan deriv."
1,Apoptosis,0.0176141114581381,IFITM3;BTG3;ANXA1;DPYD;TXNIP,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,tryptophan deriv."
2,Interferon Alpha Response,0.0176141114581381,IFITM3;LGALS3BP;TXNIP;PSMB8,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,tryptophan deriv."
0,IL-2/STAT5 Signaling,0.0022282220650034,IFITM3;CTSZ;SPP1;LIF;PLIN2;AHR;IGF1R,"iH-Pyrano[3',7]indolizino[1,2-b]quinoline,4-aminobenzoic acid deriv."
1,Interferon Alpha Response,0.0249929959878987,IFITM3;LGALS3BP;TXNIP;PSMB8,"iH-Pyrano[3',7]indolizino[1,2-b]quinoline,4-aminobenzoic acid deriv."
2,p53 Pathway,0.0387779169019451,LDHB;HDAC3;LIF;TXNIP;TM4SF1,"iH-Pyrano[3',7]indolizino[1,2-b]quinoline,4-aminobenzoic acid deriv."
0,Protein Secretion,0.00027699399786039534,TPD52;SCRN1;DST;CAV2;PAM;EGFR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
1,Cholesterol Homeostasis,0.0005540457752794171,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
2,Glycolysis,0.0007008573622530579,MIF;PYGL;PAM;MET;EGFR;IER3;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
3,Hypoxia,0.0032449908962063,TPD52;SDC4;MIF;PAM;EGFR;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
4,Apical Junction,0.0032449908962063,TJP1;RRAS;ITGA3;FSCN1;CTNNA1;EGFR,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
5,Epithelial Mesenchymal Transition,0.0177270477266034,TNFRSF12A;SDC4;DST;PFN2;CAP2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
6,UV Response Dn,0.027087875608201,TJP1;ID1;MET;CAP2,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
7,Fatty Acid Metabolism,0.0303715851897012,ELOVL5;PCBD1;MIF;S100A10,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
8,Apoptosis,0.0303715851897012,APP;GPX1;TNFRSF12A;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
9,IL-6/JAK/STAT3 Signaling,0.0303715851897012,TNFRSF12A;CD9;IL13RA1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
10,Pperoxisome,0.0444881775519091,SEMA3C;ELOVL5;PRDX1,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
11,TNF-alpha Signaling via NF-kB,0.0444881775519091,TUBB2A;SDC4;PLK2;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
12,p53 Pathway,0.0444881775519091,APP;PLK2;S100A10;IER3,"1H-Pyrano[3',7]indolizino[1,2-b]quinoline,glycine deriv."
0,Epithelial Mesenchymal Transition,4.866103637245348e-11,SPARC;DST;FN1;EMP3;THBS1;LGALS1;CDH2;COL4A2;BASP1;SPP1;TGFBI;VIM;CD44;PFN2,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
1,IL-2/STAT5 Signaling,0.0011777745200732,ALCAM;AHNAK;CTSZ;SPP1;LIF;CKAP4;CD44,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
2,Apoptosis,0.0019527714601056,APP;BTG3;GPX1;CAV1;TXNIP;CD44,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
3,Glycolysis,0.0037520207237386,TGFBI;PYGL;PAM;MET;CD44;IL13RA1,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
4,p53 Pathway,0.0037520207237386,APP;LDHB;LIF;TXNIP;TM4SF1;S100A10,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
5,TNF-alpha Signaling via NF-kB,0.0204968989338852,BTG3;MARCKS;TUBB2A;LIF;CD44,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
6,Coagulation,0.0250014832861547,SPARC;CAPN2;FN1;THBS1,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
7,UV Response Dn,0.0250014832861547,CAV1;MAP1B;MET;RND3,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
8,Cholesterol Homeostasis,0.0250014832861547,ALCAM;GPX8;S100A11,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
9,Protein Secretion,0.0445808612551423,SCRN1;DST;PAM,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
10,Angiogenesis,0.0445808612551423,APP;SPP1,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
11,Estrogen Response Late,0.0445808612551423,BTG3;CAV1;MYOF;CD44,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
12,Myogenesis,0.0445808612551423,APP;MEF2C;SPARC;COL4A2,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
13,Apical Junction,0.0445808612551423,SGCE;CTNNA1;MSN;TGFBI,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
14,KRAS Signaling Up,0.0445808612551423,SPP1;LIF;ETV1;LCP1,"4-Amino-4-ethyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione"
0,UV Response Dn,1.3285963373444218e-06,INPP4B;BDNF;SDC2;DLC1;ITGB3;PMP22;LPAR1;VLDLR;PLPP3,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
1,Epithelial Mesenchymal Transition,1.3285963373444218e-06,GLIPR1;CALD1;BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;SPOCK1;VEGFC,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
2,Hedgehog Signaling,0.0107544784703991,NRP2;CDK6;VLDLR,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
3,Androgen Response,0.0167785567274409,INPP4B;CDK6;HMGCR;ELL2,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
4,Myogenesis,0.0279201001694004,WWTR1;PRNP;MEF2C;ADAM12;IGFBP7,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
0,UV Response Dn,2.5298107857379512e-05,INPP4B;BDNF;DLC1;ITGB3;PMP22;LPAR1;PTEN;IGF1R,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
1,Epithelial Mesenchymal Transition,0.0001473202678322468,GLIPR1;BDNF;ITGB3;TFPI2;PMP22;SPP1;SPOCK1;VEGFC,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
2,Androgen Response,0.001947648167844,INPP4B;CDK6;ADAMTS1;HMGCR;ELL2,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
3,Complement,0.0332382144873815,DOCK10;ERAP2;TFPI2;FDX1;JAK2,"(19S)-10-[[4-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
0,Apical Junction,0.0081124772405159,TJP1;RRAS;CTNNA1;RHOF;EGFR;PTK2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
1,p53 Pathway,0.0081124772405159,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
3,TGF-beta Signaling,0.020004758548032,TJP1;SMURF2;ID1,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
4,UV Response Dn,0.0379230258514814,TJP1;ANXA2;ID1;CAP2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
5,Apoptosis,0.046522111071361,APP;KRT18;TNFRSF12A;PTK2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione"
0,UV Response Dn,0.0002618194200144215,TJP1;NRP1;ANXA2;MAP1B;ID1;MET;CAP2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
1,Epithelial Mesenchymal Transition,0.0056946534920319,TNFRSF12A;SDC4;DST;COL12A1;PFN2;CAP2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
2,Cholesterol Homeostasis,0.0056946534920319,ALCAM;TNFRSF12A;MAL2;CD9,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
3,Angiogenesis,0.0063374605271994,APP;NRP1;PTK2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
4,Apical Junction,0.0182810179680598,TJP1;RRAS;CTNNA1;RHOF;PTK2,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
5,p53 Pathway,0.0182810179680598,VAMP8;APP;HDAC3;SFN;S100A10,"(19S)-10-[[2-[[(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl]amino]phenyl]iminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;hydrochloride"
0,Epithelial Mesenchymal Transition,2.4673931979253548e-06,NOTCH2;NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;FSTL1;CD44;LOXL2,Irofulven
1,Hypoxia,1.4129955211188108e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;PAM;EGFR,Irofulven
2,Apical Junction,6.18845901852269e-05,TJP1;SGCE;ITGA3;AKT3;RAC2;EGFR;ACTB;PTK2,Irofulven
3,Glycolysis,6.18845901852269e-05,EXT1;NT5E;CDK1;MIF;PAM;MET;EGFR;CD44,Irofulven
4,UV Response Dn,6.18845901852269e-05,NOTCH2;TJP1;CAV1;SERPINE1;AKT3;MET;RND3,Irofulven
5,Apoptosis,0.00010678975310416964,APP;TNFRSF12A;CAV1;TIMP2;BAX;PTK2;CD44,Irofulven
6,TNF-alpha Signaling via NF-kB,0.0003660728186768204,FOSL1;MARCKS;SDC4;PLK2;SERPINE1;IL6ST;CD44,Irofulven
7,IL-6/JAK/STAT3 Signaling,0.00036785963684910167,TNFRSF12A;CD9;OSMR;IL6ST;CD44,Irofulven
8,Mitotic Spindle,0.0021397568161128,NOTCH2;MYO1E;MARCKS;PLK1;CDK1;ARHGAP29,Irofulven
9,Angiogenesis,0.0029958904310397,APP;FSTL1;PTK2,Irofulven
10,G2-M Checkpoint,0.0108024197083989,NOTCH2;MARCKS;MT2A;PLK1;CDK1,Irofulven
11,Estrogen Response Late,0.0108024197083989,ELOVL5;CAV1;CD9;IL6ST;CD44,Irofulven
12,Cholesterol Homeostasis,0.018244325641248,TNFRSF12A;CD9;HMGCR,Irofulven
13,Protein Secretion,0.0345114910390851,CAV2;PAM;EGFR,Irofulven
14,IL-2/STAT5 Signaling,0.0370978717414769,MYO1E;NT5E;AHNAK;CD44,Irofulven
15,Complement,0.0370978717414769,GCA;ERAP2;SERPINE1;TIMP2,Irofulven
16,mTORC1 Signaling,0.0370978717414769,ELOVL5;PLK1;CD9;HMGCR,Irofulven
17,Inflammatory Response,0.0370978717414769,AXL;SERPINE1;OSMR;MET,Irofulven
18,p53 Pathway,0.0370978717414769,APP;PLK2;BAX;PTPN14,Irofulven
0,Epithelial Mesenchymal Transition,2.0877942443983774e-06,GLIPR1;CALD1;BDNF;SPOCK1;SNAI2;VEGFC;LAMC1;DKK1;FGF2;LOXL2,Torisel (TM)
1,UV Response Dn,0.0014157483895807,DDAH1;ANXA2;DUSP1;BDNF;SNAI2;LAMC1,Torisel (TM)
2,Estrogen Response Early,0.0274215269520897,ABLIM1;KRT19;KRT8;MYBL1;PRSS23,Torisel (TM)
3,Xenobiotic Metabolism,0.0274215269520897,TPST1;TGFB2;GCH1;PTGR1;EPHA2,Torisel (TM)
0,Apical Junction,0.0021682774644703,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,Epothilone B
1,Angiogenesis,0.0086352904897123,APP;FSTL1;PTK2,Epothilone B
2,UV Response Dn,0.0086352904897123,TJP1;ANXA2;DUSP1;ID1;LAMC1,Epothilone B
3,p53 Pathway,0.0274215269520897,VAMP8;APP;PTPN14;EPHA2;S100A10,Epothilone B
0,Epithelial Mesenchymal Transition,7.849230926268477e-10,NOTCH2;TNFRSF12A;SERPINE1;FN1;LAMC1;FSTL1;LOXL2;NT5E;LGALS1;CDH2;VIM;FERMT2;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
1,UV Response Dn,1.1067922187603535e-05,NOTCH2;ANXA2;CAV1;MAP1B;SERPINE1;AKT3;LAMC1;RND3,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
2,TNF-alpha Signaling via NF-kB,6.445261717660797e-05,FOSL1;MARCKS;CCND1;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
3,Hypoxia,6.445261717660797e-05,EXT1;MT2A;ANXA2;CAV1;SERPINE1;NEDD4L;ETS1;EGFR,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
4,Apoptosis,0.0011083297476275,APP;CCND1;TNFRSF12A;CAV1;TIMP2;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
5,IL-2/STAT5 Signaling,0.0028804418678441,MYO1E;NT5E;AHNAK;PHLDA1;CKAP4;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
6,IL-6/JAK/STAT3 Signaling,0.0047653858310196,TNFRSF12A;OSMR;IL6ST;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
7,Apical Junction,0.0145417188382294,SGCE;RRAS;ITGA3;AKT3;EGFR,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
8,Cholesterol Homeostasis,0.0236500517571733,TNFRSF12A;GPX8;S100A11,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
9,Notch Signaling,0.0372097808568358,NOTCH2;CCND1,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
10,Androgen Response,0.0372097808568358,CCND1;B2M;ELL2,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
11,Angiogenesis,0.0372097808568358,APP;FSTL1,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
12,G2-M Checkpoint,0.0372097808568358,NOTCH2;MARCKS;MT2A;CCND1,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
13,Estrogen Response Late,0.0372097808568358,CCND1;CAV1;IL6ST;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
14,Inflammatory Response,0.0372097808568358,AXL;SERPINE1;SGMS2;OSMR,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
15,Glycolysis,0.0372097808568358,EXT1;NT5E;EGFR;CD44,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
16,p53 Pathway,0.0372097808568358,APP;PLK2;PTPN14;S100A10,"N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine"
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,NT5E;VCAN;ECM1;SPARC;LGALS1;COL12A1;TNC;SNAI2;CD44,Sjg-136
1,KRAS Signaling Up,0.0012155494876576,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,Sjg-136
2,TNF-alpha Signaling via NF-kB,0.0046900259046732,FOSL1;PLAU;PLK2;TNC;CD44;IER3,Sjg-136
3,Glycolysis,0.0046900259046732,NT5E;VCAN;CDK1;MIF;CD44;IER3,Sjg-136
4,Hedgehog Signaling,0.0056845100486395,NRP1;NRP2;CDK6,Sjg-136
5,IL-2/STAT5 Signaling,0.0200626422130012,NRP1;NT5E;ECM1;ALCAM;CD44,Sjg-136
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
1,IL-2/STAT5 Signaling,8.593682290214397e-05,PRNP;CSF1;BHLHE40;LIF;ITGA6;AHR;WLS;IGF1R,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
2,Hypoxia,8.593682290214397e-05,SRPX;TES;DTNA;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
3,TNF-alpha Signaling via NF-kB,0.0005749220549732116,CEBPB;CSF1;BHLHE40;LIF;SGK1;FJX1;LITAF,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
4,UV Response Dn,0.0006006205289130573,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
5,Myogenesis,0.0029576739939381,WWTR1;FDPS;PRNP;DTNA;ITGB5;BHLHE40,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
6,Interferon Alpha Response,0.0071408559965424,LGALS3BP;CSF1;PSMB8;PSMB9,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
7,Estrogen Response Early,0.0096944792254862,DYNLT3;BHLHE40;RHOBTB3;FLNB;IGF1R,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
8,Complement,0.0096944792254862,DOCK10;LYN;CEBPB;FN1;PSMB9,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
9,Inflammatory Response,0.0096944792254862,LYN;CSF1;ITGB3;LIF;AHR,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
10,Allograft Rejection,0.0096944792254862,LYN;TGFB2;CSF1;LIF;BCAT1,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
11,KRAS Signaling Up,0.0096944792254862,TMEM158;LIF;SOX9;GNG11;PSMB8,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
12,mTORC1 Signaling,0.0486589441974006,TES;BHLHE40;BCAT1;HSP90B1,2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,ITGB5;IGFBP3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-"
1,Hypoxia,0.0013141075542244,CDKN1C;SRPX;DTNA;IGFBP3;CAV1;TGFBI;MT1E,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-"
2,Myogenesis,0.0067603977004299,PRNP;MEF2C;DTNA;ITGB5;IGFBP3;ADAM12,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-"
3,Estrogen Response Late,0.0265905715899052,CAV1;DYNLT3;FLNB;IL6ST;MAPK13,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-"
4,KRAS Signaling Up,0.0265905715899052,IGFBP3;SPP1;LY96;PLAT;LCP1,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-"
0,Hypoxia,0.0009636788730979544,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,2-(4-((7-Chloro-2-quinoxalinyl)oxy)phenoxy)propanoic acid
1,mTORC1 Signaling,0.0009636788730979544,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,2-(4-((7-Chloro-2-quinoxalinyl)oxy)phenoxy)propanoic acid
2,Epithelial Mesenchymal Transition,0.0009636788730979544,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,2-(4-((7-Chloro-2-quinoxalinyl)oxy)phenoxy)propanoic acid
3,Interferon Alpha Response,0.0013917756304235,LGALS3BP;HLA-C;TXNIP;PSMB8;PSMB9,2-(4-((7-Chloro-2-quinoxalinyl)oxy)phenoxy)propanoic acid
4,UV Response Dn,0.0069082323917698,ITGB3;PMP22;NR3C1;MT1E;IGF1R,2-(4-((7-Chloro-2-quinoxalinyl)oxy)phenoxy)propanoic acid
0,Epithelial Mesenchymal Transition,0.0016731571876863,NT5E;TNFRSF12A;COL4A1;COL12A1;SERPINE1;CD44;LOXL2,5-Fluoro deoxy uridine 10mer
1,UV Response Dn,0.0016731571876863,INPP4B;DLC1;SERPINE1;ATP2B4;PTEN;VLDLR,5-Fluoro deoxy uridine 10mer
2,Estrogen Response Early,0.0049435408184394,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,5-Fluoro deoxy uridine 10mer
3,Glycolysis,0.0049435408184394,EXT1;NT5E;CDK1;MIF;VLDLR;CD44,5-Fluoro deoxy uridine 10mer
4,Hedgehog Signaling,0.0059917808620795,NRP2;CDK6;VLDLR,5-Fluoro deoxy uridine 10mer
5,Androgen Response,0.0103867255931777,INPP4B;CDK6;ELOVL5;HMGCR,5-Fluoro deoxy uridine 10mer
6,Hypoxia,0.0144032262778653,EXT1;SERPINE1;MIF;VLDLR;ETS1,5-Fluoro deoxy uridine 10mer
7,Estrogen Response Late,0.0144032262778653,FARP1;ELOVL5;ATP2B4;JAK2;CD44,5-Fluoro deoxy uridine 10mer
8,p53 Pathway,0.0144032262778653,VAMP8;HDAC3;BAX;STOM;TP53,5-Fluoro deoxy uridine 10mer
9,PI3K/AKT/mTOR  Signaling,0.046990637539204,CDK1;PTEN;PLCB1,5-Fluoro deoxy uridine 10mer
10,Mitotic Spindle,0.046990637539204,FARP1;PLK1;CDK1;CDC42EP1,5-Fluoro deoxy uridine 10mer
11,Complement,0.046990637539204,GCA;ERAP2;SERPINE1;JAK2,5-Fluoro deoxy uridine 10mer
12,mTORC1 Signaling,0.046990637539204,ELOVL5;PLK1;VLDLR;HMGCR,5-Fluoro deoxy uridine 10mer
13,E2F Targets,0.046990637539204,DNMT1;PLK1;CDK1;TP53,5-Fluoro deoxy uridine 10mer
14,Xenobiotic Metabolism,0.046990637539204,GSTM4;ELOVL5;SERPINE1;MAN1A1,5-Fluoro deoxy uridine 10mer
0,Epithelial Mesenchymal Transition,0.0027596258638714,VCAN;SPARC;COL4A1;COL12A1;TNC;SPP1;SNAI2,Seliciclib
1,KRAS Signaling Up,0.0080658588527993,NRP1;GABRA3;SPP1;LCP1;TRIB2;DUSP6,Seliciclib
2,Hedgehog Signaling,0.0080658588527993,NRP1;NRP2;CDK6,Seliciclib
3,Angiogenesis,0.0080658588527993,NRP1;VCAN;SPP1,Seliciclib
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,GJA1;LGALS1;DST;ITGB5;FN1;TGFBI;EMP3;EDIL3;PFN2,Vorinostat
1,Estrogen Response Early,0.0010296351924223,ABLIM1;GJA1;MYOF;KRT8;FLNB;SFN;IL6ST,Vorinostat
2,UV Response Dn,0.0010296351924223,TJP1;GJA1;ANXA2;CAV1;MAP1B;RND3,Vorinostat
3,p53 Pathway,0.0045632684477902,APP;LIF;SFN;PTPN14;TM4SF1;S100A10,Vorinostat
4,Estrogen Response Late,0.0239315144309146,CAV1;MYOF;FLNB;SFN;IL6ST,Vorinostat
0,Apical Junction,0.0002430784419232072,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,Emcyt (Pharmacia)
1,Cholesterol Homeostasis,0.0084499473695993,TNFRSF12A;GPX8;MAL2;CD9,Emcyt (Pharmacia)
2,Angiogenesis,0.0084499473695993,APP;FSTL1;PTK2,Emcyt (Pharmacia)
3,Protein Secretion,0.0113395824663766,KRT18;SCRN1;CAV2;EGFR,Emcyt (Pharmacia)
4,p53 Pathway,0.0219372215616718,VAMP8;APP;PTPN14;EPHA2;S100A10,Emcyt (Pharmacia)
5,Apoptosis,0.0447438531812563,APP;KRT18;TNFRSF12A;PTK2,Emcyt (Pharmacia)
6,IL-6/JAK/STAT3 Signaling,0.0447438531812563,TNFRSF12A;CD9;OSMR,Emcyt (Pharmacia)
0,UV Response Dn,0.0345411619588494,BDNF;ITGB3;PMP22;MT1E;IGF1R,LMP-744 hydrochloride
1,IL-2/STAT5 Signaling,0.0365620359361196,PRNP;PLAGL1;SPP1;PLIN2;IGF1R,LMP-744 hydrochloride
2,Hypoxia,0.0365620359361196,SRPX;DTNA;GCNT2;PLIN2;MT1E,LMP-744 hydrochloride
3,mTORC1 Signaling,0.0365620359361196,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,LMP-744 hydrochloride
0,Epithelial Mesenchymal Transition,0.0012870439905279,TNFRSF12A;SDC4;CALD1;SERPINE1;LAMC1;FSTL1;LOXL2,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
1,UV Response Dn,0.0012870439905279,TJP1;ANXA2;DUSP1;SERPINE1;ID1;LAMC1,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
2,TGF-beta Signaling,0.0015358406385611,TJP1;SMURF2;SERPINE1;ID1,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
3,Apical Junction,0.0038027237064918,TJP1;RRAS;FLNC;RHOF;EGFR;PTK2,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
4,Angiogenesis,0.0046090622015996,APP;FSTL1;PTK2,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
5,Apoptosis,0.0064635883614456,APP;KRT18;TNFRSF12A;CLU;PTK2,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
6,Hypoxia,0.0142449490660206,ANXA2;SDC4;DUSP1;SERPINE1;EGFR,"(1S,3S,6S,9S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid"
0,UV Response Dn,1.675926765118113e-06,INPP4B;SDC2;DLC1;ITGB3;PMP22;ATP2B4;SNAI2;VLDLR;PLPP3,"Geldanamycin, monohydrochloride"
1,Epithelial Mesenchymal Transition,0.0012484021765132,CALD1;COL4A1;ITGB3;PMP22;SNAI2;VEGFC;PDLIM4,"Geldanamycin, monohydrochloride"
2,Hedgehog Signaling,0.0097302424255992,NRP2;CDK6;VLDLR,"Geldanamycin, monohydrochloride"
3,Androgen Response,0.0151805989438751,INPP4B;CDK6;HMGCR;ELL2,"Geldanamycin, monohydrochloride"
0,Glycolysis,0.00013849699893019767,MIF;PYGL;PAM;MET;EGFR;CD44;IER3;IL13RA1,Silatecan
1,Protein Secretion,0.00013849699893019767,TPD52;SCRN1;DST;CAV2;PAM;EGFR,Silatecan
2,Cholesterol Homeostasis,0.0003693638501862781,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Silatecan
3,Hypoxia,0.0004205144173518348,TPD52;SDC4;CAV1;MIF;PAM;EGFR;IER3,Silatecan
4,Epithelial Mesenchymal Transition,0.0004205144173518348,TNFRSF12A;SDC4;DST;VIM;CD44;PFN2;CAP2,Silatecan
5,UV Response Dn,0.0004576156410766151,TJP1;CAV1;MAP1B;ID1;MET;CAP2,Silatecan
6,Apoptosis,0.0007238071821241176,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,Silatecan
7,TNF-alpha Signaling via NF-kB,0.0018027727201146,MARCKS;TUBB2A;SDC4;PLK2;CD44;IER3,Silatecan
8,Apical Junction,0.0018027727201146,TJP1;RRAS;ITGA3;FSCN1;CTNNA1;EGFR,Silatecan
9,IL-6/JAK/STAT3 Signaling,0.0030498469318525,TNFRSF12A;CD9;CD44;IL13RA1,Silatecan
10,Estrogen Response Late,0.0096692987599655,ELOVL5;CAV1;CD9;LSR;CD44,Silatecan
11,Fatty Acid Metabolism,0.0218048520034869,ELOVL5;PCBD1;MIF;S100A10,Silatecan
12,Mitotic Spindle,0.0413104505839156,MARCKS;DST;FSCN1;ARHGAP29,Silatecan
13,p53 Pathway,0.0413104505839156,APP;PLK2;S100A10;IER3,Silatecan
0,Hypoxia,1.0755303683264367e-06,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;PAM;EGFR;IER3,10-Hydroxy-7-trimethylsilylethylcamptothecin
1,Epithelial Mesenchymal Transition,1.0755303683264367e-06,NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;FSTL1;CD44;LOXL2;CAP2,10-Hydroxy-7-trimethylsilylethylcamptothecin
2,TNF-alpha Signaling via NF-kB,6.159211245902508e-06,FOSL1;MARCKS;SDC4;PLAU;PLK2;SERPINE1;PHLDA1;CD44;IER3,10-Hydroxy-7-trimethylsilylethylcamptothecin
3,Apical Junction,6.159211245902508e-06,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;EGFR;ACTB;PTK2,10-Hydroxy-7-trimethylsilylethylcamptothecin
4,Apoptosis,1.0005739774251556e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,10-Hydroxy-7-trimethylsilylethylcamptothecin
5,Glycolysis,3.853619169043433e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,10-Hydroxy-7-trimethylsilylethylcamptothecin
6,UV Response Dn,3.853619169043433e-05,TJP1;CAV1;SERPINE1;AKT3;MET;RND3;CAP2,10-Hydroxy-7-trimethylsilylethylcamptothecin
7,p53 Pathway,0.002154876767012,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,10-Hydroxy-7-trimethylsilylethylcamptothecin
8,Angiogenesis,0.002902002126933,APP;FSTL1;PTK2,10-Hydroxy-7-trimethylsilylethylcamptothecin
9,IL-6/JAK/STAT3 Signaling,0.0032404623650933,TNFRSF12A;CD9;OSMR;CD44,10-Hydroxy-7-trimethylsilylethylcamptothecin
10,Fatty Acid Metabolism,0.003675605829054,LGALS1;ELOVL5;PCBD1;MIF;S100A10,10-Hydroxy-7-trimethylsilylethylcamptothecin
11,Protein Secretion,0.0038944020591596,SCRN1;CAV2;PAM;EGFR,10-Hydroxy-7-trimethylsilylethylcamptothecin
12,IL-2/STAT5 Signaling,0.0080721378040783,MYO1E;NT5E;AHNAK;PHLDA1;CD44,10-Hydroxy-7-trimethylsilylethylcamptothecin
13,Inflammatory Response,0.0080721378040783,AXL;SERPINE1;SGMS2;OSMR;MET,10-Hydroxy-7-trimethylsilylethylcamptothecin
14,Cholesterol Homeostasis,0.0137846015956096,TNFRSF12A;GPX8;CD9,10-Hydroxy-7-trimethylsilylethylcamptothecin
15,Mitotic Spindle,0.0341384973575414,MYO1E;MARCKS;ARHGAP29;CDC42EP1,10-Hydroxy-7-trimethylsilylethylcamptothecin
16,Estrogen Response Late,0.0341384973575414,ELOVL5;CAV1;CD9;CD44,10-Hydroxy-7-trimethylsilylethylcamptothecin
17,Complement,0.0341384973575414,GCA;SERPINE1;GNB4;TIMP2,10-Hydroxy-7-trimethylsilylethylcamptothecin
0,UV Response Dn,0.0147197807015546,TJP1;MAP1B;ID1;MET;CAP2,Karenitecin
1,Protein Secretion,0.0147197807015546,TPD52;SCRN1;DST;CAV2,Karenitecin
2,TGF-beta Signaling,0.0147197807015546,TJP1;RAB31;ID1,Karenitecin
3,Estrogen Response Early,0.0147197807015546,ABLIM1;RAB31;MYOF;SFN;PAPSS2,Karenitecin
4,Apical Junction,0.0147197807015546,TJP1;RRAS;ITGA3;FSCN1;CTNNA1,Karenitecin
5,Epithelial Mesenchymal Transition,0.0147197807015546,SDC4;DST;BASP1;PFN2;CAP2,Karenitecin
6,p53 Pathway,0.0147197807015546,APP;LIF;SFN;TM4SF1;S100A10,Karenitecin
0,Hypoxia,0.0003167385758393306,SRPX;TES;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Omdpi
1,Epithelial Mesenchymal Transition,0.0109011412919433,ITGB3;ADAM12;PMP22;SPP1;FAS;TGFBI,Omdpi
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Omdpi
3,Interferon Alpha Response,0.0153528403925663,LGALS3BP;TXNIP;PSMB8;PSMB9,Omdpi
4,TNF-alpha Signaling via NF-kB,0.0238207203826234,CEBPB;IRS2;SGK1;FJX1;LITAF,Omdpi
5,Interferon Gamma Response,0.0238207203826234,LGALS3BP;FAS;TXNIP;PSMB8;PSMB9,Omdpi
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
1,UV Response Dn,0.0001626453972816861,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
2,IL-2/STAT5 Signaling,0.0008700676634775469,PRNP;CSF1;BHLHE40;ITGA6;AHR;WLS;IGF1R,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
3,TNF-alpha Signaling via NF-kB,0.0051970557322055,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
4,Hypoxia,0.0151418532664738,SRPX;BHLHE40;GCNT2;AMPD3;MT1E,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
5,Myogenesis,0.0151418532664738,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
6,Inflammatory Response,0.0151418532664738,LYN;CSF1;ITGB3;LPAR1;AHR,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
7,Xenobiotic Metabolism,0.0151418532664738,TGFB2;PROS1;GCNT2;FAS;BCAT1,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
8,Allograft Rejection,0.0151418532664738,LYN;TGFB2;CSF1;FAS;BCAT1,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
9,Apoptosis,0.0353759941130043,TGFB2;FAS;BAX;BCL2L2,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
10,IL-6/JAK/STAT3 Signaling,0.0353759941130043,CSF1;ITGB3;FAS,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
11,Interferon Alpha Response,0.0435233677677298,CSF1;PSMB8;PSMB9,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
12,Estrogen Response Early,0.0494004138232658,MLPH;BHLHE40;RHOBTB3;IGF1R,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
13,Complement,0.0494004138232658,DOCK10;LYN;CEBPB;PSMB9,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
14,mTORC1 Signaling,0.0494004138232658,BHLHE40;BCAT1;AURKA;HSP90B1,"2-(S)-Mercapto-4-(3,4-trimethylhydantoyl)-butanoyl-L-leucyl-L-t-leucinyl-N-methylamide"
0,Epithelial Mesenchymal Transition,1.4064670468503941e-13,SPARC;TNFRSF12A;SDC4;DST;COL12A1;TNC;THBS1;NT5E;GJA1;VCAN;LGALS1;COL4A2;COL4A1;SNAI2;SDC1;CD44,Imexon
1,TNF-alpha Signaling via NF-kB,9.661507836709818e-06,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;TNC;IL6ST;CD44,Imexon
2,Glycolysis,9.661507836709818e-06,NT5E;VCAN;ELF3;SDC1;PAM;MET;EGFR;CD44;IL13RA1,Imexon
3,IL-2/STAT5 Signaling,6.347137454895067e-05,CDKN1C;MYO1E;NRP1;NT5E;ALCAM;AHNAK;CKAP4;CD44,Imexon
4,UV Response Dn,6.347137454895067e-05,NRP1;GJA1;ANXA2;CAV1;SNAI2;MET;RND3,Imexon
5,Estrogen Response Late,0.0004311907831198261,ST14;ELOVL5;CAV1;CD9;IL6ST;CD44;MAPK13,Imexon
6,IL-6/JAK/STAT3 Signaling,0.0004311907831198261,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,Imexon
8,Apical Junction,0.0020707830880116,SGCE;VCAN;ITGA3;MSN;EGFR;MAPK13,Imexon
9,Cholesterol Homeostasis,0.0020707830880116,ALCAM;TNFRSF12A;MAL2;CD9,Imexon
7,Hypoxia,0.0020707830880116,CDKN1C;ANXA2;SDC4;CAV1;PAM;EGFR,Imexon
10,Angiogenesis,0.0027933710312724,APP;NRP1;VCAN,Imexon
11,Protein Secretion,0.0045816494813642,DST;CAV2;PAM;EGFR,Imexon
12,Estrogen Response Early,0.0102271429191943,GJA1;ELF3;ELOVL5;IL6ST;CD44,Imexon
13,Coagulation,0.0145804026948645,SPARC;PLAU;CD9;THBS1,Imexon
14,Apoptosis,0.0232610555356805,APP;TNFRSF12A;CAV1;CD44,Imexon
15,Hedgehog Signaling,0.0349022880911989,NRP1;NRP2,Imexon
17,p53 Pathway,0.0380490992220275,APP;ST14;PLK2;SDC1,Imexon
16,Mitotic Spindle,0.0380490992220275,MYO1E;MARCKS;DST;ARHGAP29,Imexon
18,KRAS Signaling Up,0.0380490992220275,NRP1;PLAU;GABRA3;LY96,Imexon
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;CD44,Gefitinib
1,KRAS Signaling Up,0.0013141075542244,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Gefitinib
2,Glycolysis,0.0067603977004299,NT5E;VCAN;CDK1;MIF;EGFR;CD44,Gefitinib
3,Angiogenesis,0.0076817703359993,NRP1;VCAN;ITGAV,Gefitinib
4,IL-2/STAT5 Signaling,0.0221588096582543,NRP1;NT5E;ALCAM;ITGAV;CD44,Gefitinib
5,Estrogen Response Early,0.0221588096582543,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,Gefitinib
6,Cholesterol Homeostasis,0.03475109645952,ALCAM;MAL2;HMGCR,Gefitinib
0,UV Response Dn,0.00031735687274475334,INPP4B;DLC1;SERPINE1;AKT3;ATP2B4;SNAI2;VLDLR,Erlotinib hydrochloride
1,Epithelial Mesenchymal Transition,0.0013141075542244,NT5E;TNFRSF12A;SERPINE1;COL12A1;SNAI2;CD44;LOXL2,Erlotinib hydrochloride
2,Androgen Response,0.001947648167844,INPP4B;CDK6;ELOVL5;HMGCR;B2M,Erlotinib hydrochloride
3,Hypoxia,0.0033801988502149,EXT1;MT2A;SERPINE1;MIF;VLDLR;ETS1,Erlotinib hydrochloride
4,Estrogen Response Early,0.0033801988502149,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Erlotinib hydrochloride
5,Glycolysis,0.0033801988502149,EXT1;NT5E;CDK1;MIF;VLDLR;CD44,Erlotinib hydrochloride
6,Hedgehog Signaling,0.0043895830491425,NRP2;CDK6;VLDLR,Erlotinib hydrochloride
7,TNF-alpha Signaling via NF-kB,0.0132952857949526,FOSL1;PLAU;PLK2;SERPINE1;CD44,Erlotinib hydrochloride
8,Estrogen Response Late,0.0132952857949526,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Erlotinib hydrochloride
9,Complement,0.0132952857949526,GCA;ERAP2;SERPINE1;GNB4;JAK2,Erlotinib hydrochloride
0,Epithelial Mesenchymal Transition,1.4327941240524444e-08,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,Celecoxib
1,Angiogenesis,0.0004732474330511688,APP;NRP1;VCAN;ITGAV,Celecoxib
2,Cholesterol Homeostasis,0.0004732474330511688,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Celecoxib
3,Glycolysis,0.0006734801215400478,NT5E;VCAN;CDK1;MIF;PAM;MET;CD44,Celecoxib
4,TNF-alpha Signaling via NF-kB,0.0041576445857644,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44,Celecoxib
5,Coagulation,0.0044257479761019,SPARC;PLAU;CD9;THBS1;DUSP6,Celecoxib
7,Estrogen Response Late,0.0151418532664738,ELOVL5;ATP2B4;CD9;JAK2;CD44,Celecoxib
8,mTORC1 Signaling,0.0151418532664738,ELOVL5;PRDX1;PLK1;CD9;HMGCR,Celecoxib
6,IL-2/STAT5 Signaling,0.0151418532664738,NRP1;NT5E;ALCAM;ITGAV;CD44,Celecoxib
9,UV Response Dn,0.0242944384361053,NRP1;ATP2B4;SNAI2;MET,Celecoxib
10,IL-6/JAK/STAT3 Signaling,0.0353759941130043,TNFRSF12A;CD9;CD44,Celecoxib
15,Apical Junction,0.0435886004322933,VCAN;CDH3;ITGA3;ACTB,Celecoxib
11,Androgen Response,0.0435886004322933,ELOVL5;ITGAV;HMGCR,Celecoxib
12,Hedgehog Signaling,0.0435886004322933,NRP1;NRP2,Celecoxib
13,Hypoxia,0.0435886004322933,SDC4;MIF;ETS1;PAM,Celecoxib
14,Estrogen Response Early,0.0435886004322933,ELOVL5;ENDOD1;JAK2;CD44,Celecoxib
16,KRAS Signaling Up,0.0435886004322933,NRP1;PLAU;ETS1;DUSP6,Celecoxib
0,Epithelial Mesenchymal Transition,7.62496718551795e-10,NOTCH2;TNFRSF12A;SDC4;DST;SERPINE1;LAMC1;FSTL1;LOXL2;NT5E;LGALS1;VIM;FERMT2;CD44,Zoledronic acid
1,UV Response Dn,4.627245307873584e-08,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;MAP1B;SERPINE1;AKT3;LAMC1;RND3,Zoledronic acid
2,TNF-alpha Signaling via NF-kB,7.170202455509579e-07,FOSL1;MARCKS;CCND1;SDC4;DUSP1;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,Zoledronic acid
3,Hypoxia,6.261111382870489e-05,EXT1;ERRFI1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;EGFR,Zoledronic acid
4,Apoptosis,0.0001117185109397467,APP;CCND1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Zoledronic acid
5,Cholesterol Homeostasis,0.00019622454541146024,ERRFI1;TNFRSF12A;GPX8;CD9;S100A11,Zoledronic acid
6,Apical Junction,0.000319140406025946,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR;PTK2,Zoledronic acid
7,IL-6/JAK/STAT3 Signaling,0.00032069814494537066,TNFRSF12A;CD9;OSMR;IL6ST;CD44,Zoledronic acid
9,p53 Pathway,0.0017239014136096,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Zoledronic acid
8,IL-2/STAT5 Signaling,0.0017239014136096,MYO1E;NT5E;AHNAK;PHLDA1;CKAP4;CD44,Zoledronic acid
10,Angiogenesis,0.0023743653765816,APP;FSTL1;PTK2,Zoledronic acid
11,Mitotic Spindle,0.0086930714813151,NOTCH2;MYO1E;MARCKS;DST;ARHGAP29,Zoledronic acid
12,Estrogen Response Late,0.0086930714813151,CCND1;CAV1;CD9;IL6ST;CD44,Zoledronic acid
13,Fatty Acid Metabolism,0.0198579902174613,CBR1;LGALS1;PCBD1;S100A10,Zoledronic acid
14,Notch Signaling,0.0252382501437097,NOTCH2;CCND1,Zoledronic acid
15,Protein Secretion,0.0263260732926354,DST;CAV2;EGFR,Zoledronic acid
17,Inflammatory Response,0.0323417343387234,AXL;SERPINE1;SGMS2;OSMR,Zoledronic acid
16,Estrogen Response Early,0.0323417343387234,ABLIM1;CCND1;IL6ST;CD44,Zoledronic acid
18,Glycolysis,0.0323417343387234,EXT1;NT5E;EGFR;CD44,Zoledronic acid
0,Epithelial Mesenchymal Transition,1.3279555296095826e-08,NT5E;VCAN;ECM1;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,(Bis-allyl)amino-wortmannin
1,KRAS Signaling Up,0.0012484021765132,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,(Bis-allyl)amino-wortmannin
2,Angiogenesis,0.0097302424255992,NRP1;VCAN;ITGAV,(Bis-allyl)amino-wortmannin
3,Estrogen Response Early,0.0315763037630124,ELOVL5;ENDOD1;PMAIP1;JAK2;AREG,(Bis-allyl)amino-wortmannin
4,Cholesterol Homeostasis,0.0462189582911617,TNFRSF12A;MAL2;HMGCR,(Bis-allyl)amino-wortmannin
0,Hypoxia,0.0025625097307377,CDKN1C;SRPX;DTNA;IRS2;TGFBI;AMPD3;MT1E,Belinostat
0,Apical Junction,0.0078589623267498,TJP1;RRAS;CTNNA1;RHOF;EGFR;PTK2,Tyverb
1,p53 Pathway,0.0078589623267498,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Tyverb
2,Angiogenesis,0.0079378293471993,APP;FSTL1;PTK2,Tyverb
0,Estrogen Response Late,0.0096819923672532,TFAP2C;FABP5;ELOVL5;ATP2B4;JAK2;MICB,Irinotecan
1,Hedgehog Signaling,0.0096819923672532,NRP2;CDK6;VLDLR,Irinotecan
2,UV Response Dn,0.0096819923672532,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,Irinotecan
3,Androgen Response,0.0147811094979836,INPP4B;CDK6;ELOVL5;HMGCR,Irinotecan
4,Estrogen Response Early,0.0204968989338852,TFAP2C;ELOVL5;DLC1;JAK2;MICB,Irinotecan
5,p53 Pathway,0.0204968989338852,HDAC3;BAX;STOM;TXNIP;TP53,Irinotecan
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,ITGB5;BASP1;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
2,UV Response Dn,0.0107286942447941,ITGB3;PMP22;LPAR1;MT1E;IGF1R,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
3,Interferon Alpha Response,0.0146387547929121,LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
4,TNF-alpha Signaling via NF-kB,0.017034584924783,CEBPB;IRS2;SGK1;FJX1;LITAF,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
5,Myogenesis,0.017034584924783,FDPS;PRNP;DTNA;ITGB5;ADAM12,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
6,Complement,0.017034584924783,DOCK10;LYN;CEBPB;FN1;PSMB9,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
7,Inflammatory Response,0.017034584924783,LYN;ITGB3;LPAR1;AHR;EMP3,N-(2-amino-phenyl)-4-(1-{[benzyl(methyl)amino]methyl}vinyl)benzamide
0,Hypoxia,1.3043035579558251e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;PAM;EGFR,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
1,Epithelial Mesenchymal Transition,1.3043035579558251e-05,NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;FSTL1;CD44;LOXL2,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
2,Apical Junction,8.839216069934808e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR;ACTB;PTK2,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
3,Apoptosis,0.00014786273506731183,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
4,Glycolysis,0.00047307871952081406,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
5,UV Response Dn,0.000514817596211192,TJP1;CAV1;SERPINE1;AKT3;MET;RND3,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
6,TNF-alpha Signaling via NF-kB,0.0026075819701658,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
7,Angiogenesis,0.0034567966511997,APP;FSTL1;PTK2,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
8,IL-6/JAK/STAT3 Signaling,0.0038123086648157,TNFRSF12A;CD9;OSMR;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
9,Mitotic Spindle,0.0099714643462144,FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
10,Estrogen Response Late,0.0099714643462144,FARP1;ELOVL5;CAV1;CD9;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
11,Inflammatory Response,0.0099714643462144,AXL;SERPINE1;SGMS2;OSMR;MET,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
12,Protein Secretion,0.0343072810329367,CAV2;PAM;EGFR,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
13,IL-2/STAT5 Signaling,0.0406649747935419,MYO1E;NT5E;AHNAK;CD44,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
14,Complement,0.0406649747935419,GCA;SERPINE1;GNB4;TIMP2,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
15,p53 Pathway,0.0406649747935419,VAMP8;APP;PLK2;PTPN14,N-(2-aminophenyl)-4-{1-[(4-pyridin-2-ylpiperazin-1-yl)methyl]vinyl}benzamide
0,Epithelial Mesenchymal Transition,0.0002725424954896566,NT5E;VCAN;SPARC;LGALS1;COL4A1;COL12A1;SNAI2;CD44,"N-(2-aminophenyl)-4-[1-(1,3,4,9-tetrahydro-2H-beta-carbolin-2-ylmethyl)vinyl]benzamide"
1,Glycolysis,0.0012155494876576,NT5E;VCAN;CITED2;CDK1;MIF;CD44;IER3,"N-(2-aminophenyl)-4-[1-(1,3,4,9-tetrahydro-2H-beta-carbolin-2-ylmethyl)vinyl]benzamide"
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
2,UV Response Dn,0.0107286942447941,ITGB3;PMP22;LPAR1;MT1E;IGF1R,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
3,Interferon Alpha Response,0.0146387547929121,LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
4,TNF-alpha Signaling via NF-kB,0.017034584924783,CEBPB;IRS2;SGK1;FJX1;LITAF,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
5,Myogenesis,0.017034584924783,FDPS;PRNP;DTNA;ITGB5;ADAM12,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
6,Complement,0.017034584924783,DOCK10;LYN;CEBPB;FN1;PSMB9,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
7,Inflammatory Response,0.017034584924783,LYN;ITGB3;LPAR1;AHR;EMP3,N-(2-aminophenyl)-4-{1-[(benzylamino)methyl]vinyl}benzamide
0,Cholesterol Homeostasis,0.0006220712620885236,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
1,Apical Junction,0.0006220712620885236,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
2,Epithelial Mesenchymal Transition,0.0006220712620885236,TNFRSF12A;SDC4;DST;VIM;FSTL1;PFN2;CAP2,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
3,UV Response Dn,0.0006220712620885236,TJP1;ANXA2;CAV1;ID1;MET;CAP2,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
4,Hypoxia,0.002940772999687,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
5,Angiogenesis,0.0037128556623996,APP;FSTL1;PTK2,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
6,Apoptosis,0.0049825438109836,APP;GPX1;TNFRSF12A;CAV1;PTK2,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
7,Protein Secretion,0.0049825438109836,SCRN1;DST;CAV2;EGFR,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
8,p53 Pathway,0.0107100913348229,VAMP8;APP;PLK2;PTPN14;S100A10,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
9,IL-6/JAK/STAT3 Signaling,0.0275242490781667,TNFRSF12A;CD9;OSMR,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
10,Glycolysis,0.047647849253039,EXT1;MIF;MET;EGFR,N-(2-aminophenyl)-4-[1-({4-[3-(trifluoromethyl)phenyl]pipera zin-1-yl}methyl)viny l]benzamide
0,Estrogen Response Early,0.0001988823615735332,ABLIM1;RAB31;KRT18;MYOF;NRIP1;KRT8;RHOBTB3;FLNB,N-(2-aminophenyl)-4-(1-{[4-(2-methoxyphenyl)piperazin-1-yl]m ethyl}vinyl)benzamide
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,NOTCH2;NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
1,Apical Junction,1.340534212343487e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;FLNC;EGFR;ACTB;PTK2,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
2,Hypoxia,9.08474984965522e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
3,Apoptosis,0.00015197003326362604,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
4,UV Response Dn,0.0006349417019938035,NOTCH2;TJP1;CAV1;SERPINE1;AKT3;LAMC1,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
5,Mitotic Spindle,0.0030450385460066,NOTCH2;FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
6,Angiogenesis,0.0040603643204568,APP;FSTL1;PTK2,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
7,IL-6/JAK/STAT3 Signaling,0.0044079818936931,TNFRSF12A;CD9;OSMR;CD44,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
8,TNF-alpha Signaling via NF-kB,0.0111801266912101,FOSL1;SDC4;PLK2;SERPINE1;CD44,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
9,Estrogen Response Late,0.0111801266912101,FARP1;ELOVL5;CAV1;CD9;CD44,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
10,Glycolysis,0.0111801266912101,EXT1;NT5E;MIF;EGFR;CD44,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
11,Fatty Acid Metabolism,0.0252118601290317,LGALS1;ELOVL5;PCBD1;MIF,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
12,Complement,0.0445808612551423,GCA;SERPINE1;GNB4;TIMP2,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
13,Inflammatory Response,0.0445808612551423,AXL;SERPINE1;SGMS2;OSMR,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
14,p53 Pathway,0.0445808612551423,VAMP8;APP;PLK2;PTPN14,"4,2-diyl}bi s[N-(2-aminophenyl)b enzamide]"
0,Complement,0.0013798129319357,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,"21-(2-N,3,5(10)-triene-3-O-sulfamate"
1,Epithelial Mesenchymal Transition,0.0013798129319357,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,"21-(2-N,3,5(10)-triene-3-O-sulfamate"
2,UV Response Dn,0.0109903697141793,BDNF;ITGB3;PMP22;LPAR1;MT1E,"21-(2-N,3,5(10)-triene-3-O-sulfamate"
3,PI3K/AKT/mTOR  Signaling,0.0200692070489926,CDK1;THEM4;PLCB1;HSP90B1,"21-(2-N,3,5(10)-triene-3-O-sulfamate"
4,KRAS Signaling Up,0.0279201001694004,TMEM158;SPP1;LCP1;GNG11;PSMB8,"21-(2-N,3,5(10)-triene-3-O-sulfamate"
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;CD44,Dasatinib
1,KRAS Signaling Up,0.0013141075542244,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Dasatinib
2,Angiogenesis,0.0102423604479991,NRP1;VCAN;ITGAV,Dasatinib
3,IL-2/STAT5 Signaling,0.0189932654213608,NRP1;NT5E;ALCAM;ITGAV;CD44,Dasatinib
4,Estrogen Response Early,0.0189932654213608,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,Dasatinib
5,Complement,0.0189932654213608,LYN;SRC;FYN;JAK2;DUSP6,Dasatinib
6,Glycolysis,0.0189932654213608,NT5E;VCAN;CDK1;MIF;CD44,Dasatinib
9,Cholesterol Homeostasis,0.024325767521664,ALCAM;MAL2;HMGCR,Dasatinib
8,UV Response Dn,0.024325767521664,NRP1;ATP2B4;SNAI2;FYN,Dasatinib
7,Coagulation,0.024325767521664,SPARC;PLAU;FYN;DUSP6,Dasatinib
10,Androgen Response,0.0401629380676957,ELOVL5;ITGAV;HMGCR,Dasatinib
11,Hedgehog Signaling,0.0401629380676957,NRP1;NRP2,Dasatinib
12,Mitotic Spindle,0.0401629380676957,PLK1;ABL1;CDK1;ARHGAP29,Dasatinib
13,TNF-alpha Signaling via NF-kB,0.0401629380676957,PLAU;PLK2;TNC;CD44,Dasatinib
14,Estrogen Response Late,0.0401629380676957,ELOVL5;ATP2B4;JAK2;CD44,Dasatinib
15,Apical Junction,0.0401629380676957,VCAN;CDH3;SRC;ACTB,Dasatinib
16,Xenobiotic Metabolism,0.0401629380676957,ELOVL5;FBLN1;MAN1A1;EPHA2,Dasatinib
17,Allograft Rejection,0.0401629380676957,LYN;CSK;JAK2;ETS1,Dasatinib
0,UV Response Dn,0.00030148902910751566,INPP4B;RBPMS;DLC1;SERPINE1;AKT3;ATP2B4;PTEN,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
1,Androgen Response,0.0027753986391777,INPP4B;CDK6;ELOVL5;HMGCR;B2M,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
2,Estrogen Response Early,0.0048167833615563,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
3,Complement,0.0048167833615563,GCA;ERAP2;SERPINE1;GNB4;TIMP2;JAK2,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
4,Hypoxia,0.0180436021502928,EXT1;MT2A;SERPINE1;MIF;ETS1,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
5,Estrogen Response Late,0.0180436021502928,FARP1;ELOVL5;ATP2B4;JAK2;CD44,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
6,Epithelial Mesenchymal Transition,0.0180436021502928,NT5E;TNFRSF12A;SERPINE1;CD44;LOXL2,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
7,Apoptosis,0.0414337551729308,TNFRSF12A;TIMP2;BAX;CD44,"N-(2-Aminophenyl)-4-[1-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-yl)methyl]vinyl]benzamide"
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,ITGB5;BASP1;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
1,Hypoxia,0.001182696798802,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
2,IL-2/STAT5 Signaling,0.0059254804138508,IFITM3;SPP1;LIF;AHR;CKAP4;IGF1R,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
3,UV Response Dn,0.007065237673401,PMP22;PTPRM;NR3C1;MT1E;IGF1R,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
4,Interferon Alpha Response,0.0102828326350211,IFITM3;LGALS3BP;HLA-C;PSMB8,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
5,Estrogen Response Early,0.0170939388792247,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
6,KRAS Signaling Up,0.0170939388792247,SPP1;LIF;SOX9;GNG11;PSMB8,N-(2-aminophenyl)-4-(3-benzamidoprop-1-en-2-yl)benzamide
0,Epithelial Mesenchymal Transition,1.1182783407238592e-08,GLIPR1;LOX;TNFRSF12A;CALD1;COL4A1;SERPINE1;COL12A1;SNAI2;VEGFC;LAMC1;DKK1;LOXL2,42-O-(2-hydroxyethyl)rapamycin)
1,Hypoxia,0.00091523128215323,LOX;ANXA2;DUSP1;SERPINE1;KDELR3;ETS1;TMEM45A,42-O-(2-hydroxyethyl)rapamycin)
2,UV Response Dn,0.00091523128215323,DDAH1;ANXA2;DUSP1;SERPINE1;SNAI2;LAMC1,42-O-(2-hydroxyethyl)rapamycin)
3,Xenobiotic Metabolism,0.0265905715899052,TPST1;SERPINE1;MAN1A1;PTGR1;EPHA2,42-O-(2-hydroxyethyl)rapamycin)
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;PDLIM4;CD44,DMAPT fumarate salt
1,Hedgehog Signaling,0.0005669761703886634,NRP1;NRP2;CDK6;VLDLR,DMAPT fumarate salt
2,KRAS Signaling Up,0.0008103663251050982,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,DMAPT fumarate salt
3,Estrogen Response Early,0.0037520207237386,ELOVL5;ELOVL2;ENDOD1;PMAIP1;JAK2;CD44,DMAPT fumarate salt
4,Glycolysis,0.0037520207237386,NT5E;VCAN;CDK1;MIF;VLDLR;CD44,DMAPT fumarate salt
5,UV Response Dn,0.0365404155339795,NRP1;ATP2B4;SNAI2;VLDLR,DMAPT fumarate salt
0,IL-2/STAT5 Signaling,0.0007227591548234659,IFITM3;PRNP;BHLHE40;LIF;AHR;WLS;IGF1R,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
1,Hypoxia,0.0007227591548234659,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
2,Epithelial Mesenchymal Transition,0.0007227591548234659,ITGB5;BASP1;BDNF;PMP22;FN1;TGFBI;EDIL3,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
3,Interferon Alpha Response,0.0010438317228176,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
4,Estrogen Response Early,0.0033463968617128,DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;IGF1R,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
5,UV Response Dn,0.0043176452448561,BDNF;BHLHE40;PMP22;MT1E;IGF1R,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
6,Apoptosis,0.0060942404550773,IFITM3;TGFB2;DPYD;TXNIP;BCL2L2,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
7,TNF-alpha Signaling via NF-kB,0.0099714643462144,CEBPB;BHLHE40;LIF;FJX1;LITAF,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
8,Interferon Gamma Response,0.0099714643462144,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
9,Complement,0.0099714643462144,DOCK10;CEBPB;CTSL;FN1;PSMB9,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
10,mTORC1 Signaling,0.0099714643462144,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
11,KRAS Signaling Up,0.0497016358587735,LIF;SOX9;GNG11;PSMB8,"N-(4-aminophenyl)-4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]benzamide"
0,p53 Pathway,0.011906744020799,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,"N-(2-aminophenyl)-4-[4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]phenyl]butanamide"
1,Angiogenesis,0.011906744020799,APP;FSTL1;PTK2,"N-(2-aminophenyl)-4-[4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]phenyl]butanamide"
2,TGF-beta Signaling,0.0257596162277206,TJP1;SMURF2;ID1,"N-(2-aminophenyl)-4-[4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]phenyl]butanamide"
3,Apical Junction,0.0257596162277206,TJP1;RRAS;CTNNA1;RHOF;PTK2,"N-(2-aminophenyl)-4-[4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]phenyl]butanamide"
4,UV Response Dn,0.0367379312936226,TJP1;ANXA2;MAP1B;ID1,"N-(2-aminophenyl)-4-[4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]phenyl]butanamide"
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;BASP1;ITGB3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
1,Hypoxia,0.00134696024308,SRPX;TES;DTNA;IRS2;TGFBI;AMPD3;MT1E,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
2,Interferon Alpha Response,0.0017291757832535,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
3,TNF-alpha Signaling via NF-kB,0.0227127798997107,CEBPB;IRS2;SGK1;FJX1;LITAF,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
4,Interferon Gamma Response,0.0227127798997107,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
5,Complement,0.0227127798997107,DOCK10;LYN;CEBPB;FN1;PSMB9,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
6,UV Response Dn,0.0347063406230075,ITGB3;PMP22;MT1E;IGF1R,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
7,Apoptosis,0.0447048411076359,IFITM3;TGFB2;BAX;TXNIP,"4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide"
0,Hedgehog Signaling,0.0013178365041466,ADGRG1;CDK6;DPYSL2;VLDLR,Cyclopamine
1,UV Response Dn,0.0018447630530901,INPP4B;DLC1;ITGB3;PMP22;VLDLR;MT1E,Cyclopamine
2,Androgen Response,0.0229040615644431,INPP4B;CDK6;ADAMTS1;HMGCR,Cyclopamine
0,Hypoxia,0.000324104589230943,SRPX;TES;DTNA;IRS2;PLIN2;TGFBI;AMPD3;MT1E,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
1,mTORC1 Signaling,0.0111546562057094,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
2,Interferon Alpha Response,0.0209465109231913,LGALS3BP;TXNIP;PSMB8;PSMB9,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
3,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
4,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
5,KRAS Signaling Up,0.0243746906240797,SPP1;LCP1;GNG11;PSMB8;ENG,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,"N-(2-Amino-phenyl)-4-{1-[4-(3,5-bis-trifluoromethylphenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide"
0,Hypoxia,1.107163614453685e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
1,Glycolysis,1.107163614453685e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
2,Epithelial Mesenchymal Transition,8.45381935712109e-06,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
3,UV Response Dn,6.94218159129148e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;PRKCA;MET,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
4,Apoptosis,0.00011500434949679808,APP;GPX1;TNFRSF12A;CAV1;TIMP2;CD44;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
5,TNF-alpha Signaling via NF-kB,0.0025351491376612,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
6,Apical Junction,0.0025351491376612,VCAN;ITGA3;AKT3;CTNNA1;EGFR;ACTB,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
7,Angiogenesis,0.0033607745219997,APP;NRP1;VCAN,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
8,IL-6/JAK/STAT3 Signaling,0.0037064112019041,TNFRSF12A;CD9;CD44;IL13RA1,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
9,Protein Secretion,0.0048107319554325,SCRN1;CAV2;PAM;EGFR,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
10,IL-2/STAT5 Signaling,0.008948750054295,MYO1E;NRP1;NT5E;ALCAM;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
11,Estrogen Response Late,0.008948750054295,ELOVL5;CAV1;ATP2B4;CD9;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
12,KRAS Signaling Up,0.008948750054295,NRP1;GALNT3;PLAU;SPRY2;ETS1,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
13,Cholesterol Homeostasis,0.01520360470104,ALCAM;TNFRSF12A;CD9,N-(2-Amino-phenyl)-4-{1-[4-(3-chloro-4-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
0,Epithelial Mesenchymal Transition,2.7837256591978365e-06,ITGB5;BASP1;ITGB3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
1,Hypoxia,0.0014455183096469,SRPX;TES;PLIN2;TGFBI;AMPD3;NR3C1;MT1E,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
2,Interferon Alpha Response,0.0018557008405647,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
3,mTORC1 Signaling,0.0055773281028547,TES;PLK1;DHCR24;BCAT1;AURKA;HSP90B1,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
4,UV Response Dn,0.0069082323917698,ITGB3;PMP22;NR3C1;MT1E;IGF1R,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
5,IL-2/STAT5 Signaling,0.0182810179680598,IFITM3;SPP1;PLIN2;AHR;IGF1R,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
6,Estrogen Response Early,0.0182810179680598,DYNLT3;RHOBTB3;FLNB;MICB;IGF1R,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
7,Interferon Gamma Response,0.0182810179680598,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
8,Apoptosis,0.0426452684820809,IFITM3;TGFB2;BAX;TXNIP,N-(2-Amino-phenyl)-4-{1-[4-(2-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
0,Hypoxia,1.107163614453685e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
1,Glycolysis,1.107163614453685e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
2,Epithelial Mesenchymal Transition,8.45381935712109e-06,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
3,UV Response Dn,6.94218159129148e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;PRKCA;MET,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
4,Apoptosis,0.00011500434949679808,APP;GPX1;TNFRSF12A;CAV1;TIMP2;CD44;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
5,TNF-alpha Signaling via NF-kB,0.0022649190025126,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
6,Apical Junction,0.0022649190025126,VCAN;ITGA3;AKT3;CTNNA1;EGFR;ACTB,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
7,Cholesterol Homeostasis,0.0022649190025126,ALCAM;TNFRSF12A;MAL2;CD9,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
8,Angiogenesis,0.0029873551306664,APP;NRP1;VCAN,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
9,IL-6/JAK/STAT3 Signaling,0.0033357700817137,TNFRSF12A;CD9;CD44;IL13RA1,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
10,Protein Secretion,0.0043733926867568,SCRN1;CAV2;PAM;EGFR,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
11,IL-2/STAT5 Signaling,0.0083095536218453,MYO1E;NRP1;NT5E;ALCAM;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
12,Estrogen Response Late,0.0083095536218453,ELOVL5;CAV1;ATP2B4;CD9;CD44,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
13,KRAS Signaling Up,0.0083095536218453,NRP1;GALNT3;PLAU;SPRY2;ETS1,N-(2-Amino-phenyl)-4-{1-[4-(3-fluorophenyl)-piperazin-1-ylmethyl]-vinyl}-benzamide
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;BASP1;ITGB3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;IRS2;TGFBI;AMPD3;NR3C1;MT1E,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
2,Interferon Alpha Response,0.0017291757832535,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
3,UV Response Dn,0.0080465206835956,ITGB3;PMP22;NR3C1;MT1E;IGF1R,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
4,TNF-alpha Signaling via NF-kB,0.0194680970568948,CEBPB;IRS2;SGK1;FJX1;LITAF,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
5,Interferon Gamma Response,0.0194680970568948,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
6,Complement,0.0194680970568948,DOCK10;LYN;CEBPB;FN1;PSMB9,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
7,Apoptosis,0.0447048411076359,IFITM3;TGFB2;BAX;TXNIP,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
8,IL-2/STAT5 Signaling,0.0494004138232658,IFITM3;SPP1;AHR;IGF1R,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
9,Estrogen Response Early,0.0494004138232658,DYNLT3;RHOBTB3;FLNB;IGF1R,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
10,Myogenesis,0.0494004138232658,FDPS;DTNA;ITGB5;ADAM12,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
11,mTORC1 Signaling,0.0494004138232658,TES;BCAT1;AURKA;HSP90B1,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
12,Inflammatory Response,0.0494004138232658,LYN;ITGB3;AHR;EMP3,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
13,Glycolysis,0.0494004138232658,IRS2;TGFBI;SOX9;AURKA,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
14,KRAS Signaling Up,0.0494004138232658,SPP1;SOX9;GNG11;PSMB8,N-(2-Amino-phenyl)-4-[1-(6-oxo-6H-phenanthridin-5-ylmethyl)-vinyl]-benzamide
0,Angiogenesis,0.0008887734562849319,APP;FSTL1;PTK2;FGFR1,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
1,Apical Junction,0.0049012883328117,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
2,p53 Pathway,0.0049012883328117,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
3,TGF-beta Signaling,0.018129312434154,TJP1;SMURF2;ID1,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
4,UV Response Dn,0.034367742177905,TJP1;ANXA2;MAP1B;ID1,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
5,Apoptosis,0.0421606631584209,APP;GPX1;KRT18;PTK2,N-(2-Aminophenyl)-4-{1-[(9-oxoacridin-10(9H)-yl)methyl]vinyl}benzamide
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
2,UV Response Dn,0.0107286942447941,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
3,Interferon Alpha Response,0.0146387547929121,LGALS3BP;TXNIP;PSMB8;PSMB9,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
4,TNF-alpha Signaling via NF-kB,0.017034584924783,CEBPB;IRS2;SGK1;FJX1;LITAF,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
5,Myogenesis,0.017034584924783,FDPS;PRNP;DTNA;ITGB5;ADAM12,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
6,Complement,0.017034584924783,DOCK10;LYN;CEBPB;FN1;PSMB9,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
7,mTORC1 Signaling,0.017034584924783,TES;HMGCR;BCAT1;AURKA;HSP90B1,"N-(2-aminophenyl)-4-[3-(3-methyl-2,5-dioxoimidazolidin-1-yl)prop-1-en-2-yl]benzamide"
0,Hypoxia,0.0012584430129606,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
1,Epithelial Mesenchymal Transition,0.0012584430129606,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
3,IL-2/STAT5 Signaling,0.0243746906240797,PRNP;SPP1;PLIN2;AHR;IGF1R,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
4,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
5,Xenobiotic Metabolism,0.0243746906240797,TGFB2;PROS1;GCNT2;FAS;BCAT1,"4-[3-[(6aR)-6,11-dioxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-5-yl]but-1-en-2-yl]-N-(2-aminophenyl)-N-methylbenzamide"
0,Epithelial Mesenchymal Transition,2.657192674688844e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
1,Hypoxia,0.00015468628122385913,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
2,Complement,0.0053238131890886,DOCK10;LYN;CEBPB;ERAP2;FN1;PSMB9,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
3,mTORC1 Signaling,0.0053238131890886,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
4,UV Response Dn,0.0065942218285076,ITGB3;PMP22;LPAR1;MT1E;IGF1R,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
5,Interferon Alpha Response,0.0099971983951594,LGALS3BP;TXNIP;PSMB8;PSMB9,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
6,Glycolysis,0.0199429286924289,CDK1;IRS2;TGFBI;SOX9;AURKA,N-(2-aminophenyl)-4-(3-phenothiazin-10-ylprop-1-en-2-yl)benzamide
0,Hedgehog Signaling,0.0153080149590355,NRP2;CDK6;VLDLR,"6-(3-Azidopropyl)-9-fluoro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline"
1,UV Response Dn,0.0153080149590355,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,"6-(3-Azidopropyl)-9-fluoro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline"
2,E2F Targets,0.0432096788335959,DNMT1;PLK1;CDK1;TP53;AURKB,"6-(3-Azidopropyl)-9-fluoro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline"
0,PI3K/AKT/mTOR  Signaling,0.034069169849566,CDK1;PTEN;PLCB1;HSP90B1,"6-(3-Azidopropyl)-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline"
1,mTORC1 Signaling,0.034069169849566,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"6-(3-Azidopropyl)-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline"
2,E2F Targets,0.034069169849566,DNMT1;PLK1;CDK1;TP53;AURKA,"6-(3-Azidopropyl)-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline"
3,p53 Pathway,0.034069169849566,HDAC3;BAX;STOM;TXNIP;TP53,"6-(3-Azidopropyl)-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline"
0,Hedgehog Signaling,0.0291907272767976,NRP2;CDK6;VLDLR,"6-[3-[2-[1,4]-Triazolyl-1-propyl]-5,6-dihydro-2,3-dimethox y-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinolin e Hydrochloride"
1,TGF-beta Signaling,0.0421017383506832,CDKN1C;CDK9;ID3,"6-[3-[2-[1,4]-Triazolyl-1-propyl]-5,6-dihydro-2,3-dimethox y-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinolin e Hydrochloride"
2,E2F Targets,0.0421017383506832,DNMT1;PLK1;CDK1;TP53;AURKB,"6-[3-[2-[1,4]-Triazolyl-1-propyl]-5,6-dihydro-2,3-dimethox y-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinolin e Hydrochloride"
0,UV Response Dn,0.00034115863820060986,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Pazopanib hydrochloride
1,Hypoxia,0.0014126656207913,SRPX;TES;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,Pazopanib hydrochloride
2,Interferon Alpha Response,0.0158804802550822,LGALS3BP;TXNIP;PSMB8;PSMB9,Pazopanib hydrochloride
3,IL-2/STAT5 Signaling,0.0158804802550822,PRNP;BHLHE40;PLIN2;AHR;IGF1R,Pazopanib hydrochloride
4,TNF-alpha Signaling via NF-kB,0.0158804802550822,CEBPB;BHLHE40;SGK1;FJX1;LITAF,Pazopanib hydrochloride
5,Estrogen Response Early,0.0158804802550822,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,Pazopanib hydrochloride
6,Complement,0.0158804802550822,DOCK10;LYN;CEBPB;CTSL;PSMB9,Pazopanib hydrochloride
7,mTORC1 Signaling,0.0158804802550822,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Pazopanib hydrochloride
8,Epithelial Mesenchymal Transition,0.0158804802550822,ITGB5;BDNF;ITGB3;PMP22;EDIL3,Pazopanib hydrochloride
9,Apoptosis,0.0375084520512848,TGFB2;BAX;TXNIP;BCL2L2,Pazopanib hydrochloride
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;TPM1;ITGAV;THBS1,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
1,UV Response Dn,0.0001467775536444484,TJP1;NRP1;GJA1;CITED2;ID1;ATP2B4;MET,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
2,Angiogenesis,0.0003779841135924423,APP;NRP1;VCAN;ITGAV,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
3,Glycolysis,0.0006077747438288237,VCAN;CITED2;CDK1;MIF;MET;IL13RA1;IER3,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
4,TGF-beta Signaling,0.0011365220725352,TJP1;ID1;ID3;THBS1,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
5,Cholesterol Homeostasis,0.0031924572606845,ALCAM;TNFRSF12A;MAL2;CD9,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
6,Coagulation,0.0034234008735004,SPARC;PLAU;CD9;THBS1;DUSP6,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
7,TNF-alpha Signaling via NF-kB,0.0153726742004139,TUBB2A;SDC4;PLAU;PLK2;IER3,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
8,IL-6/JAK/STAT3 Signaling,0.0390190504173245,TNFRSF12A;CD9;IL13RA1,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
9,Pperoxisome,0.0477652084876524,SEMA3C;ELOVL5;PRDX1,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
10,Hypoxia,0.0477652084876524,SDC4;CITED2;MIF;IER3,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
11,Estrogen Response Late,0.0477652084876524,ELOVL5;ATP2B4;CD9;LSR,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
12,Apical Junction,0.0477652084876524,TJP1;VCAN;CDH3;ITGA3,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
13,p53 Pathway,0.0477652084876524,APP;HDAC3;PLK2;IER3,"6-[3-(Dimethylamino)propyl]-9-methoxy-3-nitroindeno[1,2-c]isoquinoline-5,11-dione;hydrochloride"
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,Selumetinib
1,Glycolysis,0.0001362712477448283,NT5E;VCAN;CDK1;MIF;PAM;MET;CD44;IER3,Selumetinib
2,Cholesterol Homeostasis,0.0004270769517778841,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Selumetinib
3,TNF-alpha Signaling via NF-kB,0.0046900259046732,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Selumetinib
4,Angiogenesis,0.0056845100486395,APP;NRP1;VCAN,Selumetinib
5,Hypoxia,0.0153726742004139,SDC4;MIF;ETS1;PAM;IER3,Selumetinib
6,Estrogen Response Late,0.0153726742004139,ELOVL5;ATP2B4;CD9;JAK2;CD44,Selumetinib
7,KRAS Signaling Up,0.0153726742004139,NRP1;GALNT3;PLAU;SPRY2;ETS1,Selumetinib
8,UV Response Dn,0.024360277022653,NRP1;ATP2B4;SNAI2;MET,Selumetinib
9,Apoptosis,0.0319246776141746,APP;TNFRSF12A;CD44;IER3,Selumetinib
10,IL-6/JAK/STAT3 Signaling,0.0319246776141746,TNFRSF12A;CD9;CD44,Selumetinib
11,Hedgehog Signaling,0.0430461553124786,NRP1;NRP2,Selumetinib
12,IL-2/STAT5 Signaling,0.0445808612551423,NRP1;NT5E;ALCAM;CD44,Selumetinib
13,Estrogen Response Early,0.0445808612551423,ELOVL5;ENDOD1;JAK2;CD44,Selumetinib
14,mTORC1 Signaling,0.0445808612551423,ELOVL5;PLK1;CD9;HMGCR,Selumetinib
0,Epithelial Mesenchymal Transition,2.0877942443983774e-06,GJA1;VCAN;SPARC;LGALS1;SDC4;DST;COL4A1;COL12A1;ITGAV;THBS1,Chk2 Inhibitor II
1,Angiogenesis,0.0005056814492655647,APP;NRP1;VCAN;ITGAV,Chk2 Inhibitor II
2,TGF-beta Signaling,0.0016894247024173,TJP1;ID1;ID3;THBS1,Chk2 Inhibitor II
3,Glycolysis,0.004182996077141,VCAN;MIF;PAM;MET;IL13RA1;IER3,Chk2 Inhibitor II
4,UV Response Dn,0.0051811742938274,TJP1;NRP1;GJA1;ID1;MET,Chk2 Inhibitor II
5,Apical Junction,0.0182810179680598,TJP1;VCAN;ITGA3;CTNNA1;MSN,Chk2 Inhibitor II
6,Cholesterol Homeostasis,0.028669654579104,ALCAM;MAL2;CD9,Chk2 Inhibitor II
7,Fatty Acid Metabolism,0.0337293804428938,LGALS1;ELOVL5;MIF;S100A10,Chk2 Inhibitor II
8,Protein Secretion,0.042601402164663,SCRN1;DST;PAM,Chk2 Inhibitor II
9,Pperoxisome,0.042601402164663,SEMA3C;ELOVL5;PRDX1,Chk2 Inhibitor II
10,IL-2/STAT5 Signaling,0.042601402164663,NRP1;ALCAM;AHNAK;ITGAV,Chk2 Inhibitor II
11,TNF-alpha Signaling via NF-kB,0.042601402164663,TUBB2A;SDC4;PLK2;IER3,Chk2 Inhibitor II
12,Hypoxia,0.042601402164663,SDC4;MIF;PAM;IER3,Chk2 Inhibitor II
13,p53 Pathway,0.042601402164663,APP;PLK2;S100A10;IER3,Chk2 Inhibitor II
0,Angiogenesis,0.0215089569407982,APP;FSTL1;PTK2,cyclo(-(R)-b2hPhe-D-Pro-Lys-Phe)
1,TGF-beta Signaling,0.023266750141167,TJP1;SMURF2;ID1,cyclo(-(R)-b2hPhe-D-Pro-Lys-Phe)
2,Apical Junction,0.023266750141167,TJP1;RRAS;CTNNA1;RHOF;PTK2,cyclo(-(R)-b2hPhe-D-Pro-Lys-Phe)
3,p53 Pathway,0.023266750141167,VAMP8;APP;SFN;PTPN14;EPHA2,cyclo(-(R)-b2hPhe-D-Pro-Lys-Phe)
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
1,UV Response Dn,0.0001626453972816861,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
2,IL-2/STAT5 Signaling,0.0008700676634775469,PRNP;CSF1;BHLHE40;ITGA6;AHR;WLS;IGF1R,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
3,TNF-alpha Signaling via NF-kB,0.0041576445857644,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
4,Hypoxia,0.0041576445857644,SRPX;TES;BHLHE40;GCNT2;AMPD3;MT1E,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
5,Myogenesis,0.0136276679398264,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
6,mTORC1 Signaling,0.0136276679398264,TES;BHLHE40;BCAT1;AURKA;HSP90B1,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
7,Inflammatory Response,0.0136276679398264,LYN;CSF1;ITGB3;LPAR1;AHR,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
8,Xenobiotic Metabolism,0.0136276679398264,TGFB2;PROS1;GCNT2;FAS;BCAT1,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
9,Allograft Rejection,0.0136276679398264,LYN;TGFB2;CSF1;FAS;BCAT1,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
10,Apoptosis,0.0324279946035873,TGFB2;FAS;BAX;BCL2L2,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
11,IL-6/JAK/STAT3 Signaling,0.0324279946035873,CSF1;ITGB3;FAS,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
12,Interferon Alpha Response,0.0401754164009814,CSF1;PSMB8;PSMB9,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
13,Estrogen Response Early,0.0494004138232658,DYNLT3;BHLHE40;RHOBTB3;IGF1R,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
14,Complement,0.0494004138232658,DOCK10;LYN;CEBPB;PSMB9,N-(2-aminophenyl)-4-[3-[4-[6-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]prop-1-en-2-yl]benzamide
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1,"3-Carboxy-2,5-dimethyl-1H-pyrrol-2-ylmethylene)-5-(1H-indol-2-yl)-3-methoxy-2H-pyrrolium, tartrate"
1,Estrogen Response Early,0.0432096788335959,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,"3-Carboxy-2,5-dimethyl-1H-pyrrol-2-ylmethylene)-5-(1H-indol-2-yl)-3-methoxy-2H-pyrrolium, tartrate"
2,KRAS Signaling Up,0.0432096788335959,NRP1;GABRA3;ETS1;TRIB2;DUSP6,"3-Carboxy-2,5-dimethyl-1H-pyrrol-2-ylmethylene)-5-(1H-indol-2-yl)-3-methoxy-2H-pyrrolium, tartrate"
0,Angiogenesis,0.0010296351924223,APP;NRP1;ITGAV;PTK2,Lapatinib
1,Epithelial Mesenchymal Transition,0.0010296351924223,TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;CAP2,Lapatinib
2,UV Response Dn,0.0010296351924223,TJP1;NRP1;ANXA2;ID1;MET;CAP2,Lapatinib
3,Apical Junction,0.0037274095584208,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Lapatinib
4,Cholesterol Homeostasis,0.0037274095584208,ALCAM;TNFRSF12A;MAL2;CD9,Lapatinib
5,Protein Secretion,0.0082469690664557,SCRN1;DST;CAV2;EGFR,Lapatinib
6,Hypoxia,0.0149571965193216,ANXA2;SDC4;MIF;ETS1;EGFR,Lapatinib
7,p53 Pathway,0.0149571965193216,VAMP8;APP;PLK2;PTPN14;S100A10,Lapatinib
8,Fatty Acid Metabolism,0.0327072780052303,ELOVL5;PCBD1;MIF;S100A10,Lapatinib
0,IL-2/STAT5 Signaling,0.0028011934531472,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;AHR;IGF1R,Nelfinavir
1,mTORC1 Signaling,0.0487493812481595,PLK1;BHLHE40;BCAT1;AURKA;HSP90B1,Nelfinavir
2,p53 Pathway,0.0487493812481595,HDAC3;BAX;STOM;TXNIP;TP53,Nelfinavir
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,Nilotinib
1,Glycolysis,1.2680729035681635e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,Nilotinib
2,Hypoxia,8.593682290214397e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Nilotinib
3,TNF-alpha Signaling via NF-kB,0.0036238704040203,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Nilotinib
4,Cholesterol Homeostasis,0.0036238704040203,ALCAM;TNFRSF12A;MAL2;CD9,Nilotinib
5,Angiogenesis,0.0039251320407783,APP;NRP1;VCAN,Nilotinib
6,UV Response Dn,0.0039251320407783,NRP1;ATP2B4;SNAI2;PRKCA;MET,Nilotinib
8,KRAS Signaling Up,0.0129259723006483,NRP1;GALNT3;PLAU;SPRY2;ETS1,Nilotinib
7,Estrogen Response Late,0.0129259723006483,ELOVL5;ATP2B4;CD9;JAK2;CD44,Nilotinib
9,Apoptosis,0.0301990193647598,APP;TNFRSF12A;CD44;IER3,Nilotinib
10,IL-6/JAK/STAT3 Signaling,0.0301990193647598,TNFRSF12A;CD9;CD44,Nilotinib
11,Protein Secretion,0.036133826087931,CAV2;PAM;EGFR,Nilotinib
15,Apical Junction,0.0372097808568358,VCAN;ITGA3;EGFR;ACTB,Nilotinib
12,Hedgehog Signaling,0.0372097808568358,NRP1;NRP2,Nilotinib
13,IL-2/STAT5 Signaling,0.0372097808568358,NRP1;NT5E;ALCAM;CD44,Nilotinib
14,Estrogen Response Early,0.0372097808568358,ELOVL5;ENDOD1;JAK2;CD44,Nilotinib
16,p53 Pathway,0.0372097808568358,VAMP8;APP;PLK2;IER3,Nilotinib
0,Hypoxia,0.0465335002823341,SRPX;DTNA;GCNT2;PLIN2;MT1E,Olaparib
1,Complement,0.0465335002823341,DOCK10;CEBPB;ERAP2;FDX1;PSMB9,Olaparib
2,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Olaparib
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;ECM1;COL4A1;COL12A1;TNC;SNAI2;FBLN1;PDLIM4,Ixabepilone
1,Hedgehog Signaling,0.0005976235309502128,NRP1;NRP2;CDK6;VLDLR,Ixabepilone
2,UV Response Dn,0.0102053433060237,NRP1;SDC2;ATP2B4;SNAI2;VLDLR,Ixabepilone
3,Estrogen Response Early,0.0259258073001575,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,Ixabepilone
4,Glycolysis,0.0259258073001575,VCAN;SDC2;CDK1;MIF;VLDLR,Ixabepilone
0,Hypoxia,3.115836277338916e-05,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Raloxifene
1,Epithelial Mesenchymal Transition,0.0014126656207913,ITGB5;ITGB3;ADAM12;PMP22;SPP1;FAS;TGFBI,Raloxifene
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Raloxifene
3,Interferon Alpha Response,0.0153528403925663,LGALS3BP;TXNIP;PSMB8;PSMB9,Raloxifene
4,TNF-alpha Signaling via NF-kB,0.0238207203826234,CEBPB;IRS2;SGK1;FJX1;LITAF,Raloxifene
5,Interferon Gamma Response,0.0238207203826234,LGALS3BP;FAS;TXNIP;PSMB8;PSMB9,Raloxifene
0,Estrogen Response Early,0.00017678432139869616,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,Abiraterone
1,Estrogen Response Late,0.0060843579303869,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,Abiraterone
2,UV Response Dn,0.0062802112652453,TJP1;ANXA2;NFIB;MAP1B;ID1,Abiraterone
3,Apical Junction,0.0199429286924289,TJP1;RRAS;FSCN1;CTNNA1;RHOF,Abiraterone
0,Epithelial Mesenchymal Transition,1.7320144107363228e-07,NT5E;GJA1;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,Abiraterone acetate
1,UV Response Dn,8.45381935712109e-06,TJP1;NRP1;GJA1;ID1;ATP2B4;SNAI2;PRKCA;MET,Abiraterone acetate
2,Glycolysis,8.45381935712109e-06,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Abiraterone acetate
3,Angiogenesis,0.00026816440491355705,APP;NRP1;VCAN;ITGAV,Abiraterone acetate
4,TNF-alpha Signaling via NF-kB,0.000383281369982141,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Abiraterone acetate
5,Hypoxia,0.000383281369982141,SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Abiraterone acetate
6,TGF-beta Signaling,0.000767920319280594,TJP1;ID1;ID3;THBS1,Abiraterone acetate
8,Cholesterol Homeostasis,0.0020132613355668,ALCAM;TNFRSF12A;MAL2;CD9,Abiraterone acetate
7,Apical Junction,0.0020132613355668,TJP1;VCAN;CDH3;ITGA3;EGFR;ACTB,Abiraterone acetate
9,IL-6/JAK/STAT3 Signaling,0.0033357700817137,TNFRSF12A;CD9;CD44;IL13RA1,Abiraterone acetate
10,Protein Secretion,0.0043733926867568,SCRN1;CAV2;PAM;EGFR,Abiraterone acetate
11,IL-2/STAT5 Signaling,0.008948750054295,NRP1;NT5E;ALCAM;ITGAV;CD44,Abiraterone acetate
12,Estrogen Response Late,0.008948750054295,ELOVL5;ATP2B4;CD9;LSR;CD44,Abiraterone acetate
13,Apoptosis,0.0218072395647004,APP;TNFRSF12A;CD44;IER3,Abiraterone acetate
14,Pperoxisome,0.0358057543527429,SEMA3C;ELOVL5;PRDX1,Abiraterone acetate
15,Estrogen Response Early,0.039535392160388,GJA1;ELOVL5;ENDOD1;CD44,Abiraterone acetate
16,Apical Surface,0.0420607020678256,APP;ATP8B1,Abiraterone acetate
0,Hypoxia,0.0018447630530901,SRPX;TES;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,Sunitinib
1,UV Response Dn,0.0018447630530901,ITGB3;PMP22;LPAR1;MET;MT1E;IGF1R,Sunitinib
2,mTORC1 Signaling,0.0054505706459716,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Sunitinib
3,Epithelial Mesenchymal Transition,0.0054505706459716,ITGB5;ITGB3;PMP22;SPP1;TGFBI;EDIL3,Sunitinib
4,Interferon Alpha Response,0.012282272314053,LGALS3BP;TXNIP;PSMB8;PSMB9,Sunitinib
5,Complement,0.0204177603279629,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Sunitinib
6,Inflammatory Response,0.0204177603279629,LYN;ITGB3;LPAR1;AHR;MET,Sunitinib
0,UV Response Dn,1.631823429193952e-06,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,Afatinib
1,Hypoxia,0.0008103663251050982,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1;EGFR,Afatinib
2,Epithelial Mesenchymal Transition,0.0008103663251050982,NT5E;TNFRSF12A;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,Afatinib
3,Estrogen Response Early,0.0037520207237386,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Afatinib
4,Glycolysis,0.0037520207237386,EXT1;NT5E;MIF;VLDLR;EGFR;CD44,Afatinib
5,Hedgehog Signaling,0.0047370917071996,NRP2;CDK6;VLDLR,Afatinib
6,Androgen Response,0.0084463482845621,INPP4B;CDK6;ELOVL5;HMGCR,Afatinib
7,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Afatinib
0,Epithelial Mesenchymal Transition,0.0002578104687064319,GJA1;TNFRSF12A;SDC4;COL4A1;COL12A1;ITGAV;LOXL2;CAP2,Salinomycin sodium salt hydrate
1,Angiogenesis,0.0005363288098271141,APP;NRP1;ITGAV;PTK2,Salinomycin sodium salt hydrate
2,UV Response Dn,0.001001034214855,TJP1;NRP1;GJA1;ANXA2;ID1;CAP2,Salinomycin sodium salt hydrate
3,Apical Junction,0.0044365109909071,TJP1;RRAS;ITGA3;RHOF;EGFR;PTK2,Salinomycin sodium salt hydrate
4,p53 Pathway,0.023266750141167,VAMP8;APP;PLK2;PTPN14;EPHA2,Salinomycin sodium salt hydrate
5,Cholesterol Homeostasis,0.03547507763576,TNFRSF12A;MAL2;CD9,Salinomycin sodium salt hydrate
6,IL-6/JAK/STAT3 Signaling,0.0474556018589082,TNFRSF12A;PDGFC;CD9,Salinomycin sodium salt hydrate
0,Epithelial Mesenchymal Transition,1.476790399192914e-13,SPARC;TNFRSF12A;SDC4;DST;SERPINE1;FN1;EMP3;THBS1;LOXL2;NT5E;LGALS1;CDH2;COL4A2;SPP1;VIM;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
1,Coagulation,0.0001259138637485808,SPARC;SERPINE1;CAPN2;FN1;CD9;GNG12;THBS1,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
2,TNF-alpha Signaling via NF-kB,0.0006899064659678538,FOSL1;MARCKS;SDC4;PLK2;SERPINE1;IL6ST;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
3,Hypoxia,0.0006899064659678538,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;EGFR,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
4,Apoptosis,0.001329995697153,APP;TNFRSF12A;CAV1;TIMP2;BAX;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
5,Mitotic Spindle,0.0026619065945443,MYO1E;MARCKS;DST;PLK1;CDK1;ARHGAP29,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
6,IL-2/STAT5 Signaling,0.0026619065945443,MYO1E;NT5E;AHNAK;SPP1;CKAP4;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
7,Apical Junction,0.0026619065945443,SGCE;ITGA3;AKT3;RAC2;MSN;EGFR,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
8,UV Response Dn,0.0036634565713931,ANXA2;CAV1;SERPINE1;AKT3;RND3,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
9,IL-6/JAK/STAT3 Signaling,0.0040029240980565,TNFRSF12A;CD9;IL6ST;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
11,Glycolysis,0.0116333750705835,EXT1;NT5E;CDK1;EGFR;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
10,Complement,0.0116333750705835,ERAP2;COL4A2;SERPINE1;FN1;TIMP2,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
12,Cholesterol Homeostasis,0.0196477353059594,TNFRSF12A;CD9;HMGCR,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
21,Inflammatory Response,0.0330034578034543,BST2;AXL;SERPINE1;EMP3,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
13,Protein Secretion,0.0330034578034543,DST;CAV2;EGFR,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
14,Interferon Alpha Response,0.0330034578034543,BST2;HLA-C;B2M,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
15,Androgen Response,0.0330034578034543,DHCR24;HMGCR;B2M,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
16,Angiogenesis,0.0330034578034543,APP;SPP1,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
17,G2-M Checkpoint,0.0330034578034543,MARCKS;MT2A;PLK1;CDK1,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
18,Estrogen Response Late,0.0330034578034543,CAV1;CD9;IL6ST;CD44,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
19,Interferon Gamma Response,0.0330034578034543,BST2;MT2A;HLA-B;B2M,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
20,mTORC1 Signaling,0.0330034578034543,PLK1;CD9;DHCR24;HMGCR,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
22,p53 Pathway,0.0330034578034543,APP;PLK2;BAX;PTPN14,Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine
0,Hypoxia,0.00015468628122385913,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,"1-(5-Phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)naphthalen-2-ol"
1,Epithelial Mesenchymal Transition,0.00015468628122385913,ITGB5;BDNF;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,"1-(5-Phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)naphthalen-2-ol"
2,UV Response Dn,0.0012012410578261,BDNF;ITGB3;PMP22;NR3C1;MT1E;IGF1R,"1-(5-Phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)naphthalen-2-ol"
3,mTORC1 Signaling,0.0053238131890886,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"1-(5-Phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)naphthalen-2-ol"
4,Interferon Alpha Response,0.0119966380741913,HLA-C;TXNIP;PSMB8;PSMB9,"1-(5-Phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)naphthalen-2-ol"
0,Androgen Response,0.0054047236657671,INPP4B;CDK6;ELOVL5;HMGCR;B2M,Pazopanib
1,Hedgehog Signaling,0.0096819923672532,NRP2;CDK6;VLDLR,Pazopanib
2,UV Response Dn,0.0096819923672532,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,Pazopanib
3,p53 Pathway,0.0307453484008279,HDAC3;BAX;STOM;TXNIP;TP53,Pazopanib
0,Hypoxia,0.00134696024308,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,Veliparib
1,Epithelial Mesenchymal Transition,0.00134696024308,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,Veliparib
2,mTORC1 Signaling,0.0069294076429407,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Veliparib
3,Interferon Alpha Response,0.0146387547929121,LGALS3BP;TXNIP;PSMB8;PSMB9,Veliparib
4,UV Response Dn,0.0485888768722106,ITGB3;PMP22;MT1E;IGF1R,Veliparib
0,Estrogen Response Early,1.8115327193830903e-05,ABLIM1;KRT19;RAB31;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)"
1,Estrogen Response Late,0.0008213172213903023,KRT19;RAB31;MYOF;NRIP1;FLNB;SFN;LSR,"Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)"
2,UV Response Dn,0.0065418867346305,TJP1;ANXA2;NFIB;MAP1B;ID1,"Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)"
3,TGF-beta Signaling,0.01562871761565,TJP1;RAB31;ID1,"Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)"
4,Apical Junction,0.0166191072436907,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)"
0,Complement,0.0027596258638714,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,"4-cyano-N-(5-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide"
1,Epithelial Mesenchymal Transition,0.0106476263781772,ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,"4-cyano-N-(5-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide"
2,KRAS Signaling Up,0.0465335002823341,TMEM158;SPP1;LCP1;GNG11;PSMB8,"4-cyano-N-(5-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide"
0,Epithelial Mesenchymal Transition,0.000302006549056106,VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
1,Hedgehog Signaling,0.0006282708915117622,NRP1;NRP2;CDK6;VLDLR,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
2,KRAS Signaling Up,0.0069294076429407,NRP1;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
3,Angiogenesis,0.0078738145943993,NRP1;VCAN;ITGAV,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
4,Androgen Response,0.0131032538252395,CDK6;ELOVL5;ITGAV;HMGCR,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
5,Estrogen Response Early,0.0194680970568948,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
6,Glycolysis,0.0194680970568948,VCAN;CDK1;MIF;VLDLR;CD44,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
7,UV Response Dn,0.0303680480451316,NRP1;ATP2B4;SNAI2;VLDLR,"1-(2-Hydroxy-2-methylpropyl)-N-(5-((7-methoxyquinolin-4-yl)oxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide"
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,Nirogacestat
1,Cholesterol Homeostasis,0.0006406154276668261,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Nirogacestat
2,KRAS Signaling Up,0.0062533678728977,NRP1;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Nirogacestat
3,Angiogenesis,0.0071056375607994,NRP1;VCAN;ITGAV,Nirogacestat
4,Estrogen Response Late,0.0245962787206623,ELOVL5;ATP2B4;CD9;JAK2;AREG,Nirogacestat
5,Coagulation,0.0314693691497492,SPARC;PLAU;CD9;DUSP6,Nirogacestat
0,UV Response Dn,0.003174708509969,NOTCH2;INPP4B;DUSP1;PTEN;LAMC1;MET,Amuvatinib
1,p53 Pathway,0.0093800518093465,HDAC3;BAX;STOM;TXNIP;TP53;PTPN14,Amuvatinib
2,Glycolysis,0.0409937978677705,EXT1;CYB5A;CDK1;MIF;MET,Amuvatinib
0,E2F Targets,0.0202811931012899,DNMT1;WEE1;PLK1;CDK1;TP53;AURKA,Adavosertib
0,Hypoxia,0.0476414407652468,SRPX;DTNA;GCNT2;PLIN2;MT1E,Buparlisib
1,Complement,0.0476414407652468,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Buparlisib
2,mTORC1 Signaling,0.0476414407652468,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Buparlisib
0,Angiogenesis,0.0172838715334383,APP;FSTL1;PTK2,PF-00562271 free base
1,TGF-beta Signaling,0.0172838715334383,TJP1;SMURF2;ID1,PF-00562271 free base
2,Estrogen Response Early,0.0172838715334383,ABLIM1;KRT18;KRT8;FLNB;SFN,PF-00562271 free base
3,Apical Junction,0.0172838715334383,TJP1;RRAS;CTNNA1;RHOF;PTK2,PF-00562271 free base
4,p53 Pathway,0.0172838715334383,VAMP8;APP;SFN;PTPN14;EPHA2,PF-00562271 free base
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
1,Glycolysis,0.0012484021765132,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
2,Hypoxia,0.0049181098340275,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;CD9;HMGCR,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
4,Angiogenesis,0.0058381454553595,APP;NRP1;VCAN,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
5,TNF-alpha Signaling via NF-kB,0.0210508691753416,FOSL1;SDC4;PLAU;PLK2;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
6,UV Response Dn,0.0321668522847387,NRP1;ATP2B4;SNAI2;PRKCA,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
7,IL-6/JAK/STAT3 Signaling,0.0429241400598498,TNFRSF12A;CD9;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
8,Hedgehog Signaling,0.0429241400598498,NRP1;NRP2,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
9,Mitotic Spindle,0.0429241400598498,PLK1;CDK1;ARHGAP29;CDC42EP1,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
10,IL-2/STAT5 Signaling,0.0429241400598498,NRP1;NT5E;ALCAM;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
11,Estrogen Response Late,0.0429241400598498,ELOVL5;ATP2B4;CD9;CD44,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
12,Apical Junction,0.0429241400598498,VCAN;ITGA3;EGFR;ACTB,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
13,mTORC1 Signaling,0.0429241400598498,ELOVL5;PLK1;CD9;HMGCR,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
14,p53 Pathway,0.0429241400598498,VAMP8;APP;PLK2;PTPN14,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
15,KRAS Signaling Up,0.0429241400598498,NRP1;PLAU;SPRY2;ETS1,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine
0,Apical Junction,0.00023571242853159488,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,Aeg-40730 (iap)
1,p53 Pathway,0.0062802112652453,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Aeg-40730 (iap)
2,Angiogenesis,0.0062802112652453,APP;FSTL1;PTK2,Aeg-40730 (iap)
3,UV Response Dn,0.0062802112652453,TJP1;ANXA2;DUSP1;ID1;LAMC1,Aeg-40730 (iap)
4,Protein Secretion,0.0087967670042194,KRT18;SCRN1;CAV2;EGFR,Aeg-40730 (iap)
5,Apoptosis,0.046522111071361,APP;KRT18;TNFRSF12A;PTK2,Aeg-40730 (iap)
0,UV Response Dn,0.0003252907945633722,INPP4B;DLC1;ITGB3;PMP22;LPAR1;MT1E;IGF1R,MI-219 (Mdm-2)
1,Androgen Response,0.0327581345630989,INPP4B;CDK6;ADAMTS1;HMGCR,MI-219 (Mdm-2)
2,Epithelial Mesenchymal Transition,0.0454255597994214,ITGB3;ADAM12;PMP22;SPP1;VEGFC,MI-219 (Mdm-2)
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;AREG;THBS1,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
1,Angiogenesis,0.0005516524901078888,APP;NRP1;VCAN;ITGAV,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
2,UV Response Dn,0.0010296351924223,TJP1;NRP1;GJA1;ID1;ATP2B4;MET,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
3,TGF-beta Signaling,0.001382256574705,TJP1;ID1;ID3;THBS1,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
4,TNF-alpha Signaling via NF-kB,0.002662435398872,TUBB2A;SDC4;PLAU;PLK2;AREG;IER3,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
5,Glycolysis,0.002662435398872,VCAN;MIF;PAM;MET;IER3;IL13RA1,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
6,Cholesterol Homeostasis,0.002662435398872,ALCAM;TNFRSF12A;MAL2;CD9,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
7,Coagulation,0.0029145169598719,SPARC;PLAU;CD9;THBS1;DUSP6,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
8,IL-6/JAK/STAT3 Signaling,0.0379644814871266,TNFRSF12A;CD9;IL13RA1,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
9,Protein Secretion,0.0406649747935419,SCRN1;DST;PAM,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
10,Pperoxisome,0.0406649747935419,SEMA3C;ELOVL5;PRDX1,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
11,Hypoxia,0.0406649747935419,SDC4;MIF;PAM;IER3,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
12,Estrogen Response Early,0.0406649747935419,GJA1;ELOVL5;ENDOD1;AREG,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
13,Estrogen Response Late,0.0406649747935419,ELOVL5;ATP2B4;CD9;AREG,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
14,Apical Junction,0.0406649747935419,TJP1;VCAN;CDH3;ITGA3,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
15,p53 Pathway,0.0406649747935419,APP;HDAC3;PLK2;IER3,"5-(2-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime"
0,Hypoxia,0.0101405965506449,SRPX;TES;DTNA;PLIN2;TGFBI;MT1E,Q2L4XU3YX6
1,mTORC1 Signaling,0.0101405965506449,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Q2L4XU3YX6
2,Interferon Alpha Response,0.0190422826574466,LGALS3BP;TXNIP;PSMB8;PSMB9,Q2L4XU3YX6
3,KRAS Signaling Up,0.0332382144873815,SPP1;LCP1;GNG11;PSMB8;BIRC3,Q2L4XU3YX6
0,Epithelial Mesenchymal Transition,6.3008984907718505e-15,SPARC;TNFRSF12A;SDC4;DST;COL12A1;TNC;FBLN1;AREG;THBS1;NT5E;GJA1;VCAN;LGALS1;COL4A1;SNAI2;ITGAV;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
1,Glycolysis,1.4129955211188108e-05,NT5E;VCAN;CDK1;MIF;PAM;MET;EGFR;CD44;IL13RA1,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
2,TNF-alpha Signaling via NF-kB,9.57581740909604e-05,FOSL1;TUBB2A;SDC4;PLAU;PLK2;TNC;AREG;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
3,Angiogenesis,0.0002700973154487158,APP;NRP1;VCAN;ITGAV,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
4,Cholesterol Homeostasis,0.0002700973154487158,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
5,UV Response Dn,0.0005577190625621247,NRP1;GJA1;CAV1;ATP2B4;SNAI2;MET,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
6,Estrogen Response Late,0.0028248804676796,ELOVL5;CAV1;ATP2B4;CD9;AREG;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
7,IL-6/JAK/STAT3 Signaling,0.0046462511852441,TNFRSF12A;CD9;CD44;IL13RA1,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
8,Protein Secretion,0.0059561443257735,DST;CAV2;PAM;EGFR,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
9,IL-2/STAT5 Signaling,0.0099714643462144,NRP1;NT5E;ALCAM;ITGAV;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
10,Hypoxia,0.0099714643462144,SDC4;CAV1;MIF;PAM;EGFR,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
11,Estrogen Response Early,0.0099714643462144,GJA1;ELOVL5;ENDOD1;AREG;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
12,Apical Junction,0.0099714643462144,VCAN;CDH3;ITGA3;EGFR;ACTB,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
13,Coagulation,0.0142158926274929,SPARC;PLAU;CD9;THBS1,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
14,Apoptosis,0.0226795291472884,APP;TNFRSF12A;CAV1;CD44,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
15,Androgen Response,0.0336905347166305,ELOVL5;ITGAV;HMGCR,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
16,Pperoxisome,0.0352039769686631,SEMA3C;ELOVL5;PRDX1,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
17,mTORC1 Signaling,0.0391588646160033,ELOVL5;PRDX1;CD9;HMGCR,"N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide)"
0,UV Response Dn,1.1614228839507708e-05,TJP1;NRP1;GJA1;ID1;ATP2B4;SNAI2;PRKCA;MET,Itraconazolum [Latin]
1,Epithelial Mesenchymal Transition,1.1614228839507708e-05,GJA1;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1,Itraconazolum [Latin]
2,Angiogenesis,1.1614228839507708e-05,APP;NRP1;VCAN;ITGAV;PTK2,Itraconazolum [Latin]
3,Apical Junction,0.0006077747438288237,TJP1;VCAN;RRAS;ITGA3;EGFR;ACTB;PTK2,Itraconazolum [Latin]
4,TGF-beta Signaling,0.0011365220725352,TJP1;ID1;ID3;THBS1,Itraconazolum [Latin]
5,Hypoxia,0.0027363919377296,SDC4;PRKCA;MIF;ETS1;PAM;EGFR,Itraconazolum [Latin]
6,Cholesterol Homeostasis,0.0027363919377296,ALCAM;TNFRSF12A;MAL2;CD9,Itraconazolum [Latin]
7,Glycolysis,0.0153726742004139,VCAN;MIF;PAM;MET;EGFR,Itraconazolum [Latin]
0,IL-2/STAT5 Signaling,0.00011107490546066368,PRNP;CSF1;BHLHE40;ITGA6;PLIN2;AHR;WLS;IGF1R,Alimta
1,Epithelial Mesenchymal Transition,0.00011107490546066368,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;FAS;VEGFC;EDIL3,Alimta
2,UV Response Dn,0.00011107490546066368,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Alimta
3,TNF-alpha Signaling via NF-kB,0.0042590505512708,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Alimta
4,Hypoxia,0.0042590505512708,SRPX;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,Alimta
5,Myogenesis,0.015511166760778,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,Alimta
6,Inflammatory Response,0.015511166760778,LYN;CSF1;ITGB3;LPAR1;AHR,Alimta
7,Xenobiotic Metabolism,0.015511166760778,TGFB2;PROS1;GCNT2;FAS;BCAT1,Alimta
8,Allograft Rejection,0.015511166760778,LYN;TGFB2;CSF1;FAS;BCAT1,Alimta
9,Apoptosis,0.0362388232377117,TGFB2;FAS;BAX;BCL2L2,Alimta
10,IL-6/JAK/STAT3 Signaling,0.0362388232377117,CSF1;ITGB3;FAS,Alimta
11,Interferon Alpha Response,0.0445849133230403,CSF1;PSMB8;PSMB9,Alimta
0,UV Response Dn,2.276829707164156e-05,INPP4B;RBPMS;DLC1;SERPINE1;AKT3;ATP2B4;PTEN;SNAI2,Ispinesib
1,Estrogen Response Early,0.0060843579303869,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Ispinesib
2,Epithelial Mesenchymal Transition,0.0060843579303869,NT5E;TNFRSF12A;SERPINE1;SNAI2;CD44;LOXL2,Ispinesib
3,Androgen Response,0.0143816200520922,INPP4B;CDK6;ELOVL5;HMGCR,Ispinesib
4,Hypoxia,0.0170939388792247,EXT1;MT2A;SERPINE1;MIF;ETS1,Ispinesib
5,Estrogen Response Late,0.0170939388792247,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Ispinesib
6,Complement,0.0170939388792247,GCA;ERAP2;SERPINE1;GNB4;JAK2,Ispinesib
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,Sepantronium
1,Apical Junction,1.340534212343487e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;FLNC;EGFR;ACTB;PTK2,Sepantronium
2,Hypoxia,9.08474984965522e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,Sepantronium
3,Apoptosis,0.00015197003326362604,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Sepantronium
4,UV Response Dn,0.0006349417019938035,NOTCH2;TJP1;CAV1;SERPINE1;AKT3;LAMC1,Sepantronium
5,Mitotic Spindle,0.0030450385460066,NOTCH2;FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,Sepantronium
6,Angiogenesis,0.0040603643204568,APP;FSTL1;PTK2,Sepantronium
7,IL-6/JAK/STAT3 Signaling,0.0044079818936931,TNFRSF12A;CD9;OSMR;CD44,Sepantronium
8,TNF-alpha Signaling via NF-kB,0.0111801266912101,FOSL1;SDC4;PLK2;SERPINE1;CD44,Sepantronium
9,Estrogen Response Late,0.0111801266912101,FARP1;ELOVL5;CAV1;CD9;CD44,Sepantronium
10,Glycolysis,0.0111801266912101,EXT1;NT5E;MIF;EGFR;CD44,Sepantronium
11,Estrogen Response Early,0.0445808612551423,FARP1;ELOVL5;ENDOD1;CD44,Sepantronium
12,Complement,0.0445808612551423,GCA;SERPINE1;GNB4;TIMP2,Sepantronium
13,Inflammatory Response,0.0445808612551423,AXL;SERPINE1;SGMS2;OSMR,Sepantronium
14,p53 Pathway,0.0445808612551423,VAMP8;APP;PLK2;PTPN14,Sepantronium
0,Epithelial Mesenchymal Transition,3.18829758611424e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
2,IL-2/STAT5 Signaling,0.0055773281028547,PRNP;CSF1;BHLHE40;AHR;WLS;IGF1R,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
3,TNF-alpha Signaling via NF-kB,0.0055773281028547,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
4,Myogenesis,0.0182810179680598,WWTR1;FDPS;PRNP;ITGB5;BHLHE40,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
5,Inflammatory Response,0.0182810179680598,LYN;CSF1;ITGB3;LPAR1;AHR,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
6,Xenobiotic Metabolism,0.0182810179680598,TGFB2;PROS1;GCNT2;FAS;BCAT1,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
7,Allograft Rejection,0.0182810179680598,LYN;TGFB2;CSF1;FAS;BCAT1,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
8,Apoptosis,0.0417609296358392,TGFB2;FAS;BAX;BCL2L2,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
9,IL-6/JAK/STAT3 Signaling,0.0417609296358392,CSF1;ITGB3;FAS,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
10,Interferon Alpha Response,0.0497016358587735,CSF1;PSMB8;PSMB9,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
11,Androgen Response,0.0497016358587735,ADAMTS1;SGK1;ELL2,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
12,Hypoxia,0.0497016358587735,SRPX;BHLHE40;GCNT2;MT1E,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
13,Estrogen Response Early,0.0497016358587735,BHLHE40;RHOBTB3;PRSS23;IGF1R,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
14,Complement,0.0497016358587735,DOCK10;LYN;CEBPB;PSMB9,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
15,mTORC1 Signaling,0.0497016358587735,BHLHE40;BCAT1;AURKA;HSP90B1,"4-[(3,5-Dichloro-4-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methylpiperazin-1-Yl)propoxy]quinoline-3-Carbonitrile"
0,Estrogen Response Early,0.001774045198203,ABLIM1;GJA1;KRT18;MYOF;KRT8;FLNB;SFN,Masitinib
1,Protein Secretion,0.0185556803995253,TPD52;KRT18;SCRN1;DST,Masitinib
2,Mitotic Spindle,0.0224357947789825,DST;FSCN1;ARHGAP29;FLNB;RHOF,Masitinib
3,Apical Junction,0.0224357947789825,TJP1;RRAS;FSCN1;CTNNA1;RHOF,Masitinib
4,UV Response Dn,0.0319975530621874,TJP1;GJA1;MAP1B;ID1,Masitinib
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,GJA1;VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;ITGAV;THBS1,Cediranib
1,Angiogenesis,0.0005822998506694381,NRP1;VCAN;SPP1;ITGAV,Cediranib
2,UV Response Dn,0.0010868371475569,NRP1;GJA1;CITED2;SDC2;ATP2B4;SNAI2,Cediranib
3,Glycolysis,0.0315763037630124,VCAN;CITED2;SDC2;CDK1;MIF,Cediranib
4,Coagulation,0.038515798575968,SPARC;PLAU;THBS1;DUSP6,Cediranib
5,Cholesterol Homeostasis,0.038515798575968,ALCAM;MAL2;HMGCR,Cediranib
0,Angiogenesis,0.0207407799071983,APP;FSTL1;PTK2,"3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one"
1,Estrogen Response Early,0.0224357947789825,ABLIM1;KRT18;MYOF;KRT8;SFN,"3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one"
2,Apical Junction,0.0224357947789825,TJP1;RRAS;CTNNA1;RHOF;PTK2,"3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one"
3,p53 Pathway,0.0224357947789825,APP;SFN;PTPN14;EPHA2;S100A10,"3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one"
4,UV Response Dn,0.0319975530621874,TJP1;ANXA2;MAP1B;ID1,"3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one"
0,Epithelial Mesenchymal Transition,0.0027596258638714,VCAN;ECM1;SPARC;COL4A1;TNC;SPP1;SNAI2,Luminespib
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,Pimasertib
1,KRAS Signaling Up,0.0012484021765132,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Pimasertib
2,IL-2/STAT5 Signaling,0.0048167833615563,NRP1;NT5E;ALCAM;LRIG1;ITGAV;CD44,Pimasertib
3,Estrogen Response Early,0.0048167833615563,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;CD44,Pimasertib
4,Angiogenesis,0.0058381454553595,NRP1;VCAN;ITGAV,Pimasertib
5,Glycolysis,0.0210508691753416,NT5E;VCAN;CDK1;MIF;CD44,Pimasertib
6,Cholesterol Homeostasis,0.033013541636544,ALCAM;MAL2;HMGCR,Pimasertib
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
1,Estrogen Response Early,0.0078502640815566,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
2,Angiogenesis,0.0078502640815566,NRP1;VCAN;ITGAV,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
3,UV Response Dn,0.0078502640815566,NRP1;CELF2;ATP2B4;SNAI2;FYN,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
4,Androgen Response,0.0127836622685264,ELOVL5;STK39;ITGAV;HMGCR,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
5,IL-2/STAT5 Signaling,0.0189932654213608,CDKN1C;NRP1;ECM1;LRIG1;ITGAV,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
6,Complement,0.0189932654213608,ERAP2;KYNU;FYN;JAK2;DUSP6,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide"
0,Epithelial Mesenchymal Transition,5.2606525808057816e-11,SPARC;TNFRSF12A;COL12A1;TNC;FBLN1;THBS1;NT5E;GJA1;VCAN;LGALS1;COL4A1;SPP1;SNAI2;ITGAV,"1,9-Pyrazoloanthrone"
1,Angiogenesis,1.8833884604607092e-05,APP;NRP1;VCAN;SPP1;ITGAV,"1,9-Pyrazoloanthrone"
2,KRAS Signaling Up,0.0008580293270186533,NRP1;PLAU;GABRA3;SPP1;LY96;PLAT;LCP1,"1,9-Pyrazoloanthrone"
3,UV Response Dn,0.0008580293270186533,NRP1;GJA1;CAV1;ATP2B4;SNAI2;RND3,"1,9-Pyrazoloanthrone"
4,Apoptosis,0.0012666625687172,APP;TNFRSF12A;CAV1;BAX;PMAIP1;PLAT,"1,9-Pyrazoloanthrone"
5,Coagulation,0.004317802903514,SPARC;PLAU;CD9;PLAT;THBS1,"1,9-Pyrazoloanthrone"
6,IL-2/STAT5 Signaling,0.0166191072436907,CDKN1C;NRP1;NT5E;SPP1;ITGAV,"1,9-Pyrazoloanthrone"
7,Estrogen Response Late,0.0166191072436907,ST14;CAV1;ATP2B4;CD9;IL6ST,"1,9-Pyrazoloanthrone"
8,Cholesterol Homeostasis,0.0270286305796267,TNFRSF12A;CD9;HMGCR,"1,9-Pyrazoloanthrone"
9,IL-6/JAK/STAT3 Signaling,0.0379644814871266,TNFRSF12A;CD9;IL6ST,"1,9-Pyrazoloanthrone"
10,Hedgehog Signaling,0.0451833053261577,NRP1;NRP2,"1,9-Pyrazoloanthrone"
11,TNF-alpha Signaling via NF-kB,0.0451833053261577,PLAU;PLK2;TNC;IL6ST,"1,9-Pyrazoloanthrone"
12,G2-M Checkpoint,0.0451833053261577,PLK1;CDK1;TTK;AURKB,"1,9-Pyrazoloanthrone"
13,Myogenesis,0.0451833053261577,APP;MEF2C;SPARC;IGFBP7,"1,9-Pyrazoloanthrone"
14,E2F Targets,0.0451833053261577,DNMT1;PLK1;CDK1;AURKB,"1,9-Pyrazoloanthrone"
15,p53 Pathway,0.0451833053261577,APP;ST14;PLK2;BAX,"1,9-Pyrazoloanthrone"
0,Epithelial Mesenchymal Transition,1.293009331461962e-08,NT5E;GJA1;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,Foretinib
1,Glycolysis,1.340534212343487e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Foretinib
2,UV Response Dn,9.785170242963228e-05,TJP1;NRP1;GJA1;ATP2B4;SNAI2;PRKCA;MET,Foretinib
3,Angiogenesis,0.0002834880851943317,APP;NRP1;VCAN;ITGAV,Foretinib
4,TNF-alpha Signaling via NF-kB,0.0004051831625525491,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Foretinib
5,Hypoxia,0.0004051831625525491,SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Foretinib
6,Apical Junction,0.0023943429455134,TJP1;VCAN;CDH3;ITGA3;EGFR;ACTB,Foretinib
7,Cholesterol Homeostasis,0.0023943429455134,ALCAM;TNFRSF12A;MAL2;CD9,Foretinib
8,IL-6/JAK/STAT3 Signaling,0.0039182061277272,TNFRSF12A;CD9;CD44;IL13RA1,Foretinib
9,TGF-beta Signaling,0.0092522008284648,TJP1;ID3;THBS1,Foretinib
10,IL-2/STAT5 Signaling,0.0109432593889097,NRP1;NT5E;ALCAM;ITGAV;CD44,Foretinib
11,Coagulation,0.0157346845748746,SPARC;PLAU;CD9;THBS1,Foretinib
12,Apoptosis,0.0248267035044282,APP;TNFRSF12A;CD44;IER3,Foretinib
13,Pperoxisome,0.0393360540486549,SEMA3C;ELOVL5;PRDX1,Foretinib
14,Estrogen Response Early,0.0393360540486549,GJA1;ELOVL5;ENDOD1;CD44,Foretinib
15,Estrogen Response Late,0.0393360540486549,ELOVL5;ATP2B4;CD9;CD44,Foretinib
16,p53 Pathway,0.0393360540486549,VAMP8;APP;PLK2;IER3,Foretinib
17,Apical Surface,0.0419939390486703,APP;ATP8B1,Foretinib
0,mTORC1 Signaling,0.0027596258638714,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,"N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide"
1,IL-2/STAT5 Signaling,0.0053238131890886,IFITM3;CTSZ;SPP1;PLIN2;AHR;IGF1R,"N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide"
2,Hypoxia,0.0053238131890886,SRPX;TES;DTNA;PLIN2;TGFBI;NR3C1,"N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide"
3,Epithelial Mesenchymal Transition,0.0053238131890886,BASP1;ITGB3;SPP1;FN1;TGFBI;EMP3,"N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide"
4,Interferon Alpha Response,0.0119966380741913,IFITM3;LGALS3BP;TXNIP;PSMB8,"N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide"
0,IL-2/STAT5 Signaling,0.00012522222765740977,IFITM3;PRNP;BHLHE40;LIF;ITGA6;AHR;WLS;IGF1R,Vismodegib
1,Epithelial Mesenchymal Transition,0.00012522222765740977,ITGB5;BASP1;BDNF;ITGB3;PMP22;FN1;TGFBI;EDIL3,Vismodegib
2,Hypoxia,0.0007293249279658553,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Vismodegib
3,UV Response Dn,0.0007293249279658553,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,Vismodegib
4,Estrogen Response Early,0.0034478028272192,DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;IGF1R,Vismodegib
5,Interferon Alpha Response,0.0080929701294148,IFITM3;LGALS3BP;PSMB8;PSMB9,Vismodegib
6,TNF-alpha Signaling via NF-kB,0.0125566588063441,CEBPB;BHLHE40;LIF;FJX1;LITAF,Vismodegib
7,Complement,0.0125566588063441,DOCK10;CEBPB;CTSL;FN1;PSMB9,Vismodegib
8,mTORC1 Signaling,0.0125566588063441,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Vismodegib
9,Apoptosis,0.0296578458079926,IFITM3;TGFB2;DPYD;BCL2L2,Vismodegib
0,Estrogen Response Early,0.0016426344427806,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,"2-Amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester"
1,TGF-beta Signaling,0.0276985120728179,TJP1;SMURF2;ID1,"2-Amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester"
2,Estrogen Response Late,0.0276985120728179,KRT19;MYOF;FLNB;SFN;LSR,"2-Amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester"
3,UV Response Dn,0.0370342049330873,TJP1;ANXA2;MAP1B;ID1,"2-Amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester"
0,UV Response Dn,0.0003570264818378475,INPP4B;BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
1,IL-2/STAT5 Signaling,0.0076054474129837,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;IGF1R,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
2,mTORC1 Signaling,0.0076054474129837,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
3,Hedgehog Signaling,0.0086419916279992,ADGRG1;CDK6;DPYSL2,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
4,Androgen Response,0.0143816200520922,INPP4B;CDK6;ADAMTS1;HMGCR,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
5,Hypoxia,0.0213674235990309,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
6,Epithelial Mesenchymal Transition,0.0213674235990309,BDNF;ITGB3;PMP22;SPP1;VEGFC,"[(6R,7S,8R)-11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate"
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,VCAN;ECM1;COL5A1;COL4A1;WIPF1;TNC;SPP1;SNAI2;TIMP3;FBLN1,"1-{4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl}-3-[2-fluoro-5-(trifluorome thyl)phenyl]urea"
1,KRAS Signaling Up,0.0096335667231127,GYPC;GABRA3;SPP1;LCP1;TRIB2;DUSP6,"1-{4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl}-3-[2-fluoro-5-(trifluorome thyl)phenyl]urea"
2,Complement,0.0421017383506832,ERAP2;KYNU;FYN;JAK2;DUSP6,"1-{4-[4-Amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl}-3-[2-fluoro-5-(trifluorome thyl)phenyl]urea"
0,Estrogen Response Early,0.0103703899535991,ABLIM1;KRT18;MYOF;KRT8;FLNB;SFN,Lenvatinib
1,Angiogenesis,0.0103703899535991,APP;PTK2;FGFR1,Lenvatinib
2,Apical Junction,0.0299143930386433,TJP1;RRAS;CTNNA1;RHOF;PTK2,Lenvatinib
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;CD44,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
1,KRAS Signaling Up,0.00013995425444063446,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
2,Hedgehog Signaling,0.00038819990044629206,NRP1;NRP2;CDK6;VLDLR,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
3,Estrogen Response Early,0.003853426689245,ELOVL5;ELOVL2;ENDOD1;PMAIP1;JAK2;CD44,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
4,Glycolysis,0.003853426689245,NT5E;VCAN;CDK1;MIF;VLDLR;CD44,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
5,UV Response Dn,0.0375279943321951,NRP1;ATP2B4;SNAI2;VLDLR,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide"
0,p53 Pathway,0.0122908325375989,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Nelarabine
1,Angiogenesis,0.0122908325375989,APP;FSTL1;PTK2,Nelarabine
2,TGF-beta Signaling,0.0265905715899052,TJP1;SMURF2;ID1,Nelarabine
3,Apical Junction,0.0265905715899052,TJP1;RRAS;CTNNA1;RHOF;PTK2,Nelarabine
4,UV Response Dn,0.0379230258514814,TJP1;ANXA2;MAP1B;ID1,Nelarabine
5,Apoptosis,0.046522111071361,APP;GPX1;KRT18;PTK2,Nelarabine
0,Epithelial Mesenchymal Transition,2.657192674688844e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
1,Hypoxia,0.0013798129319357,SRPX;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
2,UV Response Dn,0.0109903697141793,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
3,Interferon Alpha Response,0.0149957975927392,CSF1;TXNIP;PSMB8;PSMB9,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
4,TNF-alpha Signaling via NF-kB,0.0174500626058753,CSF1;IRS2;SGK1;FJX1;LITAF,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
5,Myogenesis,0.0174500626058753,FDPS;PRNP;DTNA;ITGB5;ADAM12,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
6,Complement,0.0174500626058753,DOCK10;LYN;ERAP2;FN1;PSMB9,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
7,KRAS Signaling Up,0.0174500626058753,TMEM158;SPP1;LCP1;GNG11;PSMB8,"1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one"
0,mTORC1 Signaling,0.0197741632737576,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide"
0,UV Response Dn,0.003775329038882,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide"
1,IL-2/STAT5 Signaling,0.0365620359361196,PRNP;PLAGL1;SPP1;PLIN2;IGF1R,"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide"
2,mTORC1 Signaling,0.0365620359361196,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide"
3,Epithelial Mesenchymal Transition,0.0365620359361196,BDNF;ITGB3;PMP22;SPP1;VEGFC,"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide"
0,Estrogen Response Early,0.0001988823615735332,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
1,Estrogen Response Late,0.0068449026716853,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
2,Apical Junction,0.0299143930386433,TJP1;RRAS;FSCN1;CTNNA1;RHOF,N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
3,UV Response Dn,0.0399969413277343,TJP1;ANXA2;MAP1B;ID1,N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
0,Angiogenesis,0.0010726576196542,APP;NRP1;ITGAV;PTK2,Quizartinib
1,Apical Junction,0.0011498441099464,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Quizartinib
2,p53 Pathway,0.0045298380050253,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Quizartinib
3,Cholesterol Homeostasis,0.0045298380050253,ALCAM;TNFRSF12A;MAL2;CD9,Quizartinib
4,UV Response Dn,0.0414783095250578,TJP1;NRP1;ANXA2;ID1,Quizartinib
5,Fatty Acid Metabolism,0.0436144791294009,ELOVL5;PCBD1;MIF;S100A10,Quizartinib
6,Apoptosis,0.0436144791294009,APP;GPX1;TNFRSF12A;PTK2,Quizartinib
7,Protein Secretion,0.0486589441974006,SCRN1;CAV2;EGFR,Quizartinib
8,Androgen Response,0.0486589441974006,ELOVL5;KRT8;ITGAV,Quizartinib
9,Pperoxisome,0.0486589441974006,SEMA3C;ELOVL5;PRDX1,Quizartinib
10,IL-2/STAT5 Signaling,0.0486589441974006,NRP1;ALCAM;AHNAK;ITGAV,Quizartinib
11,Hypoxia,0.0486589441974006,ANXA2;SDC4;MIF;EGFR,Quizartinib
12,Epithelial Mesenchymal Transition,0.0486589441974006,TNFRSF12A;SDC4;COL12A1;ITGAV,Quizartinib
0,Hypoxia,0.0019305659857919,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
1,UV Response Dn,0.0019305659857919,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
2,Epithelial Mesenchymal Transition,0.0076054474129837,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
3,IL-2/STAT5 Signaling,0.0213674235990309,PRNP;SPP1;PLIN2;AHR;IGF1R,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
4,TNF-alpha Signaling via NF-kB,0.0213674235990309,CEBPB;IRS2;SGK1;FJX1;LITAF,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
5,Complement,0.0213674235990309,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
6,mTORC1 Signaling,0.0213674235990309,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
7,Cholesterol Homeostasis,0.03420811057734,FDPS;FABP5;HMGCR,"(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine"
0,Epithelial Mesenchymal Transition,0.0002946405356644936,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1,MK-2206
1,UV Response Dn,0.0157005281631133,NRP1;CELF2;ATP2B4;SNAI2;FYN,MK-2206
2,Estrogen Response Early,0.0265905715899052,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,MK-2206
3,Complement,0.0265905715899052,ERAP2;KYNU;FYN;JAK2;DUSP6,MK-2206
4,KRAS Signaling Up,0.0265905715899052,NRP1;GYPC;GABRA3;TRIB2;DUSP6,MK-2206
0,Hypoxia,0.0001473202678322468,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,PDK1 inhibitor AR-12
1,Epithelial Mesenchymal Transition,0.0001473202678322468,ITGB5;BASP1;BDNF;ITGB3;PMP22;FN1;TGFBI;EDIL3,PDK1 inhibitor AR-12
2,IL-2/STAT5 Signaling,0.0008488465009537043,IFITM3;PRNP;BHLHE40;ITGA6;PLIN2;AHR;IGF1R,PDK1 inhibitor AR-12
3,UV Response Dn,0.0008580293270186533,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,PDK1 inhibitor AR-12
4,Interferon Alpha Response,0.0010122004584898,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,PDK1 inhibitor AR-12
5,Complement,0.0033801988502149,DOCK10;LYN;CEBPB;CTSL;FN1;PSMB9,PDK1 inhibitor AR-12
6,Apoptosis,0.0073869581273665,IFITM3;TGFB2;DPYD;TXNIP;BCL2L2,PDK1 inhibitor AR-12
7,TNF-alpha Signaling via NF-kB,0.0120866234499569,CEBPB;BHLHE40;SGK1;FJX1;LITAF,PDK1 inhibitor AR-12
8,Estrogen Response Early,0.0120866234499569,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,PDK1 inhibitor AR-12
9,Interferon Gamma Response,0.0120866234499569,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,PDK1 inhibitor AR-12
10,mTORC1 Signaling,0.0120866234499569,TES;BHLHE40;BCAT1;AURKA;HSP90B1,PDK1 inhibitor AR-12
0,Epithelial Mesenchymal Transition,1.6950496144146385e-05,GJA1;VCAN;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;THBS1,Nintedanib
1,Angiogenesis,1.6950496144146385e-05,APP;NRP1;VCAN;ITGAV;FGFR1,Nintedanib
2,TGF-beta Signaling,0.0018430087662734,TJP1;ID1;ID3;THBS1,Nintedanib
3,Apical Junction,0.0037274095584208,TJP1;VCAN;RRAS;ITGA3;SRC;EGFR,Nintedanib
4,Cholesterol Homeostasis,0.0037274095584208,ALCAM;TNFRSF12A;MAL2;CD9,Nintedanib
5,UV Response Dn,0.004710158448934,TJP1;NRP1;GJA1;ID1;MET,Nintedanib
6,Apical Surface,0.0071190438310063,LYN;APP;ATP8B1,Nintedanib
7,Glycolysis,0.0149571965193216,VCAN;MIF;MET;EGFR;IL13RA1,Nintedanib
8,IL-6/JAK/STAT3 Signaling,0.0379644814871266,TNFRSF12A;CD9;IL13RA1,Nintedanib
9,Protein Secretion,0.0433759731131114,SCRN1;DST;EGFR,Nintedanib
10,Pperoxisome,0.0433759731131114,SEMA3C;ELOVL5;PRDX1,Nintedanib
11,IL-2/STAT5 Signaling,0.0433759731131114,NRP1;ALCAM;AHNAK;ITGAV,Nintedanib
12,TNF-alpha Signaling via NF-kB,0.0433759731131114,TUBB2A;SDC4;PLAU;PLK2,Nintedanib
13,Estrogen Response Early,0.0433759731131114,ABLIM1;GJA1;ELOVL5;ENDOD1,Nintedanib
14,Inflammatory Response,0.0433759731131114,LYN;AXL;SGMS2;MET,Nintedanib
0,mTORC1 Signaling,0.0013141075542244,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Quercetin
1,Epithelial Mesenchymal Transition,0.0013141075542244,ITGB5;BASP1;ITGB3;SPP1;FN1;TGFBI;EMP3,Quercetin
2,Interferon Alpha Response,0.0016870007641498,IFITM3;LGALS3BP;HLA-C;TXNIP;PSMB8,Quercetin
3,Fatty Acid Metabolism,0.0118916659175276,CBR1;HSP90AA1;DHCR24;PTPRG;CBR3,Quercetin
4,Hypoxia,0.0265905715899052,SRPX;TES;DTNA;TGFBI;MT1E,Quercetin
0,Interferon Alpha Response,0.0349001252117506,BST2;TXNIP;PSMB8;PSMB9,"(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole"
1,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,"(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole"
2,Hypoxia,0.0349001252117506,SRPX;DTNA;IRS2;AMPD3;MT1E,"(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole"
3,Complement,0.0349001252117506,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"(2E)-2-[(5E)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole"
0,UV Response Dn,0.0321860827343824,SDC2;DLC1;ITGB3;PMP22;VLDLR,Daunorubicin
1,E2F Targets,0.0454255597994214,TOP2A;DNMT1;PLK1;CDK1;TP53,Daunorubicin
2,Epithelial Mesenchymal Transition,0.0454255597994214,ITGB3;ADAM12;PMP22;SPP1;VEGFC,Daunorubicin
0,Apical Junction,0.0002430784419232072,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,nutlin-3A
1,Apoptosis,0.0002710816809567383,APP;GPX1;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,nutlin-3A
2,Hypoxia,0.004182996077141,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,nutlin-3A
3,p53 Pathway,0.004182996077141,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,nutlin-3A
4,Angiogenesis,0.0043176452448561,APP;FSTL1;PTK2,nutlin-3A
5,UV Response Dn,0.0043176452448561,TJP1;ANXA2;CAV1;ID1;LAMC1,nutlin-3A
6,Protein Secretion,0.006479761409358,KRT18;SCRN1;CAV2;EGFR,nutlin-3A
7,Epithelial Mesenchymal Transition,0.0137107634760448,TNFRSF12A;SDC4;VIM;LAMC1;FSTL1,nutlin-3A
8,Cholesterol Homeostasis,0.022298620228192,TNFRSF12A;MAL2;CD9,nutlin-3A
9,Fatty Acid Metabolism,0.026983504354315,ELOVL5;PCBD1;MIF;S100A10,nutlin-3A
10,IL-6/JAK/STAT3 Signaling,0.0284733611153449,TNFRSF12A;CD9;OSMR,nutlin-3A
11,Estrogen Response Early,0.042601402164663,ABLIM1;KRT18;ELOVL5;KRT8,nutlin-3A
12,Estrogen Response Late,0.042601402164663,ELOVL5;CAV1;CD9;LSR,nutlin-3A
13,Glycolysis,0.042601402164663,EXT1;CYB5A;MIF;EGFR,nutlin-3A
0,Epithelial Mesenchymal Transition,0.0202811931012899,SPARC;ITGB3;ADAM12;SPP1;TGFBI;EMP3,N-[4-[bis(2-chloroethyl)amino]phenyl]-N'-hydroxyoctanediamide
0,Hypoxia,0.0028910366192938,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
1,Epithelial Mesenchymal Transition,0.0111546562057094,ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
2,UV Response Dn,0.0115137206529498,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
3,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
4,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
5,mTORC1 Signaling,0.0243746906240797,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,"(13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
0,Epithelial Mesenchymal Transition,7.176439704016895e-10,SERPINE2;DST;ITGB5;FN1;EMP3;GJA1;LGALS1;DPYSL3;ADAM12;SPP1;SDC1;TGFBI;EDIL3,Mechlorethamine
1,Estrogen Response Early,0.0007008573622530579,GJA1;DYNLT3;CLDN7;TBC1D30;FLNB;SFN;IL6ST,Mechlorethamine
2,Estrogen Response Late,0.0007008573622530579,ST14;CAV1;DYNLT3;FLNB;SFN;IL6ST;MAPK13,Mechlorethamine
3,IL-2/STAT5 Signaling,0.0027041590801719,CDKN1C;PRNP;AHNAK;SPP1;LIF;CKAP4,Mechlorethamine
4,Apical Junction,0.0027041590801719,SGCE;CLDN4;ITGA3;CLDN7;TGFBI;MAPK13,Mechlorethamine
5,p53 Pathway,0.0027041590801719,APP;ST14;LIF;SDC1;SFN;TM4SF1,Mechlorethamine
6,UV Response Dn,0.0035886921515687,GJA1;ANXA2;CAV1;MAP1B;RND3,Mechlorethamine
7,Hypoxia,0.0118180318177356,CDKN1C;SRPX;ANXA2;CAV1;TGFBI,Mechlorethamine
8,Myogenesis,0.0118180318177356,APP;PRNP;MEF2C;ITGB5;ADAM12,Mechlorethamine
9,Angiogenesis,0.0446749287567346,APP;SPP1,Mechlorethamine
10,Glycolysis,0.0481955256812349,TPST1;PKP2;SDC1;TGFBI,Mechlorethamine
11,KRAS Signaling Up,0.0481955256812349,SPP1;LIF;LY96;PLAT,Mechlorethamine
0,Epithelial Mesenchymal Transition,8.74628588927059e-10,SPARC;TNFRSF12A;COL12A1;TNC;FBLN1;THBS1;NT5E;VCAN;LGALS1;COL4A1;SNAI2;ITGAV;CD44,Melphalan
1,IL-2/STAT5 Signaling,0.0012414380076447,CDKN1C;NRP1;NT5E;ALCAM;LRIG1;ITGAV;CD44,Melphalan
2,Estrogen Response Early,0.0050475337770282,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;CD44,Melphalan
3,Cholesterol Homeostasis,0.0050475337770282,ALCAM;TNFRSF12A;CD9;HMGCR,Melphalan
4,Angiogenesis,0.0059917808620795,NRP1;VCAN;ITGAV,Melphalan
5,Androgen Response,0.0103867255931777,ELOVL5;STK39;ITGAV;HMGCR,Melphalan
7,Glycolysis,0.0144032262778653,NT5E;VCAN;CDK1;MIF;CD44,Melphalan
8,KRAS Signaling Up,0.0144032262778653,NRP1;PLAU;GABRA3;ETS1;TRIB2,Melphalan
6,Estrogen Response Late,0.0144032262778653,ELOVL5;ATP2B4;CD9;JAK2;CD44,Melphalan
9,Coagulation,0.01990224967849,SPARC;PLAU;CD9;THBS1,Melphalan
10,IL-6/JAK/STAT3 Signaling,0.0336503358635895,TNFRSF12A;CD9;CD44,Melphalan
15,mTORC1 Signaling,0.0414623272404741,ELOVL5;PLK1;CD9;HMGCR,Melphalan
11,Hedgehog Signaling,0.0414623272404741,NRP1;NRP2,Melphalan
12,TNF-alpha Signaling via NF-kB,0.0414623272404741,PLAU;PLK2;TNC;CD44,Melphalan
13,Hypoxia,0.0414623272404741,CDKN1C;HOXB9;MIF;ETS1,Melphalan
14,Apical Junction,0.0414623272404741,VCAN;CDH3;ITGA3;ACTB,Melphalan
16,E2F Targets,0.0414623272404741,DNMT1;PLK1;CDK1;AURKB,Melphalan
0,IL-2/STAT5 Signaling,0.00011107490546066368,PRNP;CSF1;BHLHE40;ITGA6;PLIN2;AHR;WLS;IGF1R,DL-Amethopterin
1,Epithelial Mesenchymal Transition,0.00011107490546066368,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;FAS;VEGFC;EDIL3,DL-Amethopterin
2,UV Response Dn,0.00011107490546066368,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,DL-Amethopterin
3,TNF-alpha Signaling via NF-kB,0.0042590505512708,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,DL-Amethopterin
4,Hypoxia,0.0042590505512708,SRPX;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,DL-Amethopterin
5,Myogenesis,0.015511166760778,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,DL-Amethopterin
6,Inflammatory Response,0.015511166760778,LYN;CSF1;ITGB3;LPAR1;AHR,DL-Amethopterin
7,Xenobiotic Metabolism,0.015511166760778,TGFB2;PROS1;GCNT2;FAS;BCAT1,DL-Amethopterin
8,Allograft Rejection,0.015511166760778,LYN;TGFB2;CSF1;FAS;BCAT1,DL-Amethopterin
9,Apoptosis,0.0362388232377117,TGFB2;FAS;BAX;BCL2L2,DL-Amethopterin
10,IL-6/JAK/STAT3 Signaling,0.0362388232377117,CSF1;ITGB3;FAS,DL-Amethopterin
11,Interferon Alpha Response,0.0445849133230403,CSF1;PSMB8;PSMB9,DL-Amethopterin
0,mTORC1 Signaling,0.0202811931012899,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide
1,E2F Targets,0.0443176193165087,DNMT1;PLK1;CDK1;TP53;AURKA,(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide
2,Epithelial Mesenchymal Transition,0.0443176193165087,VCAN;SPARC;ITGB3;ADAM12;SPP1,(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide
0,UV Response Dn,0.0033463143753727,SDC2;DLC1;ITGB3;PMP22;LPAR1;VLDLR,Volasertib
0,Epithelial Mesenchymal Transition,1.3978479259048237e-08,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;PLOD3;SPOCK1;VEGFC;EDIL3;FBN1,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
1,UV Response Dn,0.00015867843637237667,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
2,TNF-alpha Signaling via NF-kB,0.0008760717028163224,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
3,Hypoxia,0.0040562386202579,SRPX;DTNA;BHLHE40;GCNT2;IRS2;MT1E,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
4,Myogenesis,0.0040562386202579,WWTR1;FDPS;PRNP;DTNA;BHLHE40;ADAM12,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
5,Coagulation,0.004317802903514,PROS1;ITGB3;TFPI2;PRSS23;FBN1,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
6,Estrogen Response Early,0.0166191072436907,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
7,Complement,0.0166191072436907,DOCK10;LYN;CEBPB;TFPI2;PSMB9,N-[6-[2-[4-[[4-(difluoromethoxy)phenyl]methyl]piperazine-1-carbonyl]-1-methylindol-5-yl]oxypyridin-3-yl]-N-methyl-4-(trifluoromethyl)benzamide
0,Epithelial Mesenchymal Transition,4.866103637245348e-11,TNFRSF12A;COL12A1;SERPINE1;TNC;PLOD2;LOXL2;NT5E;MMP14;LOX;CALD1;COL4A1;SNAI2;ITGAV;PDLIM4,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
1,UV Response Dn,1.1700374884038024e-05,NRP1;RBPMS;SERPINE1;ATP2B4;SNAI2;PRKCA;VLDLR;PLPP3,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
2,Hypoxia,9.08474984965522e-05,LOX;SERPINE1;PRKCA;VLDLR;KDELR3;ETS1;EGFR;TMEM45A,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
3,Hedgehog Signaling,0.0002267904681554654,NRP1;NRP2;CDK6;VLDLR,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
4,Angiogenesis,0.0002267904681554654,NRP1;JAG1;ITGAV;PTK2,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
5,TNF-alpha Signaling via NF-kB,0.0004051831625525491,NFKBIA;JAG1;PLAU;SERPINE1;TNC;IL6ST;PLPP3,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
6,Estrogen Response Early,0.0020844559576325,FARP1;ELOVL5;ENDOD1;IL6ST;JAK2;MYBL1,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
7,Glycolysis,0.0020844559576325,TPST1;NT5E;PLOD2;VLDLR;KDELR3;EGFR,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
8,KRAS Signaling Up,0.0020844559576325,NRP1;PLAU;SPRY2;PLEK2;ETS1;TRIB2,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
9,Androgen Response,0.0059124437991934,CDK6;ELOVL5;ITGAV;ELL2,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
10,Estrogen Response Late,0.0111801266912101,FARP1;ELOVL5;ATP2B4;IL6ST;JAK2,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
11,IL-6/JAK/STAT3 Signaling,0.0292642878129934,TNFRSF12A;PDGFC;IL6ST,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
12,Notch Signaling,0.0316905629632554,JAG1;PRKCA,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
13,Complement,0.0417945574266959,MMP14;GCA;SERPINE1;JAK2,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
14,Inflammatory Response,0.0417945574266959,NFKBIA;MMP14;AXL;SERPINE1,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
15,Xenobiotic Metabolism,0.0417945574266959,TPST1;ELOVL5;SERPINE1;MAN1A1,"rel-(3aR,3a1R,4R,5S,5aR,10bR)-Methyl 4-acetoxy-3a-ethyl-9-((5S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-2,4,5,6,7,8,9,10-octahydro-1H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indoliz"
0,Epithelial Mesenchymal Transition,1.2580631333143412e-08,NT5E;GJA1;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,Tyrosine kinase inhibitor
1,Glycolysis,1.3043035579558251e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Tyrosine kinase inhibitor
2,UV Response Dn,9.5207061823426e-05,TJP1;NRP1;GJA1;ATP2B4;SNAI2;PRKCA;MET,Tyrosine kinase inhibitor
3,Angiogenesis,0.0002758262450539444,APP;NRP1;VCAN;ITGAV,Tyrosine kinase inhibitor
4,TNF-alpha Signaling via NF-kB,0.0003942322662673451,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Tyrosine kinase inhibitor
5,Hypoxia,0.0003942322662673451,SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Tyrosine kinase inhibitor
6,Apical Junction,0.002329630974013,TJP1;VCAN;CDH3;ITGA3;EGFR;ACTB,Tyrosine kinase inhibitor
7,Cholesterol Homeostasis,0.002329630974013,ALCAM;TNFRSF12A;MAL2;CD9,Tyrosine kinase inhibitor
8,IL-6/JAK/STAT3 Signaling,0.0038123086648157,TNFRSF12A;CD9;CD44;IL13RA1,Tyrosine kinase inhibitor
9,TGF-beta Signaling,0.0090021413466144,TJP1;ID3;THBS1,Tyrosine kinase inhibitor
10,IL-2/STAT5 Signaling,0.0106474956216419,NRP1;NT5E;ALCAM;ITGAV;CD44,Tyrosine kinase inhibitor
11,Coagulation,0.0153094228296077,SPARC;PLAU;CD9;THBS1,Tyrosine kinase inhibitor
12,Apoptosis,0.024155711517822,APP;TNFRSF12A;CD44;IER3,Tyrosine kinase inhibitor
13,Pperoxisome,0.039459402756084,SEMA3C;ELOVL5;PRDX1,Tyrosine kinase inhibitor
14,Estrogen Response Early,0.0406649747935419,GJA1;ELOVL5;ENDOD1;CD44,Tyrosine kinase inhibitor
15,Estrogen Response Late,0.0406649747935419,ELOVL5;ATP2B4;CD9;CD44,Tyrosine kinase inhibitor
16,Apical Surface,0.0432624364126206,APP;ATP8B1,Tyrosine kinase inhibitor
0,Hedgehog Signaling,0.0010296351924223,NRP1;NRP2;CDK6;VLDLR,Salinomycin
1,Epithelial Mesenchymal Transition,0.0010296351924223,VCAN;COL4A1;COL12A1;TNC;SNAI2;ITGAV;PDLIM4,Salinomycin
2,UV Response Dn,0.0010296351924223,NRP1;SDC2;DLC1;ATP2B4;SNAI2;VLDLR,Salinomycin
3,Estrogen Response Early,0.0045632684477902,TFAP2C;ELOVL5;ELOVL2;DLC1;ENDOD1;JAK2,Salinomycin
4,Angiogenesis,0.0055308746419195,NRP1;VCAN;ITGAV,Salinomycin
5,Androgen Response,0.0095877467013948,CDK6;ELOVL5;ITGAV;HMGCR,Salinomycin
6,Glycolysis,0.0149571965193216,TPST1;VCAN;SDC2;CDK1;VLDLR,Salinomycin
7,KRAS Signaling Up,0.0149571965193216,NRP1;SPRY2;ETS1;TRIB2;DUSP6,Salinomycin
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
1,Estrogen Response Early,0.0074577508774788,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
2,Angiogenesis,0.0074577508774788,NRP1;VCAN;ITGAV,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
3,UV Response Dn,0.0074577508774788,NRP1;CELF2;ATP2B4;SNAI2;FYN,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
4,Androgen Response,0.0121444791551001,ELOVL5;STK39;ITGAV;HMGCR,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
5,IL-2/STAT5 Signaling,0.0180436021502928,CDKN1C;NRP1;ECM1;LRIG1;ITGAV,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
6,Complement,0.0180436021502928,ERAP2;KYNU;FYN;JAK2;DUSP6,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide"
0,Hypoxia,0.00010049634303583857,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1;EGFR;TMEM45A,Neratinib
1,Epithelial Mesenchymal Transition,0.00010049634303583857,NT5E;TNFRSF12A;COL4A1;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,Neratinib
2,UV Response Dn,0.00010049634303583857,INPP4B;RBPMS;SERPINE1;ATP2B4;SNAI2;PRKCA;VLDLR,Neratinib
3,Glycolysis,0.0006242010882566297,EXT1;TPST1;NT5E;MIF;VLDLR;EGFR;CD44,Neratinib
4,Estrogen Response Early,0.003853426689245,FARP1;ELOVL5;ENDOD1;JAK2;MYBL1;CD44,Neratinib
5,Hedgehog Signaling,0.0048651212127996,NRP2;CDK6;VLDLR,Neratinib
6,Androgen Response,0.0086746279679286,INPP4B;CDK6;ELOVL5;HMGCR,Neratinib
7,Estrogen Response Late,0.014033912783561,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Neratinib
8,Xenobiotic Metabolism,0.014033912783561,GSTM4;TPST1;ELOVL5;SERPINE1;MAN1A1,Neratinib
9,Apoptosis,0.0331470041383447,TNFRSF12A;BAX;PTK2;CD44,Neratinib
10,TNF-alpha Signaling via NF-kB,0.0457857493971732,FOSL1;PLAU;SERPINE1;CD44,Neratinib
11,Apical Junction,0.0457857493971732,RAC2;EGFR;ACTB;PTK2,Neratinib
12,Complement,0.0457857493971732,GCA;ERAP2;SERPINE1;JAK2,Neratinib
13,mTORC1 Signaling,0.0457857493971732,ELOVL5;PLK1;VLDLR;HMGCR,Neratinib
14,KRAS Signaling Up,0.0457857493971732,GALNT3;PLAU;SPRY2;ETS1,Neratinib
0,Epithelial Mesenchymal Transition,0.0147038649984352,GLIPR1;CALD1;VEGFC;LAMC1;DKK1;LOXL2,Ridaforolimus
0,E2F Targets,0.0207882229288221,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,Axitinib
0,UV Response Dn,0.0272553358796528,INPP4B;DLC1;ITGB3;PTEN;IGF1R,Azd-1152hqpa
1,PI3K/AKT/mTOR  Signaling,0.0272553358796528,CDK1;PTEN;PLCB1;HSP90B1,Azd-1152hqpa
2,Estrogen Response Early,0.0272553358796528,TFAP2C;DLC1;JAK2;MICB;IGF1R,Azd-1152hqpa
3,E2F Targets,0.0272553358796528,DNMT1;PLK1;CDK1;TP53;AURKA,Azd-1152hqpa
4,p53 Pathway,0.0272553358796528,HDAC3;BAX;STOM;TXNIP;TP53,Azd-1152hqpa
0,Epithelial Mesenchymal Transition,0.0218022825838866,ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,Pharmakon1600-01500903
1,Androgen Response,0.0343560923466647,CDK6;ADAMTS1;HMGCR;SGK1,Pharmakon1600-01500903
2,Complement,0.0476414407652468,DOCK10;LYN;ERAP2;TFPI2;JAK2,Pharmakon1600-01500903
0,Apical Junction,0.0056914414591286,TJP1;RRAS;CTNNA1;FLNC;RHOF;PTK2,Sapitinib
1,p53 Pathway,0.0056914414591286,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Sapitinib
2,Angiogenesis,0.0056914414591286,APP;FSTL1;PTK2,Sapitinib
3,UV Response Dn,0.0056914414591286,TJP1;ANXA2;DUSP1;ID1;LAMC1,Sapitinib
0,Hypoxia,0.0012584430129606,SRPX;TES;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Tivozanib
1,Epithelial Mesenchymal Transition,0.0012584430129606,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,Tivozanib
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Tivozanib
3,IL-2/STAT5 Signaling,0.0208925919634969,PRNP;SPP1;PLIN2;AHR;IGF1R,Tivozanib
4,TNF-alpha Signaling via NF-kB,0.0208925919634969,CEBPB;IRS2;SGK1;FJX1;LITAF,Tivozanib
5,Complement,0.0208925919634969,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Tivozanib
6,mTORC1 Signaling,0.0208925919634969,TES;HMGCR;BCAT1;AURKA;HSP90B1,Tivozanib
7,Cholesterol Homeostasis,0.033447930342288,FDPS;FABP5;HMGCR,Tivozanib
8,Apoptosis,0.0426452684820809,TGFB2;FAS;BAX;TXNIP,Tivozanib
9,Interferon Alpha Response,0.0467780102200221,TXNIP;PSMB8;PSMB9,Tivozanib
10,Androgen Response,0.0467780102200221,ADAMTS1;HMGCR;SGK1,Tivozanib
11,Angiogenesis,0.0467780102200221,SPP1;FGFR1,Tivozanib
12,Interferon Gamma Response,0.0467780102200221,FAS;TXNIP;PSMB8;PSMB9,Tivozanib
13,Inflammatory Response,0.0467780102200221,LYN;ITGB3;LPAR1;AHR,Tivozanib
14,Xenobiotic Metabolism,0.0467780102200221,TGFB2;GCNT2;FAS;BCAT1,Tivozanib
15,p53 Pathway,0.0467780102200221,FAS;BAX;TXNIP;TP53,Tivozanib
16,Allograft Rejection,0.0467780102200221,LYN;TGFB2;FAS;BCAT1,Tivozanib
17,Apical Surface,0.0499387383281485,LYN;SRPX,Tivozanib
0,Epithelial Mesenchymal Transition,0.0028253312415826,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,Azacitidine
1,mTORC1 Signaling,0.0109011412919433,PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Azacitidine
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;NR3C1;MT1E;IGF1R,Azacitidine
3,Hypoxia,0.0238207203826234,SRPX;DTNA;TGFBI;NR3C1;MT1E,Azacitidine
4,E2F Targets,0.0238207203826234,DNMT1;PLK1;CDK1;TP53;AURKA,Azacitidine
5,KRAS Signaling Up,0.0238207203826234,TMEM158;SPP1;LCP1;GNG11;PSMB8,Azacitidine
0,Apical Junction,0.00025044445531481954,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
1,Apoptosis,0.0002792962773493668,APP;GPX1;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
2,p53 Pathway,0.0053381795754585,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
3,Angiogenesis,0.0053381795754585,APP;FSTL1;PTK2,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
4,UV Response Dn,0.0053381795754585,TJP1;ANXA2;CAV1;ID1;LAMC1,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
5,Protein Secretion,0.0077888041183192,KRT18;SCRN1;CAV2;EGFR,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
6,Hypoxia,0.0141262411571371,EXT1;ANXA2;SDC4;CAV1;EGFR,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
7,Epithelial Mesenchymal Transition,0.0141262411571371,TNFRSF12A;SDC4;VIM;LAMC1;FSTL1,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
8,Cholesterol Homeostasis,0.0229743359926827,TNFRSF12A;GPX8;CD9,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
9,IL-6/JAK/STAT3 Signaling,0.0322698092640576,TNFRSF12A;CD9;OSMR,"5-fluoro-1-[(4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
0,UV Response Dn,0.0306160299180711,SDC2;DLC1;ITGB3;VLDLR;IGF1R,Bms-754807
0,Angiogenesis,0.0010582361699896,NRP1;VCAN;SPP1;ITGAV,Tepotinib
1,Epithelial Mesenchymal Transition,0.0010582361699896,VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;ITGAV,Tepotinib
2,UV Response Dn,0.0010582361699896,NRP1;SDC2;ATP2B4;SNAI2;VLDLR;MET,Tepotinib
3,Glycolysis,0.0307453484008279,VCAN;SDC2;CDK1;VLDLR;MET,Tepotinib
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,NT5E;VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;SNAI2;ITGAV;CD44,Trametinib
1,KRAS Signaling Up,0.001182696798802,NRP1;GALNT3;PLAU;SPRY2;ETS1;TRIB2;DUSP6,Trametinib
2,Cholesterol Homeostasis,0.0055308746419195,TNFRSF12A;MAL2;CD9;HMGCR,Trametinib
3,Hedgehog Signaling,0.0055308746419195,NRP1;NRP2;CDK6,Trametinib
4,Angiogenesis,0.0055308746419195,NRP1;VCAN;ITGAV,Trametinib
5,Androgen Response,0.0095877467013948,CDK6;ELOVL5;ITGAV;HMGCR,Trametinib
6,Estrogen Response Late,0.0149571965193216,ELOVL5;ATP2B4;CD9;JAK2;CD44,Trametinib
7,Glycolysis,0.0149571965193216,NT5E;VCAN;CDK1;MIF;CD44,Trametinib
8,Coagulation,0.0204125637728103,SPARC;PLAU;CD9;DUSP6,Trametinib
9,IL-6/JAK/STAT3 Signaling,0.0341680333384139,TNFRSF12A;CD9;CD44,Trametinib
0,E2F Targets,0.0207882229288221,DNMT1;CDK4;PLK1;CDK1;TP53;AURKB,Palbociclib
1,PI3K/AKT/mTOR  Signaling,0.0391827375718428,CDK4;CDK1;PLCB1;HSP90B1,Palbociclib
0,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,Pracinostat
1,Hypoxia,0.0349001252117506,SRPX;DTNA;IRS2;AMPD3;MT1E,Pracinostat
2,Complement,0.0349001252117506,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Pracinostat
3,KRAS Signaling Up,0.0349001252117506,SPP1;LCP1;GNG11;PSMB8;ENG,Pracinostat
4,UV Response Dn,0.0497739714300694,ITGB3;PMP22;MT1E;IGF1R,Pracinostat
0,mTORC1 Signaling,0.0172705809794247,PSMB5;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Carfilzomib
1,UV Response Dn,0.0172705809794247,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Carfilzomib
2,TNF-alpha Signaling via NF-kB,0.0292496287488957,CEBPB;IRS2;SGK1;FJX1;LITAF,Carfilzomib
3,Hypoxia,0.0292496287488957,SRPX;IRS2;PLIN2;AMPD3;MT1E,Carfilzomib
4,Complement,0.0292496287488957,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Carfilzomib
5,Cholesterol Homeostasis,0.0445972404563841,FDPS;FABP5;HMGCR,Carfilzomib
0,Estrogen Response Early,0.00020624837496514552,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
1,Estrogen Response Late,0.0070984175854514,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,"4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,"4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
0,Epithelial Mesenchymal Transition,2.761916001931682e-12,ITGB5;BDNF;ITGB3;TFPI2;PLOD3;VEGFC;FGF2;GLIPR1;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;EDIL3;FBN1,Teniposide
1,UV Response Dn,0.00015471147546306725,EFEMP1;BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E,Teniposide
2,Myogenesis,0.0008541699102459143,WWTR1;FDPS;PRNP;ITGB5;BHLHE40;ADAM12;FGF2,Teniposide
3,Coagulation,0.0063147867463893,PROS1;ITGB3;TFPI2;PRSS23;FBN1,Teniposide
4,TNF-alpha Signaling via NF-kB,0.0216048394167979,CEBPB;CSF1;BHLHE40;SGK1;FJX1,Teniposide
5,Complement,0.0216048394167979,DOCK10;LYN;CEBPB;TFPI2;PSMB9,Teniposide
0,IL-2/STAT5 Signaling,0.0013798129319357,IFITM3;PLAGL1;BHLHE40;SPP1;PLIN2;AHR;IGF1R,Gedatolisib
1,mTORC1 Signaling,0.0013798129319357,TES;PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,Gedatolisib
2,UV Response Dn,0.0109903697141793,ITGB3;BHLHE40;NR3C1;MT1E;IGF1R,Gedatolisib
3,Interferon Alpha Response,0.0149957975927392,IFITM3;LGALS3BP;TXNIP;PSMB8,Gedatolisib
4,Hypoxia,0.023266750141167,TES;BHLHE40;PLIN2;NR3C1;MT1E,Gedatolisib
5,Estrogen Response Early,0.023266750141167,UGCG;BHLHE40;RHOBTB3;MICB;IGF1R,Gedatolisib
0,UV Response Dn,2.6563013250248486e-05,EFEMP1;BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Prexasertib
1,IL-2/STAT5 Signaling,0.00014910746152054077,PRNP;CSF1;PLAGL1;BHLHE40;PLIN2;AHR;WLS;IGF1R,Prexasertib
2,Epithelial Mesenchymal Transition,0.0009198752879571384,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;VEGFC;EDIL3,Prexasertib
3,Hypoxia,0.0042590505512708,SRPX;TES;BHLHE40;GCNT2;PLIN2;MT1E,Prexasertib
4,Estrogen Response Early,0.0042590505512708,DYNLT3;BHLHE40;RHOBTB3;PRSS23;MICB;IGF1R,Prexasertib
5,mTORC1 Signaling,0.023266750141167,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Prexasertib
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;VIM;THBS1;CD44,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
1,Glycolysis,1.3043035579558251e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
2,Angiogenesis,0.0003677683267385925,APP;NRP1;VCAN;PTK2,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
3,Hypoxia,0.00047307871952081406,EXT1;ANXA2;SDC4;CAV1;MIF;PAM;EGFR,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
4,Apical Junction,0.00047307871952081406,TJP1;VCAN;RRAS;ITGA3;CTNNA1;EGFR;PTK2,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
5,UV Response Dn,0.000514817596211192,TJP1;NRP1;ANXA2;CAV1;ID1;MET,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
6,Protein Secretion,0.000619595017819556,SCRN1;DST;CAV2;PAM;EGFR,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
7,Apoptosis,0.0007124976949034283,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
9,Cholesterol Homeostasis,0.0018637047792104,ALCAM;TNFRSF12A;MAL2;CD9,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
8,TNF-alpha Signaling via NF-kB,0.0018637047792104,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
10,IL-6/JAK/STAT3 Signaling,0.0031191616348492,TNFRSF12A;CD9;CD44;IL13RA1,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
11,Fatty Acid Metabolism,0.0035674997752582,LGALS1;ELOVL5;PCBD1;MIF;S100A10,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
12,TGF-beta Signaling,0.0069247241127803,TJP1;ID1;THBS1,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
13,IL-2/STAT5 Signaling,0.0079771714769715,NRP1;NT5E;ALCAM;AHNAK;CD44,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
14,p53 Pathway,0.0079771714769715,VAMP8;APP;PLK2;PTPN14;S100A10,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
15,Pperoxisome,0.0345269774115735,SEMA3C;ELOVL5;PRDX1,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
16,Estrogen Response Late,0.0382729174527454,ELOVL5;CAV1;CD9;CD44,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
17,Apical Surface,0.0408589677230306,APP;ATP8B1,N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
0,Apical Junction,0.0022339828421816,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
1,p53 Pathway,0.0053381795754585,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
2,Cholesterol Homeostasis,0.0053381795754585,ALCAM;TNFRSF12A;MAL2;CD9,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
3,Angiogenesis,0.0053381795754585,APP;NRP1;PTK2,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
4,UV Response Dn,0.0053381795754585,TJP1;NRP1;ID1;MET;CAP2,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
5,Apoptosis,0.0066761178157022,APP;GPX1;TNFRSF12A;PTK2;IER3,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
6,Protein Secretion,0.0066761178157022,SCRN1;DST;CAV2;EGFR,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
7,Epithelial Mesenchymal Transition,0.0141262411571371,TNFRSF12A;SDC4;DST;COL12A1;CAP2,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
8,Fatty Acid Metabolism,0.0308902070049398,ELOVL5;PCBD1;MIF;S100A10,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
9,Pperoxisome,0.0472686886489035,SEMA3C;ELOVL5;PRDX1,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
10,TNF-alpha Signaling via NF-kB,0.0472686886489035,TUBB2A;SDC4;PLK2;IER3,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
11,Hypoxia,0.0472686886489035,SDC4;MIF;EGFR;IER3,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
12,Glycolysis,0.0472686886489035,MIF;MET;EGFR;IER3,N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide
0,UV Response Dn,0.000333224716381991,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Lexibulin
1,Hypoxia,0.0070984175854514,SRPX;TES;BHLHE40;GCNT2;PLIN2;MT1E,Lexibulin
2,Epithelial Mesenchymal Transition,0.0070984175854514,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;EDIL3,Lexibulin
3,IL-2/STAT5 Signaling,0.0174500626058753,PRNP;BHLHE40;PLIN2;AHR;IGF1R,Lexibulin
4,TNF-alpha Signaling via NF-kB,0.0174500626058753,CEBPB;BHLHE40;SGK1;FJX1;LITAF,Lexibulin
5,Estrogen Response Early,0.0174500626058753,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,Lexibulin
6,Complement,0.0174500626058753,DOCK10;LYN;CEBPB;CTSL;PSMB9,Lexibulin
7,mTORC1 Signaling,0.0174500626058753,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Lexibulin
0,UV Response Dn,0.0028314967791615,ANXA2;DUSP1;NFIB;MAP1B;ID1;LAMC1,Indibulin
1,TGF-beta Signaling,0.0365620359361196,RAB31;SMURF2;ID1,Indibulin
2,Epithelial Mesenchymal Transition,0.0365620359361196,SLC6A8;LAMC1;FSTL1;FERMT2;PFN2,Indibulin
0,Apical Junction,0.0074257113247993,TJP1;RRAS;ITGA3;CTNNA1;RHOF;PTK2,Sgx-523
1,Cholesterol Homeostasis,0.0074257113247993,TNFRSF12A;GPX8;MAL2;CD9,Sgx-523
2,Angiogenesis,0.0074257113247993,APP;FSTL1;PTK2,Sgx-523
3,Apoptosis,0.0079720700975738,APP;GPX1;KRT18;TNFRSF12A;PTK2,Sgx-523
4,Protein Secretion,0.0079720700975738,KRT18;SCRN1;DST;CAV2,Sgx-523
5,Epithelial Mesenchymal Transition,0.0137701174304866,TNFRSF12A;SDC4;DST;FSTL1;PFN2,Sgx-523
6,p53 Pathway,0.0137701174304866,VAMP8;APP;SFN;PTPN14;S100A10,Sgx-523
7,UV Response Dn,0.0214798388611906,TJP1;ANXA2;ID1;MET,Sgx-523
8,IL-6/JAK/STAT3 Signaling,0.0305824989757408,TNFRSF12A;CD9;OSMR,Sgx-523
0,Epithelial Mesenchymal Transition,7.400703444767422e-10,BDNF;SERPINE1;TNC;VEGFC;DKK1;LOXL2;GLIPR1;MMP14;LOX;CALD1;SPOCK1;SNAI2;MYL9,Pharmakon1600-01503692
1,TNF-alpha Signaling via NF-kB,0.004182996077141,NFKBIA;GCH1;SERPINE1;TNC;IL6ST;PLPP3,Pharmakon1600-01503692
2,Hypoxia,0.004182996077141,LOX;SERPINE1;ADM;KDELR3;ETS1;TMEM45A,Pharmakon1600-01503692
3,Xenobiotic Metabolism,0.004182996077141,TPST1;GCH1;SERPINE1;MAN1A1;PTGR1;EPHA2,Pharmakon1600-01503692
4,UV Response Dn,0.0051811742938274,DDAH1;BDNF;SERPINE1;SNAI2;PLPP3,Pharmakon1600-01503692
5,Estrogen Response Early,0.0156694439726227,ABLIM1;NAV2;IL6ST;MYBL1;PRSS23,Pharmakon1600-01503692
6,Inflammatory Response,0.0156694439726227,NFKBIA;MMP14;GCH1;SERPINE1;ADM,Pharmakon1600-01503692
7,Coagulation,0.0210504563907106,MMP14;SERPINE1;CLU;PRSS23,Pharmakon1600-01503692
8,UV Response Up,0.0299816715047945,NFKBIA;MMP14;GCH1;IL6ST,Pharmakon1600-01503692
9,Estrogen Response Late,0.0458784331004063,LSR;IL6ST;PRSS23;ASS1,Pharmakon1600-01503692
10,Myogenesis,0.0458784331004063,PRNP;ABLIM1;NAV2;CLU,Pharmakon1600-01503692
11,Apical Junction,0.0458784331004063,RRAS;LAYN;PARVA;MYL9,Pharmakon1600-01503692
12,Complement,0.0458784331004063,MMP14;GCA;SERPINE1;CLU,Pharmakon1600-01503692
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,GLIPR1;LOX;TNFRSF12A;CALD1;SERPINE1;COL12A1;SNAI2;LAMC1;DKK1;LOXL2,Pharmakon1600-01504008
1,Hypoxia,0.0001325882410490221,LOX;ANXA2;DUSP1;SERPINE1;KDELR3;ETS1;EGFR;TMEM45A,Pharmakon1600-01504008
2,UV Response Dn,0.0010296351924223,DDAH1;ANXA2;DUSP1;SERPINE1;SNAI2;LAMC1,Pharmakon1600-01504008
3,TNF-alpha Signaling via NF-kB,0.0199429286924289,CCND1;PLAU;DUSP1;SERPINE1;IL6ST,Pharmakon1600-01504008
4,Estrogen Response Early,0.0199429286924289,ABLIM1;CCND1;ENDOD1;IL6ST;MYBL1,Pharmakon1600-01504008
5,Xenobiotic Metabolism,0.0199429286924289,TPST1;SERPINE1;MAN1A1;PTGR1;EPHA2,Pharmakon1600-01504008
6,Apoptosis,0.0427100416730174,CCND1;TNFRSF12A;CLU;PTK2,Pharmakon1600-01504008
7,IL-6/JAK/STAT3 Signaling,0.0427100416730174,TNFRSF12A;PDGFC;IL6ST,Pharmakon1600-01504008
0,Epithelial Mesenchymal Transition,0.00017057931910030493,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;SPOCK1;VEGFC,"(8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one"
1,UV Response Dn,0.00017057931910030493,BDNF;SDC2;DLC1;ITGB3;PMP22;LPAR1;VLDLR,"(8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one"
2,Hedgehog Signaling,0.0110105374815991,ADGRG1;CDK6;VLDLR,"(8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one"
3,Androgen Response,0.0171780461733323,CDK6;ADAMTS1;HMGCR;ELL2,"(8aR,9R)-5-[[(2R,4aR,6R,7R,8R)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one"
0,UV Response Dn,0.00024595157637718383,TJP1;ANXA2;CAV1;MAP1B;ID1;LAMC1;RND3,Verubulin
1,Protein Secretion,0.0016361058179263,KRT18;SCRN1;DST;CAV2;EGFR,Verubulin
2,Apoptosis,0.0016361058179263,APP;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,Verubulin
3,Apical Junction,0.0026747614886816,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Verubulin
4,Epithelial Mesenchymal Transition,0.0026747614886816,TNFRSF12A;SDC4;DST;LAMC1;FSTL1;PFN2,Verubulin
5,Cholesterol Homeostasis,0.0026747614886816,TNFRSF12A;GPX8;CD9;S100A11,Verubulin
6,Angiogenesis,0.0034019268630854,APP;FSTL1;PTK2,Verubulin
7,Estrogen Response Early,0.0103038464910882,ABLIM1;KRT18;MYOF;KRT8;SFN,Verubulin
8,Estrogen Response Late,0.0103038464910882,CAV1;MYOF;CD9;SFN;LSR,Verubulin
9,p53 Pathway,0.0103038464910882,APP;SFN;PTPN14;EPHA2;S100A10,Verubulin
10,IL-6/JAK/STAT3 Signaling,0.0267477028659301,TNFRSF12A;CD9;OSMR,Verubulin
11,Hypoxia,0.0466894155036963,ANXA2;SDC4;CAV1;EGFR,Verubulin
0,Hypoxia,2.753529733462298e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
1,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;CD44;LOXL2,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
2,Apoptosis,0.0020055490671355,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
3,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
4,Estrogen Response Late,0.003853426689245,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
5,Glycolysis,0.0180436021502928,EXT1;NT5E;MIF;EGFR;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
6,p53 Pathway,0.0180436021502928,VAMP8;APP;PLK2;STOM;PTPN14,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
8,Cholesterol Homeostasis,0.0256771990506453,TNFRSF12A;CD9;HMGCR,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
7,UV Response Dn,0.0256771990506453,CAV1;SERPINE1;ATP2B4;PRKCA,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
9,IL-6/JAK/STAT3 Signaling,0.0360662574127702,TNFRSF12A;CD9;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
16,Complement,0.038154791164311,GCA;SERPINE1;GNB4;TIMP2,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
10,Androgen Response,0.038154791164311,CDK6;ELOVL5;HMGCR,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
11,Hedgehog Signaling,0.038154791164311,NRP2;CDK6,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
12,Angiogenesis,0.038154791164311,APP;PTK2,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
13,Mitotic Spindle,0.038154791164311,FARP1;PLK1;ARHGAP29;CDC42EP1,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
14,Estrogen Response Early,0.038154791164311,FARP1;ELOVL5;ENDOD1;CD44,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
15,Apical Junction,0.038154791164311,ITGA3;EGFR;ACTB;PTK2,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
17,mTORC1 Signaling,0.038154791164311,ELOVL5;PLK1;CD9;HMGCR,"[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol"
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,NT5E;VCAN;ECM1;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV,Saracatinib
1,KRAS Signaling Up,0.0012484021765132,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Saracatinib
2,Hedgehog Signaling,0.0072976818191994,NRP1;NRP2;VLDLR,Saracatinib
3,Angiogenesis,0.0072976818191994,NRP1;VCAN;ITGAV,Saracatinib
4,IL-2/STAT5 Signaling,0.0180436021502928,NRP1;NT5E;ECM1;LRIG1;ITGAV,Saracatinib
5,Estrogen Response Early,0.0180436021502928,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,Saracatinib
6,Glycolysis,0.0180436021502928,NT5E;VCAN;CDK1;MIF;VLDLR,Saracatinib
7,UV Response Dn,0.0256771990506453,NRP1;ATP2B4;SNAI2;VLDLR,Saracatinib
8,Cholesterol Homeostasis,0.0256771990506453,TNFRSF12A;MAL2;HMGCR,Saracatinib
0,Estrogen Response Early,0.0131827755158384,ABLIM1;KRT18;MYOF;KRT8;FLNB;SFN,Abt-737
1,Apical Junction,0.0432096788335959,TJP1;RRAS;CTNNA1;RHOF;PTK2,Abt-737
0,Glycolysis,0.0192671334462254,EXT1;NT5E;VCAN;CDK1;MIF;CD44,Fluvastatin
1,Androgen Response,0.0252610430104099,CDK6;ELOVL5;HMGCR;B2M,Fluvastatin
2,Hypoxia,0.0252610430104099,EXT1;MT2A;PLIN2;MIF;ETS1,Fluvastatin
3,Estrogen Response Early,0.0252610430104099,ELOVL5;DLC1;ENDOD1;JAK2;CD44,Fluvastatin
4,Epithelial Mesenchymal Transition,0.0252610430104099,NT5E;VCAN;TNFRSF12A;COL12A1;CD44,Fluvastatin
0,Epithelial Mesenchymal Transition,2.657192674688844e-06,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;PLOD3;VEGFC;EDIL3,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
1,UV Response Dn,0.0001666123581909955,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
2,Interferon Alpha Response,0.0167785567274409,CSF1;TXNIP;PSMB8;PSMB9,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
3,Androgen Response,0.0167785567274409,ADAMTS1;HMGCR;SGK1;ELL2,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
4,IL-2/STAT5 Signaling,0.0199429286924289,PRNP;CSF1;PLAGL1;BHLHE40;IGF1R,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
5,TNF-alpha Signaling via NF-kB,0.0199429286924289,CSF1;BHLHE40;SGK1;FJX1;LITAF,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
6,Myogenesis,0.0199429286924289,WWTR1;FDPS;PRNP;BHLHE40;ADAM12,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
7,Coagulation,0.0267914899518135,PROS1;ITGB3;TFPI2;PRSS23,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
8,Cholesterol Homeostasis,0.028380062108608,FDPS;FABP5;HMGCR,"(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
0,Epithelial Mesenchymal Transition,1.5340699066521717e-07,MMP14;LOX;CALD1;COL4A1;COL12A1;SERPINE1;TNC;SNAI2;ENO2;PDLIM4;LOXL2,CID 9832825
1,Hypoxia,0.00011417320756999128,LOX;SDC2;SERPINE1;VLDLR;KDELR3;ENO2;ETS1;TMEM45A,CID 9832825
2,UV Response Dn,0.0008866303045859418,SDC2;SERPINE1;ATP2B4;SNAI2;VLDLR;PLPP3,CID 9832825
3,Hedgehog Signaling,0.0059533720103995,NRP2;CDK6;VLDLR,CID 9832825
4,Androgen Response,0.0099073382581079,CDK6;ELOVL5;HMGCR;ELL2,CID 9832825
5,TNF-alpha Signaling via NF-kB,0.0128798081138603,NFKBIA;PLAU;SERPINE1;TNC;PLPP3,CID 9832825
6,Glycolysis,0.0128798081138603,TPST1;SDC2;VLDLR;KDELR3;ENO2,CID 9832825
7,KRAS Signaling Up,0.0128798081138603,PLAU;GABRA3;SPRY2;ETS1;TRIB2,CID 9832825
0,UV Response Dn,0.00034115863820060986,INPP4B;BDNF;DLC1;ITGB3;PMP22;LPAR1;MT1E,Epirubicin hydrochloride
1,Epithelial Mesenchymal Transition,0.0014126656207913,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,Epirubicin hydrochloride
2,Androgen Response,0.0229040615644431,INPP4B;CDK6;ADAMTS1;HMGCR,Epirubicin hydrochloride
0,Apical Junction,0.0021682774644703,TJP1;RRAS;ITGA3;FSCN1;CTNNA1;RHOF;EGFR,Idelalisib
1,Epithelial Mesenchymal Transition,0.0042709901190239,TNFRSF12A;SDC4;DST;COL12A1;PFN2;CAP2,Idelalisib
2,p53 Pathway,0.0042709901190239,VAMP8;APP;PLK2;SFN;S100A10;IER3,Idelalisib
3,Cholesterol Homeostasis,0.0042709901190239,ALCAM;TNFRSF12A;MAL2;CD9,Idelalisib
4,UV Response Dn,0.0051811742938274,TJP1;NRP1;ID1;MET;CAP2,Idelalisib
5,Protein Secretion,0.007559721644251,TPD52;SCRN1;DST;EGFR,Idelalisib
6,Hypoxia,0.0156694439726227,TPD52;SDC4;MIF;EGFR;IER3,Idelalisib
7,Apoptosis,0.0359819452817557,APP;GPX1;TNFRSF12A;IER3,Idelalisib
8,Angiogenesis,0.0497016358587735,APP;NRP1,Idelalisib
9,Mitotic Spindle,0.0497016358587735,DST;FSCN1;ARHGAP29;RHOF,Idelalisib
10,TNF-alpha Signaling via NF-kB,0.0497016358587735,TUBB2A;SDC4;PLK2;IER3,Idelalisib
11,Glycolysis,0.0497016358587735,MIF;MET;EGFR;IER3,Idelalisib
0,Estrogen Response Early,0.0001215392209616036,ABLIM1;GJA1;MYOF;TBC1D30;KRT8;FLNB;SFN;IL6ST,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
1,Epithelial Mesenchymal Transition,0.0001215392209616036,GJA1;LGALS1;TNFRSF12A;DST;ITGB5;FN1;SDC1;EDIL3,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
2,Estrogen Response Late,0.0004336554928940795,CAV1;MYOF;CD9;FLNB;SFN;IL6ST;MAPK13,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
3,Apical Junction,0.0004336554928940795,TJP1;SGCE;CLDN4;JUP;ITGA3;EGFR;MAPK13,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
4,p53 Pathway,0.0004336554928940795,APP;LIF;SDC1;SFN;PTPN14;TM4SF1;EPHA2,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
5,UV Response Dn,0.0004719161298602593,TJP1;GJA1;ANXA2;CAV1;MAP1B;RND3,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
6,Coagulation,0.0240576644465264,CAPN2;FN1;CD9;GNG12,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
7,Cholesterol Homeostasis,0.025085947756716,TNFRSF12A;GPX8;CD9,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
8,IL-6/JAK/STAT3 Signaling,0.0348007746965327,TNFRSF12A;CD9;IL6ST,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
9,Protein Secretion,0.0408828432309162,DST;CAV2;EGFR,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
10,TNF-alpha Signaling via NF-kB,0.0497016358587735,MARCKS;TUBB2A;LIF;IL6ST,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
11,Glycolysis,0.0497016358587735,TPST1;PKP2;SDC1;EGFR,"Tricyclo[3.3.1.1~3,7~]tetraarsoxane"
0,UV Response Dn,0.0027023618328835,INPP4B;DLC1;AKT3;ATP2B4;SNAI2;VLDLR,Quisinostat
1,Androgen Response,0.0027023618328835,INPP4B;CDK6;ELOVL5;HMGCR;B2M,Quisinostat
2,Estrogen Response Early,0.0046900259046732,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Quisinostat
3,Glycolysis,0.0046900259046732,EXT1;NT5E;CDK1;MIF;VLDLR;CD44,Quisinostat
4,Hedgehog Signaling,0.0056845100486395,NRP2;CDK6;VLDLR,Quisinostat
5,Hypoxia,0.0153726742004139,EXT1;MT2A;MIF;VLDLR;ETS1,Quisinostat
6,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Quisinostat
7,Epithelial Mesenchymal Transition,0.0153726742004139,NT5E;TNFRSF12A;SNAI2;CD44;LOXL2,Quisinostat
0,Estrogen Response Early,0.0016426344427806,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,Navitoclax
1,Estrogen Response Late,0.0415477681092269,KRT19;MYOF;FLNB;SFN;LSR,Navitoclax
2,UV Response Dn,0.0493789399107831,TJP1;ANXA2;MAP1B;ID1,Navitoclax
0,Hypoxia,0.0122981393603311,EXT1;MT2A;SERPINE1;MIF;ETS1;EGFR,OSI-027 sodium salt
1,UV Response Dn,0.0122981393603311,INPP4B;RBPMS;SERPINE1;ATP2B4;PTEN,OSI-027 sodium salt
2,Apoptosis,0.0122981393603311,TNFRSF12A;TIMP2;BAX;PTK2;CD44,OSI-027 sodium salt
3,Androgen Response,0.0122981393603311,INPP4B;CDK6;ELOVL5;HMGCR,OSI-027 sodium salt
4,Estrogen Response Early,0.0122981393603311,FARP1;ELOVL5;ENDOD1;JAK2;CD44,OSI-027 sodium salt
5,Estrogen Response Late,0.0122981393603311,FARP1;ELOVL5;ATP2B4;JAK2;CD44,OSI-027 sodium salt
6,Apical Junction,0.0122981393603311,PTEN;RAC2;EGFR;ACTB;PTK2,OSI-027 sodium salt
7,Complement,0.0122981393603311,GCA;ERAP2;SERPINE1;TIMP2;JAK2,OSI-027 sodium salt
8,Epithelial Mesenchymal Transition,0.0122981393603311,NT5E;TNFRSF12A;SERPINE1;CD44;LOXL2,OSI-027 sodium salt
9,Glycolysis,0.0122981393603311,EXT1;NT5E;MIF;EGFR;CD44,OSI-027 sodium salt
10,Hedgehog Signaling,0.0469594421590676,NRP2;CDK6,OSI-027 sodium salt
0,Epithelial Mesenchymal Transition,0.0002725424954896566,NT5E;VCAN;SPARC;LGALS1;COL4A1;COL12A1;SNAI2;CD44,Dovitinib
1,Glycolysis,0.0093800518093465,NT5E;VCAN;CDK1;MIF;CD44;IER3,Dovitinib
0,Hypoxia,1.159380940405178e-05,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,PI-103
1,Epithelial Mesenchymal Transition,1.159380940405178e-05,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;FSTL1;CD44;LOXL2,PI-103
2,Apical Junction,7.857080951053162e-05,TJP1;RRAS;ITGA3;CTNNA1;FLNC;EGFR;ACTB;PTK2,PI-103
3,Apoptosis,0.00013143354228205495,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,PI-103
4,TNF-alpha Signaling via NF-kB,0.0027041590801719,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,PI-103
5,Glycolysis,0.0027041590801719,EXT1;NT5E;MIF;MET;EGFR;CD44,PI-103
6,Angiogenesis,0.0031401056326226,APP;FSTL1;PTK2,PI-103
7,UV Response Dn,0.0031401056326226,TJP1;ANXA2;CAV1;SERPINE1;MET,PI-103
8,IL-6/JAK/STAT3 Signaling,0.0033887188131695,TNFRSF12A;CD9;OSMR;CD44,PI-103
9,Estrogen Response Late,0.0096692987599655,FARP1;ELOVL5;CAV1;CD9;CD44,PI-103
10,Inflammatory Response,0.0096692987599655,AXL;SERPINE1;SGMS2;OSMR;MET,PI-103
11,Complement,0.0444881775519091,GCA;SERPINE1;GNB4;TIMP2,PI-103
12,p53 Pathway,0.0444881775519091,VAMP8;APP;PLK2;PTPN14,PI-103
0,Epithelial Mesenchymal Transition,0.000324104589230943,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;FAS;VEGFC,Alisertib
1,UV Response Dn,0.001887664519441,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Alisertib
2,Hypoxia,0.0055773281028547,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Alisertib
3,Complement,0.0055773281028547,DOCK10;LYN;CEBPB;ERAP2;TFPI2;PSMB9,Alisertib
4,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,Alisertib
5,Xenobiotic Metabolism,0.0243746906240797,TGFB2;PROS1;GCNT2;FAS;BCAT1,Alisertib
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,Alisertib
15,Allograft Rejection,0.0467780102200221,LYN;TGFB2;FAS;BCAT1,Alisertib
14,p53 Pathway,0.0467780102200221,FAS;BAX;TXNIP;TP53,Alisertib
13,mTORC1 Signaling,0.0467780102200221,HMGCR;BCAT1;AURKA;HSP90B1,Alisertib
12,Interferon Gamma Response,0.0467780102200221,FAS;TXNIP;PSMB8;PSMB9,Alisertib
8,Interferon Alpha Response,0.0467780102200221,TXNIP;PSMB8;PSMB9,Alisertib
10,PI3K/AKT/mTOR  Signaling,0.0467780102200221,CDK1;THEM4;HSP90B1,Alisertib
9,Androgen Response,0.0467780102200221,ADAMTS1;HMGCR;SGK1,Alisertib
16,KRAS Signaling Up,0.0467780102200221,TMEM158;SPP1;GNG11;PSMB8,Alisertib
7,Apoptosis,0.0467780102200221,TGFB2;FAS;BAX;TXNIP,Alisertib
11,IL-2/STAT5 Signaling,0.0467780102200221,PRNP;SPP1;PLIN2;IGF1R,Alisertib
17,Apical Surface,0.0499387383281485,LYN;SRPX,Alisertib
0,Apical Junction,0.0015015513222826,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
1,UV Response Dn,0.0015015513222826,TJP1;NRP1;ANXA2;ID1;MET;CAP2,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
2,p53 Pathway,0.0045298380050253,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
3,Cholesterol Homeostasis,0.0045298380050253,ALCAM;TNFRSF12A;MAL2;CD9,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
4,Angiogenesis,0.0053772392351995,APP;NRP1;PTK2,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
5,Protein Secretion,0.0080178865923875,SCRN1;DST;CAV2;EGFR,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
6,Hypoxia,0.0145417188382294,ANXA2;SDC4;MIF;ETS1;EGFR,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
7,Epithelial Mesenchymal Transition,0.0145417188382294,TNFRSF12A;SDC4;DST;COL12A1;CAP2,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
8,Fatty Acid Metabolism,0.0317987425050851,ELOVL5;PCBD1;MIF;S100A10,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
9,Pperoxisome,0.0486589441974006,SEMA3C;ELOVL5;PRDX1,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
10,TNF-alpha Signaling via NF-kB,0.0486589441974006,TUBB2A;SDC4;PLAU;PLK2,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
11,Estrogen Response Early,0.0486589441974006,ABLIM1;ELOVL5;KRT8;ENDOD1,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
12,KRAS Signaling Up,0.0486589441974006,NRP1;PLAU;PLEK2;ETS1,"(1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate"
0,Cholesterol Homeostasis,0.0165662647040928,ALCAM;TNFRSF12A;MAL2;CD9,Pharmakon1600-01502269
1,Apical Junction,0.0354540954532069,TJP1;RRAS;ITGA3;CTNNA1;RHOF,Pharmakon1600-01502269
2,p53 Pathway,0.0354540954532069,APP;PLK2;SFN;PTPN14;S100A10,Pharmakon1600-01502269
3,UV Response Dn,0.0474037823143518,TJP1;NRP1;ID1;MET,Pharmakon1600-01502269
0,Estrogen Response Early,0.0017083398204918,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,Vinorelbine
1,Estrogen Response Late,0.0288064525557306,KRT19;MYOF;FLNB;SFN;LSR,Vinorelbine
2,p53 Pathway,0.0288064525557306,APP;LIF;SFN;EPHA2;S100A10,Vinorelbine
3,UV Response Dn,0.0385155731304108,TJP1;ANXA2;MAP1B;ID1,Vinorelbine
0,Hypoxia,0.0101405965506449,CDKN1C;SRPX;DTNA;IRS2;AMPD3;MT1E,Mocetinostat
1,E2F Targets,0.0101405965506449,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,Mocetinostat
2,Interferon Alpha Response,0.0190422826574466,BST2;TXNIP;PSMB8;PSMB9,Mocetinostat
3,mTORC1 Signaling,0.0332382144873815,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Mocetinostat
0,Epithelial Mesenchymal Transition,1.1881707370191004e-08,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TPM1;SNAI2;ITGAV;THBS1;CD44,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
1,Glycolysis,1.0755303683264367e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
2,Hypoxia,8.348148510493986e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
3,Angiogenesis,0.00026050256477316966,APP;NRP1;VCAN;ITGAV,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
4,TNF-alpha Signaling via NF-kB,0.0004467965684363244,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
5,Cholesterol Homeostasis,0.0029336093746831,ALCAM;TNFRSF12A;MAL2;CD9,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
6,UV Response Dn,0.0038129854110418,NRP1;ATP2B4;SNAI2;PRKCA;MET,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
7,IL-6/JAK/STAT3 Signaling,0.0040505779563667,TNFRSF12A;CD9;CD44;IL13RA1,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
8,IL-2/STAT5 Signaling,0.0113009929257097,NRP1;NT5E;ALCAM;ITGAV;CD44,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
9,Apical Junction,0.0113009929257097,VCAN;CDH3;ITGA3;EGFR;ACTB,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
10,Coagulation,0.0157733447335352,SPARC;PLAU;CD9;THBS1,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
11,Apoptosis,0.0247148715066605,APP;TNFRSF12A;CD44;IER3,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
12,Protein Secretion,0.0324013209755513,CAV2;PAM;EGFR,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
13,Estrogen Response Late,0.0438923537454103,ELOVL5;ATP2B4;CD9;CD44,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
14,Apical Surface,0.0463068300861014,APP;ATP8B1,1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,VCAN;ECM1;COL5A1;COL4A1;WIPF1;TNC;SPP1;SNAI2;TIMP3;FBLN1,"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate"
1,KRAS Signaling Up,0.0101405965506449,GYPC;GABRA3;SPP1;LCP1;TRIB2;DUSP6,"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate"
2,Complement,0.0443176193165087,ERAP2;KYNU;FYN;JAK2;DUSP6,"(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate"
0,Epithelial Mesenchymal Transition,2.8259910422376216e-05,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV,Copanlisib
1,KRAS Signaling Up,0.0012812548653688,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,Copanlisib
2,Hedgehog Signaling,0.0061232059836142,NRP1;NRP2;VLDLR,Copanlisib
3,Angiogenesis,0.0061232059836142,NRP1;VCAN;ITGAV,Copanlisib
4,UV Response Dn,0.0061232059836142,NRP1;ATP2B4;SNAI2;PIK3CD;VLDLR,Copanlisib
5,Estrogen Response Early,0.0216048394167979,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,Copanlisib
0,Apoptosis,0.0045298380050253,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,Tipifarnib
1,Hypoxia,0.0045298380050253,EXT1;SDC4;CAV1;MIF;ETS1;EGFR,Tipifarnib
2,Apical Junction,0.0045298380050253,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Tipifarnib
3,Cholesterol Homeostasis,0.0045298380050253,ALCAM;TNFRSF12A;MAL2;CD9,Tipifarnib
4,Angiogenesis,0.0045793207142414,APP;NRP1;PTK2,Tipifarnib
5,UV Response Dn,0.0045793207142414,TJP1;NRP1;CAV1;ID1;MET,Tipifarnib
6,TNF-alpha Signaling via NF-kB,0.0105757955187123,TUBB2A;SDC4;PLAU;PLK2;CD44,Tipifarnib
7,Estrogen Response Late,0.0105757955187123,ELOVL5;CAV1;CD9;LSR;CD44,Tipifarnib
8,Epithelial Mesenchymal Transition,0.0105757955187123,TNFRSF12A;SDC4;COL12A1;VIM;CD44,Tipifarnib
9,Glycolysis,0.0105757955187123,EXT1;MIF;MET;EGFR;CD44,Tipifarnib
10,p53 Pathway,0.0105757955187123,VAMP8;APP;PLK2;PTPN14;S100A10,Tipifarnib
11,Fatty Acid Metabolism,0.0238490568788138,ELOVL5;PCBD1;MIF;S100A10,Tipifarnib
12,IL-6/JAK/STAT3 Signaling,0.0255530163855659,TNFRSF12A;CD9;CD44,Tipifarnib
13,Protein Secretion,0.0309718509325123,SCRN1;CAV2;EGFR,Tipifarnib
14,IL-2/STAT5 Signaling,0.0414827736465244,NRP1;ALCAM;AHNAK;CD44,Tipifarnib
15,Apical Surface,0.0446894959470647,APP;ATP8B1,Tipifarnib
0,Hedgehog Signaling,0.0010726576196542,NRP2;CDK6;DPYSL2;VLDLR,PF-04691502
1,Androgen Response,0.0025562882202952,INPP4B;CDK6;ELOVL5;HMGCR;B2M,PF-04691502
2,UV Response Dn,0.0091586414284828,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,PF-04691502
3,Estrogen Response Early,0.0193889584509725,UGCG;ELOVL5;DLC1;JAK2;MICB,PF-04691502
4,Estrogen Response Late,0.0193889584509725,FABP5;ELOVL5;ATP2B4;JAK2;MICB,PF-04691502
5,p53 Pathway,0.0193889584509725,HDAC3;BAX;STOM;TXNIP;TP53,PF-04691502
0,Hypoxia,0.00030937256244771826,SRPX;TES;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Voreloxin
1,mTORC1 Signaling,0.0106476263781772,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Voreloxin
2,UV Response Dn,0.0109903697141793,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Voreloxin
3,Interferon Alpha Response,0.0149957975927392,LGALS3BP;TXNIP;PSMB8;PSMB9,Voreloxin
4,TNF-alpha Signaling via NF-kB,0.023266750141167,CEBPB;IRS2;SGK1;FJX1;LITAF,Voreloxin
5,Complement,0.023266750141167,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Voreloxin
0,Estrogen Response Late,0.0096335667231127,FARP1;ELOVL5;ATP2B4;CD9;JAK2;CD44,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
1,Epithelial Mesenchymal Transition,0.0096335667231127,NT5E;TNFRSF12A;COL12A1;SERPINE1;CD44;LOXL2,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
2,Mitotic Spindle,0.0210508691753416,FARP1;PLK1;CDK1;ARHGAP29;CDC42EP1,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
3,Estrogen Response Early,0.0210508691753416,FARP1;ELOVL5;ENDOD1;JAK2;CD44,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
4,Glycolysis,0.0210508691753416,EXT1;NT5E;CDK1;MIF;CD44,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
5,p53 Pathway,0.0210508691753416,VAMP8;HDAC3;BAX;STOM;PTPN14,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
6,Cholesterol Homeostasis,0.033013541636544,TNFRSF12A;CD9;HMGCR,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
7,Apoptosis,0.0400736193475225,TNFRSF12A;BAX;PTK2;CD44,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;CD44,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
9,Androgen Response,0.0429241400598498,CDK6;ELOVL5;HMGCR,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
10,Hedgehog Signaling,0.0429241400598498,NRP2;CDK6,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
11,Hypoxia,0.0429241400598498,EXT1;SERPINE1;MIF;ETS1,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
12,Apical Junction,0.0429241400598498,PTEN;RAC2;ACTB;PTK2,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
13,Complement,0.0429241400598498,GCA;ERAP2;SERPINE1;JAK2,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
14,mTORC1 Signaling,0.0429241400598498,ELOVL5;PLK1;CD9;HMGCR,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
15,Xenobiotic Metabolism,0.0429241400598498,GSTM4;ELOVL5;SERPINE1;MAN1A1,"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol"
0,Epithelial Mesenchymal Transition,2.9709136597882687e-05,VCAN;ECM1;COL4A1;WIPF1;COL12A1;TNC;SNAI2;FBLN1;VEGFA,Vandetanib
1,Hedgehog Signaling,0.0080465206835956,NRP1;NRP2;VEGFA,Vandetanib
2,Angiogenesis,0.0080465206835956,NRP1;VCAN;VEGFA,Vandetanib
3,UV Response Dn,0.0080465206835956,NRP1;CELF2;ATP2B4;SNAI2;FYN,Vandetanib
4,Estrogen Response Early,0.0194680970568948,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,Vandetanib
5,Glycolysis,0.0194680970568948,VCAN;CDK1;MIF;EGFR;VEGFA,Vandetanib
6,KRAS Signaling Up,0.0194680970568948,NRP1;GYPC;GABRA3;LCP1;TRIB2,Vandetanib
0,UV Response Dn,0.00034115863820060986,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Tandutinib
1,Hypoxia,0.0014126656207913,SRPX;TES;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,Tandutinib
2,IL-2/STAT5 Signaling,0.0054505706459716,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,Tandutinib
3,Epithelial Mesenchymal Transition,0.0054505706459716,ITGB5;BDNF;ITGB3;PMP22;SPP1;EDIL3,Tandutinib
4,TNF-alpha Signaling via NF-kB,0.0204177603279629,CEBPB;BHLHE40;SGK1;FJX1;LITAF,Tandutinib
5,Complement,0.0204177603279629,DOCK10;LYN;CEBPB;CTSL;PSMB9,Tandutinib
6,mTORC1 Signaling,0.0204177603279629,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Tandutinib
0,E2F Targets,0.0207882229288221,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,Motesanib
0,Cholesterol Homeostasis,0.0006351519845418337,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Cabozantinib
1,Apical Junction,0.0006351519845418337,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Cabozantinib
2,Epithelial Mesenchymal Transition,0.0006351519845418337,TNFRSF12A;SDC4;DST;VIM;FSTL1;CD44;PFN2,Cabozantinib
3,Apoptosis,0.0011479129528999,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,Cabozantinib
4,Angiogenesis,0.0037942943060857,APP;FSTL1;PTK2,Cabozantinib
5,UV Response Dn,0.0037942943060857,TJP1;ANXA2;CAV1;ID1;MET,Cabozantinib
6,IL-6/JAK/STAT3 Signaling,0.003948462545702,TNFRSF12A;CD9;OSMR;CD44,Cabozantinib
7,Protein Secretion,0.0049825438109836,SCRN1;DST;CAV2;EGFR,Cabozantinib
8,Hypoxia,0.0096390822013406,EXT1;ANXA2;SDC4;CAV1;EGFR,Cabozantinib
9,p53 Pathway,0.0096390822013406,VAMP8;APP;PLK2;PTPN14;S100A10,Cabozantinib
10,Estrogen Response Late,0.0403174109064176,CAV1;CD9;LSR;CD44,Cabozantinib
11,Inflammatory Response,0.0403174109064176,AXL;SGMS2;OSMR;MET,Cabozantinib
12,Glycolysis,0.0403174109064176,EXT1;MET;EGFR;CD44,Cabozantinib
0,UV Response Dn,0.0035179202407764,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine
0,Angiogenesis,0.0009194208168464812,APP;FSTL1;PTK2;FGFR1,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
1,Apical Junction,0.0076054474129837,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
2,TGF-beta Signaling,0.0249286608655361,TJP1;SMURF2;ID1,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
3,p53 Pathway,0.0249286608655361,VAMP8;APP;SFN;EPHA2;S100A10,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
4,UV Response Dn,0.0355528367357638,TJP1;ANXA2;MAP1B;ID1,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
5,Apoptosis,0.0436144791294009,APP;GPX1;KRT18;PTK2,3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
0,Hypoxia,0.0002578104687064319,EXT1;ANXA2;SDC4;CAV1;MIF;ETS1;EGFR;IER3,Rabusertib
1,Apoptosis,0.0002875108737419952,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44;IER3,Rabusertib
2,UV Response Dn,0.001001034214855,TJP1;NRP1;ANXA2;CAV1;ID1;MET,Rabusertib
3,TNF-alpha Signaling via NF-kB,0.0022649190025126,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Rabusertib
4,Apical Junction,0.0022649190025126,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Rabusertib
5,Glycolysis,0.0022649190025126,EXT1;MIF;MET;EGFR;CD44;IER3,Rabusertib
6,p53 Pathway,0.0022649190025126,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,Rabusertib
7,Cholesterol Homeostasis,0.0022649190025126,ALCAM;TNFRSF12A;MAL2;CD9,Rabusertib
8,Angiogenesis,0.0029873551306664,APP;NRP1;PTK2,Rabusertib
9,Protein Secretion,0.0048107319554325,SCRN1;DST;CAV2;EGFR,Rabusertib
10,Estrogen Response Late,0.0096944792254862,ELOVL5;CAV1;CD9;LSR;CD44,Rabusertib
11,Epithelial Mesenchymal Transition,0.0096944792254862,TNFRSF12A;SDC4;DST;COL12A1;CD44,Rabusertib
12,Fatty Acid Metabolism,0.0220145140419819,ELOVL5;PCBD1;MIF;S100A10,Rabusertib
13,IL-6/JAK/STAT3 Signaling,0.0237278009294541,TNFRSF12A;CD9;CD44,Rabusertib
14,Pperoxisome,0.0358057543527429,SEMA3C;ELOVL5;PRDX1,Rabusertib
15,IL-2/STAT5 Signaling,0.0388901002936167,NRP1;ALCAM;AHNAK;CD44,Rabusertib
16,Apical Surface,0.0420607020678256,APP;ATP8B1,Rabusertib
0,Complement,0.0012012410578261,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,Teglarinad
1,Epithelial Mesenchymal Transition,0.0012012410578261,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,Teglarinad
2,UV Response Dn,0.0012012410578261,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Teglarinad
3,KRAS Signaling Up,0.0349001252117506,TMEM158;SPP1;LCP1;GNG11;PSMB8,Teglarinad
0,mTORC1 Signaling,0.0027596258638714,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Panobinostat
1,IL-2/STAT5 Signaling,0.010369590724239,IFITM3;CTSZ;SPP1;PLIN2;AHR;IGF1R,Panobinostat
2,Interferon Alpha Response,0.0199943967903189,IFITM3;LGALS3BP;TXNIP;PSMB8,Panobinostat
3,Mitotic Spindle,0.0279201001694004,CCDC88A;PLK1;CDK1;FLNB;AURKA,Panobinostat
4,Hypoxia,0.0279201001694004,SRPX;TES;PLIN2;TGFBI;NR3C1,Panobinostat
0,Complement,0.0212952527563544,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
1,Interferon Alpha Response,0.0299915951854784,BST2;TXNIP;PSMB8;PSMB9,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
2,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
3,Interferon Gamma Response,0.0349001252117506,BST2;TXNIP;JAK2;PSMB8;PSMB9,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
4,UV Response Dn,0.0425700931629121,ITGB3;PMP22;MT1E;IGF1R,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
5,Cholesterol Homeostasis,0.0425700931629121,FDPS;FABP5;HMGCR,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(3-pyrrolidin-1-ylpropoxy)phenyl]pyrimidine-2,4-diamine"
0,UV Response Dn,2.846037133955195e-05,INPP4B;BDNF;ITGB3;BHLHE40;PMP22;PTEN;MT1E;IGF1R,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
1,IL-2/STAT5 Signaling,0.0076054474129837,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;IGF1R,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
2,mTORC1 Signaling,0.0076054474129837,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
3,Hedgehog Signaling,0.0086419916279992,ADGRG1;CDK6;DPYSL2,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
4,Androgen Response,0.0143816200520922,INPP4B;CDK6;ADAMTS1;HMGCR,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
5,Epithelial Mesenchymal Transition,0.0249286608655361,BDNF;ITGB3;PMP22;SPP1;VEGFC,"[(1S,2S,4R)-4-[4-(2,3-Dihydro-1H-inden-1-ylamino)pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate"
0,Epithelial Mesenchymal Transition,0.0011726400802588,NT5E;VCAN;SPARC;LGALS1;SPP1;VIM;CD44,Silmitasertib
1,Glycolysis,0.0011726400802588,EXT1;NT5E;VCAN;CITED2;CDK1;MIF;CD44,Silmitasertib
2,UV Response Dn,0.0011726400802588,CITED2;CAV1;DLC1;AKT3;ATP2B4;PTEN,Silmitasertib
3,Apical Junction,0.0051970557322055,VCAN;AKT3;PTEN;RAC2;MSN;ACTB,Silmitasertib
4,Androgen Response,0.0131032538252395,CDK6;ELOVL5;HMGCR;B2M,Silmitasertib
5,Hypoxia,0.0227127798997107,EXT1;MT2A;CITED2;CAV1;MIF,Silmitasertib
0,Epithelial Mesenchymal Transition,0.00025044445531481954,VCAN;TNFRSF12A;SDC4;COL12A1;ITGAV;VIM;THBS1;CD44,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
1,Angiogenesis,0.0005210051295463393,APP;NRP1;VCAN;ITGAV,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
2,Cholesterol Homeostasis,0.0058672187493662,ALCAM;TNFRSF12A;MAL2;CD9,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
3,Apoptosis,0.0109881002144576,APP;GPX1;TNFRSF12A;CD44;IER3,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
4,IL-2/STAT5 Signaling,0.0141262411571371,NRP1;ALCAM;AHNAK;ITGAV;CD44,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
5,TNF-alpha Signaling via NF-kB,0.0141262411571371,TUBB2A;SDC4;PLK2;CD44;IER3,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
6,Glycolysis,0.0141262411571371,VCAN;MIF;MET;CD44;IER3,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
7,p53 Pathway,0.0141262411571371,APP;LDHB;HDAC3;PLK2;IER3,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
8,IL-6/JAK/STAT3 Signaling,0.0358553436267306,TNFRSF12A;CD9;CD44,"(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione"
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,Avagacestat
1,Hypoxia,1.3043035579558251e-05,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR,Avagacestat
2,Glycolysis,7.140529636756951e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44,Avagacestat
3,UV Response Dn,7.140529636756951e-05,NRP1;CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA;MET,Avagacestat
4,Angiogenesis,0.0002206609960431555,APP;NRP1;VCAN;PTK2,Avagacestat
5,TNF-alpha Signaling via NF-kB,0.002329630974013,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Avagacestat
6,Estrogen Response Late,0.002329630974013,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,Avagacestat
7,Cholesterol Homeostasis,0.002329630974013,ALCAM;TNFRSF12A;MAL2;CD9,Avagacestat
8,Apoptosis,0.0051708706891565,APP;TNFRSF12A;CAV1;PTK2;CD44,Avagacestat
9,IL-2/STAT5 Signaling,0.0099714643462144,MYO1E;NRP1;NT5E;ALCAM;CD44,Avagacestat
10,Apical Junction,0.0099714643462144,VCAN;ITGA3;EGFR;ACTB;PTK2,Avagacestat
11,KRAS Signaling Up,0.0099714643462144,NRP1;GALNT3;PLAU;SPRY2;ETS1,Avagacestat
12,IL-6/JAK/STAT3 Signaling,0.0262831025680107,TNFRSF12A;CD9;CD44,Avagacestat
13,Protein Secretion,0.0318567609591555,CAV2;PAM;EGFR,Avagacestat
14,Hedgehog Signaling,0.0335061965675509,NRP1;NRP2,Avagacestat
15,Mitotic Spindle,0.0361466442609262,FARP1;MYO1E;ARHGAP29;CDC42EP1,Avagacestat
16,Estrogen Response Early,0.0361466442609262,FARP1;ELOVL5;ENDOD1;CD44,Avagacestat
17,p53 Pathway,0.0361466442609262,VAMP8;APP;PLK2;PTPN14,Avagacestat
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,Vemurafenib
1,Estrogen Response Early,0.0096335667231127,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,Vemurafenib
2,Angiogenesis,0.0097302424255992,NRP1;VCAN;ITGAV,Vemurafenib
3,Androgen Response,0.0151805989438751,ELOVL5;STK39;ITGAV;HMGCR,Vemurafenib
4,IL-2/STAT5 Signaling,0.0247258509435907,CDKN1C;NRP1;ECM1;LRIG1;ITGAV,Vemurafenib
5,UV Response Dn,0.0375279943321951,NRP1;CELF2;ATP2B4;SNAI2,Vemurafenib
0,Hypoxia,2.39122318958568e-05,EXT1;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
1,Apoptosis,2.4278633275757453e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
2,Epithelial Mesenchymal Transition,6.07696104808018e-05,NT5E;TNFRSF12A;SDC4;COL12A1;VIM;FSTL1;CD44;CAP2,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
3,Glycolysis,6.07696104808018e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
4,Apical Junction,0.0004336554928940795,TJP1;RRAS;ITGA3;CTNNA1;EGFR;ACTB;PTK2,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
5,TNF-alpha Signaling via NF-kB,0.0021354950595119,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
6,p53 Pathway,0.0021354950595119,VAMP8;APP;HDAC3;PLK2;PTPN14;IER3,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
7,Cholesterol Homeostasis,0.0021354950595119,ALCAM;TNFRSF12A;MAL2;CD9,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
8,Angiogenesis,0.0025905871469137,APP;FSTL1;PTK2,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
9,UV Response Dn,0.0025905871469137,TJP1;CAV1;PRKCA;MET;CAP2,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
10,Protein Secretion,0.0041234845332278,SCRN1;CAV2;PAM;EGFR,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
11,IL-6/JAK/STAT3 Signaling,0.0261005810223995,TNFRSF12A;CD9;CD44,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
12,IL-2/STAT5 Signaling,0.042601402164663,NT5E;ALCAM;AHNAK;CD44,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
13,Estrogen Response Late,0.042601402164663,ELOVL5;CAV1;CD9;CD44,"2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol"
0,E2F Targets,0.0197741632737576,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,3-Amino-6-[4-[[2-(dimethylamino)-1-methylethyl]sulfonyl]phenyl]-N-phenyl-2-pyrazinecarboxamide
1,Hypoxia,0.0432096788335959,SRPX;DTNA;IRS2;AMPD3;MT1E,3-Amino-6-[4-[[2-(dimethylamino)-1-methylethyl]sulfonyl]phenyl]-N-phenyl-2-pyrazinecarboxamide
2,mTORC1 Signaling,0.0432096788335959,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,3-Amino-6-[4-[[2-(dimethylamino)-1-methylethyl]sulfonyl]phenyl]-N-phenyl-2-pyrazinecarboxamide
0,UV Response Dn,0.0321860827343824,DLC1;ITGB3;PMP22;MT1E;IGF1R,6-Des-fluoro TAK-960
0,Interferon Alpha Response,0.0053140524070718,IFITM3;BST2;LGALS3BP;TXNIP;PSMB8,3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-cyclohepta[b]pyrrol-2-one
1,mTORC1 Signaling,0.0070984175854514,PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-cyclohepta[b]pyrrol-2-one
2,E2F Targets,0.0070984175854514,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-cyclohepta[b]pyrrol-2-one
3,Interferon Gamma Response,0.0349001252117506,IFITM3;LGALS3BP;BST2;TXNIP;PSMB8,3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-cyclohepta[b]pyrrol-2-one
0,UV Response Dn,1.631823429193952e-06,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,PCI-32765 Racemate
1,Epithelial Mesenchymal Transition,0.0012155494876576,NT5E;TNFRSF12A;SERPINE1;COL12A1;SNAI2;CD44;LOXL2,PCI-32765 Racemate
2,Hypoxia,0.0046900259046732,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1,PCI-32765 Racemate
3,Estrogen Response Early,0.0046900259046732,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,PCI-32765 Racemate
4,Hedgehog Signaling,0.0056845100486395,NRP2;CDK6;VLDLR,PCI-32765 Racemate
5,Androgen Response,0.0098540729986557,INPP4B;CDK6;ELOVL5;HMGCR,PCI-32765 Racemate
6,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,PCI-32765 Racemate
7,Glycolysis,0.0153726742004139,EXT1;NT5E;MIF;VLDLR;CD44,PCI-32765 Racemate
8,Apoptosis,0.0358607939508407,TNFRSF12A;BAX;PTK2;CD44,PCI-32765 Racemate
9,TNF-alpha Signaling via NF-kB,0.0445808612551423,FOSL1;PLAU;SERPINE1;CD44,PCI-32765 Racemate
10,Apical Junction,0.0445808612551423,PTEN;RAC2;ACTB;PTK2,PCI-32765 Racemate
11,Complement,0.0445808612551423,GCA;ERAP2;SERPINE1;JAK2,PCI-32765 Racemate
12,mTORC1 Signaling,0.0445808612551423,ELOVL5;PLK1;VLDLR;HMGCR,PCI-32765 Racemate
13,Xenobiotic Metabolism,0.0445808612551423,GSTM4;ELOVL5;SERPINE1;MAN1A1,PCI-32765 Racemate
14,KRAS Signaling Up,0.0445808612551423,GALNT3;PLAU;SPRY2;ETS1,PCI-32765 Racemate
0,Hypoxia,0.0025625097307377,CDKN1C;SRPX;DTNA;IRS2;TGFBI;AMPD3;MT1E,N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]benzamide
1,Myogenesis,0.0432096788335959,MEF2C;DTNA;ITGB5;ADAM12;NCAM1,N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]benzamide
2,Epithelial Mesenchymal Transition,0.0432096788335959,ITGB5;ITGB3;ADAM12;SPP1;TGFBI,N-[2-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]benzamide
0,Hypoxia,0.00013995425444063446,EXT1;MT2A;SDC4;SERPINE1;PRKCA;MIF;ETS1;EGFR,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
1,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;CD44;LOXL2,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
2,TNF-alpha Signaling via NF-kB,0.0064223778154084,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
3,Apoptosis,0.0122808178867468,APP;TNFRSF12A;BAX;PTK2;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
4,Estrogen Response Late,0.0180436021502928,FARP1;ELOVL5;ATP2B4;CD9;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
5,Glycolysis,0.0180436021502928,EXT1;NT5E;MIF;EGFR;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
6,p53 Pathway,0.0180436021502928,VAMP8;APP;PLK2;BAX;PTPN14,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
7,Cholesterol Homeostasis,0.028886848931976,TNFRSF12A;CD9;HMGCR,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
9,Androgen Response,0.0403991906445645,CDK6;ELOVL5;HMGCR,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
10,Hedgehog Signaling,0.0403991906445645,NRP2;CDK6,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
11,Angiogenesis,0.0403991906445645,APP;PTK2,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
12,Mitotic Spindle,0.0403991906445645,FARP1;PLK1;ARHGAP29;CDC42EP1,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
13,Estrogen Response Early,0.0403991906445645,FARP1;ELOVL5;ENDOD1;CD44,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
14,Apical Junction,0.0403991906445645,ITGA3;EGFR;ACTB;PTK2,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
15,mTORC1 Signaling,0.0403991906445645,ELOVL5;PLK1;CD9;HMGCR,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
16,Xenobiotic Metabolism,0.0403991906445645,MT2A;ELOVL5;SERPINE1;MAN1A1,"5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
0,mTORC1 Signaling,0.0207882229288221,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,ONX-0914 TFA salt
0,Epithelial Mesenchymal Transition,1.929958914820474e-07,SPARC;LGALS1;DST;ITGB5;ADAM12;SPP1;FN1;TGFBI;EMP3;EDIL3;THBS1,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
1,Myogenesis,0.0084197156618524,APP;MEF2C;DTNA;SPARC;ITGB5;ADAM12,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
2,Coagulation,0.0084197156618524,SPARC;CAPN2;FN1;PLAT;THBS1,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
3,Hypoxia,0.0216048394167979,CDKN1C;SRPX;DTNA;CAV1;TGFBI,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
4,Estrogen Response Late,0.0216048394167979,CAV1;DYNLT3;FLNB;IL6ST;MAPK13,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
5,KRAS Signaling Up,0.0216048394167979,SPP1;LIF;PLAT;ETV1;LCP1,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
6,Apoptosis,0.0485989910299039,APP;CAV1;BAX;PLAT,N-Hydroxy-E-3-(4''-methoxybiphenyl-4-yl)-acrylamide
0,Epithelial Mesenchymal Transition,2.7837256591978365e-06,ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;EDIL3,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
2,IL-2/STAT5 Signaling,0.0044618624822837,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
3,TNF-alpha Signaling via NF-kB,0.0044618624822837,CEBPB;BHLHE40;IRS2;SGK1;FJX1;LITAF,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
4,Hypoxia,0.0044618624822837,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;MT1E,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
5,Myogenesis,0.0182810179680598,FDPS;PRNP;ITGB5;BHLHE40;ADAM12,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
6,Complement,0.0182810179680598,DOCK10;LYN;CEBPB;TFPI2;PSMB9,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
7,mTORC1 Signaling,0.0182810179680598,BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
8,Cholesterol Homeostasis,0.0297314936375894,FDPS;FABP5;HMGCR,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
9,Interferon Alpha Response,0.0497016358587735,TXNIP;PSMB8;PSMB9,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
10,Androgen Response,0.0497016358587735,ADAMTS1;HMGCR;SGK1,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
11,Estrogen Response Early,0.0497016358587735,BHLHE40;RHOBTB3;MICB;IGF1R,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
12,Estrogen Response Late,0.0497016358587735,FABP5;TFPI2;SGK1;MICB,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
13,Inflammatory Response,0.0497016358587735,LYN;ITGB3;LPAR1;AHR,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
14,Xenobiotic Metabolism,0.0497016358587735,TGFB2;PROS1;GCNT2;BCAT1,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
15,KRAS Signaling Up,0.0497016358587735,TMEM158;SPP1;GNG11;PSMB8,"4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
0,Epithelial Mesenchymal Transition,2.72045916694334e-06,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;SPOCK1;VEGFC,"(R)-4-(7-Cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-ylamino)-N-(1'-(cyclopropylmethyl)-1,4'-bipiperidin-4-yl)-3-methoxybenzamide"
1,UV Response Dn,0.0018447630530901,BDNF;DLC1;ITGB3;PMP22;LPAR1;PLPP3,"(R)-4-(7-Cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-ylamino)-N-(1'-(cyclopropylmethyl)-1,4'-bipiperidin-4-yl)-3-methoxybenzamide"
2,Androgen Response,0.0229040615644431,CDK6;ADAMTS1;HMGCR;ELL2,"(R)-4-(7-Cyano-5-cyclopentyl-6-ethyl-5,6-dihydroimidazo[1,5-f]pteridin-3-ylamino)-N-(1'-(cyclopropylmethyl)-1,4'-bipiperidin-4-yl)-3-methoxybenzamide"
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
1,Estrogen Response Early,0.0101405965506449,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
2,Angiogenesis,0.0102423604479991,NRP1;VCAN;ITGAV,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
3,IL-2/STAT5 Signaling,0.0265905715899052,CDKN1C;NRP1;ECM1;LRIG1;ITGAV,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
4,KRAS Signaling Up,0.0265905715899052,NRP1;PLAU;GABRA3;TRIB2;DUSP6,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
5,UV Response Dn,0.0395031519286265,NRP1;CELF2;ATP2B4;SNAI2,"3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide"
0,Hypoxia,0.00011636418667307622,SRPX;TES;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Zotiraciclib
1,Epithelial Mesenchymal Transition,0.00011636418667307622,ITGB5;BDNF;ITGB3;PMP22;SPP1;FAS;VEGFC;EDIL3,Zotiraciclib
2,UV Response Dn,0.00011636418667307622,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Zotiraciclib
3,IL-2/STAT5 Signaling,0.000700298363286806,PRNP;BHLHE40;SPP1;ITGA6;PLIN2;AHR;IGF1R,Zotiraciclib
4,TNF-alpha Signaling via NF-kB,0.0044618624822837,CEBPB;BHLHE40;IRS2;SGK1;FJX1;LITAF,Zotiraciclib
5,mTORC1 Signaling,0.0208925919634969,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Zotiraciclib
6,Xenobiotic Metabolism,0.0208925919634969,TGFB2;PROS1;GCNT2;FAS;BCAT1,Zotiraciclib
0,Hypoxia,1.2318422491805016e-05,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
1,Glycolysis,1.2318422491805016e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
2,Epithelial Mesenchymal Transition,8.348148510493986e-05,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;VIM;FSTL1;CD44,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
3,Apoptosis,0.0001396481386746834,APP;GPX1;TNFRSF12A;CAV1;TIMP2;CD44;IER3,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
4,Apical Junction,0.0004467965684363244,SGCE;RRAS;ITGA3;AKT3;CTNNA1;EGFR;ACTB,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
5,TNF-alpha Signaling via NF-kB,0.0028731690226827,FOSL1;SDC4;PLK2;PHLDA1;CD44;IER3,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
6,IL-6/JAK/STAT3 Signaling,0.0046292319501333,TNFRSF12A;CD9;CD44;IL13RA1,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
7,Protein Secretion,0.0058416030887394,SCRN1;CAV2;PAM;EGFR,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
8,p53 Pathway,0.0125566588063441,VAMP8;APP;PLK2;S100A10;IER3,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
9,Cholesterol Homeostasis,0.0206769023934144,ALCAM;TNFRSF12A;CD9,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
10,Fatty Acid Metabolism,0.0252738057313143,LGALS1;ELOVL5;MIF;S100A10,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
11,Angiogenesis,0.0395559265033588,APP;FSTL1,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
12,IL-2/STAT5 Signaling,0.0438923537454103,NT5E;ALCAM;PHLDA1;CD44,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
13,Estrogen Response Late,0.0438923537454103,ELOVL5;CAV1;CD9;CD44,"Methyl 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoate"
0,E2F Targets,0.0138271866047988,DNMT1;CHEK1;PLK1;CDK1;TP53;AURKA,PF-477736
1,Angiogenesis,0.0138271866047988,VCAN;SPP1;ITGAV,PF-477736
2,TNF-alpha Signaling via NF-kB,0.0299143930386433,BTG3;TUBB2A;FJX1;LITAF;BIRC3,PF-477736
3,mTORC1 Signaling,0.0299143930386433,PSMB5;PLK1;HMGCR;AURKA;HSP90B1,PF-477736
0,Epithelial Mesenchymal Transition,3.18829758611424e-05,BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC,Crenolanib
1,Hypoxia,0.0012584430129606,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Crenolanib
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Crenolanib
3,Complement,0.0055773281028547,DOCK10;LYN;CEBPB;ERAP2;TFPI2;PSMB9,Crenolanib
4,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,Crenolanib
5,Xenobiotic Metabolism,0.0243746906240797,TGFB2;PROS1;GCNT2;FAS;BCAT1,Crenolanib
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,Crenolanib
16,Allograft Rejection,0.0441792318744653,LYN;TGFB2;FAS;BCAT1,Crenolanib
15,p53 Pathway,0.0441792318744653,FAS;BAX;TXNIP;TP53,Crenolanib
14,mTORC1 Signaling,0.0441792318744653,HMGCR;BCAT1;AURKA;HSP90B1,Crenolanib
13,Interferon Gamma Response,0.0441792318744653,FAS;TXNIP;PSMB8;PSMB9,Crenolanib
12,Myogenesis,0.0441792318744653,FDPS;PRNP;DTNA;ADAM12,Crenolanib
9,Androgen Response,0.0441792318744653,ADAMTS1;HMGCR;SGK1,Crenolanib
10,IL-2/STAT5 Signaling,0.0441792318744653,PRNP;SPP1;PLIN2;IGF1R,Crenolanib
17,KRAS Signaling Up,0.0441792318744653,TMEM158;SPP1;GNG11;PSMB8,Crenolanib
8,Interferon Alpha Response,0.0441792318744653,TXNIP;PSMB8;PSMB9,Crenolanib
7,Apoptosis,0.0441792318744653,TGFB2;FAS;BAX;TXNIP,Crenolanib
11,Estrogen Response Late,0.0441792318744653,FABP5;TFPI2;SGK1;MICB,Crenolanib
18,Apical Surface,0.0473103836792986,LYN;SRPX,Crenolanib
0,UV Response Dn,0.0345411619588494,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Cenisertib
0,IL-2/STAT5 Signaling,0.0177764412415525,IFITM3;CTSZ;LIF;PLIN2;AHR;IGF1R,"2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol"
1,Mitotic Spindle,0.0299143930386433,CCDC88A;FSCN1;FLNB;MID1;AURKA,"2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol"
2,Estrogen Response Early,0.0299143930386433,RAB31;NRIP1;RHOBTB3;FLNB;IGF1R,"2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol"
3,Epithelial Mesenchymal Transition,0.0299143930386433,ITGB5;BASP1;TGFBI;FGF2;EDIL3,"2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol"
0,Epithelial Mesenchymal Transition,0.0018447630530901,ITGB5;BDNF;ITGB3;PMP22;SPP1;TGFBI;EDIL3,Dinaciclib
1,UV Response Dn,0.0018447630530901,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Dinaciclib
2,Hypoxia,0.0054505706459716,SRPX;TES;GCNT2;PLIN2;TGFBI;MT1E,Dinaciclib
3,Complement,0.0054505706459716,DOCK10;LYN;CEBPB;CTSL;FDX1;PSMB9,Dinaciclib
4,IL-2/STAT5 Signaling,0.0279792523835368,PRNP;SPP1;PLIN2;AHR;IGF1R,Dinaciclib
0,PI3K/AKT/mTOR  Signaling,0.0454255597994214,CDK1;PTEN;PLCB1;HSP90B1,"4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid"
1,mTORC1 Signaling,0.0454255597994214,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid"
2,E2F Targets,0.0454255597994214,DNMT1;PLK1;CDK1;TP53;AURKA,"4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid"
0,Epithelial Mesenchymal Transition,1.340534212343487e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,Capivasertib
1,Glycolysis,1.340534212343487e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,Capivasertib
2,Hypoxia,9.08474984965522e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Capivasertib
3,TNF-alpha Signaling via NF-kB,0.0038309487128214,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Capivasertib
4,Cholesterol Homeostasis,0.0038309487128214,ALCAM;TNFRSF12A;MAL2;CD9,Capivasertib
5,Angiogenesis,0.0041494253002513,APP;NRP1;VCAN,Capivasertib
6,UV Response Dn,0.0041494253002513,NRP1;ATP2B4;SNAI2;PRKCA;MET,Capivasertib
7,Estrogen Response Late,0.0136645992892568,ELOVL5;ATP2B4;CD9;JAK2;CD44,Capivasertib
8,KRAS Signaling Up,0.0136645992892568,NRP1;GALNT3;PLAU;SPRY2;ETS1,Capivasertib
9,Apoptosis,0.0319246776141746,APP;TNFRSF12A;CD44;IER3,Capivasertib
10,IL-6/JAK/STAT3 Signaling,0.0319246776141746,TNFRSF12A;CD9;CD44,Capivasertib
11,Protein Secretion,0.0381986161500985,CAV2;PAM;EGFR,Capivasertib
12,Hedgehog Signaling,0.0397349125961341,NRP1;NRP2,Capivasertib
13,IL-2/STAT5 Signaling,0.0417945574266959,NRP1;NT5E;ALCAM;CD44,Capivasertib
14,Estrogen Response Early,0.0417945574266959,ELOVL5;ENDOD1;JAK2;CD44,Capivasertib
15,Apical Junction,0.0417945574266959,VCAN;ITGA3;EGFR;ACTB,Capivasertib
0,Epithelial Mesenchymal Transition,1.5725789166429272e-08,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;PLOD3;VEGFC;EDIL3,Alectinib
1,UV Response Dn,0.00017851324091892374,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Alectinib
2,TNF-alpha Signaling via NF-kB,0.0076054474129837,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Alectinib
8,Xenobiotic Metabolism,0.0149571965193216,TGFB2;PROS1;GCNT2;FAS;BCAT1,Alectinib
7,mTORC1 Signaling,0.0149571965193216,BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,Alectinib
6,Complement,0.0149571965193216,DOCK10;LYN;CEBPB;TFPI2;PSMB9,Alectinib
9,Allograft Rejection,0.0149571965193216,LYN;TGFB2;CSF1;FAS;BCAT1,Alectinib
4,IL-2/STAT5 Signaling,0.0149571965193216,PRNP;CSF1;BHLHE40;SPP1;IGF1R,Alectinib
3,Androgen Response,0.0149571965193216,ADAMTS1;HMGCR;SGK1;ELL2,Alectinib
5,Myogenesis,0.0149571965193216,WWTR1;FDPS;PRNP;BHLHE40;ADAM12,Alectinib
10,Coagulation,0.0208764856767378,PROS1;ITGB3;TFPI2;PRSS23,Alectinib
11,Cholesterol Homeostasis,0.02280540705156,FDPS;FABP5;HMGCR,Alectinib
12,IL-6/JAK/STAT3 Signaling,0.0328538782100134,CSF1;ITGB3;FAS,Alectinib
13,Interferon Alpha Response,0.0409453285619758,CSF1;PSMB8;PSMB9,Alectinib
18,KRAS Signaling Up,0.042805236624781,TMEM158;SPP1;GNG11;PSMB8,Alectinib
14,Hypoxia,0.042805236624781,SRPX;BHLHE40;GCNT2;MT1E,Alectinib
15,Estrogen Response Early,0.042805236624781,BHLHE40;RHOBTB3;PRSS23;IGF1R,Alectinib
16,Estrogen Response Late,0.042805236624781,FABP5;TFPI2;SGK1;PRSS23,Alectinib
17,Inflammatory Response,0.042805236624781,LYN;CSF1;ITGB3;LPAR1,Alectinib
19,Apical Surface,0.0459663386884094,LYN;SRPX,Alectinib
0,UV Response Dn,0.0035179202407764,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine"
1,Complement,0.0069294076429407,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine"
2,Epithelial Mesenchymal Transition,0.0069294076429407,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine"
3,PI3K/AKT/mTOR  Signaling,0.0195913687859214,CDK1;THEM4;PLCB1;HSP90B1,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine"
4,KRAS Signaling Up,0.0272553358796528,TMEM158;SPP1;LCP1;GNG11;PSMB8,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine"
0,Epithelial Mesenchymal Transition,1.293009331461962e-08,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;ITGAV;THBS1;CD44,Binimetinib
1,Glycolysis,0.0001362712477448283,NT5E;VCAN;CDK1;MIF;PAM;MET;CD44;IER3,Binimetinib
2,Cholesterol Homeostasis,0.0004270769517778841,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Binimetinib
3,TNF-alpha Signaling via NF-kB,0.0031266839364488,SDC4;PLAU;PLK2;TNC;CD44;IER3,Binimetinib
4,Hypoxia,0.0031266839364488,MAP3K1;SDC4;MIF;ETS1;PAM;IER3,Binimetinib
5,KRAS Signaling Up,0.0031266839364488,NRP1;MAP3K1;GALNT3;PLAU;ETS1;DUSP6,Binimetinib
6,Coagulation,0.0034234008735004,SPARC;PLAU;CD9;THBS1;DUSP6,Binimetinib
7,Angiogenesis,0.0035528187803997,NRP1;VCAN;ITGAV,Binimetinib
8,IL-2/STAT5 Signaling,0.0122981393603311,NRP1;NT5E;ALCAM;ITGAV;CD44,Binimetinib
9,Estrogen Response Late,0.0122981393603311,ELOVL5;ATP2B4;CD9;JAK2;CD44,Binimetinib
10,UV Response Dn,0.019931135745807,NRP1;ATP2B4;SNAI2;MET,Binimetinib
11,IL-6/JAK/STAT3 Signaling,0.0292642878129934,TNFRSF12A;CD9;CD44,Binimetinib
12,Androgen Response,0.0368967045535531,ELOVL5;ITGAV;HMGCR,Binimetinib
13,Hedgehog Signaling,0.0368967045535531,NRP1;NRP2,Binimetinib
14,Estrogen Response Early,0.0417945574266959,ELOVL5;ENDOD1;JAK2;CD44,Binimetinib
15,Apical Junction,0.0417945574266959,VCAN;CDH3;ITGA3;ACTB,Binimetinib
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;SNAI2;VIM;CD44;LOXL2,Apitolisib
1,Hypoxia,0.00013995425444063446,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,Apitolisib
2,Apoptosis,0.0020055490671355,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Apitolisib
3,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Apitolisib
4,Estrogen Response Late,0.003853426689245,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,Apitolisib
5,UV Response Dn,0.0049718339183192,CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA,Apitolisib
6,Glycolysis,0.0157881518815062,EXT1;NT5E;MIF;EGFR;CD44,Apitolisib
7,p53 Pathway,0.0157881518815062,VAMP8;APP;PLK2;STOM;PTPN14,Apitolisib
8,Cholesterol Homeostasis,0.0256771990506453,TNFRSF12A;CD9;HMGCR,Apitolisib
9,IL-6/JAK/STAT3 Signaling,0.0360662574127702,TNFRSF12A;CD9;CD44,Apitolisib
10,Androgen Response,0.038154791164311,CDK6;ELOVL5;HMGCR,Apitolisib
11,Hedgehog Signaling,0.038154791164311,NRP2;CDK6,Apitolisib
12,Angiogenesis,0.038154791164311,APP;PTK2,Apitolisib
13,Mitotic Spindle,0.038154791164311,FARP1;PLK1;ARHGAP29;CDC42EP1,Apitolisib
14,Estrogen Response Early,0.038154791164311,FARP1;ELOVL5;ENDOD1;CD44,Apitolisib
15,Apical Junction,0.038154791164311,ITGA3;EGFR;ACTB;PTK2,Apitolisib
16,mTORC1 Signaling,0.038154791164311,ELOVL5;PLK1;CD9;HMGCR,Apitolisib
17,KRAS Signaling Up,0.038154791164311,PLAU;SPRY2;PLEK2;ETS1,Apitolisib
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;AREG;THBS1,Dabrafenib
1,Angiogenesis,0.0005822998506694381,APP;NRP1;VCAN;ITGAV,Dabrafenib
2,TNF-alpha Signaling via NF-kB,0.0008151278606677206,TUBB2A;SDC4;PLAU;PLK2;SIK1;AREG;IER3,Dabrafenib
3,UV Response Dn,0.0008151278606677206,TJP1;NRP1;GJA1;ID1;ATP2B4;MET,Dabrafenib
4,TGF-beta Signaling,0.0011672388853065,TJP1;ID1;ID3;THBS1,Dabrafenib
5,Cholesterol Homeostasis,0.0032787398893517,ALCAM;TNFRSF12A;MAL2;CD9,Dabrafenib
6,Coagulation,0.0035159252214328,SPARC;PLAU;CD9;THBS1;DUSP6,Dabrafenib
7,Glycolysis,0.0157881518815062,VCAN;MIF;MET;IER3;IL13RA1,Dabrafenib
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;IL13RA1,Dabrafenib
9,Pperoxisome,0.0457857493971732,SEMA3C;ELOVL5;PRDX1,Dabrafenib
10,Estrogen Response Early,0.0457857493971732,GJA1;ELOVL5;ENDOD1;AREG,Dabrafenib
11,Estrogen Response Late,0.0457857493971732,ELOVL5;ATP2B4;CD9;AREG,Dabrafenib
12,Apical Junction,0.0457857493971732,TJP1;VCAN;CDH3;ITGA3,Dabrafenib
13,Inflammatory Response,0.0457857493971732,AXL;SGMS2;RAF1;MET,Dabrafenib
14,p53 Pathway,0.0457857493971732,APP;HDAC3;PLK2;IER3,Dabrafenib
0,Hypoxia,0.0011154381251242,EXT1;SERPINE1;PRKCA;MIF;KDELR3;ETS1;EGFR,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
1,Epithelial Mesenchymal Transition,0.0011154381251242,NT5E;TNFRSF12A;COL4A1;COL12A1;SERPINE1;SNAI2;LOXL2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
2,UV Response Dn,0.0011154381251242,TJP1;NRP1;SERPINE1;ATP2B4;SNAI2;PRKCA,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
3,Glycolysis,0.0039548326547515,EXT1;TPST1;NT5E;MIF;KDELR3;EGFR,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
4,p53 Pathway,0.0039548326547515,VAMP8;APP;PLK2;STOM;PTPN14;EPHA2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
5,Hedgehog Signaling,0.0042798434729139,NRP1;NRP2;CDK6,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
6,Angiogenesis,0.0042798434729139,APP;NRP1;PTK2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
7,Estrogen Response Late,0.0117844578637079,FARP1;ELOVL5;ATP2B4;CD9;JAK2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
8,Apical Junction,0.0117844578637079,TJP1;RRAS;EGFR;ACTB;PTK2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
9,Xenobiotic Metabolism,0.0117844578637079,TPST1;ELOVL5;SERPINE1;MAN1A1;EPHA2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
10,KRAS Signaling Up,0.0117844578637079,NRP1;PLAU;SPRY2;PLEK2;ETS1,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate"
0,IL-2/STAT5 Signaling,1.557918138669458e-05,PRNP;CSF1;BHLHE40;SPP1;ITGA6;PLIN2;AHR;WLS;IGF1R,Abexinostat
1,Epithelial Mesenchymal Transition,1.557918138669458e-05,ITGB5;BDNF;ITGB3;DPYSL3;PMP22;SPP1;VEGFC;TGFBI;EDIL3,Abexinostat
2,Hypoxia,8.528965955015247e-05,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,Abexinostat
3,UV Response Dn,8.528965955015247e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Abexinostat
4,TNF-alpha Signaling via NF-kB,0.0043604565167773,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Abexinostat
5,Interferon Alpha Response,0.0102352269283775,LGALS3BP;CSF1;PSMB8;PSMB9,Abexinostat
6,mTORC1 Signaling,0.0178655402869675,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Abexinostat
7,Inflammatory Response,0.0178655402869675,LYN;CSF1;ITGB3;LPAR1;AHR,Abexinostat
0,Hedgehog Signaling,0.0157005281631133,NRP2;CDK6;VLDLR,GSK-3 Inhibitor X
1,UV Response Dn,0.0157005281631133,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,GSK-3 Inhibitor X
2,E2F Targets,0.0443176193165087,DNMT1;PLK1;CDK1;TP53;AURKB,GSK-3 Inhibitor X
0,Epithelial Mesenchymal Transition,0.0019305659857919,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,Azd4547
1,UV Response Dn,0.0019305659857919,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Azd4547
2,Hypoxia,0.0076054474129837,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,Azd4547
3,TNF-alpha Signaling via NF-kB,0.0249286608655361,CEBPB;IRS2;SGK1;FJX1;LITAF,Azd4547
4,Complement,0.0249286608655361,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Azd4547
5,mTORC1 Signaling,0.0249286608655361,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Azd4547
6,Cholesterol Homeostasis,0.03909498351696,FDPS;FABP5;HMGCR,Azd4547
17,Allograft Rejection,0.042805236624781,LYN;TGFB2;FAS;BCAT1,Azd4547
16,p53 Pathway,0.042805236624781,FAS;BAX;TXNIP;TP53,Azd4547
15,Xenobiotic Metabolism,0.042805236624781,TGFB2;GCNT2;FAS;BCAT1,Azd4547
14,E2F Targets,0.042805236624781,PLK1;CDK1;TP53;AURKA,Azd4547
13,Interferon Gamma Response,0.042805236624781,FAS;TXNIP;PSMB8;PSMB9,Azd4547
9,Androgen Response,0.042805236624781,ADAMTS1;HMGCR;SGK1,Azd4547
11,Mitotic Spindle,0.042805236624781,PLK1;CDK1;MYH10;AURKA,Azd4547
10,PI3K/AKT/mTOR  Signaling,0.042805236624781,CDK1;THEM4;HSP90B1,Azd4547
18,KRAS Signaling Up,0.042805236624781,SPP1;LCP1;GNG11;PSMB8,Azd4547
8,Interferon Alpha Response,0.042805236624781,TXNIP;PSMB8;PSMB9,Azd4547
7,Apoptosis,0.042805236624781,TGFB2;FAS;BAX;TXNIP,Azd4547
12,IL-2/STAT5 Signaling,0.042805236624781,PRNP;SPP1;PLIN2;IGF1R,Azd4547
19,Apical Surface,0.0459663386884094,LYN;SRPX,Azd4547
0,Hypoxia,3.043374968563592e-05,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,Delanzomib
1,Epithelial Mesenchymal Transition,0.0013798129319357,ITGB5;BASP1;ITGB3;PMP22;SPP1;TGFBI;EDIL3,Delanzomib
2,Interferon Alpha Response,0.0017713508023572,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Delanzomib
3,IL-2/STAT5 Signaling,0.0051847953621195,IFITM3;SPP1;ITGA6;PLIN2;AHR;IGF1R,Delanzomib
4,TNF-alpha Signaling via NF-kB,0.023266750141167,CEBPB;IRS2;SGK1;FJX1;LITAF,Delanzomib
5,Interferon Gamma Response,0.023266750141167,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Delanzomib
6,UV Response Dn,0.0355528367357638,ITGB3;PMP22;MT1E;IGF1R,Delanzomib
7,Apoptosis,0.0457952030858709,IFITM3;TGFB2;BAX;TXNIP,Delanzomib
0,UV Response Dn,0.0038611319715839,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Brivanib alaninate
1,Epithelial Mesenchymal Transition,0.0114081711194755,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,Brivanib alaninate
2,IL-2/STAT5 Signaling,0.0373929912983042,PRNP;PLAGL1;SPP1;PLIN2;IGF1R,Brivanib alaninate
3,mTORC1 Signaling,0.0373929912983042,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Brivanib alaninate
0,Angiogenesis,0.0307270813439974,VCAN;SPP1;FGFR1,Infigratinib
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;CD44;LOXL2,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
1,Hypoxia,0.0001362712477448283,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
2,Apoptosis,0.0019527714601056,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
3,TNF-alpha Signaling via NF-kB,0.0046900259046732,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
4,Mitotic Spindle,0.0153726742004139,FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
5,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;CAV1;CD9;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
6,Apical Junction,0.0153726742004139,ITGA3;AKT3;EGFR;ACTB;PTK2,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
7,Glycolysis,0.0153726742004139,EXT1;NT5E;MIF;EGFR;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
8,Cholesterol Homeostasis,0.0250014832861547,TNFRSF12A;CD9;HMGCR,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
9,IL-6/JAK/STAT3 Signaling,0.0351171453755921,TNFRSF12A;CD9;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
10,Androgen Response,0.0393360540486549,CDK6;ELOVL5;HMGCR,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
11,Hedgehog Signaling,0.0393360540486549,NRP2;CDK6,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
12,Angiogenesis,0.0393360540486549,APP;PTK2,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
13,Estrogen Response Early,0.0393360540486549,FARP1;ELOVL5;ENDOD1;CD44,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
14,Complement,0.0393360540486549,GCA;SERPINE1;GNB4;TIMP2,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
15,mTORC1 Signaling,0.0393360540486549,ELOVL5;PLK1;CD9;HMGCR,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
16,p53 Pathway,0.0393360540486549,VAMP8;APP;PLK2;PTPN14,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol"
0,Epithelial Mesenchymal Transition,1.293009331461962e-08,NOTCH2;NT5E;LGALS1;TNFRSF12A;SDC4;DST;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
1,UV Response Dn,8.15911714596976e-07,NOTCH2;TJP1;ANXA2;CAV1;SERPINE1;AKT3;LAMC1;MET;RND3,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
2,TNF-alpha Signaling via NF-kB,6.702671061717435e-06,FOSL1;MARCKS;CCND1;SDC4;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
3,Hypoxia,6.702671061717435e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;ETS1;PAM;EGFR,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
4,Apoptosis,1.0888599166097284e-05,APP;GPX1;CCND1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
5,Apical Junction,4.5423749248276095e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR;ACTB;PTK2,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
6,IL-6/JAK/STAT3 Signaling,0.00039885147438583913,TNFRSF12A;CD9;OSMR;IL6ST;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
11,Cholesterol Homeostasis,0.0015962286303422,TNFRSF12A;GPX8;CD9;HMGCR,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
9,Estrogen Response Late,0.0015962286303422,CCND1;ELOVL5;CAV1;CD9;IL6ST;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
10,Glycolysis,0.0015962286303422,EXT1;NT5E;PAM;MET;EGFR;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
7,Mitotic Spindle,0.0015962286303422,NOTCH2;MYO1E;MARCKS;DST;PLK1;ARHGAP29,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
8,IL-2/STAT5 Signaling,0.0015962286303422,MYO1E;NT5E;AHNAK;PHLDA1;CKAP4;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
12,Angiogenesis,0.0021863500187075,APP;FSTL1;PTK2,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
13,Protein Secretion,0.0036325935173673,DST;CAV2;PAM;EGFR,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
14,G2-M Checkpoint,0.0076863371002069,NOTCH2;MARCKS;MT2A;CCND1;PLK1,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
15,Inflammatory Response,0.0076863371002069,AXL;SERPINE1;SGMS2;OSMR;MET,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
16,Notch Signaling,0.0242339599130776,NOTCH2;CCND1,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
17,Androgen Response,0.0284113911000644,CCND1;ELOVL5;HMGCR,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
19,mTORC1 Signaling,0.0318434723251016,ELOVL5;PLK1;CD9;HMGCR,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
18,Estrogen Response Early,0.0318434723251016,CCND1;ELOVL5;IL6ST;CD44,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
20,p53 Pathway,0.0318434723251016,APP;PLK2;PTPN14;S100A10,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine"
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,GJA1;VCAN;SPARC;SDC4;DST;COL4A1;COL12A1;ITGAV;THBS1,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
1,Angiogenesis,0.0005669761703886634,APP;NRP1;VCAN;ITGAV,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
2,TGF-beta Signaling,0.0018942034542254,TJP1;ID1;ID3;THBS1,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
3,Glycolysis,0.0046900259046732,VCAN;CDK1;MIF;MET;IL13RA1;IER3,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
4,Coagulation,0.0047927612229006,SPARC;PLAU;CD9;THBS1;DUSP6,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
5,UV Response Dn,0.0048409961836266,TJP1;NRP1;GJA1;ID1;MET,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
6,TNF-alpha Signaling via NF-kB,0.0175687705147588,TUBB2A;SDC4;PLAU;PLK2;IER3,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
7,Cholesterol Homeostasis,0.028126668696924,ALCAM;MAL2;CD9,2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine
0,Apical Junction,0.0099863014367991,TJP1;RRAS;CTNNA1;FLNC;RHOF;PTK2,MK-2461
1,Angiogenesis,0.0099863014367991,APP;FSTL1;PTK2,MK-2461
2,TGF-beta Signaling,0.0172838715334383,TJP1;SMURF2;ID1,MK-2461
3,Estrogen Response Early,0.0172838715334383,ABLIM1;KRT18;KRT8;FLNB;SFN,MK-2461
4,p53 Pathway,0.0172838715334383,VAMP8;APP;SFN;PTPN14;EPHA2,MK-2461
0,Apical Junction,0.0021682774644703,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Tucatinib
1,p53 Pathway,0.008365992154282,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Tucatinib
2,Angiogenesis,0.0084499473695993,APP;FSTL1;PTK2,Tucatinib
3,Protein Secretion,0.0113395824663766,KRT18;SCRN1;CAV2;EGFR,Tucatinib
4,Cholesterol Homeostasis,0.0401375164107456,TNFRSF12A;MAL2;CD9,Tucatinib
5,Apoptosis,0.0447438531812563,APP;KRT18;TNFRSF12A;PTK2,Tucatinib
6,IL-6/JAK/STAT3 Signaling,0.0447438531812563,TNFRSF12A;CD9;OSMR,Tucatinib
0,Hypoxia,0.0101405965506449,SRPX;TES;DTNA;GCNT2;PLIN2;MT1E,Sapanisertib
1,mTORC1 Signaling,0.0101405965506449,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Sapanisertib
2,Interferon Alpha Response,0.0190422826574466,LGALS3BP;TXNIP;PSMB8;PSMB9,Sapanisertib
0,Estrogen Response Early,0.0443176193165087,DLC1;RHOBTB3;JAK2;MICB;IGF1R,"6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine"
1,mTORC1 Signaling,0.0443176193165087,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine"
2,E2F Targets,0.0443176193165087,DNMT1;PLK1;CDK1;TP53;AURKA,"6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine"
0,Apical Junction,0.0002578104687064319,TJP1;RRAS;PTEN;CTNNA1;FLNC;RHOF;EGFR;PTK2,Xevinapant
1,Epithelial Mesenchymal Transition,0.001001034214855,NOTCH2;TNFRSF12A;SDC4;VIM;LAMC1;FSTL1;LOXL2,Xevinapant
2,UV Response Dn,0.001001034214855,NOTCH2;TJP1;ANXA2;DUSP1;PTEN;LAMC1,Xevinapant
3,Hypoxia,0.0044365109909071,EXT1;ANXA2;SDC4;DUSP1;MIF;EGFR,Xevinapant
4,Angiogenesis,0.0053772392351995,APP;FSTL1;PTK2,Xevinapant
5,Apoptosis,0.0075408530883533,APP;KRT18;TNFRSF12A;TIMP2;PTK2,Xevinapant
6,Fatty Acid Metabolism,0.0408840975065379,CBR1;ELOVL5;PCBD1;MIF,Xevinapant
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
1,Angiogenesis,0.0005822998506694381,APP;NRP1;VCAN;PTK2,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
2,Hypoxia,0.0008322681176755062,EXT1;SDC4;SERPINE1;PRKCA;MIF;ETS1;EGFR,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
3,TNF-alpha Signaling via NF-kB,0.0032111889077042,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
4,Estrogen Response Late,0.0032111889077042,FARP1;ELOVL5;ATP2B4;CD9;JAK2;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
5,Glycolysis,0.0032111889077042,EXT1;NT5E;VCAN;MIF;EGFR;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
6,Hedgehog Signaling,0.0037288754387394,NRP1;NRP2;CDK6,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
7,UV Response Dn,0.0037288754387394,NRP1;SERPINE1;ATP2B4;SNAI2;PRKCA,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
8,Estrogen Response Early,0.011482292277459,FARP1;ELOVL5;ENDOD1;JAK2;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
9,Apical Junction,0.011482292277459,VCAN;ITGA3;EGFR;ACTB;PTK2,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
10,p53 Pathway,0.011482292277459,VAMP8;APP;HDAC3;PLK2;PTPN14,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
11,Cholesterol Homeostasis,0.019257899287984,TNFRSF12A;MAL2;CD9,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
12,Apoptosis,0.0254976954910343,APP;TNFRSF12A;PTK2;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
13,IL-6/JAK/STAT3 Signaling,0.025761612437693,TNFRSF12A;CD9;CD44,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
14,Mitotic Spindle,0.0429241400598498,FARP1;PLK1;ARHGAP29;CDC42EP1,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
15,KRAS Signaling Up,0.0429241400598498,NRP1;PLAU;SPRY2;ETS1,"3-[5-[2-[[(3S)-1-(1-methylpyrazol-3-yl)sulfonylpiperidin-3-yl]amino]pyrimidin-4-yl]imidazo[2,1-b][1,3]oxazol-6-yl]phenol"
0,Epithelial Mesenchymal Transition,0.0003167385758393306,ITGB5;BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC;EDIL3,Gandotinib
1,UV Response Dn,0.0018447630530901,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Gandotinib
2,Hypoxia,0.0072674275279622,SRPX;TES;GCNT2;PLIN2;AMPD3;MT1E,Gandotinib
3,IL-2/STAT5 Signaling,0.0285848644591481,PRNP;SPP1;PLIN2;AHR;IGF1R,Gandotinib
4,Complement,0.0285848644591481,DOCK10;LYN;CEBPB;CTSL;PSMB9,Gandotinib
0,UV Response Dn,1.631823429193952e-06,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,Varlitinib
1,Hypoxia,0.0008103663251050982,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1;EGFR,Varlitinib
2,Epithelial Mesenchymal Transition,0.0008103663251050982,NT5E;TNFRSF12A;SERPINE1;COL12A1;SNAI2;CD44;LOXL2,Varlitinib
3,Estrogen Response Early,0.0037520207237386,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Varlitinib
4,Glycolysis,0.0037520207237386,EXT1;NT5E;MIF;VLDLR;EGFR;CD44,Varlitinib
5,Hedgehog Signaling,0.0047370917071996,NRP2;CDK6;VLDLR,Varlitinib
6,Androgen Response,0.0084463482845621,INPP4B;CDK6;ELOVL5;HMGCR,Varlitinib
7,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Varlitinib
8,TNF-alpha Signaling via NF-kB,0.0477652084876524,FOSL1;PLAU;SERPINE1;CD44,Varlitinib
9,Apical Junction,0.0477652084876524,PTEN;RAC2;EGFR;ACTB,Varlitinib
10,Complement,0.0477652084876524,GCA;ERAP2;SERPINE1;JAK2,Varlitinib
11,mTORC1 Signaling,0.0477652084876524,ELOVL5;PLK1;VLDLR;HMGCR,Varlitinib
12,Xenobiotic Metabolism,0.0477652084876524,GSTM4;ELOVL5;SERPINE1;MAN1A1,Varlitinib
13,KRAS Signaling Up,0.0477652084876524,GALNT3;PLAU;SPRY2;ETS1,Varlitinib
0,IL-2/STAT5 Signaling,0.0465335002823341,PLAGL1;SPP1;PLIN2;AHR;IGF1R,"5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one"
1,Complement,0.0465335002823341,DOCK10;CEBPB;ERAP2;FDX1;PSMB9,"5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one"
2,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one"
0,Hypoxia,0.0026939204861601,CDKN1C;SRPX;TES;DTNA;TGFBI;AMPD3;MT1E,"4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one"
1,mTORC1 Signaling,0.010394111464411,TES;PLK1;DHCR24;HMGCR;BCAT1;HSP90B1,"4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one"
2,Epithelial Mesenchymal Transition,0.0454255597994214,ITGB3;ADAM12;SPP1;TGFBI;EMP3,"4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one"
0,Epithelial Mesenchymal Transition,2.0784172928835875e-07,GLIPR1;ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;PMP22;FAS;PLOD3;VEGFC;EDIL3,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
1,UV Response Dn,0.0001666123581909955,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
2,TNF-alpha Signaling via NF-kB,0.0053238131890886,CEBPB;BHLHE40;IRS2;SGK1;FJX1;LITAF,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
3,Hypoxia,0.0053238131890886,SRPX;BHLHE40;GCNT2;IRS2;AMPD3;MT1E,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
4,IL-2/STAT5 Signaling,0.0174500626058753,PRNP;BHLHE40;ITGA6;AHR;IGF1R,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
5,Myogenesis,0.0174500626058753,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
6,Complement,0.0174500626058753,DOCK10;LYN;CEBPB;TFPI2;PSMB9,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
7,Xenobiotic Metabolism,0.0174500626058753,TGFB2;PROS1;GCNT2;FAS;BCAT1,"3-[[(3Z)-3-[[4-(morpholin-4-ylmethyl)-1H-pyrrol-2-yl]methylidene]-2-oxo-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one"
0,Epithelial Mesenchymal Transition,2.898452351012945e-05,VCAN;ECM1;COL5A1;COL4A1;WIPF1;TNC;SNAI2;TIMP3;FBLN1,Bosutinib
1,Complement,0.0001473202678322468,LYN;DPP4;ERAP2;SRC;KYNU;FYN;JAK2;DUSP6,Bosutinib
2,KRAS Signaling Up,0.0443176193165087,GYPC;GABRA3;LCP1;TRIB2;DUSP6,Bosutinib
3,Coagulation,0.0474037823143518,DPP4;TIMP3;FYN;DUSP6,Bosutinib
4,UV Response Dn,0.0474037823143518,CELF2;ATP2B4;SNAI2;FYN,Bosutinib
0,Angiogenesis,0.0245816650751979,FSTL1;PTK2;FGFR1,"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide"
1,Estrogen Response Early,0.0354540954532069,KRT18;MYOF;NRIP1;KRT8;FLNB,"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide"
2,Apical Junction,0.0354540954532069,TJP1;CTNNA1;FLNC;RHOF;PTK2,"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide"
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,Gemcitabine elaidate
1,UV Response Dn,0.0001666123581909955,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Gemcitabine elaidate
2,IL-2/STAT5 Signaling,0.0053238131890886,PRNP;CSF1;BHLHE40;AHR;WLS;IGF1R,Gemcitabine elaidate
3,TNF-alpha Signaling via NF-kB,0.0053238131890886,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Gemcitabine elaidate
4,Estrogen Response Early,0.015511166760778,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,Gemcitabine elaidate
5,Myogenesis,0.015511166760778,WWTR1;FDPS;PRNP;ITGB5;BHLHE40,Gemcitabine elaidate
6,Inflammatory Response,0.015511166760778,LYN;CSF1;ITGB3;LPAR1;AHR,Gemcitabine elaidate
7,Xenobiotic Metabolism,0.015511166760778,TGFB2;PROS1;GCNT2;FAS;BCAT1,Gemcitabine elaidate
8,Allograft Rejection,0.015511166760778,LYN;TGFB2;CSF1;FAS;BCAT1,Gemcitabine elaidate
9,Apoptosis,0.0362388232377117,TGFB2;FAS;BAX;BCL2L2,Gemcitabine elaidate
10,IL-6/JAK/STAT3 Signaling,0.0362388232377117,CSF1;ITGB3;FAS,Gemcitabine elaidate
11,Interferon Alpha Response,0.0445849133230403,CSF1;PSMB8;PSMB9,Gemcitabine elaidate
12,Androgen Response,0.0446549099202676,ADAMTS1;SGK1;ELL2,Gemcitabine elaidate
13,Hypoxia,0.0474424705924656,SRPX;BHLHE40;GCNT2;MT1E,Gemcitabine elaidate
14,Complement,0.0474424705924656,DOCK10;LYN;CEBPB;PSMB9,Gemcitabine elaidate
15,mTORC1 Signaling,0.0474424705924656,BHLHE40;BCAT1;AURKA;HSP90B1,Gemcitabine elaidate
0,Complement,0.0168780677753468,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone"
1,UV Response Dn,0.0168780677753468,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone"
2,TNF-alpha Signaling via NF-kB,0.0357310805739351,CEBPB;IRS2;SGK1;FJX1;LITAF,"1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone"
3,Epithelial Mesenchymal Transition,0.0357310805739351,ITGB3;ADAM12;PMP22;SPP1;VEGFC,"1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone"
0,Complement,0.0212952527563544,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
1,Interferon Alpha Response,0.0299915951854784,BST2;TXNIP;PSMB8;PSMB9,"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
2,Interferon Gamma Response,0.0465335002823341,BST2;TXNIP;JAK2;PSMB8;PSMB9,"N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;ITGAV;AREG;THBS1,Bay 869766;rdea119
1,Angiogenesis,0.0005822998506694381,APP;NRP1;VCAN;ITGAV,Bay 869766;rdea119
2,UV Response Dn,0.0010868371475569,TJP1;NRP1;GJA1;ID1;ATP2B4;MET,Bay 869766;rdea119
3,TGF-beta Signaling,0.0014590486066331,TJP1;ID1;ID3;THBS1,Bay 869766;rdea119
4,TNF-alpha Signaling via NF-kB,0.0028103484765871,TUBB2A;SDC4;PLAU;PLK2;AREG;IER3,Bay 869766;rdea119
5,Glycolysis,0.0028103484765871,VCAN;CDK1;MIF;MET;IER3;IL13RA1,Bay 869766;rdea119
6,Cholesterol Homeostasis,0.0028103484765871,ALCAM;TNFRSF12A;MAL2;CD9,Bay 869766;rdea119
7,Coagulation,0.0030764345687537,SPARC;PLAU;CD9;THBS1;DUSP6,Bay 869766;rdea119
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;IL13RA1,Bay 869766;rdea119
9,Pperoxisome,0.0490561600683998,SEMA3C;ELOVL5;PRDX1,Bay 869766;rdea119
10,Estrogen Response Early,0.0490561600683998,GJA1;ELOVL5;ENDOD1;AREG,Bay 869766;rdea119
11,Estrogen Response Late,0.0490561600683998,ELOVL5;ATP2B4;CD9;AREG,Bay 869766;rdea119
12,Apical Junction,0.0490561600683998,TJP1;VCAN;CDH3;ITGA3,Bay 869766;rdea119
13,p53 Pathway,0.0490561600683998,APP;HDAC3;PLK2;IER3,Bay 869766;rdea119
0,UV Response Dn,2.3400749768076048e-05,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;PTEN;SNAI2;VLDLR,Dacomitinib
1,Glycolysis,0.0012155494876576,EXT1;NT5E;CDK1;MIF;VLDLR;EGFR;CD44,Dacomitinib
2,Hypoxia,0.0037520207237386,EXT1;SERPINE1;MIF;VLDLR;ETS1;EGFR,Dacomitinib
3,Estrogen Response Early,0.0037520207237386,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,Dacomitinib
4,Epithelial Mesenchymal Transition,0.0037520207237386,NT5E;TNFRSF12A;SERPINE1;SNAI2;CD44;LOXL2,Dacomitinib
5,Hedgehog Signaling,0.0047370917071996,NRP2;CDK6;VLDLR,Dacomitinib
6,Androgen Response,0.0084463482845621,INPP4B;CDK6;ELOVL5;HMGCR,Dacomitinib
7,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,Dacomitinib
8,PI3K/AKT/mTOR  Signaling,0.0477652084876524,CDK1;PTEN;EGFR,Dacomitinib
9,Mitotic Spindle,0.0477652084876524,FARP1;PLK1;CDK1;CDC42EP1,Dacomitinib
10,Apical Junction,0.0477652084876524,PTEN;RAC2;EGFR;ACTB,Dacomitinib
11,Complement,0.0477652084876524,GCA;ERAP2;SERPINE1;JAK2,Dacomitinib
12,mTORC1 Signaling,0.0477652084876524,ELOVL5;PLK1;VLDLR;HMGCR,Dacomitinib
13,Xenobiotic Metabolism,0.0477652084876524,GSTM4;ELOVL5;SERPINE1;MAN1A1,Dacomitinib
0,Apical Junction,0.0021025720867591,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,Gdc-0152
1,p53 Pathway,0.0081124772405159,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Gdc-0152
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,Gdc-0152
3,Protein Secretion,0.0109959587552742,KRT18;SCRN1;CAV2;EGFR,Gdc-0152
0,UV Response Dn,0.00030148902910751566,INPP4B;RBPMS;DLC1;SERPINE1;AKT3;ATP2B4;PTEN,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
1,Androgen Response,0.0027753986391777,INPP4B;CDK6;ELOVL5;HMGCR;B2M,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
2,Estrogen Response Early,0.003853426689245,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
3,Complement,0.003853426689245,GCA;ERAP2;SERPINE1;GNB4;TIMP2;JAK2,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
4,Epithelial Mesenchymal Transition,0.003853426689245,NT5E;TNFRSF12A;SERPINE1;VIM;CD44;LOXL2,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
5,Hypoxia,0.0180436021502928,EXT1;MT2A;SERPINE1;MIF;ETS1,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
6,Estrogen Response Late,0.0180436021502928,FARP1;ELOVL5;ATP2B4;JAK2;CD44,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
7,Apoptosis,0.0414337551729308,TNFRSF12A;TIMP2;BAX;CD44,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine"
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;PLOD3;VEGFC,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
1,UV Response Dn,0.0001626453972816861,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
2,TNF-alpha Signaling via NF-kB,0.0008979734953867304,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
3,Hypoxia,0.0041576445857644,SRPX;DTNA;BHLHE40;GCNT2;IRS2;MT1E,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
4,Myogenesis,0.0041576445857644,FDPS;WWTR1;PRNP;DTNA;BHLHE40;ADAM12,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
5,Androgen Response,0.0109193781876996,ADAMTS1;HMGCR;SGK1;ELL2,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
7,Estrogen Response Early,0.0151418532664738,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
8,Complement,0.0151418532664738,DOCK10;LYN;CEBPB;TFPI2;PSMB9,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
6,IL-2/STAT5 Signaling,0.0151418532664738,PRNP;CSF1;BHLHE40;SPP1;IGF1R,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
9,Coagulation,0.0209228778671305,PROS1;ITGB3;TFPI2;PRSS23,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
10,IL-6/JAK/STAT3 Signaling,0.0353759941130043,CSF1;ITGB3;FAS,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
11,Interferon Alpha Response,0.0435233677677298,CSF1;PSMB8;PSMB9,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
15,KRAS Signaling Up,0.0463128879593117,TMEM158;SPP1;GNG11;PSMB8,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
12,Inflammatory Response,0.0463128879593117,LYN;CSF1;ITGB3;LPAR1,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
13,Xenobiotic Metabolism,0.0463128879593117,TGFB2;PROS1;GCNT2;FAS,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
14,Allograft Rejection,0.0463128879593117,LYN;TGFB2;CSF1;FAS,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
16,Apical Surface,0.0492711081365957,LYN;SRPX,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide"
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;ITGAV;LOXL2;CAP2,Venetoclax
1,UV Response Dn,0.00014281059273513902,TJP1;NRP1;ANXA2;SERPINE1;ID1;SNAI2;CAP2,Venetoclax
2,Angiogenesis,0.0003677683267385925,APP;NRP1;ITGAV;PTK2,Venetoclax
3,Hypoxia,0.0031061746320174,EXT1;ANXA2;SDC4;SERPINE1;ETS1;EGFR,Venetoclax
4,Apical Junction,0.0031061746320174,TJP1;RRAS;ITGA3;EGFR;ACTB;PTK2,Venetoclax
5,Cholesterol Homeostasis,0.0031061746320174,ALCAM;TNFRSF12A;MAL2;CD9,Venetoclax
6,TGF-beta Signaling,0.0128602019237348,TJP1;SERPINE1;ID1,Venetoclax
8,p53 Pathway,0.0132952857949526,VAMP8;APP;PLK2;PTPN14;EPHA2,Venetoclax
7,TNF-alpha Signaling via NF-kB,0.0132952857949526,TUBB2A;SDC4;PLAU;PLK2;SERPINE1,Venetoclax
9,IL-6/JAK/STAT3 Signaling,0.0341680333384139,TNFRSF12A;PDGFC;CD9,Venetoclax
15,KRAS Signaling Up,0.0406649747935419,NRP1;PLAU;PLEK2;ETS1,Venetoclax
10,Androgen Response,0.0406649747935419,ELOVL5;KRT8;ITGAV,Venetoclax
11,Pperoxisome,0.0406649747935419,SEMA3C;ELOVL5;PRDX1,Venetoclax
12,IL-2/STAT5 Signaling,0.0406649747935419,NRP1;ALCAM;AHNAK;ITGAV,Venetoclax
13,Estrogen Response Early,0.0406649747935419,ABLIM1;ELOVL5;KRT8;ENDOD1,Venetoclax
14,Xenobiotic Metabolism,0.0406649747935419,ELOVL5;SERPINE1;MAN1A1;EPHA2,Venetoclax
16,Apical Surface,0.0432624364126206,APP;ATP8B1,Venetoclax
0,Epithelial Mesenchymal Transition,1.647964902903121e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;CD44,Pha-665752
1,Angiogenesis,1.647964902903121e-05,APP;NRP1;VCAN;ITGAV;PTK2,Pha-665752
2,Apical Junction,0.0005749220549732116,TJP1;VCAN;RRAS;ITGA3;EGFR;ACTB;PTK2,Pha-665752
3,Glycolysis,0.0005749220549732116,EXT1;NT5E;VCAN;MIF;MET;EGFR;CD44,Pha-665752
4,IL-2/STAT5 Signaling,0.0025884788600145,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,Pha-665752
5,Hypoxia,0.0025884788600145,EXT1;ANXA2;SDC4;MIF;ETS1;EGFR,Pha-665752
6,Cholesterol Homeostasis,0.0025884788600145,ALCAM;TNFRSF12A;MAL2;CD9,Pha-665752
7,UV Response Dn,0.003434490535681,TJP1;NRP1;ANXA2;SNAI2;MET,Pha-665752
8,TNF-alpha Signaling via NF-kB,0.0129259723006483,TUBB2A;SDC4;PLAU;PLK2;CD44,Pha-665752
9,Apoptosis,0.0301990193647598,APP;TNFRSF12A;PTK2;CD44,Pha-665752
10,IL-6/JAK/STAT3 Signaling,0.0301990193647598,TNFRSF12A;CD9;CD44,Pha-665752
11,Pperoxisome,0.0447571929409286,SEMA3C;ELOVL5;PRDX1,Pha-665752
12,p53 Pathway,0.0451833053261577,VAMP8;APP;PLK2;PTPN14,Pha-665752
13,KRAS Signaling Up,0.0451833053261577,NRP1;PLAU;PLEK2;ETS1,Pha-665752
14,Apical Surface,0.047668795676869,APP;ATP8B1,Pha-665752
0,Apical Junction,0.0107544784703991,TJP1;RRAS;CTNNA1;FLNC;RHOF;PTK2,Bms-911543
1,Angiogenesis,0.0107544784703991,APP;FSTL1;PTK2,Bms-911543
2,TGF-beta Signaling,0.023266750141167,TJP1;SMURF2;ID1,Bms-911543
3,p53 Pathway,0.023266750141167,VAMP8;APP;SFN;PTPN14;EPHA2,Bms-911543
4,UV Response Dn,0.0331826476200462,TJP1;ANXA2;DUSP1;ID1,Bms-911543
0,UV Response Dn,0.0329711091425381,INPP4B;DLC1;ITGB3;PTEN;IGF1R,"(1S,2S,4R)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3H-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide"
1,PI3K/AKT/mTOR  Signaling,0.0349001252117506,CDK1;PTEN;PLCB1;HSP90B1,"(1S,2S,4R)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3H-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide"
2,Estrogen Response Early,0.0349001252117506,TFAP2C;DLC1;JAK2;MICB;IGF1R,"(1S,2S,4R)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3H-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide"
3,E2F Targets,0.0349001252117506,DNMT1;PLK1;CDK1;TP53;AURKA,"(1S,2S,4R)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3H-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide"
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
1,Glycolysis,0.0012484021765132,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
2,Hypoxia,0.0049181098340275,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;CD9;HMGCR,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
4,Angiogenesis,0.0058381454553595,APP;NRP1;VCAN,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
5,TNF-alpha Signaling via NF-kB,0.0180436021502928,FOSL1;SDC4;PLAU;PLK2;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
6,Estrogen Response Late,0.0180436021502928,ELOVL5;ATP2B4;CD9;JAK2;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
7,UV Response Dn,0.0281459957491463,NRP1;ATP2B4;SNAI2;PRKCA,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
9,Hedgehog Signaling,0.0403991906445645,NRP1;NRP2,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
10,Mitotic Spindle,0.0403991906445645,PLK1;CDK1;ARHGAP29;CDC42EP1,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
11,IL-2/STAT5 Signaling,0.0403991906445645,NRP1;NT5E;ALCAM;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
12,Estrogen Response Early,0.0403991906445645,ELOVL5;ENDOD1;JAK2;CD44,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
13,Apical Junction,0.0403991906445645,VCAN;ITGA3;EGFR;ACTB,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
14,mTORC1 Signaling,0.0403991906445645,ELOVL5;PLK1;CD9;HMGCR,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
15,p53 Pathway,0.0403991906445645,VAMP8;APP;HDAC3;PLK2,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
16,KRAS Signaling Up,0.0403991906445645,NRP1;PLAU;SPRY2;ETS1,(r)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
0,IL-2/STAT5 Signaling,0.0005749220549732116,IFITM3;PRNP;BHLHE40;LIF;AHR;WLS;IGF1R,Ixazomib
1,Hypoxia,0.0005749220549732116,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Ixazomib
2,Estrogen Response Early,0.0005749220549732116,RAB31;DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;IGF1R,Ixazomib
3,Epithelial Mesenchymal Transition,0.0005749220549732116,ITGB5;BASP1;BDNF;PMP22;FN1;TGFBI;EDIL3,Ixazomib
4,UV Response Dn,0.0006006205289130573,EFEMP1;BDNF;BHLHE40;PMP22;MT1E;IGF1R,Ixazomib
5,Interferon Alpha Response,0.0083309986626329,IFITM3;LGALS3BP;PSMB8;PSMB9,Ixazomib
6,mTORC1 Signaling,0.0166191072436907,TES;BHLHE40;BCAT1;AURKA;HSP90B1,Ixazomib
7,Apoptosis,0.0381626692382258,IFITM3;TGFB2;DPYD;BCL2L2,Ixazomib
8,TNF-alpha Signaling via NF-kB,0.0451833053261577,BHLHE40;LIF;FJX1;LITAF,Ixazomib
9,Estrogen Response Late,0.0451833053261577,RAB31;DYNLT3;NRIP1;FLNB,Ixazomib
10,Myogenesis,0.0451833053261577,WWTR1;PRNP;ITGB5;BHLHE40,Ixazomib
11,Interferon Gamma Response,0.0451833053261577,IFITM3;LGALS3BP;PSMB8;PSMB9,Ixazomib
12,Complement,0.0451833053261577,DOCK10;CTSL;FN1;PSMB9,Ixazomib
13,KRAS Signaling Up,0.0451833053261577,LIF;SOX9;GNG11;PSMB8,Ixazomib
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;ITGAV;AREG;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
1,KRAS Signaling Up,0.0012484021765132,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2;DUSP6,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
2,IL-2/STAT5 Signaling,0.0032787398893517,NRP1;NT5E;ALCAM;LRIG1;ITGAV;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
3,Estrogen Response Early,0.0032787398893517,ELOVL5;ENDOD1;LRIG1;JAK2;AREG;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
4,Estrogen Response Late,0.0032787398893517,ELOVL5;ATP2B4;CD9;JAK2;AREG;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
5,Cholesterol Homeostasis,0.0032787398893517,ALCAM;MAL2;CD9;HMGCR,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
6,Angiogenesis,0.0041701038966853,NRP1;VCAN;ITGAV,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
7,TNF-alpha Signaling via NF-kB,0.014033912783561,PLAU;PLK2;TNC;AREG;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
8,Glycolysis,0.014033912783561,NT5E;VCAN;CDK1;MIF;CD44,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
9,Coagulation,0.0193919355841698,SPARC;PLAU;CD9;DUSP6,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
10,Androgen Response,0.0442095649155186,ELOVL5;ITGAV;HMGCR,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
11,Hedgehog Signaling,0.0442095649155186,NRP1;NRP2,"1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea"
0,Hypoxia,2.277593721161866e-06,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
1,UV Response Dn,8.695357053038835e-06,TJP1;NRP1;CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA;MET,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
2,Epithelial Mesenchymal Transition,8.695357053038835e-06,NT5E;TNFRSF12A;SDC4;COL4A1;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
3,TNF-alpha Signaling via NF-kB,5.3035296419608846e-05,FOSL1;TUBB2A;SDC4;PLAU;PLK2;SERPINE1;CD44;IER3,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
4,Glycolysis,5.3035296419608846e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
5,Apoptosis,0.0009499969265379044,APP;TNFRSF12A;CAV1;PTK2;CD44;IER3,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
6,Apical Junction,0.002329630974013,TJP1;RRAS;ITGA3;EGFR;ACTB;PTK2,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
7,Cholesterol Homeostasis,0.002329630974013,ALCAM;TNFRSF12A;MAL2;CD9,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
8,Angiogenesis,0.0030727081343997,APP;NRP1;PTK2,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
9,Estrogen Response Late,0.0108779611049612,ELOVL5;CAV1;ATP2B4;CD9;CD44,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
10,p53 Pathway,0.0108779611049612,VAMP8;APP;PLK2;PTPN14;IER3,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
11,IL-6/JAK/STAT3 Signaling,0.0284733611153449,TNFRSF12A;CD9;CD44,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
12,Protein Secretion,0.0343072810329367,CAV2;PAM;EGFR,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
13,IL-2/STAT5 Signaling,0.0406649747935419,NRP1;NT5E;ALCAM;CD44,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
14,Inflammatory Response,0.0406649747935419,AXL;SERPINE1;SGMS2;MET,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
15,KRAS Signaling Up,0.0406649747935419,NRP1;PLAU;SPRY2;ETS1,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
16,Apical Surface,0.0432624364126206,APP;ATP8B1,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol"
0,Androgen Response,0.0049435408184394,INPP4B;CDK6;ELOVL5;HMGCR;B2M,BAY-61-3606 free base
1,Estrogen Response Early,0.0049435408184394,UGCG;ELOVL5;DLC1;JAK2;CD44;MICB,BAY-61-3606 free base
2,Estrogen Response Late,0.0049435408184394,FABP5;ELOVL5;ATP2B4;JAK2;CD44;MICB,BAY-61-3606 free base
3,Interferon Gamma Response,0.0049435408184394,MT2A;IFITM2;TXNIP;JAK2;B2M;PSMB8,BAY-61-3606 free base
4,Interferon Alpha Response,0.0111397353546062,IFITM2;TXNIP;B2M;PSMB8,BAY-61-3606 free base
5,p53 Pathway,0.0216048394167979,HDAC3;BAX;STOM;TXNIP;TP53,BAY-61-3606 free base
6,UV Response Dn,0.033013348397495,INPP4B;DLC1;ATP2B4;PTEN,BAY-61-3606 free base
0,Complement,0.016485554571269,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,Nvp-aew541
1,UV Response Dn,0.016485554571269,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Nvp-aew541
2,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,Nvp-aew541
3,Epithelial Mesenchymal Transition,0.0349001252117506,ITGB3;ADAM12;PMP22;SPP1;VEGFC,Nvp-aew541
0,IL-2/STAT5 Signaling,3.057349698093366e-05,PRNP;CSF1;BHLHE40;SPP1;ITGA6;PLIN2;AHR;WLS;IGF1R,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
1,Hypoxia,8.727314000480716e-05,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
2,Epithelial Mesenchymal Transition,8.727314000480716e-05,ITGB5;BDNF;ITGB3;PMP22;SPP1;VEGFC;TGFBI;EDIL3,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
3,UV Response Dn,8.727314000480716e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
4,TNF-alpha Signaling via NF-kB,0.0044618624822837,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
5,Interferon Alpha Response,0.0104732554615956,LGALS3BP;CSF1;PSMB8;PSMB9,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
6,mTORC1 Signaling,0.0182810179680598,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
7,Inflammatory Response,0.0182810179680598,LYN;CSF1;ITGB3;LPAR1;AHR,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide"
0,UV Response Dn,0.0002142158891027085,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1;LAMC1,Enzastaurin
1,TGF-beta Signaling,0.0020733848620576,TJP1;RAB31;SMURF2;ID1,Enzastaurin
2,Apical Junction,0.0299143930386433,TJP1;RRAS;CTNNA1;RHOF;PTK2,Enzastaurin
0,Cholesterol Homeostasis,0.0010841387322351,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,Talazoparib
1,Apical Junction,0.0010841387322351,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Talazoparib
2,Protein Secretion,0.0013252448992251,TPD52;SCRN1;DST;CAV2;EGFR,Talazoparib
3,UV Response Dn,0.0064764678672842,TJP1;ANXA2;ID1;MET;CAP2,Talazoparib
4,Epithelial Mesenchymal Transition,0.0182810179680598,TNFRSF12A;SDC4;DST;PFN2;CAP2,Talazoparib
5,p53 Pathway,0.0182810179680598,VAMP8;APP;PLK2;PTPN14;S100A10,Talazoparib
6,Apoptosis,0.0411222231791494,APP;GPX1;TNFRSF12A;PTK2,Talazoparib
0,Apical Junction,0.0021025720867591,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,Birinapant
1,p53 Pathway,0.0081124772405159,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,Birinapant
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,Birinapant
3,Protein Secretion,0.0109959587552742,KRT18;SCRN1;CAV2;EGFR,Birinapant
0,Hypoxia,7.170202455509579e-07,EXT1;MT2A;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;MIF;ETS1;EGFR,Vistusertib
1,Apical Junction,7.170202455509579e-07,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;FLNC;EGFR;ACTB;PTK2,Vistusertib
2,Epithelial Mesenchymal Transition,7.170202455509579e-07,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,Vistusertib
3,UV Response Dn,5.375847919693146e-06,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;AKT3;LAMC1,Vistusertib
4,Apoptosis,0.0001117185109397467,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Vistusertib
5,Angiogenesis,0.00017366837651544646,APP;FSTL1;PTK2;FGFR1,Vistusertib
6,TNF-alpha Signaling via NF-kB,0.0024627163051566,FOSL1;SDC4;DUSP1;PLK2;SERPINE1;CD44,Vistusertib
7,IL-6/JAK/STAT3 Signaling,0.0040505779563667,TNFRSF12A;CD9;OSMR;CD44,Vistusertib
8,Mitotic Spindle,0.009417494104758,NOTCH2;FARP1;MYO1E;ARHGAP29;CDC42EP1,Vistusertib
9,Estrogen Response Late,0.009417494104758,FARP1;ELOVL5;CAV1;CD9;CD44,Vistusertib
10,Glycolysis,0.009417494104758,EXT1;NT5E;MIF;EGFR;CD44,Vistusertib
11,p53 Pathway,0.009417494104758,VAMP8;APP;PLK2;PTPN14;S100A10,Vistusertib
12,Fatty Acid Metabolism,0.0213855279264967,ELOVL5;PCBD1;MIF;S100A10,Vistusertib
13,IL-2/STAT5 Signaling,0.038405809527234,MYO1E;NT5E;AHNAK;CD44,Vistusertib
14,Complement,0.038405809527234,GCA;SERPINE1;GNB4;TIMP2,Vistusertib
15,Inflammatory Response,0.038405809527234,AXL;SERPINE1;SGMS2;OSMR,Vistusertib
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,GLIPR1;DST;ITGB5;DPYSL3;PMP22;FN1;TGFBI;EMP3;EDIL3,"1H-Pyrrole-2,5-dione, 3,4-bis(1-methyl-1H-indol-3-yl)-"
1,Estrogen Response Late,0.001182696798802,KRT19;CAV1;DYNLT3;MYOF;FLNB;SFN;IL6ST,"1H-Pyrrole-2,5-dione, 3,4-bis(1-methyl-1H-indol-3-yl)-"
2,Estrogen Response Early,0.0060843579303869,KRT19;DYNLT3;MYOF;FLNB;SFN;IL6ST,"1H-Pyrrole-2,5-dione, 3,4-bis(1-methyl-1H-indol-3-yl)-"
3,UV Response Dn,0.007065237673401,ANXA2;CAV1;MAP1B;PMP22;RND3,"1H-Pyrrole-2,5-dione, 3,4-bis(1-methyl-1H-indol-3-yl)-"
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,(Arylindolyl)maleimide deriv. 20
1,Hypoxia,0.010394111464411,CDKN1C;SRPX;DTNA;TGFBI;AMPD3;MT1E,(Arylindolyl)maleimide deriv. 20
2,Myogenesis,0.0454255597994214,MEF2C;DTNA;ITGB5;ADAM12;NCAM1,(Arylindolyl)maleimide deriv. 20
0,Epithelial Mesenchymal Transition,1.4327941240524444e-08,ITGB5;BDNF;IGFBP3;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,(Phenylindolyl)maleimide deriv. 60
1,Hypoxia,1.4854568298941343e-05,SRPX;TES;DTNA;IGFBP3;GCNT2;IRS2;TGFBI;AMPD3;MT1E,(Phenylindolyl)maleimide deriv. 60
2,UV Response Dn,0.0011726400802588,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,(Phenylindolyl)maleimide deriv. 60
3,TNF-alpha Signaling via NF-kB,0.0029697461326888,CEBPB;CSF1;IRS2;SGK1;FJX1;LITAF,(Phenylindolyl)maleimide deriv. 60
4,Myogenesis,0.0029697461326888,FDPS;PRNP;DTNA;ITGB5;IGFBP3;ADAM12,(Phenylindolyl)maleimide deriv. 60
5,Complement,0.0029697461326888,DOCK10;LYN;CEBPB;ERAP2;FN1;PSMB9,(Phenylindolyl)maleimide deriv. 60
6,KRAS Signaling Up,0.0029697461326888,TMEM158;IGFBP3;SPP1;SOX9;GNG11;PSMB8,(Phenylindolyl)maleimide deriv. 60
7,IL-2/STAT5 Signaling,0.0136276679398264,PRNP;CSF1;SPP1;AHR;IGF1R,(Phenylindolyl)maleimide deriv. 60
8,Inflammatory Response,0.0136276679398264,LYN;CSF1;ITGB3;LPAR1;AHR,(Phenylindolyl)maleimide deriv. 60
9,Glycolysis,0.0136276679398264,IGFBP3;CDK1;IRS2;TGFBI;SOX9,(Phenylindolyl)maleimide deriv. 60
10,Interferon Alpha Response,0.0472243392609179,CSF1;PSMB8;PSMB9,(Phenylindolyl)maleimide deriv. 60
11,Androgen Response,0.0472243392609179,ADAMTS1;HMGCR;SGK1,(Phenylindolyl)maleimide deriv. 60
0,Estrogen Response Early,0.00011785621426579744,KRT19;RAB31;DYNLT3;MYOF;NRIP1;RHOBTB3;FLNB;IGF1R,Bisindolylmaleimide deriv. 43
1,Epithelial Mesenchymal Transition,0.00011785621426579744,ITGB5;BASP1;BDNF;PMP22;FN1;TGFBI;EMP3;EDIL3,Bisindolylmaleimide deriv. 43
2,Estrogen Response Late,0.0054083181603439,KRT19;RAB31;DYNLT3;MYOF;NRIP1;FLNB,Bisindolylmaleimide deriv. 43
3,IL-2/STAT5 Signaling,0.0260272115195691,PRNP;LIF;AHR;CKAP4;IGF1R,Bisindolylmaleimide deriv. 43
4,UV Response Dn,0.0379230258514814,BDNF;MAP1B;PMP22;IGF1R,Bisindolylmaleimide deriv. 43
0,UV Response Dn,0.00026975334183304035,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1;LAMC1,(Arylindolyl)maleimide deriv. 25
1,TGF-beta Signaling,0.002610929085554,TJP1;RAB31;SMURF2;ID1,(Arylindolyl)maleimide deriv. 25
2,Apical Junction,0.0282524823142742,TJP1;RRAS;FSCN1;CTNNA1;RHOF,(Arylindolyl)maleimide deriv. 25
3,Epithelial Mesenchymal Transition,0.0282524823142742,SLC6A8;LAMC1;FSTL1;FERMT2;PFN2,(Arylindolyl)maleimide deriv. 25
0,Angiogenesis,0.0008581260957233824,APP;FSTL1;PTK2;FGFR1,Bisindolylmaleimide deriv. 57
1,Estrogen Response Early,0.0070984175854514,ABLIM1;KRT18;MYOF;KRT8;SFN;PAPSS2,Bisindolylmaleimide deriv. 57
2,TGF-beta Signaling,0.0186134001129336,TJP1;SMURF2;ID1,Bisindolylmaleimide deriv. 57
3,Apical Junction,0.0186134001129336,TJP1;RRAS;CTNNA1;RHOF;PTK2,Bisindolylmaleimide deriv. 57
4,p53 Pathway,0.0186134001129336,APP;SFN;PTPN14;EPHA2;S100A10,Bisindolylmaleimide deriv. 57
5,UV Response Dn,0.0276522063500385,TJP1;ANXA2;MAP1B;ID1,Bisindolylmaleimide deriv. 57
6,Protein Secretion,0.0495549614920197,KRT18;SCRN1;CAV2,Bisindolylmaleimide deriv. 57
0,Epithelial Mesenchymal Transition,2.024527752143881e-06,GLIPR1;ITGB5;BASP1;BDNF;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,Bisindolylmaleimide deriv. 30
1,Hypoxia,0.0010512860433795,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide deriv. 30
2,IL-2/STAT5 Signaling,0.0052670937012007,PRNP;CSF1;LIF;AHR;WLS;IGF1R,Bisindolylmaleimide deriv. 30
3,Interferon Alpha Response,0.0114253695944679,LGALS3BP;CSF1;PSMB8;PSMB9,Bisindolylmaleimide deriv. 30
4,Estrogen Response Early,0.0151946123370886,DYNLT3;RHOBTB3;FLNB;PRSS23;IGF1R,Bisindolylmaleimide deriv. 30
5,Allograft Rejection,0.0151946123370886,TGFB2;CSF1;LIF;HLA-A;BCAT1,Bisindolylmaleimide deriv. 30
6,KRAS Signaling Up,0.0151946123370886,TMEM158;LIF;SOX9;GNG11;PSMB8,Bisindolylmaleimide deriv. 30
7,UV Response Dn,0.0237018911571759,BDNF;PMP22;MT1E;IGF1R,Bisindolylmaleimide deriv. 30
0,Epithelial Mesenchymal Transition,7.849230926268477e-10,TNFRSF12A;SDC4;DST;COL12A1;TPM1;THBS1;NT5E;GJA1;LGALS1;COL4A2;COL4A1;CD44;CAP2,(Phenylindolyl)maleimide deriv. 63
1,UV Response Dn,4.763340758105159e-08,TJP1;NRP1;GJA1;ANXA2;CAV1;MAP1B;ID1;MET;RND3;CAP2,(Phenylindolyl)maleimide deriv. 63
2,TNF-alpha Signaling via NF-kB,8.45381935712109e-06,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;IL6ST;PHLDA1;CD44,(Phenylindolyl)maleimide deriv. 63
3,Cholesterol Homeostasis,1.6535830212062116e-05,ERRFI1;ALCAM;TNFRSF12A;GPX8;MAL2;CD9,(Phenylindolyl)maleimide deriv. 63
4,IL-2/STAT5 Signaling,4.970248717351359e-05,MYO1E;NRP1;NT5E;ALCAM;AHNAK;PHLDA1;CKAP4;CD44,(Phenylindolyl)maleimide deriv. 63
5,Hypoxia,0.00032852688855612087,EXT1;ERRFI1;ANXA2;SDC4;CAV1;PAM;EGFR,(Phenylindolyl)maleimide deriv. 63
6,Glycolysis,0.00032852688855612087,EXT1;NT5E;PAM;MET;EGFR;CD44;IL13RA1,(Phenylindolyl)maleimide deriv. 63
7,IL-6/JAK/STAT3 Signaling,0.00033013044332611685,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,(Phenylindolyl)maleimide deriv. 63
8,Protein Secretion,0.00046852092396849134,SCRN1;DST;CAV2;PAM;EGFR,(Phenylindolyl)maleimide deriv. 63
9,Estrogen Response Late,0.0017746043963628,CAV1;CD9;SFN;LSR;IL6ST;CD44,(Phenylindolyl)maleimide deriv. 63
10,TGF-beta Signaling,0.0079564380588763,TJP1;ID1;THBS1,(Phenylindolyl)maleimide deriv. 63
11,Apical Junction,0.008948750054295,TJP1;SGCE;RRAS;ITGA3;EGFR,(Phenylindolyl)maleimide deriv. 63
12,p53 Pathway,0.008948750054295,APP;PLK2;SFN;PTPN14;S100A10,(Phenylindolyl)maleimide deriv. 63
13,Apoptosis,0.0218072395647004,APP;TNFRSF12A;CAV1;CD44,(Phenylindolyl)maleimide deriv. 63
14,Angiogenesis,0.032575468885119,APP;NRP1,(Phenylindolyl)maleimide deriv. 63
15,Mitotic Spindle,0.0372097808568358,MYO1E;MARCKS;DST;ARHGAP29,(Phenylindolyl)maleimide deriv. 63
16,Estrogen Response Early,0.0372097808568358,GJA1;SFN;IL6ST;CD44,(Phenylindolyl)maleimide deriv. 63
17,Apical Surface,0.0397239963973909,APP;ATP8B1,(Phenylindolyl)maleimide deriv. 63
0,Complement,0.00134696024308,DOCK10;CEBPB;ERAP2;CTSL;FDX1;FN1;PSMB9,Bisindolylmaleimide deriv. 58
1,mTORC1 Signaling,0.00134696024308,TES;PLK1;DHCR24;HMGCR;BCAT1;AURKA;HSP90B1,Bisindolylmaleimide deriv. 58
2,Interferon Alpha Response,0.0017291757832535,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Bisindolylmaleimide deriv. 58
3,Hypoxia,0.0051970557322055,SRPX;TES;DTNA;PLIN2;TGFBI;MT1E,Bisindolylmaleimide deriv. 58
4,IL-2/STAT5 Signaling,0.0194680970568948,IFITM3;SPP1;PLIN2;AHR;IGF1R,Bisindolylmaleimide deriv. 58
5,Interferon Gamma Response,0.0194680970568948,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,Bisindolylmaleimide deriv. 58
6,Epithelial Mesenchymal Transition,0.0194680970568948,BASP1;ITGB3;SPP1;FN1;TGFBI,Bisindolylmaleimide deriv. 58
7,Apoptosis,0.0447048411076359,IFITM3;BAX;TXNIP;BIRC3,Bisindolylmaleimide deriv. 58
0,Epithelial Mesenchymal Transition,4.471554693684914e-11,NOTCH2;TNFRSF12A;SDC4;SERPINE1;FN1;LAMC1;FSTL1;LOXL2;NT5E;LGALS1;CDH2;VIM;FERMT2;CD44,Bisindolylmaleimide deriv. 40
1,UV Response Dn,6.159211245902508e-06,NOTCH2;ANXA2;CAV1;MAP1B;SERPINE1;AKT3;LAMC1;RND3,Bisindolylmaleimide deriv. 40
2,TNF-alpha Signaling via NF-kB,6.159211245902508e-06,FOSL1;MARCKS;CCND1;SDC4;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,Bisindolylmaleimide deriv. 40
3,Hypoxia,6.159211245902508e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;NEDD4L;ETS1;EGFR,Bisindolylmaleimide deriv. 40
4,Apoptosis,0.0010766631834096,APP;CCND1;TNFRSF12A;CAV1;TIMP2;CD44,Bisindolylmaleimide deriv. 40
5,IL-2/STAT5 Signaling,0.0027981435287629,MYO1E;NT5E;AHNAK;PHLDA1;CKAP4;CD44,Bisindolylmaleimide deriv. 40
6,IL-6/JAK/STAT3 Signaling,0.0046292319501333,TNFRSF12A;OSMR;IL6ST;CD44,Bisindolylmaleimide deriv. 40
7,Apical Junction,0.0141262411571371,SGCE;RRAS;ITGA3;AKT3;EGFR,Bisindolylmaleimide deriv. 40
8,Cholesterol Homeostasis,0.0229743359926827,TNFRSF12A;GPX8;S100A11,Bisindolylmaleimide deriv. 40
9,Notch Signaling,0.0378573752155645,NOTCH2;CCND1,Bisindolylmaleimide deriv. 40
10,Angiogenesis,0.038405809527234,APP;FSTL1,Bisindolylmaleimide deriv. 40
11,G2-M Checkpoint,0.038405809527234,NOTCH2;MARCKS;MT2A;CCND1,Bisindolylmaleimide deriv. 40
12,Estrogen Response Late,0.038405809527234,CCND1;CAV1;IL6ST;CD44,Bisindolylmaleimide deriv. 40
13,Inflammatory Response,0.038405809527234,AXL;SERPINE1;SGMS2;OSMR,Bisindolylmaleimide deriv. 40
14,Glycolysis,0.038405809527234,EXT1;NT5E;EGFR;CD44,Bisindolylmaleimide deriv. 40
15,p53 Pathway,0.038405809527234,APP;PLK2;PTPN14;S100A10,Bisindolylmaleimide deriv. 40
0,UV Response Dn,0.0023166791829503,TJP1;ANXA2;CAV1;MAP1B;ID1;LAMC1,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
1,Estrogen Response Early,0.0045632684477902,ABLIM1;KRT18;MYOF;KRT8;FLNB;SFN,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
2,p53 Pathway,0.0045632684477902,APP;LIF;SFN;PTPN14;TM4SF1;S100A10,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
3,Angiogenesis,0.0051851949767995,APP;FSTL1;PTK2,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
4,Apoptosis,0.0061852267998417,APP;KRT18;CAV1;TIMP2;PTK2,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
5,Protein Secretion,0.0061852267998417,KRT18;SCRN1;DST;CAV2,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
6,Epithelial Mesenchymal Transition,0.0128204541594185,DST;LAMC1;FSTL1;FERMT2;PFN2,"3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
0,Epithelial Mesenchymal Transition,0.000302006549056106,ITGB5;BDNF;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,(Phenylindolyl)maleimide deriv. 70
1,Hypoxia,0.00134696024308,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,(Phenylindolyl)maleimide deriv. 70
2,mTORC1 Signaling,0.0069294076429407,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,(Phenylindolyl)maleimide deriv. 70
3,UV Response Dn,0.0080465206835956,BDNF;ITGB3;PMP22;MT1E;IGF1R,(Phenylindolyl)maleimide deriv. 70
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,Bisindolylmaleimide deriv. 49
1,Hypoxia,0.00013995425444063446,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,Bisindolylmaleimide deriv. 49
2,UV Response Dn,0.0099436678366384,ITGB3;PMP22;NR3C1;MT1E;IGF1R,Bisindolylmaleimide deriv. 49
3,IL-2/STAT5 Signaling,0.0210508691753416,PRNP;SPP1;LIF;AHR;IGF1R,Bisindolylmaleimide deriv. 49
4,mTORC1 Signaling,0.0210508691753416,TES;DHCR24;HMGCR;BCAT1;HSP90B1,Bisindolylmaleimide deriv. 49
5,KRAS Signaling Up,0.0210508691753416,SPP1;LIF;SOX9;GNG11;PSMB8,Bisindolylmaleimide deriv. 49
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,"3-(1,5-Dimethyl-1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
1,Estrogen Response Late,0.031022333521556,KRT19;MYOF;FLNB;SFN;LSR,"3-(1,5-Dimethyl-1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"3-(1,5-Dimethyl-1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,"3-(1,5-Dimethyl-1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
0,Epithelial Mesenchymal Transition,1.4327941240524444e-08,SERPINE2;ITGB5;IGFBP3;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,Bisindolylmaleimide deriv. 42
1,Hypoxia,1.4854568298941343e-05,CDKN1C;SRPX;DTNA;IGFBP3;GCNT2;IRS2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide deriv. 42
2,Myogenesis,0.0008979734953867304,PRNP;MEF2C;DTNA;ITGB5;IGFBP3;ADAM12;NCAM1,Bisindolylmaleimide deriv. 42
3,KRAS Signaling Up,0.034069169849566,TMEM158;IGFBP3;SPP1;LCP1;PSMB8,Bisindolylmaleimide deriv. 42
0,Epithelial Mesenchymal Transition,2.39122318958568e-05,GLIPR1;ITGB5;BDNF;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,Bisindolylmaleimide deriv. 48
1,Hypoxia,0.0001215392209616036,SRPX;TES;DTNA;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide deriv. 48
2,IL-2/STAT5 Signaling,0.000700298363286806,PRNP;CSF1;BHLHE40;LIF;AHR;WLS;IGF1R,Bisindolylmaleimide deriv. 48
3,UV Response Dn,0.0007078741947903889,EFEMP1;BDNF;BHLHE40;PMP22;MT1E;IGF1R,Bisindolylmaleimide deriv. 48
4,Estrogen Response Early,0.0033463968617128,DYNLT3;BHLHE40;RHOBTB3;FLNB;PRSS23;IGF1R,Bisindolylmaleimide deriv. 48
5,Interferon Alpha Response,0.0078549415961967,LGALS3BP;CSF1;PSMB8;PSMB9,Bisindolylmaleimide deriv. 48
6,TNF-alpha Signaling via NF-kB,0.0121873453120398,CSF1;BHLHE40;LIF;FJX1;LITAF,Bisindolylmaleimide deriv. 48
7,Myogenesis,0.0121873453120398,WWTR1;PRNP;DTNA;ITGB5;BHLHE40,Bisindolylmaleimide deriv. 48
8,KRAS Signaling Up,0.0121873453120398,TMEM158;LIF;SOX9;GNG11;PSMB8,Bisindolylmaleimide deriv. 48
0,Estrogen Response Early,0.001774045198203,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,Bisindolylmaleimide deriv. 47
1,Estrogen Response Late,0.0299143930386433,KRT19;MYOF;FLNB;SFN;LSR,Bisindolylmaleimide deriv. 47
2,Apical Junction,0.0299143930386433,TJP1;RRAS;FSCN1;CTNNA1;RHOF,Bisindolylmaleimide deriv. 47
3,UV Response Dn,0.0399969413277343,TJP1;ANXA2;MAP1B;ID1,Bisindolylmaleimide deriv. 47
0,Epithelial Mesenchymal Transition,1.4677403222000651e-08,SPARC;LGALS1;DST;COL4A2;ITGB5;BASP1;SPP1;FN1;TGFBI;EMP3;EDIL3;THBS1,(Phenylindolyl)maleimide deriv. 72
1,Myogenesis,0.0106476263781772,APP;MEF2C;DTNA;SPARC;COL4A2;ITGB5,(Phenylindolyl)maleimide deriv. 72
2,UV Response Dn,0.0109903697141793,CAV1;MAP1B;PTPRM;NR3C1;RND3,(Phenylindolyl)maleimide deriv. 72
3,Hypoxia,0.0279201001694004,SRPX;DTNA;CAV1;TGFBI;NR3C1,(Phenylindolyl)maleimide deriv. 72
4,p53 Pathway,0.0279201001694004,APP;LIF;BAX;TXNIP;TM4SF1,(Phenylindolyl)maleimide deriv. 72
5,Coagulation,0.035721986602418,SPARC;CAPN2;FN1;THBS1,(Phenylindolyl)maleimide deriv. 72
0,Epithelial Mesenchymal Transition,0.00028727452227288126,SPARC;ITGB5;ADAM12;SPP1;FN1;TGFBI;EMP3;EDIL3,Bisindolylmaleimide deriv. 28
1,Hypoxia,0.0012812548653688,CDKN1C;SRPX;TES;DTNA;TGFBI;AMPD3;MT1E,Bisindolylmaleimide deriv. 28
2,Myogenesis,0.0324072591251969,MEF2C;DTNA;SPARC;ITGB5;ADAM12,Bisindolylmaleimide deriv. 28
3,mTORC1 Signaling,0.0324072591251969,TES;DHCR24;HMGCR;BCAT1;HSP90B1,Bisindolylmaleimide deriv. 28
0,Epithelial Mesenchymal Transition,8.073494667019005e-10,SPARC;TNFRSF12A;SDC4;DST;COL12A1;THBS1;NT5E;VCAN;LGALS1;COL4A1;ITGAV;VIM;CD44,(Phenylindolyl)maleimide deriv. 66
1,Glycolysis,1.1300330762764256e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1,(Phenylindolyl)maleimide deriv. 66
2,Angiogenesis,1.1300330762764256e-05,APP;NRP1;VCAN;ITGAV;PTK2,(Phenylindolyl)maleimide deriv. 66
3,Hypoxia,0.0005913483994010176,EXT1;SDC4;CAV1;MIF;ETS1;PAM;EGFR,(Phenylindolyl)maleimide deriv. 66
4,Protein Secretion,0.0008674330249473783,SCRN1;DST;CAV2;PAM;EGFR,(Phenylindolyl)maleimide deriv. 66
5,Apoptosis,0.0009499969265379044,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,(Phenylindolyl)maleimide deriv. 66
6,IL-2/STAT5 Signaling,0.0018637047792104,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,(Phenylindolyl)maleimide deriv. 66
7,TNF-alpha Signaling via NF-kB,0.0018637047792104,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44,(Phenylindolyl)maleimide deriv. 66
8,Apical Junction,0.0018637047792104,TJP1;VCAN;ITGA3;EGFR;ACTB;PTK2,(Phenylindolyl)maleimide deriv. 66
9,Cholesterol Homeostasis,0.0018637047792104,ALCAM;TNFRSF12A;MAL2;CD9,(Phenylindolyl)maleimide deriv. 66
10,IL-6/JAK/STAT3 Signaling,0.0031191616348492,TNFRSF12A;CD9;CD44;IL13RA1,(Phenylindolyl)maleimide deriv. 66
11,Coagulation,0.0153094228296077,SPARC;PLAU;CD9;THBS1,(Phenylindolyl)maleimide deriv. 66
12,UV Response Dn,0.0164090015703525,TJP1;NRP1;CAV1;MET,(Phenylindolyl)maleimide deriv. 66
13,Estrogen Response Late,0.0433759731131114,ELOVL5;CAV1;CD9;CD44,(Phenylindolyl)maleimide deriv. 66
14,p53 Pathway,0.0433759731131114,VAMP8;APP;PLK2;PTPN14,(Phenylindolyl)maleimide deriv. 66
15,Apical Surface,0.0459663386884094,APP;ATP8B1,(Phenylindolyl)maleimide deriv. 66
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,ITGB5;BASP1;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,(Phenylindolyl)maleimide deriv. 77
1,Hypoxia,0.0011498441099464,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,(Phenylindolyl)maleimide deriv. 77
2,IL-2/STAT5 Signaling,0.0057608837356883,IFITM3;SPP1;LIF;AHR;CKAP4;IGF1R,(Phenylindolyl)maleimide deriv. 77
3,UV Response Dn,0.0068689810713621,PMP22;PTPRM;NR3C1;MT1E;IGF1R,(Phenylindolyl)maleimide deriv. 77
4,Interferon Alpha Response,0.0099971983951594,IFITM3;LGALS3BP;HLA-C;PSMB8,(Phenylindolyl)maleimide deriv. 77
5,Estrogen Response Early,0.0145417188382294,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,(Phenylindolyl)maleimide deriv. 77
6,Interferon Gamma Response,0.0145417188382294,IFITM3;LGALS3BP;TNFAIP2;HLA-A;PSMB8,(Phenylindolyl)maleimide deriv. 77
7,KRAS Signaling Up,0.0145417188382294,SPP1;LIF;SOX9;GNG11;PSMB8,(Phenylindolyl)maleimide deriv. 77
0,Epithelial Mesenchymal Transition,2.246300572035033e-05,LGALS1;TNFRSF12A;SDC4;DST;COL12A1;THBS1;CD44;PFN2;CAP2,(Phenylindolyl)maleimide deriv. 74
1,TNF-alpha Signaling via NF-kB,0.00011417320756999128,FOSL1;MARCKS;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,(Phenylindolyl)maleimide deriv. 74
2,Cholesterol Homeostasis,0.00035782122986795695,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,(Phenylindolyl)maleimide deriv. 74
3,UV Response Dn,0.0006649727284394563,TJP1;NRP1;CAV1;ID1;MET;CAP2,(Phenylindolyl)maleimide deriv. 74
4,Protein Secretion,0.0007469562159269091,SCRN1;DST;CAV2;PAM;EGFR,(Phenylindolyl)maleimide deriv. 74
5,Apoptosis,0.0008180529089631955,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,(Phenylindolyl)maleimide deriv. 74
6,Glycolysis,0.0022454178076428,PAM;MET;EGFR;CD44;IL13RA1;IER3,(Phenylindolyl)maleimide deriv. 74
7,IL-6/JAK/STAT3 Signaling,0.0036931740190402,TNFRSF12A;CD9;CD44;IL13RA1,(Phenylindolyl)maleimide deriv. 74
8,TGF-beta Signaling,0.0079260357623755,TJP1;ID1;THBS1,(Phenylindolyl)maleimide deriv. 74
9,IL-2/STAT5 Signaling,0.0079260357623755,NRP1;ALCAM;AHNAK;CKAP4;CD44,(Phenylindolyl)maleimide deriv. 74
10,Hypoxia,0.0079260357623755,SDC4;CAV1;PAM;EGFR;IER3,(Phenylindolyl)maleimide deriv. 74
11,Apical Junction,0.0079260357623755,TJP1;RRAS;ITGA3;CTNNA1;EGFR,(Phenylindolyl)maleimide deriv. 74
12,p53 Pathway,0.0079260357623755,APP;PLK2;PTPN14;S100A10;IER3,(Phenylindolyl)maleimide deriv. 74
13,Angiogenesis,0.0309134551664904,APP;NRP1,(Phenylindolyl)maleimide deriv. 74
14,Estrogen Response Late,0.037351532402957,CAV1;CD9;LSR;CD44,(Phenylindolyl)maleimide deriv. 74
15,Apical Surface,0.0395821249816859,APP;ATP8B1,(Phenylindolyl)maleimide deriv. 74
0,Epithelial Mesenchymal Transition,1.682528284715285e-07,GLIPR1;ITGB5;BASP1;BDNF;ITGB3;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,Bisindolylmaleimide deriv. 56
1,IL-2/STAT5 Signaling,0.000120706040278533,PRNP;CSF1;BHLHE40;LIF;ITGA6;AHR;WLS;IGF1R,Bisindolylmaleimide deriv. 56
2,Hypoxia,0.0007293249279658553,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide deriv. 56
3,UV Response Dn,0.0007293249279658553,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,Bisindolylmaleimide deriv. 56
4,TNF-alpha Signaling via NF-kB,0.0028731690226827,CEBPB;CSF1;BHLHE40;LIF;FJX1;LITAF,Bisindolylmaleimide deriv. 56
5,Estrogen Response Early,0.0028731690226827,DYNLT3;BHLHE40;RHOBTB3;FLNB;PRSS23;IGF1R,Bisindolylmaleimide deriv. 56
6,Interferon Alpha Response,0.0069368315394984,LGALS3BP;CSF1;PSMB8;PSMB9,Bisindolylmaleimide deriv. 56
7,Complement,0.0102736299324633,DOCK10;LYN;CEBPB;FN1;PSMB9,Bisindolylmaleimide deriv. 56
8,Inflammatory Response,0.0102736299324633,LYN;CSF1;ITGB3;LIF;AHR,Bisindolylmaleimide deriv. 56
9,Allograft Rejection,0.0102736299324633,LYN;TGFB2;CSF1;LIF;BCAT1,Bisindolylmaleimide deriv. 56
10,KRAS Signaling Up,0.0102736299324633,TMEM158;LIF;SOX9;GNG11;PSMB8,Bisindolylmaleimide deriv. 56
11,Coagulation,0.0144588993390739,ITGB3;CAPN2;FN1;PRSS23,Bisindolylmaleimide deriv. 56
12,Myogenesis,0.0438923537454103,WWTR1;PRNP;ITGB5;BHLHE40,Bisindolylmaleimide deriv. 56
13,mTORC1 Signaling,0.0438923537454103,TES;BHLHE40;BCAT1;HSP90B1,Bisindolylmaleimide deriv. 56
14,Apical Surface,0.0463068300861014,LYN;SRPX,Bisindolylmaleimide deriv. 56
0,Epithelial Mesenchymal Transition,1.3629017277572033e-08,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,Bisindolylmaleimide 6d
1,Hypoxia,0.00014363726113644063,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide 6d
2,IL-2/STAT5 Signaling,0.0008276253384298616,PRNP;CSF1;SPP1;ITGA6;AHR;WLS;IGF1R,Bisindolylmaleimide 6d
3,UV Response Dn,0.000836578593843187,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,Bisindolylmaleimide 6d
4,TNF-alpha Signaling via NF-kB,0.0039548326547515,CEBPB;CSF1;IRS2;SGK1;FJX1;LITAF,Bisindolylmaleimide 6d
5,Interferon Alpha Response,0.0092831127955052,LGALS3BP;CSF1;PSMB8;PSMB9,Bisindolylmaleimide 6d
6,Myogenesis,0.0144032262778653,FDPS;PRNP;DTNA;ITGB5;ADAM12,Bisindolylmaleimide 6d
7,Complement,0.0144032262778653,DOCK10;LYN;CEBPB;FN1;PSMB9,Bisindolylmaleimide 6d
8,Inflammatory Response,0.0144032262778653,LYN;CSF1;ITGB3;LPAR1;AHR,Bisindolylmaleimide 6d
0,UV Response Dn,0.000238017654558565,TJP1;ANXA2;CAV1;MAP1B;ID1;MET;CAP2,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
1,Cholesterol Homeostasis,0.0005194179143244536,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
2,Epithelial Mesenchymal Transition,0.0006570537771122417,TNFRSF12A;SDC4;DST;VIM;FSTL1;PFN2;CAP2,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
3,Protein Secretion,0.0009035760676535192,TPD52;SCRN1;DST;CAV2;EGFR,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
4,Apoptosis,0.0009499969265379044,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
5,Apical Junction,0.0025351491376612,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
6,Angiogenesis,0.0032921872868568,APP;FSTL1;PTK2,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
7,Hypoxia,0.0099714643462144,TPD52;ANXA2;SDC4;CAV1;EGFR,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
8,Estrogen Response Late,0.0099714643462144,CAV1;MYOF;CD9;SFN;LSR,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
9,p53 Pathway,0.0099714643462144,APP;PLK2;SFN;PTPN14;S100A10,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
10,IL-6/JAK/STAT3 Signaling,0.0258848737412226,TNFRSF12A;CD9;OSMR,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
11,Inflammatory Response,0.0451833053261577,AXL;SGMS2;OSMR;MET,"1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-"
0,Epithelial Mesenchymal Transition,1.8309866627783985e-07,ITGB5;BASP1;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
1,Hypoxia,0.0010582361699896,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
2,UV Response Dn,0.0010582361699896,ITGB3;PMP22;PTPRM;NR3C1;MT1E;IGF1R,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
3,IL-2/STAT5 Signaling,0.00456755781901,IFITM3;PRNP;SPP1;LIF;AHR;IGF1R,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
4,Interferon Alpha Response,0.0105684668748828,IFITM3;LGALS3BP;HLA-C;PSMB8,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
5,Estrogen Response Early,0.0175687705147588,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
6,KRAS Signaling Up,0.0175687705147588,SPP1;LIF;SOX9;GNG11;PSMB8,"3-(1-methyl-1H-indol-3-yl)-4-(pyridin-3-yl)-1H-pyrrole-2,5-dione"
0,UV Response Dn,0.00019834804546547084,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1;LAMC1,Bisindolylmaleimide 6c
1,TGF-beta Signaling,0.0019198007982014,TJP1;RAB31;SMURF2;ID1,Bisindolylmaleimide 6c
2,Estrogen Response Early,0.0207738840546134,ABLIM1;RAB31;KRT18;KRT8;SFN,Bisindolylmaleimide 6c
3,Apical Junction,0.0207738840546134,TJP1;RRAS;CTNNA1;RHOF;PTK2,Bisindolylmaleimide 6c
0,Epithelial Mesenchymal Transition,1.293009331461962e-08,ITGB5;BASP1;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EMP3;EDIL3,Bisindolylmaleimide 5a
1,Hypoxia,0.0010582361699896,SRPX;TES;DTNA;TGFBI;AMPD3;NR3C1;MT1E,Bisindolylmaleimide 5a
2,UV Response Dn,0.0010582361699896,ITGB3;PMP22;PTPRM;NR3C1;MT1E;IGF1R,Bisindolylmaleimide 5a
3,IL-2/STAT5 Signaling,0.00456755781901,PRNP;SPP1;LIF;AHR;CKAP4;IGF1R,Bisindolylmaleimide 5a
4,Estrogen Response Early,0.0204968989338852,DYNLT3;MYOF;RHOBTB3;FLNB;IGF1R,Bisindolylmaleimide 5a
5,KRAS Signaling Up,0.0204968989338852,SPP1;LIF;SOX9;GNG11;PSMB8,Bisindolylmaleimide 5a
0,Epithelial Mesenchymal Transition,7.62496718551795e-10,SPARC;TNFRSF12A;SDC4;DST;COL12A1;THBS1;NT5E;VCAN;LGALS1;COL4A1;SNAI2;ITGAV;CD44,Bisindolylmaleimide 7
1,Glycolysis,1.2318422491805016e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1;IER3,Bisindolylmaleimide 7
2,Angiogenesis,0.0003473367530308929,APP;NRP1;VCAN;ITGAV,Bisindolylmaleimide 7
3,TNF-alpha Signaling via NF-kB,0.0004467965684363244,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,Bisindolylmaleimide 7
4,Hypoxia,0.0004467965684363244,SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,Bisindolylmaleimide 7
5,UV Response Dn,0.0004862166186439036,TJP1;NRP1;CAV1;ATP2B4;SNAI2;MET,Bisindolylmaleimide 7
6,Protein Secretion,0.0005851730723851361,SCRN1;DST;CAV2;PAM;EGFR,Bisindolylmaleimide 7
7,Apoptosis,0.0006729144896310157,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,Bisindolylmaleimide 7
8,IL-2/STAT5 Signaling,0.0017601656248098,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,Bisindolylmaleimide 7
9,Cholesterol Homeostasis,0.0017601656248098,ALCAM;TNFRSF12A;MAL2;CD9,Bisindolylmaleimide 7
10,IL-6/JAK/STAT3 Signaling,0.0029458748773576,TNFRSF12A;CD9;CD44;IL13RA1,Bisindolylmaleimide 7
11,Estrogen Response Late,0.0086930714813151,ELOVL5;CAV1;ATP2B4;CD9;CD44,Bisindolylmaleimide 7
12,Apical Junction,0.0086930714813151,TJP1;VCAN;ITGA3;EGFR;ACTB,Bisindolylmaleimide 7
13,Coagulation,0.0123933422906348,SPARC;PLAU;CD9;THBS1,Bisindolylmaleimide 7
14,Pperoxisome,0.0347827327998073,SEMA3C;ELOVL5;PRDX1,Bisindolylmaleimide 7
0,Epithelial Mesenchymal Transition,1.1497347860651384e-17,SPARC;TNFRSF12A;SDC4;DST;COL12A1;SERPINE1;TPM1;PLOD2;THBS1;LOXL2;NT5E;VCAN;LGALS1;CDH2;COL4A2;COL4A1;SNAI2;ITGAV;CD44,Bisindolylmaleimide 6a
1,UV Response Dn,8.857308915629479e-07,NRP1;CAV1;SERPINE1;AKT3;ATP2B4;SNAI2;PRKCA;MET;RND3,Bisindolylmaleimide 6a
2,Glycolysis,8.857308915629479e-07,EXT1;NT5E;VCAN;CDK1;PLOD2;PAM;MET;EGFR;CD44;IL13RA1,Bisindolylmaleimide 6a
3,TNF-alpha Signaling via NF-kB,6.086749937127185e-06,FOSL1;JAG1;TUBB2A;SDC4;PLAU;PLK2;SERPINE1;IL6ST;CD44,Bisindolylmaleimide 6a
4,Hypoxia,6.086749937127185e-06,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;ETS1;PAM;EGFR,Bisindolylmaleimide 6a
5,Angiogenesis,6.591859611612482e-06,APP;NRP1;VCAN;JAG1;ITGAV,Bisindolylmaleimide 6a
6,IL-2/STAT5 Signaling,4.260213186301165e-05,MYO1E;NRP1;NT5E;ALCAM;AHNAK;ITGAV;CKAP4;CD44,Bisindolylmaleimide 6a
7,Cholesterol Homeostasis,0.0001817962700135588,ALCAM;JAG1;TNFRSF12A;MAL2;CD9,Bisindolylmaleimide 6a
8,IL-6/JAK/STAT3 Signaling,0.00035213913954785803,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,Bisindolylmaleimide 6a
10,Apical Junction,0.0019359320687594,SGCE;VCAN;ITGA3;AKT3;EGFR;ACTB,Bisindolylmaleimide 6a
9,Estrogen Response Late,0.0019359320687594,ELOVL5;CAV1;ATP2B4;CD9;IL6ST;CD44,Bisindolylmaleimide 6a
11,Coagulation,0.0022668465243448,SPARC;PLAU;SERPINE1;CD9;THBS1,Bisindolylmaleimide 6a
12,Protein Secretion,0.004152775568087,DST;CAV2;PAM;EGFR,Bisindolylmaleimide 6a
13,Apical Surface,0.004152775568087,APP;ATP8B1;DCBLD2,Bisindolylmaleimide 6a
14,Apoptosis,0.0244241083124645,APP;TNFRSF12A;CAV1;CD44,Bisindolylmaleimide 6a
15,Notch Signaling,0.0292281205708403,JAG1;PRKCA,Bisindolylmaleimide 6a
16,Hedgehog Signaling,0.0344916729371848,NRP1;NRP2,Bisindolylmaleimide 6a
20,Xenobiotic Metabolism,0.0345036149763386,MT2A;ELOVL5;SERPINE1;MAN1A1,Bisindolylmaleimide 6a
17,Mitotic Spindle,0.0345036149763386,MYO1E;DST;CDK1;ARHGAP29,Bisindolylmaleimide 6a
18,Estrogen Response Early,0.0345036149763386,ELOVL5;ENDOD1;IL6ST;CD44,Bisindolylmaleimide 6a
19,Inflammatory Response,0.0345036149763386,AXL;SERPINE1;MET;DCBLD2,Bisindolylmaleimide 6a
21,KRAS Signaling Up,0.0345036149763386,NRP1;PLAU;ETS1;DCBLD2,Bisindolylmaleimide 6a
0,Interferon Alpha Response,0.0054405774643831,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
1,Hypoxia,0.0072674275279622,SRPX;TES;PLIN2;TGFBI;AMPD3;MT1E,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
2,Epithelial Mesenchymal Transition,0.0072674275279622,ITGB5;ITGB3;PMP22;SPP1;TGFBI;EDIL3,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
3,IL-2/STAT5 Signaling,0.0204177603279629,IFITM3;SPP1;PLIN2;AHR;IGF1R,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
4,Interferon Gamma Response,0.0204177603279629,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
5,Complement,0.0204177603279629,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
6,mTORC1 Signaling,0.0204177603279629,TES;PLK1;BCAT1;AURKA;HSP90B1,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
7,UV Response Dn,0.0318494162424551,ITGB3;PMP22;MT1E;IGF1R,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
8,Apoptosis,0.0416760578347609,IFITM3;TGFB2;BAX;TXNIP,"1-[3-[3-[4-(1-Methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl]-2-nitroguanidine"
0,Hypoxia,0.0013798129319357,SRPX;TES;IRS2;PLIN2;TGFBI;AMPD3;MT1E,bisindolylmaleimide IX
1,Epithelial Mesenchymal Transition,0.0013798129319357,ITGB5;ITGB3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,bisindolylmaleimide IX
2,Interferon Alpha Response,0.0017713508023572,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,bisindolylmaleimide IX
3,mTORC1 Signaling,0.0053238131890886,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,bisindolylmaleimide IX
4,IL-2/STAT5 Signaling,0.0199429286924289,IFITM3;SPP1;PLIN2;AHR;IGF1R,bisindolylmaleimide IX
5,Interferon Gamma Response,0.0199429286924289,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,bisindolylmaleimide IX
6,Complement,0.0199429286924289,DOCK10;LYN;CEBPB;ERAP2;PSMB9,bisindolylmaleimide IX
7,UV Response Dn,0.0311087321437933,ITGB3;PMP22;MT1E;IGF1R,bisindolylmaleimide IX
8,Apoptosis,0.0407068471874408,IFITM3;TGFB2;BAX;TXNIP,bisindolylmaleimide IX
0,Estrogen Response Early,0.0001915163481819208,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,Bisindolylmaleimide deriv. 5b
1,Estrogen Response Late,0.0065913877579192,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,Bisindolylmaleimide deriv. 5b
2,Apical Junction,0.0288064525557306,TJP1;RRAS;FSCN1;CTNNA1;RHOF,Bisindolylmaleimide deriv. 5b
3,UV Response Dn,0.0385155731304108,TJP1;ANXA2;MAP1B;ID1,Bisindolylmaleimide deriv. 5b
0,Hypoxia,0.00015468628122385913,SRPX;TES;DTNA;GCNT2;IRS2;TGFBI;AMPD3;MT1E,Bisindolylmaleimide 13
1,Epithelial Mesenchymal Transition,0.00015468628122385913,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;TGFBI,Bisindolylmaleimide 13
2,mTORC1 Signaling,0.0070984175854514,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Bisindolylmaleimide 13
3,UV Response Dn,0.0082427772856345,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Bisindolylmaleimide 13
4,TNF-alpha Signaling via NF-kB,0.023266750141167,CEBPB;IRS2;SGK1;FJX1;LITAF,Bisindolylmaleimide 13
5,Complement,0.023266750141167,DOCK10;LYN;CEBPB;ERAP2;PSMB9,Bisindolylmaleimide 13
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,Bisindolylmaleimide deriv. 17
1,Apical Junction,0.0070984175854514,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,Bisindolylmaleimide deriv. 17
2,Estrogen Response Late,0.031022333521556,MYOF;NRIP1;FLNB;SFN;LSR,Bisindolylmaleimide deriv. 17
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,Bisindolylmaleimide deriv. 17
0,Hypoxia,0.0026282151084489,SRPX;TES;IRS2;PLIN2;TGFBI;AMPD3;MT1E,"3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
1,mTORC1 Signaling,0.0101405965506449,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
2,Interferon Alpha Response,0.0190422826574466,LGALS3BP;TXNIP;PSMB8;PSMB9,"3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
0,mTORC1 Signaling,0.0027596258638714,TES;PRDX1;PLK1;DHCR24;HMGCR;BCAT1;HSP90B1,Bisindolylmaleimide 11a
1,IL-2/STAT5 Signaling,0.0070984175854514,IFITM3;CTSZ;SPP1;LIF;PLIN2;IGF1R,Bisindolylmaleimide 11a
2,p53 Pathway,0.0070984175854514,LDHB;LIF;BAX;TXNIP;TP53;TM4SF1,Bisindolylmaleimide 11a
3,Epithelial Mesenchymal Transition,0.0349001252117506,SPARC;BASP1;SPP1;TGFBI;EMP3,Bisindolylmaleimide 11a
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,(Arylindolyl)maleimide deriv. 15
1,Hypoxia,0.00134696024308,CDKN1C;SRPX;TES;DTNA;TGFBI;AMPD3;MT1E,(Arylindolyl)maleimide deriv. 15
2,mTORC1 Signaling,0.0454255597994214,TES;DHCR24;HMGCR;BCAT1;HSP90B1,(Arylindolyl)maleimide deriv. 15
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,ITGB5;BASP1;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,(Phenylindolyl)maleimide deriv. 67
1,Hypoxia,0.00015100327452805296,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,(Phenylindolyl)maleimide deriv. 67
2,IL-2/STAT5 Signaling,0.0067484638046634,IFITM3;PRNP;SPP1;LIF;AHR;IGF1R,(Phenylindolyl)maleimide deriv. 67
3,UV Response Dn,0.0080465206835956,ITGB3;PMP22;NR3C1;MT1E;IGF1R,(Phenylindolyl)maleimide deriv. 67
4,Interferon Alpha Response,0.0117110038343296,IFITM3;LGALS3BP;PSMB8;PSMB9,(Phenylindolyl)maleimide deriv. 67
5,Interferon Gamma Response,0.017034584924783,IFITM3;LGALS3BP;HLA-A;PSMB8;PSMB9,(Phenylindolyl)maleimide deriv. 67
6,mTORC1 Signaling,0.017034584924783,TES;DHCR24;BCAT1;AURKA;HSP90B1,(Phenylindolyl)maleimide deriv. 67
7,KRAS Signaling Up,0.017034584924783,SPP1;LIF;SOX9;GNG11;PSMB8,(Phenylindolyl)maleimide deriv. 67
0,Hypoxia,2.277593721161866e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,Bisindolylmaleimide deriv. 9a
1,Glycolysis,1.3043035579558251e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,Bisindolylmaleimide deriv. 9a
2,Apoptosis,1.765718783691451e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,Bisindolylmaleimide deriv. 9a
3,Apical Junction,0.0004527503222758174,TJP1;ITGA3;AKT3;CTNNA1;EGFR;ACTB;PTK2,Bisindolylmaleimide deriv. 9a
4,Epithelial Mesenchymal Transition,0.0004527503222758174,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;VIM;CD44,Bisindolylmaleimide deriv. 9a
5,IL-6/JAK/STAT3 Signaling,0.0004527503222758174,TNFRSF12A;CD9;OSMR;CD44;IL13RA1,Bisindolylmaleimide deriv. 9a
6,TNF-alpha Signaling via NF-kB,0.0026075819701658,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,Bisindolylmaleimide deriv. 9a
7,UV Response Dn,0.0035326188367005,TJP1;CAV1;AKT3;PRKCA;MET,Bisindolylmaleimide deriv. 9a
8,Protein Secretion,0.0054979793776371,SCRN1;CAV2;PAM;EGFR,Bisindolylmaleimide deriv. 9a
9,p53 Pathway,0.0119657572154573,VAMP8;APP;PLK2;PTPN14;IER3,Bisindolylmaleimide deriv. 9a
10,Cholesterol Homeostasis,0.0199029006995433,ALCAM;TNFRSF12A;CD9,Bisindolylmaleimide deriv. 9a
11,Angiogenesis,0.0418827457094387,APP;PTK2,Bisindolylmaleimide deriv. 9a
12,IL-2/STAT5 Signaling,0.0433759731131114,NT5E;ALCAM;AHNAK;CD44,Bisindolylmaleimide deriv. 9a
13,Estrogen Response Late,0.0433759731131114,ELOVL5;CAV1;CD9;CD44,Bisindolylmaleimide deriv. 9a
14,Inflammatory Response,0.0433759731131114,AXL;SGMS2;OSMR;MET,Bisindolylmaleimide deriv. 9a
0,Hypoxia,0.0027202887321915,SRPX;TES;PLIN2;TGFBI;AMPD3;NR3C1;MT1E,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
1,Interferon Alpha Response,0.0027202887321915,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
2,Epithelial Mesenchymal Transition,0.0072674275279622,ITGB5;BASP1;ITGB3;SPP1;TGFBI;EDIL3,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
3,IL-2/STAT5 Signaling,0.0204177603279629,IFITM3;SPP1;PLIN2;AHR;IGF1R,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
4,Interferon Gamma Response,0.0204177603279629,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
5,Complement,0.0204177603279629,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
6,mTORC1 Signaling,0.0204177603279629,TES;PLK1;BCAT1;AURKA;HSP90B1,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
7,UV Response Dn,0.0318494162424551,ITGB3;NR3C1;MT1E;IGF1R,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
8,Apoptosis,0.0416760578347609,IFITM3;TGFB2;BAX;TXNIP,"5-(2-Chlorophenyl)-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
0,Epithelial Mesenchymal Transition,2.0289311668625494e-07,ITGB5;IGFBP3;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
1,Hypoxia,1.4854568298941343e-05,SRPX;TES;DTNA;IGFBP3;GCNT2;IRS2;TGFBI;AMPD3;MT1E,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
2,Myogenesis,0.0041576445857644,FDPS;PRNP;DTNA;ITGB5;IGFBP3;ADAM12,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
3,Complement,0.0041576445857644,DOCK10;LYN;CEBPB;ERAP2;FN1;PSMB9,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
4,KRAS Signaling Up,0.0041576445857644,TMEM158;IGFBP3;SPP1;LCP1;GNG11;PSMB8,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
5,TNF-alpha Signaling via NF-kB,0.0227127798997107,CEBPB;IRS2;SGK1;FJX1;LITAF,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
6,UV Response Dn,0.0347063406230075,ITGB3;PMP22;MT1E;IGF1R,"3-(1H-Pyrrole-2-ylmethylene)-5-fluoro-2,3-dihydro-1H-indole-2-one"
0,Epithelial Mesenchymal Transition,2.593926182434348e-06,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FN1;VEGFC;TGFBI;EDIL3,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
1,Hypoxia,0.00134696024308,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
2,Myogenesis,0.0272553358796528,FDPS;PRNP;DTNA;ITGB5;ADAM12,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
3,mTORC1 Signaling,0.0272553358796528,TES;PLK1;HMGCR;BCAT1;HSP90B1,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
4,KRAS Signaling Up,0.0272553358796528,TMEM158;SPP1;SOX9;GNG11;PSMB8,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
5,UV Response Dn,0.0404907307268421,ITGB3;PMP22;LPAR1;MT1E,"(3Z)-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
0,Hypoxia,0.0001362712477448283,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,PharmaGSID_48505
1,Epithelial Mesenchymal Transition,0.0001362712477448283,ITGB5;BASP1;BDNF;ITGB3;PMP22;FN1;TGFBI;EDIL3,PharmaGSID_48505
2,IL-2/STAT5 Signaling,0.0007851830133821765,IFITM3;PRNP;BHLHE40;PLIN2;AHR;WLS;IGF1R,PharmaGSID_48505
3,UV Response Dn,0.0007936771274922543,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,PharmaGSID_48505
4,Interferon Alpha Response,0.0105684668748828,IFITM3;LGALS3BP;PSMB8;PSMB9,PharmaGSID_48505
5,Estrogen Response Early,0.0153726742004139,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,PharmaGSID_48505
6,Complement,0.0153726742004139,DOCK10;CEBPB;CTSL;FN1;PSMB9,PharmaGSID_48505
7,mTORC1 Signaling,0.0153726742004139,TES;BHLHE40;BCAT1;AURKA;HSP90B1,PharmaGSID_48505
8,Apoptosis,0.0358607939508407,IFITM3;TGFB2;DPYD;BCL2L2,PharmaGSID_48505
0,Hypoxia,0.0028910366192938,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
1,UV Response Dn,0.0172705809794247,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
2,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
3,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
4,mTORC1 Signaling,0.0243746906240797,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
5,Epithelial Mesenchymal Transition,0.0243746906240797,ITGB3;ADAM12;PMP22;SPP1;VEGFC,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,"5-(2-Chlorophenyl)-3-isopropyl-7-nitro-2,10-dihydrobenzo[e]pyrazolo[4,3-b][1,4]diazepine"
0,Hedgehog Signaling,0.0149155017549577,NRP2;CDK6;VLDLR,"(Z)-1,3-Dihydro-5-fluoro-4-[3-(N-methylamino)-1-propynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
1,UV Response Dn,0.0149155017549577,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,"(Z)-1,3-Dihydro-5-fluoro-4-[3-(N-methylamino)-1-propynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
2,TGF-beta Signaling,0.0315763037630124,CDKN1C;CDK9;ID3,"(Z)-1,3-Dihydro-5-fluoro-4-[3-(N-methylamino)-1-propynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
3,E2F Targets,0.0315763037630124,DNMT1;PLK1;CDK1;TP53;AURKB,"(Z)-1,3-Dihydro-5-fluoro-4-[3-(N-methylamino)-1-propynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
0,E2F Targets,0.0207882229288221,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,"N-[5-(2-chlorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepin-7-yl]acetamide"
0,Epithelial Mesenchymal Transition,0.0104670187754089,VCAN;ECM1;COL4A1;TNC;SPP1;SNAI2,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
1,Hedgehog Signaling,0.0104670187754089,NRP2;CDK6;VLDLR,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
2,UV Response Dn,0.0104670187754089,SDC2;DLC1;ATP2B4;SNAI2;VLDLR,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
3,Estrogen Response Early,0.0221588096582543,ELOVL5;DLC1;ENDOD1;PMAIP1;JAK2,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
4,Glycolysis,0.0221588096582543,VCAN;SDC2;CDK1;MIF;VLDLR,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
5,KRAS Signaling Up,0.0221588096582543,GABRA3;SPP1;LCP1;TRIB2;DUSP6,"(Z)-1,3-Dihydro-5-fluoro-4-[(4-hydroxy-tetrahydro-pyran-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylene]-2H-indol-2-one"
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,NT5E;VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
1,KRAS Signaling Up,0.0012155494876576,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
2,Cholesterol Homeostasis,0.0063849145213691,ALCAM;TNFRSF12A;CD9;HMGCR,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
3,Hedgehog Signaling,0.0071056375607994,NRP1;NRP2;CDK6,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
4,TNF-alpha Signaling via NF-kB,0.0153726742004139,FOSL1;PLAU;PLK2;TNC;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
5,Estrogen Response Early,0.0153726742004139,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
6,Estrogen Response Late,0.0153726742004139,ELOVL5;ATP2B4;CD9;JAK2;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
7,Glycolysis,0.0153726742004139,NT5E;VCAN;CDK1;MIF;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
8,Apoptosis,0.0351171453755921,TNFRSF12A;BAX;PMAIP1;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
9,IL-6/JAK/STAT3 Signaling,0.0351171453755921,TNFRSF12A;CD9;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
10,Androgen Response,0.0430461553124786,CDK6;ELOVL5;HMGCR,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
11,Angiogenesis,0.0430461553124786,NRP1;VCAN,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
12,IL-2/STAT5 Signaling,0.0445808612551423,NRP1;NT5E;ALCAM;CD44,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
13,Apical Junction,0.0445808612551423,VCAN;CDH3;ITGA3;ACTB,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
14,mTORC1 Signaling,0.0445808612551423,ELOVL5;PLK1;CD9;HMGCR,"5-(2-Fluorophenyl)-3-methyl-2,10-dihydropyrazolo[3,4-b][1,4]benzodiazepine-7-carboxamide"
0,Epithelial Mesenchymal Transition,0.000324104589230943,BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;VEGFC,"(3Z)-5-fluoro-4-[2-(4-hydroxypiperidin-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one hydrochloride"
1,UV Response Dn,0.001887664519441,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(3Z)-5-fluoro-4-[2-(4-hydroxypiperidin-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one hydrochloride"
2,Complement,0.0074364374704729,DOCK10;LYN;ERAP2;TFPI2;JAK2;PSMB9,"(3Z)-5-fluoro-4-[2-(4-hydroxypiperidin-4-yl)ethynyl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one hydrochloride"
0,Hedgehog Signaling,0.0307270813439974,ADGRG1;CDK6;VLDLR,"(3Z)-5-fluoro-4-[(3R)-4-hydroxy-3-(methylamino)but-1-yn-1-yl]-3-[(3-methoxy-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one"
0,Complement,0.016485554571269,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one"
1,UV Response Dn,0.016485554571269,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one"
2,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,"4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one"
3,Epithelial Mesenchymal Transition,0.0349001252117506,ITGB3;ADAM12;PMP22;SPP1;VEGFC,"4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one"
0,Epithelial Mesenchymal Transition,1.682528284715285e-07,GLIPR1;ITGB5;BASP1;BDNF;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EMP3;EDIL3,(Arylindolyl)maleimide deriv. 27
1,Hypoxia,0.0011169914210908,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;MT1E,(Arylindolyl)maleimide deriv. 27
2,IL-2/STAT5 Signaling,0.0055962870575258,PRNP;CSF1;LIF;AHR;CKAP4;WLS,(Arylindolyl)maleimide deriv. 27
3,Estrogen Response Early,0.0188349882095161,DYNLT3;MYOF;RHOBTB3;FLNB;PRSS23,(Arylindolyl)maleimide deriv. 27
4,Allograft Rejection,0.0188349882095161,TGFB2;CSF1;LIF;HLA-A;BCAT1,(Arylindolyl)maleimide deriv. 27
5,KRAS Signaling Up,0.0188349882095161,TMEM158;LIF;SOX9;GNG11;PSMB8,(Arylindolyl)maleimide deriv. 27
0,UV Response Dn,0.0025145223211569,TJP1;NRP1;ANXA2;CAV1;ID1;MET,Bisindolylmaleimide deriv. 5c
1,Apoptosis,0.0025145223211569,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,Bisindolylmaleimide deriv. 5c
2,Hypoxia,0.0025145223211569,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,Bisindolylmaleimide deriv. 5c
3,Apical Junction,0.0025145223211569,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,Bisindolylmaleimide deriv. 5c
4,Epithelial Mesenchymal Transition,0.0025145223211569,TNFRSF12A;SDC4;DST;COL12A1;VIM;CD44,Bisindolylmaleimide deriv. 5c
5,p53 Pathway,0.0025145223211569,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Bisindolylmaleimide deriv. 5c
6,Cholesterol Homeostasis,0.0025145223211569,ALCAM;TNFRSF12A;MAL2;CD9,Bisindolylmaleimide deriv. 5c
7,Angiogenesis,0.0032647523927997,APP;NRP1;PTK2,Bisindolylmaleimide deriv. 5c
8,Protein Secretion,0.0051925360788795,SCRN1;DST;CAV2;EGFR,Bisindolylmaleimide deriv. 5c
9,TNF-alpha Signaling via NF-kB,0.009417494104758,TUBB2A;SDC4;PLAU;PLK2;CD44,Bisindolylmaleimide deriv. 5c
10,Estrogen Response Late,0.009417494104758,ELOVL5;CAV1;CD9;LSR;CD44,Bisindolylmaleimide deriv. 5c
11,Glycolysis,0.009417494104758,EXT1;MIF;MET;EGFR;CD44,Bisindolylmaleimide deriv. 5c
12,Fatty Acid Metabolism,0.0213855279264967,ELOVL5;PCBD1;MIF;S100A10,Bisindolylmaleimide deriv. 5c
13,IL-6/JAK/STAT3 Signaling,0.0230498637600411,TNFRSF12A;CD9;CD44,Bisindolylmaleimide deriv. 5c
14,Pperoxisome,0.0347827327998073,SEMA3C;ELOVL5;PRDX1,Bisindolylmaleimide deriv. 5c
15,IL-2/STAT5 Signaling,0.0377789545709419,NRP1;ALCAM;AHNAK;CD44,Bisindolylmaleimide deriv. 5c
16,Apical Surface,0.0408589677230306,APP;ATP8B1,Bisindolylmaleimide deriv. 5c
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,Bisindolylmaleimide deriv. 46
1,Estrogen Response Late,0.031022333521556,KRT19;MYOF;FLNB;SFN;LSR,Bisindolylmaleimide deriv. 46
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,Bisindolylmaleimide deriv. 46
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,Bisindolylmaleimide deriv. 46
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,Bisindolylmaleimide deriv. 9f
1,Cholesterol Homeostasis,0.0006579293581443079,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,Bisindolylmaleimide deriv. 9f
2,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;TNC;CD44,Bisindolylmaleimide deriv. 9f
3,Glycolysis,0.003853426689245,NT5E;VCAN;CDK1;MIF;EGFR;CD44,Bisindolylmaleimide deriv. 9f
4,KRAS Signaling Up,0.003853426689245,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2,Bisindolylmaleimide deriv. 9f
5,Angiogenesis,0.0048651212127996,NRP1;VCAN;ITGAV,Bisindolylmaleimide deriv. 9f
6,IL-2/STAT5 Signaling,0.0126305215052049,NRP1;NT5E;ALCAM;ITGAV;CD44,Bisindolylmaleimide deriv. 9f
7,Hypoxia,0.0126305215052049,SDC4;PRKCA;MIF;ETS1;EGFR,Bisindolylmaleimide deriv. 9f
8,Estrogen Response Late,0.0126305215052049,ELOVL5;ATP2B4;CD9;JAK2;CD44,Bisindolylmaleimide deriv. 9f
9,Apical Junction,0.0126305215052049,VCAN;CDH3;ITGA3;EGFR;ACTB,Bisindolylmaleimide deriv. 9f
10,UV Response Dn,0.0204698150902882,NRP1;ATP2B4;SNAI2;PRKCA,Bisindolylmaleimide deriv. 9f
11,IL-6/JAK/STAT3 Signaling,0.0300552145106419,TNFRSF12A;CD9;CD44,Bisindolylmaleimide deriv. 9f
12,Androgen Response,0.0378939127847302,ELOVL5;ITGAV;HMGCR,Bisindolylmaleimide deriv. 9f
13,Hedgehog Signaling,0.0378939127847302,NRP1;NRP2,Bisindolylmaleimide deriv. 9f
14,Estrogen Response Early,0.0429241400598498,ELOVL5;ENDOD1;JAK2;CD44,Bisindolylmaleimide deriv. 9f
15,mTORC1 Signaling,0.0429241400598498,ELOVL5;PLK1;CD9;HMGCR,Bisindolylmaleimide deriv. 9f
0,Complement,0.0212952527563544,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
1,Interferon Alpha Response,0.0299915951854784,BST2;TXNIP;PSMB8;PSMB9,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
2,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
3,Interferon Gamma Response,0.0349001252117506,BST2;TXNIP;JAK2;PSMB8;PSMB9,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
4,UV Response Dn,0.0425700931629121,ITGB3;PMP22;MT1E;IGF1R,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
5,Cholesterol Homeostasis,0.0425700931629121,FDPS;FABP5;HMGCR,"10-(4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-3,4-dihydropyrazino[1,2-a]indole-2(1H)-carbothioamide"
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;THBS1;CD44,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
1,KRAS Signaling Up,0.0012484021765132,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
2,Glycolysis,0.0049181098340275,NT5E;VCAN;CDK1;MIF;PAM;CD44,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;MAL2;HMGCR,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
4,TNF-alpha Signaling via NF-kB,0.0252610430104099,FOSL1;PLAU;PLK2;TNC;CD44,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
5,UV Response Dn,0.0375279943321951,NRP1;ATP2B4;SNAI2;PRKCA,"3-(1-Methyl-1H-indol-3-yl)-4-[[6,7,8,9-tetrahydro-12-methyl-7beta,8alpha-(methaniminomethano)pyrido[1,2-a]indol]-10-yl]-1H-pyrrole-2,5-dione"
0,Estrogen Response Early,0.0009867337260714513,ABLIM1;KRT19;KRT18;NRIP1;KRT8;FLNB;SFN,(4R)-4-(2-Fluoro-6-hydroxy-3-methoxy-benzoyl)-benzoic acid (3R)-3-[(pyridine-4-carbonyl)amino]-azepan-4-YL ester
1,UV Response Dn,0.0009867337260714513,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,(4R)-4-(2-Fluoro-6-hydroxy-3-methoxy-benzoyl)-benzoic acid (3R)-3-[(pyridine-4-carbonyl)amino]-azepan-4-YL ester
2,TGF-beta Signaling,0.0191119733302443,TJP1;SMURF2;ID1,(4R)-4-(2-Fluoro-6-hydroxy-3-methoxy-benzoyl)-benzoic acid (3R)-3-[(pyridine-4-carbonyl)amino]-azepan-4-YL ester
3,Estrogen Response Late,0.0191119733302443,KRT19;NRIP1;FLNB;SFN;LSR,(4R)-4-(2-Fluoro-6-hydroxy-3-methoxy-benzoyl)-benzoic acid (3R)-3-[(pyridine-4-carbonyl)amino]-azepan-4-YL ester
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,NT5E;VCAN;ECM1;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
1,IL-2/STAT5 Signaling,0.0049181098340275,NRP1;NT5E;ECM1;ALCAM;ITGAV;CD44,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
2,KRAS Signaling Up,0.0049181098340275,NRP1;GALNT3;PLAU;GABRA3;ETS1;TRIB2,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;MAL2;HMGCR,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
4,Angiogenesis,0.0058381454553595,NRP1;VCAN;ITGAV,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
5,TNF-alpha Signaling via NF-kB,0.0157881518815062,FOSL1;PLAU;PLK2;TNC;CD44,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
6,Estrogen Response Early,0.0157881518815062,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
7,Glycolysis,0.0157881518815062,NT5E;VCAN;CDK1;MIF;CD44,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
8,UV Response Dn,0.0250186628881301,NRP1;ATP2B4;SNAI2;PRKCA,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
9,Androgen Response,0.0482286162714748,ELOVL5;ITGAV;HMGCR,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
10,Hedgehog Signaling,0.0482286162714748,NRP1;NRP2,"(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride"
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
1,Cholesterol Homeostasis,0.0006059875667118624,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
2,KRAS Signaling Up,0.000766562739964282,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
3,TNF-alpha Signaling via NF-kB,0.0035492087927257,FOSL1;SDC4;PLAU;PLK2;TNC;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
4,Glycolysis,0.0035492087927257,EXT1;NT5E;VCAN;CDK1;MIF;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
5,Angiogenesis,0.0044810326959996,APP;NRP1;VCAN,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
6,Estrogen Response Late,0.0166191072436907,ELOVL5;ATP2B4;CD9;JAK2;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
7,IL-6/JAK/STAT3 Signaling,0.0415236516265447,TNFRSF12A;CD9;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
8,Hedgehog Signaling,0.0451833053261577,NRP1;NRP2,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
9,IL-2/STAT5 Signaling,0.0451833053261577,NRP1;NT5E;ALCAM;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
10,Hypoxia,0.0451833053261577,EXT1;SDC4;MIF;ETS1,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
11,Estrogen Response Early,0.0451833053261577,ELOVL5;ENDOD1;JAK2;CD44,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
12,Apical Junction,0.0451833053261577,VCAN;CDH3;ITGA3;ACTB,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
13,mTORC1 Signaling,0.0451833053261577,ELOVL5;PLK1;CD9;HMGCR,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone"
0,Epithelial Mesenchymal Transition,0.0003314706026225553,ITGB5;BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC;EDIL3,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
1,Hypoxia,0.0012870439905279,SRPX;TES;GCNT2;IRS2;PLIN2;AMPD3;MT1E,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
2,UV Response Dn,0.0012870439905279,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
3,mTORC1 Signaling,0.0057040855597377,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
4,IL-2/STAT5 Signaling,0.0213674235990309,PRNP;SPP1;PLIN2;AHR;IGF1R,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
5,TNF-alpha Signaling via NF-kB,0.0213674235990309,CEBPB;IRS2;SGK1;FJX1;LITAF,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
6,Complement,0.0213674235990309,DOCK10;LYN;CEBPB;ERAP2;PSMB9,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
7,Cholesterol Homeostasis,0.03420811057734,FDPS;FABP5;HMGCR,5-Amino-1-(4-fluorophenyl)-4-[3-(3-morpholin-4-ylprop-1-ynyl)benzoyl]pyrazole
0,Complement,0.0024310989753152,DPP4;PLSCR1;CFH;ERAP2;KYNU;FYN;JAK2,"3-(4-Fluorophenyl)-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine"
1,Interferon Gamma Response,0.0062533678728977,BST2;PLSCR1;CFH;ISG15;SAMHD1;JAK2,"3-(4-Fluorophenyl)-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine"
2,Epithelial Mesenchymal Transition,0.0062533678728977,VCAN;COL5A1;COL4A1;WIPF1;TIMP3;FBLN1,"3-(4-Fluorophenyl)-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine"
3,Interferon Alpha Response,0.0132105835936036,BST2;PLSCR1;SAMD9;ISG15,"3-(4-Fluorophenyl)-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine"
4,Coagulation,0.0377632429796991,DPP4;CFH;TIMP3;FYN,"3-(4-Fluorophenyl)-2-(pyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine"
0,UV Response Dn,0.0027456938464596,TJP1;ANXA2;CAV1;MAP1B;ID1;LAMC1,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
1,Epithelial Mesenchymal Transition,0.0054083181603439,DST;VIM;LAMC1;FSTL1;FERMT2;PFN2,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
2,p53 Pathway,0.0054083181603439,APP;LIF;SFN;PTPN14;EPHA2;S100A10,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
3,Angiogenesis,0.0061454162687994,APP;FSTL1;PTK2,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
4,Apoptosis,0.0082733931026504,APP;KRT18;CAV1;TIMP2;PTK2,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
5,TGF-beta Signaling,0.013336505698688,TJP1;SMURF2;ID1,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
6,Estrogen Response Early,0.0151946123370886,ABLIM1;KRT18;KRT8;SFN;IL6ST,4-Benzoyl-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
0,Estrogen Response Early,0.00020624837496514552,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,1-(4-fluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
1,Estrogen Response Late,0.0070984175854514,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,1-(4-fluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,1-(4-fluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,1-(4-fluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
0,mTORC1 Signaling,0.0096335667231127,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"1-(2,4-difluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine"
1,E2F Targets,0.0096335667231127,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,"1-(2,4-difluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine"
2,Hypoxia,0.0421017383506832,SRPX;TES;TGFBI;AMPD3;MT1E,"1-(2,4-difluorophenyl)-4-{[3-(pyridin-4-yl)phenyl]carbonyl}-1H-pyrazol-5-amine"
0,Angiogenesis,0.00098071553796958,APP;FSTL1;PTK2;FGFR1,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
1,Apical Junction,0.0081124772405159,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
2,Apoptosis,0.0137889885044174,APP;GPX1;KRT18;GCH1;PTK2,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
3,TGF-beta Signaling,0.020004758548032,TJP1;SMURF2;ID1,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
4,p53 Pathway,0.0212724572719241,VAMP8;APP;SFN;EPHA2;S100A10,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
5,UV Response Dn,0.0316025215429012,TJP1;ANXA2;MAP1B;ID1,1-(4-fluorophenyl)-4-{[4-(pyridin-3-yl)phenyl]carbonyl}-1H-pyrazol-5-amine
0,Hypoxia,0.0109011412919433,SRPX;DTNA;GCNT2;IRS2;AMPD3;MT1E,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
1,Epithelial Mesenchymal Transition,0.0109011412919433,ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
3,TNF-alpha Signaling via NF-kB,0.0238207203826234,CEBPB;IRS2;SGK1;FJX1;LITAF,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
4,Complement,0.0238207203826234,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
5,mTORC1 Signaling,0.0238207203826234,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
6,Cholesterol Homeostasis,0.037357428693984,FDPS;FABP5;HMGCR,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
16,Allograft Rejection,0.0431751584227729,LYN;TGFB2;FAS;BCAT1,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
15,p53 Pathway,0.0431751584227729,FAS;BAX;TXNIP;TP53,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
14,Xenobiotic Metabolism,0.0431751584227729,TGFB2;GCNT2;FAS;BCAT1,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
13,E2F Targets,0.0431751584227729,PLK1;CDK1;TP53;AURKA,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
12,Interferon Gamma Response,0.0431751584227729,FAS;TXNIP;PSMB8;PSMB9,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
9,Androgen Response,0.0431751584227729,ADAMTS1;HMGCR;SGK1,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
10,PI3K/AKT/mTOR  Signaling,0.0431751584227729,CDK1;THEM4;HSP90B1,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
17,KRAS Signaling Up,0.0431751584227729,SPP1;LCP1;GNG11;PSMB8,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
8,Interferon Alpha Response,0.0431751584227729,TXNIP;PSMB8;PSMB9,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
7,Apoptosis,0.0431751584227729,TGFB2;FAS;BAX;TXNIP,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
11,Myogenesis,0.0431751584227729,FDPS;PRNP;DTNA;ADAM12,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
18,Apical Surface,0.0462351476865873,LYN;SRPX,"3-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
0,Estrogen Response Early,1.739071410607767e-05,ABLIM1;KRT19;RAB31;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"3-(3,4-dimethoxyphenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
1,Estrogen Response Late,0.0007884645325346902,KRT19;RAB31;MYOF;NRIP1;FLNB;SFN;LSR,"3-(3,4-dimethoxyphenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
2,UV Response Dn,0.0062802112652453,TJP1;ANXA2;NFIB;MAP1B;ID1,"3-(3,4-dimethoxyphenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
3,TGF-beta Signaling,0.015003568911024,TJP1;RAB31;ID1,"3-(3,4-dimethoxyphenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione"
0,Epithelial Mesenchymal Transition,1.7320144107363228e-07,NT5E;VCAN;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;THBS1;CD44;CAP2,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
1,Glycolysis,1.107163614453685e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IL13RA1;IER3,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
2,Hypoxia,6.94218159129148e-05,EXT1;SDC4;CAV1;PRKCA;MIF;PAM;EGFR;IER3,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
3,UV Response Dn,6.94218159129148e-05,TJP1;NRP1;CAV1;ID1;PRKCA;MET;CAP2,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
4,Angiogenesis,0.0002145315239308456,APP;NRP1;VCAN;ITGAV,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
5,TNF-alpha Signaling via NF-kB,0.000383281369982141,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
6,Protein Secretion,0.000602384045102346,SCRN1;DST;CAV2;PAM;EGFR,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
7,Apoptosis,0.000692706092267222,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
8,IL-2/STAT5 Signaling,0.0016472138200092,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
9,Apical Junction,0.0016472138200092,TJP1;VCAN;RRAS;ITGA3;EGFR;ACTB,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
10,Cholesterol Homeostasis,0.0016472138200092,ALCAM;TNFRSF12A;MAL2;CD9,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
11,IL-6/JAK/STAT3 Signaling,0.0027798084014281,TNFRSF12A;CD9;CD44;IL13RA1,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
12,TGF-beta Signaling,0.006732370665203,TJP1;ID1;THBS1,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
13,Estrogen Response Late,0.0083095536218453,ELOVL5;CAV1;CD9;LSR;CD44,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
14,Pperoxisome,0.0358057543527429,SEMA3C;ELOVL5;PRDX1,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
15,Apical Surface,0.0446894959470647,APP;ATP8B1,"3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione"
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,ITGB5;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;TGFBI;EDIL3,"3-(4-methoxy-1-methyl-1H-indol-3-yl)-4-(3-methoxyphenyl)-1H-pyrrole-2,5-dione"
1,Hypoxia,0.00015468628122385913,SRPX;TES;DTNA;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,"3-(4-methoxy-1-methyl-1H-indol-3-yl)-4-(3-methoxyphenyl)-1H-pyrrole-2,5-dione"
2,mTORC1 Signaling,0.0070984175854514,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"3-(4-methoxy-1-methyl-1H-indol-3-yl)-4-(3-methoxyphenyl)-1H-pyrrole-2,5-dione"
3,UV Response Dn,0.0082427772856345,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"3-(4-methoxy-1-methyl-1H-indol-3-yl)-4-(3-methoxyphenyl)-1H-pyrrole-2,5-dione"
0,IL-2/STAT5 Signaling,0.00012890523435321594,IFITM3;PRNP;BHLHE40;LIF;ITGA6;AHR;WLS;IGF1R,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
1,Epithelial Mesenchymal Transition,0.00012890523435321594,ITGB5;BASP1;BDNF;ITGB3;PMP22;FN1;TGFBI;EDIL3,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
2,Hypoxia,0.0007507756611413217,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
3,UV Response Dn,0.0007507756611413217,BDNF;ITGB3;BHLHE40;PMP22;MT1E;IGF1R,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
4,TNF-alpha Signaling via NF-kB,0.0029576739939381,CEBPB;BHLHE40;LIF;SGK1;FJX1;LITAF,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
5,Complement,0.0029576739939381,DOCK10;LYN;CEBPB;CTSL;FN1;PSMB9,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
6,Interferon Alpha Response,0.0071408559965424,IFITM3;LGALS3BP;PSMB8;PSMB9,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
7,Estrogen Response Early,0.0129259723006483,DYNLT3;BHLHE40;RHOBTB3;FLNB;IGF1R,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
8,mTORC1 Signaling,0.0129259723006483,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
9,Apoptosis,0.0305301353905806,IFITM3;TGFB2;DPYD;BCL2L2,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
10,Interferon Gamma Response,0.0451833053261577,IFITM3;LGALS3BP;PSMB8;PSMB9,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
11,Inflammatory Response,0.0451833053261577,LYN;ITGB3;LIF;AHR,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
12,Allograft Rejection,0.0451833053261577,LYN;TGFB2;LIF;BCAT1,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
13,KRAS Signaling Up,0.0451833053261577,LIF;SOX9;GNG11;PSMB8,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
14,Apical Surface,0.047668795676869,LYN;SRPX,"3-(1,7-Dimethylindol-3-yl)-4-(3-methoxyphenyl)pyrrole-2,5-dione"
0,Apical Junction,0.00023571242853159488,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
1,Angiogenesis,0.0109959587552742,APP;FSTL1;PTK2,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
2,Apoptosis,0.0109959587552742,APP;GPX1;KRT18;TNFRSF12A;PTK2,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
3,Protein Secretion,0.0109959587552742,KRT18;SCRN1;CAV2;EGFR,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
4,p53 Pathway,0.0212724572719241,VAMP8;APP;PTPN14;EPHA2;S100A10,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
5,Cholesterol Homeostasis,0.032434356695552,TNFRSF12A;GPX8;CD9,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
6,IL-6/JAK/STAT3 Signaling,0.0433879788424304,TNFRSF12A;CD9;OSMR,"(R,S)-3-(5-chloro-1-methyl-1H-indol-3-yl)-4-(3-(2,3-dihydroxypropylamino)phenyl)-1H-pyrrole-2,5-dione"
0,Interferon Alpha Response,0.0189932654213608,IFITM2;TXNIP;B2M;PSMB8,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
1,Androgen Response,0.0189932654213608,INPP4B;CDK6;HMGCR;B2M,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
2,PI3K/AKT/mTOR  Signaling,0.0189932654213608,CDK1;PTEN;PLCB1;HSP90B1,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
3,Interferon Gamma Response,0.0189932654213608,IFITM2;TXNIP;JAK2;B2M;PSMB8,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
4,mTORC1 Signaling,0.0189932654213608,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
5,E2F Targets,0.0189932654213608,DNMT1;PLK1;CDK1;TP53;AURKA,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
6,p53 Pathway,0.0189932654213608,HDAC3;BAX;STOM;TXNIP;TP53,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
7,UV Response Dn,0.0296273639464698,INPP4B;DLC1;ITGB3;PTEN,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
8,DNA Repair,0.030363473875406,IMPDH2;STX3;TYMS;TP53,"6-(3-Fluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
0,Androgen Response,0.0048167833615563,INPP4B;CDK6;ELOVL5;HMGCR;B2M,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
1,Estrogen Response Early,0.0048167833615563,UGCG;ELOVL5;DLC1;JAK2;CD44;MICB,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
2,Estrogen Response Late,0.0048167833615563,FABP5;ELOVL5;ATP2B4;JAK2;CD44;MICB,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
3,Interferon Gamma Response,0.0048167833615563,MT2A;IFITM2;TXNIP;JAK2;B2M;PSMB8,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
4,Interferon Alpha Response,0.0108541011147445,IFITM2;TXNIP;B2M;PSMB8,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
5,p53 Pathway,0.0210508691753416,HDAC3;BAX;STOM;TXNIP;TP53,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
6,UV Response Dn,0.0321668522847387,INPP4B;DLC1;ATP2B4;PTEN,"6-(2-Fluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one"
0,Epithelial Mesenchymal Transition,1.3629017277572033e-08,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;AREG;THBS1;CD44,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
1,Glycolysis,1.2336965989626774e-06,NT5E;VCAN;CDK1;MIF;PAM;MET;EGFR;CD44;IL13RA1;IER3,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
2,Angiogenesis,0.0003376216443108948,APP;NRP1;VCAN;ITGAV,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
3,Cholesterol Homeostasis,0.0003376216443108948,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
4,TNF-alpha Signaling via NF-kB,0.0005125019461475486,TUBB2A;SDC4;PLAU;PLK2;AREG;CD44;IER3,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
5,Coagulation,0.0042098578309262,SPARC;PLAU;CD9;THBS1;DUSP6,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
6,IL-6/JAK/STAT3 Signaling,0.0053100013545647,TNFRSF12A;CD9;CD44;IL13RA1,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
10,Apical Junction,0.0117844578637079,VCAN;CDH3;ITGA3;EGFR;ACTB,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
9,Estrogen Response Late,0.0117844578637079,ELOVL5;ATP2B4;CD9;AREG;CD44,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
8,Hypoxia,0.0117844578637079,SDC4;MIF;PAM;EGFR;IER3,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
7,IL-2/STAT5 Signaling,0.0117844578637079,NRP1;NT5E;ALCAM;ITGAV;CD44,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
11,UV Response Dn,0.0192577865652054,NRP1;ATP2B4;SNAI2;MET,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
12,Apoptosis,0.0261686874776405,APP;TNFRSF12A;CD44;IER3,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
13,Androgen Response,0.0385034682475777,ELOVL5;ITGAV;HMGCR,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
14,Pperoxisome,0.0398978405644849,SEMA3C;ELOVL5;PRDX1,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
15,Estrogen Response Early,0.0414623272404741,ELOVL5;ENDOD1;AREG;CD44,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
16,mTORC1 Signaling,0.0414623272404741,ELOVL5;PRDX1;CD9;HMGCR,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
17,Apical Surface,0.0442638816999498,APP;ATP8B1,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
0,IL-2/STAT5 Signaling,0.002419212527718,IFITM3;CTSZ;SPP1;LIF;PLIN2;AHR;IGF1R,"trans-6-(2,4-Difluorophenoxy)-2-(trans-4-hydroxy-cyclohexylamino)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
1,mTORC1 Signaling,0.0096335667231127,TES;PLK1;DHCR24;BCAT1;AURKA;HSP90B1,"trans-6-(2,4-Difluorophenoxy)-2-(trans-4-hydroxy-cyclohexylamino)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
2,Estrogen Response Early,0.0315763037630124,MYOF;NRIP1;RHOBTB3;FLNB;IGF1R,"trans-6-(2,4-Difluorophenoxy)-2-(trans-4-hydroxy-cyclohexylamino)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
3,p53 Pathway,0.0315763037630124,LDHB;HDAC3;LIF;TP53;TM4SF1,"trans-6-(2,4-Difluorophenoxy)-2-(trans-4-hydroxy-cyclohexylamino)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
0,Hypoxia,0.0014126656207913,SRPX;TES;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
1,Epithelial Mesenchymal Transition,0.0014126656207913,ITGB5;ITGB3;ADAM12;PMP22;SPP1;TGFBI;EDIL3,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
2,mTORC1 Signaling,0.0072674275279622,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
3,UV Response Dn,0.0084390338876734,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
4,Interferon Alpha Response,0.012282272314053,LGALS3BP;TXNIP;PSMB8;PSMB9,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
5,Complement,0.0238207203826234,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"N-[(3S,4S)-4-[[4-(2-fluoro-6-hydroxy-3-methoxybenzoyl)benzoyl]amino]azepan-3-yl]pyridine-4-carboxamide"
0,Epithelial Mesenchymal Transition,3.333220203664887e-05,ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;EDIL3,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
1,UV Response Dn,0.0001824802018282332,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
2,IL-2/STAT5 Signaling,0.00097617347609676,PRNP;CSF1;BHLHE40;SPP1;PLIN2;AHR;IGF1R,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
3,Myogenesis,0.0046646744132966,WWTR1;FDPS;PRNP;ITGB5;BHLHE40;ADAM12,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
4,mTORC1 Signaling,0.0046646744132966,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
5,Interferon Alpha Response,0.0109493125280318,CSF1;TXNIP;PSMB8;PSMB9,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
6,Hypoxia,0.016988420737995,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
7,Estrogen Response Early,0.016988420737995,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
8,Inflammatory Response,0.016988420737995,LYN;CSF1;ITGB3;LPAR1;AHR,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
9,Cholesterol Homeostasis,0.0279746326499136,FDPS;FABP5;HMGCR,"(+)-(1R,3R)-1-(3-hydroxy-cyclopentyl)-3-(4-methoxy-phenyl)-7-phenylamino-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one"
0,Estrogen Response Early,0.0001841503347903085,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"6-(2,4-Difluorophenoxy)-8-cyclopropyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
1,Estrogen Response Late,0.0042252485627687,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,"6-(2,4-Difluorophenoxy)-8-cyclopropyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
2,Apical Junction,0.0042252485627687,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,"6-(2,4-Difluorophenoxy)-8-cyclopropyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
3,UV Response Dn,0.0370342049330873,TJP1;ANXA2;MAP1B;ID1,"6-(2,4-Difluorophenoxy)-8-cyclopropyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one"
0,IL-2/STAT5 Signaling,0.0005584957105454055,IFITM3;PRNP;BHLHE40;LIF;AHR;WLS;IGF1R,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Hypoxia,0.0005584957105454055,SRPX;TES;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,Estrogen Response Early,0.0005584957105454055,RAB31;DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;IGF1R,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,Epithelial Mesenchymal Transition,0.0005584957105454055,ITGB5;BASP1;BDNF;PMP22;FN1;TGFBI;EDIL3,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
4,UV Response Dn,0.0053381795754585,BDNF;BHLHE40;PMP22;MT1E;IGF1R,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
5,Interferon Alpha Response,0.0080929701294148,IFITM3;LGALS3BP;PSMB8;PSMB9,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
6,TNF-alpha Signaling via NF-kB,0.0113009929257097,CEBPB;BHLHE40;LIF;FJX1;LITAF,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
7,Interferon Gamma Response,0.0113009929257097,IFITM3;LGALS3BP;HLA-A;PSMB8;PSMB9,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
8,Complement,0.0113009929257097,DOCK10;CEBPB;CTSL;FN1;PSMB9,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
9,mTORC1 Signaling,0.0113009929257097,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
10,Apoptosis,0.026961678007266,IFITM3;TGFB2;DPYD;BCL2L2,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
11,Estrogen Response Late,0.0438923537454103,RAB31;DYNLT3;NRIP1;FLNB,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
12,Allograft Rejection,0.0438923537454103,TGFB2;LIF;HLA-A;BCAT1,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
13,KRAS Signaling Up,0.0438923537454103,LIF;SOX9;GNG11;PSMB8,"(5Z)-2-benzylimino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,mTORC1 Signaling,0.0212952527563544,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"(5Z)-2-[2-(4-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Interferon Alpha Response,0.0299915951854784,LGALS3BP;TXNIP;PSMB8;PSMB9,"(5Z)-2-[2-(4-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,Hypoxia,0.0349001252117506,SRPX;TES;DTNA;PLIN2;MT1E,"(5Z)-2-[2-(4-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,Complement,0.0349001252117506,DOCK10;CEBPB;ERAP2;FDX1;PSMB9,"(5Z)-2-[2-(4-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,Interferon Alpha Response,0.0279201001694004,BST2;TXNIP;PSMB8;PSMB9,"ROCHE screening, 69"
1,Hypoxia,0.0279201001694004,SRPX;DTNA;IRS2;AMPD3;MT1E,"ROCHE screening, 69"
2,Complement,0.0279201001694004,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"ROCHE screening, 69"
3,mTORC1 Signaling,0.0279201001694004,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"ROCHE screening, 69"
4,E2F Targets,0.0279201001694004,PLK1;CDK1;TP53;AURKB;AURKA,"ROCHE screening, 69"
5,Cholesterol Homeostasis,0.0425700931629121,FDPS;FABP5;HMGCR,"ROCHE screening, 69"
0,IL-2/STAT5 Signaling,3.057349698093366e-05,PRNP;CSF1;BHLHE40;SPP1;ITGA6;PLIN2;AHR;WLS;IGF1R,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Hypoxia,8.727314000480716e-05,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,Epithelial Mesenchymal Transition,8.727314000480716e-05,ITGB5;BDNF;ITGB3;PMP22;SPP1;VEGFC;TGFBI;EDIL3,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,UV Response Dn,8.727314000480716e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
4,TNF-alpha Signaling via NF-kB,0.0044618624822837,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
5,Interferon Alpha Response,0.0104732554615956,LGALS3BP;CSF1;PSMB8;PSMB9,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
6,mTORC1 Signaling,0.0182810179680598,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
7,Inflammatory Response,0.0182810179680598,LYN;CSF1;ITGB3;LPAR1;AHR,"(5Z)-2-[2-(2-chlorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,UV Response Dn,5.377651841632184e-07,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;AKT3;LAMC1;MET,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
1,Hypoxia,5.377651841632184e-07,EXT1;MT2A;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;MIF;ETS1;EGFR,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
2,Apical Junction,5.377651841632184e-07,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;FLNC;EGFR;ACTB;PTK2,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
3,Epithelial Mesenchymal Transition,5.377651841632184e-07,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
4,Apoptosis,0.0001117185109397467,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
5,Angiogenesis,0.00017366837651544646,APP;FSTL1;PTK2;FGFR1,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
6,TNF-alpha Signaling via NF-kB,0.002154876767012,FOSL1;SDC4;DUSP1;PLK2;SERPINE1;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
7,Glycolysis,0.002154876767012,EXT1;NT5E;MIF;MET;EGFR;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
8,IL-6/JAK/STAT3 Signaling,0.0036005137389926,TNFRSF12A;CD9;OSMR;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
9,Mitotic Spindle,0.0086930714813151,NOTCH2;FARP1;MYO1E;ARHGAP29;CDC42EP1,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
10,Estrogen Response Late,0.0086930714813151,FARP1;ELOVL5;CAV1;CD9;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
11,Inflammatory Response,0.0086930714813151,AXL;SERPINE1;SGMS2;OSMR;MET,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
12,p53 Pathway,0.0086930714813151,VAMP8;APP;PLK2;PTPN14;S100A10,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
13,Fatty Acid Metabolism,0.0198579902174613,ELOVL5;PCBD1;MIF;S100A10,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
14,IL-2/STAT5 Signaling,0.038405809527234,MYO1E;NT5E;AHNAK;CD44,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
15,Complement,0.038405809527234,GCA;SERPINE1;GNB4;TIMP2,2-[2-(2-Ethoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,Interferon Alpha Response,0.034069169849566,BST2;TXNIP;PSMB8;PSMB9,2-[2-(2-Methoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
1,Complement,0.034069169849566,DOCK10;LYN;CEBPB;ERAP2;PSMB9,2-[2-(2-Methoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
2,mTORC1 Signaling,0.034069169849566,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,2-[2-(2-Methoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
3,E2F Targets,0.034069169849566,PLK1;CDK1;TP53;AURKB;AURKA,2-[2-(2-Methoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
4,Cholesterol Homeostasis,0.0498678234194113,FDPS;FABP5;HMGCR,2-[2-(2-Methoxy-phenyl)-ethylamino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,Hypoxia,3.043374968563592e-05,SRPX;TES;DTNA;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Epithelial Mesenchymal Transition,0.00011107490546066368,ITGB5;BDNF;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,UV Response Dn,0.00011107490546066368,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,IL-2/STAT5 Signaling,0.0006684666195010421,PRNP;BHLHE40;SPP1;ITGA6;PLIN2;AHR;IGF1R,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
4,Interferon Alpha Response,0.0119966380741913,LGALS3BP;TXNIP;PSMB8;PSMB9,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
5,TNF-alpha Signaling via NF-kB,0.015511166760778,CEBPB;BHLHE40;SGK1;FJX1;LITAF,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
6,Estrogen Response Early,0.015511166760778,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
7,Complement,0.015511166760778,DOCK10;LYN;CEBPB;FN1;PSMB9,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
8,mTORC1 Signaling,0.015511166760778,TES;BHLHE40;BCAT1;AURKA;HSP90B1,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
9,Apoptosis,0.0366361624686968,TGFB2;BAX;TXNIP;BCL2L2,"(5Z)-2-[(2-chlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,p53 Pathway,0.0157179246534997,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,"(5Z)-2-[(2-bromophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Estrogen Response Early,0.0343461549702942,ABLIM1;KRT18;MYOF;KRT8;SFN,"(5Z)-2-[(2-bromophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,Apical Junction,0.0343461549702942,TJP1;RRAS;CTNNA1;RHOF;PTK2,"(5Z)-2-[(2-bromophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,UV Response Dn,0.0459224141170283,TJP1;ANXA2;MAP1B;ID1,"(5Z)-2-[(2-bromophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,Hypoxia,0.000324104589230943,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Epithelial Mesenchymal Transition,0.0012584430129606,ITGB5;BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,mTORC1 Signaling,0.0055773281028547,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
4,IL-2/STAT5 Signaling,0.0182810179680598,PRNP;SPP1;PLIN2;AHR;IGF1R,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
5,TNF-alpha Signaling via NF-kB,0.0182810179680598,CEBPB;IRS2;SGK1;FJX1;LITAF,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
6,Myogenesis,0.0182810179680598,FDPS;PRNP;DTNA;ITGB5;ADAM12,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
7,Complement,0.0182810179680598,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
8,Cholesterol Homeostasis,0.0297314936375894,FDPS;FABP5;HMGCR,"(5Z)-2-[2-(3-fluorophenyl)ethylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,Hypoxia,0.0101405965506449,SRPX;TES;DTNA;PLIN2;TGFBI;MT1E,2-(2-Pyridin-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
1,mTORC1 Signaling,0.0101405965506449,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,2-(2-Pyridin-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
2,Interferon Alpha Response,0.0190422826574466,LGALS3BP;TXNIP;PSMB8;PSMB9,2-(2-Pyridin-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
3,KRAS Signaling Up,0.0332382144873815,SPP1;LCP1;GNG11;PSMB8;BIRC3,2-(2-Pyridin-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,UV Response Dn,0.00030148902910751566,INPP4B;RBPMS;DLC1;SERPINE1;AKT3;ATP2B4;PTEN,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
1,Androgen Response,0.0027753986391777,INPP4B;CDK6;ELOVL5;HMGCR;B2M,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
2,Estrogen Response Early,0.0048167833615563,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
3,Complement,0.0048167833615563,GCA;ERAP2;SERPINE1;GNB4;TIMP2;JAK2,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
4,Hypoxia,0.0180436021502928,EXT1;MT2A;SERPINE1;MIF;ETS1,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
5,Estrogen Response Late,0.0180436021502928,FARP1;ELOVL5;ATP2B4;JAK2;CD44,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
6,Epithelial Mesenchymal Transition,0.0180436021502928,NT5E;TNFRSF12A;SERPINE1;CD44;LOXL2,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
7,Apoptosis,0.0414337551729308,TNFRSF12A;TIMP2;BAX;CD44,2-(2-Thiophen-2-yl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,Hypoxia,3.18829758611424e-05,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Epithelial Mesenchymal Transition,0.0001620522946154715,ITGB5;BDNF;ITGB3;PMP22;SPP1;FAS;TGFBI;EDIL3,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,IL-2/STAT5 Signaling,0.0054316903793632,PRNP;SPP1;ITGA6;PLIN2;AHR;IGF1R,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
4,Interferon Alpha Response,0.0125679065539147,LGALS3BP;TXNIP;PSMB8;PSMB9,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
5,TNF-alpha Signaling via NF-kB,0.0208925919634969,CEBPB;IRS2;SGK1;FJX1;LITAF,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
6,Interferon Gamma Response,0.0208925919634969,LGALS3BP;FAS;TXNIP;PSMB8;PSMB9,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
7,Apoptosis,0.047975927042341,TGFB2;FAS;BAX;TXNIP,"(5Z)-2-(1-hydroxy-3-phenylpropan-2-yl)imino-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,Cholesterol Homeostasis,0.020707830880116,FDPS;GSTM2;FABP5;HMGCR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-methoxyphenyl)methanone
0,Epithelial Mesenchymal Transition,2.7837256591978365e-06,ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC;EDIL3,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
1,IL-2/STAT5 Signaling,0.00011636418667307622,PRNP;CSF1;BHLHE40;SPP1;ITGA6;PLIN2;AHR;IGF1R,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
2,UV Response Dn,0.00011636418667307622,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
3,TNF-alpha Signaling via NF-kB,0.0005782073238587728,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
4,Hypoxia,0.0005782073238587728,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
5,Myogenesis,0.0162497937493865,FDPS;PRNP;ITGB5;BHLHE40;ADAM12,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
6,Inflammatory Response,0.0162497937493865,LYN;CSF1;ITGB3;LPAR1;AHR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
7,Xenobiotic Metabolism,0.0162497937493865,TGFB2;PROS1;GCNT2;FAS;BCAT1,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
8,Allograft Rejection,0.0162497937493865,LYN;TGFB2;CSF1;FAS;BCAT1,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
9,IL-6/JAK/STAT3 Signaling,0.0417609296358392,CSF1;ITGB3;FAS,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](5-fluoro-2-methoxyphenyl)methanone
0,Estrogen Response Early,0.0001988823615735332,ABLIM1;RAB31;KRT18;MYOF;NRIP1;KRT8;SFN;PAPSS2,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
1,Apical Junction,0.000772226394316788,TJP1;RRAS;FSCN1;CTNNA1;FLNC;RHOF;PTK2,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
2,UV Response Dn,0.000772226394316788,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
3,TGF-beta Signaling,0.0010366924310288,TJP1;RAB31;SMURF2;ID1,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
4,Estrogen Response Late,0.0027379610686741,RAB31;MYOF;NRIP1;SFN;LSR;PAPSS2,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
5,Angiogenesis,0.0034567966511997,FSTL1;PTK2;FGFR1,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
6,Protein Secretion,0.0477851414387333,TPD52;KRT18;SCRN1,2-((r)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,Epithelial Mesenchymal Transition,2.7837256591978365e-06,ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC;EDIL3,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
1,IL-2/STAT5 Signaling,0.00011636418667307622,PRNP;CSF1;BHLHE40;SPP1;ITGA6;PLIN2;AHR;IGF1R,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
2,UV Response Dn,0.00011636418667307622,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
3,TNF-alpha Signaling via NF-kB,0.0005782073238587728,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
4,Hypoxia,0.0005782073238587728,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
5,Myogenesis,0.0162497937493865,FDPS;PRNP;ITGB5;BHLHE40;ADAM12,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
6,Inflammatory Response,0.0162497937493865,LYN;CSF1;ITGB3;LPAR1;AHR,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
7,Xenobiotic Metabolism,0.0162497937493865,TGFB2;PROS1;GCNT2;FAS;BCAT1,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
8,Allograft Rejection,0.0162497937493865,LYN;TGFB2;CSF1;FAS;BCAT1,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
9,IL-6/JAK/STAT3 Signaling,0.0417609296358392,CSF1;ITGB3;FAS,"[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](4,5-difluoro-2-methoxyphenyl)methanone"
0,Estrogen Response Early,0.0001915163481819208,ABLIM1;KRT19;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"(5Z)-2-[(2,6-dichlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
1,Estrogen Response Late,0.0065913877579192,KRT19;MYOF;NRIP1;FLNB;SFN;LSR,"(5Z)-2-[(2,6-dichlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
2,UV Response Dn,0.0068035622040158,TJP1;ANXA2;NFIB;MAP1B;ID1,"(5Z)-2-[(2,6-dichlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
3,Apical Junction,0.0216048394167979,TJP1;RRAS;FSCN1;CTNNA1;RHOF,"(5Z)-2-[(2,6-dichlorophenyl)methylimino]-5-(quinolin-6-ylmethylidene)-1,3-thiazolidin-4-one"
0,Hypoxia,0.0001362712477448283,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
1,Epithelial Mesenchymal Transition,0.0001362712477448283,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;CD44;LOXL2,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
2,Apoptosis,0.00020262671101816808,APP;TNFRSF12A;CAV1;TIMP2;BAX;PTK2;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
3,TNF-alpha Signaling via NF-kB,0.0037520207237386,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
4,Estrogen Response Late,0.0037520207237386,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
5,Complement,0.0153726742004139,GCA;ERAP2;SERPINE1;GNB4;TIMP2,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
6,Glycolysis,0.0153726742004139,EXT1;NT5E;MIF;EGFR;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
7,p53 Pathway,0.0153726742004139,VAMP8;APP;PLK2;BAX;PTPN14,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
8,Cholesterol Homeostasis,0.0250014832861547,TNFRSF12A;CD9;HMGCR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
9,IL-6/JAK/STAT3 Signaling,0.0351171453755921,TNFRSF12A;CD9;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
10,Androgen Response,0.0371507177126186,CDK6;ELOVL5;HMGCR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
11,Hedgehog Signaling,0.0371507177126186,NRP2;CDK6,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
12,Angiogenesis,0.0371507177126186,APP;PTK2,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
13,Mitotic Spindle,0.0371507177126186,FARP1;PLK1;ARHGAP29;CDC42EP1,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
14,Estrogen Response Early,0.0371507177126186,FARP1;ELOVL5;ENDOD1;CD44,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
15,Apical Junction,0.0371507177126186,ITGA3;EGFR;ACTB;PTK2,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
16,mTORC1 Signaling,0.0371507177126186,ELOVL5;PLK1;CD9;HMGCR,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
17,Xenobiotic Metabolism,0.0371507177126186,GSTM4;MT2A;ELOVL5;SERPINE1,[4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2-fluoro-6-methoxyphenyl)methanone
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,DST;ITGB5;BASP1;PMP22;SPP1;FN1;TGFBI;EMP3;EDIL3,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
1,UV Response Dn,0.0001666123581909955,CAV1;MAP1B;PMP22;PTPRM;NR3C1;RND3;MT1E,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
2,TNF-alpha Signaling via NF-kB,0.0053238131890886,MARCKS;LIF;TNFAIP2;IL6ST;FJX1;LITAF,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
3,Hypoxia,0.0053238131890886,SRPX;DTNA;CAV1;TGFBI;NR3C1;MT1E,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
4,Estrogen Response Late,0.0199429286924289,CAV1;DYNLT3;MYOF;FLNB;IL6ST,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
5,Allograft Rejection,0.0199429286924289,TGFB2;LIF;HLA-A;TLR6;BCAT1,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
6,KRAS Signaling Up,0.0199429286924289,TMEM158;SPP1;LIF;SOX9;PSMB8,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
7,Apoptosis,0.0457952030858709,TGFB2;CAV1;BAX;TXNIP,"(5Z)-5-(quinolin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione"
0,Apical Junction,0.00021361438835675785,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,"ROCHE screening, 75"
1,Angiogenesis,0.00044438672814246593,APP;FSTL1;PTK2;FGFR1,"ROCHE screening, 75"
2,UV Response Dn,0.0008294283494513648,TJP1;ANXA2;DUSP1;CAV1;ID1;LAMC1,"ROCHE screening, 75"
3,Apoptosis,0.0011479129528999,APP;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,"ROCHE screening, 75"
4,Hypoxia,0.002940772999687,EXT1;ANXA2;SDC4;DUSP1;CAV1;EGFR,"ROCHE screening, 75"
5,Protein Secretion,0.0066433917479782,KRT18;SCRN1;CAV2;EGFR,"ROCHE screening, 75"
6,TGF-beta Signaling,0.0103596071052308,TJP1;SMURF2;ID1,"ROCHE screening, 75"
7,Epithelial Mesenchymal Transition,0.0107100913348229,TNFRSF12A;SDC4;LAMC1;FSTL1;FERMT2,"ROCHE screening, 75"
8,p53 Pathway,0.0107100913348229,VAMP8;APP;PTPN14;EPHA2;S100A10,"ROCHE screening, 75"
9,Cholesterol Homeostasis,0.0176361814532064,TNFRSF12A;GPX8;S100A11,"ROCHE screening, 75"
0,E2F Targets,0.0202811931012899,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,2-((s)-2-Hydroxy-1-phenyl-ethylamino)-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one
0,Angiogenesis,0.0008581260957233824,APP;FSTL1;PTK2;FGFR1,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
1,Apical Junction,0.0009198752879571384,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
2,UV Response Dn,0.0073269131427862,TJP1;ANXA2;DUSP1;ID1;LAMC1,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
3,Protein Secretion,0.009621463910865,KRT18;SCRN1;CAV2;EGFR,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
4,TGF-beta Signaling,0.0132952857949526,TJP1;SMURF2;ID1,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
5,Epithelial Mesenchymal Transition,0.0132952857949526,TNFRSF12A;SDC4;LAMC1;FSTL1;FERMT2,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
6,p53 Pathway,0.0132952857949526,VAMP8;APP;PTPN14;EPHA2;S100A10,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
7,Apoptosis,0.0305301353905806,APP;KRT18;TNFRSF12A;PTK2,"6-(2,4-Difluorophenoxy)-8-(2-methanesulfonyl-ethyl)-2-(tetrahydro-pyran-4-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one"
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT18;MYOF;NRIP1;KRT8;FLNB;SFN,"2-(1-Acetyl-piperidin-4-ylamino)-6-(2,4-difluorophenoxy)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
1,Estrogen Response Late,0.031022333521556,MYOF;NRIP1;FLNB;SFN;LSR,"2-(1-Acetyl-piperidin-4-ylamino)-6-(2,4-difluorophenoxy)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
2,Apical Junction,0.031022333521556,TJP1;RRAS;CTNNA1;RHOF;PTK2,"2-(1-Acetyl-piperidin-4-ylamino)-6-(2,4-difluorophenoxy)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one"
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;AREG;THBS1,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
1,Angiogenesis,0.0005516524901078888,APP;NRP1;VCAN;ITGAV,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
2,UV Response Dn,0.0010296351924223,TJP1;NRP1;GJA1;ID1;ATP2B4;MET,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
3,TGF-beta Signaling,0.001382256574705,TJP1;ID1;ID3;THBS1,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
4,TNF-alpha Signaling via NF-kB,0.0031061746320174,TUBB2A;SDC4;PLAU;PLK2;AREG;IER3,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
5,Cholesterol Homeostasis,0.0031061746320174,ALCAM;TNFRSF12A;MAL2;CD9,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
6,Coagulation,0.0033308765255679,SPARC;PLAU;CD9;THBS1;DUSP6,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
7,Estrogen Response Late,0.0132952857949526,ELOVL5;ATP2B4;CD9;LSR;AREG,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
8,Glycolysis,0.0132952857949526,VCAN;MIF;MET;IER3;IL13RA1,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
9,IL-6/JAK/STAT3 Signaling,0.0341680333384139,TNFRSF12A;CD9;IL13RA1,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
10,Pperoxisome,0.0464742569069051,SEMA3C;ELOVL5;PRDX1,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
11,Estrogen Response Early,0.0464742569069051,GJA1;ELOVL5;ENDOD1;AREG,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
12,Apical Junction,0.0464742569069051,TJP1;VCAN;CDH3;ITGA3,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
13,p53 Pathway,0.0464742569069051,APP;HDAC3;PLK2;IER3,"(2S)-2-[(4R)-4-[4-[(2R)-2,3-dihydroxypropoxy]phenyl]-2,5-dioxoimidazolidin-1-yl]-N-(2-fluoro-4-iodophenyl)-3-phenylbutanamide"
0,Epithelial Mesenchymal Transition,1.7320144107363228e-07,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
1,Glycolysis,1.2680729035681635e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
2,Angiogenesis,0.0003575525398847427,APP;NRP1;VCAN;ITGAV,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
3,TNF-alpha Signaling via NF-kB,0.0005749220549732116,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
4,Hypoxia,0.0030198920033502,SDC4;MIF;ETS1;PAM;EGFR;IER3,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
5,Cholesterol Homeostasis,0.0030198920033502,ALCAM;TNFRSF12A;MAL2;CD9,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
6,UV Response Dn,0.0039251320407783,TJP1;NRP1;ATP2B4;SNAI2;MET,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
7,IL-6/JAK/STAT3 Signaling,0.0041697126021422,TNFRSF12A;CD9;CD44;IL13RA1,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
9,Protein Secretion,0.0048107319554325,SCRN1;CAV2;PAM;EGFR,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
8,Apoptosis,0.0048107319554325,APP;GPX1;TNFRSF12A;CD44;IER3,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
10,TGF-beta Signaling,0.0079564380588763,TJP1;ID3;THBS1,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
11,IL-2/STAT5 Signaling,0.0083095536218453,NRP1;NT5E;ALCAM;ITGAV;CD44,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
12,Apical Junction,0.0083095536218453,TJP1;VCAN;ITGA3;EGFR;ACTB,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
13,p53 Pathway,0.0083095536218453,VAMP8;APP;HDAC3;PLK2;IER3,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
14,Coagulation,0.0119073288674726,SPARC;PLAU;CD9;THBS1,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
15,Pperoxisome,0.0335678947056964,SEMA3C;ELOVL5;PRDX1,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
16,Estrogen Response Late,0.0372097808568358,ELOVL5;ATP2B4;CD9;CD44,"2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione"
0,UV Response Dn,0.0036895261061802,INPP4B;ITGB3;PMP22;PTEN;MT1E;IGF1R,Momelotinib
1,mTORC1 Signaling,0.0476414407652468,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Momelotinib
2,E2F Targets,0.0476414407652468,DNMT1;PLK1;CDK1;TP53;AURKA,Momelotinib
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,VCAN;SPARC;COL4A1;COL12A1;TNC;SPP1;SNAI2;FBLN1;ITGAV;AREG,"7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one"
1,Angiogenesis,0.0006129472112309875,NRP1;VCAN;SPP1;ITGAV,"7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one"
2,UV Response Dn,0.0104670187754089,NRP1;SDC2;CELF2;ATP2B4;SNAI2,"7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one"
3,Estrogen Response Early,0.0332382144873815,ELOVL5;ENDOD1;PMAIP1;JAK2;AREG,"7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one"
0,Hedgehog Signaling,0.0011952470619004,NRP1;NRP2;CDK6;VLDLR,Fedratinib
1,Epithelial Mesenchymal Transition,0.0012812548653688,VCAN;ECM1;COL4A1;COL12A1;TNC;SNAI2;FBLN1,Fedratinib
2,KRAS Signaling Up,0.0065913877579192,NRP1;GABRA3;LCP1;ETS1;TRIB2;DUSP6,Fedratinib
3,Estrogen Response Early,0.0324072591251969,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,Fedratinib
4,UV Response Dn,0.046218687756493,NRP1;ATP2B4;SNAI2;VLDLR,Fedratinib
0,Complement,0.016485554571269,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
1,UV Response Dn,0.016485554571269,ITGB3;PMP22;LPAR1;MT1E;IGF1R,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
2,PI3K/AKT/mTOR  Signaling,0.0267589427319902,CDK1;THEM4;PLCB1;HSP90B1,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
3,TNF-alpha Signaling via NF-kB,0.0279201001694004,CEBPB;IRS2;SGK1;FJX1;LITAF,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
4,Epithelial Mesenchymal Transition,0.0279201001694004,ITGB3;ADAM12;PMP22;SPP1;VEGFC,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
5,Cholesterol Homeostasis,0.0425700931629121,FDPS;FABP5;HMGCR,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine"
0,Epithelial Mesenchymal Transition,0.000324104589230943,ITGB5;BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
1,Hypoxia,0.0012584430129606,SRPX;TES;GCNT2;IRS2;PLIN2;AMPD3;MT1E,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
3,IL-2/STAT5 Signaling,0.0208925919634969,PRNP;SPP1;PLIN2;AHR;IGF1R,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
4,TNF-alpha Signaling via NF-kB,0.0208925919634969,CEBPB;IRS2;SGK1;FJX1;LITAF,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
5,Complement,0.0208925919634969,DOCK10;LYN;CEBPB;ERAP2;PSMB9,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
6,mTORC1 Signaling,0.0208925919634969,TES;HMGCR;BCAT1;AURKA;HSP90B1,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
7,Cholesterol Homeostasis,0.033447930342288,FDPS;FABP5;HMGCR,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
8,Apoptosis,0.0426452684820809,TGFB2;FAS;BAX;TXNIP,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
9,Interferon Alpha Response,0.0467780102200221,TXNIP;PSMB8;PSMB9,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
10,Androgen Response,0.0467780102200221,ADAMTS1;HMGCR;SGK1,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
11,Myogenesis,0.0467780102200221,FDPS;PRNP;ITGB5;ADAM12,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
12,Interferon Gamma Response,0.0467780102200221,FAS;TXNIP;PSMB8;PSMB9,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
13,Inflammatory Response,0.0467780102200221,LYN;ITGB3;LPAR1;AHR,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
14,Xenobiotic Metabolism,0.0467780102200221,TGFB2;GCNT2;FAS;BCAT1,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
15,p53 Pathway,0.0467780102200221,FAS;BAX;TXNIP;TP53,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
16,Allograft Rejection,0.0467780102200221,LYN;TGFB2;FAS;BCAT1,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
17,Apical Surface,0.0499387383281485,LYN;SRPX,N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
0,UV Response Dn,0.00026975334183304035,TJP1;NRP1;ANXA2;CAV1;ID1;MET;CAP2,Ipatasertib
1,Apoptosis,0.0002792962773493668,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44;IER3,Ipatasertib
2,Hypoxia,0.0005584957105454055,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR;IER3,Ipatasertib
3,Apical Junction,0.0005584957105454055,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Ipatasertib
4,Epithelial Mesenchymal Transition,0.0022002070310123,TNFRSF12A;SDC4;DST;COL12A1;CD44;CAP2,Ipatasertib
5,Glycolysis,0.0022002070310123,EXT1;MIF;MET;EGFR;CD44;IER3,Ipatasertib
6,p53 Pathway,0.0022002070310123,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,Ipatasertib
7,Cholesterol Homeostasis,0.0022002070310123,ALCAM;TNFRSF12A;MAL2;CD9,Ipatasertib
8,Angiogenesis,0.002902002126933,APP;NRP1;PTK2,Ipatasertib
9,Protein Secretion,0.0046732824709915,SCRN1;DST;CAV2;EGFR,Ipatasertib
10,TNF-alpha Signaling via NF-kB,0.009417494104758,TUBB2A;SDC4;PLK2;CD44;IER3,Ipatasertib
11,Estrogen Response Late,0.009417494104758,ELOVL5;CAV1;CD9;LSR;CD44,Ipatasertib
12,Fatty Acid Metabolism,0.0213855279264967,ELOVL5;PCBD1;MIF;S100A10,Ipatasertib
13,IL-6/JAK/STAT3 Signaling,0.0230498637600411,TNFRSF12A;CD9;CD44,Ipatasertib
14,Pperoxisome,0.0347827327998073,SEMA3C;ELOVL5;PRDX1,Ipatasertib
15,IL-2/STAT5 Signaling,0.0377789545709419,NRP1;ALCAM;AHNAK;CD44,Ipatasertib
16,Apical Surface,0.0408589677230306,APP;ATP8B1,Ipatasertib
0,Estrogen Response Early,0.001774045198203,ABLIM1;KRT19;KRT18;NRIP1;KRT8;FLNB;SFN,"N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide"
1,TGF-beta Signaling,0.0299143930386433,TJP1;SMURF2;ID1,"N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide"
2,Estrogen Response Late,0.0299143930386433,KRT19;NRIP1;FLNB;SFN;LSR,"N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide"
0,Hypoxia,0.0202811931012899,CDKN1C;SRPX;DTNA;IRS2;AMPD3;MT1E,Ricolinostat
1,Interferon Alpha Response,0.0285634239861699,BST2;TXNIP;PSMB8;PSMB9,Ricolinostat
0,Apical Junction,0.00023571242853159488,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
1,Cholesterol Homeostasis,0.0081938883583993,TNFRSF12A;GPX8;MAL2;CD9,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
3,Apoptosis,0.0087967670042194,APP;GPX1;KRT18;TNFRSF12A;PTK2,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
4,Protein Secretion,0.0087967670042194,KRT18;SCRN1;CAV2;EGFR,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
5,p53 Pathway,0.0177270477266034,VAMP8;APP;PTPN14;EPHA2;S100A10,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
6,IL-6/JAK/STAT3 Signaling,0.0433879788424304,TNFRSF12A;CD9;OSMR,"4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine)"
0,Epithelial Mesenchymal Transition,2.530659690179851e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,Cobimetinib
1,Estrogen Response Early,0.0078502640815566,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,Cobimetinib
2,Angiogenesis,0.0078502640815566,NRP1;VCAN;ITGAV,Cobimetinib
3,UV Response Dn,0.0078502640815566,NRP1;CELF2;ATP2B4;SNAI2;FYN,Cobimetinib
4,Androgen Response,0.0127836622685264,ELOVL5;STK39;ITGAV;HMGCR,Cobimetinib
5,IL-2/STAT5 Signaling,0.0216893429329743,CDKN1C;NRP1;ECM1;LRIG1;ITGAV,Cobimetinib
0,Epithelial Mesenchymal Transition,1.7320144107363228e-07,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;AREG;THBS1,Cobimetinib (R-enantiomer)
1,Angiogenesis,0.0005363288098271141,APP;NRP1;VCAN;ITGAV,Cobimetinib (R-enantiomer)
2,Glycolysis,0.0007507756611413217,VCAN;MIF;PAM;MET;EGFR;IER3;IL13RA1,Cobimetinib (R-enantiomer)
3,UV Response Dn,0.0007507756611413217,TJP1;NRP1;GJA1;ID1;ATP2B4;MET,Cobimetinib (R-enantiomer)
4,TGF-beta Signaling,0.0010750884469928,TJP1;ID1;ID3;THBS1,Cobimetinib (R-enantiomer)
5,TNF-alpha Signaling via NF-kB,0.0025884788600145,TUBB2A;SDC4;PLAU;PLK2;AREG;IER3,Cobimetinib (R-enantiomer)
6,Cholesterol Homeostasis,0.0025884788600145,ALCAM;TNFRSF12A;MAL2;CD9,Cobimetinib (R-enantiomer)
7,Coagulation,0.0028335581554311,SPARC;PLAU;CD9;THBS1;DUSP6,Cobimetinib (R-enantiomer)
8,Protein Secretion,0.0053452577282583,SCRN1;DST;PAM;EGFR,Cobimetinib (R-enantiomer)
9,Hypoxia,0.0105757955187123,SDC4;MIF;PAM;EGFR;IER3,Cobimetinib (R-enantiomer)
10,Apical Junction,0.0105757955187123,TJP1;VCAN;CDH3;ITGA3;EGFR,Cobimetinib (R-enantiomer)
11,IL-6/JAK/STAT3 Signaling,0.0276824344176964,TNFRSF12A;CD9;IL13RA1,Cobimetinib (R-enantiomer)
12,Pperoxisome,0.0372097808568358,SEMA3C;ELOVL5;PRDX1,Cobimetinib (R-enantiomer)
13,IL-2/STAT5 Signaling,0.0372097808568358,NRP1;ALCAM;AHNAK;ITGAV,Cobimetinib (R-enantiomer)
14,Estrogen Response Early,0.0372097808568358,GJA1;ELOVL5;ENDOD1;AREG,Cobimetinib (R-enantiomer)
15,Estrogen Response Late,0.0372097808568358,ELOVL5;ATP2B4;CD9;AREG,Cobimetinib (R-enantiomer)
16,p53 Pathway,0.0372097808568358,APP;HDAC3;PLK2;IER3,Cobimetinib (R-enantiomer)
0,Epithelial Mesenchymal Transition,0.00017454628000961432,BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC;EDIL3,"4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
2,mTORC1 Signaling,0.0074364374704729,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,"4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
3,IL-2/STAT5 Signaling,0.0292496287488957,PRNP;BHLHE40;SPP1;PLIN2;IGF1R,"4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
4,Hypoxia,0.0292496287488957,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,"4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide"
0,E2F Targets,0.0207882229288221,DNMT1;CDK4;PLK1;CDK1;TP53;AURKB,Abemaciclib
1,PI3K/AKT/mTOR  Signaling,0.0391827375718428,CDK4;CDK1;PLCB1;HSP90B1,Abemaciclib
0,Glycolysis,2.024527752143881e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
1,Epithelial Mesenchymal Transition,0.00011785621426579744,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;VIM;CD44,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
2,Hypoxia,0.0007008573622530579,EXT1;SDC4;MIF;ETS1;PAM;EGFR;IER3,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
3,TNF-alpha Signaling via NF-kB,0.0040562386202579,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
4,Angiogenesis,0.0049163330150396,APP;NRP1;VCAN,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
5,IL-6/JAK/STAT3 Signaling,0.0050830782197543,TNFRSF12A;CD9;CD44;IL13RA1,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
6,Apoptosis,0.0054979793776371,APP;GPX1;TNFRSF12A;CD44;IER3,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
7,Protein Secretion,0.0054979793776371,SCRN1;CAV2;PAM;EGFR,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
8,Apical Junction,0.010636228635962,VCAN;ITGA3;CTNNA1;EGFR;ACTB,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
9,KRAS Signaling Up,0.010636228635962,NRP1;GALNT3;PLAU;SPRY2;ETS1,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
10,Cholesterol Homeostasis,0.0176914672884829,ALCAM;TNFRSF12A;CD9,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
11,IL-2/STAT5 Signaling,0.0413104505839156,NRP1;NT5E;ALCAM;CD44,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
12,Estrogen Response Late,0.0413104505839156,ELOVL5;ATP2B4;CD9;CD44,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
13,p53 Pathway,0.0413104505839156,APP;HDAC3;PLK2;IER3,"N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide"
0,Androgen Response,0.0051125764405905,INPP4B;CDK6;ELOVL5;HMGCR;B2M,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
1,Hedgehog Signaling,0.0091586414284828,CDK6;DPYSL2;VLDLR,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
2,UV Response Dn,0.0091586414284828,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
3,Interferon Alpha Response,0.0124964979939493,IFITM2;TXNIP;B2M;PSMB8,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
4,Estrogen Response Early,0.0145417188382294,UGCG;ELOVL5;DLC1;JAK2;MICB,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
5,Estrogen Response Late,0.0145417188382294,FABP5;ELOVL5;ATP2B4;JAK2;MICB,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
6,Interferon Gamma Response,0.0145417188382294,IFITM2;TXNIP;JAK2;B2M;PSMB8,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
7,p53 Pathway,0.0145417188382294,HDAC3;BAX;STOM;TXNIP;TP53,2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,GLIPR1;ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;PMP22;FAS;PLOD3;VEGFC;EDIL3,Snx-5422
1,UV Response Dn,0.00015074451455375783,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,Snx-5422
2,IL-2/STAT5 Signaling,0.0048167833615563,PRNP;CSF1;BHLHE40;AHR;WLS;IGF1R,Snx-5422
3,TNF-alpha Signaling via NF-kB,0.0048167833615563,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,Snx-5422
9,Allograft Rejection,0.0126305215052049,LYN;TGFB2;CSF1;FAS;BCAT1,Snx-5422
7,Inflammatory Response,0.0126305215052049,LYN;CSF1;ITGB3;LPAR1;AHR,Snx-5422
8,Xenobiotic Metabolism,0.0126305215052049,TGFB2;PROS1;GCNT2;FAS;BCAT1,Snx-5422
5,Myogenesis,0.0126305215052049,WWTR1;FDPS;PRNP;ITGB5;BHLHE40,Snx-5422
4,Estrogen Response Early,0.0126305215052049,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,Snx-5422
6,Complement,0.0126305215052049,DOCK10;LYN;CEBPB;TFPI2;PSMB9,Snx-5422
10,Coagulation,0.0176290323492452,PROS1;ITGB3;TFPI2;PRSS23,Snx-5422
11,Apoptosis,0.0276225034486205,TGFB2;FAS;BAX;BCL2L2,Snx-5422
12,IL-6/JAK/STAT3 Signaling,0.0277432749329002,CSF1;ITGB3;FAS,Snx-5422
13,Interferon Alpha Response,0.0345760552301129,CSF1;PSMB8;PSMB9,Snx-5422
14,Androgen Response,0.0350151198422416,ADAMTS1;SGK1;ELL2,Snx-5422
15,Hypoxia,0.0429241400598498,SRPX;BHLHE40;GCNT2;MT1E,Snx-5422
16,Apical Surface,0.0456659051022107,LYN;SRPX,Snx-5422
0,Epithelial Mesenchymal Transition,3.115836277338916e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FAS;VEGFC;EDIL3,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
1,IL-2/STAT5 Signaling,0.00011371954606686996,PRNP;CSF1;BHLHE40;ITGA6;PLIN2;AHR;WLS;IGF1R,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
2,UV Response Dn,0.00011371954606686996,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
3,TNF-alpha Signaling via NF-kB,0.0005650662483165278,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
4,Hypoxia,0.0005650662483165278,SRPX;BHLHE40;GCNT2;IRS2;PLIN2;AMPD3;MT1E,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
5,Inflammatory Response,0.0178655402869675,LYN;CSF1;ITGB3;LPAR1;AHR,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
6,Xenobiotic Metabolism,0.0178655402869675,TGFB2;PROS1;GCNT2;FAS;BCAT1,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
7,Allograft Rejection,0.0178655402869675,LYN;TGFB2;CSF1;FAS;BCAT1,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
8,IL-6/JAK/STAT3 Signaling,0.0453464639985123,CSF1;ITGB3;FAS,"4,5,6,7-Tetrahydro-11-methoxy-2-((4-methyl-1-piperazinyl)methyl)-1H-cyclopenta(a)pyrrolo(3,4-C)carbazole-1,3(2H)-dione"
0,UV Response Dn,0.0036895261061802,INPP4B;ITGB3;PMP22;PTEN;MT1E;IGF1R,Gdc-0349
1,Hedgehog Signaling,0.0165158062223986,ADGRG1;CDK6;DPYSL2,Gdc-0349
2,Androgen Response,0.0229040615644431,INPP4B;CDK6;ADAMTS1;HMGCR,Gdc-0349
3,mTORC1 Signaling,0.0357310805739351,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Gdc-0349
0,Estrogen Response Early,0.0018397505759142,ABLIM1;KRT19;KRT18;MYOF;KRT8;FLNB;SFN,(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
1,Estrogen Response Late,0.031022333521556,KRT19;MYOF;FLNB;SFN;LSR,(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
2,p53 Pathway,0.031022333521556,APP;LIF;SFN;EPHA2;S100A10,(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
3,UV Response Dn,0.0414783095250578,TJP1;ANXA2;MAP1B;ID1,(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
0,UV Response Dn,0.0038611319715839,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
1,Epithelial Mesenchymal Transition,0.0114081711194755,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
2,TNF-alpha Signaling via NF-kB,0.0249286608655361,CEBPB;IRS2;SGK1;FJX1;LITAF,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
3,Hypoxia,0.0249286608655361,SRPX;GCNT2;IRS2;PLIN2;MT1E,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
4,Complement,0.0249286608655361,DOCK10;LYN;CEBPB;ERAP2;PSMB9,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
5,mTORC1 Signaling,0.0249286608655361,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
6,Cholesterol Homeostasis,0.03909498351696,FDPS;FABP5;HMGCR,"3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine"
0,UV Response Dn,0.0321860827343824,ITGB3;PMP22;LPAR1;MT1E;IGF1R,Lestaurtinib
1,mTORC1 Signaling,0.0454255597994214,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,Lestaurtinib
2,Epithelial Mesenchymal Transition,0.0454255597994214,ITGB3;ADAM12;PMP22;SPP1;VEGFC,Lestaurtinib
0,Hypoxia,0.0009438322597205188,EXT1;ANXA2;SDC4;CAV1;MIF;ETS1;EGFR,Merestinib
1,Apical Junction,0.0009438322597205188,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,Merestinib
2,UV Response Dn,0.0009438322597205188,TJP1;NRP1;ANXA2;CAV1;ID1;MET,Merestinib
3,Apoptosis,0.0013062457739896,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,Merestinib
4,p53 Pathway,0.0028473267460159,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,Merestinib
5,Cholesterol Homeostasis,0.0028473267460159,ALCAM;TNFRSF12A;MAL2;CD9,Merestinib
6,Angiogenesis,0.0036214060155425,APP;NRP1;PTK2,Merestinib
7,Estrogen Response Late,0.0109686107808359,ELOVL5;CAV1;CD9;LSR;CD44,Merestinib
8,Epithelial Mesenchymal Transition,0.0109686107808359,TNFRSF12A;SDC4;COL12A1;VIM;CD44,Merestinib
9,Glycolysis,0.0109686107808359,EXT1;MIF;MET;EGFR;CD44,Merestinib
10,Fatty Acid Metabolism,0.0245304585039227,ELOVL5;PCBD1;MIF;S100A10,Merestinib
11,IL-6/JAK/STAT3 Signaling,0.0261005810223995,TNFRSF12A;CD9;CD44,Merestinib
12,Protein Secretion,0.0314483409468586,SCRN1;CAV2;EGFR,Merestinib
13,IL-2/STAT5 Signaling,0.0419060672551624,NRP1;ALCAM;AHNAK;CD44,Merestinib
14,Apical Surface,0.0449448644953337,APP;ATP8B1,Merestinib
0,Epithelial Mesenchymal Transition,1.682528284715285e-07,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;CD44;LOXL2,Duvelisib
1,Hypoxia,7.170202455509579e-07,EXT1;MT2A;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;MIF;ETS1;EGFR,Duvelisib
2,Apical Junction,7.170202455509579e-07,TJP1;SGCE;RRAS;ITGA3;AKT3;CTNNA1;FLNC;EGFR;ACTB;PTK2,Duvelisib
3,UV Response Dn,5.375847919693146e-06,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;AKT3;LAMC1,Duvelisib
4,Apoptosis,0.0001117185109397467,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Duvelisib
5,Angiogenesis,0.00017366837651544646,APP;FSTL1;PTK2;FGFR1,Duvelisib
6,TNF-alpha Signaling via NF-kB,0.000319140406025946,FOSL1;MARCKS;SDC4;DUSP1;PLK2;SERPINE1;CD44,Duvelisib
7,Mitotic Spindle,0.0020986076465721,NOTCH2;FARP1;MYO1E;MARCKS;ARHGAP29;CDC42EP1,Duvelisib
8,IL-6/JAK/STAT3 Signaling,0.0036005137389926,TNFRSF12A;CD9;OSMR;CD44,Duvelisib
9,Estrogen Response Late,0.009417494104758,FARP1;ELOVL5;CAV1;CD9;CD44,Duvelisib
10,Glycolysis,0.009417494104758,EXT1;NT5E;MIF;EGFR;CD44,Duvelisib
11,p53 Pathway,0.009417494104758,VAMP8;APP;PLK2;PTPN14;S100A10,Duvelisib
12,Cholesterol Homeostasis,0.0159053095333957,TNFRSF12A;GPX8;CD9,Duvelisib
13,Fatty Acid Metabolism,0.0198579902174613,ELOVL5;PCBD1;MIF;S100A10,Duvelisib
14,IL-2/STAT5 Signaling,0.0361466442609262,MYO1E;NT5E;AHNAK;CD44,Duvelisib
15,Complement,0.0361466442609262,GCA;SERPINE1;GNB4;TIMP2,Duvelisib
16,Inflammatory Response,0.0361466442609262,AXL;SERPINE1;SGMS2;OSMR,Duvelisib
0,Hypoxia,0.00025044445531481954,EXT1;ANXA2;SDC4;CAV1;MIF;ETS1;PAM;EGFR,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
1,Apical Junction,0.0007293249279658553,TJP1;RRAS;ITGA3;CTNNA1;EGFR;ACTB;PTK2,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
2,Glycolysis,0.0007293249279658553,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
3,UV Response Dn,0.0007293249279658553,TJP1;NRP1;ANXA2;CAV1;ID1;MET,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
4,Apoptosis,0.0010766631834096,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
5,Epithelial Mesenchymal Transition,0.0025145223211569,NT5E;TNFRSF12A;SDC4;COL12A1;VIM;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
6,Cholesterol Homeostasis,0.0025145223211569,ALCAM;TNFRSF12A;MAL2;CD9,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
7,Angiogenesis,0.0032647523927997,APP;NRP1;PTK2,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
8,IL-6/JAK/STAT3 Signaling,0.0036005137389926,TNFRSF12A;CD9;OSMR;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
9,Protein Secretion,0.0046732824709915,SCRN1;CAV2;PAM;EGFR,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
10,IL-2/STAT5 Signaling,0.0100559680871062,NRP1;NT5E;ALCAM;AHNAK;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
11,TNF-alpha Signaling via NF-kB,0.0409661968290497,SDC4;PLAU;PLK2;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
12,Estrogen Response Late,0.0409661968290497,ELOVL5;CAV1;CD9;CD44,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
13,Inflammatory Response,0.0409661968290497,AXL;SGMS2;OSMR;MET,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
14,p53 Pathway,0.0409661968290497,VAMP8;APP;PLK2;PTPN14,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
15,Apical Surface,0.04341265320572,APP;ATP8B1,"2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide"
0,Apical Junction,0.0021025720867591,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide"
1,p53 Pathway,0.0081124772405159,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide"
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide"
3,UV Response Dn,0.0474037823143518,TJP1;ANXA2;ID1;LAMC1,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide"
0,UV Response Dn,0.0021501768939856,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,"2-Amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide"
1,TGF-beta Signaling,0.0021501768939856,TJP1;RAB31;SMURF2;ID1,"2-Amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide"
2,Apical Junction,0.0047322783903009,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,"2-Amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide"
3,Angiogenesis,0.0053772392351995,FSTL1;PTK2;FGFR1,"2-Amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide"
4,Estrogen Response Early,0.0186134001129336,ABLIM1;RAB31;KRT18;KRT8;SFN,"2-Amino-4-(4-chloro-2-(2-(4-fluoro-1H-pyrazol-1-yl)ethoxy)-6-methylphenyl)-N-(2,2-difluoropropyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide"
0,Hypoxia,1.340534212343487e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
1,Epithelial Mesenchymal Transition,1.340534212343487e-05,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;SNAI2;VIM;CD44;LOXL2,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
2,Apoptosis,0.0019527714601056,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
3,TNF-alpha Signaling via NF-kB,0.0037520207237386,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
4,Estrogen Response Late,0.0037520207237386,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
5,UV Response Dn,0.0048409961836266,CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
6,Glycolysis,0.0175687705147588,EXT1;NT5E;MIF;EGFR;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
7,Cholesterol Homeostasis,0.028126668696924,TNFRSF12A;CD9;HMGCR,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
17,Xenobiotic Metabolism,0.0334356459413567,MT2A;ELOVL5;SERPINE1;MAN1A1,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
16,mTORC1 Signaling,0.0334356459413567,ELOVL5;PLK1;CD9;HMGCR,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
15,Complement,0.0334356459413567,GCA;SERPINE1;GNB4;TIMP2,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
14,Apical Junction,0.0334356459413567,ITGA3;EGFR;ACTB;PTK2,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
13,Estrogen Response Early,0.0334356459413567,FARP1;ELOVL5;ENDOD1;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
9,Androgen Response,0.0334356459413567,CDK6;ELOVL5;HMGCR,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
11,Angiogenesis,0.0334356459413567,APP;PTK2,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
10,Hedgehog Signaling,0.0334356459413567,NRP2;CDK6,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
18,p53 Pathway,0.0334356459413567,VAMP8;APP;PLK2;PTPN14,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
8,IL-6/JAK/STAT3 Signaling,0.0334356459413567,TNFRSF12A;CD9;CD44,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
12,Mitotic Spindle,0.0334356459413567,FARP1;PLK1;ARHGAP29;CDC42EP1,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
19,KRAS Signaling Up,0.0334356459413567,GALNT3;PLAU;SPRY2;ETS1,Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide
0,Epithelial Mesenchymal Transition,2.024527752143881e-06,NOTCH2;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;CD44;LOXL2,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
1,Hypoxia,6.347137454895067e-05,EXT1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;ETS1;EGFR,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
2,Apical Junction,6.347137454895067e-05,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
3,UV Response Dn,6.347137454895067e-05,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
4,Apoptosis,0.00010514683382564396,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
5,Angiogenesis,0.00016345258966159664,APP;FSTL1;PTK2;FGFR1,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
6,TNF-alpha Signaling via NF-kB,0.0020281193101289,MARCKS;SDC4;DUSP1;PLK2;SERPINE1;CD44,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
7,p53 Pathway,0.0020281193101289,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
8,IL-6/JAK/STAT3 Signaling,0.0033887188131695,TNFRSF12A;CD9;OSMR;CD44,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
9,TGF-beta Signaling,0.0080019034192128,TJP1;SMURF2;SERPINE1,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
10,Mitotic Spindle,0.0094644405525706,NOTCH2;MARCKS;ARHGAP29;CDC42EP1;RHOF,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
11,Cholesterol Homeostasis,0.016217178347776,TNFRSF12A;GPX8;CD9,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
12,Protein Secretion,0.030495360918166,SCRN1;CAV2;EGFR,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
13,Xenobiotic Metabolism,0.0385564205449879,CYB5A;CBR1;SERPINE1;EPHA2,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
14,Glycolysis,0.0385564205449879,EXT1;CYB5A;EGFR;CD44,N-[4-[4-(2-methoxyphenyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,VCAN;ECM1;COL5A1;COL4A1;COL12A1;TNC;SNAI2;TIMP3;FBLN1,772992
1,UV Response Dn,0.0149155017549577,CELF2;ATP2B4;SNAI2;FYN;VLDLR,772992
2,Complement,0.0315763037630124,ERAP2;KYNU;FYN;JAK2;DUSP6,772992
3,KRAS Signaling Up,0.0315763037630124,GYPC;GABRA3;LCP1;TRIB2;DUSP6,772992
0,Cholesterol Homeostasis,0.0217432224241218,FDPS;GSTM2;FABP5;HMGCR,773094
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;ECM1;COL4A1;COL12A1;TNC;SNAI2;PDLIM4;CD44,773261
1,Hedgehog Signaling,0.0005822998506694381,NRP1;NRP2;CDK6;VLDLR,773261
2,KRAS Signaling Up,0.0008322681176755062,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,773261
3,Glycolysis,0.0048167833615563,NT5E;VCAN;CDK1;MIF;VLDLR;CD44,773261
4,Estrogen Response Early,0.0252610430104099,ELOVL5;ENDOD1;PMAIP1;JAK2;CD44,773261
5,UV Response Dn,0.0375279943321951,NRP1;ATP2B4;SNAI2;VLDLR,773261
0,Epithelial Mesenchymal Transition,2.4673931979253548e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,773263
1,Estrogen Response Early,0.0098870816368788,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,773263
2,Angiogenesis,0.0099863014367991,NRP1;VCAN;ITGAV,773263
3,KRAS Signaling Up,0.0324072591251969,NRP1;PLAU;GABRA3;TRIB2;DUSP6,773263
4,UV Response Dn,0.046218687756493,NRP1;CELF2;ATP2B4;SNAI2,773263
0,Hypoxia,0.0212952527563544,SRPX;DTNA;IRS2;TGFBI;AMPD3;MT1E,773264
1,Interferon Alpha Response,0.023266750141167,BST2;TXNIP;PSMB8;PSMB9,773264
2,TNF-alpha Signaling via NF-kB,0.023266750141167,CEBPB;IRS2;SGK1;FJX1;LITAF,773264
3,Complement,0.023266750141167,DOCK10;LYN;CEBPB;ERAP2;PSMB9,773264
4,Epithelial Mesenchymal Transition,0.023266750141167,ITGB3;ADAM12;PMP22;SPP1;TGFBI,773264
5,KRAS Signaling Up,0.023266750141167,SPP1;LCP1;GNG11;PSMB8;ENG,773264
6,UV Response Dn,0.0355528367357638,ITGB3;PMP22;MT1E;IGF1R,773264
0,Interferon Alpha Response,0.0357310805739351,BST2;TXNIP;PSMB8;PSMB9,773265
1,TNF-alpha Signaling via NF-kB,0.0357310805739351,CEBPB;IRS2;SGK1;FJX1;LITAF,773265
2,Hypoxia,0.0357310805739351,SRPX;DTNA;IRS2;AMPD3;MT1E,773265
3,Complement,0.0357310805739351,DOCK10;LYN;CEBPB;ERAP2;PSMB9,773265
4,UV Response Dn,0.0435836668096481,ITGB3;PMP22;MT1E;IGF1R,773265
5,Cholesterol Homeostasis,0.0435836668096481,FDPS;FABP5;HMGCR,773265
0,Epithelial Mesenchymal Transition,0.0003167385758393306,ITGB5;BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC,773394
1,UV Response Dn,0.0018447630530901,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,773394
2,Hypoxia,0.0072674275279622,SRPX;DTNA;GCNT2;IRS2;AMPD3;MT1E,773394
3,TNF-alpha Signaling via NF-kB,0.0178655402869675,CEBPB;IRS2;SGK1;FJX1;LITAF,773394
4,Myogenesis,0.0178655402869675,FDPS;PRNP;DTNA;ITGB5;ADAM12,773394
5,Complement,0.0178655402869675,DOCK10;LYN;CEBPB;ERAP2;PSMB9,773394
6,mTORC1 Signaling,0.0178655402869675,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,773394
7,KRAS Signaling Up,0.0178655402869675,TMEM158;SPP1;LCP1;GNG11;PSMB8,773394
0,Epithelial Mesenchymal Transition,2.2763617969677386e-07,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC;EDIL3,774769
1,UV Response Dn,0.0001824802018282332,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,774769
2,IL-2/STAT5 Signaling,0.0029154215083104,PRNP;CSF1;BHLHE40;SPP1;PLIN2;IGF1R,774769
3,TNF-alpha Signaling via NF-kB,0.0029154215083104,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,774769
4,Estrogen Response Early,0.0029154215083104,BHLHE40;RHOBTB3;JAK2;PRSS23;MICB;IGF1R,774769
5,Estrogen Response Late,0.0029154215083104,FABP5;TFPI2;SGK1;JAK2;PRSS23;MICB,774769
6,Complement,0.0029154215083104,DOCK10;LYN;CEBPB;TFPI2;JAK2;PSMB9,774769
7,Allograft Rejection,0.0029154215083104,LYN;TGFB2;CSF1;FAS;BCAT1;JAK2,774769
8,Androgen Response,0.0081673397826696,ADAMTS1;HMGCR;SGK1;ELL2,774769
12,Xenobiotic Metabolism,0.0117612143570734,TGFB2;PROS1;GCNT2;FAS;BCAT1,774769
11,mTORC1 Signaling,0.0117612143570734,BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,774769
10,Myogenesis,0.0117612143570734,FDPS;WWTR1;PRNP;BHLHE40;ADAM12,774769
9,Hypoxia,0.0117612143570734,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,774769
13,Coagulation,0.0167674630990941,PROS1;ITGB3;TFPI2;PRSS23,774769
14,Cholesterol Homeostasis,0.0186497550999424,FDPS;FABP5;HMGCR,774769
15,IL-6/JAK/STAT3 Signaling,0.0272869710688722,CSF1;ITGB3;FAS,774769
16,Interferon Alpha Response,0.0344690086194933,CSF1;PSMB8;PSMB9,774769
17,Interferon Gamma Response,0.0415686409000651,FAS;JAK2;PSMB8;PSMB9,774769
18,Inflammatory Response,0.0415686409000651,LYN;CSF1;ITGB3;LPAR1,774769
19,KRAS Signaling Up,0.0415686409000651,TMEM158;SPP1;GNG11;PSMB8,774769
20,Apical Surface,0.0447502979823669,LYN;SRPX,774769
0,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,774829
1,Hypoxia,0.0349001252117506,SRPX;IRS2;PLIN2;AMPD3;MT1E,774829
2,Complement,0.0349001252117506,DOCK10;LYN;CEBPB;ERAP2;PSMB9,774829
3,mTORC1 Signaling,0.0349001252117506,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,774829
4,UV Response Dn,0.0497739714300694,ITGB3;PMP22;MT1E;IGF1R,774829
0,Epithelial Mesenchymal Transition,0.0024968043530265,NT5E;VCAN;SPARC;COL4A1;COL12A1;SNAI2;CD44,774830
1,KRAS Signaling Up,0.0096335667231127,NRP1;GALNT3;SPRY2;ETS1;TRIB2;DUSP6,774830
2,Glycolysis,0.0421017383506832,NT5E;VCAN;CDK1;MIF;CD44,774830
0,Cholesterol Homeostasis,0.0010388358286489,ALCAM;TNFRSF12A;GPX8;MAL2;CD9,774831
1,Apical Junction,0.0076054474129837,TJP1;RRAS;ITGA3;CTNNA1;RHOF;PTK2,774831
2,Apoptosis,0.0103087113330696,APP;GPX1;KRT18;TNFRSF12A;PTK2,774831
3,Protein Secretion,0.0103087113330696,TPD52;KRT18;SCRN1;DST,774831
4,p53 Pathway,0.0199429286924289,VAMP8;APP;SFN;PTPN14;S100A10,774831
5,UV Response Dn,0.0296273639464698,TJP1;ANXA2;ID1;MET,774831
0,Epithelial Mesenchymal Transition,2.024527752143881e-06,NOTCH2;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;CD44;LOXL2,775306
1,Hypoxia,6.347137454895067e-05,EXT1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;ETS1;EGFR,775306
2,Apical Junction,6.347137454895067e-05,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,775306
3,UV Response Dn,6.347137454895067e-05,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1,775306
4,Apoptosis,0.00010514683382564396,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,775306
5,Angiogenesis,0.00016345258966159664,APP;FSTL1;PTK2;FGFR1,775306
6,TNF-alpha Signaling via NF-kB,0.0020281193101289,MARCKS;SDC4;DUSP1;PLK2;SERPINE1;CD44,775306
7,p53 Pathway,0.0020281193101289,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,775306
8,IL-6/JAK/STAT3 Signaling,0.0033887188131695,TNFRSF12A;CD9;OSMR;CD44,775306
9,Mitotic Spindle,0.0104108846078276,NOTCH2;MARCKS;ARHGAP29;CDC42EP1;RHOF,775306
10,Cholesterol Homeostasis,0.0176914672884829,TNFRSF12A;GPX8;CD9,775306
11,Protein Secretion,0.0330366409946798,SCRN1;CAV2;EGFR,775306
12,Xenobiotic Metabolism,0.0413104505839156,CYB5A;CBR1;SERPINE1;EPHA2,775306
13,Glycolysis,0.0413104505839156,EXT1;CYB5A;EGFR;CD44,775306
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,GJA1;VCAN;SPARC;COL4A1;COL12A1;SNAI2;ITGAV;AREG;THBS1,775636
1,Angiogenesis,0.0138271866047988,NRP1;VCAN;ITGAV,775636
2,Estrogen Response Early,0.036488651282496,GJA1;ELOVL5;ENDOD1;JAK2;AREG,775636
3,Coagulation,0.036488651282496,SPARC;PLAU;THBS1;DUSP6,775636
4,UV Response Dn,0.036488651282496,NRP1;GJA1;ATP2B4;SNAI2,775636
5,Cholesterol Homeostasis,0.036488651282496,ALCAM;MAL2;HMGCR,775636
0,Epithelial Mesenchymal Transition,2.4636844983610032e-05,VCAN;TNFRSF12A;SDC4;DST;COL12A1;ITGAV;VIM;THBS1;CD44,775771
1,Glycolysis,0.00012522222765740977,VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,775771
2,Angiogenesis,0.0003473367530308929,APP;NRP1;VCAN;ITGAV,775771
3,Protein Secretion,0.0010240528766739,SCRN1;DST;CAV2;PAM;EGFR,775771
4,Cholesterol Homeostasis,0.0035203312496197,ALCAM;TNFRSF12A;MAL2;CD9,775771
5,IL-6/JAK/STAT3 Signaling,0.0054007706084889,TNFRSF12A;CD9;CD44;IL13RA1,775771
6,Apoptosis,0.0062789144082615,APP;GPX1;TNFRSF12A;CD44;IER3,775771
7,TGF-beta Signaling,0.0086930714813151,TJP1;ID1;THBS1,775771
8,IL-2/STAT5 Signaling,0.0086930714813151,NRP1;ALCAM;AHNAK;ITGAV;CD44,775771
9,TNF-alpha Signaling via NF-kB,0.0086930714813151,TUBB2A;SDC4;PLK2;CD44;IER3,775771
10,Hypoxia,0.0086930714813151,SDC4;MIF;PAM;EGFR;IER3,775771
11,Apical Junction,0.0086930714813151,TJP1;VCAN;ITGA3;CTNNA1;EGFR,775771
12,p53 Pathway,0.0086930714813151,APP;HDAC3;PLK2;S100A10;IER3,775771
13,UV Response Dn,0.0143904339168568,TJP1;NRP1;ID1;MET,775771
14,Fatty Acid Metabolism,0.0185341242029638,ELOVL5;PCBD1;MIF;S100A10,775771
15,Pperoxisome,0.0326088119998194,SEMA3C;ELOVL5;PRDX1,775771
0,Hypoxia,0.0012155494876576,EXT1;MT2A;SDC4;PRKCA;MIF;ETS1;EGFR,776017
1,Epithelial Mesenchymal Transition,0.0012155494876576,NT5E;TNFRSF12A;SDC4;COL12A1;VIM;CD44;LOXL2,776017
2,Apoptosis,0.0159435179582327,APP;TNFRSF12A;BAX;PTK2;CD44,776017
3,TNF-alpha Signaling via NF-kB,0.0175687705147588,FOSL1;SDC4;PLAU;PLK2;CD44,776017
4,Estrogen Response Late,0.0175687705147588,FARP1;ELOVL5;ATP2B4;CD9;CD44,776017
5,Glycolysis,0.0175687705147588,EXT1;NT5E;MIF;EGFR;CD44,776017
6,p53 Pathway,0.0175687705147588,VAMP8;APP;PLK2;BAX;PTPN14,776017
7,Cholesterol Homeostasis,0.028126668696924,TNFRSF12A;CD9;HMGCR,776017
8,IL-6/JAK/STAT3 Signaling,0.0390190504173245,TNFRSF12A;CD9;CD44,776017
9,Androgen Response,0.0393360540486549,CDK6;ELOVL5;HMGCR,776017
10,Hedgehog Signaling,0.0393360540486549,NRP2;CDK6,776017
11,Angiogenesis,0.0393360540486549,APP;PTK2,776017
12,Mitotic Spindle,0.0393360540486549,FARP1;PLK1;ARHGAP29;CDC42EP1,776017
13,Estrogen Response Early,0.0393360540486549,FARP1;ELOVL5;ENDOD1;CD44,776017
14,Apical Junction,0.0393360540486549,ITGA3;EGFR;ACTB;PTK2,776017
15,mTORC1 Signaling,0.0393360540486549,ELOVL5;PLK1;CD9;HMGCR,776017
16,Xenobiotic Metabolism,0.0393360540486549,GSTM4;MT2A;ELOVL5;MAN1A1,776017
0,Epithelial Mesenchymal Transition,2.8259910422376216e-05,VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;FBLN1;ITGAV;AREG,776043
1,Angiogenesis,0.0005976235309502128,NRP1;VCAN;SPP1;ITGAV,776043
2,Estrogen Response Early,0.0324072591251969,ELOVL5;ENDOD1;PMAIP1;JAK2;AREG,776043
3,KRAS Signaling Up,0.0324072591251969,NRP1;PLAU;GABRA3;SPP1;DUSP6,776043
4,UV Response Dn,0.046218687756493,NRP1;SDC2;ATP2B4;SNAI2,776043
0,Angiogenesis,0.0010113628985311,APP;FSTL1;PTK2;FGFR1,776066
1,Apical Junction,0.0010841387322351,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,776066
2,UV Response Dn,0.0086352904897123,TJP1;ANXA2;MAP1B;ID1;CAP2,776066
3,Apoptosis,0.0090716659731012,APP;GPX1;KRT18;TNFRSF12A;PTK2,776066
4,Protein Secretion,0.0090716659731012,KRT18;SCRN1;CAV2;EGFR,776066
5,Epithelial Mesenchymal Transition,0.0182810179680598,TNFRSF12A;SDC4;FSTL1;PFN2;CAP2,776066
6,Cholesterol Homeostasis,0.028669654579104,TNFRSF12A;GPX8;CD9,776066
7,IL-6/JAK/STAT3 Signaling,0.0391508715335993,TNFRSF12A;CD9;OSMR,776066
0,Androgen Response,0.0056968708909437,INPP4B;CDK6;ELOVL5;HMGCR;B2M,776762
1,Estrogen Response Early,0.0061232059836142,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,776762
2,Glycolysis,0.0061232059836142,EXT1;VCAN;CDK1;MIF;VLDLR;CD44,776762
3,Hedgehog Signaling,0.0061232059836142,NRP2;CDK6;VLDLR,776762
4,UV Response Dn,0.0061232059836142,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,776762
5,Hypoxia,0.0162036295625984,EXT1;PLIN2;MIF;VLDLR;ETS1,776762
6,Estrogen Response Late,0.0162036295625984,FARP1;ELOVL5;ATP2B4;JAK2;CD44,776762
7,p53 Pathway,0.0162036295625984,HDAC3;BAX;STOM;TXNIP;TP53,776762
0,Epithelial Mesenchymal Transition,0.00027990850888126893,VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;FBLN1;ITGAV,776763
1,Angiogenesis,0.0005822998506694381,NRP1;VCAN;SPP1;ITGAV,776763
0,Epithelial Mesenchymal Transition,2.0877942443983774e-06,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,776996
1,Hypoxia,1.1956115947928398e-05,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,776996
2,Apical Junction,8.102614730773575e-05,TJP1;SGCE;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,776996
3,Apoptosis,0.00013554084047836916,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,776996
4,UV Response Dn,0.0005662993558323111,NOTCH2;TJP1;ANXA2;CAV1;SERPINE1;LAMC1,776996
5,TNF-alpha Signaling via NF-kB,0.0027886640514273,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,776996
6,Angiogenesis,0.0036214060155425,APP;FSTL1;PTK2,776996
7,IL-6/JAK/STAT3 Signaling,0.0039314433105912,TNFRSF12A;CD9;OSMR;CD44,776996
8,Mitotic Spindle,0.0099714643462144,NOTCH2;FARP1;MYO1E;ARHGAP29;CDC42EP1,776996
9,Estrogen Response Late,0.0099714643462144,FARP1;ELOVL5;CAV1;CD9;CD44,776996
10,Glycolysis,0.0099714643462144,EXT1;NT5E;MIF;EGFR;CD44,776996
11,Coagulation,0.0140336375938071,PLAU;SERPINE1;CD9;GNG12,776996
12,IL-2/STAT5 Signaling,0.0372762268940801,MYO1E;NT5E;AHNAK;CD44,776996
13,Complement,0.0372762268940801,GCA;SERPINE1;GNB4;TIMP2,776996
14,Inflammatory Response,0.0372762268940801,AXL;SERPINE1;SGMS2;OSMR,776996
15,p53 Pathway,0.0372762268940801,VAMP8;APP;PLK2;PTPN14,776996
0,UV Response Dn,0.0003570264818378475,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,777193
1,IL-2/STAT5 Signaling,0.0076054474129837,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;IGF1R,777193
2,mTORC1 Signaling,0.0076054474129837,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,777193
3,TNF-alpha Signaling via NF-kB,0.0213674235990309,CEBPB;BHLHE40;SGK1;FJX1;LITAF,777193
4,Hypoxia,0.0213674235990309,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,777193
5,Complement,0.0213674235990309,DOCK10;LYN;CEBPB;ERAP2;PSMB9,777193
6,Epithelial Mesenchymal Transition,0.0213674235990309,BDNF;ITGB3;PMP22;SPP1;VEGFC,777193
0,E2F Targets,0.0202811931012899,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,777194
0,Estrogen Response Late,0.0421017383506832,TFAP2C;FABP5;ELOVL5;ATP2B4;JAK2,777445
1,E2F Targets,0.0421017383506832,DNMT1;CHEK1;PLK1;CDK1;TP53,777445
2,p53 Pathway,0.0421017383506832,HDAC3;BAX;STOM;TXNIP;TP53,777445
0,Interferon Alpha Response,0.034069169849566,BST2;TXNIP;PSMB8;PSMB9,777448
1,TNF-alpha Signaling via NF-kB,0.034069169849566,CEBPB;IRS2;SGK1;FJX1;LITAF,777448
2,Hypoxia,0.034069169849566,SRPX;DTNA;IRS2;AMPD3;MT1E,777448
3,Complement,0.034069169849566,DOCK10;LYN;CEBPB;ERAP2;PSMB9,777448
4,UV Response Dn,0.0485888768722106,ITGB3;PMP22;MT1E;IGF1R,777448
0,mTORC1 Signaling,0.0197741632737576,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,777571
0,Hypoxia,1.0755303683264367e-06,EXT1;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,777572
1,Epithelial Mesenchymal Transition,1.0755303683264367e-06,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;SERPINE1;SNAI2;VIM;CD44;LOXL2,777572
2,Apoptosis,1.6676232957085928e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,777572
3,Glycolysis,5.395066836660807e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,777572
4,UV Response Dn,5.395066836660807e-05,NRP1;CAV1;SERPINE1;ATP2B4;SNAI2;PRKCA;MET,777572
5,TNF-alpha Signaling via NF-kB,0.000372330473696937,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44;IER3,777572
6,Estrogen Response Late,0.0024627163051566,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,777572
7,Angiogenesis,0.0032647523927997,APP;NRP1;PTK2,777572
9,KRAS Signaling Up,0.0113009929257097,NRP1;GALNT3;PLAU;SPRY2;ETS1,777572
8,IL-2/STAT5 Signaling,0.0113009929257097,MYO1E;NRP1;NT5E;ALCAM;CD44,777572
10,Cholesterol Homeostasis,0.0187971839940131,ALCAM;TNFRSF12A;CD9,777572
11,IL-6/JAK/STAT3 Signaling,0.026891507720048,TNFRSF12A;CD9;CD44,777572
12,Protein Secretion,0.0324013209755513,CAV2;PAM;EGFR,777572
13,Mitotic Spindle,0.0341384973575414,FARP1;MYO1E;ARHGAP29;CDC42EP1,777572
14,Estrogen Response Early,0.0341384973575414,FARP1;ELOVL5;ENDOD1;CD44,777572
15,Apical Junction,0.0341384973575414,ITGA3;EGFR;ACTB;PTK2,777572
16,Inflammatory Response,0.0341384973575414,AXL;SERPINE1;SGMS2;MET,777572
17,p53 Pathway,0.0341384973575414,VAMP8;APP;PLK2;IER3,777572
0,Hedgehog Signaling,0.0153080149590355,NRP2;CDK6;VLDLR,777638
1,UV Response Dn,0.0153080149590355,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,777638
2,E2F Targets,0.0432096788335959,DNMT1;PLK1;CDK1;TP53;AURKB,777638
0,Hypoxia,0.0069294076429407,SRPX;TES;PLIN2;TGFBI;NR3C1;MT1E,777639
1,mTORC1 Signaling,0.0069294076429407,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,777639
2,Epithelial Mesenchymal Transition,0.0069294076429407,ITGB5;BASP1;ITGB3;SPP1;TGFBI;EDIL3,777639
3,Interferon Alpha Response,0.0146387547929121,IFITM3;LGALS3BP;TXNIP;PSMB8,777639
4,IL-2/STAT5 Signaling,0.0266778918075583,IFITM3;SPP1;PLIN2;AHR;IGF1R,777639
5,UV Response Dn,0.0404907307268421,ITGB3;NR3C1;MT1E;IGF1R,777639
0,UV Response Dn,0.00034115863820060986,BDNF;ITGB3;BHLHE40;PMP22;PTEN;MT1E;IGF1R,777877
1,IL-2/STAT5 Signaling,0.0054505706459716,PRNP;PLAGL1;BHLHE40;PLIN2;AHR;IGF1R,777877
2,Estrogen Response Early,0.0054505706459716,UGCG;BHLHE40;RHOBTB3;PRSS23;MICB;IGF1R,777877
3,mTORC1 Signaling,0.0054505706459716,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,777877
4,Epithelial Mesenchymal Transition,0.0285848644591481,BDNF;ITGB3;PMP22;VEGFC;EDIL3,777877
0,p53 Pathway,0.0152108948259674,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,778304
1,Estrogen Response Early,0.0332382144873815,ABLIM1;KRT18;CCND1;KRT8;SFN,778304
2,Apical Junction,0.0332382144873815,TJP1;RRAS;CTNNA1;RHOF;PTK2,778304
0,UV Response Dn,1.376764866731149e-05,EFEMP1;BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,778367
1,Epithelial Mesenchymal Transition,1.376764866731149e-05,GLIPR1;ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;PMP22;VEGFC;EDIL3,778367
2,IL-2/STAT5 Signaling,0.0032111889077042,PRNP;CSF1;BHLHE40;AHR;WLS;IGF1R,778367
3,TNF-alpha Signaling via NF-kB,0.0032111889077042,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,778367
4,Estrogen Response Early,0.0032111889077042,MLPH;DYNLT3;BHLHE40;RHOBTB3;PRSS23;IGF1R,778367
5,Complement,0.0032111889077042,DOCK10;LYN;CEBPB;CTSL;TFPI2;PSMB9,778367
6,Inflammatory Response,0.0180436021502928,LYN;CSF1;ITGB3;LPAR1;AHR,778367
7,Coagulation,0.0242399194802122,PROS1;ITGB3;TFPI2;PRSS23,778367
14,Xenobiotic Metabolism,0.0429241400598498,TGFB2;PROS1;GCNT2;BCAT1,778367
13,mTORC1 Signaling,0.0429241400598498,BHLHE40;BCAT1;AURKA;HSP90B1,778367
12,Myogenesis,0.0429241400598498,WWTR1;PRNP;ITGB5;BHLHE40,778367
8,Interferon Alpha Response,0.0429241400598498,CSF1;PSMB8;PSMB9,778367
10,Hypoxia,0.0429241400598498,SRPX;BHLHE40;GCNT2;MT1E,778367
9,Androgen Response,0.0429241400598498,ADAMTS1;SGK1;ELL2,778367
15,Allograft Rejection,0.0429241400598498,LYN;TGFB2;CSF1;BCAT1,778367
11,Estrogen Response Late,0.0429241400598498,DYNLT3;TFPI2;SGK1;PRSS23,778367
16,Apical Surface,0.0456659051022107,LYN;SRPX,778367
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,778368
1,Glycolysis,1.3043035579558251e-05,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3,778368
2,Cholesterol Homeostasis,0.0004155343314595629,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,778368
3,Hypoxia,0.0005913483994010176,EXT1;SDC4;MIF;ETS1;PAM;EGFR;IER3,778368
4,TNF-alpha Signaling via NF-kB,0.0036506147582321,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,778368
5,Angiogenesis,0.0046090622015996,APP;NRP1;VCAN,778368
6,Estrogen Response Late,0.0149571965193216,ELOVL5;ATP2B4;CD9;JAK2;CD44,778368
7,KRAS Signaling Up,0.0149571965193216,NRP1;GALNT3;PLAU;SPRY2;ETS1,778368
8,UV Response Dn,0.0237018911571759,NRP1;ATP2B4;SNAI2;MET,778368
9,Apoptosis,0.0310618484894672,APP;TNFRSF12A;CD44;IER3,778368
10,IL-6/JAK/STAT3 Signaling,0.0310618484894672,TNFRSF12A;CD9;CD44,778368
11,Hedgehog Signaling,0.0406649747935419,NRP1;NRP2,778368
12,IL-2/STAT5 Signaling,0.0406649747935419,NRP1;NT5E;ALCAM;CD44,778368
13,Estrogen Response Early,0.0406649747935419,ELOVL5;ENDOD1;JAK2;CD44,778368
14,Apical Junction,0.0406649747935419,VCAN;ITGA3;EGFR;ACTB,778368
15,mTORC1 Signaling,0.0406649747935419,ELOVL5;PLK1;CD9;HMGCR,778368
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,778590
1,Estrogen Response Early,0.0062533678728977,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,778590
2,KRAS Signaling Up,0.0062533678728977,NRP1;PLAU;GABRA3;ETS1;TRIB2;DUSP6,778590
3,Angiogenesis,0.0071056375607994,NRP1;VCAN;ITGAV,778590
4,Cholesterol Homeostasis,0.0450026699150785,ALCAM;MAL2;HMGCR,778590
0,UV Response Dn,0.0036895261061802,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,778747
1,Epithelial Mesenchymal Transition,0.0109011412919433,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS,778747
2,TNF-alpha Signaling via NF-kB,0.0357310805739351,CEBPB;IRS2;SGK1;FJX1;LITAF,778747
3,Complement,0.0357310805739351,DOCK10;LYN;CEBPB;ERAP2;PSMB9,778747
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,778809
1,Estrogen Response Early,0.0062533678728977,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,778809
2,KRAS Signaling Up,0.0062533678728977,NRP1;PLAU;GABRA3;ETS1;TRIB2;DUSP6,778809
3,Angiogenesis,0.0071056375607994,NRP1;VCAN;ITGAV,778809
4,UV Response Dn,0.0438484986407754,NRP1;CELF2;ATP2B4;SNAI2,778809
0,Epithelial Mesenchymal Transition,2.6086071159116503e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44;LOXL2,778810
1,Hypoxia,0.0005913483994010176,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;EGFR,778810
2,Estrogen Response Late,0.0005913483994010176,FARP1;ELOVL5;CAV1;ATP2B4;CD9;JAK2;CD44,778810
3,Glycolysis,0.0005913483994010176,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,778810
4,Apoptosis,0.0093075672404817,APP;TNFRSF12A;CAV1;BAX;CD44,778810
7,Estrogen Response Early,0.0132952857949526,FARP1;ELOVL5;ENDOD1;JAK2;CD44,778810
8,Apical Junction,0.0132952857949526,VCAN;ITGA3;RAC2;EGFR;ACTB,778810
5,Mitotic Spindle,0.0132952857949526,FARP1;PLK1;CDK1;ARHGAP29;CDC42EP1,778810
6,TNF-alpha Signaling via NF-kB,0.0132952857949526,FOSL1;SDC4;PLAU;PLK2;CD44,778810
9,Cholesterol Homeostasis,0.0218931907694976,TNFRSF12A;CD9;HMGCR,778810
10,IL-6/JAK/STAT3 Signaling,0.0310618484894672,TNFRSF12A;CD9;CD44,778810
11,Androgen Response,0.035899496322376,CDK6;ELOVL5;HMGCR,778810
12,Hedgehog Signaling,0.035899496322376,NRP2;CDK6,778810
13,Angiogenesis,0.035899496322376,APP;VCAN,778810
15,Xenobiotic Metabolism,0.0382729174527454,GSTM4;MT2A;ELOVL5;MAN1A1,778810
14,mTORC1 Signaling,0.0382729174527454,ELOVL5;PLK1;CD9;HMGCR,778810
16,p53 Pathway,0.0382729174527454,APP;PLK2;BAX;PTPN14,778810
0,Hypoxia,0.0028253312415826,SRPX;TES;IRS2;PLIN2;TGFBI;AMPD3;MT1E,778909
1,mTORC1 Signaling,0.0109011412919433,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,778909
2,UV Response Dn,0.0112520451835645,ITGB3;PMP22;LPAR1;MT1E;IGF1R,778909
3,Interferon Alpha Response,0.0137424369386659,LGALS3BP;TXNIP;PSMB8;PSMB9,778909
4,Androgen Response,0.0137424369386659,CDK6;ADAMTS1;HMGCR;SGK1,778909
5,TNF-alpha Signaling via NF-kB,0.0178655402869675,CEBPB;IRS2;SGK1;FJX1;LITAF,778909
6,Complement,0.0178655402869675,DOCK10;LYN;CEBPB;ERAP2;PSMB9,778909
7,Epithelial Mesenchymal Transition,0.0178655402869675,ITGB3;ADAM12;PMP22;SPP1;TGFBI,778909
0,Epithelial Mesenchymal Transition,1.7815005367573604e-07,NT5E;VCAN;ECM1;SPARC;TNFRSF12A;COL4A1;COL12A1;TNC;SNAI2;PDLIM4;CD44,779217
1,Hedgehog Signaling,0.0005516524901078888,NRP1;NRP2;CDK6;VLDLR,779217
2,Glycolysis,0.0005913483994010176,NT5E;VCAN;CDK1;MIF;VLDLR;EGFR;CD44,779217
3,KRAS Signaling Up,0.0005913483994010176,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,779217
4,Estrogen Response Early,0.0036506147582321,ELOVL5;ELOVL2;DLC1;ENDOD1;JAK2;CD44,779217
5,UV Response Dn,0.004710158448934,NRP1;DLC1;ATP2B4;SNAI2;VLDLR,779217
6,Androgen Response,0.0433759731131114,CDK6;ELOVL5;HMGCR,779217
7,Angiogenesis,0.0433759731131114,NRP1;VCAN,779217
8,PI3K/AKT/mTOR  Signaling,0.0433759731131114,CDK1;PLCB1;EGFR,779217
9,IL-2/STAT5 Signaling,0.0433759731131114,NRP1;NT5E;ECM1;CD44,779217
10,TNF-alpha Signaling via NF-kB,0.0433759731131114,FOSL1;PLAU;TNC;CD44,779217
11,Hypoxia,0.0433759731131114,MIF;VLDLR;ETS1;EGFR,779217
12,Estrogen Response Late,0.0433759731131114,ELOVL5;ATP2B4;JAK2;CD44,779217
13,Apical Junction,0.0433759731131114,VCAN;RAC2;EGFR;ACTB,779217
14,mTORC1 Signaling,0.0433759731131114,ELOVL5;PLK1;VLDLR;HMGCR,779217
0,Epithelial Mesenchymal Transition,8.74628588927059e-10,ITGB5;BDNF;ITGB3;TFPI2;PLOD3;VEGFC;GLIPR1;DPYSL3;ADAM12;PMP22;FAS;EDIL3;FBN1,779218
1,UV Response Dn,0.00015471147546306725,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,779218
2,TNF-alpha Signaling via NF-kB,0.0008541699102459143,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,779218
3,Myogenesis,0.0049435408184394,WWTR1;FDPS;PRNP;ITGB5;BHLHE40;ADAM12,779218
4,Coagulation,0.0050518293971114,PROS1;ITGB3;TFPI2;PRSS23;FBN1,779218
5,IL-2/STAT5 Signaling,0.0144032262778653,PRNP;CSF1;PLAGL1;BHLHE40;IGF1R,779218
6,Hypoxia,0.0144032262778653,SRPX;BHLHE40;GCNT2;IRS2;MT1E,779218
7,Estrogen Response Early,0.0144032262778653,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,779218
8,Complement,0.0144032262778653,DOCK10;LYN;CEBPB;TFPI2;PSMB9,779218
9,IL-6/JAK/STAT3 Signaling,0.0370153694499484,CSF1;ITGB3;FAS,779218
10,Interferon Alpha Response,0.0449207129555073,CSF1;PSMB8;PSMB9,779218
11,Androgen Response,0.0449207129555073,ADAMTS1;SGK1;ELL2,779218
12,Inflammatory Response,0.046990637539204,LYN;CSF1;ITGB3;LPAR1,779218
13,Xenobiotic Metabolism,0.046990637539204,TGFB2;PROS1;GCNT2;FAS,779218
14,Allograft Rejection,0.046990637539204,LYN;TGFB2;CSF1;FAS,779218
15,Apical Surface,0.0497968669124436,LYN;SRPX,779218
0,Epithelial Mesenchymal Transition,0.0002946405356644936,VCAN;ECM1;COL4A1;WIPF1;COL12A1;TNC;SNAI2;FBLN1,779405
1,Hedgehog Signaling,0.0006129472112309875,NRP1;NRP2;CDK6;VLDLR,779405
2,UV Response Dn,0.0011440391026915,NRP1;CELF2;ATP2B4;SNAI2;FYN;VLDLR,779405
3,KRAS Signaling Up,0.0050702982753224,NRP1;GYPC;GABRA3;LCP1;TRIB2;DUSP6,779405
4,Estrogen Response Early,0.0265905715899052,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,779405
0,UV Response Dn,0.0002935551072888968,INPP4B;SDC2;DLC1;ATP2B4;PTEN;SNAI2;VLDLR,779704
1,Hedgehog Signaling,0.0142112751215988,NRP2;CDK6;VLDLR,779704
2,Androgen Response,0.0197081459973115,INPP4B;CDK6;ELOVL5;HMGCR,779704
3,Epithelial Mesenchymal Transition,0.0245962787206623,VCAN;COL4A1;COL12A1;SNAI2;PDLIM4,779704
4,Glycolysis,0.0245962787206623,VCAN;SDC2;CDK1;MIF;VLDLR,779704
0,Apical Junction,0.0020368667090479,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,780019
1,p53 Pathway,0.0060839546632064,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,780019
2,Angiogenesis,0.0060839546632064,APP;FSTL1;PTK2,780019
3,UV Response Dn,0.0060839546632064,TJP1;ANXA2;DUSP1;ID1;LAMC1,780019
0,Androgen Response,0.0056968708909437,INPP4B;CDK6;ELOVL5;HMGCR;B2M,780020
1,Hedgehog Signaling,0.0102053433060237,NRP2;CDK6;VLDLR,780020
2,UV Response Dn,0.0102053433060237,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,780020
0,Epithelial Mesenchymal Transition,0.0002725424954896566,NT5E;VCAN;TNFRSF12A;COL4A1;COL12A1;SNAI2;CD44;LOXL2,780042
1,Glycolysis,0.0010582361699896,EXT1;NT5E;VCAN;CDK1;MIF;VLDLR;CD44,780042
2,UV Response Dn,0.0010582361699896,INPP4B;DLC1;ATP2B4;PTEN;SNAI2;VLDLR,780042
3,Estrogen Response Early,0.0046900259046732,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,780042
4,Hedgehog Signaling,0.0056845100486395,NRP2;CDK6;VLDLR,780042
5,Androgen Response,0.0098540729986557,INPP4B;CDK6;ELOVL5;HMGCR,780042
6,Estrogen Response Late,0.0175687705147588,FARP1;ELOVL5;ATP2B4;JAK2;CD44,780042
0,Complement,0.016485554571269,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,780108
1,UV Response Dn,0.016485554571269,ITGB3;PMP22;LPAR1;MT1E;IGF1R,780108
2,TNF-alpha Signaling via NF-kB,0.0349001252117506,CEBPB;IRS2;SGK1;FJX1;LITAF,780108
3,Epithelial Mesenchymal Transition,0.0349001252117506,ITGB3;ADAM12;PMP22;SPP1;VEGFC,780108
0,Complement,0.0160930413671912,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,780204
1,UV Response Dn,0.0160930413671912,ITGB3;PMP22;LPAR1;MT1E;IGF1R,780204
2,PI3K/AKT/mTOR  Signaling,0.0261218250478951,CDK1;THEM4;PLCB1;HSP90B1,780204
3,TNF-alpha Signaling via NF-kB,0.0272553358796528,CEBPB;IRS2;SGK1;FJX1;LITAF,780204
4,Epithelial Mesenchymal Transition,0.0272553358796528,ITGB3;ADAM12;PMP22;SPP1;VEGFC,780204
5,Cholesterol Homeostasis,0.041556519516176,FDPS;FABP5;HMGCR,780204
0,UV Response Dn,0.0038611319715839,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,780250
1,Epithelial Mesenchymal Transition,0.0114081711194755,BDNF;ITGB3;ADAM12;PMP22;SPP1;VEGFC,780250
2,TNF-alpha Signaling via NF-kB,0.0249286608655361,CEBPB;IRS2;SGK1;FJX1;LITAF,780250
3,Hypoxia,0.0249286608655361,SRPX;GCNT2;IRS2;PLIN2;MT1E,780250
4,Complement,0.0249286608655361,DOCK10;LYN;CEBPB;ERAP2;PSMB9,780250
5,mTORC1 Signaling,0.0249286608655361,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,780250
6,Cholesterol Homeostasis,0.03909498351696,FDPS;FABP5;HMGCR,780250
0,Apical Junction,0.0020368667090479,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,780290
1,p53 Pathway,0.0078589623267498,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,780290
2,Angiogenesis,0.0079378293471993,APP;FSTL1;PTK2,780290
3,Protein Secretion,0.0106523350441719,KRT18;SCRN1;CAV2;EGFR,780290
0,Angiogenesis,0.0007968313746002838,APP;FSTL1;PTK2;FGFR1,780291
1,Apical Junction,0.0065913877579192,TJP1;RRAS;CTNNA1;FLNC;RHOF;PTK2,780291
2,UV Response Dn,0.0068035622040158,TJP1;ANXA2;DUSP1;ID1;LAMC1,780291
3,Estrogen Response Early,0.0216048394167979,ABLIM1;KRT18;NRIP1;KRT8;FLNB,780291
4,Apoptosis,0.0453590582945769,APP;KRT18;TIMP2;PTK2,780291
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,780404
1,Hypoxia,8.45381935712109e-06,EXT1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;MIF;ETS1;EGFR,780404
2,Apical Junction,8.45381935712109e-06,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;ACTB;PTK2,780404
3,UV Response Dn,6.94218159129148e-05,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1,780404
4,TNF-alpha Signaling via NF-kB,0.0004599376439785693,FOSL1;SDC4;PLAU;DUSP1;PLK2;SERPINE1;CD44,780404
5,Apoptosis,0.0009236081230229626,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,780404
7,Glycolysis,0.0019717826626254,EXT1;CYB5A;NT5E;MIF;EGFR;CD44,780404
8,p53 Pathway,0.0019717826626254,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,780404
6,Mitotic Spindle,0.0019717826626254,NOTCH2;FARP1;MYO1E;ARHGAP29;CDC42EP1;RHOF,780404
9,Angiogenesis,0.0026886196175997,APP;FSTL1;PTK2,780404
10,IL-6/JAK/STAT3 Signaling,0.0030325182561034,TNFRSF12A;CD9;OSMR;CD44,780404
11,Estrogen Response Late,0.0096944792254862,FARP1;ELOVL5;CAV1;CD9;CD44,780404
12,Fatty Acid Metabolism,0.0220145140419819,ELOVL5;PCBD1;MIF;S100A10,780404
16,Xenobiotic Metabolism,0.0372097808568358,CYB5A;ELOVL5;SERPINE1;EPHA2,780404
13,IL-2/STAT5 Signaling,0.0372097808568358,MYO1E;NT5E;AHNAK;CD44,780404
14,Estrogen Response Early,0.0372097808568358,FARP1;ELOVL5;ENDOD1;CD44,780404
15,Inflammatory Response,0.0372097808568358,AXL;SERPINE1;SGMS2;OSMR,780404
17,Apical Surface,0.0397239963973909,APP;ATP8B1,780404
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;SPARC;LGALS1;SDC4;COL12A1;TNC;SNAI2;CD44,781008
1,Glycolysis,0.00013995425444063446,NT5E;VCAN;CDK1;MIF;PAM;MET;CD44;IER3,781008
2,TNF-alpha Signaling via NF-kB,0.0006242010882566297,FOSL1;SDC4;PLAU;PLK2;TNC;CD44;IER3,781008
3,KRAS Signaling Up,0.0006242010882566297,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,781008
4,UV Response Dn,0.005966200701983,NRP1;AKT3;ATP2B4;SNAI2;MET,781008
5,Hypoxia,0.0180436021502928,SDC4;MIF;ETS1;PAM;IER3,781008
6,Apical Junction,0.0180436021502928,VCAN;ITGA3;AKT3;RAC2;ACTB,781008
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44,781343
1,Glycolysis,0.00013995425444063446,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44;IER3,781343
2,Hypoxia,0.0008322681176755062,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR;IER3,781343
3,TNF-alpha Signaling via NF-kB,0.003934487867222,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,781343
4,Cholesterol Homeostasis,0.003934487867222,ALCAM;TNFRSF12A;CD9;HMGCR,781343
5,Angiogenesis,0.0048651212127996,APP;NRP1;VCAN,781343
6,p53 Pathway,0.0180436021502928,VAMP8;APP;HDAC3;PLK2;IER3,781343
7,UV Response Dn,0.0281459957491463,NRP1;ATP2B4;SNAI2;PRKCA,781343
9,IL-6/JAK/STAT3 Signaling,0.0360662574127702,TNFRSF12A;CD9;CD44,781343
8,Apoptosis,0.0360662574127702,APP;TNFRSF12A;CD44;IER3,781343
10,Hedgehog Signaling,0.0403991906445645,NRP1;NRP2,781343
11,Mitotic Spindle,0.0403991906445645,PLK1;CDK1;ARHGAP29;CDC42EP1,781343
12,IL-2/STAT5 Signaling,0.0403991906445645,NRP1;NT5E;ALCAM;CD44,781343
13,Estrogen Response Late,0.0403991906445645,ELOVL5;ATP2B4;CD9;CD44,781343
14,Apical Junction,0.0403991906445645,VCAN;ITGA3;EGFR;ACTB,781343
15,mTORC1 Signaling,0.0403991906445645,ELOVL5;PLK1;CD9;HMGCR,781343
16,KRAS Signaling Up,0.0403991906445645,NRP1;PLAU;SPRY2;ETS1,781343
0,UV Response Dn,0.0035179202407764,DLC1;ITGB3;PMP22;LPAR1;MT1E;IGF1R,781344
1,E2F Targets,0.0454255597994214,DNMT1;PLK1;CDK1;TP53;AURKA,781344
2,Epithelial Mesenchymal Transition,0.0454255597994214,ITGB3;ADAM12;PMP22;SPP1;VEGFC,781344
0,Hypoxia,1.340534212343487e-05,EXT1;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,781468
1,Epithelial Mesenchymal Transition,1.340534212343487e-05,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;FSTL1;CD44;LOXL2,781468
2,Angiogenesis,0.0003779841135924423,APP;NRP1;FSTL1;PTK2,781468
3,Apical Junction,0.0006077747438288237,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,781468
4,UV Response Dn,0.0006349417019938035,TJP1;NRP1;ANXA2;CAV1;SERPINE1;PRKCA,781468
5,Apoptosis,0.0009763857300528464,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,781468
6,TNF-alpha Signaling via NF-kB,0.0026800148026704,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,781468
7,Estrogen Response Late,0.0122981393603311,FARP1;ELOVL5;CAV1;CD9;CD44,781468
8,Glycolysis,0.0122981393603311,EXT1;NT5E;MIF;EGFR;CD44,781468
9,p53 Pathway,0.0122981393603311,VAMP8;APP;PLK2;PTPN14;EPHA2,781468
10,Cholesterol Homeostasis,0.0204557590523084,TNFRSF12A;MAL2;CD9,781468
11,IL-6/JAK/STAT3 Signaling,0.0292642878129934,TNFRSF12A;CD9;CD44,781468
12,Mitotic Spindle,0.0417945574266959,FARP1;PLK1;ARHGAP29;CDC42EP1,781468
13,Estrogen Response Early,0.0417945574266959,FARP1;ELOVL5;ENDOD1;CD44,781468
14,Xenobiotic Metabolism,0.0417945574266959,ELOVL5;SERPINE1;MAN1A1;EPHA2,781468
15,KRAS Signaling Up,0.0417945574266959,NRP1;PLAU;PLEK2;ETS1,781468
0,UV Response Dn,0.0321860827343824,SDC2;CELF2;ITGB3;ATP2B4;VLDLR,781470
0,Angiogenesis,0.0215089569407982,APP;ITGAV;PTK2,781516
1,Estrogen Response Early,0.0465335002823341,ABLIM1;GJA1;KRT18;KRT8;FLNB,781516
0,Hypoxia,2.681068424686974e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,781556
1,Epithelial Mesenchymal Transition,0.0001362712477448283,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;CD44;LOXL2,781556
2,Angiogenesis,0.0003779841135924423,APP;NRP1;PTK2;FGFR1,781556
3,Apoptosis,0.0014645785950792,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,781556
4,TNF-alpha Signaling via NF-kB,0.0037520207237386,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,781556
5,UV Response Dn,0.0048409961836266,TJP1;NRP1;CAV1;SERPINE1;PRKCA,781556
6,Estrogen Response Late,0.0136645992892568,FARP1;ELOVL5;CAV1;CD9;CD44,781556
7,Apical Junction,0.0136645992892568,TJP1;ITGA3;EGFR;ACTB;PTK2,781556
8,Glycolysis,0.0136645992892568,EXT1;NT5E;MIF;EGFR;CD44,781556
9,IL-6/JAK/STAT3 Signaling,0.0351171453755921,TNFRSF12A;CD9;CD44,781556
10,Mitotic Spindle,0.0417945574266959,FARP1;PLK1;ARHGAP29;CDC42EP1,781556
11,Estrogen Response Early,0.0417945574266959,FARP1;ELOVL5;ENDOD1;CD44,781556
12,Complement,0.0417945574266959,GCA;SERPINE1;GNB4;TIMP2,781556
13,Xenobiotic Metabolism,0.0417945574266959,MT2A;ELOVL5;SERPINE1;MAN1A1,781556
14,p53 Pathway,0.0417945574266959,VAMP8;APP;PLK2;PTPN14,781556
15,KRAS Signaling Up,0.0417945574266959,NRP1;PLAU;SPRY2;ETS1,781556
0,Epithelial Mesenchymal Transition,0.0003314706026225553,BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;VEGFC,781627
1,UV Response Dn,0.0019305659857919,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,781627
2,Estrogen Response Late,0.0299143930386433,FABP5;TFPI2;SGK1;JAK2;MICB,781627
3,Complement,0.0299143930386433,DOCK10;LYN;ERAP2;TFPI2;JAK2,781627
4,mTORC1 Signaling,0.0299143930386433,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,781627
5,Cholesterol Homeostasis,0.0456108141031201,FDPS;FABP5;HMGCR,781627
0,Glycolysis,2.681068424686974e-05,EXT1;NT5E;VCAN;CDK1;MIF;PAM;EGFR;CD44;IER3,781761
1,Hypoxia,0.0001362712477448283,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,781761
2,Epithelial Mesenchymal Transition,0.0008103663251050982,NT5E;VCAN;TNFRSF12A;SDC4;COL12A1;VIM;CD44,781761
3,TNF-alpha Signaling via NF-kB,0.0031924572606845,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,781761
4,p53 Pathway,0.0031924572606845,VAMP8;APP;HDAC3;PLK2;PTPN14;IER3,781761
5,Cholesterol Homeostasis,0.0031924572606845,ALCAM;TNFRSF12A;CD9;HMGCR,781761
6,Angiogenesis,0.0040603643204568,APP;NRP1;VCAN,781761
7,Apoptosis,0.0059788192343372,APP;GPX1;TNFRSF12A;CD44;IER3,781761
8,IL-6/JAK/STAT3 Signaling,0.0390190504173245,TNFRSF12A;CD9;CD44,781761
9,Protein Secretion,0.0417945574266959,CAV2;PAM;EGFR,781761
10,Mitotic Spindle,0.0417945574266959,PLK1;CDK1;ARHGAP29;CDC42EP1,781761
11,IL-2/STAT5 Signaling,0.0417945574266959,NRP1;NT5E;ALCAM;CD44,781761
12,Estrogen Response Late,0.0417945574266959,ELOVL5;ATP2B4;CD9;CD44,781761
13,Apical Junction,0.0417945574266959,VCAN;ITGA3;EGFR;ACTB,781761
14,mTORC1 Signaling,0.0417945574266959,ELOVL5;PLK1;CD9;HMGCR,781761
15,KRAS Signaling Up,0.0417945574266959,NRP1;PLAU;SPRY2;ETS1,781761
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,GJA1;VCAN;SPARC;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;AREG;THBS1,782007
1,Angiogenesis,0.0005669761703886634,APP;NRP1;VCAN;ITGAV,782007
2,TNF-alpha Signaling via NF-kB,0.0047886858910268,TUBB2A;SDC4;PLAU;PLK2;AREG;IER3,782007
3,Cholesterol Homeostasis,0.0047886858910268,ALCAM;MAL2;CD9;HMGCR,782007
4,Coagulation,0.0047927612229006,SPARC;PLAU;CD9;THBS1;DUSP6,782007
5,UV Response Dn,0.0048409961836266,NRP1;GJA1;ATP2B4;SNAI2;MET,782007
6,Glycolysis,0.0175687705147588,VCAN;CDK1;MIF;MET;IER3,782007
0,Apical Junction,0.0014157483895807,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,782121
1,UV Response Dn,0.0014157483895807,TJP1;NRP1;ANXA2;CAV1;ID1;MET,782121
2,Apoptosis,0.0017416610319861,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44,782121
3,Hypoxia,0.0034167920952191,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,782121
4,Cholesterol Homeostasis,0.0034167920952191,ALCAM;TNFRSF12A;MAL2;CD9,782121
5,Angiogenesis,0.0042249736847996,APP;NRP1;PTK2,782121
6,IL-6/JAK/STAT3 Signaling,0.0044930780692471,TNFRSF12A;CD9;OSMR;CD44,782121
7,Estrogen Response Late,0.0099714643462144,ELOVL5;CAV1;CD9;LSR;CD44,782121
8,Epithelial Mesenchymal Transition,0.0099714643462144,TNFRSF12A;SDC4;COL12A1;VIM;CD44,782121
9,Glycolysis,0.0099714643462144,EXT1;MIF;MET;EGFR;CD44,782121
10,p53 Pathway,0.0099714643462144,VAMP8;APP;PLK2;PTPN14;S100A10,782121
11,Fatty Acid Metabolism,0.0224862536285958,ELOVL5;PCBD1;MIF;S100A10,782121
12,Protein Secretion,0.0314483409468586,SCRN1;CAV2;EGFR,782121
13,IL-2/STAT5 Signaling,0.0397613086870188,NRP1;ALCAM;AHNAK;CD44,782121
14,Inflammatory Response,0.0397613086870188,AXL;SGMS2;OSMR;MET,782121
15,Apical Surface,0.0421358104643753,APP;ATP8B1,782121
0,Epithelial Mesenchymal Transition,2.277593721161866e-06,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;THBS1;CD44,782122
1,Glycolysis,1.3043035579558251e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,782122
2,Angiogenesis,0.0003677683267385925,APP;NRP1;VCAN;ITGAV,782122
3,TNF-alpha Signaling via NF-kB,0.0005913483994010176,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,782122
4,IL-2/STAT5 Signaling,0.002329630974013,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,782122
5,Hypoxia,0.002329630974013,SDC4;MIF;ETS1;PAM;EGFR;IER3,782122
6,Apical Junction,0.002329630974013,TJP1;VCAN;CDH3;ITGA3;EGFR;ACTB,782122
7,Cholesterol Homeostasis,0.002329630974013,ALCAM;TNFRSF12A;MAL2;CD9,782122
8,UV Response Dn,0.0031401056326226,TJP1;NRP1;ATP2B4;SNAI2;MET,782122
9,IL-6/JAK/STAT3 Signaling,0.0034310777983341,TNFRSF12A;CD9;CD44;IL13RA1,782122
10,Protein Secretion,0.0044983467635212,SCRN1;CAV2;PAM;EGFR,782122
11,TGF-beta Signaling,0.007501784455512,TJP1;ID3;THBS1,782122
12,Apoptosis,0.024155711517822,APP;TNFRSF12A;CD44;IER3,782122
13,Pperoxisome,0.039459402756084,SEMA3C;ELOVL5;PRDX1,782122
14,Estrogen Response Late,0.0406649747935419,ELOVL5;ATP2B4;CD9;CD44,782122
15,p53 Pathway,0.0406649747935419,VAMP8;APP;PLK2;IER3,782122
16,Apical Surface,0.0432624364126206,APP;ATP8B1,782122
0,Epithelial Mesenchymal Transition,2.8259910422376216e-05,ITGB5;BDNF;ITGB3;DPYSL3;PMP22;SPP1;FN1;TGFBI;EDIL3,782153
1,IL-2/STAT5 Signaling,7.735573773153362e-05,PRNP;CSF1;BHLHE40;SPP1;ITGA6;AHR;WLS;IGF1R,782153
2,Hypoxia,7.735573773153362e-05,SRPX;TES;DTNA;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,782153
3,UV Response Dn,7.735573773153362e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,782153
4,Interferon Alpha Response,0.0009868954470276365,LGALS3BP;CSF1;TXNIP;PSMB8;PSMB9,782153
5,TNF-alpha Signaling via NF-kB,0.0032956938789596,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,782153
6,Myogenesis,0.0129629036500787,FDPS;PRNP;DTNA;ITGB5;BHLHE40,782153
7,Complement,0.0129629036500787,DOCK10;LYN;CEBPB;FN1;PSMB9,782153
8,mTORC1 Signaling,0.0129629036500787,TES;BHLHE40;BCAT1;AURKA;HSP90B1,782153
9,Inflammatory Response,0.0129629036500787,LYN;CSF1;ITGB3;LPAR1;AHR,782153
10,Apoptosis,0.0309266306553933,TGFB2;BAX;TXNIP;BCL2L2,782153
11,Estrogen Response Early,0.046990637539204,DYNLT3;BHLHE40;RHOBTB3;IGF1R,782153
12,Interferon Gamma Response,0.046990637539204,LGALS3BP;TXNIP;PSMB8;PSMB9,782153
13,Allograft Rejection,0.046990637539204,LYN;TGFB2;CSF1;BCAT1,782153
14,KRAS Signaling Up,0.046990637539204,TMEM158;SPP1;GNG11;PSMB8,782153
15,Apical Surface,0.0497968669124436,LYN;SRPX,782153
0,Epithelial Mesenchymal Transition,7.400703444767422e-10,NOTCH2;TNFRSF12A;SDC4;DST;SERPINE1;LAMC1;FSTL1;LOXL2;NT5E;LGALS1;VIM;FERMT2;CD44,782154
1,UV Response Dn,4.491149857642007e-08,NOTCH2;TJP1;ANXA2;CAV1;MAP1B;SERPINE1;AKT3;LAMC1;MET;RND3,782154
2,TNF-alpha Signaling via NF-kB,5.978057973964199e-06,FOSL1;MARCKS;CCND1;SDC4;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,782154
3,Hypoxia,5.978057973964199e-06,EXT1;ERRFI1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;PAM;EGFR,782154
4,Apoptosis,0.00010843267238269532,APP;CCND1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,782154
5,Cholesterol Homeostasis,0.00019045323525229964,ERRFI1;TNFRSF12A;GPX8;CD9;S100A11,782154
6,Apical Junction,0.00030975392349577113,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR;PTK2,782154
7,IL-6/JAK/STAT3 Signaling,0.00031126584656462447,TNFRSF12A;CD9;OSMR;IL6ST;CD44,782154
8,IL-2/STAT5 Signaling,0.0016731984308564,MYO1E;NT5E;AHNAK;PHLDA1;CKAP4;CD44,782154
9,Glycolysis,0.0016731984308564,EXT1;NT5E;PAM;MET;EGFR;CD44,782154
10,Angiogenesis,0.0023045311007998,APP;FSTL1;PTK2,782154
11,Protein Secretion,0.0037798608221255,DST;CAV2;PAM;EGFR,782154
12,Mitotic Spindle,0.0068553817380224,NOTCH2;MYO1E;MARCKS;DST;ARHGAP29,782154
13,Estrogen Response Late,0.0068553817380224,CCND1;CAV1;CD9;IL6ST;CD44,782154
14,Inflammatory Response,0.0068553817380224,AXL;SERPINE1;SGMS2;OSMR;MET,782154
15,p53 Pathway,0.0068553817380224,APP;PLK2;PTPN14;EPHA2;S100A10,782154
16,Fatty Acid Metabolism,0.0158726496201853,CBR1;LGALS1;PCBD1;S100A10,782154
17,Notch Signaling,0.0204132905574122,NOTCH2;CCND1,782154
18,G2-M Checkpoint,0.0298209815152641,NOTCH2;MARCKS;MT2A;CCND1,782154
19,Xenobiotic Metabolism,0.0298209815152641,CBR1;MT2A;SERPINE1;EPHA2,782154
20,TGF-beta Signaling,0.0470263141574883,TJP1;SERPINE1,782154
21,Coagulation,0.0480063777688828,SERPINE1;CD9;GNG12,782154
0,UV Response Dn,0.0306160299180711,SDC2;CELF2;ITGB3;ATP2B4;VLDLR,782164
0,Androgen Response,0.0061350917287086,INPP4B;CDK6;ELOVL5;HMGCR;B2M,782180
1,Hedgehog Signaling,0.0109903697141793,NRP2;CDK6;VLDLR,782180
2,UV Response Dn,0.0109903697141793,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,782180
3,Estrogen Response Late,0.023266750141167,FABP5;ELOVL5;ATP2B4;JAK2;CD44,782180
4,Epithelial Mesenchymal Transition,0.023266750141167,VCAN;SPARC;COL4A1;SPP1;CD44,782180
5,Glycolysis,0.023266750141167,VCAN;CDK1;MIF;VLDLR;CD44,782180
6,DNA Repair,0.0409906897317981,IMPDH2;STX3;TYMS;TP53,782180
0,Epithelial Mesenchymal Transition,2.127903418904625e-07,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;PLOD3;VEGFC,782362
1,UV Response Dn,0.0018447630530901,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,782362
2,Complement,0.0072674275279622,DOCK10;LYN;CEBPB;ERAP2;TFPI2;PSMB9,782362
3,TNF-alpha Signaling via NF-kB,0.0285848644591481,CEBPB;IRS2;SGK1;FJX1;LITAF,782362
4,Hypoxia,0.0285848644591481,SRPX;DTNA;GCNT2;IRS2;MT1E,782362
0,Hypoxia,0.010394111464411,SRPX;TES;DTNA;PLIN2;TGFBI;MT1E,782363
1,mTORC1 Signaling,0.010394111464411,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,782363
2,Interferon Alpha Response,0.0195183397238828,LGALS3BP;TXNIP;PSMB8;PSMB9,782363
0,Angiogenesis,3.766776920921419e-05,APP;NRP1;VCAN;SPP1;ITGAV,782549
1,Epithelial Mesenchymal Transition,0.0001473202678322468,VCAN;SPARC;TNFRSF12A;COL4A1;COL12A1;SPP1;ITGAV;CD44,782549
2,Cholesterol Homeostasis,0.0004617048127328476,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,782549
3,IL-2/STAT5 Signaling,0.0265905715899052,NRP1;ALCAM;SPP1;ITGAV;CD44,782549
4,Estrogen Response Late,0.0265905715899052,ELOVL5;ATP2B4;CD9;JAK2;CD44,782549
0,Hypoxia,0.0012870439905279,SRPX;DTNA;GCNT2;IRS2;PLIN2;AMPD3;MT1E,782762
1,Epithelial Mesenchymal Transition,0.0012870439905279,BDNF;ITGB3;DPYSL3;ADAM12;PMP22;SPP1;VEGFC,782762
2,UV Response Dn,0.0012870439905279,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,782762
3,IL-2/STAT5 Signaling,0.0213674235990309,PRNP;SPP1;PLIN2;AHR;IGF1R,782762
4,TNF-alpha Signaling via NF-kB,0.0213674235990309,CEBPB;IRS2;SGK1;FJX1;LITAF,782762
5,Complement,0.0213674235990309,DOCK10;LYN;CEBPB;ERAP2;PSMB9,782762
6,mTORC1 Signaling,0.0213674235990309,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,782762
7,Cholesterol Homeostasis,0.03420811057734,FDPS;FABP5;HMGCR,782762
0,Complement,0.0012812548653688,DPP4;CFH;ERAP2;KYNU;FYN;JAK2;DUSP6,782763
1,Epithelial Mesenchymal Transition,0.0012812548653688,VCAN;COL5A1;COL4A1;WIPF1;SNAI2;TIMP3;FBLN1,782763
2,Coagulation,0.0084197156618524,DPP4;CFH;TIMP3;FYN;DUSP6,782763
3,KRAS Signaling Up,0.0324072591251969,CFH;GYPC;GABRA3;LCP1;DUSP6,782763
4,UV Response Dn,0.046218687756493,CELF2;ATP2B4;SNAI2;FYN,782763
0,Complement,0.0212952527563544,DOCK10;LYN;CEBPB;ERAP2;JAK2;PSMB9,783102
1,Interferon Alpha Response,0.0267589427319902,BST2;TXNIP;PSMB8;PSMB9,783102
2,PI3K/AKT/mTOR  Signaling,0.0267589427319902,CDK1;THEM4;PLCB1;HSP90B1,783102
3,Interferon Gamma Response,0.0349001252117506,BST2;TXNIP;JAK2;PSMB8;PSMB9,783102
4,UV Response Dn,0.0425700931629121,ITGB3;PMP22;MT1E;IGF1R,783102
5,Cholesterol Homeostasis,0.0425700931629121,FDPS;FABP5;HMGCR,783102
0,UV Response Dn,0.0219807394283587,TJP1;ANXA2;MAP1B;ID1;CAP2,783107
1,TGF-beta Signaling,0.031022333521556,TJP1;SMURF2;ID1,783107
2,Apical Junction,0.031022333521556,TJP1;RRAS;FSCN1;CTNNA1;RHOF,783107
0,Hedgehog Signaling,0.0011726400802588,NRP1;NRP2;CDK6;VLDLR,783249
1,Glycolysis,0.0011726400802588,EXT1;NT5E;VCAN;CDK1;MIF;VLDLR;CD44,783249
2,UV Response Dn,0.0011726400802588,INPP4B;NRP1;DLC1;ATP2B4;SNAI2;VLDLR,783249
3,Epithelial Mesenchymal Transition,0.0051970557322055,NT5E;VCAN;COL4A1;COL12A1;SNAI2;CD44,783249
4,Androgen Response,0.0131032538252395,INPP4B;CDK6;ELOVL5;HMGCR,783249
5,Estrogen Response Early,0.0227127798997107,ELOVL5;DLC1;ENDOD1;JAK2;CD44,783249
0,Estrogen Response Late,0.0098870816368788,FARP1;ELOVL5;ATP2B4;CD9;JAK2;CD44,783296
1,Glycolysis,0.0098870816368788,EXT1;NT5E;CDK1;MIF;EGFR;CD44,783296
2,Mitotic Spindle,0.0162036295625984,FARP1;PLK1;CDK1;ARHGAP29;CDC42EP1,783296
3,Hypoxia,0.0162036295625984,EXT1;PRKCA;MIF;ETS1;EGFR,783296
4,Estrogen Response Early,0.0162036295625984,FARP1;ELOVL5;ENDOD1;JAK2;CD44,783296
5,Apical Junction,0.0162036295625984,PTEN;RAC2;EGFR;ACTB;PTK2,783296
6,Epithelial Mesenchymal Transition,0.0162036295625984,NT5E;TNFRSF12A;COL12A1;CD44;LOXL2,783296
7,p53 Pathway,0.0162036295625984,VAMP8;HDAC3;BAX;STOM;PTPN14,783296
8,Cholesterol Homeostasis,0.026352914815136,TNFRSF12A;CD9;HMGCR,783296
9,Apoptosis,0.0336503358635895,TNFRSF12A;BAX;PTK2;CD44,783296
10,IL-6/JAK/STAT3 Signaling,0.0336503358635895,TNFRSF12A;CD9;CD44,783296
11,Androgen Response,0.0418827457094387,CDK6;ELOVL5;HMGCR,783296
12,Hedgehog Signaling,0.0418827457094387,NRP2;CDK6,783296
13,PI3K/AKT/mTOR  Signaling,0.0438483713223518,CDK1;PTEN;EGFR,783296
14,mTORC1 Signaling,0.046990637539204,ELOVL5;PLK1;CD9;HMGCR,783296
0,Hypoxia,0.0026282151084489,CDKN1C;SRPX;DTNA;IRS2;TGFBI;AMPD3;MT1E,783333
1,Interferon Alpha Response,0.0285634239861699,BST2;TXNIP;PSMB8;PSMB9,783333
0,Epithelial Mesenchymal Transition,0.0177460439636286,ITGB5;BASP1;TGFBI;EMP3;EDIL3;PFN2,783916
1,Androgen Response,0.0193889584509725,TPD52;ADAMTS1;LIFR;DHCR24,783916
2,IL-2/STAT5 Signaling,0.0193889584509725,IFITM3;CTSZ;LIF;AHR;IGF1R,783916
3,TNF-alpha Signaling via NF-kB,0.0193889584509725,BTG3;LIF;TNFAIP2;FJX1;LITAF,783916
4,Estrogen Response Early,0.0193889584509725,RAB31;MYOF;NRIP1;FLNB;IGF1R,783916
5,Estrogen Response Late,0.0193889584509725,BTG3;RAB31;MYOF;NRIP1;FLNB,783916
0,Epithelial Mesenchymal Transition,0.0019305659857919,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,784415
1,UV Response Dn,0.0019305659857919,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,784415
2,Hypoxia,0.0076054474129837,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,784415
3,TNF-alpha Signaling via NF-kB,0.0249286608655361,CEBPB;IRS2;SGK1;FJX1;LITAF,784415
4,Complement,0.0249286608655361,DOCK10;LYN;CEBPB;ERAP2;PSMB9,784415
5,mTORC1 Signaling,0.0249286608655361,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,784415
6,Cholesterol Homeostasis,0.03909498351696,FDPS;FABP5;HMGCR,784415
17,Allograft Rejection,0.042805236624781,LYN;TGFB2;FAS;BCAT1,784415
16,p53 Pathway,0.042805236624781,FAS;BAX;TXNIP;TP53,784415
15,Xenobiotic Metabolism,0.042805236624781,TGFB2;GCNT2;FAS;BCAT1,784415
14,E2F Targets,0.042805236624781,PLK1;CDK1;TP53;AURKA,784415
13,Interferon Gamma Response,0.042805236624781,FAS;TXNIP;PSMB8;PSMB9,784415
9,Androgen Response,0.042805236624781,ADAMTS1;HMGCR;SGK1,784415
11,Mitotic Spindle,0.042805236624781,PLK1;CDK1;MYH10;AURKA,784415
10,PI3K/AKT/mTOR  Signaling,0.042805236624781,CDK1;THEM4;HSP90B1,784415
18,KRAS Signaling Up,0.042805236624781,SPP1;LCP1;GNG11;PSMB8,784415
8,Interferon Alpha Response,0.042805236624781,TXNIP;PSMB8;PSMB9,784415
7,Apoptosis,0.042805236624781,TGFB2;FAS;BAX;TXNIP,784415
12,IL-2/STAT5 Signaling,0.042805236624781,PRNP;SPP1;PLIN2;IGF1R,784415
19,Apical Surface,0.0459663386884094,LYN;SRPX,784415
0,UV Response Dn,0.0023805529897698,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,784590
1,TGF-beta Signaling,0.0023805529897698,TJP1;RAB31;SMURF2;ID1,784590
2,Apical Junction,0.0052393082178332,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,784590
3,Angiogenesis,0.0059533720103995,FSTL1;PTK2;FGFR1,784590
0,Epithelial Mesenchymal Transition,0.0013728469232298,GLIPR1;CALD1;BDNF;VEGFC;LAMC1;FGF2;EDIL3,784722
1,UV Response Dn,0.0013728469232298,EFEMP1;DUSP1;BDNF;NFIB;BHLHE40;LAMC1,784722
2,Estrogen Response Early,0.0040562386202579,ABLIM1;KRT19;BHLHE40;KRT8;FLNB;PRSS23,784722
3,Myogenesis,0.0040562386202579,WWTR1;PRNP;ABLIM1;BHLHE40;CLU;FGF2,784722
4,Estrogen Response Late,0.0212724572719241,TOP2A;KRT19;FLNB;LSR;PRSS23,784722
5,Apoptosis,0.046522111071361,TOP2A;TGFB2;GCH1;CLU,784722
0,UV Response Dn,0.00036496040365646633,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,784815
1,IL-2/STAT5 Signaling,0.0058308430166208,PRNP;PLAGL1;BHLHE40;SPP1;PLIN2;IGF1R,784815
2,mTORC1 Signaling,0.0058308430166208,PLK1;BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,784815
3,Epithelial Mesenchymal Transition,0.0058308430166208,GLIPR1;BDNF;ITGB3;PMP22;SPP1;VEGFC,784815
4,Androgen Response,0.0147012116088053,ADAMTS1;HMGCR;SGK1;ELL2,784815
5,Hypoxia,0.0254826311069925,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,784815
0,Epithelial Mesenchymal Transition,1.2231169351667208e-08,GLIPR1;CALD1;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPOCK1;VEGFC;FGF2;EDIL3,784817
1,UV Response Dn,0.0001388436318258296,EFEMP1;BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3,784817
2,Myogenesis,0.0387779169019451,WWTR1;PRNP;BHLHE40;ADAM12;FGF2,784817
3,Coagulation,0.0446524832530225,PROS1;ITGB3;TFPI2;PRSS23,784817
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;COL5A1;COL4A1;WIPF1;SPP1;SNAI2;TIMP3;FBLN1,784856
1,Complement,0.0098870816368788,DPP4;CFH;ERAP2;KYNU;FYN;JAK2,784856
2,KRAS Signaling Up,0.0432096788335959,CFH;GYPC;GABRA3;SPP1;LCP1,784856
3,Coagulation,0.046218687756493,DPP4;CFH;TIMP3;FYN,784856
4,UV Response Dn,0.046218687756493,CELF2;ATP2B4;SNAI2;FYN,784856
0,Hypoxia,2.753529733462298e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,785299
1,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;CD44;LOXL2,785299
2,Apoptosis,0.0020055490671355,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,785299
3,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,785299
4,Estrogen Response Late,0.003853426689245,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,785299
5,UV Response Dn,0.0049718339183192,CAV1;SERPINE1;AKT3;ATP2B4;PRKCA,785299
7,Apical Junction,0.014033912783561,ITGA3;AKT3;EGFR;ACTB;PTK2,785299
8,Glycolysis,0.014033912783561,EXT1;NT5E;MIF;EGFR;CD44,785299
6,Mitotic Spindle,0.014033912783561,FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,785299
9,Cholesterol Homeostasis,0.0231094791455808,TNFRSF12A;CD9;HMGCR,785299
10,IL-6/JAK/STAT3 Signaling,0.032787506738882,TNFRSF12A;CD9;CD44,785299
11,Androgen Response,0.0378939127847302,CDK6;ELOVL5;HMGCR,785299
12,Hedgehog Signaling,0.0378939127847302,NRP2;CDK6,785299
13,Angiogenesis,0.0378939127847302,APP;PTK2,785299
16,mTORC1 Signaling,0.038154791164311,ELOVL5;PLK1;CD9;HMGCR,785299
14,Estrogen Response Early,0.038154791164311,FARP1;ELOVL5;ENDOD1;CD44,785299
15,Complement,0.038154791164311,GCA;SERPINE1;GNB4;TIMP2,785299
17,p53 Pathway,0.038154791164311,VAMP8;APP;PLK2;PTPN14,785299
0,UV Response Dn,0.00034115863820060986,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,785306
1,Hypoxia,0.0109011412919433,SRPX;TES;BHLHE40;GCNT2;PLIN2;MT1E,785306
2,Interferon Alpha Response,0.0178655402869675,LGALS3BP;TXNIP;PSMB8;PSMB9,785306
3,IL-2/STAT5 Signaling,0.0178655402869675,PRNP;BHLHE40;PLIN2;AHR;IGF1R,785306
4,TNF-alpha Signaling via NF-kB,0.0178655402869675,CEBPB;BHLHE40;SGK1;FJX1;LITAF,785306
5,Complement,0.0178655402869675,DOCK10;LYN;CEBPB;CTSL;PSMB9,785306
6,mTORC1 Signaling,0.0178655402869675,TES;BHLHE40;BCAT1;AURKA;HSP90B1,785306
7,Epithelial Mesenchymal Transition,0.0178655402869675,ITGB5;BDNF;ITGB3;PMP22;EDIL3,785306
8,Apoptosis,0.0416760578347609,TGFB2;BAX;TXNIP;BCL2L2,785306
0,Epithelial Mesenchymal Transition,2.898452351012945e-05,VCAN;ECM1;COL5A1;COL4A1;WIPF1;TNC;SNAI2;TIMP3;FBLN1,785345
1,Complement,0.0101405965506449,DPP4;ERAP2;KYNU;FYN;JAK2;DUSP6,785345
2,KRAS Signaling Up,0.0443176193165087,GYPC;GABRA3;LCP1;TRIB2;DUSP6,785345
3,Coagulation,0.0474037823143518,DPP4;TIMP3;FYN;DUSP6,785345
4,UV Response Dn,0.0474037823143518,CELF2;ATP2B4;SNAI2;FYN,785345
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;FN1;VEGFC;TGFBI;EDIL3,785657
1,Hypoxia,9.256242121721973e-05,SRPX;TES;DTNA;BHLHE40;GCNT2;TGFBI;AMPD3;MT1E,785657
2,UV Response Dn,9.256242121721973e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,785657
3,IL-2/STAT5 Signaling,0.0005570555162508684,PRNP;CSF1;BHLHE40;ITGA6;AHR;WLS;IGF1R,785657
4,TNF-alpha Signaling via NF-kB,0.0029576739939381,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,785657
5,Myogenesis,0.0029576739939381,FDPS;WWTR1;PRNP;DTNA;ITGB5;BHLHE40,785657
6,Interferon Alpha Response,0.0071408559965424,LGALS3BP;CSF1;PSMB8;PSMB9,785657
7,Estrogen Response Early,0.0116333750705835,DYNLT3;BHLHE40;RHOBTB3;FLNB;IGF1R,785657
8,Complement,0.0116333750705835,DOCK10;LYN;CEBPB;FN1;PSMB9,785657
9,Inflammatory Response,0.0116333750705835,LYN;CSF1;ITGB3;LPAR1;AHR,785657
10,mTORC1 Signaling,0.0486589441974006,TES;BHLHE40;BCAT1;HSP90B1,785657
11,Allograft Rejection,0.0486589441974006,LYN;TGFB2;CSF1;BCAT1,785657
12,KRAS Signaling Up,0.0486589441974006,TMEM158;SOX9;GNG11;PSMB8,785657
0,Estrogen Response Early,0.0024968043530265,DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;MICB;IGF1R,786098
1,Epithelial Mesenchymal Transition,0.0096335667231127,ITGB5;BASP1;BDNF;FN1;TGFBI;EDIL3,786098
2,Apoptosis,0.0135676263934307,IFITM3;TGFB2;BAX;TXNIP;BCL2L2,786098
3,Interferon Alpha Response,0.0135676263934307,IFITM3;LGALS3BP;TXNIP;PSMB8,786098
4,IL-2/STAT5 Signaling,0.0157881518815062,IFITM3;BHLHE40;PLIN2;AHR;IGF1R,786098
5,Hypoxia,0.0157881518815062,TES;BHLHE40;PLIN2;TGFBI;MT1E,786098
6,Estrogen Response Late,0.0157881518815062,FABP5;DYNLT3;NRIP1;FLNB;MICB,786098
7,mTORC1 Signaling,0.0157881518815062,TES;BHLHE40;BCAT1;AURKA;HSP90B1,786098
8,UV Response Dn,0.0250186628881301,BDNF;BHLHE40;MT1E;IGF1R,786098
0,UV Response Dn,0.0306160299180711,SDC2;CELF2;ITGB3;ATP2B4;VLDLR,786099
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;TNFRSF12A;COL4A1;COL12A1;SERPINE1;SNAI2;PDLIM4;CD44;LOXL2,787027
1,UV Response Dn,1.2016601232255267e-05,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;SNAI2;PRKCA;VLDLR,787027
2,Glycolysis,0.0008322681176755062,EXT1;NT5E;VCAN;CDK1;MIF;VLDLR;CD44,787027
3,Hypoxia,0.003853426689245,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1,787027
4,Estrogen Response Early,0.003853426689245,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,787027
5,Hedgehog Signaling,0.0048651212127996,NRP2;CDK6;VLDLR,787027
6,Androgen Response,0.0086746279679286,INPP4B;CDK6;ELOVL5;HMGCR,787027
7,Estrogen Response Late,0.014033912783561,FARP1;ELOVL5;ATP2B4;JAK2;CD44,787027
8,KRAS Signaling Up,0.014033912783561,GALNT3;PLAU;SPRY2;ETS1;TRIB2,787027
0,Apical Junction,0.0021025720867591,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,787039
1,p53 Pathway,0.0081124772405159,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,787039
2,Angiogenesis,0.0081938883583993,APP;FSTL1;PTK2,787039
3,UV Response Dn,0.0474037823143518,TJP1;ANXA2;ID1;LAMC1,787039
0,Epithelial Mesenchymal Transition,2.21432722890737e-06,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;CD44;LOXL2,787048
1,Angiogenesis,1.647964902903121e-05,APP;NRP1;VCAN;ITGAV;PTK2,787048
2,UV Response Dn,9.256242121721973e-05,TJP1;NRP1;CAV1;ATP2B4;SNAI2;PRKCA;MET,787048
3,Hypoxia,0.0004599376439785693,EXT1;SDC4;CAV1;PRKCA;MIF;ETS1;EGFR,787048
4,Glycolysis,0.0004599376439785693,EXT1;NT5E;VCAN;MIF;MET;EGFR;CD44,787048
5,Apical Junction,0.0025884788600145,TJP1;VCAN;ITGA3;EGFR;ACTB;PTK2,787048
6,Cholesterol Homeostasis,0.0025884788600145,ALCAM;TNFRSF12A;MAL2;CD9,787048
7,Apoptosis,0.0056556398162649,APP;TNFRSF12A;CAV1;PTK2;CD44,787048
8,IL-2/STAT5 Signaling,0.0105757955187123,NRP1;NT5E;ALCAM;ITGAV;CD44,787048
9,TNF-alpha Signaling via NF-kB,0.0105757955187123,FOSL1;SDC4;PLAU;PLK2;CD44,787048
10,Estrogen Response Late,0.0105757955187123,ELOVL5;CAV1;ATP2B4;CD9;CD44,787048
11,IL-6/JAK/STAT3 Signaling,0.0276824344176964,TNFRSF12A;CD9;CD44,787048
12,Hedgehog Signaling,0.0375870794828296,NRP1;NRP2,787048
13,p53 Pathway,0.0451833053261577,VAMP8;APP;PLK2;PTPN14,787048
14,Apical Surface,0.047668795676869,APP;ATP8B1,787048
0,Apoptosis,0.0005421633619134766,APP;GPX1;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,787137
1,Apical Junction,0.0010841387322351,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,787137
2,p53 Pathway,0.0042709901190239,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,787137
3,Cholesterol Homeostasis,0.0042709901190239,TNFRSF12A;GPX8;MAL2;CD9,787137
4,Angiogenesis,0.0043176452448561,APP;FSTL1;PTK2,787137
5,UV Response Dn,0.0043176452448561,TJP1;ANXA2;CAV1;ID1;MET,787137
6,Protein Secretion,0.006479761409358,KRT18;SCRN1;CAV2;EGFR,787137
7,Hypoxia,0.0137107634760448,EXT1;ANXA2;SDC4;CAV1;EGFR,787137
8,IL-6/JAK/STAT3 Signaling,0.0348007746965327,TNFRSF12A;CD9;OSMR,787137
0,Epithelial Mesenchymal Transition,1.6075251147905473e-08,GLIPR1;ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;SPP1;FAS;VEGFC;EDIL3,787457
1,UV Response Dn,1.454641201799322e-05,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MET;MT1E;IGF1R,787457
2,IL-2/STAT5 Signaling,0.00097617347609676,PRNP;CSF1;BHLHE40;SPP1;PLIN2;AHR;IGF1R,787457
3,TNF-alpha Signaling via NF-kB,0.0029154215083104,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,787457
4,Hypoxia,0.0029154215083104,SRPX;BHLHE40;GCNT2;PLIN2;EGFR;MT1E,787457
5,Myogenesis,0.0029154215083104,FDPS;WWTR1;PRNP;ITGB5;BHLHE40;ADAM12,787457
6,Inflammatory Response,0.0029154215083104,LYN;CSF1;ITGB3;LPAR1;AHR;MET,787457
7,Allograft Rejection,0.0029154215083104,LYN;TGFB2;CSF1;FAS;BCAT1;EGFR,787457
8,Complement,0.0152895786641954,DOCK10;LYN;CEBPB;TFPI2;PSMB9,787457
9,Xenobiotic Metabolism,0.0152895786641954,TGFB2;PROS1;GCNT2;FAS;BCAT1,787457
10,IL-6/JAK/STAT3 Signaling,0.0396901397365414,CSF1;ITGB3;FAS,787457
11,Interferon Alpha Response,0.0488310955442822,CSF1;PSMB8;PSMB9,787457
0,Hypoxia,0.00030937256244771826,SRPX;TES;DTNA;PLIN2;TGFBI;AMPD3;NR3C1;MT1E,787780
1,mTORC1 Signaling,0.0106476263781772,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,787780
2,UV Response Dn,0.0109903697141793,ITGB3;PMP22;NR3C1;MT1E;IGF1R,787780
3,Epithelial Mesenchymal Transition,0.0349001252117506,ITGB3;ADAM12;PMP22;SPP1;TGFBI,787780
0,Complement,0.00134696024308,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,787846
1,Epithelial Mesenchymal Transition,0.00134696024308,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,787846
2,UV Response Dn,0.0107286942447941,BDNF;ITGB3;PMP22;LPAR1;MT1E,787846
3,PI3K/AKT/mTOR  Signaling,0.0195913687859214,CDK1;THEM4;PLCB1;HSP90B1,787846
4,KRAS Signaling Up,0.0272553358796528,TMEM158;SPP1;LCP1;GNG11;PSMB8,787846
0,IL-2/STAT5 Signaling,0.00011107490546066368,PRNP;CSF1;BHLHE40;ITGA6;PLIN2;AHR;WLS;IGF1R,787880
1,Epithelial Mesenchymal Transition,0.00011107490546066368,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;FAS;VEGFC;EDIL3,787880
2,UV Response Dn,0.00011107490546066368,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,787880
3,TNF-alpha Signaling via NF-kB,0.0042590505512708,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,787880
4,Hypoxia,0.0042590505512708,SRPX;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,787880
5,Myogenesis,0.015511166760778,FDPS;WWTR1;PRNP;ITGB5;BHLHE40,787880
6,Inflammatory Response,0.015511166760778,LYN;CSF1;ITGB3;LPAR1;AHR,787880
7,Xenobiotic Metabolism,0.015511166760778,TGFB2;PROS1;GCNT2;FAS;BCAT1,787880
8,Allograft Rejection,0.015511166760778,LYN;TGFB2;CSF1;FAS;BCAT1,787880
9,Apoptosis,0.0362388232377117,TGFB2;FAS;BAX;BCL2L2,787880
10,IL-6/JAK/STAT3 Signaling,0.0362388232377117,CSF1;ITGB3;FAS,787880
11,Interferon Alpha Response,0.0445849133230403,CSF1;PSMB8;PSMB9,787880
0,Epithelial Mesenchymal Transition,1.2231169351667208e-08,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;DST;COL4A1;COL12A1;ITGAV;VIM;THBS1;CD44,787960
1,Glycolysis,1.2680729035681635e-05,NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,787960
2,Angiogenesis,0.0003575525398847427,APP;NRP1;VCAN;ITGAV,787960
3,TNF-alpha Signaling via NF-kB,0.0004599376439785693,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,787960
4,Hypoxia,0.0004599376439785693,SDC4;CAV1;MIF;ETS1;PAM;EGFR;IER3,787960
5,Protein Secretion,0.000702781385952737,SCRN1;DST;CAV2;PAM;EGFR,787960
6,Apoptosis,0.0007916641054482537,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,787960
7,IL-2/STAT5 Signaling,0.0020132613355668,NRP1;NT5E;ALCAM;AHNAK;ITGAV;CD44,787960
8,Cholesterol Homeostasis,0.0020132613355668,ALCAM;TNFRSF12A;MAL2;CD9,787960
9,UV Response Dn,0.0027475924285448,TJP1;NRP1;CAV1;ID1;MET,787960
10,IL-6/JAK/STAT3 Signaling,0.0030325182561034,TNFRSF12A;CD9;CD44;IL13RA1,787960
11,TGF-beta Signaling,0.00729340155397,TJP1;ID1;THBS1,787960
12,Apical Junction,0.008948750054295,TJP1;VCAN;ITGA3;CTNNA1;EGFR,787960
13,Pperoxisome,0.0383633082350816,SEMA3C;ELOVL5;PRDX1,787960
14,Estrogen Response Late,0.0421710849710805,ELOVL5;CAV1;CD9;CD44,787960
0,Estrogen Response Early,0.00028727452227288126,RAB31;DYNLT3;BHLHE40;NRIP1;RHOBTB3;FLNB;MICB;IGF1R,787962
1,IL-2/STAT5 Signaling,0.0011154381251242,IFITM3;PRNP;BHLHE40;LIF;PLIN2;AHR;IGF1R,787962
2,UV Response Dn,0.0011154381251242,EFEMP1;BDNF;BHLHE40;NR3C1;MT1E;IGF1R,787962
3,Hypoxia,0.0032956938789596,TES;BHLHE40;PLIN2;TGFBI;NR3C1;MT1E,787962
4,Estrogen Response Late,0.0032956938789596,RAB31;FABP5;DYNLT3;NRIP1;FLNB;MICB,787962
5,Epithelial Mesenchymal Transition,0.0032956938789596,ITGB5;BASP1;BDNF;FN1;TGFBI;EDIL3,787962
6,Apoptosis,0.0069623345966289,IFITM3;TGFB2;BAX;TXNIP;BCL2L2,787962
7,Interferon Alpha Response,0.0069623345966289,IFITM3;LGALS3BP;TXNIP;PSMB8,787962
8,mTORC1 Signaling,0.0129629036500787,TES;BHLHE40;BCAT1;AURKA;HSP90B1,787962
9,p53 Pathway,0.0129629036500787,LIF;BAX;TXNIP;TP53;TM4SF1,787962
0,Glycolysis,0.0024310989753152,EXT1;NT5E;VCAN;CDK1;MIF;VLDLR;CD44,788121
1,Estrogen Response Early,0.0058091954203519,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,788121
2,Epithelial Mesenchymal Transition,0.0058091954203519,NT5E;VCAN;TNFRSF12A;COL12A1;CD44;LOXL2,788121
3,Hedgehog Signaling,0.0058091954203519,NRP2;CDK6;VLDLR,788121
4,UV Response Dn,0.0058091954203519,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,788121
5,Androgen Response,0.0098540729986557,INPP4B;CDK6;ELOVL5;HMGCR,788121
6,Hypoxia,0.0153726742004139,EXT1;PLIN2;MIF;VLDLR;ETS1,788121
7,Estrogen Response Late,0.0153726742004139,FARP1;ELOVL5;ATP2B4;JAK2;CD44,788121
8,PI3K/AKT/mTOR  Signaling,0.0477652084876524,CDK1;PTEN;PLCB1,788121
9,IL-2/STAT5 Signaling,0.0477652084876524,NT5E;PLAGL1;PLIN2;CD44,788121
10,Apical Junction,0.0477652084876524,VCAN;PTEN;RAC2;ACTB,788121
11,mTORC1 Signaling,0.0477652084876524,ELOVL5;PLK1;VLDLR;HMGCR,788121
12,E2F Targets,0.0477652084876524,DNMT1;PLK1;CDK1;TP53,788121
13,p53 Pathway,0.0477652084876524,HDAC3;BAX;STOM;TP53,788121
0,Epithelial Mesenchymal Transition,0.0025625097307377,VCAN;ECM1;COL4A1;COL12A1;TNC;SPP1;SNAI2,788186
1,Hedgehog Signaling,0.0102053433060237,NRP2;CDK6;VLDLR,788186
2,UV Response Dn,0.0102053433060237,SDC2;CELF2;ATP2B4;SNAI2;VLDLR,788186
3,KRAS Signaling Up,0.0324072591251969,GABRA3;SPP1;LCP1;TRIB2;DUSP6,788186
0,Angiogenesis,0.0009438322597205188,APP;NRP1;FSTL1;PTK2,788203
1,Apical Junction,0.0009438322597205188,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,788203
2,UV Response Dn,0.0009438322597205188,TJP1;NRP1;ANXA2;CAV1;ID1;MET,788203
3,Hypoxia,0.0028473267460159,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR,788203
4,p53 Pathway,0.0028473267460159,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,788203
5,Cholesterol Homeostasis,0.0028473267460159,ALCAM;TNFRSF12A;MAL2;CD9,788203
6,Apoptosis,0.0060942404550773,APP;GPX1;TNFRSF12A;CAV1;PTK2,788203
7,IL-6/JAK/STAT3 Signaling,0.0391508715335993,TNFRSF12A;CD9;OSMR,788203
8,Protein Secretion,0.0454253813676847,SCRN1;CAV2;EGFR,788203
9,Epithelial Mesenchymal Transition,0.0497016358587735,TNFRSF12A;SDC4;COL12A1;FSTL1,788203
10,Inflammatory Response,0.0497016358587735,AXL;SGMS2;OSMR;MET,788203
11,Glycolysis,0.0497016358587735,EXT1;MIF;MET;EGFR,788203
0,Epithelial Mesenchymal Transition,0.00027990850888126893,NT5E;TNFRSF12A;COL4A1;COL12A1;SERPINE1;SNAI2;CD44;LOXL2,788365
1,Hypoxia,0.0048167833615563,EXT1;SERPINE1;PRKCA;MIF;ETS1;EGFR,788365
2,Estrogen Response Late,0.0048167833615563,FARP1;ELOVL5;ATP2B4;CD9;JAK2;CD44,788365
3,Glycolysis,0.0048167833615563,EXT1;NT5E;CDK1;MIF;EGFR;CD44,788365
4,UV Response Dn,0.005966200701983,SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA,788365
5,Estrogen Response Early,0.0180436021502928,FARP1;ELOVL5;ENDOD1;JAK2;CD44,788365
6,Apical Junction,0.0180436021502928,PTEN;RAC2;EGFR;ACTB;PTK2,788365
7,Cholesterol Homeostasis,0.028886848931976,TNFRSF12A;CD9;HMGCR,788365
9,IL-6/JAK/STAT3 Signaling,0.0360662574127702,TNFRSF12A;CD9;CD44,788365
8,Apoptosis,0.0360662574127702,TNFRSF12A;BAX;PTK2;CD44,788365
10,Androgen Response,0.038154791164311,CDK6;ELOVL5;HMGCR,788365
11,Hedgehog Signaling,0.038154791164311,NRP2;CDK6,788365
12,PI3K/AKT/mTOR  Signaling,0.038154791164311,CDK1;PTEN;EGFR,788365
13,Mitotic Spindle,0.038154791164311,FARP1;PLK1;CDK1;CDC42EP1,788365
14,Complement,0.038154791164311,GCA;ERAP2;SERPINE1;JAK2,788365
15,mTORC1 Signaling,0.038154791164311,ELOVL5;PLK1;CD9;HMGCR,788365
16,Xenobiotic Metabolism,0.038154791164311,GSTM4;ELOVL5;SERPINE1;MAN1A1,788365
17,p53 Pathway,0.038154791164311,VAMP8;BAX;STOM;PTPN14,788365
0,Angiogenesis,0.0011645997013388,NRP1;VCAN;SPP1;ITGAV,788794
1,Epithelial Mesenchymal Transition,0.0012484021765132,VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;ITGAV,788794
2,UV Response Dn,0.0099436678366384,NRP1;SDC2;ATP2B4;PTEN;SNAI2,788794
3,E2F Targets,0.0315763037630124,DNMT1;CHEK1;PLK1;CDK1;TP53,788794
0,Epithelial Mesenchymal Transition,0.0016426344427806,GJA1;GLIPR1;CALD1;VEGFC;LAMC1;FGF2;EDIL3,789043
1,Estrogen Response Early,0.0063378728441531,ABLIM1;GJA1;KRT19;KRT18;KRT8;FLNB,789043
2,UV Response Dn,0.0065418867346305,GJA1;ANXA2;DUSP1;NFIB;LAMC1,789043
0,UV Response Dn,2.403320246451053e-05,INPP4B;RBPMS;DLC1;SERPINE1;AKT3;ATP2B4;PTEN;SNAI2,789722
1,Androgen Response,0.0027753986391777,INPP4B;CDK6;ELOVL5;HMGCR;B2M,789722
2,Estrogen Response Early,0.0048167833615563,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,789722
3,Epithelial Mesenchymal Transition,0.0048167833615563,NT5E;TNFRSF12A;SERPINE1;SNAI2;CD44;LOXL2,789722
4,Hypoxia,0.0180436021502928,EXT1;MT2A;SERPINE1;MIF;ETS1,789722
5,Estrogen Response Late,0.0180436021502928,FARP1;ELOVL5;ATP2B4;JAK2;CD44,789722
6,Complement,0.0180436021502928,GCA;ERAP2;SERPINE1;GNB4;JAK2,789722
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;CD44,789797
1,Cholesterol Homeostasis,0.0006242010882566297,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,789797
2,Glycolysis,0.0006242010882566297,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,789797
3,KRAS Signaling Up,0.0006242010882566297,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,789797
4,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;TNC;CD44,789797
5,Hypoxia,0.0157881518815062,EXT1;SDC4;MIF;ETS1;EGFR,789797
6,Estrogen Response Late,0.0157881518815062,ELOVL5;ATP2B4;CD9;JAK2;CD44,789797
7,Apical Junction,0.0157881518815062,VCAN;CDH3;ITGA3;EGFR;ACTB,789797
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;CD44,789797
9,Hedgehog Signaling,0.0482286162714748,NRP1;NRP2,789797
10,Angiogenesis,0.0482286162714748,NRP1;VCAN,789797
11,IL-2/STAT5 Signaling,0.0490561600683998,NRP1;NT5E;ALCAM;CD44,789797
12,Estrogen Response Early,0.0490561600683998,ELOVL5;ENDOD1;JAK2;CD44,789797
13,mTORC1 Signaling,0.0490561600683998,ELOVL5;PLK1;CD9;HMGCR,789797
0,Apical Junction,0.0020368667090479,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,789968
1,p53 Pathway,0.0078589623267498,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,789968
2,Angiogenesis,0.0079378293471993,APP;FSTL1;PTK2,789968
3,Protein Secretion,0.0106523350441719,KRT18;SCRN1;CAV2;EGFR,789968
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,789969
1,Estrogen Response Early,0.0096335667231127,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,789969
2,Angiogenesis,0.0097302424255992,NRP1;VCAN;ITGAV,789969
3,Androgen Response,0.0151805989438751,ELOVL5;STK39;ITGAV;HMGCR,789969
4,IL-2/STAT5 Signaling,0.0210508691753416,CDKN1C;NRP1;ALCAM;LRIG1;ITGAV,789969
5,KRAS Signaling Up,0.0210508691753416,NRP1;PLAU;GABRA3;TRIB2;DUSP6,789969
6,UV Response Dn,0.0321668522847387,NRP1;CELF2;ATP2B4;SNAI2,789969
0,Complement,0.0027596258638714,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,790865
1,Epithelial Mesenchymal Transition,0.0106476263781772,ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,790865
2,UV Response Dn,0.0109903697141793,ITGB3;PMP22;LPAR1;MT1E;IGF1R,790865
3,TNF-alpha Signaling via NF-kB,0.0279201001694004,CEBPB;IRS2;SGK1;FJX1;LITAF,790865
4,KRAS Signaling Up,0.0279201001694004,TMEM158;SPP1;LCP1;GNG11;PSMB8,790865
0,Apical Junction,0.0021025720867591,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,791059
1,Apoptosis,0.0025333251374344,APP;GPX1;KRT18;TNFRSF12A;CAV1;PTK2,791059
2,p53 Pathway,0.0041415661760232,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,791059
3,Cholesterol Homeostasis,0.0041415661760232,ALCAM;TNFRSF12A;MAL2;CD9,791059
4,Angiogenesis,0.0041868075101635,APP;FSTL1;PTK2,791059
5,UV Response Dn,0.0041868075101635,TJP1;ANXA2;CAV1;ID1;MET,791059
6,Protein Secretion,0.0062834050030138,KRT18;SCRN1;CAV2;EGFR,791059
7,Hypoxia,0.0132952857949526,EXT1;ANXA2;SDC4;CAV1;EGFR,791059
0,Hypoxia,3.043374968563592e-05,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;TGFBI;AMPD3;MT1E,791163
1,mTORC1 Signaling,0.0070984175854514,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,791163
2,Epithelial Mesenchymal Transition,0.0070984175854514,ITGB3;ADAM12;PMP22;SPP1;VEGFC;TGFBI,791163
3,UV Response Dn,0.0082427772856345,ITGB3;PMP22;LPAR1;MT1E;IGF1R,791163
0,Apical Junction,0.0002430784419232072,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,791164
1,Angiogenesis,0.0126749210543989,APP;FSTL1;PTK2,791164
2,Protein Secretion,0.0151194432885021,KRT18;SCRN1;CAV2;EGFR,791164
3,p53 Pathway,0.0274215269520897,VAMP8;APP;PTPN14;EPHA2;S100A10,791164
4,UV Response Dn,0.033447930342288,TJP1;ANXA2;ID1;LAMC1,791164
5,Cholesterol Homeostasis,0.033447930342288,TNFRSF12A;GPX8;CD9,791164
6,Apoptosis,0.0391508715335993,APP;KRT18;TNFRSF12A;PTK2,791164
7,IL-6/JAK/STAT3 Signaling,0.0391508715335993,TNFRSF12A;CD9;OSMR,791164
0,Hypoxia,1.1704301067081812e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;MIF;ETS1;PAM;EGFR,791226
1,Epithelial Mesenchymal Transition,1.1704301067081812e-06,NOTCH2;NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;FSTL1;CD44;LOXL2,791226
2,UV Response Dn,7.800249922692017e-06,NOTCH2;TJP1;ANXA2;CAV1;SERPINE1;AKT3;MET;RND3,791226
3,TNF-alpha Signaling via NF-kB,5.450849909793132e-05,FOSL1;MARCKS;SDC4;PLK2;SERPINE1;IL6ST;PHLDA1;CD44,791226
4,Apical Junction,5.450849909793132e-05,TJP1;SGCE;RRAS;ITGA3;AKT3;EGFR;ACTB;PTK2,791226
5,Apoptosis,0.00010131335550908404,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,791226
6,Glycolysis,0.00034729985361647066,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44,791226
7,IL-6/JAK/STAT3 Signaling,0.00034899504008760923,TNFRSF12A;CD9;OSMR;IL6ST;CD44,791226
8,Angiogenesis,0.003158061138133,APP;FSTL1;PTK2,791226
13,p53 Pathway,0.0087843852573794,VAMP8;APP;PLK2;PTPN14;S100A10,791226
12,Inflammatory Response,0.0087843852573794,AXL;SERPINE1;SGMS2;OSMR;MET,791226
9,Mitotic Spindle,0.0087843852573794,NOTCH2;MYO1E;MARCKS;PLK1;ARHGAP29,791226
10,IL-2/STAT5 Signaling,0.0087843852573794,MYO1E;NT5E;AHNAK;PHLDA1;CD44,791226
11,Estrogen Response Late,0.0087843852573794,ELOVL5;CAV1;CD9;IL6ST;CD44,791226
14,Cholesterol Homeostasis,0.0150008899716928,TNFRSF12A;GPX8;CD9,791226
15,Fatty Acid Metabolism,0.0189088950967738,LGALS1;ELOVL5;MIF;S100A10,791226
16,Protein Secretion,0.0269637290471283,CAV2;PAM;EGFR,791226
17,G2-M Checkpoint,0.0351954167803755,NOTCH2;MARCKS;MT2A;PLK1,791226
18,Complement,0.0351954167803755,GCA;SERPINE1;GNB4;TIMP2,791226
0,Hypoxia,2.21432722890737e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,791227
1,Apoptosis,2.5750065595500327e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,791227
2,Apical Junction,6.445261717660797e-05,TJP1;RRAS;ITGA3;AKT3;CTNNA1;EGFR;ACTB;PTK2,791227
3,Glycolysis,6.445261717660797e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,791227
4,Epithelial Mesenchymal Transition,0.0004599376439785693,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;VIM;CD44,791227
5,TNF-alpha Signaling via NF-kB,0.0029576739939381,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,791227
6,UV Response Dn,0.0039251320407783,TJP1;CAV1;AKT3;PRKCA;MET,791227
7,Protein Secretion,0.0060134149442906,SCRN1;CAV2;PAM;EGFR,791227
8,Estrogen Response Late,0.0116333750705835,FARP1;ELOVL5;CAV1;CD9;CD44,791227
9,p53 Pathway,0.0116333750705835,VAMP8;APP;PLK2;PTPN14;IER3,791227
10,Cholesterol Homeostasis,0.0193500423467782,ALCAM;TNFRSF12A;CD9,791227
11,IL-6/JAK/STAT3 Signaling,0.0276824344176964,TNFRSF12A;CD9;CD44,791227
12,Angiogenesis,0.0375870794828296,APP;PTK2,791227
13,Estrogen Response Early,0.0451833053261577,FARP1;ELOVL5;ENDOD1;CD44,791227
0,Hypoxia,1.7320144107363228e-07,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,791328
1,Epithelial Mesenchymal Transition,1.2680729035681635e-05,NT5E;LGALS1;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;CD44;LOXL2,791328
2,Apoptosis,1.716671039700022e-05,APP;GPX1;TNFRSF12A;CAV1;TIMP2;PTK2;CD44;IER3,791328
3,Glycolysis,6.445261717660797e-05,EXT1;NT5E;MIF;PAM;MET;EGFR;CD44;IER3,791328
4,TNF-alpha Signaling via NF-kB,0.0004599376439785693,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44;IER3,791328
5,UV Response Dn,0.0005005171074275478,CAV1;SERPINE1;AKT3;ATP2B4;PRKCA;MET,791328
6,Estrogen Response Late,0.0022182554954535,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,791328
7,Apical Junction,0.0022182554954535,ITGA3;AKT3;CTNNA1;EGFR;ACTB;PTK2,791328
8,Protein Secretion,0.0053452577282583,SCRN1;CAV2;PAM;EGFR,791328
9,Cholesterol Homeostasis,0.021285046581456,ALCAM;TNFRSF12A;CD9,791328
10,IL-6/JAK/STAT3 Signaling,0.0301990193647598,TNFRSF12A;CD9;CD44,791328
11,Angiogenesis,0.0351425708092338,APP;PTK2,791328
12,Mitotic Spindle,0.0351425708092338,FARP1;MYO1E;ARHGAP29;CDC42EP1,791328
13,IL-2/STAT5 Signaling,0.0351425708092338,MYO1E;NT5E;ALCAM;CD44,791328
14,Estrogen Response Early,0.0351425708092338,FARP1;ELOVL5;ENDOD1;CD44,791328
15,Inflammatory Response,0.0351425708092338,AXL;SERPINE1;SGMS2;MET,791328
16,Xenobiotic Metabolism,0.0351425708092338,MT2A;ELOVL5;SERPINE1;MAN1A1,791328
17,p53 Pathway,0.0351425708092338,VAMP8;APP;PLK2;IER3,791328
0,Epithelial Mesenchymal Transition,2.761916001931682e-12,SPARC;TNFRSF12A;SDC4;COL12A1;TNC;THBS1;LOXL2;NT5E;VCAN;LGALS1;CDH2;SNAI2;VIM;PDLIM4;CD44,791496
1,Glycolysis,1.2336965989626774e-06,EXT1;NT5E;VCAN;CDK1;MIF;PAM;MET;EGFR;CD44;IL13RA1,791496
2,Hypoxia,7.735573773153362e-05,EXT1;MT2A;SDC4;CAV1;MIF;ETS1;PAM;EGFR,791496
3,UV Response Dn,7.735573773153362e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;MET;RND3,791496
4,TNF-alpha Signaling via NF-kB,0.00042041101354183046,FOSL1;SDC4;PLAU;PLK2;TNC;IL6ST;CD44,791496
5,Apical Junction,0.00042041101354183046,SGCE;VCAN;ITGA3;AKT3;MSN;EGFR;ACTB,791496
6,IL-6/JAK/STAT3 Signaling,0.00042041101354183046,TNFRSF12A;CD9;IL6ST;CD44;IL13RA1,791496
9,Cholesterol Homeostasis,0.0020190135108113,ALCAM;TNFRSF12A;CD9;HMGCR,791496
8,KRAS Signaling Up,0.0020190135108113,NRP1;PLAU;GABRA3;SPRY2;ETS1;TRIB2,791496
7,Estrogen Response Late,0.0020190135108113,ELOVL5;CAV1;ATP2B4;CD9;IL6ST;CD44,791496
10,Angiogenesis,0.0027235367554906,APP;NRP1;VCAN,791496
11,Apoptosis,0.0042013324349396,APP;TNFRSF12A;CAV1;TIMP2;CD44,791496
12,IL-2/STAT5 Signaling,0.0097602043198384,MYO1E;NRP1;NT5E;ALCAM;CD44,791496
13,Coagulation,0.0142158926274929,SPARC;PLAU;CD9;THBS1,791496
14,Protein Secretion,0.0322107249698128,CAV2;PAM;EGFR,791496
15,Hedgehog Signaling,0.0340297308889189,NRP1;NRP2,791496
16,Estrogen Response Early,0.0414623272404741,ELOVL5;ENDOD1;IL6ST;CD44,791496
0,UV Response Dn,0.0329711091425381,INPP4B;DLC1;ITGB3;PMP22;IGF1R,791966
0,Hypoxia,0.0111546562057094,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,791967
1,Epithelial Mesenchymal Transition,0.0111546562057094,ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,791967
2,UV Response Dn,0.0115137206529498,ITGB3;PMP22;LPAR1;MT1E;IGF1R,791967
3,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,791967
4,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,791967
5,mTORC1 Signaling,0.0243746906240797,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,791967
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,791967
15,p53 Pathway,0.0467780102200221,FAS;BAX;TXNIP;TP53,791967
14,Xenobiotic Metabolism,0.0467780102200221,TGFB2;GCNT2;FAS;BCAT1,791967
13,E2F Targets,0.0467780102200221,PLK1;CDK1;TP53;AURKA,791967
12,Interferon Gamma Response,0.0467780102200221,FAS;TXNIP;PSMB8;PSMB9,791967
8,Interferon Alpha Response,0.0467780102200221,TXNIP;PSMB8;PSMB9,791967
10,PI3K/AKT/mTOR  Signaling,0.0467780102200221,CDK1;THEM4;HSP90B1,791967
9,Androgen Response,0.0467780102200221,ADAMTS1;HMGCR;SGK1,791967
16,Allograft Rejection,0.0467780102200221,LYN;TGFB2;FAS;BCAT1,791967
7,Apoptosis,0.0467780102200221,TGFB2;FAS;BAX;TXNIP,791967
11,Mitotic Spindle,0.0467780102200221,PLK1;CDK1;MYH10;AURKA,791967
17,Apical Surface,0.0499387383281485,LYN;SRPX,791967
0,Epithelial Mesenchymal Transition,0.0019305659857919,BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS;VEGFC,791968
1,UV Response Dn,0.0019305659857919,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,791968
2,Hypoxia,0.0076054474129837,SRPX;GCNT2;IRS2;PLIN2;AMPD3;MT1E,791968
3,TNF-alpha Signaling via NF-kB,0.0249286608655361,CEBPB;IRS2;SGK1;FJX1;LITAF,791968
4,Complement,0.0249286608655361,DOCK10;LYN;CEBPB;ERAP2;PSMB9,791968
5,mTORC1 Signaling,0.0249286608655361,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,791968
6,Cholesterol Homeostasis,0.03909498351696,FDPS;FABP5;HMGCR,791968
16,p53 Pathway,0.0451833053261577,FAS;BAX;TXNIP;TP53,791968
15,Xenobiotic Metabolism,0.0451833053261577,TGFB2;GCNT2;FAS;BCAT1,791968
14,E2F Targets,0.0451833053261577,PLK1;CDK1;TP53;AURKA,791968
13,Interferon Gamma Response,0.0451833053261577,FAS;TXNIP;PSMB8;PSMB9,791968
12,IL-2/STAT5 Signaling,0.0451833053261577,PRNP;SPP1;PLIN2;IGF1R,791968
9,Androgen Response,0.0451833053261577,ADAMTS1;HMGCR;SGK1,791968
10,PI3K/AKT/mTOR  Signaling,0.0451833053261577,CDK1;THEM4;HSP90B1,791968
17,Allograft Rejection,0.0451833053261577,LYN;TGFB2;FAS;BCAT1,791968
8,Interferon Alpha Response,0.0451833053261577,TXNIP;PSMB8;PSMB9,791968
7,Apoptosis,0.0451833053261577,TGFB2;FAS;BAX;TXNIP,791968
11,Mitotic Spindle,0.0451833053261577,PLK1;CDK1;MYH10;AURKA,791968
18,Apical Surface,0.0483856196720099,LYN;SRPX,791968
0,Glycolysis,2.0877942443983774e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,792847
1,Epithelial Mesenchymal Transition,1.1956115947928398e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,792847
2,Hypoxia,8.102614730773575e-05,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;EGFR;IER3,792847
3,TNF-alpha Signaling via NF-kB,0.0034167920952191,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,792847
4,Cholesterol Homeostasis,0.0034167920952191,ALCAM;TNFRSF12A;MAL2;CD9,792847
5,Angiogenesis,0.0037008387813052,APP;NRP1;VCAN,792847
6,UV Response Dn,0.0037008387813052,NRP1;ATP2B4;SNAI2;PRKCA;MET,792847
7,IL-6/JAK/STAT3 Signaling,0.0039314433105912,TNFRSF12A;CD9;CD44;IL13RA1,792847
8,Apoptosis,0.0047399647983935,APP;GPX1;TNFRSF12A;CD44;IER3,792847
9,KRAS Signaling Up,0.0109686107808359,NRP1;GALNT3;PLAU;SPRY2;ETS1,792847
10,Protein Secretion,0.0371662211190148,CAV2;PAM;EGFR,792847
11,IL-2/STAT5 Signaling,0.0397613086870188,NRP1;NT5E;ALCAM;CD44,792847
12,Estrogen Response Late,0.0397613086870188,ELOVL5;ATP2B4;CD9;CD44,792847
13,Apical Junction,0.0397613086870188,VCAN;ITGA3;EGFR;ACTB,792847
14,p53 Pathway,0.0397613086870188,APP;HDAC3;PLK2;IER3,792847
0,Hypoxia,3.18829758611424e-05,SRPX;TES;DTNA;GCNT2;IRS2;PLIN2;AMPD3;EGFR;MT1E,792848
1,Epithelial Mesenchymal Transition,0.0012584430129606,ITGB5;BDNF;ITGB3;ADAM12;PMP22;SPP1;FAS,792848
2,UV Response Dn,0.0012584430129606,BDNF;ITGB3;PMP22;LPAR1;MT1E;IGF1R,792848
3,TNF-alpha Signaling via NF-kB,0.0292496287488957,CEBPB;IRS2;SGK1;FJX1;LITAF,792848
4,Allograft Rejection,0.0292496287488957,LYN;TGFB2;FAS;BCAT1;EGFR,792848
5,Apoptosis,0.0497016358587735,TGFB2;FAS;BAX;TXNIP,792848
6,Interferon Alpha Response,0.0497016358587735,TXNIP;PSMB8;PSMB9,792848
7,PI3K/AKT/mTOR  Signaling,0.0497016358587735,THEM4;EGFR;HSP90B1,792848
8,IL-2/STAT5 Signaling,0.0497016358587735,SPP1;PLIN2;AHR;IGF1R,792848
9,Myogenesis,0.0497016358587735,FDPS;DTNA;ITGB5;ADAM12,792848
10,Interferon Gamma Response,0.0497016358587735,FAS;TXNIP;PSMB8;PSMB9,792848
11,Complement,0.0497016358587735,DOCK10;LYN;CEBPB;PSMB9,792848
12,mTORC1 Signaling,0.0497016358587735,TES;BCAT1;AURKA;HSP90B1,792848
13,Inflammatory Response,0.0497016358587735,LYN;ITGB3;LPAR1;AHR,792848
14,Xenobiotic Metabolism,0.0497016358587735,TGFB2;GCNT2;FAS;BCAT1,792848
15,p53 Pathway,0.0497016358587735,FAS;BAX;TXNIP;TP53,792848
0,Hypoxia,0.0002578104687064319,EXT1;ANXA2;SDC4;CAV1;MIF;ETS1;EGFR;IER3,792956
1,Apoptosis,0.0002875108737419952,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44;IER3,792956
2,UV Response Dn,0.001001034214855,TJP1;NRP1;ANXA2;CAV1;ID1;MET,792956
3,TNF-alpha Signaling via NF-kB,0.0022649190025126,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,792956
4,Apical Junction,0.0022649190025126,TJP1;RRAS;ITGA3;CTNNA1;EGFR;PTK2,792956
5,Glycolysis,0.0022649190025126,EXT1;MIF;MET;EGFR;CD44;IER3,792956
6,p53 Pathway,0.0022649190025126,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,792956
7,Cholesterol Homeostasis,0.0022649190025126,ALCAM;TNFRSF12A;MAL2;CD9,792956
8,Angiogenesis,0.0029873551306664,APP;NRP1;PTK2,792956
9,Estrogen Response Late,0.0105757955187123,ELOVL5;CAV1;CD9;LSR;CD44,792956
10,Epithelial Mesenchymal Transition,0.0105757955187123,TNFRSF12A;SDC4;COL12A1;VIM;CD44,792956
11,Fatty Acid Metabolism,0.0238490568788138,ELOVL5;PCBD1;MIF;S100A10,792956
12,IL-6/JAK/STAT3 Signaling,0.0255530163855659,TNFRSF12A;CD9;CD44,792956
13,Protein Secretion,0.0309718509325123,SCRN1;CAV2;EGFR,792956
14,IL-2/STAT5 Signaling,0.0414827736465244,NRP1;ALCAM;AHNAK;CD44,792956
15,Apical Surface,0.0446894959470647,APP;ATP8B1,792956
0,Angiogenesis,0.0008581260957233824,APP;NRP1;ITGAV;PTK2,792970
1,UV Response Dn,0.0012012410578261,TJP1;NRP1;GJA1;MAP1B;ID1;CAP2,792970
2,Epithelial Mesenchymal Transition,0.031022333521556,GJA1;DST;COL12A1;ITGAV;CAP2,792970
3,Fatty Acid Metabolism,0.048848216624929,ELOVL5;PCBD1;MIF;S100A10,792970
4,Apoptosis,0.048848216624929,APP;BTG3;PTK2;IER3,792970
0,Hypoxia,2.681068424686974e-05,EXT1;MT2A;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,792971
1,Epithelial Mesenchymal Transition,0.0001362712477448283,NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;CD44;LOXL2,792971
2,Apoptosis,0.0019527714601056,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,792971
3,TNF-alpha Signaling via NF-kB,0.0037520207237386,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,792971
4,Estrogen Response Late,0.0037520207237386,FARP1;ELOVL5;CAV1;ATP2B4;CD9;CD44,792971
5,Mitotic Spindle,0.0175687705147588,FARP1;MYO1E;PLK1;ARHGAP29;CDC42EP1,792971
6,Glycolysis,0.0175687705147588,EXT1;NT5E;MIF;EGFR;CD44,792971
8,Cholesterol Homeostasis,0.0250014832861547,TNFRSF12A;CD9;HMGCR,792971
7,UV Response Dn,0.0250014832861547,CAV1;SERPINE1;ATP2B4;PRKCA,792971
9,IL-6/JAK/STAT3 Signaling,0.0351171453755921,TNFRSF12A;CD9;CD44,792971
16,mTORC1 Signaling,0.0371507177126186,ELOVL5;PLK1;CD9;HMGCR,792971
10,Androgen Response,0.0371507177126186,CDK6;ELOVL5;HMGCR,792971
11,Hedgehog Signaling,0.0371507177126186,NRP2;CDK6,792971
12,Angiogenesis,0.0371507177126186,APP;PTK2,792971
13,Estrogen Response Early,0.0371507177126186,FARP1;ELOVL5;ENDOD1;CD44,792971
14,Apical Junction,0.0371507177126186,ITGA3;EGFR;ACTB;PTK2,792971
15,Complement,0.0371507177126186,GCA;SERPINE1;GNB4;TIMP2,792971
17,p53 Pathway,0.0371507177126186,VAMP8;APP;PLK2;PTPN14,792971
0,IL-2/STAT5 Signaling,0.0180556073875804,PRNP;PLAGL1;SPP1;PLIN2;AHR;IGF1R,792987
1,UV Response Dn,0.0180556073875804,BDNF;ITGB3;PMP22;MT1E;IGF1R,792987
2,Hypoxia,0.0305791573283909,SRPX;DTNA;GCNT2;PLIN2;MT1E,792987
3,Complement,0.0305791573283909,DOCK10;LYN;CEBPB;ERAP2;PSMB9,792987
4,mTORC1 Signaling,0.0305791573283909,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,792987
5,Cholesterol Homeostasis,0.0466243877498561,FDPS;FABP5;HMGCR,792987
0,IL-2/STAT5 Signaling,0.00011107490546066368,PRNP;CSF1;BHLHE40;ITGA6;PLIN2;AHR;WLS;IGF1R,792996
1,Epithelial Mesenchymal Transition,0.00011107490546066368,GLIPR1;ITGB5;BDNF;ITGB3;PMP22;FAS;VEGFC;EDIL3,792996
2,UV Response Dn,0.00011107490546066368,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,792996
3,TNF-alpha Signaling via NF-kB,0.0042590505512708,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,792996
4,Hypoxia,0.0042590505512708,SRPX;BHLHE40;GCNT2;PLIN2;AMPD3;MT1E,792996
5,Myogenesis,0.015511166760778,WWTR1;FDPS;PRNP;ITGB5;BHLHE40,792996
6,Inflammatory Response,0.015511166760778,LYN;CSF1;ITGB3;LPAR1;AHR,792996
7,Xenobiotic Metabolism,0.015511166760778,TGFB2;PROS1;GCNT2;FAS;BCAT1,792996
8,Allograft Rejection,0.015511166760778,LYN;TGFB2;CSF1;FAS;BCAT1,792996
9,Apoptosis,0.0362388232377117,TGFB2;FAS;BAX;BCL2L2,792996
10,IL-6/JAK/STAT3 Signaling,0.0362388232377117,CSF1;ITGB3;FAS,792996
11,Interferon Alpha Response,0.0445849133230403,CSF1;PSMB8;PSMB9,792996
0,Epithelial Mesenchymal Transition,1.3279555296095826e-08,GJA1;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;AREG;THBS1;CD44,793103
1,Glycolysis,0.00013995425444063446,VCAN;CDK1;MIF;PAM;MET;CD44;IER3;IL13RA1,793103
2,Angiogenesis,0.00038819990044629206,APP;NRP1;VCAN;ITGAV,793103
3,TNF-alpha Signaling via NF-kB,0.0006242010882566297,TUBB2A;SDC4;PLAU;PLK2;AREG;CD44;IER3,793103
4,UV Response Dn,0.0006521022885341765,TJP1;NRP1;GJA1;ATP2B4;SNAI2;MET,793103
5,Cholesterol Homeostasis,0.0032787398893517,ALCAM;TNFRSF12A;MAL2;CD9,793103
6,Coagulation,0.0035159252214328,SPARC;PLAU;CD9;THBS1;DUSP6,793103
7,IL-6/JAK/STAT3 Signaling,0.0045271165394686,TNFRSF12A;CD9;CD44;IL13RA1,793103
8,TGF-beta Signaling,0.0105580670114613,TJP1;ID3;THBS1,793103
9,Estrogen Response Early,0.011482292277459,GJA1;ELOVL5;ENDOD1;AREG;CD44,793103
10,Estrogen Response Late,0.011482292277459,ELOVL5;ATP2B4;CD9;AREG;CD44,793103
11,Apoptosis,0.0276225034486205,APP;TNFRSF12A;CD44;IER3,793103
12,Pperoxisome,0.0429241400598498,SEMA3C;ELOVL5;PRDX1,793103
13,IL-2/STAT5 Signaling,0.0429241400598498,NRP1;ALCAM;ITGAV;CD44,793103
14,Hypoxia,0.0429241400598498,SDC4;MIF;PAM;IER3,793103
15,Apical Junction,0.0429241400598498,TJP1;VCAN;CDH3;ITGA3,793103
0,Epithelial Mesenchymal Transition,2.72045916694334e-06,GLIPR1;BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;FAS;PLOD3;VEGFC,793150
1,UV Response Dn,0.00017057931910030493,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,793150
2,TNF-alpha Signaling via NF-kB,0.0054505706459716,CEBPB;BHLHE40;IRS2;SGK1;FJX1;LITAF,793150
3,Complement,0.0054505706459716,DOCK10;LYN;CEBPB;ERAP2;TFPI2;PSMB9,793150
4,Hypoxia,0.0204177603279629,SRPX;BHLHE40;GCNT2;IRS2;MT1E,793150
5,mTORC1 Signaling,0.0204177603279629,BHLHE40;HMGCR;BCAT1;AURKA;HSP90B1,793150
6,Xenobiotic Metabolism,0.0204177603279629,TGFB2;PROS1;GCNT2;FAS;BCAT1,793150
7,Cholesterol Homeostasis,0.032687750107236,FDPS;FABP5;HMGCR,793150
8,Apoptosis,0.0416760578347609,TGFB2;FAS;BAX;TXNIP,793150
16,Allograft Rejection,0.0431751584227729,LYN;TGFB2;FAS;BCAT1,793150
15,p53 Pathway,0.0431751584227729,FAS;BAX;TXNIP;TP53,793150
14,Interferon Gamma Response,0.0431751584227729,FAS;TXNIP;PSMB8;PSMB9,793150
13,Myogenesis,0.0431751584227729,FDPS;PRNP;BHLHE40;ADAM12,793150
9,Interferon Alpha Response,0.0431751584227729,TXNIP;PSMB8;PSMB9,793150
11,IL-2/STAT5 Signaling,0.0431751584227729,PRNP;BHLHE40;SPP1;IGF1R,793150
10,Androgen Response,0.0431751584227729,ADAMTS1;HMGCR;SGK1,793150
17,KRAS Signaling Up,0.0431751584227729,TMEM158;SPP1;GNG11;PSMB8,793150
12,Estrogen Response Early,0.0431751584227729,MLPH;BHLHE40;RHOBTB3;IGF1R,793150
18,Apical Surface,0.0462351476865873,LYN;SRPX,793150
0,E2F Targets,0.0207882229288221,DNMT1;PLK1;CDK1;TP53;AURKB;AURKA,793151
0,Apical Junction,0.0062802112652453,TJP1;RRAS;CTNNA1;FLNC;RHOF;PTK2,793323
1,Angiogenesis,0.0062802112652453,APP;FSTL1;PTK2,793323
2,UV Response Dn,0.0062802112652453,TJP1;ANXA2;MAP1B;ID1;LAMC1,793323
3,TGF-beta Signaling,0.015003568911024,TJP1;SMURF2;ID1,793323
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;ECM1;SPARC;LGALS1;COL4A1;COL12A1;TNC;SNAI2;CD44,793324
1,KRAS Signaling Up,0.00013995425444063446,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,793324
2,IL-2/STAT5 Signaling,0.0048167833615563,NRP1;NT5E;ECM1;ALCAM;LRIG1;CD44,793324
3,Estrogen Response Early,0.0048167833615563,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;CD44,793324
4,TNF-alpha Signaling via NF-kB,0.0210508691753416,FOSL1;PLAU;PLK2;TNC;CD44,793324
5,Glycolysis,0.0210508691753416,NT5E;VCAN;CDK1;MIF;CD44,793324
6,Cholesterol Homeostasis,0.033013541636544,ALCAM;MAL2;HMGCR,793324
0,UV Response Dn,0.0024573450216979,TJP1;ANXA2;DUSP1;NFIB;MAP1B;ID1,793677
1,TGF-beta Signaling,0.0024573450216979,TJP1;RAB31;SMURF2;ID1,793677
2,Apical Junction,0.0054083181603439,TJP1;RRAS;FSCN1;CTNNA1;RHOF;PTK2,793677
3,Angiogenesis,0.0061454162687994,FSTL1;PTK2;FGFR1,793677
0,UV Response Dn,0.00026975334183304035,TJP1;NRP1;ANXA2;CAV1;ID1;MET;CAP2,793726
1,Apoptosis,0.0002792962773493668,APP;GPX1;TNFRSF12A;CAV1;PTK2;CD44;IER3,793726
2,Hypoxia,0.0005584957105454055,EXT1;ANXA2;SDC4;CAV1;MIF;EGFR;IER3,793726
3,Apical Junction,0.0005584957105454055,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,793726
4,Epithelial Mesenchymal Transition,0.0022002070310123,TNFRSF12A;SDC4;DST;COL12A1;CD44;CAP2,793726
5,Glycolysis,0.0022002070310123,EXT1;MIF;MET;EGFR;CD44;IER3,793726
6,p53 Pathway,0.0022002070310123,VAMP8;APP;PLK2;PTPN14;S100A10;IER3,793726
7,Cholesterol Homeostasis,0.0022002070310123,ALCAM;TNFRSF12A;MAL2;CD9,793726
8,Angiogenesis,0.002902002126933,APP;NRP1;PTK2,793726
9,Protein Secretion,0.0046732824709915,SCRN1;DST;CAV2;EGFR,793726
10,TNF-alpha Signaling via NF-kB,0.009417494104758,TUBB2A;SDC4;PLK2;CD44;IER3,793726
11,Estrogen Response Late,0.009417494104758,ELOVL5;CAV1;CD9;LSR;CD44,793726
12,Fatty Acid Metabolism,0.0213855279264967,ELOVL5;PCBD1;MIF;S100A10,793726
13,IL-6/JAK/STAT3 Signaling,0.0230498637600411,TNFRSF12A;CD9;CD44,793726
14,Pperoxisome,0.0347827327998073,SEMA3C;ELOVL5;PRDX1,793726
15,IL-2/STAT5 Signaling,0.0377789545709419,NRP1;ALCAM;AHNAK;CD44,793726
16,Apical Surface,0.0408589677230306,APP;ATP8B1,793726
0,Epithelial Mesenchymal Transition,1.880472788799436e-07,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,794109
1,Cholesterol Homeostasis,0.0006579293581443079,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,794109
2,KRAS Signaling Up,0.0008322681176755062,NRP1;GALNT3;PLAU;GABRA3;SPRY2;ETS1;TRIB2,794109
3,TNF-alpha Signaling via NF-kB,0.003853426689245,FOSL1;SDC4;PLAU;PLK2;TNC;CD44,794109
4,Glycolysis,0.003853426689245,NT5E;VCAN;CDK1;MIF;EGFR;CD44,794109
5,Angiogenesis,0.0048651212127996,NRP1;VCAN;ITGAV,794109
6,IL-2/STAT5 Signaling,0.0126305215052049,NRP1;NT5E;ALCAM;ITGAV;CD44,794109
7,Hypoxia,0.0126305215052049,SDC4;PRKCA;MIF;ETS1;EGFR,794109
8,Estrogen Response Late,0.0126305215052049,ELOVL5;ATP2B4;CD9;JAK2;CD44,794109
9,Apical Junction,0.0126305215052049,VCAN;CDH3;ITGA3;EGFR;ACTB,794109
10,UV Response Dn,0.0204698150902882,NRP1;ATP2B4;SNAI2;PRKCA,794109
11,IL-6/JAK/STAT3 Signaling,0.0300552145106419,TNFRSF12A;CD9;CD44,794109
12,Androgen Response,0.0378939127847302,ELOVL5;ITGAV;HMGCR,794109
13,Hedgehog Signaling,0.0378939127847302,NRP1;NRP2,794109
14,Estrogen Response Early,0.0429241400598498,ELOVL5;ENDOD1;JAK2;CD44,794109
15,mTORC1 Signaling,0.0429241400598498,ELOVL5;PLK1;CD9;HMGCR,794109
0,Hypoxia,0.00014363726113644063,EXT1;MT2A;SDC4;CAV1;SERPINE1;MIF;ETS1;EGFR,794442
1,Epithelial Mesenchymal Transition,0.00014363726113644063,NT5E;LGALS1;TNFRSF12A;SDC4;SERPINE1;VIM;CD44;LOXL2,794442
2,Apoptosis,0.0002135795062083393,APP;TNFRSF12A;CAV1;TIMP2;BAX;PTK2;CD44,794442
3,Mitotic Spindle,0.0032956938789596,FARP1;MYO1E;PLK1;CDK1;ARHGAP29;CDC42EP1,794442
4,Apical Junction,0.0032956938789596,ITGA3;AKT3;RAC2;EGFR;ACTB;PTK2,794442
5,Glycolysis,0.0032956938789596,EXT1;NT5E;CDK1;MIF;EGFR;CD44,794442
9,p53 Pathway,0.0129629036500787,VAMP8;APP;PLK2;BAX;PTPN14,794442
8,Complement,0.0129629036500787,GCA;ERAP2;SERPINE1;GNB4;TIMP2,794442
6,TNF-alpha Signaling via NF-kB,0.0129629036500787,FOSL1;SDC4;PLK2;SERPINE1;CD44,794442
7,Estrogen Response Late,0.0129629036500787,FARP1;ELOVL5;CAV1;CD9;CD44,794442
10,Cholesterol Homeostasis,0.0215614757578385,TNFRSF12A;CD9;HMGCR,794442
11,IL-6/JAK/STAT3 Signaling,0.0308461412082903,TNFRSF12A;CD9;CD44,794442
12,Androgen Response,0.0362983796148468,CDK6;ELOVL5;HMGCR,794442
13,Hedgehog Signaling,0.0362983796148468,NRP2;CDK6,794442
14,Angiogenesis,0.0362983796148468,APP;PTK2,794442
16,mTORC1 Signaling,0.0391588646160033,ELOVL5;PLK1;CD9;HMGCR,794442
15,Estrogen Response Early,0.0391588646160033,FARP1;ELOVL5;ENDOD1;CD44,794442
17,Xenobiotic Metabolism,0.0391588646160033,GSTM4;MT2A;ELOVL5;SERPINE1,794442
0,Complement,0.0013798129319357,DOCK10;LYN;CEBPB;ERAP2;TFPI2;JAK2;PSMB9,794590
1,Epithelial Mesenchymal Transition,0.0013798129319357,BDNF;ITGB3;TFPI2;ADAM12;PMP22;SPP1;VEGFC,794590
2,UV Response Dn,0.0109903697141793,BDNF;ITGB3;PMP22;LPAR1;MT1E,794590
3,PI3K/AKT/mTOR  Signaling,0.0200692070489926,CDK1;THEM4;PLCB1;HSP90B1,794590
4,KRAS Signaling Up,0.0279201001694004,TMEM158;SPP1;LCP1;GNG11;PSMB8,794590
0,Epithelial Mesenchymal Transition,2.3408602134163623e-06,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;CD44,797771
1,Glycolysis,0.0001362712477448283,NT5E;VCAN;CDK1;MIF;PAM;MET;CD44;IER3,797771
2,Cholesterol Homeostasis,0.0004270769517778841,ALCAM;TNFRSF12A;MAL2;CD9;HMGCR,797771
3,TNF-alpha Signaling via NF-kB,0.0046900259046732,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,797771
4,Angiogenesis,0.0056845100486395,APP;NRP1;VCAN,797771
5,Hypoxia,0.0153726742004139,SDC4;MIF;ETS1;PAM;IER3,797771
6,Estrogen Response Late,0.0153726742004139,ELOVL5;ATP2B4;CD9;JAK2;CD44,797771
7,KRAS Signaling Up,0.0153726742004139,NRP1;GALNT3;PLAU;SPRY2;ETS1,797771
8,UV Response Dn,0.024360277022653,NRP1;ATP2B4;SNAI2;MET,797771
9,Apoptosis,0.0319246776141746,APP;TNFRSF12A;CD44;IER3,797771
10,IL-6/JAK/STAT3 Signaling,0.0319246776141746,TNFRSF12A;CD9;CD44,797771
11,Hedgehog Signaling,0.0430461553124786,NRP1;NRP2,797771
12,IL-2/STAT5 Signaling,0.0445808612551423,NRP1;NT5E;ALCAM;CD44,797771
13,Estrogen Response Early,0.0445808612551423,ELOVL5;ENDOD1;JAK2;CD44,797771
14,mTORC1 Signaling,0.0445808612551423,ELOVL5;PLK1;CD9;HMGCR,797771
0,Epithelial Mesenchymal Transition,2.4673931979253548e-06,VCAN;ECM1;SPARC;COL4A1;COL12A1;TNC;SNAI2;FBLN1;ITGAV;AREG,797932
1,Estrogen Response Early,0.0098870816368788,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2;AREG,797932
2,Angiogenesis,0.0099863014367991,NRP1;VCAN;ITGAV,797932
3,KRAS Signaling Up,0.0324072591251969,NRP1;PLAU;GABRA3;TRIB2;DUSP6,797932
4,UV Response Dn,0.046218687756493,NRP1;CELF2;ATP2B4;SNAI2,797932
0,Glycolysis,2.151060736652873e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,797937
1,Hypoxia,1.2318422491805016e-05,EXT1;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,797937
2,Epithelial Mesenchymal Transition,8.348148510493986e-05,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;CD44,797937
3,TNF-alpha Signaling via NF-kB,0.0005584957105454055,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,797937
4,UV Response Dn,0.0005834599423726843,NRP1;CAV1;ATP2B4;SNAI2;PRKCA;MET,797937
5,Apoptosis,0.0008972193195080209,APP;GPX1;TNFRSF12A;CAV1;CD44;IER3,797937
6,Cholesterol Homeostasis,0.0025145223211569,ALCAM;TNFRSF12A;MAL2;CD9,797937
7,Angiogenesis,0.0032647523927997,APP;NRP1;VCAN,797937
8,IL-6/JAK/STAT3 Signaling,0.0036005137389926,TNFRSF12A;CD9;CD44;IL13RA1,797937
9,Protein Secretion,0.0046732824709915,SCRN1;CAV2;PAM;EGFR,797937
10,Estrogen Response Late,0.0086930714813151,ELOVL5;CAV1;ATP2B4;CD9;CD44,797937
11,p53 Pathway,0.0086930714813151,VAMP8;APP;HDAC3;PLK2;IER3,797937
12,KRAS Signaling Up,0.0086930714813151,NRP1;GALNT3;PLAU;SPRY2;ETS1,797937
13,IL-2/STAT5 Signaling,0.0409661968290497,NRP1;NT5E;ALCAM;CD44,797937
14,Apical Junction,0.0409661968290497,VCAN;ITGA3;EGFR;ACTB,797937
0,Hedgehog Signaling,0.0011645997013388,NRP1;NRP2;CDK6;VLDLR,797938
1,Epithelial Mesenchymal Transition,0.0012484021765132,VCAN;ECM1;COL4A1;COL12A1;TNC;SNAI2;FBLN1,797938
2,Estrogen Response Early,0.0315763037630124,ELOVL5;ENDOD1;LRIG1;PMAIP1;JAK2,797938
3,KRAS Signaling Up,0.0315763037630124,NRP1;GABRA3;ETS1;TRIB2;DUSP6,797938
4,UV Response Dn,0.0450335931986342,NRP1;ATP2B4;SNAI2;VLDLR,797938
0,IL-2/STAT5 Signaling,0.0349001252117506,PLAGL1;SPP1;PLIN2;AHR;IGF1R,798200
1,Hypoxia,0.0349001252117506,SRPX;DTNA;GCNT2;PLIN2;MT1E,798200
2,Complement,0.0349001252117506,DOCK10;LYN;CEBPB;ERAP2;PSMB9,798200
3,mTORC1 Signaling,0.0349001252117506,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,798200
4,UV Response Dn,0.0497739714300694,ITGB3;PMP22;MT1E;IGF1R,798200
0,UV Response Dn,0.0019276289443275,TJP1;ANXA2;CAV1;MAP1B;ID1;MET,798303
1,Protein Secretion,0.0019276289443275,TPD52;KRT18;SCRN1;DST;CAV2,798303
2,Estrogen Response Early,0.0177270477266034,ABLIM1;KRT18;MYOF;KRT8;SFN,798303
3,Apical Junction,0.0177270477266034,TJP1;RRAS;ITGA3;FSCN1;CTNNA1,798303
4,Epithelial Mesenchymal Transition,0.0177270477266034,SDC4;DST;VIM;FSTL1;PFN2,798303
5,p53 Pathway,0.0177270477266034,APP;LIF;SFN;PTPN14;S100A10,798303
6,Apoptosis,0.0398760952040237,APP;GPX1;KRT18;CAV1,798303
0,Apical Junction,0.0021025720867591,TJP1;RRAS;ITGA3;CTNNA1;RHOF;EGFR;PTK2,799318
1,p53 Pathway,0.0055220882346976,VAMP8;APP;PLK2;SFN;PTPN14;S100A10,799318
2,Cholesterol Homeostasis,0.0055220882346976,TNFRSF12A;GPX8;MAL2;CD9,799318
3,Angiogenesis,0.0061454162687994,APP;FSTL1;PTK2,799318
4,Apoptosis,0.0073306391701828,APP;GPX1;KRT18;TNFRSF12A;PTK2,799318
5,Protein Secretion,0.0073306391701828,KRT18;SCRN1;CAV2;EGFR,799318
6,UV Response Dn,0.027087875608201,TJP1;ANXA2;ID1;MET,799318
7,IL-6/JAK/STAT3 Signaling,0.0379644814871266,TNFRSF12A;CD9;OSMR,799318
0,Epithelial Mesenchymal Transition,1.5026865203476855e-08,GJA1;VCAN;SPARC;LGALS1;DST;COL4A2;BASP1;SPP1;TGFBI;VIM;EMP3;THBS1,799337
1,Apoptosis,0.0034041556534274,APP;BTG3;GPX1;CAV1;BAX;TXNIP,799337
2,p53 Pathway,0.0067512271101387,APP;LDHB;LIF;BAX;TXNIP;TM4SF1,799337
3,Angiogenesis,0.0067512271101387,APP;VCAN;SPP1,799337
4,UV Response Dn,0.0067512271101387,GJA1;CAV1;TFPI;NR3C1;MGLL,799337
5,mTORC1 Signaling,0.0238207203826234,TES;PRDX1;PLK1;DHCR24;HMGCR,799337
0,Hypoxia,0.00017454628000961432,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,799349
1,UV Response Dn,0.00017454628000961432,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,799349
2,Epithelial Mesenchymal Transition,0.0009636788730979544,ITGB5;BDNF;ITGB3;PMP22;SPP1;TGFBI;EDIL3,799349
3,IL-2/STAT5 Signaling,0.0054316903793632,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,799349
4,Interferon Alpha Response,0.0125679065539147,LGALS3BP;TXNIP;PSMB8;PSMB9,799349
5,Estrogen Response Early,0.0208925919634969,DYNLT3;BHLHE40;RHOBTB3;MICB;IGF1R,799349
6,mTORC1 Signaling,0.0208925919634969,TES;BHLHE40;BCAT1;AURKA;HSP90B1,799349
7,Apoptosis,0.047975927042341,TGFB2;BAX;TXNIP;BCL2L2,799349
0,Glycolysis,0.00025044445531481954,VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,800081
1,Angiogenesis,0.0005210051295463393,APP;NRP1;VCAN;ITGAV,800081
2,Epithelial Mesenchymal Transition,0.000744660947393874,VCAN;TNFRSF12A;SDC4;DST;COL12A1;ITGAV;CD44,800081
3,Protein Secretion,0.0010240528766739,SCRN1;DST;CAV2;PAM;EGFR,800081
4,Cholesterol Homeostasis,0.0035203312496197,ALCAM;TNFRSF12A;MAL2;CD9,800081
5,IL-6/JAK/STAT3 Signaling,0.0054007706084889,TNFRSF12A;CD9;CD44;IL13RA1,800081
6,Apoptosis,0.0062789144082615,APP;GPX1;TNFRSF12A;CD44;IER3,800081
7,IL-2/STAT5 Signaling,0.009417494104758,NRP1;ALCAM;AHNAK;ITGAV;CD44,800081
8,TNF-alpha Signaling via NF-kB,0.009417494104758,TUBB2A;SDC4;PLK2;CD44;IER3,800081
9,Hypoxia,0.009417494104758,SDC4;MIF;PAM;EGFR;IER3,800081
10,Apical Junction,0.009417494104758,TJP1;VCAN;ITGA3;CTNNA1;EGFR,800081
11,p53 Pathway,0.009417494104758,APP;HDAC3;PLK2;S100A10;IER3,800081
12,UV Response Dn,0.0154973903719996,TJP1;NRP1;ID1;MET,800081
13,Fatty Acid Metabolism,0.0198579902174613,ELOVL5;PCBD1;MIF;S100A10,800081
14,Pperoxisome,0.0347827327998073,SEMA3C;ELOVL5;PRDX1,800081
0,Epithelial Mesenchymal Transition,1.9612612598893845e-06,NOTCH2;TNFRSF12A;SDC4;SERPINE1;VIM;LAMC1;FSTL1;FERMT2;LOXL2;CAP2,800085
1,UV Response Dn,9.80301679473456e-06,NOTCH2;TJP1;ANXA2;DUSP1;CAV1;SERPINE1;LAMC1;CAP2,800085
2,Hypoxia,5.708660378499564e-05,EXT1;ERRFI1;ANXA2;SDC4;DUSP1;CAV1;SERPINE1;EGFR,800085
3,Apical Junction,5.708660378499564e-05,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,800085
4,Angiogenesis,0.0001900136354816061,APP;FSTL1;PTK2;FGFR1,800085
5,Apoptosis,0.0066790413068272,APP;TNFRSF12A;CAV1;TIMP2;PTK2,800085
6,TGF-beta Signaling,0.0110740627676605,TJP1;SMURF2;SERPINE1,800085
7,Mitotic Spindle,0.0126069305797913,NOTCH2;MARCKS;ARHGAP29;CDC42EP1;RHOF,800085
8,Cholesterol Homeostasis,0.0209471886992107,ERRFI1;TNFRSF12A;GPX8,800085
9,Protein Secretion,0.0384050951563153,SCRN1;CAV2;EGFR,800085
10,TNF-alpha Signaling via NF-kB,0.043097922003412,MARCKS;SDC4;DUSP1;SERPINE1,800085
11,Xenobiotic Metabolism,0.043097922003412,CYB5A;CBR1;SERPINE1;PAPSS2,800085
12,p53 Pathway,0.043097922003412,VAMP8;APP;PTPN14;S100A10,800085
0,UV Response Dn,0.0345411619588494,ITGB3;PMP22;LPAR1;MT1E;IGF1R,800522
1,mTORC1 Signaling,0.0487493812481595,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,800522
2,Epithelial Mesenchymal Transition,0.0487493812481595,ITGB3;ADAM12;PMP22;SPP1;VEGFC,800522
0,Epithelial Mesenchymal Transition,2.536145807136327e-05,NT5E;VCAN;SPARC;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;CD44,800525
1,Glycolysis,0.00012890523435321594,EXT1;NT5E;VCAN;MIF;PAM;MET;CD44;IER3,800525
2,Hypoxia,0.000766562739964282,EXT1;SDC4;PRKCA;MIF;ETS1;PAM;IER3,800525
3,TNF-alpha Signaling via NF-kB,0.0044365109909071,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,800525
4,UV Response Dn,0.0054951848570896,NRP1;ATP2B4;SNAI2;PRKCA;MET,800525
5,Estrogen Response Late,0.0166191072436907,ELOVL5;ATP2B4;CD9;JAK2;CD44,800525
6,KRAS Signaling Up,0.0166191072436907,NRP1;GALNT3;PLAU;SPRY2;ETS1,800525
7,Cholesterol Homeostasis,0.02660630822682,ALCAM;TNFRSF12A;CD9,800525
8,IL-6/JAK/STAT3 Signaling,0.0369099125569286,TNFRSF12A;CD9;CD44,800525
9,Hedgehog Signaling,0.0444210939342531,NRP1;NRP2,800525
10,Angiogenesis,0.0444210939342531,NRP1;VCAN,800525
11,IL-2/STAT5 Signaling,0.0451833053261577,NRP1;NT5E;ALCAM;CD44,800525
12,Estrogen Response Early,0.0451833053261577,ELOVL5;ENDOD1;JAK2;CD44,800525
13,p53 Pathway,0.0451833053261577,HDAC3;PLK2;STOM;IER3,800525
0,Epithelial Mesenchymal Transition,0.0024968043530265,ITGB5;ITGB3;ADAM12;SPP1;FN1;TGFBI;EMP3,800773
1,Hypoxia,0.0096335667231127,CDKN1C;SRPX;DTNA;TGFBI;AMPD3;MT1E,800773
0,UV Response Dn,2.403320246451053e-05,INPP4B;RBPMS;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,800812
1,Hypoxia,0.0008322681176755062,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1;EGFR,800812
2,Epithelial Mesenchymal Transition,0.0008322681176755062,NT5E;TNFRSF12A;SERPINE1;COL12A1;SNAI2;CD44;LOXL2,800812
3,Glycolysis,0.0048167833615563,EXT1;NT5E;MIF;VLDLR;EGFR;CD44,800812
4,Hedgehog Signaling,0.0058381454553595,NRP2;CDK6;VLDLR,800812
5,Androgen Response,0.0101203992959167,INPP4B;CDK6;ELOVL5;HMGCR,800812
6,Estrogen Response Early,0.014033912783561,FARP1;ELOVL5;ENDOD1;JAK2;CD44,800812
7,Estrogen Response Late,0.014033912783561,FARP1;ELOVL5;ATP2B4;JAK2;CD44,800812
8,Apical Junction,0.014033912783561,PTEN;RAC2;EGFR;ACTB;PTK2,800812
9,Apoptosis,0.0331470041383447,TNFRSF12A;BAX;PTK2;CD44,800812
10,Complement,0.0490561600683998,GCA;ERAP2;SERPINE1;JAK2,800812
11,mTORC1 Signaling,0.0490561600683998,ELOVL5;PLK1;VLDLR;HMGCR,800812
12,Xenobiotic Metabolism,0.0490561600683998,GSTM4;ELOVL5;SERPINE1;MAN1A1,800812
13,KRAS Signaling Up,0.0490561600683998,GALNT3;PLAU;SPRY2;ETS1,800812
0,Epithelial Mesenchymal Transition,0.00013995425444063446,NT5E;VCAN;TNFRSF12A;COL4A1;COL12A1;SNAI2;CD44;LOXL2,800841
1,Glycolysis,0.00013995425444063446,EXT1;NT5E;VCAN;CDK1;MIF;VLDLR;EGFR;CD44,800841
2,UV Response Dn,0.0010868371475569,INPP4B;DLC1;ATP2B4;PTEN;SNAI2;VLDLR,800841
3,Estrogen Response Early,0.0048167833615563,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,800841
4,Hedgehog Signaling,0.0058381454553595,NRP2;CDK6;VLDLR,800841
5,Androgen Response,0.0101203992959167,INPP4B;CDK6;ELOVL5;HMGCR,800841
6,PI3K/AKT/mTOR  Signaling,0.0103759165695472,CDK1;PTEN;PLCB1;EGFR,800841
7,Hypoxia,0.0126305215052049,EXT1;MIF;VLDLR;ETS1;EGFR,800841
8,Estrogen Response Late,0.0126305215052049,FARP1;ELOVL5;ATP2B4;JAK2;CD44,800841
9,Apical Junction,0.0126305215052049,VCAN;PTEN;RAC2;EGFR;ACTB,800841
0,IL-2/STAT5 Signaling,0.0465335002823341,PLAGL1;SPP1;PLIN2;AHR;IGF1R,800851
1,Complement,0.0465335002823341,DOCK10;CEBPB;ERAP2;FDX1;PSMB9,800851
2,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,800851
0,Angiogenesis,3.390099228829277e-05,APP;NRP1;VCAN;ITGAV;PTK2,800858
1,Apical Junction,0.0007884645325346902,TJP1;VCAN;ITGA3;CTNNA1;RHOF;EGFR;PTK2,800858
2,Epithelial Mesenchymal Transition,0.0007884645325346902,GJA1;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;ITGAV,800858
3,Cholesterol Homeostasis,0.0046592619480261,ALCAM;TNFRSF12A;MAL2;CD9,800858
4,p53 Pathway,0.0239315144309146,VAMP8;APP;HDAC3;PLK2;PTPN14,800858
5,UV Response Dn,0.0355528367357638,TJP1;NRP1;GJA1;ID1,800858
6,Apoptosis,0.0448606071045266,APP;GPX1;TNFRSF12A;PTK2,800858
0,Epithelial Mesenchymal Transition,3.043374968563592e-05,GLIPR1;ITGB5;BDNF;ITGB3;DPYSL3;PMP22;SPP1;VEGFC;EDIL3,800888
1,UV Response Dn,0.0001666123581909955,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,800888
2,IL-2/STAT5 Signaling,0.006913060482826,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,800888
3,TNF-alpha Signaling via NF-kB,0.023266750141167,CEBPB;BHLHE40;SGK1;FJX1;LITAF,800888
4,Hypoxia,0.023266750141167,SRPX;BHLHE40;GCNT2;PLIN2;MT1E,800888
5,Complement,0.023266750141167,DOCK10;LYN;CEBPB;CTSL;PSMB9,800888
0,UV Response Dn,1.675926765118113e-06,INPP4B;RBPMS;DLC1;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,801011
1,Hypoxia,0.0008322681176755062,EXT1;SERPINE1;PRKCA;MIF;VLDLR;ETS1;EGFR,801011
2,Epithelial Mesenchymal Transition,0.0008322681176755062,NT5E;TNFRSF12A;SERPINE1;COL12A1;SNAI2;CD44;LOXL2,801011
3,Estrogen Response Early,0.003853426689245,FARP1;ELOVL5;DLC1;ENDOD1;JAK2;CD44,801011
4,Glycolysis,0.003853426689245,EXT1;NT5E;MIF;VLDLR;EGFR;CD44,801011
5,Hedgehog Signaling,0.0048651212127996,NRP2;CDK6;VLDLR,801011
6,Androgen Response,0.0086746279679286,INPP4B;CDK6;ELOVL5;HMGCR,801011
7,Estrogen Response Late,0.014033912783561,FARP1;ELOVL5;ATP2B4;JAK2;CD44,801011
8,Apical Junction,0.014033912783561,PTEN;RAC2;EGFR;ACTB;PTK2,801011
9,Apoptosis,0.0331470041383447,TNFRSF12A;BAX;PTK2;CD44,801011
10,Complement,0.0490561600683998,GCA;ERAP2;SERPINE1;JAK2,801011
11,mTORC1 Signaling,0.0490561600683998,ELOVL5;PLK1;VLDLR;HMGCR,801011
12,Xenobiotic Metabolism,0.0490561600683998,GSTM4;ELOVL5;SERPINE1;MAN1A1,801011
13,KRAS Signaling Up,0.0490561600683998,GALNT3;PLAU;SPRY2;ETS1,801011
0,Hypoxia,0.000302006549056106,SRPX;TES;DTNA;GCNT2;TGFBI;AMPD3;NR3C1;MT1E,801012
1,Epithelial Mesenchymal Transition,0.00134696024308,ITGB5;ITGB3;PMP22;SPP1;FN1;TGFBI;EDIL3,801012
2,UV Response Dn,0.0107286942447941,ITGB3;PMP22;NR3C1;MT1E;IGF1R,801012
3,Interferon Alpha Response,0.0146387547929121,LGALS3BP;TXNIP;PSMB8;PSMB9,801012
4,Estrogen Response Early,0.0227127798997107,DYNLT3;RHOBTB3;FLNB;MICB;IGF1R,801012
5,mTORC1 Signaling,0.0227127798997107,TES;PLK1;BCAT1;AURKA;HSP90B1,801012
0,UV Response Dn,0.0243746906240797,ITGB3;PMP22;LPAR1;MT1E;IGF1R,801089
1,TNF-alpha Signaling via NF-kB,0.0243746906240797,CEBPB;IRS2;SGK1;FJX1;LITAF,801089
2,Hypoxia,0.0243746906240797,SRPX;GCNT2;IRS2;PLIN2;MT1E,801089
3,Complement,0.0243746906240797,DOCK10;LYN;CEBPB;ERAP2;PSMB9,801089
4,mTORC1 Signaling,0.0243746906240797,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,801089
5,Epithelial Mesenchymal Transition,0.0243746906240797,ITGB3;ADAM12;PMP22;SPP1;VEGFC,801089
6,Cholesterol Homeostasis,0.038226206105472,FDPS;FABP5;HMGCR,801089
0,UV Response Dn,0.0298310035099154,SDC2;DLC1;ITGB3;ATP2B4;VLDLR,801661
1,TGF-beta Signaling,0.0315763037630124,CDKN1C;CDK9;ID3,801661
2,E2F Targets,0.0315763037630124,DNMT1;PLK1;CDK1;TP53;AURKB,801661
3,Epithelial Mesenchymal Transition,0.0315763037630124,VCAN;SPARC;COL4A1;ITGB3;SPP1,801661
0,Epithelial Mesenchymal Transition,1.682528284715285e-07,NOTCH2;NT5E;TNFRSF12A;SDC4;SERPINE1;COL12A1;VIM;LAMC1;FSTL1;CD44;LOXL2,802820
1,Hypoxia,1.0755303683264367e-06,EXT1;MT2A;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,802820
2,UV Response Dn,8.991778061101345e-05,NOTCH2;TJP1;ANXA2;CAV1;SERPINE1;PRKCA;LAMC1,802820
3,Apical Junction,0.0005584957105454055,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,802820
4,Apoptosis,0.0010766631834096,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,802820
5,TNF-alpha Signaling via NF-kB,0.0028731690226827,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,802820
6,Angiogenesis,0.0037311455917711,APP;FSTL1;PTK2,802820
7,IL-6/JAK/STAT3 Signaling,0.0040505779563667,TNFRSF12A;CD9;OSMR;CD44,802820
10,Glycolysis,0.0102736299324633,EXT1;NT5E;MIF;EGFR;CD44,802820
8,Mitotic Spindle,0.0102736299324633,NOTCH2;FARP1;MYO1E;ARHGAP29;CDC42EP1,802820
9,Estrogen Response Late,0.0102736299324633,FARP1;ELOVL5;CAV1;CD9;CD44,802820
11,Notch Signaling,0.0315478126796371,NOTCH2;PRKCA,802820
15,p53 Pathway,0.0361466442609262,VAMP8;APP;PLK2;PTPN14,802820
12,Estrogen Response Early,0.0361466442609262,FARP1;ELOVL5;ENDOD1;CD44,802820
13,Complement,0.0361466442609262,GCA;SERPINE1;GNB4;TIMP2,802820
14,Inflammatory Response,0.0361466442609262,AXL;SERPINE1;SGMS2;OSMR,802820
16,KRAS Signaling Up,0.0361466442609262,PLAU;SPRY2;PLEK2;ETS1,802820
0,UV Response Dn,0.0292496287488957,BDNF;ITGB3;PMP22;MT1E;IGF1R,802821
1,IL-2/STAT5 Signaling,0.0292496287488957,PLAGL1;SPP1;PLIN2;AHR;IGF1R,802821
2,Hypoxia,0.0292496287488957,SRPX;DTNA;GCNT2;PLIN2;MT1E,802821
3,Complement,0.0292496287488957,DOCK10;LYN;CEBPB;ERAP2;PSMB9,802821
4,mTORC1 Signaling,0.0292496287488957,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,802821
5,Cholesterol Homeostasis,0.0445972404563841,FDPS;FABP5;HMGCR,802821
0,Hypoxia,0.0026939204861601,SRPX;TES;IRS2;PLIN2;TGFBI;AMPD3;MT1E,803248
1,mTORC1 Signaling,0.010394111464411,TES;PLK1;HMGCR;BCAT1;AURKA;HSP90B1,803248
2,Interferon Alpha Response,0.0195183397238828,LGALS3BP;TXNIP;PSMB8;PSMB9,803248
3,Complement,0.034069169849566,DOCK10;LYN;CEBPB;ERAP2;PSMB9,803248
0,PI3K/AKT/mTOR  Signaling,0.0454255597994214,CDK1;PTEN;PLCB1;HSP90B1,803409
1,Estrogen Response Early,0.0454255597994214,TFAP2C;DLC1;JAK2;MICB;IGF1R,803409
2,E2F Targets,0.0454255597994214,DNMT1;PLK1;CDK1;TP53;AURKA,803409
3,UV Response Dn,0.0498678234194113,DLC1;ITGB3;PTEN;IGF1R,803409
4,Cholesterol Homeostasis,0.0498678234194113,GSTM2;FABP5;HMGCR,803409
0,Apical Junction,0.00025044445531481954,TJP1;RRAS;ITGA3;CTNNA1;FLNC;RHOF;EGFR;PTK2,803410
1,Apoptosis,0.0002792962773493668,APP;GPX1;KRT18;TNFRSF12A;CAV1;TIMP2;PTK2,803410
2,p53 Pathway,0.0053381795754585,VAMP8;APP;PLK2;PTPN14;EPHA2;S100A10,803410
3,Angiogenesis,0.0053381795754585,APP;FSTL1;PTK2,803410
4,UV Response Dn,0.0053381795754585,TJP1;ANXA2;CAV1;ID1;LAMC1,803410
5,Protein Secretion,0.0077888041183192,KRT18;SCRN1;CAV2;EGFR,803410
6,Hypoxia,0.0141262411571371,EXT1;ANXA2;SDC4;CAV1;EGFR,803410
7,Epithelial Mesenchymal Transition,0.0141262411571371,TNFRSF12A;SDC4;VIM;LAMC1;FSTL1,803410
8,Cholesterol Homeostasis,0.0229743359926827,TNFRSF12A;GPX8;CD9,803410
9,IL-6/JAK/STAT3 Signaling,0.0322698092640576,TNFRSF12A;CD9;OSMR,803410
0,Epithelial Mesenchymal Transition,0.00012890523435321594,VCAN;TNFRSF12A;SDC4;DST;COL12A1;ITGAV;CD44;CAP2,803789
1,Glycolysis,0.00012890523435321594,VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,803789
2,Angiogenesis,0.0003575525398847427,APP;NRP1;VCAN;ITGAV,803789
3,Protein Secretion,0.0010541720789291,SCRN1;DST;CAV2;PAM;EGFR,803789
4,TNF-alpha Signaling via NF-kB,0.0022649190025126,TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,803789
5,Hypoxia,0.0022649190025126,SDC4;MIF;ETS1;PAM;EGFR;IER3,803789
6,Apical Junction,0.0022649190025126,TJP1;VCAN;RRAS;ITGA3;CTNNA1;EGFR,803789
7,Cholesterol Homeostasis,0.0022649190025126,ALCAM;TNFRSF12A;MAL2;CD9,803789
8,UV Response Dn,0.0030528804761609,TJP1;NRP1;ID1;MET;CAP2,803789
9,IL-6/JAK/STAT3 Signaling,0.0033357700817137,TNFRSF12A;CD9;CD44;IL13RA1,803789
10,Apoptosis,0.0041131925936472,APP;GPX1;TNFRSF12A;CD44;IER3,803789
11,IL-2/STAT5 Signaling,0.008948750054295,NRP1;ALCAM;AHNAK;ITGAV;CD44,803789
12,p53 Pathway,0.008948750054295,VAMP8;APP;PLK2;S100A10;IER3,803789
13,Fatty Acid Metabolism,0.0204420487532689,ELOVL5;PCBD1;MIF;S100A10,803789
14,Pperoxisome,0.0358057543527429,SEMA3C;ELOVL5;PRDX1,803789
15,Estrogen Response Late,0.039535392160388,ELOVL5;CD9;LSR;CD44,803789
16,Apical Surface,0.0420607020678256,APP;ATP8B1,803789
0,UV Response Dn,2.846037133955195e-05,INPP4B;BDNF;DLC1;ITGB3;BHLHE40;PMP22;LPAR1;MT1E,804518
1,Androgen Response,0.0032866562832367,INPP4B;CDK6;ADAMTS1;HMGCR;ELL2,804518
2,Hedgehog Signaling,0.011522655503999,ADGRG1;CDK6;DPYSL2,804518
3,Epithelial Mesenchymal Transition,0.0373929912983042,GLIPR1;BDNF;ITGB3;PMP22;VEGFC,804518
0,Hypoxia,7.735573773153362e-05,EXT1;SERPINE1;PRKCA;MIF;VLDLR;KDELR3;ETS1;TMEM45A,804521
1,Epithelial Mesenchymal Transition,7.735573773153362e-05,NT5E;TNFRSF12A;COL4A1;COL12A1;SERPINE1;SNAI2;PLOD2;LOXL2,804521
2,Glycolysis,7.735573773153362e-05,EXT1;TPST1;NT5E;CDK1;PLOD2;MIF;VLDLR;KDELR3,804521
3,UV Response Dn,7.735573773153362e-05,NRP1;SERPINE1;ATP2B4;PTEN;SNAI2;PRKCA;VLDLR,804521
4,Hedgehog Signaling,0.0002390494123800851,NRP1;NRP2;CDK6;VLDLR,804521
5,Estrogen Response Early,0.0185184337858268,FARP1;ELOVL5;ENDOD1;JAK2;MYBL1,804521
6,mTORC1 Signaling,0.0185184337858268,ELOVL5;PLK1;PLOD2;VLDLR;HMGCR,804521
0,Apical Junction,0.0078589623267498,TJP1;RRAS;CTNNA1;RHOF;EGFR;PTK2,804861
1,p53 Pathway,0.0078589623267498,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,804861
2,Angiogenesis,0.0079378293471993,APP;FSTL1;PTK2,804861
3,UV Response Dn,0.0459224141170283,TJP1;ANXA2;ID1;LAMC1,804861
0,Epithelial Mesenchymal Transition,8.297758407769535e-10,BDNF;ITGB3;TFPI2;PLOD3;VEGFC;FGF2;GLIPR1;CALD1;DPYSL3;ADAM12;PMP22;SPOCK1;EDIL3,804962
1,UV Response Dn,0.0001467775536444484,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;PLPP3;MT1E,804962
2,TNF-alpha Signaling via NF-kB,0.0046900259046732,CSF1;BHLHE40;PLPP3;SGK1;FJX1;LITAF,804962
3,Myogenesis,0.0046900259046732,WWTR1;FDPS;PRNP;BHLHE40;ADAM12;FGF2,804962
4,Coagulation,0.0377632429796991,PROS1;ITGB3;TFPI2;PRSS23,804962
0,Hypoxia,1.107163614453685e-06,EXT1;MT2A;SDC4;CAV1;PRKCA;MIF;ETS1;PAM;EGFR;IER3,805500
1,Glycolysis,1.107163614453685e-06,EXT1;NT5E;VCAN;MIF;PAM;MET;EGFR;CD44;IER3;IL13RA1,805500
2,Epithelial Mesenchymal Transition,8.45381935712109e-06,NT5E;VCAN;LGALS1;TNFRSF12A;SDC4;COL12A1;SNAI2;VIM;CD44,805500
3,UV Response Dn,6.94218159129148e-05,NRP1;CAV1;AKT3;ATP2B4;SNAI2;PRKCA;MET,805500
4,Apoptosis,0.00011500434949679808,APP;GPX1;TNFRSF12A;CAV1;TIMP2;CD44;IER3,805500
5,TNF-alpha Signaling via NF-kB,0.0025351491376612,FOSL1;SDC4;PLAU;PLK2;CD44;IER3,805500
6,Apical Junction,0.0025351491376612,VCAN;ITGA3;AKT3;CTNNA1;EGFR;ACTB,805500
7,Angiogenesis,0.0033607745219997,APP;NRP1;VCAN,805500
8,IL-6/JAK/STAT3 Signaling,0.0037064112019041,TNFRSF12A;CD9;CD44;IL13RA1,805500
9,Protein Secretion,0.0048107319554325,SCRN1;CAV2;PAM;EGFR,805500
10,IL-2/STAT5 Signaling,0.008948750054295,MYO1E;NRP1;NT5E;ALCAM;CD44,805500
11,Estrogen Response Late,0.008948750054295,ELOVL5;CAV1;ATP2B4;CD9;CD44,805500
12,KRAS Signaling Up,0.008948750054295,NRP1;GALNT3;PLAU;SPRY2;ETS1,805500
13,Cholesterol Homeostasis,0.01520360470104,ALCAM;TNFRSF12A;CD9,805500
0,Epithelial Mesenchymal Transition,1.3629017277572033e-08,GLIPR1;ITGB5;BDNF;ITGB3;TFPI2;DPYSL3;ADAM12;PMP22;FAS;PLOD3;VEGFC;EDIL3,805746
1,UV Response Dn,0.00015471147546306725,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,805746
2,TNF-alpha Signaling via NF-kB,0.0008541699102459143,CEBPB;CSF1;BHLHE40;IRS2;SGK1;FJX1;LITAF,805746
3,Myogenesis,0.0049435408184394,WWTR1;FDPS;PRNP;ITGB5;BHLHE40;ADAM12,805746
4,IL-2/STAT5 Signaling,0.0162036295625984,PRNP;CSF1;BHLHE40;WLS;IGF1R,805746
5,Hypoxia,0.0162036295625984,SRPX;BHLHE40;GCNT2;IRS2;MT1E,805746
6,Estrogen Response Early,0.0162036295625984,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,805746
7,Complement,0.0162036295625984,DOCK10;LYN;CEBPB;TFPI2;PSMB9,805746
8,Coagulation,0.0221136107538778,PROS1;ITGB3;TFPI2;PRSS23,805746
9,IL-6/JAK/STAT3 Signaling,0.0370153694499484,CSF1;ITGB3;FAS,805746
10,Interferon Alpha Response,0.0449207129555073,CSF1;PSMB8;PSMB9,805746
11,Androgen Response,0.0449207129555073,ADAMTS1;SGK1;ELL2,805746
12,Inflammatory Response,0.046990637539204,LYN;CSF1;ITGB3;LPAR1,805746
13,Xenobiotic Metabolism,0.046990637539204,TGFB2;PROS1;GCNT2;FAS,805746
14,Allograft Rejection,0.046990637539204,LYN;TGFB2;CSF1;FAS,805746
15,Apical Surface,0.0497968669124436,LYN;SRPX,805746
0,Hedgehog Signaling,0.0010726576196542,NRP2;CDK6;DPYSL2;VLDLR,806387
1,Androgen Response,0.0025562882202952,INPP4B;CDK6;ELOVL5;HMGCR;B2M,806387
2,UV Response Dn,0.0091586414284828,INPP4B;DLC1;ATP2B4;PTEN;VLDLR,806387
3,p53 Pathway,0.0290834376764588,HDAC3;BAX;STOM;TXNIP;TP53,806387
0,Epithelial Mesenchymal Transition,2.4041267056708588e-06,NT5E;VCAN;SPARC;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;ITGAV;CD44,806388
1,Angiogenesis,0.0005822998506694381,APP;NRP1;VCAN;ITGAV,806388
2,TNF-alpha Signaling via NF-kB,0.0008322681176755062,FOSL1;TUBB2A;SDC4;PLAU;PLK2;CD44;IER3,806388
3,Glycolysis,0.0032787398893517,NT5E;VCAN;CDK1;MIF;CD44;IER3,806388
4,KRAS Signaling Up,0.0032787398893517,NRP1;GALNT3;PLAU;SPRY2;ETS1;DUSP6,806388
5,Cholesterol Homeostasis,0.0032787398893517,ALCAM;TNFRSF12A;MAL2;CD9,806388
6,IL-2/STAT5 Signaling,0.0157881518815062,NRP1;NT5E;ALCAM;ITGAV;CD44,806388
7,Estrogen Response Late,0.0157881518815062,ELOVL5;ATP2B4;CD9;JAK2;CD44,806388
8,Coagulation,0.021546595093522,SPARC;PLAU;CD9;DUSP6,806388
9,Apoptosis,0.032787506738882,APP;TNFRSF12A;CD44;IER3,806388
10,IL-6/JAK/STAT3 Signaling,0.032787506738882,TNFRSF12A;CD9;CD44,806388
11,Hedgehog Signaling,0.0442095649155186,NRP1;NRP2,806388
12,Hypoxia,0.0490561600683998,SDC4;MIF;ETS1;IER3,806388
13,Estrogen Response Early,0.0490561600683998,ELOVL5;ENDOD1;JAK2;CD44,806388
0,Epithelial Mesenchymal Transition,2.753529733462298e-05,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;SNAI2;VIM;CD44,807047
1,Glycolysis,0.0012484021765132,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,807047
2,Hypoxia,0.0049181098340275,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR,807047
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;CD9;HMGCR,807047
4,Angiogenesis,0.0058381454553595,APP;NRP1;VCAN,807047
5,TNF-alpha Signaling via NF-kB,0.0180436021502928,FOSL1;SDC4;PLAU;PLK2;CD44,807047
6,Estrogen Response Late,0.0180436021502928,ELOVL5;ATP2B4;CD9;JAK2;CD44,807047
7,UV Response Dn,0.0281459957491463,NRP1;ATP2B4;SNAI2;PRKCA,807047
8,IL-6/JAK/STAT3 Signaling,0.0400736193475225,TNFRSF12A;CD9;CD44,807047
9,Hedgehog Signaling,0.0403991906445645,NRP1;NRP2,807047
10,Mitotic Spindle,0.0403991906445645,PLK1;CDK1;ARHGAP29;CDC42EP1,807047
11,IL-2/STAT5 Signaling,0.0403991906445645,NRP1;NT5E;ALCAM;CD44,807047
12,Estrogen Response Early,0.0403991906445645,ELOVL5;ENDOD1;JAK2;CD44,807047
13,Apical Junction,0.0403991906445645,VCAN;ITGA3;EGFR;ACTB,807047
14,mTORC1 Signaling,0.0403991906445645,ELOVL5;PLK1;CD9;HMGCR,807047
15,p53 Pathway,0.0403991906445645,VAMP8;APP;HDAC3;PLK2,807047
16,KRAS Signaling Up,0.0403991906445645,NRP1;PLAU;SPRY2;ETS1,807047
0,TNF-alpha Signaling via NF-kB,0.0357310805739351,CEBPB;IRS2;SGK1;FJX1;LITAF,808507
1,Hypoxia,0.0357310805739351,SRPX;IRS2;PLIN2;AMPD3;MT1E,808507
2,Complement,0.0357310805739351,DOCK10;LYN;CEBPB;ERAP2;PSMB9,808507
3,mTORC1 Signaling,0.0357310805739351,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,808507
0,Epithelial Mesenchymal Transition,2.681068424686974e-05,GJA1;VCAN;SPARC;COL4A1;COL12A1;SPP1;SNAI2;ITGAV;THBS1,808790
1,Angiogenesis,0.0005669761703886634,NRP1;VCAN;SPP1;ITGAV,808790
2,UV Response Dn,0.0010582361699896,NRP1;GJA1;CITED2;SDC2;ATP2B4;SNAI2,808790
3,Coagulation,0.0450026699150785,SPARC;PLAU;THBS1;DUSP6,808790
4,Cholesterol Homeostasis,0.0450026699150785,ALCAM;MAL2;HMGCR,808790
0,Epithelial Mesenchymal Transition,0.00027990850888126893,NT5E;VCAN;TNFRSF12A;SDC4;COL4A1;COL12A1;VIM;CD44,808792
1,Glycolysis,0.0012484021765132,EXT1;NT5E;VCAN;CDK1;MIF;EGFR;CD44,808792
2,Hypoxia,0.0049181098340275,EXT1;SDC4;PRKCA;MIF;ETS1;EGFR,808792
3,Cholesterol Homeostasis,0.0049181098340275,ALCAM;TNFRSF12A;CD9;HMGCR,808792
4,Angiogenesis,0.0058381454553595,APP;NRP1;VCAN,808792
5,TNF-alpha Signaling via NF-kB,0.0180436021502928,FOSL1;SDC4;PLAU;PLK2;CD44,808792
6,p53 Pathway,0.0180436021502928,VAMP8;APP;HDAC3;PLK2;PTPN14,808792
7,IL-6/JAK/STAT3 Signaling,0.0450828217659628,TNFRSF12A;CD9;CD44,808792
8,Hedgehog Signaling,0.0457857493971732,NRP1;NRP2,808792
9,Mitotic Spindle,0.0457857493971732,PLK1;CDK1;ARHGAP29;CDC42EP1,808792
10,IL-2/STAT5 Signaling,0.0457857493971732,NRP1;NT5E;ALCAM;CD44,808792
11,Estrogen Response Late,0.0457857493971732,ELOVL5;ATP2B4;CD9;CD44,808792
12,Apical Junction,0.0457857493971732,VCAN;ITGA3;EGFR;ACTB,808792
13,mTORC1 Signaling,0.0457857493971732,ELOVL5;PLK1;CD9;HMGCR,808792
14,KRAS Signaling Up,0.0457857493971732,NRP1;PLAU;SPRY2;ETS1,808792
0,Complement,0.0027596258638714,DOCK10;LYN;CEBPB;PIK3CA;ERAP2;JAK2;PSMB9,809693
1,PI3K/AKT/mTOR  Signaling,0.0401384140979853,CDK1;THEM4;PLCB1;HSP90B1,809693
2,Epithelial Mesenchymal Transition,0.0465335002823341,ITGB3;ADAM12;PMP22;SPP1;VEGFC,809693
0,Epithelial Mesenchymal Transition,0.00028727452227288126,VCAN;SPARC;COL4A1;COL12A1;TNC;SNAI2;ITGAV;CD44,810341
1,KRAS Signaling Up,0.0012812548653688,NRP1;GALNT3;GABRA3;SPRY2;ETS1;TRIB2;DUSP6,810341
2,Hedgehog Signaling,0.0074897260775993,NRP1;NRP2;CDK6,810341
3,Angiogenesis,0.0074897260775993,NRP1;VCAN;ITGAV,810341
4,Androgen Response,0.0124640707118132,CDK6;ELOVL5;ITGAV;HMGCR,810341
0,Interferon Alpha Response,0.0051875273497606,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,810717
1,Hypoxia,0.0069294076429407,SRPX;TES;PLIN2;TGFBI;AMPD3;MT1E,810717
2,Epithelial Mesenchymal Transition,0.0069294076429407,ITGB5;ITGB3;PMP22;SPP1;TGFBI;EDIL3,810717
3,IL-2/STAT5 Signaling,0.0194680970568948,IFITM3;SPP1;PLIN2;AHR;IGF1R,810717
4,Interferon Gamma Response,0.0194680970568948,IFITM3;LGALS3BP;TXNIP;PSMB8;PSMB9,810717
5,Complement,0.0194680970568948,DOCK10;CEBPB;CTSL;FDX1;PSMB9,810717
6,mTORC1 Signaling,0.0194680970568948,TES;PLK1;BCAT1;AURKA;HSP90B1,810717
7,UV Response Dn,0.0303680480451316,ITGB3;PMP22;MT1E;IGF1R,810717
0,Epithelial Mesenchymal Transition,2.151060736652873e-06,NT5E;TNFRSF12A;SDC4;COL12A1;SERPINE1;VIM;LAMC1;FSTL1;CD44;LOXL2,811429
1,Hypoxia,1.2318422491805016e-05,EXT1;ANXA2;SDC4;CAV1;SERPINE1;PRKCA;MIF;ETS1;EGFR,811429
2,UV Response Dn,8.991778061101345e-05,TJP1;NRP1;ANXA2;CAV1;SERPINE1;PRKCA;LAMC1,811429
3,Angiogenesis,0.00026050256477316966,APP;NRP1;FSTL1;PTK2,811429
4,Apical Junction,0.0004467965684363244,TJP1;RRAS;ITGA3;FLNC;EGFR;ACTB;PTK2,811429
5,Apoptosis,0.0008972193195080209,APP;TNFRSF12A;CAV1;TIMP2;PTK2;CD44,811429
6,TNF-alpha Signaling via NF-kB,0.0024627163051566,FOSL1;SDC4;PLAU;PLK2;SERPINE1;CD44,811429
7,Estrogen Response Late,0.0113009929257097,FARP1;ELOVL5;CAV1;CD9;CD44,811429
8,Glycolysis,0.0113009929257097,EXT1;NT5E;MIF;EGFR;CD44,811429
9,p53 Pathway,0.0113009929257097,VAMP8;APP;PLK2;PTPN14;EPHA2,811429
10,Cholesterol Homeostasis,0.0187971839940131,TNFRSF12A;MAL2;CD9,811429
11,IL-6/JAK/STAT3 Signaling,0.026891507720048,TNFRSF12A;CD9;CD44,811429
12,Estrogen Response Early,0.0409661968290497,FARP1;ELOVL5;ENDOD1;CD44,811429
13,Xenobiotic Metabolism,0.0409661968290497,ELOVL5;SERPINE1;MAN1A1;EPHA2,811429
14,KRAS Signaling Up,0.0409661968290497,NRP1;PLAU;PLEK2;ETS1,811429
15,Apical Surface,0.04341265320572,APP;ATP8B1,811429
0,Apical Junction,0.0020368667090479,TJP1;RRAS;CTNNA1;FLNC;RHOF;EGFR;PTK2,812926
1,p53 Pathway,0.0078589623267498,VAMP8;APP;SFN;PTPN14;EPHA2;S100A10,812926
2,Angiogenesis,0.0079378293471993,APP;FSTL1;PTK2,812926
3,Protein Secretion,0.0106523350441719,KRT18;SCRN1;CAV2;EGFR,812926
0,PI3K/AKT/mTOR  Signaling,0.0465335002823341,CDK1;PTEN;PLCB1;HSP90B1,812927
1,mTORC1 Signaling,0.0465335002823341,PLK1;HMGCR;BCAT1;AURKA;HSP90B1,812927
2,E2F Targets,0.0465335002823341,DNMT1;PLK1;CDK1;TP53;AURKA,812927
0,Epithelial Mesenchymal Transition,2.72045916694334e-06,GLIPR1;BDNF;ITGB3;TFPI2;DPYSL3;PMP22;FAS;PLOD3;VEGFC;EDIL3,813488
1,UV Response Dn,0.00017057931910030493,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,813488
2,TNF-alpha Signaling via NF-kB,0.0072674275279622,CEBPB;CSF1;BHLHE40;SGK1;FJX1;LITAF,813488
3,IL-2/STAT5 Signaling,0.0178655402869675,PRNP;CSF1;PLAGL1;BHLHE40;IGF1R,813488
4,Estrogen Response Early,0.0178655402869675,MLPH;BHLHE40;RHOBTB3;PRSS23;IGF1R,813488
5,Complement,0.0178655402869675,DOCK10;LYN;CEBPB;TFPI2;PSMB9,813488
6,Xenobiotic Metabolism,0.0178655402869675,TGFB2;PROS1;GCNT2;FAS;BCAT1,813488
7,Allograft Rejection,0.0178655402869675,LYN;TGFB2;CSF1;FAS;BCAT1,813488
8,Coagulation,0.0243816733953012,PROS1;ITGB3;TFPI2;PRSS23,813488
9,IL-6/JAK/STAT3 Signaling,0.0408118175986611,CSF1;ITGB3;FAS,813488
10,Interferon Alpha Response,0.0457148736241125,CSF1;PSMB8;PSMB9,813488
11,Androgen Response,0.0457148736241125,ADAMTS1;SGK1;ELL2,813488
12,Hypoxia,0.0457148736241125,SRPX;BHLHE40;GCNT2;MT1E,813488
13,Estrogen Response Late,0.0457148736241125,FABP5;TFPI2;SGK1;PRSS23,813488
14,Myogenesis,0.0457148736241125,WWTR1;FDPS;PRNP;BHLHE40,813488
15,mTORC1 Signaling,0.0457148736241125,BHLHE40;BCAT1;AURKA;HSP90B1,813488
16,Inflammatory Response,0.0457148736241125,LYN;CSF1;ITGB3;LPAR1,813488
17,Apical Surface,0.0488037670025088,LYN;SRPX,813488
0,Hypoxia,0.00011371954606686996,SRPX;TES;BHLHE40;GCNT2;PLIN2;TGFBI;AMPD3;MT1E,820919
1,Epithelial Mesenchymal Transition,0.00011371954606686996,ITGB5;BDNF;ITGB3;PMP22;SPP1;VEGFC;TGFBI;EDIL3,820919
2,UV Response Dn,0.00011371954606686996,BDNF;ITGB3;BHLHE40;PMP22;LPAR1;MT1E;IGF1R,820919
3,IL-2/STAT5 Signaling,0.0053082428707413,PRNP;BHLHE40;SPP1;PLIN2;AHR;IGF1R,820919
4,Interferon Alpha Response,0.012282272314053,LGALS3BP;TXNIP;PSMB8;PSMB9,820919
5,TNF-alpha Signaling via NF-kB,0.0178655402869675,CEBPB;BHLHE40;SGK1;FJX1;LITAF,820919
6,Complement,0.0178655402869675,DOCK10;LYN;CEBPB;CTSL;PSMB9,820919
7,mTORC1 Signaling,0.0178655402869675,TES;BHLHE40;BCAT1;AURKA;HSP90B1,820919
